  


<!DOCTYPE html>
<html>
  <head prefix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# githubog: http://ogp.me/ns/fb/githubog#">
    <meta charset='utf-8'>
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <title>openbel-framework-resources/knowledge/small_corpus.bel at master · OpenBEL/openbel-framework-resources</title>
    <link rel="search" type="application/opensearchdescription+xml" href="/opensearch.xml" title="GitHub" />
    <link rel="fluid-icon" href="https://github.com/fluidicon.png" title="GitHub" />
    <link rel="shortcut icon" href="/favicon.ico" type="image/x-icon" />
    <link rel="apple-touch-icon-precomposed" sizes="57x57" href="apple-touch-icon-114.png" />
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="apple-touch-icon-114.png" />
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="apple-touch-icon-144.png" />
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="apple-touch-icon-144.png" />

    
    

    <meta content="authenticity_token" name="csrf-param" />
<meta content="13TfZ2i57ug+8HhHcaUkxkAPZz4G8Ig71HWtY0/wlDA=" name="csrf-token" />

    <link href="https://a248.e.akamai.net/assets.github.com/assets/github-2ce7b3fab9fbd9a0d67ce5e4f38373b7c1abbc19.css" media="screen" rel="stylesheet" type="text/css" />
    <link href="https://a248.e.akamai.net/assets.github.com/assets/github2-f612489af1e1ee6e1cfb55a515bda8e19e3b510b.css" media="screen" rel="stylesheet" type="text/css" />
    
    


    <script src="https://a248.e.akamai.net/assets.github.com/assets/frameworks-cda884a5a58f7a231c16c075e16bc5c1509f192b.js" type="text/javascript"></script>
    
    <script defer="defer" src="https://a248.e.akamai.net/assets.github.com/assets/github-24e061385eeaff0ed974ca8bcf1dfc4fd96ab293.js" type="text/javascript"></script>
    
    

      <link rel='permalink' href='/OpenBEL/openbel-framework-resources/blob/00e6afd2fae5da40add133d5a59bc122f9d1d5ce/knowledge/small_corpus.bel'>
    <meta property="og:title" content="openbel-framework-resources"/>
    <meta property="og:type" content="githubog:gitrepository"/>
    <meta property="og:url" content="https://github.com/OpenBEL/openbel-framework-resources"/>
    <meta property="og:image" content="https://a248.e.akamai.net/assets.github.com/images/gravatars/gravatar-140.png?1329275960"/>
    <meta property="og:site_name" content="GitHub"/>
    <meta property="og:description" content="Resources for the OpenBEL Framework. Contribute to openbel-framework-resources development by creating an account on GitHub."/>

    <meta name="description" content="Resources for the OpenBEL Framework. Contribute to openbel-framework-resources development by creating an account on GitHub." />

  <link href="https://github.com/OpenBEL/openbel-framework-resources/commits/master.atom" rel="alternate" title="Recent Commits to openbel-framework-resources:master" type="application/atom+xml" />

  </head>


  <body class="logged_in page-blob linux vis-public env-production ">
    <div id="wrapper">

    
    
    

      <div id="header" class="true clearfix">
        <div class="container clearfix">
          <a class="site-logo" href="https://github.com/">
            <!--[if IE]>
            <img alt="GitHub" class="github-logo" src="https://a248.e.akamai.net/assets.github.com/images/modules/header/logov7.png?1323882778" />
            <img alt="GitHub" class="github-logo-hover" src="https://a248.e.akamai.net/assets.github.com/images/modules/header/logov7-hover.png?1324325424" />
            <![endif]-->
            <img alt="GitHub" class="github-logo-4x" height="30" src="https://a248.e.akamai.net/assets.github.com/images/modules/header/logov7@4x.png?1337118070" />
            <img alt="GitHub" class="github-logo-4x-hover" height="30" src="https://a248.e.akamai.net/assets.github.com/images/modules/header/logov7@4x-hover.png?1337118070" />
          </a>



              
    <div class="topsearch  ">
        <form accept-charset="UTF-8" action="/search" id="top_search_form" method="get">
  <a href="/search" class="advanced-search tooltipped downwards" title="Advanced Search"><span class="mini-icon mini-icon-advanced-search"></span></a>
  <div class="search placeholder-field js-placeholder-field">
    <input type="text" class="search my_repos_autocompleter" id="global-search-field" name="q" results="5" spellcheck="false" autocomplete="off" data-autocomplete="my-repos-autocomplete" placeholder="Search&hellip;" data-hotkey="s" />
    <div id="my-repos-autocomplete" class="autocomplete-results">
      <ul class="js-navigation-container"></ul>
    </div>
    <input type="submit" value="Search" class="button">
    <span class="mini-icon mini-icon-search-input"></span>
  </div>
  <input type="hidden" name="type" value="Everything" />
  <input type="hidden" name="repo" value="" />
  <input type="hidden" name="langOverride" value="" />
  <input type="hidden" name="start_value" value="1" />
</form>

      <ul class="top-nav">
          <li class="explore"><a href="https://github.com/explore">Explore</a></li>
          <li><a href="https://gist.github.com">Gist</a></li>
          <li><a href="/blog">Blog</a></li>
        <li><a href="http://help.github.com">Help</a></li>
      </ul>
    </div>


            


  <div id="userbox">
    <div id="user">
      <a href="https://github.com/jhourani"><img height="20" src="https://secure.gravatar.com/avatar/642da237bf623a5e4a7608363e3edf69?s=140&amp;d=https://a248.e.akamai.net/assets.github.com%2Fimages%2Fgravatars%2Fgravatar-140.png" width="20" /></a>
      <a href="https://github.com/jhourani" class="name">jhourani</a>
    </div>
    <ul id="user-links">
      <li>
        <a href="/new" id="new_repo" class="tooltipped downwards" title="Create a New Repo"><span class="mini-icon mini-icon-create"></span></a>
      </li>
      <li>
        <a href="/inbox/notifications" id="notifications" class="tooltipped downwards" title="Notifications">
          <span class="mini-icon mini-icon-notifications"></span>
        </a>
      </li>
      <li>
        <a href="/settings/profile" id="account_settings"
          class="tooltipped downwards"
          title="Account Settings ">
          <span class="mini-icon mini-icon-account-settings"></span>
        </a>
      </li>
      <li>
          <a href="/logout" data-method="post" id="logout" class="tooltipped downwards" title="Sign Out">
            <span class="mini-icon mini-icon-logout"></span>
          </a>
      </li>
    </ul>
  </div>



          
        </div>
      </div>

      

            <div class="site hfeed" itemscope itemtype="http://schema.org/WebPage">
      <div class="container hentry">
        <div class="pagehead repohead instapaper_ignore readability-menu">
        <div class="title-actions-bar">
          



              <ul class="pagehead-actions">



          <li class="js-toggler-container js-social-container watch-button-container on">
            <span class="watch-button"><a href="/OpenBEL/openbel-framework-resources/toggle_watch" class="minibutton btn-watch js-toggler-target lighter" data-remote="true" data-method="post" rel="nofollow">Watch</a><a class="social-count js-social-count" href="/OpenBEL/openbel-framework-resources/watchers">3</a></span>
            <span class="unwatch-button"><a href="/OpenBEL/openbel-framework-resources/toggle_watch" class="minibutton btn-unwatch js-toggler-target lighter" data-remote="true" data-method="post" rel="nofollow">Unwatch</a><a class="social-count js-social-count" href="/OpenBEL/openbel-framework-resources/watchers">3</a></span>
          </li>

              <li>
                <a href="/jhourani/openbel-framework-resources" class="minibutton btn-fork js-toggler-target lighter" rel="nofollow">Your Fork</a><a href="/OpenBEL/openbel-framework-resources/network" class="social-count">2</a>
              </li>

    </ul>

          <h1 itemscope itemtype="http://data-vocabulary.org/Breadcrumb" class="entry-title public">
            <span class="repo-label"><span>public</span></span>
            <span class="mega-icon mega-icon-public-repo"></span>
            <span class="author vcard">
<a href="/OpenBEL" class="url fn" itemprop="url" rel="author">              <span itemprop="title">OpenBEL</span>
              </a></span> /
            <strong><a href="/OpenBEL/openbel-framework-resources" class="js-current-repository">openbel-framework-resources</a></strong>
          </h1>
        </div>

          

  <ul class="tabs">
    <li><a href="/OpenBEL/openbel-framework-resources" class="selected" highlight="repo_sourcerepo_downloadsrepo_commitsrepo_tagsrepo_branches">Code</a></li>
    <li><a href="/OpenBEL/openbel-framework-resources/network" highlight="repo_network">Network</a>
    <li><a href="/OpenBEL/openbel-framework-resources/pulls" highlight="repo_pulls">Pull Requests <span class='counter'>0</span></a></li>

      <li><a href="/OpenBEL/openbel-framework-resources/issues" highlight="repo_issues">Issues <span class='counter'>0</span></a></li>


    <li><a href="/OpenBEL/openbel-framework-resources/graphs" highlight="repo_graphsrepo_contributors">Graphs</a></li>

  </ul>
  
<div class="frame frame-center tree-finder" style="display:none"
      data-tree-list-url="/OpenBEL/openbel-framework-resources/tree-list/00e6afd2fae5da40add133d5a59bc122f9d1d5ce"
      data-blob-url-prefix="/OpenBEL/openbel-framework-resources/blob/00e6afd2fae5da40add133d5a59bc122f9d1d5ce"
    >

  <div class="breadcrumb">
    <span class="bold"><a href="/OpenBEL/openbel-framework-resources">openbel-framework-resources</a></span> /
    <input class="tree-finder-input js-navigation-enable" type="text" name="query" autocomplete="off" spellcheck="false">
  </div>

    <div class="octotip">
      <p>
        <a href="/OpenBEL/openbel-framework-resources/dismiss-tree-finder-help" class="dismiss js-dismiss-tree-list-help" title="Hide this notice forever" rel="nofollow">Dismiss</a>
        <span class="bold">Octotip:</span> You've activated the <em>file finder</em>
        by pressing <span class="kbd">t</span> Start typing to filter the
        file list. Use <span class="kbd badmono">↑</span> and
        <span class="kbd badmono">↓</span> to navigate,
        <span class="kbd">enter</span> to view files.
      </p>
    </div>

  <table class="tree-browser" cellpadding="0" cellspacing="0">
    <tr class="js-header"><th>&nbsp;</th><th>name</th></tr>
    <tr class="js-no-results no-results" style="display: none">
      <th colspan="2">No matching files</th>
    </tr>
    <tbody class="js-results-list js-navigation-container">
    </tbody>
  </table>
</div>

<div id="jump-to-line" style="display:none">
  <h2>Jump to Line</h2>
  <form accept-charset="UTF-8">
    <input class="textfield" type="text">
    <div class="full-button">
      <button type="submit" class="classy">
        Go
      </button>
    </div>
  </form>
</div>


<div class="subnav-bar">

  <ul class="actions subnav">
    <li><a href="/OpenBEL/openbel-framework-resources/tags" class="blank" highlight="repo_tags">Tags <span class="counter">0</span></a></li>
    <li><a href="/OpenBEL/openbel-framework-resources/downloads" class="blank downloads-blank" highlight="repo_downloads">Downloads <span class="counter">0</span></a></li>
    
  </ul>

  <ul class="scope">
    <li class="switcher">

      <div class="context-menu-container js-menu-container js-context-menu">
        <a href="#"
           class="minibutton bigger switcher js-menu-target js-commitish-button btn-branch repo-tree"
           data-hotkey="w"
           data-master-branch="master"
           data-ref="master">
           <span><i>branch:</i> master</span>
        </a>

        <div class="context-pane commitish-context js-menu-content">
          <a href="javascript:;" class="close js-menu-close"><span class="mini-icon mini-icon-remove-close"></span></a>
          <div class="context-title">Switch branches/tags</div>
          <div class="context-body pane-selector commitish-selector js-navigation-container">
            <div class="filterbar">
              <input type="text" id="context-commitish-filter-field" class="js-navigation-enable" placeholder="Filter branches/tags" data-filterable />

              <ul class="tabs">
                <li><a href="#" data-filter="branches" class="selected">Branches</a></li>
                <li><a href="#" data-filter="tags">Tags</a></li>
              </ul>
            </div>

            <div class="js-filter-tab js-filter-branches" data-filterable-for="context-commitish-filter-field" data-filterable-type=substring>
              <div class="no-results js-not-filterable">Nothing to show</div>
                <div class="commitish-item branch-commitish selector-item js-navigation-item js-navigation-target selected">
                  <span class="mini-icon mini-icon-confirm"></span>
                  <h4>
                      <a href="/OpenBEL/openbel-framework-resources/blob/master/knowledge/small_corpus.bel" class="js-navigation-open" data-name="master" rel="nofollow">master</a>
                  </h4>
                </div>
            </div>

            <div class="js-filter-tab js-filter-tags" style="display:none" data-filterable-for="context-commitish-filter-field" data-filterable-type=substring>
              <div class="no-results js-not-filterable">Nothing to show</div>
            </div>
          </div>
        </div><!-- /.commitish-context-context -->
      </div>

    </li>
  </ul>

  <ul class="subnav with-scope">

    <li><a href="/OpenBEL/openbel-framework-resources" class="selected" highlight="repo_source">Files</a></li>
    <li><a href="/OpenBEL/openbel-framework-resources/commits/master" highlight="repo_commits">Commits</a></li>
    <li><a href="/OpenBEL/openbel-framework-resources/branches" class="" highlight="repo_branches" rel="nofollow">Branches <span class="counter">1</span></a></li>
  </ul>

</div>

  
  
  


          

        </div><!-- /.repohead -->

        <div id="js-repo-pjax-container" data-pjax-container>
          




<!-- blob contrib key: blob_contributors:v21:74416bb9ce93057dcd93197ede587851 -->
<!-- blob contrib frag key: views10/v8/blob_contributors:v21:74416bb9ce93057dcd93197ede587851 -->

<!-- block_view_fragment_key: views10/v8/blob:v21:685f0101a9a9b66d70df1e3bef3f718b -->
  <div id="slider">

    <div class="breadcrumb" data-path="knowledge/small_corpus.bel/">
      <b itemscope="" itemtype="http://data-vocabulary.org/Breadcrumb"><a href="/OpenBEL/openbel-framework-resources/tree/00e6afd2fae5da40add133d5a59bc122f9d1d5ce" class="js-rewrite-sha" itemprop="url"><span itemprop="title">openbel-framework-resources</span></a></b> / <span itemscope="" itemtype="http://data-vocabulary.org/Breadcrumb"><a href="/OpenBEL/openbel-framework-resources/tree/00e6afd2fae5da40add133d5a59bc122f9d1d5ce/knowledge" class="js-rewrite-sha" itemscope="url"><span itemprop="title">knowledge</span></a></span> / <strong class="final-path">small_corpus.bel</strong> <span class="js-clippy mini-icon mini-icon-clippy " data-clipboard-text="knowledge/small_corpus.bel" data-copied-hint="copied!" data-copy-hint="copy to clipboard"></span>
    </div>

      
  <div class="commit file-history-tease js-blob-contributors-content" data-path="knowledge/small_corpus.bel/">
    <img class="main-avatar" height="24" src="https://secure.gravatar.com/avatar/36d57c9389b7370a6b5f2e3df5c84dfc?s=140&amp;d=https://a248.e.akamai.net/assets.github.com%2Fimages%2Fgravatars%2Fgravatar-140.png" width="24" />
    <span class="author"><a href="/JamesMcMahon">JamesMcMahon</a></span>
    <time class="js-relative-date" datetime="2012-06-29T08:37:00-07:00" title="2012-06-29 08:37:00">June 29, 2012</time>
    <div class="commit-title">
        <a href="/OpenBEL/openbel-framework-resources/commit/0ef3fc22b5292dccdf9f11407d0a3daacd57aa6c" class="message">added BEL / BEL framework resources</a>
    </div>

    <div class="participation">
      <p class="quickstat"><a href="#blob_contributors_box" rel="facebox"><strong>1</strong> contributor</a></p>
      
    </div>
    <div id="blob_contributors_box" style="display:none">
      <h2>Users on GitHub who have contributed to this file</h2>
      <ul class="facebox-user-list">
        <li>
          <img height="24" src="https://secure.gravatar.com/avatar/36d57c9389b7370a6b5f2e3df5c84dfc?s=140&amp;d=https://a248.e.akamai.net/assets.github.com%2Fimages%2Fgravatars%2Fgravatar-140.png" width="24" />
          <a href="/JamesMcMahon">JamesMcMahon</a>
        </li>
      </ul>
    </div>
  </div>


    <div class="frames">
      <div class="frame frame-center" data-path="knowledge/small_corpus.bel/" data-permalink-url="/OpenBEL/openbel-framework-resources/blob/00e6afd2fae5da40add133d5a59bc122f9d1d5ce/knowledge/small_corpus.bel" data-title="openbel-framework-resources/knowledge/small_corpus.bel at master · OpenBEL/openbel-framework-resources · GitHub" data-type="blob">

        <div id="files" class="bubble">
          <div class="file">
            <div class="meta">
              <div class="info">
                <span class="icon"><b class="mini-icon mini-icon-text-file"></b></span>
                <span class="mode" title="File Mode">file</span>
                  <span>7531 lines (5662 sloc)</span>
                <span>483.306 kb</span>
              </div>
              <ul class="button-group actions">
                  <li>
                    <a class="grouped-button file-edit-link minibutton bigger lighter js-rewrite-sha" href="/OpenBEL/openbel-framework-resources/edit/00e6afd2fae5da40add133d5a59bc122f9d1d5ce/knowledge/small_corpus.bel" data-method="post" rel="nofollow" data-hotkey="e">Edit</a>
                  </li>

                <li>
                  <a href="/OpenBEL/openbel-framework-resources/raw/master/knowledge/small_corpus.bel" class="minibutton btn-raw grouped-button bigger lighter" id="raw-url">Raw</a>
                </li>
                  <li>
                    <a href="/OpenBEL/openbel-framework-resources/blame/master/knowledge/small_corpus.bel" class="minibutton btn-blame grouped-button bigger lighter">Blame</a>
                  </li>
                <li>
                  <a href="/OpenBEL/openbel-framework-resources/commits/master/knowledge/small_corpus.bel" class="minibutton btn-history grouped-button bigger lighter" rel="nofollow">History</a>
                </li>
              </ul>
            </div>
              <div class="data type-text">
      <table cellpadding="0" cellspacing="0" class="lines">
        <tr>
          <td>
            <pre class="line_numbers"><span id="L1" rel="#L1">1</span>
<span id="L2" rel="#L2">2</span>
<span id="L3" rel="#L3">3</span>
<span id="L4" rel="#L4">4</span>
<span id="L5" rel="#L5">5</span>
<span id="L6" rel="#L6">6</span>
<span id="L7" rel="#L7">7</span>
<span id="L8" rel="#L8">8</span>
<span id="L9" rel="#L9">9</span>
<span id="L10" rel="#L10">10</span>
<span id="L11" rel="#L11">11</span>
<span id="L12" rel="#L12">12</span>
<span id="L13" rel="#L13">13</span>
<span id="L14" rel="#L14">14</span>
<span id="L15" rel="#L15">15</span>
<span id="L16" rel="#L16">16</span>
<span id="L17" rel="#L17">17</span>
<span id="L18" rel="#L18">18</span>
<span id="L19" rel="#L19">19</span>
<span id="L20" rel="#L20">20</span>
<span id="L21" rel="#L21">21</span>
<span id="L22" rel="#L22">22</span>
<span id="L23" rel="#L23">23</span>
<span id="L24" rel="#L24">24</span>
<span id="L25" rel="#L25">25</span>
<span id="L26" rel="#L26">26</span>
<span id="L27" rel="#L27">27</span>
<span id="L28" rel="#L28">28</span>
<span id="L29" rel="#L29">29</span>
<span id="L30" rel="#L30">30</span>
<span id="L31" rel="#L31">31</span>
<span id="L32" rel="#L32">32</span>
<span id="L33" rel="#L33">33</span>
<span id="L34" rel="#L34">34</span>
<span id="L35" rel="#L35">35</span>
<span id="L36" rel="#L36">36</span>
<span id="L37" rel="#L37">37</span>
<span id="L38" rel="#L38">38</span>
<span id="L39" rel="#L39">39</span>
<span id="L40" rel="#L40">40</span>
<span id="L41" rel="#L41">41</span>
<span id="L42" rel="#L42">42</span>
<span id="L43" rel="#L43">43</span>
<span id="L44" rel="#L44">44</span>
<span id="L45" rel="#L45">45</span>
<span id="L46" rel="#L46">46</span>
<span id="L47" rel="#L47">47</span>
<span id="L48" rel="#L48">48</span>
<span id="L49" rel="#L49">49</span>
<span id="L50" rel="#L50">50</span>
<span id="L51" rel="#L51">51</span>
<span id="L52" rel="#L52">52</span>
<span id="L53" rel="#L53">53</span>
<span id="L54" rel="#L54">54</span>
<span id="L55" rel="#L55">55</span>
<span id="L56" rel="#L56">56</span>
<span id="L57" rel="#L57">57</span>
<span id="L58" rel="#L58">58</span>
<span id="L59" rel="#L59">59</span>
<span id="L60" rel="#L60">60</span>
<span id="L61" rel="#L61">61</span>
<span id="L62" rel="#L62">62</span>
<span id="L63" rel="#L63">63</span>
<span id="L64" rel="#L64">64</span>
<span id="L65" rel="#L65">65</span>
<span id="L66" rel="#L66">66</span>
<span id="L67" rel="#L67">67</span>
<span id="L68" rel="#L68">68</span>
<span id="L69" rel="#L69">69</span>
<span id="L70" rel="#L70">70</span>
<span id="L71" rel="#L71">71</span>
<span id="L72" rel="#L72">72</span>
<span id="L73" rel="#L73">73</span>
<span id="L74" rel="#L74">74</span>
<span id="L75" rel="#L75">75</span>
<span id="L76" rel="#L76">76</span>
<span id="L77" rel="#L77">77</span>
<span id="L78" rel="#L78">78</span>
<span id="L79" rel="#L79">79</span>
<span id="L80" rel="#L80">80</span>
<span id="L81" rel="#L81">81</span>
<span id="L82" rel="#L82">82</span>
<span id="L83" rel="#L83">83</span>
<span id="L84" rel="#L84">84</span>
<span id="L85" rel="#L85">85</span>
<span id="L86" rel="#L86">86</span>
<span id="L87" rel="#L87">87</span>
<span id="L88" rel="#L88">88</span>
<span id="L89" rel="#L89">89</span>
<span id="L90" rel="#L90">90</span>
<span id="L91" rel="#L91">91</span>
<span id="L92" rel="#L92">92</span>
<span id="L93" rel="#L93">93</span>
<span id="L94" rel="#L94">94</span>
<span id="L95" rel="#L95">95</span>
<span id="L96" rel="#L96">96</span>
<span id="L97" rel="#L97">97</span>
<span id="L98" rel="#L98">98</span>
<span id="L99" rel="#L99">99</span>
<span id="L100" rel="#L100">100</span>
<span id="L101" rel="#L101">101</span>
<span id="L102" rel="#L102">102</span>
<span id="L103" rel="#L103">103</span>
<span id="L104" rel="#L104">104</span>
<span id="L105" rel="#L105">105</span>
<span id="L106" rel="#L106">106</span>
<span id="L107" rel="#L107">107</span>
<span id="L108" rel="#L108">108</span>
<span id="L109" rel="#L109">109</span>
<span id="L110" rel="#L110">110</span>
<span id="L111" rel="#L111">111</span>
<span id="L112" rel="#L112">112</span>
<span id="L113" rel="#L113">113</span>
<span id="L114" rel="#L114">114</span>
<span id="L115" rel="#L115">115</span>
<span id="L116" rel="#L116">116</span>
<span id="L117" rel="#L117">117</span>
<span id="L118" rel="#L118">118</span>
<span id="L119" rel="#L119">119</span>
<span id="L120" rel="#L120">120</span>
<span id="L121" rel="#L121">121</span>
<span id="L122" rel="#L122">122</span>
<span id="L123" rel="#L123">123</span>
<span id="L124" rel="#L124">124</span>
<span id="L125" rel="#L125">125</span>
<span id="L126" rel="#L126">126</span>
<span id="L127" rel="#L127">127</span>
<span id="L128" rel="#L128">128</span>
<span id="L129" rel="#L129">129</span>
<span id="L130" rel="#L130">130</span>
<span id="L131" rel="#L131">131</span>
<span id="L132" rel="#L132">132</span>
<span id="L133" rel="#L133">133</span>
<span id="L134" rel="#L134">134</span>
<span id="L135" rel="#L135">135</span>
<span id="L136" rel="#L136">136</span>
<span id="L137" rel="#L137">137</span>
<span id="L138" rel="#L138">138</span>
<span id="L139" rel="#L139">139</span>
<span id="L140" rel="#L140">140</span>
<span id="L141" rel="#L141">141</span>
<span id="L142" rel="#L142">142</span>
<span id="L143" rel="#L143">143</span>
<span id="L144" rel="#L144">144</span>
<span id="L145" rel="#L145">145</span>
<span id="L146" rel="#L146">146</span>
<span id="L147" rel="#L147">147</span>
<span id="L148" rel="#L148">148</span>
<span id="L149" rel="#L149">149</span>
<span id="L150" rel="#L150">150</span>
<span id="L151" rel="#L151">151</span>
<span id="L152" rel="#L152">152</span>
<span id="L153" rel="#L153">153</span>
<span id="L154" rel="#L154">154</span>
<span id="L155" rel="#L155">155</span>
<span id="L156" rel="#L156">156</span>
<span id="L157" rel="#L157">157</span>
<span id="L158" rel="#L158">158</span>
<span id="L159" rel="#L159">159</span>
<span id="L160" rel="#L160">160</span>
<span id="L161" rel="#L161">161</span>
<span id="L162" rel="#L162">162</span>
<span id="L163" rel="#L163">163</span>
<span id="L164" rel="#L164">164</span>
<span id="L165" rel="#L165">165</span>
<span id="L166" rel="#L166">166</span>
<span id="L167" rel="#L167">167</span>
<span id="L168" rel="#L168">168</span>
<span id="L169" rel="#L169">169</span>
<span id="L170" rel="#L170">170</span>
<span id="L171" rel="#L171">171</span>
<span id="L172" rel="#L172">172</span>
<span id="L173" rel="#L173">173</span>
<span id="L174" rel="#L174">174</span>
<span id="L175" rel="#L175">175</span>
<span id="L176" rel="#L176">176</span>
<span id="L177" rel="#L177">177</span>
<span id="L178" rel="#L178">178</span>
<span id="L179" rel="#L179">179</span>
<span id="L180" rel="#L180">180</span>
<span id="L181" rel="#L181">181</span>
<span id="L182" rel="#L182">182</span>
<span id="L183" rel="#L183">183</span>
<span id="L184" rel="#L184">184</span>
<span id="L185" rel="#L185">185</span>
<span id="L186" rel="#L186">186</span>
<span id="L187" rel="#L187">187</span>
<span id="L188" rel="#L188">188</span>
<span id="L189" rel="#L189">189</span>
<span id="L190" rel="#L190">190</span>
<span id="L191" rel="#L191">191</span>
<span id="L192" rel="#L192">192</span>
<span id="L193" rel="#L193">193</span>
<span id="L194" rel="#L194">194</span>
<span id="L195" rel="#L195">195</span>
<span id="L196" rel="#L196">196</span>
<span id="L197" rel="#L197">197</span>
<span id="L198" rel="#L198">198</span>
<span id="L199" rel="#L199">199</span>
<span id="L200" rel="#L200">200</span>
<span id="L201" rel="#L201">201</span>
<span id="L202" rel="#L202">202</span>
<span id="L203" rel="#L203">203</span>
<span id="L204" rel="#L204">204</span>
<span id="L205" rel="#L205">205</span>
<span id="L206" rel="#L206">206</span>
<span id="L207" rel="#L207">207</span>
<span id="L208" rel="#L208">208</span>
<span id="L209" rel="#L209">209</span>
<span id="L210" rel="#L210">210</span>
<span id="L211" rel="#L211">211</span>
<span id="L212" rel="#L212">212</span>
<span id="L213" rel="#L213">213</span>
<span id="L214" rel="#L214">214</span>
<span id="L215" rel="#L215">215</span>
<span id="L216" rel="#L216">216</span>
<span id="L217" rel="#L217">217</span>
<span id="L218" rel="#L218">218</span>
<span id="L219" rel="#L219">219</span>
<span id="L220" rel="#L220">220</span>
<span id="L221" rel="#L221">221</span>
<span id="L222" rel="#L222">222</span>
<span id="L223" rel="#L223">223</span>
<span id="L224" rel="#L224">224</span>
<span id="L225" rel="#L225">225</span>
<span id="L226" rel="#L226">226</span>
<span id="L227" rel="#L227">227</span>
<span id="L228" rel="#L228">228</span>
<span id="L229" rel="#L229">229</span>
<span id="L230" rel="#L230">230</span>
<span id="L231" rel="#L231">231</span>
<span id="L232" rel="#L232">232</span>
<span id="L233" rel="#L233">233</span>
<span id="L234" rel="#L234">234</span>
<span id="L235" rel="#L235">235</span>
<span id="L236" rel="#L236">236</span>
<span id="L237" rel="#L237">237</span>
<span id="L238" rel="#L238">238</span>
<span id="L239" rel="#L239">239</span>
<span id="L240" rel="#L240">240</span>
<span id="L241" rel="#L241">241</span>
<span id="L242" rel="#L242">242</span>
<span id="L243" rel="#L243">243</span>
<span id="L244" rel="#L244">244</span>
<span id="L245" rel="#L245">245</span>
<span id="L246" rel="#L246">246</span>
<span id="L247" rel="#L247">247</span>
<span id="L248" rel="#L248">248</span>
<span id="L249" rel="#L249">249</span>
<span id="L250" rel="#L250">250</span>
<span id="L251" rel="#L251">251</span>
<span id="L252" rel="#L252">252</span>
<span id="L253" rel="#L253">253</span>
<span id="L254" rel="#L254">254</span>
<span id="L255" rel="#L255">255</span>
<span id="L256" rel="#L256">256</span>
<span id="L257" rel="#L257">257</span>
<span id="L258" rel="#L258">258</span>
<span id="L259" rel="#L259">259</span>
<span id="L260" rel="#L260">260</span>
<span id="L261" rel="#L261">261</span>
<span id="L262" rel="#L262">262</span>
<span id="L263" rel="#L263">263</span>
<span id="L264" rel="#L264">264</span>
<span id="L265" rel="#L265">265</span>
<span id="L266" rel="#L266">266</span>
<span id="L267" rel="#L267">267</span>
<span id="L268" rel="#L268">268</span>
<span id="L269" rel="#L269">269</span>
<span id="L270" rel="#L270">270</span>
<span id="L271" rel="#L271">271</span>
<span id="L272" rel="#L272">272</span>
<span id="L273" rel="#L273">273</span>
<span id="L274" rel="#L274">274</span>
<span id="L275" rel="#L275">275</span>
<span id="L276" rel="#L276">276</span>
<span id="L277" rel="#L277">277</span>
<span id="L278" rel="#L278">278</span>
<span id="L279" rel="#L279">279</span>
<span id="L280" rel="#L280">280</span>
<span id="L281" rel="#L281">281</span>
<span id="L282" rel="#L282">282</span>
<span id="L283" rel="#L283">283</span>
<span id="L284" rel="#L284">284</span>
<span id="L285" rel="#L285">285</span>
<span id="L286" rel="#L286">286</span>
<span id="L287" rel="#L287">287</span>
<span id="L288" rel="#L288">288</span>
<span id="L289" rel="#L289">289</span>
<span id="L290" rel="#L290">290</span>
<span id="L291" rel="#L291">291</span>
<span id="L292" rel="#L292">292</span>
<span id="L293" rel="#L293">293</span>
<span id="L294" rel="#L294">294</span>
<span id="L295" rel="#L295">295</span>
<span id="L296" rel="#L296">296</span>
<span id="L297" rel="#L297">297</span>
<span id="L298" rel="#L298">298</span>
<span id="L299" rel="#L299">299</span>
<span id="L300" rel="#L300">300</span>
<span id="L301" rel="#L301">301</span>
<span id="L302" rel="#L302">302</span>
<span id="L303" rel="#L303">303</span>
<span id="L304" rel="#L304">304</span>
<span id="L305" rel="#L305">305</span>
<span id="L306" rel="#L306">306</span>
<span id="L307" rel="#L307">307</span>
<span id="L308" rel="#L308">308</span>
<span id="L309" rel="#L309">309</span>
<span id="L310" rel="#L310">310</span>
<span id="L311" rel="#L311">311</span>
<span id="L312" rel="#L312">312</span>
<span id="L313" rel="#L313">313</span>
<span id="L314" rel="#L314">314</span>
<span id="L315" rel="#L315">315</span>
<span id="L316" rel="#L316">316</span>
<span id="L317" rel="#L317">317</span>
<span id="L318" rel="#L318">318</span>
<span id="L319" rel="#L319">319</span>
<span id="L320" rel="#L320">320</span>
<span id="L321" rel="#L321">321</span>
<span id="L322" rel="#L322">322</span>
<span id="L323" rel="#L323">323</span>
<span id="L324" rel="#L324">324</span>
<span id="L325" rel="#L325">325</span>
<span id="L326" rel="#L326">326</span>
<span id="L327" rel="#L327">327</span>
<span id="L328" rel="#L328">328</span>
<span id="L329" rel="#L329">329</span>
<span id="L330" rel="#L330">330</span>
<span id="L331" rel="#L331">331</span>
<span id="L332" rel="#L332">332</span>
<span id="L333" rel="#L333">333</span>
<span id="L334" rel="#L334">334</span>
<span id="L335" rel="#L335">335</span>
<span id="L336" rel="#L336">336</span>
<span id="L337" rel="#L337">337</span>
<span id="L338" rel="#L338">338</span>
<span id="L339" rel="#L339">339</span>
<span id="L340" rel="#L340">340</span>
<span id="L341" rel="#L341">341</span>
<span id="L342" rel="#L342">342</span>
<span id="L343" rel="#L343">343</span>
<span id="L344" rel="#L344">344</span>
<span id="L345" rel="#L345">345</span>
<span id="L346" rel="#L346">346</span>
<span id="L347" rel="#L347">347</span>
<span id="L348" rel="#L348">348</span>
<span id="L349" rel="#L349">349</span>
<span id="L350" rel="#L350">350</span>
<span id="L351" rel="#L351">351</span>
<span id="L352" rel="#L352">352</span>
<span id="L353" rel="#L353">353</span>
<span id="L354" rel="#L354">354</span>
<span id="L355" rel="#L355">355</span>
<span id="L356" rel="#L356">356</span>
<span id="L357" rel="#L357">357</span>
<span id="L358" rel="#L358">358</span>
<span id="L359" rel="#L359">359</span>
<span id="L360" rel="#L360">360</span>
<span id="L361" rel="#L361">361</span>
<span id="L362" rel="#L362">362</span>
<span id="L363" rel="#L363">363</span>
<span id="L364" rel="#L364">364</span>
<span id="L365" rel="#L365">365</span>
<span id="L366" rel="#L366">366</span>
<span id="L367" rel="#L367">367</span>
<span id="L368" rel="#L368">368</span>
<span id="L369" rel="#L369">369</span>
<span id="L370" rel="#L370">370</span>
<span id="L371" rel="#L371">371</span>
<span id="L372" rel="#L372">372</span>
<span id="L373" rel="#L373">373</span>
<span id="L374" rel="#L374">374</span>
<span id="L375" rel="#L375">375</span>
<span id="L376" rel="#L376">376</span>
<span id="L377" rel="#L377">377</span>
<span id="L378" rel="#L378">378</span>
<span id="L379" rel="#L379">379</span>
<span id="L380" rel="#L380">380</span>
<span id="L381" rel="#L381">381</span>
<span id="L382" rel="#L382">382</span>
<span id="L383" rel="#L383">383</span>
<span id="L384" rel="#L384">384</span>
<span id="L385" rel="#L385">385</span>
<span id="L386" rel="#L386">386</span>
<span id="L387" rel="#L387">387</span>
<span id="L388" rel="#L388">388</span>
<span id="L389" rel="#L389">389</span>
<span id="L390" rel="#L390">390</span>
<span id="L391" rel="#L391">391</span>
<span id="L392" rel="#L392">392</span>
<span id="L393" rel="#L393">393</span>
<span id="L394" rel="#L394">394</span>
<span id="L395" rel="#L395">395</span>
<span id="L396" rel="#L396">396</span>
<span id="L397" rel="#L397">397</span>
<span id="L398" rel="#L398">398</span>
<span id="L399" rel="#L399">399</span>
<span id="L400" rel="#L400">400</span>
<span id="L401" rel="#L401">401</span>
<span id="L402" rel="#L402">402</span>
<span id="L403" rel="#L403">403</span>
<span id="L404" rel="#L404">404</span>
<span id="L405" rel="#L405">405</span>
<span id="L406" rel="#L406">406</span>
<span id="L407" rel="#L407">407</span>
<span id="L408" rel="#L408">408</span>
<span id="L409" rel="#L409">409</span>
<span id="L410" rel="#L410">410</span>
<span id="L411" rel="#L411">411</span>
<span id="L412" rel="#L412">412</span>
<span id="L413" rel="#L413">413</span>
<span id="L414" rel="#L414">414</span>
<span id="L415" rel="#L415">415</span>
<span id="L416" rel="#L416">416</span>
<span id="L417" rel="#L417">417</span>
<span id="L418" rel="#L418">418</span>
<span id="L419" rel="#L419">419</span>
<span id="L420" rel="#L420">420</span>
<span id="L421" rel="#L421">421</span>
<span id="L422" rel="#L422">422</span>
<span id="L423" rel="#L423">423</span>
<span id="L424" rel="#L424">424</span>
<span id="L425" rel="#L425">425</span>
<span id="L426" rel="#L426">426</span>
<span id="L427" rel="#L427">427</span>
<span id="L428" rel="#L428">428</span>
<span id="L429" rel="#L429">429</span>
<span id="L430" rel="#L430">430</span>
<span id="L431" rel="#L431">431</span>
<span id="L432" rel="#L432">432</span>
<span id="L433" rel="#L433">433</span>
<span id="L434" rel="#L434">434</span>
<span id="L435" rel="#L435">435</span>
<span id="L436" rel="#L436">436</span>
<span id="L437" rel="#L437">437</span>
<span id="L438" rel="#L438">438</span>
<span id="L439" rel="#L439">439</span>
<span id="L440" rel="#L440">440</span>
<span id="L441" rel="#L441">441</span>
<span id="L442" rel="#L442">442</span>
<span id="L443" rel="#L443">443</span>
<span id="L444" rel="#L444">444</span>
<span id="L445" rel="#L445">445</span>
<span id="L446" rel="#L446">446</span>
<span id="L447" rel="#L447">447</span>
<span id="L448" rel="#L448">448</span>
<span id="L449" rel="#L449">449</span>
<span id="L450" rel="#L450">450</span>
<span id="L451" rel="#L451">451</span>
<span id="L452" rel="#L452">452</span>
<span id="L453" rel="#L453">453</span>
<span id="L454" rel="#L454">454</span>
<span id="L455" rel="#L455">455</span>
<span id="L456" rel="#L456">456</span>
<span id="L457" rel="#L457">457</span>
<span id="L458" rel="#L458">458</span>
<span id="L459" rel="#L459">459</span>
<span id="L460" rel="#L460">460</span>
<span id="L461" rel="#L461">461</span>
<span id="L462" rel="#L462">462</span>
<span id="L463" rel="#L463">463</span>
<span id="L464" rel="#L464">464</span>
<span id="L465" rel="#L465">465</span>
<span id="L466" rel="#L466">466</span>
<span id="L467" rel="#L467">467</span>
<span id="L468" rel="#L468">468</span>
<span id="L469" rel="#L469">469</span>
<span id="L470" rel="#L470">470</span>
<span id="L471" rel="#L471">471</span>
<span id="L472" rel="#L472">472</span>
<span id="L473" rel="#L473">473</span>
<span id="L474" rel="#L474">474</span>
<span id="L475" rel="#L475">475</span>
<span id="L476" rel="#L476">476</span>
<span id="L477" rel="#L477">477</span>
<span id="L478" rel="#L478">478</span>
<span id="L479" rel="#L479">479</span>
<span id="L480" rel="#L480">480</span>
<span id="L481" rel="#L481">481</span>
<span id="L482" rel="#L482">482</span>
<span id="L483" rel="#L483">483</span>
<span id="L484" rel="#L484">484</span>
<span id="L485" rel="#L485">485</span>
<span id="L486" rel="#L486">486</span>
<span id="L487" rel="#L487">487</span>
<span id="L488" rel="#L488">488</span>
<span id="L489" rel="#L489">489</span>
<span id="L490" rel="#L490">490</span>
<span id="L491" rel="#L491">491</span>
<span id="L492" rel="#L492">492</span>
<span id="L493" rel="#L493">493</span>
<span id="L494" rel="#L494">494</span>
<span id="L495" rel="#L495">495</span>
<span id="L496" rel="#L496">496</span>
<span id="L497" rel="#L497">497</span>
<span id="L498" rel="#L498">498</span>
<span id="L499" rel="#L499">499</span>
<span id="L500" rel="#L500">500</span>
<span id="L501" rel="#L501">501</span>
<span id="L502" rel="#L502">502</span>
<span id="L503" rel="#L503">503</span>
<span id="L504" rel="#L504">504</span>
<span id="L505" rel="#L505">505</span>
<span id="L506" rel="#L506">506</span>
<span id="L507" rel="#L507">507</span>
<span id="L508" rel="#L508">508</span>
<span id="L509" rel="#L509">509</span>
<span id="L510" rel="#L510">510</span>
<span id="L511" rel="#L511">511</span>
<span id="L512" rel="#L512">512</span>
<span id="L513" rel="#L513">513</span>
<span id="L514" rel="#L514">514</span>
<span id="L515" rel="#L515">515</span>
<span id="L516" rel="#L516">516</span>
<span id="L517" rel="#L517">517</span>
<span id="L518" rel="#L518">518</span>
<span id="L519" rel="#L519">519</span>
<span id="L520" rel="#L520">520</span>
<span id="L521" rel="#L521">521</span>
<span id="L522" rel="#L522">522</span>
<span id="L523" rel="#L523">523</span>
<span id="L524" rel="#L524">524</span>
<span id="L525" rel="#L525">525</span>
<span id="L526" rel="#L526">526</span>
<span id="L527" rel="#L527">527</span>
<span id="L528" rel="#L528">528</span>
<span id="L529" rel="#L529">529</span>
<span id="L530" rel="#L530">530</span>
<span id="L531" rel="#L531">531</span>
<span id="L532" rel="#L532">532</span>
<span id="L533" rel="#L533">533</span>
<span id="L534" rel="#L534">534</span>
<span id="L535" rel="#L535">535</span>
<span id="L536" rel="#L536">536</span>
<span id="L537" rel="#L537">537</span>
<span id="L538" rel="#L538">538</span>
<span id="L539" rel="#L539">539</span>
<span id="L540" rel="#L540">540</span>
<span id="L541" rel="#L541">541</span>
<span id="L542" rel="#L542">542</span>
<span id="L543" rel="#L543">543</span>
<span id="L544" rel="#L544">544</span>
<span id="L545" rel="#L545">545</span>
<span id="L546" rel="#L546">546</span>
<span id="L547" rel="#L547">547</span>
<span id="L548" rel="#L548">548</span>
<span id="L549" rel="#L549">549</span>
<span id="L550" rel="#L550">550</span>
<span id="L551" rel="#L551">551</span>
<span id="L552" rel="#L552">552</span>
<span id="L553" rel="#L553">553</span>
<span id="L554" rel="#L554">554</span>
<span id="L555" rel="#L555">555</span>
<span id="L556" rel="#L556">556</span>
<span id="L557" rel="#L557">557</span>
<span id="L558" rel="#L558">558</span>
<span id="L559" rel="#L559">559</span>
<span id="L560" rel="#L560">560</span>
<span id="L561" rel="#L561">561</span>
<span id="L562" rel="#L562">562</span>
<span id="L563" rel="#L563">563</span>
<span id="L564" rel="#L564">564</span>
<span id="L565" rel="#L565">565</span>
<span id="L566" rel="#L566">566</span>
<span id="L567" rel="#L567">567</span>
<span id="L568" rel="#L568">568</span>
<span id="L569" rel="#L569">569</span>
<span id="L570" rel="#L570">570</span>
<span id="L571" rel="#L571">571</span>
<span id="L572" rel="#L572">572</span>
<span id="L573" rel="#L573">573</span>
<span id="L574" rel="#L574">574</span>
<span id="L575" rel="#L575">575</span>
<span id="L576" rel="#L576">576</span>
<span id="L577" rel="#L577">577</span>
<span id="L578" rel="#L578">578</span>
<span id="L579" rel="#L579">579</span>
<span id="L580" rel="#L580">580</span>
<span id="L581" rel="#L581">581</span>
<span id="L582" rel="#L582">582</span>
<span id="L583" rel="#L583">583</span>
<span id="L584" rel="#L584">584</span>
<span id="L585" rel="#L585">585</span>
<span id="L586" rel="#L586">586</span>
<span id="L587" rel="#L587">587</span>
<span id="L588" rel="#L588">588</span>
<span id="L589" rel="#L589">589</span>
<span id="L590" rel="#L590">590</span>
<span id="L591" rel="#L591">591</span>
<span id="L592" rel="#L592">592</span>
<span id="L593" rel="#L593">593</span>
<span id="L594" rel="#L594">594</span>
<span id="L595" rel="#L595">595</span>
<span id="L596" rel="#L596">596</span>
<span id="L597" rel="#L597">597</span>
<span id="L598" rel="#L598">598</span>
<span id="L599" rel="#L599">599</span>
<span id="L600" rel="#L600">600</span>
<span id="L601" rel="#L601">601</span>
<span id="L602" rel="#L602">602</span>
<span id="L603" rel="#L603">603</span>
<span id="L604" rel="#L604">604</span>
<span id="L605" rel="#L605">605</span>
<span id="L606" rel="#L606">606</span>
<span id="L607" rel="#L607">607</span>
<span id="L608" rel="#L608">608</span>
<span id="L609" rel="#L609">609</span>
<span id="L610" rel="#L610">610</span>
<span id="L611" rel="#L611">611</span>
<span id="L612" rel="#L612">612</span>
<span id="L613" rel="#L613">613</span>
<span id="L614" rel="#L614">614</span>
<span id="L615" rel="#L615">615</span>
<span id="L616" rel="#L616">616</span>
<span id="L617" rel="#L617">617</span>
<span id="L618" rel="#L618">618</span>
<span id="L619" rel="#L619">619</span>
<span id="L620" rel="#L620">620</span>
<span id="L621" rel="#L621">621</span>
<span id="L622" rel="#L622">622</span>
<span id="L623" rel="#L623">623</span>
<span id="L624" rel="#L624">624</span>
<span id="L625" rel="#L625">625</span>
<span id="L626" rel="#L626">626</span>
<span id="L627" rel="#L627">627</span>
<span id="L628" rel="#L628">628</span>
<span id="L629" rel="#L629">629</span>
<span id="L630" rel="#L630">630</span>
<span id="L631" rel="#L631">631</span>
<span id="L632" rel="#L632">632</span>
<span id="L633" rel="#L633">633</span>
<span id="L634" rel="#L634">634</span>
<span id="L635" rel="#L635">635</span>
<span id="L636" rel="#L636">636</span>
<span id="L637" rel="#L637">637</span>
<span id="L638" rel="#L638">638</span>
<span id="L639" rel="#L639">639</span>
<span id="L640" rel="#L640">640</span>
<span id="L641" rel="#L641">641</span>
<span id="L642" rel="#L642">642</span>
<span id="L643" rel="#L643">643</span>
<span id="L644" rel="#L644">644</span>
<span id="L645" rel="#L645">645</span>
<span id="L646" rel="#L646">646</span>
<span id="L647" rel="#L647">647</span>
<span id="L648" rel="#L648">648</span>
<span id="L649" rel="#L649">649</span>
<span id="L650" rel="#L650">650</span>
<span id="L651" rel="#L651">651</span>
<span id="L652" rel="#L652">652</span>
<span id="L653" rel="#L653">653</span>
<span id="L654" rel="#L654">654</span>
<span id="L655" rel="#L655">655</span>
<span id="L656" rel="#L656">656</span>
<span id="L657" rel="#L657">657</span>
<span id="L658" rel="#L658">658</span>
<span id="L659" rel="#L659">659</span>
<span id="L660" rel="#L660">660</span>
<span id="L661" rel="#L661">661</span>
<span id="L662" rel="#L662">662</span>
<span id="L663" rel="#L663">663</span>
<span id="L664" rel="#L664">664</span>
<span id="L665" rel="#L665">665</span>
<span id="L666" rel="#L666">666</span>
<span id="L667" rel="#L667">667</span>
<span id="L668" rel="#L668">668</span>
<span id="L669" rel="#L669">669</span>
<span id="L670" rel="#L670">670</span>
<span id="L671" rel="#L671">671</span>
<span id="L672" rel="#L672">672</span>
<span id="L673" rel="#L673">673</span>
<span id="L674" rel="#L674">674</span>
<span id="L675" rel="#L675">675</span>
<span id="L676" rel="#L676">676</span>
<span id="L677" rel="#L677">677</span>
<span id="L678" rel="#L678">678</span>
<span id="L679" rel="#L679">679</span>
<span id="L680" rel="#L680">680</span>
<span id="L681" rel="#L681">681</span>
<span id="L682" rel="#L682">682</span>
<span id="L683" rel="#L683">683</span>
<span id="L684" rel="#L684">684</span>
<span id="L685" rel="#L685">685</span>
<span id="L686" rel="#L686">686</span>
<span id="L687" rel="#L687">687</span>
<span id="L688" rel="#L688">688</span>
<span id="L689" rel="#L689">689</span>
<span id="L690" rel="#L690">690</span>
<span id="L691" rel="#L691">691</span>
<span id="L692" rel="#L692">692</span>
<span id="L693" rel="#L693">693</span>
<span id="L694" rel="#L694">694</span>
<span id="L695" rel="#L695">695</span>
<span id="L696" rel="#L696">696</span>
<span id="L697" rel="#L697">697</span>
<span id="L698" rel="#L698">698</span>
<span id="L699" rel="#L699">699</span>
<span id="L700" rel="#L700">700</span>
<span id="L701" rel="#L701">701</span>
<span id="L702" rel="#L702">702</span>
<span id="L703" rel="#L703">703</span>
<span id="L704" rel="#L704">704</span>
<span id="L705" rel="#L705">705</span>
<span id="L706" rel="#L706">706</span>
<span id="L707" rel="#L707">707</span>
<span id="L708" rel="#L708">708</span>
<span id="L709" rel="#L709">709</span>
<span id="L710" rel="#L710">710</span>
<span id="L711" rel="#L711">711</span>
<span id="L712" rel="#L712">712</span>
<span id="L713" rel="#L713">713</span>
<span id="L714" rel="#L714">714</span>
<span id="L715" rel="#L715">715</span>
<span id="L716" rel="#L716">716</span>
<span id="L717" rel="#L717">717</span>
<span id="L718" rel="#L718">718</span>
<span id="L719" rel="#L719">719</span>
<span id="L720" rel="#L720">720</span>
<span id="L721" rel="#L721">721</span>
<span id="L722" rel="#L722">722</span>
<span id="L723" rel="#L723">723</span>
<span id="L724" rel="#L724">724</span>
<span id="L725" rel="#L725">725</span>
<span id="L726" rel="#L726">726</span>
<span id="L727" rel="#L727">727</span>
<span id="L728" rel="#L728">728</span>
<span id="L729" rel="#L729">729</span>
<span id="L730" rel="#L730">730</span>
<span id="L731" rel="#L731">731</span>
<span id="L732" rel="#L732">732</span>
<span id="L733" rel="#L733">733</span>
<span id="L734" rel="#L734">734</span>
<span id="L735" rel="#L735">735</span>
<span id="L736" rel="#L736">736</span>
<span id="L737" rel="#L737">737</span>
<span id="L738" rel="#L738">738</span>
<span id="L739" rel="#L739">739</span>
<span id="L740" rel="#L740">740</span>
<span id="L741" rel="#L741">741</span>
<span id="L742" rel="#L742">742</span>
<span id="L743" rel="#L743">743</span>
<span id="L744" rel="#L744">744</span>
<span id="L745" rel="#L745">745</span>
<span id="L746" rel="#L746">746</span>
<span id="L747" rel="#L747">747</span>
<span id="L748" rel="#L748">748</span>
<span id="L749" rel="#L749">749</span>
<span id="L750" rel="#L750">750</span>
<span id="L751" rel="#L751">751</span>
<span id="L752" rel="#L752">752</span>
<span id="L753" rel="#L753">753</span>
<span id="L754" rel="#L754">754</span>
<span id="L755" rel="#L755">755</span>
<span id="L756" rel="#L756">756</span>
<span id="L757" rel="#L757">757</span>
<span id="L758" rel="#L758">758</span>
<span id="L759" rel="#L759">759</span>
<span id="L760" rel="#L760">760</span>
<span id="L761" rel="#L761">761</span>
<span id="L762" rel="#L762">762</span>
<span id="L763" rel="#L763">763</span>
<span id="L764" rel="#L764">764</span>
<span id="L765" rel="#L765">765</span>
<span id="L766" rel="#L766">766</span>
<span id="L767" rel="#L767">767</span>
<span id="L768" rel="#L768">768</span>
<span id="L769" rel="#L769">769</span>
<span id="L770" rel="#L770">770</span>
<span id="L771" rel="#L771">771</span>
<span id="L772" rel="#L772">772</span>
<span id="L773" rel="#L773">773</span>
<span id="L774" rel="#L774">774</span>
<span id="L775" rel="#L775">775</span>
<span id="L776" rel="#L776">776</span>
<span id="L777" rel="#L777">777</span>
<span id="L778" rel="#L778">778</span>
<span id="L779" rel="#L779">779</span>
<span id="L780" rel="#L780">780</span>
<span id="L781" rel="#L781">781</span>
<span id="L782" rel="#L782">782</span>
<span id="L783" rel="#L783">783</span>
<span id="L784" rel="#L784">784</span>
<span id="L785" rel="#L785">785</span>
<span id="L786" rel="#L786">786</span>
<span id="L787" rel="#L787">787</span>
<span id="L788" rel="#L788">788</span>
<span id="L789" rel="#L789">789</span>
<span id="L790" rel="#L790">790</span>
<span id="L791" rel="#L791">791</span>
<span id="L792" rel="#L792">792</span>
<span id="L793" rel="#L793">793</span>
<span id="L794" rel="#L794">794</span>
<span id="L795" rel="#L795">795</span>
<span id="L796" rel="#L796">796</span>
<span id="L797" rel="#L797">797</span>
<span id="L798" rel="#L798">798</span>
<span id="L799" rel="#L799">799</span>
<span id="L800" rel="#L800">800</span>
<span id="L801" rel="#L801">801</span>
<span id="L802" rel="#L802">802</span>
<span id="L803" rel="#L803">803</span>
<span id="L804" rel="#L804">804</span>
<span id="L805" rel="#L805">805</span>
<span id="L806" rel="#L806">806</span>
<span id="L807" rel="#L807">807</span>
<span id="L808" rel="#L808">808</span>
<span id="L809" rel="#L809">809</span>
<span id="L810" rel="#L810">810</span>
<span id="L811" rel="#L811">811</span>
<span id="L812" rel="#L812">812</span>
<span id="L813" rel="#L813">813</span>
<span id="L814" rel="#L814">814</span>
<span id="L815" rel="#L815">815</span>
<span id="L816" rel="#L816">816</span>
<span id="L817" rel="#L817">817</span>
<span id="L818" rel="#L818">818</span>
<span id="L819" rel="#L819">819</span>
<span id="L820" rel="#L820">820</span>
<span id="L821" rel="#L821">821</span>
<span id="L822" rel="#L822">822</span>
<span id="L823" rel="#L823">823</span>
<span id="L824" rel="#L824">824</span>
<span id="L825" rel="#L825">825</span>
<span id="L826" rel="#L826">826</span>
<span id="L827" rel="#L827">827</span>
<span id="L828" rel="#L828">828</span>
<span id="L829" rel="#L829">829</span>
<span id="L830" rel="#L830">830</span>
<span id="L831" rel="#L831">831</span>
<span id="L832" rel="#L832">832</span>
<span id="L833" rel="#L833">833</span>
<span id="L834" rel="#L834">834</span>
<span id="L835" rel="#L835">835</span>
<span id="L836" rel="#L836">836</span>
<span id="L837" rel="#L837">837</span>
<span id="L838" rel="#L838">838</span>
<span id="L839" rel="#L839">839</span>
<span id="L840" rel="#L840">840</span>
<span id="L841" rel="#L841">841</span>
<span id="L842" rel="#L842">842</span>
<span id="L843" rel="#L843">843</span>
<span id="L844" rel="#L844">844</span>
<span id="L845" rel="#L845">845</span>
<span id="L846" rel="#L846">846</span>
<span id="L847" rel="#L847">847</span>
<span id="L848" rel="#L848">848</span>
<span id="L849" rel="#L849">849</span>
<span id="L850" rel="#L850">850</span>
<span id="L851" rel="#L851">851</span>
<span id="L852" rel="#L852">852</span>
<span id="L853" rel="#L853">853</span>
<span id="L854" rel="#L854">854</span>
<span id="L855" rel="#L855">855</span>
<span id="L856" rel="#L856">856</span>
<span id="L857" rel="#L857">857</span>
<span id="L858" rel="#L858">858</span>
<span id="L859" rel="#L859">859</span>
<span id="L860" rel="#L860">860</span>
<span id="L861" rel="#L861">861</span>
<span id="L862" rel="#L862">862</span>
<span id="L863" rel="#L863">863</span>
<span id="L864" rel="#L864">864</span>
<span id="L865" rel="#L865">865</span>
<span id="L866" rel="#L866">866</span>
<span id="L867" rel="#L867">867</span>
<span id="L868" rel="#L868">868</span>
<span id="L869" rel="#L869">869</span>
<span id="L870" rel="#L870">870</span>
<span id="L871" rel="#L871">871</span>
<span id="L872" rel="#L872">872</span>
<span id="L873" rel="#L873">873</span>
<span id="L874" rel="#L874">874</span>
<span id="L875" rel="#L875">875</span>
<span id="L876" rel="#L876">876</span>
<span id="L877" rel="#L877">877</span>
<span id="L878" rel="#L878">878</span>
<span id="L879" rel="#L879">879</span>
<span id="L880" rel="#L880">880</span>
<span id="L881" rel="#L881">881</span>
<span id="L882" rel="#L882">882</span>
<span id="L883" rel="#L883">883</span>
<span id="L884" rel="#L884">884</span>
<span id="L885" rel="#L885">885</span>
<span id="L886" rel="#L886">886</span>
<span id="L887" rel="#L887">887</span>
<span id="L888" rel="#L888">888</span>
<span id="L889" rel="#L889">889</span>
<span id="L890" rel="#L890">890</span>
<span id="L891" rel="#L891">891</span>
<span id="L892" rel="#L892">892</span>
<span id="L893" rel="#L893">893</span>
<span id="L894" rel="#L894">894</span>
<span id="L895" rel="#L895">895</span>
<span id="L896" rel="#L896">896</span>
<span id="L897" rel="#L897">897</span>
<span id="L898" rel="#L898">898</span>
<span id="L899" rel="#L899">899</span>
<span id="L900" rel="#L900">900</span>
<span id="L901" rel="#L901">901</span>
<span id="L902" rel="#L902">902</span>
<span id="L903" rel="#L903">903</span>
<span id="L904" rel="#L904">904</span>
<span id="L905" rel="#L905">905</span>
<span id="L906" rel="#L906">906</span>
<span id="L907" rel="#L907">907</span>
<span id="L908" rel="#L908">908</span>
<span id="L909" rel="#L909">909</span>
<span id="L910" rel="#L910">910</span>
<span id="L911" rel="#L911">911</span>
<span id="L912" rel="#L912">912</span>
<span id="L913" rel="#L913">913</span>
<span id="L914" rel="#L914">914</span>
<span id="L915" rel="#L915">915</span>
<span id="L916" rel="#L916">916</span>
<span id="L917" rel="#L917">917</span>
<span id="L918" rel="#L918">918</span>
<span id="L919" rel="#L919">919</span>
<span id="L920" rel="#L920">920</span>
<span id="L921" rel="#L921">921</span>
<span id="L922" rel="#L922">922</span>
<span id="L923" rel="#L923">923</span>
<span id="L924" rel="#L924">924</span>
<span id="L925" rel="#L925">925</span>
<span id="L926" rel="#L926">926</span>
<span id="L927" rel="#L927">927</span>
<span id="L928" rel="#L928">928</span>
<span id="L929" rel="#L929">929</span>
<span id="L930" rel="#L930">930</span>
<span id="L931" rel="#L931">931</span>
<span id="L932" rel="#L932">932</span>
<span id="L933" rel="#L933">933</span>
<span id="L934" rel="#L934">934</span>
<span id="L935" rel="#L935">935</span>
<span id="L936" rel="#L936">936</span>
<span id="L937" rel="#L937">937</span>
<span id="L938" rel="#L938">938</span>
<span id="L939" rel="#L939">939</span>
<span id="L940" rel="#L940">940</span>
<span id="L941" rel="#L941">941</span>
<span id="L942" rel="#L942">942</span>
<span id="L943" rel="#L943">943</span>
<span id="L944" rel="#L944">944</span>
<span id="L945" rel="#L945">945</span>
<span id="L946" rel="#L946">946</span>
<span id="L947" rel="#L947">947</span>
<span id="L948" rel="#L948">948</span>
<span id="L949" rel="#L949">949</span>
<span id="L950" rel="#L950">950</span>
<span id="L951" rel="#L951">951</span>
<span id="L952" rel="#L952">952</span>
<span id="L953" rel="#L953">953</span>
<span id="L954" rel="#L954">954</span>
<span id="L955" rel="#L955">955</span>
<span id="L956" rel="#L956">956</span>
<span id="L957" rel="#L957">957</span>
<span id="L958" rel="#L958">958</span>
<span id="L959" rel="#L959">959</span>
<span id="L960" rel="#L960">960</span>
<span id="L961" rel="#L961">961</span>
<span id="L962" rel="#L962">962</span>
<span id="L963" rel="#L963">963</span>
<span id="L964" rel="#L964">964</span>
<span id="L965" rel="#L965">965</span>
<span id="L966" rel="#L966">966</span>
<span id="L967" rel="#L967">967</span>
<span id="L968" rel="#L968">968</span>
<span id="L969" rel="#L969">969</span>
<span id="L970" rel="#L970">970</span>
<span id="L971" rel="#L971">971</span>
<span id="L972" rel="#L972">972</span>
<span id="L973" rel="#L973">973</span>
<span id="L974" rel="#L974">974</span>
<span id="L975" rel="#L975">975</span>
<span id="L976" rel="#L976">976</span>
<span id="L977" rel="#L977">977</span>
<span id="L978" rel="#L978">978</span>
<span id="L979" rel="#L979">979</span>
<span id="L980" rel="#L980">980</span>
<span id="L981" rel="#L981">981</span>
<span id="L982" rel="#L982">982</span>
<span id="L983" rel="#L983">983</span>
<span id="L984" rel="#L984">984</span>
<span id="L985" rel="#L985">985</span>
<span id="L986" rel="#L986">986</span>
<span id="L987" rel="#L987">987</span>
<span id="L988" rel="#L988">988</span>
<span id="L989" rel="#L989">989</span>
<span id="L990" rel="#L990">990</span>
<span id="L991" rel="#L991">991</span>
<span id="L992" rel="#L992">992</span>
<span id="L993" rel="#L993">993</span>
<span id="L994" rel="#L994">994</span>
<span id="L995" rel="#L995">995</span>
<span id="L996" rel="#L996">996</span>
<span id="L997" rel="#L997">997</span>
<span id="L998" rel="#L998">998</span>
<span id="L999" rel="#L999">999</span>
<span id="L1000" rel="#L1000">1000</span>
<span id="L1001" rel="#L1001">1001</span>
<span id="L1002" rel="#L1002">1002</span>
<span id="L1003" rel="#L1003">1003</span>
<span id="L1004" rel="#L1004">1004</span>
<span id="L1005" rel="#L1005">1005</span>
<span id="L1006" rel="#L1006">1006</span>
<span id="L1007" rel="#L1007">1007</span>
<span id="L1008" rel="#L1008">1008</span>
<span id="L1009" rel="#L1009">1009</span>
<span id="L1010" rel="#L1010">1010</span>
<span id="L1011" rel="#L1011">1011</span>
<span id="L1012" rel="#L1012">1012</span>
<span id="L1013" rel="#L1013">1013</span>
<span id="L1014" rel="#L1014">1014</span>
<span id="L1015" rel="#L1015">1015</span>
<span id="L1016" rel="#L1016">1016</span>
<span id="L1017" rel="#L1017">1017</span>
<span id="L1018" rel="#L1018">1018</span>
<span id="L1019" rel="#L1019">1019</span>
<span id="L1020" rel="#L1020">1020</span>
<span id="L1021" rel="#L1021">1021</span>
<span id="L1022" rel="#L1022">1022</span>
<span id="L1023" rel="#L1023">1023</span>
<span id="L1024" rel="#L1024">1024</span>
<span id="L1025" rel="#L1025">1025</span>
<span id="L1026" rel="#L1026">1026</span>
<span id="L1027" rel="#L1027">1027</span>
<span id="L1028" rel="#L1028">1028</span>
<span id="L1029" rel="#L1029">1029</span>
<span id="L1030" rel="#L1030">1030</span>
<span id="L1031" rel="#L1031">1031</span>
<span id="L1032" rel="#L1032">1032</span>
<span id="L1033" rel="#L1033">1033</span>
<span id="L1034" rel="#L1034">1034</span>
<span id="L1035" rel="#L1035">1035</span>
<span id="L1036" rel="#L1036">1036</span>
<span id="L1037" rel="#L1037">1037</span>
<span id="L1038" rel="#L1038">1038</span>
<span id="L1039" rel="#L1039">1039</span>
<span id="L1040" rel="#L1040">1040</span>
<span id="L1041" rel="#L1041">1041</span>
<span id="L1042" rel="#L1042">1042</span>
<span id="L1043" rel="#L1043">1043</span>
<span id="L1044" rel="#L1044">1044</span>
<span id="L1045" rel="#L1045">1045</span>
<span id="L1046" rel="#L1046">1046</span>
<span id="L1047" rel="#L1047">1047</span>
<span id="L1048" rel="#L1048">1048</span>
<span id="L1049" rel="#L1049">1049</span>
<span id="L1050" rel="#L1050">1050</span>
<span id="L1051" rel="#L1051">1051</span>
<span id="L1052" rel="#L1052">1052</span>
<span id="L1053" rel="#L1053">1053</span>
<span id="L1054" rel="#L1054">1054</span>
<span id="L1055" rel="#L1055">1055</span>
<span id="L1056" rel="#L1056">1056</span>
<span id="L1057" rel="#L1057">1057</span>
<span id="L1058" rel="#L1058">1058</span>
<span id="L1059" rel="#L1059">1059</span>
<span id="L1060" rel="#L1060">1060</span>
<span id="L1061" rel="#L1061">1061</span>
<span id="L1062" rel="#L1062">1062</span>
<span id="L1063" rel="#L1063">1063</span>
<span id="L1064" rel="#L1064">1064</span>
<span id="L1065" rel="#L1065">1065</span>
<span id="L1066" rel="#L1066">1066</span>
<span id="L1067" rel="#L1067">1067</span>
<span id="L1068" rel="#L1068">1068</span>
<span id="L1069" rel="#L1069">1069</span>
<span id="L1070" rel="#L1070">1070</span>
<span id="L1071" rel="#L1071">1071</span>
<span id="L1072" rel="#L1072">1072</span>
<span id="L1073" rel="#L1073">1073</span>
<span id="L1074" rel="#L1074">1074</span>
<span id="L1075" rel="#L1075">1075</span>
<span id="L1076" rel="#L1076">1076</span>
<span id="L1077" rel="#L1077">1077</span>
<span id="L1078" rel="#L1078">1078</span>
<span id="L1079" rel="#L1079">1079</span>
<span id="L1080" rel="#L1080">1080</span>
<span id="L1081" rel="#L1081">1081</span>
<span id="L1082" rel="#L1082">1082</span>
<span id="L1083" rel="#L1083">1083</span>
<span id="L1084" rel="#L1084">1084</span>
<span id="L1085" rel="#L1085">1085</span>
<span id="L1086" rel="#L1086">1086</span>
<span id="L1087" rel="#L1087">1087</span>
<span id="L1088" rel="#L1088">1088</span>
<span id="L1089" rel="#L1089">1089</span>
<span id="L1090" rel="#L1090">1090</span>
<span id="L1091" rel="#L1091">1091</span>
<span id="L1092" rel="#L1092">1092</span>
<span id="L1093" rel="#L1093">1093</span>
<span id="L1094" rel="#L1094">1094</span>
<span id="L1095" rel="#L1095">1095</span>
<span id="L1096" rel="#L1096">1096</span>
<span id="L1097" rel="#L1097">1097</span>
<span id="L1098" rel="#L1098">1098</span>
<span id="L1099" rel="#L1099">1099</span>
<span id="L1100" rel="#L1100">1100</span>
<span id="L1101" rel="#L1101">1101</span>
<span id="L1102" rel="#L1102">1102</span>
<span id="L1103" rel="#L1103">1103</span>
<span id="L1104" rel="#L1104">1104</span>
<span id="L1105" rel="#L1105">1105</span>
<span id="L1106" rel="#L1106">1106</span>
<span id="L1107" rel="#L1107">1107</span>
<span id="L1108" rel="#L1108">1108</span>
<span id="L1109" rel="#L1109">1109</span>
<span id="L1110" rel="#L1110">1110</span>
<span id="L1111" rel="#L1111">1111</span>
<span id="L1112" rel="#L1112">1112</span>
<span id="L1113" rel="#L1113">1113</span>
<span id="L1114" rel="#L1114">1114</span>
<span id="L1115" rel="#L1115">1115</span>
<span id="L1116" rel="#L1116">1116</span>
<span id="L1117" rel="#L1117">1117</span>
<span id="L1118" rel="#L1118">1118</span>
<span id="L1119" rel="#L1119">1119</span>
<span id="L1120" rel="#L1120">1120</span>
<span id="L1121" rel="#L1121">1121</span>
<span id="L1122" rel="#L1122">1122</span>
<span id="L1123" rel="#L1123">1123</span>
<span id="L1124" rel="#L1124">1124</span>
<span id="L1125" rel="#L1125">1125</span>
<span id="L1126" rel="#L1126">1126</span>
<span id="L1127" rel="#L1127">1127</span>
<span id="L1128" rel="#L1128">1128</span>
<span id="L1129" rel="#L1129">1129</span>
<span id="L1130" rel="#L1130">1130</span>
<span id="L1131" rel="#L1131">1131</span>
<span id="L1132" rel="#L1132">1132</span>
<span id="L1133" rel="#L1133">1133</span>
<span id="L1134" rel="#L1134">1134</span>
<span id="L1135" rel="#L1135">1135</span>
<span id="L1136" rel="#L1136">1136</span>
<span id="L1137" rel="#L1137">1137</span>
<span id="L1138" rel="#L1138">1138</span>
<span id="L1139" rel="#L1139">1139</span>
<span id="L1140" rel="#L1140">1140</span>
<span id="L1141" rel="#L1141">1141</span>
<span id="L1142" rel="#L1142">1142</span>
<span id="L1143" rel="#L1143">1143</span>
<span id="L1144" rel="#L1144">1144</span>
<span id="L1145" rel="#L1145">1145</span>
<span id="L1146" rel="#L1146">1146</span>
<span id="L1147" rel="#L1147">1147</span>
<span id="L1148" rel="#L1148">1148</span>
<span id="L1149" rel="#L1149">1149</span>
<span id="L1150" rel="#L1150">1150</span>
<span id="L1151" rel="#L1151">1151</span>
<span id="L1152" rel="#L1152">1152</span>
<span id="L1153" rel="#L1153">1153</span>
<span id="L1154" rel="#L1154">1154</span>
<span id="L1155" rel="#L1155">1155</span>
<span id="L1156" rel="#L1156">1156</span>
<span id="L1157" rel="#L1157">1157</span>
<span id="L1158" rel="#L1158">1158</span>
<span id="L1159" rel="#L1159">1159</span>
<span id="L1160" rel="#L1160">1160</span>
<span id="L1161" rel="#L1161">1161</span>
<span id="L1162" rel="#L1162">1162</span>
<span id="L1163" rel="#L1163">1163</span>
<span id="L1164" rel="#L1164">1164</span>
<span id="L1165" rel="#L1165">1165</span>
<span id="L1166" rel="#L1166">1166</span>
<span id="L1167" rel="#L1167">1167</span>
<span id="L1168" rel="#L1168">1168</span>
<span id="L1169" rel="#L1169">1169</span>
<span id="L1170" rel="#L1170">1170</span>
<span id="L1171" rel="#L1171">1171</span>
<span id="L1172" rel="#L1172">1172</span>
<span id="L1173" rel="#L1173">1173</span>
<span id="L1174" rel="#L1174">1174</span>
<span id="L1175" rel="#L1175">1175</span>
<span id="L1176" rel="#L1176">1176</span>
<span id="L1177" rel="#L1177">1177</span>
<span id="L1178" rel="#L1178">1178</span>
<span id="L1179" rel="#L1179">1179</span>
<span id="L1180" rel="#L1180">1180</span>
<span id="L1181" rel="#L1181">1181</span>
<span id="L1182" rel="#L1182">1182</span>
<span id="L1183" rel="#L1183">1183</span>
<span id="L1184" rel="#L1184">1184</span>
<span id="L1185" rel="#L1185">1185</span>
<span id="L1186" rel="#L1186">1186</span>
<span id="L1187" rel="#L1187">1187</span>
<span id="L1188" rel="#L1188">1188</span>
<span id="L1189" rel="#L1189">1189</span>
<span id="L1190" rel="#L1190">1190</span>
<span id="L1191" rel="#L1191">1191</span>
<span id="L1192" rel="#L1192">1192</span>
<span id="L1193" rel="#L1193">1193</span>
<span id="L1194" rel="#L1194">1194</span>
<span id="L1195" rel="#L1195">1195</span>
<span id="L1196" rel="#L1196">1196</span>
<span id="L1197" rel="#L1197">1197</span>
<span id="L1198" rel="#L1198">1198</span>
<span id="L1199" rel="#L1199">1199</span>
<span id="L1200" rel="#L1200">1200</span>
<span id="L1201" rel="#L1201">1201</span>
<span id="L1202" rel="#L1202">1202</span>
<span id="L1203" rel="#L1203">1203</span>
<span id="L1204" rel="#L1204">1204</span>
<span id="L1205" rel="#L1205">1205</span>
<span id="L1206" rel="#L1206">1206</span>
<span id="L1207" rel="#L1207">1207</span>
<span id="L1208" rel="#L1208">1208</span>
<span id="L1209" rel="#L1209">1209</span>
<span id="L1210" rel="#L1210">1210</span>
<span id="L1211" rel="#L1211">1211</span>
<span id="L1212" rel="#L1212">1212</span>
<span id="L1213" rel="#L1213">1213</span>
<span id="L1214" rel="#L1214">1214</span>
<span id="L1215" rel="#L1215">1215</span>
<span id="L1216" rel="#L1216">1216</span>
<span id="L1217" rel="#L1217">1217</span>
<span id="L1218" rel="#L1218">1218</span>
<span id="L1219" rel="#L1219">1219</span>
<span id="L1220" rel="#L1220">1220</span>
<span id="L1221" rel="#L1221">1221</span>
<span id="L1222" rel="#L1222">1222</span>
<span id="L1223" rel="#L1223">1223</span>
<span id="L1224" rel="#L1224">1224</span>
<span id="L1225" rel="#L1225">1225</span>
<span id="L1226" rel="#L1226">1226</span>
<span id="L1227" rel="#L1227">1227</span>
<span id="L1228" rel="#L1228">1228</span>
<span id="L1229" rel="#L1229">1229</span>
<span id="L1230" rel="#L1230">1230</span>
<span id="L1231" rel="#L1231">1231</span>
<span id="L1232" rel="#L1232">1232</span>
<span id="L1233" rel="#L1233">1233</span>
<span id="L1234" rel="#L1234">1234</span>
<span id="L1235" rel="#L1235">1235</span>
<span id="L1236" rel="#L1236">1236</span>
<span id="L1237" rel="#L1237">1237</span>
<span id="L1238" rel="#L1238">1238</span>
<span id="L1239" rel="#L1239">1239</span>
<span id="L1240" rel="#L1240">1240</span>
<span id="L1241" rel="#L1241">1241</span>
<span id="L1242" rel="#L1242">1242</span>
<span id="L1243" rel="#L1243">1243</span>
<span id="L1244" rel="#L1244">1244</span>
<span id="L1245" rel="#L1245">1245</span>
<span id="L1246" rel="#L1246">1246</span>
<span id="L1247" rel="#L1247">1247</span>
<span id="L1248" rel="#L1248">1248</span>
<span id="L1249" rel="#L1249">1249</span>
<span id="L1250" rel="#L1250">1250</span>
<span id="L1251" rel="#L1251">1251</span>
<span id="L1252" rel="#L1252">1252</span>
<span id="L1253" rel="#L1253">1253</span>
<span id="L1254" rel="#L1254">1254</span>
<span id="L1255" rel="#L1255">1255</span>
<span id="L1256" rel="#L1256">1256</span>
<span id="L1257" rel="#L1257">1257</span>
<span id="L1258" rel="#L1258">1258</span>
<span id="L1259" rel="#L1259">1259</span>
<span id="L1260" rel="#L1260">1260</span>
<span id="L1261" rel="#L1261">1261</span>
<span id="L1262" rel="#L1262">1262</span>
<span id="L1263" rel="#L1263">1263</span>
<span id="L1264" rel="#L1264">1264</span>
<span id="L1265" rel="#L1265">1265</span>
<span id="L1266" rel="#L1266">1266</span>
<span id="L1267" rel="#L1267">1267</span>
<span id="L1268" rel="#L1268">1268</span>
<span id="L1269" rel="#L1269">1269</span>
<span id="L1270" rel="#L1270">1270</span>
<span id="L1271" rel="#L1271">1271</span>
<span id="L1272" rel="#L1272">1272</span>
<span id="L1273" rel="#L1273">1273</span>
<span id="L1274" rel="#L1274">1274</span>
<span id="L1275" rel="#L1275">1275</span>
<span id="L1276" rel="#L1276">1276</span>
<span id="L1277" rel="#L1277">1277</span>
<span id="L1278" rel="#L1278">1278</span>
<span id="L1279" rel="#L1279">1279</span>
<span id="L1280" rel="#L1280">1280</span>
<span id="L1281" rel="#L1281">1281</span>
<span id="L1282" rel="#L1282">1282</span>
<span id="L1283" rel="#L1283">1283</span>
<span id="L1284" rel="#L1284">1284</span>
<span id="L1285" rel="#L1285">1285</span>
<span id="L1286" rel="#L1286">1286</span>
<span id="L1287" rel="#L1287">1287</span>
<span id="L1288" rel="#L1288">1288</span>
<span id="L1289" rel="#L1289">1289</span>
<span id="L1290" rel="#L1290">1290</span>
<span id="L1291" rel="#L1291">1291</span>
<span id="L1292" rel="#L1292">1292</span>
<span id="L1293" rel="#L1293">1293</span>
<span id="L1294" rel="#L1294">1294</span>
<span id="L1295" rel="#L1295">1295</span>
<span id="L1296" rel="#L1296">1296</span>
<span id="L1297" rel="#L1297">1297</span>
<span id="L1298" rel="#L1298">1298</span>
<span id="L1299" rel="#L1299">1299</span>
<span id="L1300" rel="#L1300">1300</span>
<span id="L1301" rel="#L1301">1301</span>
<span id="L1302" rel="#L1302">1302</span>
<span id="L1303" rel="#L1303">1303</span>
<span id="L1304" rel="#L1304">1304</span>
<span id="L1305" rel="#L1305">1305</span>
<span id="L1306" rel="#L1306">1306</span>
<span id="L1307" rel="#L1307">1307</span>
<span id="L1308" rel="#L1308">1308</span>
<span id="L1309" rel="#L1309">1309</span>
<span id="L1310" rel="#L1310">1310</span>
<span id="L1311" rel="#L1311">1311</span>
<span id="L1312" rel="#L1312">1312</span>
<span id="L1313" rel="#L1313">1313</span>
<span id="L1314" rel="#L1314">1314</span>
<span id="L1315" rel="#L1315">1315</span>
<span id="L1316" rel="#L1316">1316</span>
<span id="L1317" rel="#L1317">1317</span>
<span id="L1318" rel="#L1318">1318</span>
<span id="L1319" rel="#L1319">1319</span>
<span id="L1320" rel="#L1320">1320</span>
<span id="L1321" rel="#L1321">1321</span>
<span id="L1322" rel="#L1322">1322</span>
<span id="L1323" rel="#L1323">1323</span>
<span id="L1324" rel="#L1324">1324</span>
<span id="L1325" rel="#L1325">1325</span>
<span id="L1326" rel="#L1326">1326</span>
<span id="L1327" rel="#L1327">1327</span>
<span id="L1328" rel="#L1328">1328</span>
<span id="L1329" rel="#L1329">1329</span>
<span id="L1330" rel="#L1330">1330</span>
<span id="L1331" rel="#L1331">1331</span>
<span id="L1332" rel="#L1332">1332</span>
<span id="L1333" rel="#L1333">1333</span>
<span id="L1334" rel="#L1334">1334</span>
<span id="L1335" rel="#L1335">1335</span>
<span id="L1336" rel="#L1336">1336</span>
<span id="L1337" rel="#L1337">1337</span>
<span id="L1338" rel="#L1338">1338</span>
<span id="L1339" rel="#L1339">1339</span>
<span id="L1340" rel="#L1340">1340</span>
<span id="L1341" rel="#L1341">1341</span>
<span id="L1342" rel="#L1342">1342</span>
<span id="L1343" rel="#L1343">1343</span>
<span id="L1344" rel="#L1344">1344</span>
<span id="L1345" rel="#L1345">1345</span>
<span id="L1346" rel="#L1346">1346</span>
<span id="L1347" rel="#L1347">1347</span>
<span id="L1348" rel="#L1348">1348</span>
<span id="L1349" rel="#L1349">1349</span>
<span id="L1350" rel="#L1350">1350</span>
<span id="L1351" rel="#L1351">1351</span>
<span id="L1352" rel="#L1352">1352</span>
<span id="L1353" rel="#L1353">1353</span>
<span id="L1354" rel="#L1354">1354</span>
<span id="L1355" rel="#L1355">1355</span>
<span id="L1356" rel="#L1356">1356</span>
<span id="L1357" rel="#L1357">1357</span>
<span id="L1358" rel="#L1358">1358</span>
<span id="L1359" rel="#L1359">1359</span>
<span id="L1360" rel="#L1360">1360</span>
<span id="L1361" rel="#L1361">1361</span>
<span id="L1362" rel="#L1362">1362</span>
<span id="L1363" rel="#L1363">1363</span>
<span id="L1364" rel="#L1364">1364</span>
<span id="L1365" rel="#L1365">1365</span>
<span id="L1366" rel="#L1366">1366</span>
<span id="L1367" rel="#L1367">1367</span>
<span id="L1368" rel="#L1368">1368</span>
<span id="L1369" rel="#L1369">1369</span>
<span id="L1370" rel="#L1370">1370</span>
<span id="L1371" rel="#L1371">1371</span>
<span id="L1372" rel="#L1372">1372</span>
<span id="L1373" rel="#L1373">1373</span>
<span id="L1374" rel="#L1374">1374</span>
<span id="L1375" rel="#L1375">1375</span>
<span id="L1376" rel="#L1376">1376</span>
<span id="L1377" rel="#L1377">1377</span>
<span id="L1378" rel="#L1378">1378</span>
<span id="L1379" rel="#L1379">1379</span>
<span id="L1380" rel="#L1380">1380</span>
<span id="L1381" rel="#L1381">1381</span>
<span id="L1382" rel="#L1382">1382</span>
<span id="L1383" rel="#L1383">1383</span>
<span id="L1384" rel="#L1384">1384</span>
<span id="L1385" rel="#L1385">1385</span>
<span id="L1386" rel="#L1386">1386</span>
<span id="L1387" rel="#L1387">1387</span>
<span id="L1388" rel="#L1388">1388</span>
<span id="L1389" rel="#L1389">1389</span>
<span id="L1390" rel="#L1390">1390</span>
<span id="L1391" rel="#L1391">1391</span>
<span id="L1392" rel="#L1392">1392</span>
<span id="L1393" rel="#L1393">1393</span>
<span id="L1394" rel="#L1394">1394</span>
<span id="L1395" rel="#L1395">1395</span>
<span id="L1396" rel="#L1396">1396</span>
<span id="L1397" rel="#L1397">1397</span>
<span id="L1398" rel="#L1398">1398</span>
<span id="L1399" rel="#L1399">1399</span>
<span id="L1400" rel="#L1400">1400</span>
<span id="L1401" rel="#L1401">1401</span>
<span id="L1402" rel="#L1402">1402</span>
<span id="L1403" rel="#L1403">1403</span>
<span id="L1404" rel="#L1404">1404</span>
<span id="L1405" rel="#L1405">1405</span>
<span id="L1406" rel="#L1406">1406</span>
<span id="L1407" rel="#L1407">1407</span>
<span id="L1408" rel="#L1408">1408</span>
<span id="L1409" rel="#L1409">1409</span>
<span id="L1410" rel="#L1410">1410</span>
<span id="L1411" rel="#L1411">1411</span>
<span id="L1412" rel="#L1412">1412</span>
<span id="L1413" rel="#L1413">1413</span>
<span id="L1414" rel="#L1414">1414</span>
<span id="L1415" rel="#L1415">1415</span>
<span id="L1416" rel="#L1416">1416</span>
<span id="L1417" rel="#L1417">1417</span>
<span id="L1418" rel="#L1418">1418</span>
<span id="L1419" rel="#L1419">1419</span>
<span id="L1420" rel="#L1420">1420</span>
<span id="L1421" rel="#L1421">1421</span>
<span id="L1422" rel="#L1422">1422</span>
<span id="L1423" rel="#L1423">1423</span>
<span id="L1424" rel="#L1424">1424</span>
<span id="L1425" rel="#L1425">1425</span>
<span id="L1426" rel="#L1426">1426</span>
<span id="L1427" rel="#L1427">1427</span>
<span id="L1428" rel="#L1428">1428</span>
<span id="L1429" rel="#L1429">1429</span>
<span id="L1430" rel="#L1430">1430</span>
<span id="L1431" rel="#L1431">1431</span>
<span id="L1432" rel="#L1432">1432</span>
<span id="L1433" rel="#L1433">1433</span>
<span id="L1434" rel="#L1434">1434</span>
<span id="L1435" rel="#L1435">1435</span>
<span id="L1436" rel="#L1436">1436</span>
<span id="L1437" rel="#L1437">1437</span>
<span id="L1438" rel="#L1438">1438</span>
<span id="L1439" rel="#L1439">1439</span>
<span id="L1440" rel="#L1440">1440</span>
<span id="L1441" rel="#L1441">1441</span>
<span id="L1442" rel="#L1442">1442</span>
<span id="L1443" rel="#L1443">1443</span>
<span id="L1444" rel="#L1444">1444</span>
<span id="L1445" rel="#L1445">1445</span>
<span id="L1446" rel="#L1446">1446</span>
<span id="L1447" rel="#L1447">1447</span>
<span id="L1448" rel="#L1448">1448</span>
<span id="L1449" rel="#L1449">1449</span>
<span id="L1450" rel="#L1450">1450</span>
<span id="L1451" rel="#L1451">1451</span>
<span id="L1452" rel="#L1452">1452</span>
<span id="L1453" rel="#L1453">1453</span>
<span id="L1454" rel="#L1454">1454</span>
<span id="L1455" rel="#L1455">1455</span>
<span id="L1456" rel="#L1456">1456</span>
<span id="L1457" rel="#L1457">1457</span>
<span id="L1458" rel="#L1458">1458</span>
<span id="L1459" rel="#L1459">1459</span>
<span id="L1460" rel="#L1460">1460</span>
<span id="L1461" rel="#L1461">1461</span>
<span id="L1462" rel="#L1462">1462</span>
<span id="L1463" rel="#L1463">1463</span>
<span id="L1464" rel="#L1464">1464</span>
<span id="L1465" rel="#L1465">1465</span>
<span id="L1466" rel="#L1466">1466</span>
<span id="L1467" rel="#L1467">1467</span>
<span id="L1468" rel="#L1468">1468</span>
<span id="L1469" rel="#L1469">1469</span>
<span id="L1470" rel="#L1470">1470</span>
<span id="L1471" rel="#L1471">1471</span>
<span id="L1472" rel="#L1472">1472</span>
<span id="L1473" rel="#L1473">1473</span>
<span id="L1474" rel="#L1474">1474</span>
<span id="L1475" rel="#L1475">1475</span>
<span id="L1476" rel="#L1476">1476</span>
<span id="L1477" rel="#L1477">1477</span>
<span id="L1478" rel="#L1478">1478</span>
<span id="L1479" rel="#L1479">1479</span>
<span id="L1480" rel="#L1480">1480</span>
<span id="L1481" rel="#L1481">1481</span>
<span id="L1482" rel="#L1482">1482</span>
<span id="L1483" rel="#L1483">1483</span>
<span id="L1484" rel="#L1484">1484</span>
<span id="L1485" rel="#L1485">1485</span>
<span id="L1486" rel="#L1486">1486</span>
<span id="L1487" rel="#L1487">1487</span>
<span id="L1488" rel="#L1488">1488</span>
<span id="L1489" rel="#L1489">1489</span>
<span id="L1490" rel="#L1490">1490</span>
<span id="L1491" rel="#L1491">1491</span>
<span id="L1492" rel="#L1492">1492</span>
<span id="L1493" rel="#L1493">1493</span>
<span id="L1494" rel="#L1494">1494</span>
<span id="L1495" rel="#L1495">1495</span>
<span id="L1496" rel="#L1496">1496</span>
<span id="L1497" rel="#L1497">1497</span>
<span id="L1498" rel="#L1498">1498</span>
<span id="L1499" rel="#L1499">1499</span>
<span id="L1500" rel="#L1500">1500</span>
<span id="L1501" rel="#L1501">1501</span>
<span id="L1502" rel="#L1502">1502</span>
<span id="L1503" rel="#L1503">1503</span>
<span id="L1504" rel="#L1504">1504</span>
<span id="L1505" rel="#L1505">1505</span>
<span id="L1506" rel="#L1506">1506</span>
<span id="L1507" rel="#L1507">1507</span>
<span id="L1508" rel="#L1508">1508</span>
<span id="L1509" rel="#L1509">1509</span>
<span id="L1510" rel="#L1510">1510</span>
<span id="L1511" rel="#L1511">1511</span>
<span id="L1512" rel="#L1512">1512</span>
<span id="L1513" rel="#L1513">1513</span>
<span id="L1514" rel="#L1514">1514</span>
<span id="L1515" rel="#L1515">1515</span>
<span id="L1516" rel="#L1516">1516</span>
<span id="L1517" rel="#L1517">1517</span>
<span id="L1518" rel="#L1518">1518</span>
<span id="L1519" rel="#L1519">1519</span>
<span id="L1520" rel="#L1520">1520</span>
<span id="L1521" rel="#L1521">1521</span>
<span id="L1522" rel="#L1522">1522</span>
<span id="L1523" rel="#L1523">1523</span>
<span id="L1524" rel="#L1524">1524</span>
<span id="L1525" rel="#L1525">1525</span>
<span id="L1526" rel="#L1526">1526</span>
<span id="L1527" rel="#L1527">1527</span>
<span id="L1528" rel="#L1528">1528</span>
<span id="L1529" rel="#L1529">1529</span>
<span id="L1530" rel="#L1530">1530</span>
<span id="L1531" rel="#L1531">1531</span>
<span id="L1532" rel="#L1532">1532</span>
<span id="L1533" rel="#L1533">1533</span>
<span id="L1534" rel="#L1534">1534</span>
<span id="L1535" rel="#L1535">1535</span>
<span id="L1536" rel="#L1536">1536</span>
<span id="L1537" rel="#L1537">1537</span>
<span id="L1538" rel="#L1538">1538</span>
<span id="L1539" rel="#L1539">1539</span>
<span id="L1540" rel="#L1540">1540</span>
<span id="L1541" rel="#L1541">1541</span>
<span id="L1542" rel="#L1542">1542</span>
<span id="L1543" rel="#L1543">1543</span>
<span id="L1544" rel="#L1544">1544</span>
<span id="L1545" rel="#L1545">1545</span>
<span id="L1546" rel="#L1546">1546</span>
<span id="L1547" rel="#L1547">1547</span>
<span id="L1548" rel="#L1548">1548</span>
<span id="L1549" rel="#L1549">1549</span>
<span id="L1550" rel="#L1550">1550</span>
<span id="L1551" rel="#L1551">1551</span>
<span id="L1552" rel="#L1552">1552</span>
<span id="L1553" rel="#L1553">1553</span>
<span id="L1554" rel="#L1554">1554</span>
<span id="L1555" rel="#L1555">1555</span>
<span id="L1556" rel="#L1556">1556</span>
<span id="L1557" rel="#L1557">1557</span>
<span id="L1558" rel="#L1558">1558</span>
<span id="L1559" rel="#L1559">1559</span>
<span id="L1560" rel="#L1560">1560</span>
<span id="L1561" rel="#L1561">1561</span>
<span id="L1562" rel="#L1562">1562</span>
<span id="L1563" rel="#L1563">1563</span>
<span id="L1564" rel="#L1564">1564</span>
<span id="L1565" rel="#L1565">1565</span>
<span id="L1566" rel="#L1566">1566</span>
<span id="L1567" rel="#L1567">1567</span>
<span id="L1568" rel="#L1568">1568</span>
<span id="L1569" rel="#L1569">1569</span>
<span id="L1570" rel="#L1570">1570</span>
<span id="L1571" rel="#L1571">1571</span>
<span id="L1572" rel="#L1572">1572</span>
<span id="L1573" rel="#L1573">1573</span>
<span id="L1574" rel="#L1574">1574</span>
<span id="L1575" rel="#L1575">1575</span>
<span id="L1576" rel="#L1576">1576</span>
<span id="L1577" rel="#L1577">1577</span>
<span id="L1578" rel="#L1578">1578</span>
<span id="L1579" rel="#L1579">1579</span>
<span id="L1580" rel="#L1580">1580</span>
<span id="L1581" rel="#L1581">1581</span>
<span id="L1582" rel="#L1582">1582</span>
<span id="L1583" rel="#L1583">1583</span>
<span id="L1584" rel="#L1584">1584</span>
<span id="L1585" rel="#L1585">1585</span>
<span id="L1586" rel="#L1586">1586</span>
<span id="L1587" rel="#L1587">1587</span>
<span id="L1588" rel="#L1588">1588</span>
<span id="L1589" rel="#L1589">1589</span>
<span id="L1590" rel="#L1590">1590</span>
<span id="L1591" rel="#L1591">1591</span>
<span id="L1592" rel="#L1592">1592</span>
<span id="L1593" rel="#L1593">1593</span>
<span id="L1594" rel="#L1594">1594</span>
<span id="L1595" rel="#L1595">1595</span>
<span id="L1596" rel="#L1596">1596</span>
<span id="L1597" rel="#L1597">1597</span>
<span id="L1598" rel="#L1598">1598</span>
<span id="L1599" rel="#L1599">1599</span>
<span id="L1600" rel="#L1600">1600</span>
<span id="L1601" rel="#L1601">1601</span>
<span id="L1602" rel="#L1602">1602</span>
<span id="L1603" rel="#L1603">1603</span>
<span id="L1604" rel="#L1604">1604</span>
<span id="L1605" rel="#L1605">1605</span>
<span id="L1606" rel="#L1606">1606</span>
<span id="L1607" rel="#L1607">1607</span>
<span id="L1608" rel="#L1608">1608</span>
<span id="L1609" rel="#L1609">1609</span>
<span id="L1610" rel="#L1610">1610</span>
<span id="L1611" rel="#L1611">1611</span>
<span id="L1612" rel="#L1612">1612</span>
<span id="L1613" rel="#L1613">1613</span>
<span id="L1614" rel="#L1614">1614</span>
<span id="L1615" rel="#L1615">1615</span>
<span id="L1616" rel="#L1616">1616</span>
<span id="L1617" rel="#L1617">1617</span>
<span id="L1618" rel="#L1618">1618</span>
<span id="L1619" rel="#L1619">1619</span>
<span id="L1620" rel="#L1620">1620</span>
<span id="L1621" rel="#L1621">1621</span>
<span id="L1622" rel="#L1622">1622</span>
<span id="L1623" rel="#L1623">1623</span>
<span id="L1624" rel="#L1624">1624</span>
<span id="L1625" rel="#L1625">1625</span>
<span id="L1626" rel="#L1626">1626</span>
<span id="L1627" rel="#L1627">1627</span>
<span id="L1628" rel="#L1628">1628</span>
<span id="L1629" rel="#L1629">1629</span>
<span id="L1630" rel="#L1630">1630</span>
<span id="L1631" rel="#L1631">1631</span>
<span id="L1632" rel="#L1632">1632</span>
<span id="L1633" rel="#L1633">1633</span>
<span id="L1634" rel="#L1634">1634</span>
<span id="L1635" rel="#L1635">1635</span>
<span id="L1636" rel="#L1636">1636</span>
<span id="L1637" rel="#L1637">1637</span>
<span id="L1638" rel="#L1638">1638</span>
<span id="L1639" rel="#L1639">1639</span>
<span id="L1640" rel="#L1640">1640</span>
<span id="L1641" rel="#L1641">1641</span>
<span id="L1642" rel="#L1642">1642</span>
<span id="L1643" rel="#L1643">1643</span>
<span id="L1644" rel="#L1644">1644</span>
<span id="L1645" rel="#L1645">1645</span>
<span id="L1646" rel="#L1646">1646</span>
<span id="L1647" rel="#L1647">1647</span>
<span id="L1648" rel="#L1648">1648</span>
<span id="L1649" rel="#L1649">1649</span>
<span id="L1650" rel="#L1650">1650</span>
<span id="L1651" rel="#L1651">1651</span>
<span id="L1652" rel="#L1652">1652</span>
<span id="L1653" rel="#L1653">1653</span>
<span id="L1654" rel="#L1654">1654</span>
<span id="L1655" rel="#L1655">1655</span>
<span id="L1656" rel="#L1656">1656</span>
<span id="L1657" rel="#L1657">1657</span>
<span id="L1658" rel="#L1658">1658</span>
<span id="L1659" rel="#L1659">1659</span>
<span id="L1660" rel="#L1660">1660</span>
<span id="L1661" rel="#L1661">1661</span>
<span id="L1662" rel="#L1662">1662</span>
<span id="L1663" rel="#L1663">1663</span>
<span id="L1664" rel="#L1664">1664</span>
<span id="L1665" rel="#L1665">1665</span>
<span id="L1666" rel="#L1666">1666</span>
<span id="L1667" rel="#L1667">1667</span>
<span id="L1668" rel="#L1668">1668</span>
<span id="L1669" rel="#L1669">1669</span>
<span id="L1670" rel="#L1670">1670</span>
<span id="L1671" rel="#L1671">1671</span>
<span id="L1672" rel="#L1672">1672</span>
<span id="L1673" rel="#L1673">1673</span>
<span id="L1674" rel="#L1674">1674</span>
<span id="L1675" rel="#L1675">1675</span>
<span id="L1676" rel="#L1676">1676</span>
<span id="L1677" rel="#L1677">1677</span>
<span id="L1678" rel="#L1678">1678</span>
<span id="L1679" rel="#L1679">1679</span>
<span id="L1680" rel="#L1680">1680</span>
<span id="L1681" rel="#L1681">1681</span>
<span id="L1682" rel="#L1682">1682</span>
<span id="L1683" rel="#L1683">1683</span>
<span id="L1684" rel="#L1684">1684</span>
<span id="L1685" rel="#L1685">1685</span>
<span id="L1686" rel="#L1686">1686</span>
<span id="L1687" rel="#L1687">1687</span>
<span id="L1688" rel="#L1688">1688</span>
<span id="L1689" rel="#L1689">1689</span>
<span id="L1690" rel="#L1690">1690</span>
<span id="L1691" rel="#L1691">1691</span>
<span id="L1692" rel="#L1692">1692</span>
<span id="L1693" rel="#L1693">1693</span>
<span id="L1694" rel="#L1694">1694</span>
<span id="L1695" rel="#L1695">1695</span>
<span id="L1696" rel="#L1696">1696</span>
<span id="L1697" rel="#L1697">1697</span>
<span id="L1698" rel="#L1698">1698</span>
<span id="L1699" rel="#L1699">1699</span>
<span id="L1700" rel="#L1700">1700</span>
<span id="L1701" rel="#L1701">1701</span>
<span id="L1702" rel="#L1702">1702</span>
<span id="L1703" rel="#L1703">1703</span>
<span id="L1704" rel="#L1704">1704</span>
<span id="L1705" rel="#L1705">1705</span>
<span id="L1706" rel="#L1706">1706</span>
<span id="L1707" rel="#L1707">1707</span>
<span id="L1708" rel="#L1708">1708</span>
<span id="L1709" rel="#L1709">1709</span>
<span id="L1710" rel="#L1710">1710</span>
<span id="L1711" rel="#L1711">1711</span>
<span id="L1712" rel="#L1712">1712</span>
<span id="L1713" rel="#L1713">1713</span>
<span id="L1714" rel="#L1714">1714</span>
<span id="L1715" rel="#L1715">1715</span>
<span id="L1716" rel="#L1716">1716</span>
<span id="L1717" rel="#L1717">1717</span>
<span id="L1718" rel="#L1718">1718</span>
<span id="L1719" rel="#L1719">1719</span>
<span id="L1720" rel="#L1720">1720</span>
<span id="L1721" rel="#L1721">1721</span>
<span id="L1722" rel="#L1722">1722</span>
<span id="L1723" rel="#L1723">1723</span>
<span id="L1724" rel="#L1724">1724</span>
<span id="L1725" rel="#L1725">1725</span>
<span id="L1726" rel="#L1726">1726</span>
<span id="L1727" rel="#L1727">1727</span>
<span id="L1728" rel="#L1728">1728</span>
<span id="L1729" rel="#L1729">1729</span>
<span id="L1730" rel="#L1730">1730</span>
<span id="L1731" rel="#L1731">1731</span>
<span id="L1732" rel="#L1732">1732</span>
<span id="L1733" rel="#L1733">1733</span>
<span id="L1734" rel="#L1734">1734</span>
<span id="L1735" rel="#L1735">1735</span>
<span id="L1736" rel="#L1736">1736</span>
<span id="L1737" rel="#L1737">1737</span>
<span id="L1738" rel="#L1738">1738</span>
<span id="L1739" rel="#L1739">1739</span>
<span id="L1740" rel="#L1740">1740</span>
<span id="L1741" rel="#L1741">1741</span>
<span id="L1742" rel="#L1742">1742</span>
<span id="L1743" rel="#L1743">1743</span>
<span id="L1744" rel="#L1744">1744</span>
<span id="L1745" rel="#L1745">1745</span>
<span id="L1746" rel="#L1746">1746</span>
<span id="L1747" rel="#L1747">1747</span>
<span id="L1748" rel="#L1748">1748</span>
<span id="L1749" rel="#L1749">1749</span>
<span id="L1750" rel="#L1750">1750</span>
<span id="L1751" rel="#L1751">1751</span>
<span id="L1752" rel="#L1752">1752</span>
<span id="L1753" rel="#L1753">1753</span>
<span id="L1754" rel="#L1754">1754</span>
<span id="L1755" rel="#L1755">1755</span>
<span id="L1756" rel="#L1756">1756</span>
<span id="L1757" rel="#L1757">1757</span>
<span id="L1758" rel="#L1758">1758</span>
<span id="L1759" rel="#L1759">1759</span>
<span id="L1760" rel="#L1760">1760</span>
<span id="L1761" rel="#L1761">1761</span>
<span id="L1762" rel="#L1762">1762</span>
<span id="L1763" rel="#L1763">1763</span>
<span id="L1764" rel="#L1764">1764</span>
<span id="L1765" rel="#L1765">1765</span>
<span id="L1766" rel="#L1766">1766</span>
<span id="L1767" rel="#L1767">1767</span>
<span id="L1768" rel="#L1768">1768</span>
<span id="L1769" rel="#L1769">1769</span>
<span id="L1770" rel="#L1770">1770</span>
<span id="L1771" rel="#L1771">1771</span>
<span id="L1772" rel="#L1772">1772</span>
<span id="L1773" rel="#L1773">1773</span>
<span id="L1774" rel="#L1774">1774</span>
<span id="L1775" rel="#L1775">1775</span>
<span id="L1776" rel="#L1776">1776</span>
<span id="L1777" rel="#L1777">1777</span>
<span id="L1778" rel="#L1778">1778</span>
<span id="L1779" rel="#L1779">1779</span>
<span id="L1780" rel="#L1780">1780</span>
<span id="L1781" rel="#L1781">1781</span>
<span id="L1782" rel="#L1782">1782</span>
<span id="L1783" rel="#L1783">1783</span>
<span id="L1784" rel="#L1784">1784</span>
<span id="L1785" rel="#L1785">1785</span>
<span id="L1786" rel="#L1786">1786</span>
<span id="L1787" rel="#L1787">1787</span>
<span id="L1788" rel="#L1788">1788</span>
<span id="L1789" rel="#L1789">1789</span>
<span id="L1790" rel="#L1790">1790</span>
<span id="L1791" rel="#L1791">1791</span>
<span id="L1792" rel="#L1792">1792</span>
<span id="L1793" rel="#L1793">1793</span>
<span id="L1794" rel="#L1794">1794</span>
<span id="L1795" rel="#L1795">1795</span>
<span id="L1796" rel="#L1796">1796</span>
<span id="L1797" rel="#L1797">1797</span>
<span id="L1798" rel="#L1798">1798</span>
<span id="L1799" rel="#L1799">1799</span>
<span id="L1800" rel="#L1800">1800</span>
<span id="L1801" rel="#L1801">1801</span>
<span id="L1802" rel="#L1802">1802</span>
<span id="L1803" rel="#L1803">1803</span>
<span id="L1804" rel="#L1804">1804</span>
<span id="L1805" rel="#L1805">1805</span>
<span id="L1806" rel="#L1806">1806</span>
<span id="L1807" rel="#L1807">1807</span>
<span id="L1808" rel="#L1808">1808</span>
<span id="L1809" rel="#L1809">1809</span>
<span id="L1810" rel="#L1810">1810</span>
<span id="L1811" rel="#L1811">1811</span>
<span id="L1812" rel="#L1812">1812</span>
<span id="L1813" rel="#L1813">1813</span>
<span id="L1814" rel="#L1814">1814</span>
<span id="L1815" rel="#L1815">1815</span>
<span id="L1816" rel="#L1816">1816</span>
<span id="L1817" rel="#L1817">1817</span>
<span id="L1818" rel="#L1818">1818</span>
<span id="L1819" rel="#L1819">1819</span>
<span id="L1820" rel="#L1820">1820</span>
<span id="L1821" rel="#L1821">1821</span>
<span id="L1822" rel="#L1822">1822</span>
<span id="L1823" rel="#L1823">1823</span>
<span id="L1824" rel="#L1824">1824</span>
<span id="L1825" rel="#L1825">1825</span>
<span id="L1826" rel="#L1826">1826</span>
<span id="L1827" rel="#L1827">1827</span>
<span id="L1828" rel="#L1828">1828</span>
<span id="L1829" rel="#L1829">1829</span>
<span id="L1830" rel="#L1830">1830</span>
<span id="L1831" rel="#L1831">1831</span>
<span id="L1832" rel="#L1832">1832</span>
<span id="L1833" rel="#L1833">1833</span>
<span id="L1834" rel="#L1834">1834</span>
<span id="L1835" rel="#L1835">1835</span>
<span id="L1836" rel="#L1836">1836</span>
<span id="L1837" rel="#L1837">1837</span>
<span id="L1838" rel="#L1838">1838</span>
<span id="L1839" rel="#L1839">1839</span>
<span id="L1840" rel="#L1840">1840</span>
<span id="L1841" rel="#L1841">1841</span>
<span id="L1842" rel="#L1842">1842</span>
<span id="L1843" rel="#L1843">1843</span>
<span id="L1844" rel="#L1844">1844</span>
<span id="L1845" rel="#L1845">1845</span>
<span id="L1846" rel="#L1846">1846</span>
<span id="L1847" rel="#L1847">1847</span>
<span id="L1848" rel="#L1848">1848</span>
<span id="L1849" rel="#L1849">1849</span>
<span id="L1850" rel="#L1850">1850</span>
<span id="L1851" rel="#L1851">1851</span>
<span id="L1852" rel="#L1852">1852</span>
<span id="L1853" rel="#L1853">1853</span>
<span id="L1854" rel="#L1854">1854</span>
<span id="L1855" rel="#L1855">1855</span>
<span id="L1856" rel="#L1856">1856</span>
<span id="L1857" rel="#L1857">1857</span>
<span id="L1858" rel="#L1858">1858</span>
<span id="L1859" rel="#L1859">1859</span>
<span id="L1860" rel="#L1860">1860</span>
<span id="L1861" rel="#L1861">1861</span>
<span id="L1862" rel="#L1862">1862</span>
<span id="L1863" rel="#L1863">1863</span>
<span id="L1864" rel="#L1864">1864</span>
<span id="L1865" rel="#L1865">1865</span>
<span id="L1866" rel="#L1866">1866</span>
<span id="L1867" rel="#L1867">1867</span>
<span id="L1868" rel="#L1868">1868</span>
<span id="L1869" rel="#L1869">1869</span>
<span id="L1870" rel="#L1870">1870</span>
<span id="L1871" rel="#L1871">1871</span>
<span id="L1872" rel="#L1872">1872</span>
<span id="L1873" rel="#L1873">1873</span>
<span id="L1874" rel="#L1874">1874</span>
<span id="L1875" rel="#L1875">1875</span>
<span id="L1876" rel="#L1876">1876</span>
<span id="L1877" rel="#L1877">1877</span>
<span id="L1878" rel="#L1878">1878</span>
<span id="L1879" rel="#L1879">1879</span>
<span id="L1880" rel="#L1880">1880</span>
<span id="L1881" rel="#L1881">1881</span>
<span id="L1882" rel="#L1882">1882</span>
<span id="L1883" rel="#L1883">1883</span>
<span id="L1884" rel="#L1884">1884</span>
<span id="L1885" rel="#L1885">1885</span>
<span id="L1886" rel="#L1886">1886</span>
<span id="L1887" rel="#L1887">1887</span>
<span id="L1888" rel="#L1888">1888</span>
<span id="L1889" rel="#L1889">1889</span>
<span id="L1890" rel="#L1890">1890</span>
<span id="L1891" rel="#L1891">1891</span>
<span id="L1892" rel="#L1892">1892</span>
<span id="L1893" rel="#L1893">1893</span>
<span id="L1894" rel="#L1894">1894</span>
<span id="L1895" rel="#L1895">1895</span>
<span id="L1896" rel="#L1896">1896</span>
<span id="L1897" rel="#L1897">1897</span>
<span id="L1898" rel="#L1898">1898</span>
<span id="L1899" rel="#L1899">1899</span>
<span id="L1900" rel="#L1900">1900</span>
<span id="L1901" rel="#L1901">1901</span>
<span id="L1902" rel="#L1902">1902</span>
<span id="L1903" rel="#L1903">1903</span>
<span id="L1904" rel="#L1904">1904</span>
<span id="L1905" rel="#L1905">1905</span>
<span id="L1906" rel="#L1906">1906</span>
<span id="L1907" rel="#L1907">1907</span>
<span id="L1908" rel="#L1908">1908</span>
<span id="L1909" rel="#L1909">1909</span>
<span id="L1910" rel="#L1910">1910</span>
<span id="L1911" rel="#L1911">1911</span>
<span id="L1912" rel="#L1912">1912</span>
<span id="L1913" rel="#L1913">1913</span>
<span id="L1914" rel="#L1914">1914</span>
<span id="L1915" rel="#L1915">1915</span>
<span id="L1916" rel="#L1916">1916</span>
<span id="L1917" rel="#L1917">1917</span>
<span id="L1918" rel="#L1918">1918</span>
<span id="L1919" rel="#L1919">1919</span>
<span id="L1920" rel="#L1920">1920</span>
<span id="L1921" rel="#L1921">1921</span>
<span id="L1922" rel="#L1922">1922</span>
<span id="L1923" rel="#L1923">1923</span>
<span id="L1924" rel="#L1924">1924</span>
<span id="L1925" rel="#L1925">1925</span>
<span id="L1926" rel="#L1926">1926</span>
<span id="L1927" rel="#L1927">1927</span>
<span id="L1928" rel="#L1928">1928</span>
<span id="L1929" rel="#L1929">1929</span>
<span id="L1930" rel="#L1930">1930</span>
<span id="L1931" rel="#L1931">1931</span>
<span id="L1932" rel="#L1932">1932</span>
<span id="L1933" rel="#L1933">1933</span>
<span id="L1934" rel="#L1934">1934</span>
<span id="L1935" rel="#L1935">1935</span>
<span id="L1936" rel="#L1936">1936</span>
<span id="L1937" rel="#L1937">1937</span>
<span id="L1938" rel="#L1938">1938</span>
<span id="L1939" rel="#L1939">1939</span>
<span id="L1940" rel="#L1940">1940</span>
<span id="L1941" rel="#L1941">1941</span>
<span id="L1942" rel="#L1942">1942</span>
<span id="L1943" rel="#L1943">1943</span>
<span id="L1944" rel="#L1944">1944</span>
<span id="L1945" rel="#L1945">1945</span>
<span id="L1946" rel="#L1946">1946</span>
<span id="L1947" rel="#L1947">1947</span>
<span id="L1948" rel="#L1948">1948</span>
<span id="L1949" rel="#L1949">1949</span>
<span id="L1950" rel="#L1950">1950</span>
<span id="L1951" rel="#L1951">1951</span>
<span id="L1952" rel="#L1952">1952</span>
<span id="L1953" rel="#L1953">1953</span>
<span id="L1954" rel="#L1954">1954</span>
<span id="L1955" rel="#L1955">1955</span>
<span id="L1956" rel="#L1956">1956</span>
<span id="L1957" rel="#L1957">1957</span>
<span id="L1958" rel="#L1958">1958</span>
<span id="L1959" rel="#L1959">1959</span>
<span id="L1960" rel="#L1960">1960</span>
<span id="L1961" rel="#L1961">1961</span>
<span id="L1962" rel="#L1962">1962</span>
<span id="L1963" rel="#L1963">1963</span>
<span id="L1964" rel="#L1964">1964</span>
<span id="L1965" rel="#L1965">1965</span>
<span id="L1966" rel="#L1966">1966</span>
<span id="L1967" rel="#L1967">1967</span>
<span id="L1968" rel="#L1968">1968</span>
<span id="L1969" rel="#L1969">1969</span>
<span id="L1970" rel="#L1970">1970</span>
<span id="L1971" rel="#L1971">1971</span>
<span id="L1972" rel="#L1972">1972</span>
<span id="L1973" rel="#L1973">1973</span>
<span id="L1974" rel="#L1974">1974</span>
<span id="L1975" rel="#L1975">1975</span>
<span id="L1976" rel="#L1976">1976</span>
<span id="L1977" rel="#L1977">1977</span>
<span id="L1978" rel="#L1978">1978</span>
<span id="L1979" rel="#L1979">1979</span>
<span id="L1980" rel="#L1980">1980</span>
<span id="L1981" rel="#L1981">1981</span>
<span id="L1982" rel="#L1982">1982</span>
<span id="L1983" rel="#L1983">1983</span>
<span id="L1984" rel="#L1984">1984</span>
<span id="L1985" rel="#L1985">1985</span>
<span id="L1986" rel="#L1986">1986</span>
<span id="L1987" rel="#L1987">1987</span>
<span id="L1988" rel="#L1988">1988</span>
<span id="L1989" rel="#L1989">1989</span>
<span id="L1990" rel="#L1990">1990</span>
<span id="L1991" rel="#L1991">1991</span>
<span id="L1992" rel="#L1992">1992</span>
<span id="L1993" rel="#L1993">1993</span>
<span id="L1994" rel="#L1994">1994</span>
<span id="L1995" rel="#L1995">1995</span>
<span id="L1996" rel="#L1996">1996</span>
<span id="L1997" rel="#L1997">1997</span>
<span id="L1998" rel="#L1998">1998</span>
<span id="L1999" rel="#L1999">1999</span>
<span id="L2000" rel="#L2000">2000</span>
<span id="L2001" rel="#L2001">2001</span>
<span id="L2002" rel="#L2002">2002</span>
<span id="L2003" rel="#L2003">2003</span>
<span id="L2004" rel="#L2004">2004</span>
<span id="L2005" rel="#L2005">2005</span>
<span id="L2006" rel="#L2006">2006</span>
<span id="L2007" rel="#L2007">2007</span>
<span id="L2008" rel="#L2008">2008</span>
<span id="L2009" rel="#L2009">2009</span>
<span id="L2010" rel="#L2010">2010</span>
<span id="L2011" rel="#L2011">2011</span>
<span id="L2012" rel="#L2012">2012</span>
<span id="L2013" rel="#L2013">2013</span>
<span id="L2014" rel="#L2014">2014</span>
<span id="L2015" rel="#L2015">2015</span>
<span id="L2016" rel="#L2016">2016</span>
<span id="L2017" rel="#L2017">2017</span>
<span id="L2018" rel="#L2018">2018</span>
<span id="L2019" rel="#L2019">2019</span>
<span id="L2020" rel="#L2020">2020</span>
<span id="L2021" rel="#L2021">2021</span>
<span id="L2022" rel="#L2022">2022</span>
<span id="L2023" rel="#L2023">2023</span>
<span id="L2024" rel="#L2024">2024</span>
<span id="L2025" rel="#L2025">2025</span>
<span id="L2026" rel="#L2026">2026</span>
<span id="L2027" rel="#L2027">2027</span>
<span id="L2028" rel="#L2028">2028</span>
<span id="L2029" rel="#L2029">2029</span>
<span id="L2030" rel="#L2030">2030</span>
<span id="L2031" rel="#L2031">2031</span>
<span id="L2032" rel="#L2032">2032</span>
<span id="L2033" rel="#L2033">2033</span>
<span id="L2034" rel="#L2034">2034</span>
<span id="L2035" rel="#L2035">2035</span>
<span id="L2036" rel="#L2036">2036</span>
<span id="L2037" rel="#L2037">2037</span>
<span id="L2038" rel="#L2038">2038</span>
<span id="L2039" rel="#L2039">2039</span>
<span id="L2040" rel="#L2040">2040</span>
<span id="L2041" rel="#L2041">2041</span>
<span id="L2042" rel="#L2042">2042</span>
<span id="L2043" rel="#L2043">2043</span>
<span id="L2044" rel="#L2044">2044</span>
<span id="L2045" rel="#L2045">2045</span>
<span id="L2046" rel="#L2046">2046</span>
<span id="L2047" rel="#L2047">2047</span>
<span id="L2048" rel="#L2048">2048</span>
<span id="L2049" rel="#L2049">2049</span>
<span id="L2050" rel="#L2050">2050</span>
<span id="L2051" rel="#L2051">2051</span>
<span id="L2052" rel="#L2052">2052</span>
<span id="L2053" rel="#L2053">2053</span>
<span id="L2054" rel="#L2054">2054</span>
<span id="L2055" rel="#L2055">2055</span>
<span id="L2056" rel="#L2056">2056</span>
<span id="L2057" rel="#L2057">2057</span>
<span id="L2058" rel="#L2058">2058</span>
<span id="L2059" rel="#L2059">2059</span>
<span id="L2060" rel="#L2060">2060</span>
<span id="L2061" rel="#L2061">2061</span>
<span id="L2062" rel="#L2062">2062</span>
<span id="L2063" rel="#L2063">2063</span>
<span id="L2064" rel="#L2064">2064</span>
<span id="L2065" rel="#L2065">2065</span>
<span id="L2066" rel="#L2066">2066</span>
<span id="L2067" rel="#L2067">2067</span>
<span id="L2068" rel="#L2068">2068</span>
<span id="L2069" rel="#L2069">2069</span>
<span id="L2070" rel="#L2070">2070</span>
<span id="L2071" rel="#L2071">2071</span>
<span id="L2072" rel="#L2072">2072</span>
<span id="L2073" rel="#L2073">2073</span>
<span id="L2074" rel="#L2074">2074</span>
<span id="L2075" rel="#L2075">2075</span>
<span id="L2076" rel="#L2076">2076</span>
<span id="L2077" rel="#L2077">2077</span>
<span id="L2078" rel="#L2078">2078</span>
<span id="L2079" rel="#L2079">2079</span>
<span id="L2080" rel="#L2080">2080</span>
<span id="L2081" rel="#L2081">2081</span>
<span id="L2082" rel="#L2082">2082</span>
<span id="L2083" rel="#L2083">2083</span>
<span id="L2084" rel="#L2084">2084</span>
<span id="L2085" rel="#L2085">2085</span>
<span id="L2086" rel="#L2086">2086</span>
<span id="L2087" rel="#L2087">2087</span>
<span id="L2088" rel="#L2088">2088</span>
<span id="L2089" rel="#L2089">2089</span>
<span id="L2090" rel="#L2090">2090</span>
<span id="L2091" rel="#L2091">2091</span>
<span id="L2092" rel="#L2092">2092</span>
<span id="L2093" rel="#L2093">2093</span>
<span id="L2094" rel="#L2094">2094</span>
<span id="L2095" rel="#L2095">2095</span>
<span id="L2096" rel="#L2096">2096</span>
<span id="L2097" rel="#L2097">2097</span>
<span id="L2098" rel="#L2098">2098</span>
<span id="L2099" rel="#L2099">2099</span>
<span id="L2100" rel="#L2100">2100</span>
<span id="L2101" rel="#L2101">2101</span>
<span id="L2102" rel="#L2102">2102</span>
<span id="L2103" rel="#L2103">2103</span>
<span id="L2104" rel="#L2104">2104</span>
<span id="L2105" rel="#L2105">2105</span>
<span id="L2106" rel="#L2106">2106</span>
<span id="L2107" rel="#L2107">2107</span>
<span id="L2108" rel="#L2108">2108</span>
<span id="L2109" rel="#L2109">2109</span>
<span id="L2110" rel="#L2110">2110</span>
<span id="L2111" rel="#L2111">2111</span>
<span id="L2112" rel="#L2112">2112</span>
<span id="L2113" rel="#L2113">2113</span>
<span id="L2114" rel="#L2114">2114</span>
<span id="L2115" rel="#L2115">2115</span>
<span id="L2116" rel="#L2116">2116</span>
<span id="L2117" rel="#L2117">2117</span>
<span id="L2118" rel="#L2118">2118</span>
<span id="L2119" rel="#L2119">2119</span>
<span id="L2120" rel="#L2120">2120</span>
<span id="L2121" rel="#L2121">2121</span>
<span id="L2122" rel="#L2122">2122</span>
<span id="L2123" rel="#L2123">2123</span>
<span id="L2124" rel="#L2124">2124</span>
<span id="L2125" rel="#L2125">2125</span>
<span id="L2126" rel="#L2126">2126</span>
<span id="L2127" rel="#L2127">2127</span>
<span id="L2128" rel="#L2128">2128</span>
<span id="L2129" rel="#L2129">2129</span>
<span id="L2130" rel="#L2130">2130</span>
<span id="L2131" rel="#L2131">2131</span>
<span id="L2132" rel="#L2132">2132</span>
<span id="L2133" rel="#L2133">2133</span>
<span id="L2134" rel="#L2134">2134</span>
<span id="L2135" rel="#L2135">2135</span>
<span id="L2136" rel="#L2136">2136</span>
<span id="L2137" rel="#L2137">2137</span>
<span id="L2138" rel="#L2138">2138</span>
<span id="L2139" rel="#L2139">2139</span>
<span id="L2140" rel="#L2140">2140</span>
<span id="L2141" rel="#L2141">2141</span>
<span id="L2142" rel="#L2142">2142</span>
<span id="L2143" rel="#L2143">2143</span>
<span id="L2144" rel="#L2144">2144</span>
<span id="L2145" rel="#L2145">2145</span>
<span id="L2146" rel="#L2146">2146</span>
<span id="L2147" rel="#L2147">2147</span>
<span id="L2148" rel="#L2148">2148</span>
<span id="L2149" rel="#L2149">2149</span>
<span id="L2150" rel="#L2150">2150</span>
<span id="L2151" rel="#L2151">2151</span>
<span id="L2152" rel="#L2152">2152</span>
<span id="L2153" rel="#L2153">2153</span>
<span id="L2154" rel="#L2154">2154</span>
<span id="L2155" rel="#L2155">2155</span>
<span id="L2156" rel="#L2156">2156</span>
<span id="L2157" rel="#L2157">2157</span>
<span id="L2158" rel="#L2158">2158</span>
<span id="L2159" rel="#L2159">2159</span>
<span id="L2160" rel="#L2160">2160</span>
<span id="L2161" rel="#L2161">2161</span>
<span id="L2162" rel="#L2162">2162</span>
<span id="L2163" rel="#L2163">2163</span>
<span id="L2164" rel="#L2164">2164</span>
<span id="L2165" rel="#L2165">2165</span>
<span id="L2166" rel="#L2166">2166</span>
<span id="L2167" rel="#L2167">2167</span>
<span id="L2168" rel="#L2168">2168</span>
<span id="L2169" rel="#L2169">2169</span>
<span id="L2170" rel="#L2170">2170</span>
<span id="L2171" rel="#L2171">2171</span>
<span id="L2172" rel="#L2172">2172</span>
<span id="L2173" rel="#L2173">2173</span>
<span id="L2174" rel="#L2174">2174</span>
<span id="L2175" rel="#L2175">2175</span>
<span id="L2176" rel="#L2176">2176</span>
<span id="L2177" rel="#L2177">2177</span>
<span id="L2178" rel="#L2178">2178</span>
<span id="L2179" rel="#L2179">2179</span>
<span id="L2180" rel="#L2180">2180</span>
<span id="L2181" rel="#L2181">2181</span>
<span id="L2182" rel="#L2182">2182</span>
<span id="L2183" rel="#L2183">2183</span>
<span id="L2184" rel="#L2184">2184</span>
<span id="L2185" rel="#L2185">2185</span>
<span id="L2186" rel="#L2186">2186</span>
<span id="L2187" rel="#L2187">2187</span>
<span id="L2188" rel="#L2188">2188</span>
<span id="L2189" rel="#L2189">2189</span>
<span id="L2190" rel="#L2190">2190</span>
<span id="L2191" rel="#L2191">2191</span>
<span id="L2192" rel="#L2192">2192</span>
<span id="L2193" rel="#L2193">2193</span>
<span id="L2194" rel="#L2194">2194</span>
<span id="L2195" rel="#L2195">2195</span>
<span id="L2196" rel="#L2196">2196</span>
<span id="L2197" rel="#L2197">2197</span>
<span id="L2198" rel="#L2198">2198</span>
<span id="L2199" rel="#L2199">2199</span>
<span id="L2200" rel="#L2200">2200</span>
<span id="L2201" rel="#L2201">2201</span>
<span id="L2202" rel="#L2202">2202</span>
<span id="L2203" rel="#L2203">2203</span>
<span id="L2204" rel="#L2204">2204</span>
<span id="L2205" rel="#L2205">2205</span>
<span id="L2206" rel="#L2206">2206</span>
<span id="L2207" rel="#L2207">2207</span>
<span id="L2208" rel="#L2208">2208</span>
<span id="L2209" rel="#L2209">2209</span>
<span id="L2210" rel="#L2210">2210</span>
<span id="L2211" rel="#L2211">2211</span>
<span id="L2212" rel="#L2212">2212</span>
<span id="L2213" rel="#L2213">2213</span>
<span id="L2214" rel="#L2214">2214</span>
<span id="L2215" rel="#L2215">2215</span>
<span id="L2216" rel="#L2216">2216</span>
<span id="L2217" rel="#L2217">2217</span>
<span id="L2218" rel="#L2218">2218</span>
<span id="L2219" rel="#L2219">2219</span>
<span id="L2220" rel="#L2220">2220</span>
<span id="L2221" rel="#L2221">2221</span>
<span id="L2222" rel="#L2222">2222</span>
<span id="L2223" rel="#L2223">2223</span>
<span id="L2224" rel="#L2224">2224</span>
<span id="L2225" rel="#L2225">2225</span>
<span id="L2226" rel="#L2226">2226</span>
<span id="L2227" rel="#L2227">2227</span>
<span id="L2228" rel="#L2228">2228</span>
<span id="L2229" rel="#L2229">2229</span>
<span id="L2230" rel="#L2230">2230</span>
<span id="L2231" rel="#L2231">2231</span>
<span id="L2232" rel="#L2232">2232</span>
<span id="L2233" rel="#L2233">2233</span>
<span id="L2234" rel="#L2234">2234</span>
<span id="L2235" rel="#L2235">2235</span>
<span id="L2236" rel="#L2236">2236</span>
<span id="L2237" rel="#L2237">2237</span>
<span id="L2238" rel="#L2238">2238</span>
<span id="L2239" rel="#L2239">2239</span>
<span id="L2240" rel="#L2240">2240</span>
<span id="L2241" rel="#L2241">2241</span>
<span id="L2242" rel="#L2242">2242</span>
<span id="L2243" rel="#L2243">2243</span>
<span id="L2244" rel="#L2244">2244</span>
<span id="L2245" rel="#L2245">2245</span>
<span id="L2246" rel="#L2246">2246</span>
<span id="L2247" rel="#L2247">2247</span>
<span id="L2248" rel="#L2248">2248</span>
<span id="L2249" rel="#L2249">2249</span>
<span id="L2250" rel="#L2250">2250</span>
<span id="L2251" rel="#L2251">2251</span>
<span id="L2252" rel="#L2252">2252</span>
<span id="L2253" rel="#L2253">2253</span>
<span id="L2254" rel="#L2254">2254</span>
<span id="L2255" rel="#L2255">2255</span>
<span id="L2256" rel="#L2256">2256</span>
<span id="L2257" rel="#L2257">2257</span>
<span id="L2258" rel="#L2258">2258</span>
<span id="L2259" rel="#L2259">2259</span>
<span id="L2260" rel="#L2260">2260</span>
<span id="L2261" rel="#L2261">2261</span>
<span id="L2262" rel="#L2262">2262</span>
<span id="L2263" rel="#L2263">2263</span>
<span id="L2264" rel="#L2264">2264</span>
<span id="L2265" rel="#L2265">2265</span>
<span id="L2266" rel="#L2266">2266</span>
<span id="L2267" rel="#L2267">2267</span>
<span id="L2268" rel="#L2268">2268</span>
<span id="L2269" rel="#L2269">2269</span>
<span id="L2270" rel="#L2270">2270</span>
<span id="L2271" rel="#L2271">2271</span>
<span id="L2272" rel="#L2272">2272</span>
<span id="L2273" rel="#L2273">2273</span>
<span id="L2274" rel="#L2274">2274</span>
<span id="L2275" rel="#L2275">2275</span>
<span id="L2276" rel="#L2276">2276</span>
<span id="L2277" rel="#L2277">2277</span>
<span id="L2278" rel="#L2278">2278</span>
<span id="L2279" rel="#L2279">2279</span>
<span id="L2280" rel="#L2280">2280</span>
<span id="L2281" rel="#L2281">2281</span>
<span id="L2282" rel="#L2282">2282</span>
<span id="L2283" rel="#L2283">2283</span>
<span id="L2284" rel="#L2284">2284</span>
<span id="L2285" rel="#L2285">2285</span>
<span id="L2286" rel="#L2286">2286</span>
<span id="L2287" rel="#L2287">2287</span>
<span id="L2288" rel="#L2288">2288</span>
<span id="L2289" rel="#L2289">2289</span>
<span id="L2290" rel="#L2290">2290</span>
<span id="L2291" rel="#L2291">2291</span>
<span id="L2292" rel="#L2292">2292</span>
<span id="L2293" rel="#L2293">2293</span>
<span id="L2294" rel="#L2294">2294</span>
<span id="L2295" rel="#L2295">2295</span>
<span id="L2296" rel="#L2296">2296</span>
<span id="L2297" rel="#L2297">2297</span>
<span id="L2298" rel="#L2298">2298</span>
<span id="L2299" rel="#L2299">2299</span>
<span id="L2300" rel="#L2300">2300</span>
<span id="L2301" rel="#L2301">2301</span>
<span id="L2302" rel="#L2302">2302</span>
<span id="L2303" rel="#L2303">2303</span>
<span id="L2304" rel="#L2304">2304</span>
<span id="L2305" rel="#L2305">2305</span>
<span id="L2306" rel="#L2306">2306</span>
<span id="L2307" rel="#L2307">2307</span>
<span id="L2308" rel="#L2308">2308</span>
<span id="L2309" rel="#L2309">2309</span>
<span id="L2310" rel="#L2310">2310</span>
<span id="L2311" rel="#L2311">2311</span>
<span id="L2312" rel="#L2312">2312</span>
<span id="L2313" rel="#L2313">2313</span>
<span id="L2314" rel="#L2314">2314</span>
<span id="L2315" rel="#L2315">2315</span>
<span id="L2316" rel="#L2316">2316</span>
<span id="L2317" rel="#L2317">2317</span>
<span id="L2318" rel="#L2318">2318</span>
<span id="L2319" rel="#L2319">2319</span>
<span id="L2320" rel="#L2320">2320</span>
<span id="L2321" rel="#L2321">2321</span>
<span id="L2322" rel="#L2322">2322</span>
<span id="L2323" rel="#L2323">2323</span>
<span id="L2324" rel="#L2324">2324</span>
<span id="L2325" rel="#L2325">2325</span>
<span id="L2326" rel="#L2326">2326</span>
<span id="L2327" rel="#L2327">2327</span>
<span id="L2328" rel="#L2328">2328</span>
<span id="L2329" rel="#L2329">2329</span>
<span id="L2330" rel="#L2330">2330</span>
<span id="L2331" rel="#L2331">2331</span>
<span id="L2332" rel="#L2332">2332</span>
<span id="L2333" rel="#L2333">2333</span>
<span id="L2334" rel="#L2334">2334</span>
<span id="L2335" rel="#L2335">2335</span>
<span id="L2336" rel="#L2336">2336</span>
<span id="L2337" rel="#L2337">2337</span>
<span id="L2338" rel="#L2338">2338</span>
<span id="L2339" rel="#L2339">2339</span>
<span id="L2340" rel="#L2340">2340</span>
<span id="L2341" rel="#L2341">2341</span>
<span id="L2342" rel="#L2342">2342</span>
<span id="L2343" rel="#L2343">2343</span>
<span id="L2344" rel="#L2344">2344</span>
<span id="L2345" rel="#L2345">2345</span>
<span id="L2346" rel="#L2346">2346</span>
<span id="L2347" rel="#L2347">2347</span>
<span id="L2348" rel="#L2348">2348</span>
<span id="L2349" rel="#L2349">2349</span>
<span id="L2350" rel="#L2350">2350</span>
<span id="L2351" rel="#L2351">2351</span>
<span id="L2352" rel="#L2352">2352</span>
<span id="L2353" rel="#L2353">2353</span>
<span id="L2354" rel="#L2354">2354</span>
<span id="L2355" rel="#L2355">2355</span>
<span id="L2356" rel="#L2356">2356</span>
<span id="L2357" rel="#L2357">2357</span>
<span id="L2358" rel="#L2358">2358</span>
<span id="L2359" rel="#L2359">2359</span>
<span id="L2360" rel="#L2360">2360</span>
<span id="L2361" rel="#L2361">2361</span>
<span id="L2362" rel="#L2362">2362</span>
<span id="L2363" rel="#L2363">2363</span>
<span id="L2364" rel="#L2364">2364</span>
<span id="L2365" rel="#L2365">2365</span>
<span id="L2366" rel="#L2366">2366</span>
<span id="L2367" rel="#L2367">2367</span>
<span id="L2368" rel="#L2368">2368</span>
<span id="L2369" rel="#L2369">2369</span>
<span id="L2370" rel="#L2370">2370</span>
<span id="L2371" rel="#L2371">2371</span>
<span id="L2372" rel="#L2372">2372</span>
<span id="L2373" rel="#L2373">2373</span>
<span id="L2374" rel="#L2374">2374</span>
<span id="L2375" rel="#L2375">2375</span>
<span id="L2376" rel="#L2376">2376</span>
<span id="L2377" rel="#L2377">2377</span>
<span id="L2378" rel="#L2378">2378</span>
<span id="L2379" rel="#L2379">2379</span>
<span id="L2380" rel="#L2380">2380</span>
<span id="L2381" rel="#L2381">2381</span>
<span id="L2382" rel="#L2382">2382</span>
<span id="L2383" rel="#L2383">2383</span>
<span id="L2384" rel="#L2384">2384</span>
<span id="L2385" rel="#L2385">2385</span>
<span id="L2386" rel="#L2386">2386</span>
<span id="L2387" rel="#L2387">2387</span>
<span id="L2388" rel="#L2388">2388</span>
<span id="L2389" rel="#L2389">2389</span>
<span id="L2390" rel="#L2390">2390</span>
<span id="L2391" rel="#L2391">2391</span>
<span id="L2392" rel="#L2392">2392</span>
<span id="L2393" rel="#L2393">2393</span>
<span id="L2394" rel="#L2394">2394</span>
<span id="L2395" rel="#L2395">2395</span>
<span id="L2396" rel="#L2396">2396</span>
<span id="L2397" rel="#L2397">2397</span>
<span id="L2398" rel="#L2398">2398</span>
<span id="L2399" rel="#L2399">2399</span>
<span id="L2400" rel="#L2400">2400</span>
<span id="L2401" rel="#L2401">2401</span>
<span id="L2402" rel="#L2402">2402</span>
<span id="L2403" rel="#L2403">2403</span>
<span id="L2404" rel="#L2404">2404</span>
<span id="L2405" rel="#L2405">2405</span>
<span id="L2406" rel="#L2406">2406</span>
<span id="L2407" rel="#L2407">2407</span>
<span id="L2408" rel="#L2408">2408</span>
<span id="L2409" rel="#L2409">2409</span>
<span id="L2410" rel="#L2410">2410</span>
<span id="L2411" rel="#L2411">2411</span>
<span id="L2412" rel="#L2412">2412</span>
<span id="L2413" rel="#L2413">2413</span>
<span id="L2414" rel="#L2414">2414</span>
<span id="L2415" rel="#L2415">2415</span>
<span id="L2416" rel="#L2416">2416</span>
<span id="L2417" rel="#L2417">2417</span>
<span id="L2418" rel="#L2418">2418</span>
<span id="L2419" rel="#L2419">2419</span>
<span id="L2420" rel="#L2420">2420</span>
<span id="L2421" rel="#L2421">2421</span>
<span id="L2422" rel="#L2422">2422</span>
<span id="L2423" rel="#L2423">2423</span>
<span id="L2424" rel="#L2424">2424</span>
<span id="L2425" rel="#L2425">2425</span>
<span id="L2426" rel="#L2426">2426</span>
<span id="L2427" rel="#L2427">2427</span>
<span id="L2428" rel="#L2428">2428</span>
<span id="L2429" rel="#L2429">2429</span>
<span id="L2430" rel="#L2430">2430</span>
<span id="L2431" rel="#L2431">2431</span>
<span id="L2432" rel="#L2432">2432</span>
<span id="L2433" rel="#L2433">2433</span>
<span id="L2434" rel="#L2434">2434</span>
<span id="L2435" rel="#L2435">2435</span>
<span id="L2436" rel="#L2436">2436</span>
<span id="L2437" rel="#L2437">2437</span>
<span id="L2438" rel="#L2438">2438</span>
<span id="L2439" rel="#L2439">2439</span>
<span id="L2440" rel="#L2440">2440</span>
<span id="L2441" rel="#L2441">2441</span>
<span id="L2442" rel="#L2442">2442</span>
<span id="L2443" rel="#L2443">2443</span>
<span id="L2444" rel="#L2444">2444</span>
<span id="L2445" rel="#L2445">2445</span>
<span id="L2446" rel="#L2446">2446</span>
<span id="L2447" rel="#L2447">2447</span>
<span id="L2448" rel="#L2448">2448</span>
<span id="L2449" rel="#L2449">2449</span>
<span id="L2450" rel="#L2450">2450</span>
<span id="L2451" rel="#L2451">2451</span>
<span id="L2452" rel="#L2452">2452</span>
<span id="L2453" rel="#L2453">2453</span>
<span id="L2454" rel="#L2454">2454</span>
<span id="L2455" rel="#L2455">2455</span>
<span id="L2456" rel="#L2456">2456</span>
<span id="L2457" rel="#L2457">2457</span>
<span id="L2458" rel="#L2458">2458</span>
<span id="L2459" rel="#L2459">2459</span>
<span id="L2460" rel="#L2460">2460</span>
<span id="L2461" rel="#L2461">2461</span>
<span id="L2462" rel="#L2462">2462</span>
<span id="L2463" rel="#L2463">2463</span>
<span id="L2464" rel="#L2464">2464</span>
<span id="L2465" rel="#L2465">2465</span>
<span id="L2466" rel="#L2466">2466</span>
<span id="L2467" rel="#L2467">2467</span>
<span id="L2468" rel="#L2468">2468</span>
<span id="L2469" rel="#L2469">2469</span>
<span id="L2470" rel="#L2470">2470</span>
<span id="L2471" rel="#L2471">2471</span>
<span id="L2472" rel="#L2472">2472</span>
<span id="L2473" rel="#L2473">2473</span>
<span id="L2474" rel="#L2474">2474</span>
<span id="L2475" rel="#L2475">2475</span>
<span id="L2476" rel="#L2476">2476</span>
<span id="L2477" rel="#L2477">2477</span>
<span id="L2478" rel="#L2478">2478</span>
<span id="L2479" rel="#L2479">2479</span>
<span id="L2480" rel="#L2480">2480</span>
<span id="L2481" rel="#L2481">2481</span>
<span id="L2482" rel="#L2482">2482</span>
<span id="L2483" rel="#L2483">2483</span>
<span id="L2484" rel="#L2484">2484</span>
<span id="L2485" rel="#L2485">2485</span>
<span id="L2486" rel="#L2486">2486</span>
<span id="L2487" rel="#L2487">2487</span>
<span id="L2488" rel="#L2488">2488</span>
<span id="L2489" rel="#L2489">2489</span>
<span id="L2490" rel="#L2490">2490</span>
<span id="L2491" rel="#L2491">2491</span>
<span id="L2492" rel="#L2492">2492</span>
<span id="L2493" rel="#L2493">2493</span>
<span id="L2494" rel="#L2494">2494</span>
<span id="L2495" rel="#L2495">2495</span>
<span id="L2496" rel="#L2496">2496</span>
<span id="L2497" rel="#L2497">2497</span>
<span id="L2498" rel="#L2498">2498</span>
<span id="L2499" rel="#L2499">2499</span>
<span id="L2500" rel="#L2500">2500</span>
<span id="L2501" rel="#L2501">2501</span>
<span id="L2502" rel="#L2502">2502</span>
<span id="L2503" rel="#L2503">2503</span>
<span id="L2504" rel="#L2504">2504</span>
<span id="L2505" rel="#L2505">2505</span>
<span id="L2506" rel="#L2506">2506</span>
<span id="L2507" rel="#L2507">2507</span>
<span id="L2508" rel="#L2508">2508</span>
<span id="L2509" rel="#L2509">2509</span>
<span id="L2510" rel="#L2510">2510</span>
<span id="L2511" rel="#L2511">2511</span>
<span id="L2512" rel="#L2512">2512</span>
<span id="L2513" rel="#L2513">2513</span>
<span id="L2514" rel="#L2514">2514</span>
<span id="L2515" rel="#L2515">2515</span>
<span id="L2516" rel="#L2516">2516</span>
<span id="L2517" rel="#L2517">2517</span>
<span id="L2518" rel="#L2518">2518</span>
<span id="L2519" rel="#L2519">2519</span>
<span id="L2520" rel="#L2520">2520</span>
<span id="L2521" rel="#L2521">2521</span>
<span id="L2522" rel="#L2522">2522</span>
<span id="L2523" rel="#L2523">2523</span>
<span id="L2524" rel="#L2524">2524</span>
<span id="L2525" rel="#L2525">2525</span>
<span id="L2526" rel="#L2526">2526</span>
<span id="L2527" rel="#L2527">2527</span>
<span id="L2528" rel="#L2528">2528</span>
<span id="L2529" rel="#L2529">2529</span>
<span id="L2530" rel="#L2530">2530</span>
<span id="L2531" rel="#L2531">2531</span>
<span id="L2532" rel="#L2532">2532</span>
<span id="L2533" rel="#L2533">2533</span>
<span id="L2534" rel="#L2534">2534</span>
<span id="L2535" rel="#L2535">2535</span>
<span id="L2536" rel="#L2536">2536</span>
<span id="L2537" rel="#L2537">2537</span>
<span id="L2538" rel="#L2538">2538</span>
<span id="L2539" rel="#L2539">2539</span>
<span id="L2540" rel="#L2540">2540</span>
<span id="L2541" rel="#L2541">2541</span>
<span id="L2542" rel="#L2542">2542</span>
<span id="L2543" rel="#L2543">2543</span>
<span id="L2544" rel="#L2544">2544</span>
<span id="L2545" rel="#L2545">2545</span>
<span id="L2546" rel="#L2546">2546</span>
<span id="L2547" rel="#L2547">2547</span>
<span id="L2548" rel="#L2548">2548</span>
<span id="L2549" rel="#L2549">2549</span>
<span id="L2550" rel="#L2550">2550</span>
<span id="L2551" rel="#L2551">2551</span>
<span id="L2552" rel="#L2552">2552</span>
<span id="L2553" rel="#L2553">2553</span>
<span id="L2554" rel="#L2554">2554</span>
<span id="L2555" rel="#L2555">2555</span>
<span id="L2556" rel="#L2556">2556</span>
<span id="L2557" rel="#L2557">2557</span>
<span id="L2558" rel="#L2558">2558</span>
<span id="L2559" rel="#L2559">2559</span>
<span id="L2560" rel="#L2560">2560</span>
<span id="L2561" rel="#L2561">2561</span>
<span id="L2562" rel="#L2562">2562</span>
<span id="L2563" rel="#L2563">2563</span>
<span id="L2564" rel="#L2564">2564</span>
<span id="L2565" rel="#L2565">2565</span>
<span id="L2566" rel="#L2566">2566</span>
<span id="L2567" rel="#L2567">2567</span>
<span id="L2568" rel="#L2568">2568</span>
<span id="L2569" rel="#L2569">2569</span>
<span id="L2570" rel="#L2570">2570</span>
<span id="L2571" rel="#L2571">2571</span>
<span id="L2572" rel="#L2572">2572</span>
<span id="L2573" rel="#L2573">2573</span>
<span id="L2574" rel="#L2574">2574</span>
<span id="L2575" rel="#L2575">2575</span>
<span id="L2576" rel="#L2576">2576</span>
<span id="L2577" rel="#L2577">2577</span>
<span id="L2578" rel="#L2578">2578</span>
<span id="L2579" rel="#L2579">2579</span>
<span id="L2580" rel="#L2580">2580</span>
<span id="L2581" rel="#L2581">2581</span>
<span id="L2582" rel="#L2582">2582</span>
<span id="L2583" rel="#L2583">2583</span>
<span id="L2584" rel="#L2584">2584</span>
<span id="L2585" rel="#L2585">2585</span>
<span id="L2586" rel="#L2586">2586</span>
<span id="L2587" rel="#L2587">2587</span>
<span id="L2588" rel="#L2588">2588</span>
<span id="L2589" rel="#L2589">2589</span>
<span id="L2590" rel="#L2590">2590</span>
<span id="L2591" rel="#L2591">2591</span>
<span id="L2592" rel="#L2592">2592</span>
<span id="L2593" rel="#L2593">2593</span>
<span id="L2594" rel="#L2594">2594</span>
<span id="L2595" rel="#L2595">2595</span>
<span id="L2596" rel="#L2596">2596</span>
<span id="L2597" rel="#L2597">2597</span>
<span id="L2598" rel="#L2598">2598</span>
<span id="L2599" rel="#L2599">2599</span>
<span id="L2600" rel="#L2600">2600</span>
<span id="L2601" rel="#L2601">2601</span>
<span id="L2602" rel="#L2602">2602</span>
<span id="L2603" rel="#L2603">2603</span>
<span id="L2604" rel="#L2604">2604</span>
<span id="L2605" rel="#L2605">2605</span>
<span id="L2606" rel="#L2606">2606</span>
<span id="L2607" rel="#L2607">2607</span>
<span id="L2608" rel="#L2608">2608</span>
<span id="L2609" rel="#L2609">2609</span>
<span id="L2610" rel="#L2610">2610</span>
<span id="L2611" rel="#L2611">2611</span>
<span id="L2612" rel="#L2612">2612</span>
<span id="L2613" rel="#L2613">2613</span>
<span id="L2614" rel="#L2614">2614</span>
<span id="L2615" rel="#L2615">2615</span>
<span id="L2616" rel="#L2616">2616</span>
<span id="L2617" rel="#L2617">2617</span>
<span id="L2618" rel="#L2618">2618</span>
<span id="L2619" rel="#L2619">2619</span>
<span id="L2620" rel="#L2620">2620</span>
<span id="L2621" rel="#L2621">2621</span>
<span id="L2622" rel="#L2622">2622</span>
<span id="L2623" rel="#L2623">2623</span>
<span id="L2624" rel="#L2624">2624</span>
<span id="L2625" rel="#L2625">2625</span>
<span id="L2626" rel="#L2626">2626</span>
<span id="L2627" rel="#L2627">2627</span>
<span id="L2628" rel="#L2628">2628</span>
<span id="L2629" rel="#L2629">2629</span>
<span id="L2630" rel="#L2630">2630</span>
<span id="L2631" rel="#L2631">2631</span>
<span id="L2632" rel="#L2632">2632</span>
<span id="L2633" rel="#L2633">2633</span>
<span id="L2634" rel="#L2634">2634</span>
<span id="L2635" rel="#L2635">2635</span>
<span id="L2636" rel="#L2636">2636</span>
<span id="L2637" rel="#L2637">2637</span>
<span id="L2638" rel="#L2638">2638</span>
<span id="L2639" rel="#L2639">2639</span>
<span id="L2640" rel="#L2640">2640</span>
<span id="L2641" rel="#L2641">2641</span>
<span id="L2642" rel="#L2642">2642</span>
<span id="L2643" rel="#L2643">2643</span>
<span id="L2644" rel="#L2644">2644</span>
<span id="L2645" rel="#L2645">2645</span>
<span id="L2646" rel="#L2646">2646</span>
<span id="L2647" rel="#L2647">2647</span>
<span id="L2648" rel="#L2648">2648</span>
<span id="L2649" rel="#L2649">2649</span>
<span id="L2650" rel="#L2650">2650</span>
<span id="L2651" rel="#L2651">2651</span>
<span id="L2652" rel="#L2652">2652</span>
<span id="L2653" rel="#L2653">2653</span>
<span id="L2654" rel="#L2654">2654</span>
<span id="L2655" rel="#L2655">2655</span>
<span id="L2656" rel="#L2656">2656</span>
<span id="L2657" rel="#L2657">2657</span>
<span id="L2658" rel="#L2658">2658</span>
<span id="L2659" rel="#L2659">2659</span>
<span id="L2660" rel="#L2660">2660</span>
<span id="L2661" rel="#L2661">2661</span>
<span id="L2662" rel="#L2662">2662</span>
<span id="L2663" rel="#L2663">2663</span>
<span id="L2664" rel="#L2664">2664</span>
<span id="L2665" rel="#L2665">2665</span>
<span id="L2666" rel="#L2666">2666</span>
<span id="L2667" rel="#L2667">2667</span>
<span id="L2668" rel="#L2668">2668</span>
<span id="L2669" rel="#L2669">2669</span>
<span id="L2670" rel="#L2670">2670</span>
<span id="L2671" rel="#L2671">2671</span>
<span id="L2672" rel="#L2672">2672</span>
<span id="L2673" rel="#L2673">2673</span>
<span id="L2674" rel="#L2674">2674</span>
<span id="L2675" rel="#L2675">2675</span>
<span id="L2676" rel="#L2676">2676</span>
<span id="L2677" rel="#L2677">2677</span>
<span id="L2678" rel="#L2678">2678</span>
<span id="L2679" rel="#L2679">2679</span>
<span id="L2680" rel="#L2680">2680</span>
<span id="L2681" rel="#L2681">2681</span>
<span id="L2682" rel="#L2682">2682</span>
<span id="L2683" rel="#L2683">2683</span>
<span id="L2684" rel="#L2684">2684</span>
<span id="L2685" rel="#L2685">2685</span>
<span id="L2686" rel="#L2686">2686</span>
<span id="L2687" rel="#L2687">2687</span>
<span id="L2688" rel="#L2688">2688</span>
<span id="L2689" rel="#L2689">2689</span>
<span id="L2690" rel="#L2690">2690</span>
<span id="L2691" rel="#L2691">2691</span>
<span id="L2692" rel="#L2692">2692</span>
<span id="L2693" rel="#L2693">2693</span>
<span id="L2694" rel="#L2694">2694</span>
<span id="L2695" rel="#L2695">2695</span>
<span id="L2696" rel="#L2696">2696</span>
<span id="L2697" rel="#L2697">2697</span>
<span id="L2698" rel="#L2698">2698</span>
<span id="L2699" rel="#L2699">2699</span>
<span id="L2700" rel="#L2700">2700</span>
<span id="L2701" rel="#L2701">2701</span>
<span id="L2702" rel="#L2702">2702</span>
<span id="L2703" rel="#L2703">2703</span>
<span id="L2704" rel="#L2704">2704</span>
<span id="L2705" rel="#L2705">2705</span>
<span id="L2706" rel="#L2706">2706</span>
<span id="L2707" rel="#L2707">2707</span>
<span id="L2708" rel="#L2708">2708</span>
<span id="L2709" rel="#L2709">2709</span>
<span id="L2710" rel="#L2710">2710</span>
<span id="L2711" rel="#L2711">2711</span>
<span id="L2712" rel="#L2712">2712</span>
<span id="L2713" rel="#L2713">2713</span>
<span id="L2714" rel="#L2714">2714</span>
<span id="L2715" rel="#L2715">2715</span>
<span id="L2716" rel="#L2716">2716</span>
<span id="L2717" rel="#L2717">2717</span>
<span id="L2718" rel="#L2718">2718</span>
<span id="L2719" rel="#L2719">2719</span>
<span id="L2720" rel="#L2720">2720</span>
<span id="L2721" rel="#L2721">2721</span>
<span id="L2722" rel="#L2722">2722</span>
<span id="L2723" rel="#L2723">2723</span>
<span id="L2724" rel="#L2724">2724</span>
<span id="L2725" rel="#L2725">2725</span>
<span id="L2726" rel="#L2726">2726</span>
<span id="L2727" rel="#L2727">2727</span>
<span id="L2728" rel="#L2728">2728</span>
<span id="L2729" rel="#L2729">2729</span>
<span id="L2730" rel="#L2730">2730</span>
<span id="L2731" rel="#L2731">2731</span>
<span id="L2732" rel="#L2732">2732</span>
<span id="L2733" rel="#L2733">2733</span>
<span id="L2734" rel="#L2734">2734</span>
<span id="L2735" rel="#L2735">2735</span>
<span id="L2736" rel="#L2736">2736</span>
<span id="L2737" rel="#L2737">2737</span>
<span id="L2738" rel="#L2738">2738</span>
<span id="L2739" rel="#L2739">2739</span>
<span id="L2740" rel="#L2740">2740</span>
<span id="L2741" rel="#L2741">2741</span>
<span id="L2742" rel="#L2742">2742</span>
<span id="L2743" rel="#L2743">2743</span>
<span id="L2744" rel="#L2744">2744</span>
<span id="L2745" rel="#L2745">2745</span>
<span id="L2746" rel="#L2746">2746</span>
<span id="L2747" rel="#L2747">2747</span>
<span id="L2748" rel="#L2748">2748</span>
<span id="L2749" rel="#L2749">2749</span>
<span id="L2750" rel="#L2750">2750</span>
<span id="L2751" rel="#L2751">2751</span>
<span id="L2752" rel="#L2752">2752</span>
<span id="L2753" rel="#L2753">2753</span>
<span id="L2754" rel="#L2754">2754</span>
<span id="L2755" rel="#L2755">2755</span>
<span id="L2756" rel="#L2756">2756</span>
<span id="L2757" rel="#L2757">2757</span>
<span id="L2758" rel="#L2758">2758</span>
<span id="L2759" rel="#L2759">2759</span>
<span id="L2760" rel="#L2760">2760</span>
<span id="L2761" rel="#L2761">2761</span>
<span id="L2762" rel="#L2762">2762</span>
<span id="L2763" rel="#L2763">2763</span>
<span id="L2764" rel="#L2764">2764</span>
<span id="L2765" rel="#L2765">2765</span>
<span id="L2766" rel="#L2766">2766</span>
<span id="L2767" rel="#L2767">2767</span>
<span id="L2768" rel="#L2768">2768</span>
<span id="L2769" rel="#L2769">2769</span>
<span id="L2770" rel="#L2770">2770</span>
<span id="L2771" rel="#L2771">2771</span>
<span id="L2772" rel="#L2772">2772</span>
<span id="L2773" rel="#L2773">2773</span>
<span id="L2774" rel="#L2774">2774</span>
<span id="L2775" rel="#L2775">2775</span>
<span id="L2776" rel="#L2776">2776</span>
<span id="L2777" rel="#L2777">2777</span>
<span id="L2778" rel="#L2778">2778</span>
<span id="L2779" rel="#L2779">2779</span>
<span id="L2780" rel="#L2780">2780</span>
<span id="L2781" rel="#L2781">2781</span>
<span id="L2782" rel="#L2782">2782</span>
<span id="L2783" rel="#L2783">2783</span>
<span id="L2784" rel="#L2784">2784</span>
<span id="L2785" rel="#L2785">2785</span>
<span id="L2786" rel="#L2786">2786</span>
<span id="L2787" rel="#L2787">2787</span>
<span id="L2788" rel="#L2788">2788</span>
<span id="L2789" rel="#L2789">2789</span>
<span id="L2790" rel="#L2790">2790</span>
<span id="L2791" rel="#L2791">2791</span>
<span id="L2792" rel="#L2792">2792</span>
<span id="L2793" rel="#L2793">2793</span>
<span id="L2794" rel="#L2794">2794</span>
<span id="L2795" rel="#L2795">2795</span>
<span id="L2796" rel="#L2796">2796</span>
<span id="L2797" rel="#L2797">2797</span>
<span id="L2798" rel="#L2798">2798</span>
<span id="L2799" rel="#L2799">2799</span>
<span id="L2800" rel="#L2800">2800</span>
<span id="L2801" rel="#L2801">2801</span>
<span id="L2802" rel="#L2802">2802</span>
<span id="L2803" rel="#L2803">2803</span>
<span id="L2804" rel="#L2804">2804</span>
<span id="L2805" rel="#L2805">2805</span>
<span id="L2806" rel="#L2806">2806</span>
<span id="L2807" rel="#L2807">2807</span>
<span id="L2808" rel="#L2808">2808</span>
<span id="L2809" rel="#L2809">2809</span>
<span id="L2810" rel="#L2810">2810</span>
<span id="L2811" rel="#L2811">2811</span>
<span id="L2812" rel="#L2812">2812</span>
<span id="L2813" rel="#L2813">2813</span>
<span id="L2814" rel="#L2814">2814</span>
<span id="L2815" rel="#L2815">2815</span>
<span id="L2816" rel="#L2816">2816</span>
<span id="L2817" rel="#L2817">2817</span>
<span id="L2818" rel="#L2818">2818</span>
<span id="L2819" rel="#L2819">2819</span>
<span id="L2820" rel="#L2820">2820</span>
<span id="L2821" rel="#L2821">2821</span>
<span id="L2822" rel="#L2822">2822</span>
<span id="L2823" rel="#L2823">2823</span>
<span id="L2824" rel="#L2824">2824</span>
<span id="L2825" rel="#L2825">2825</span>
<span id="L2826" rel="#L2826">2826</span>
<span id="L2827" rel="#L2827">2827</span>
<span id="L2828" rel="#L2828">2828</span>
<span id="L2829" rel="#L2829">2829</span>
<span id="L2830" rel="#L2830">2830</span>
<span id="L2831" rel="#L2831">2831</span>
<span id="L2832" rel="#L2832">2832</span>
<span id="L2833" rel="#L2833">2833</span>
<span id="L2834" rel="#L2834">2834</span>
<span id="L2835" rel="#L2835">2835</span>
<span id="L2836" rel="#L2836">2836</span>
<span id="L2837" rel="#L2837">2837</span>
<span id="L2838" rel="#L2838">2838</span>
<span id="L2839" rel="#L2839">2839</span>
<span id="L2840" rel="#L2840">2840</span>
<span id="L2841" rel="#L2841">2841</span>
<span id="L2842" rel="#L2842">2842</span>
<span id="L2843" rel="#L2843">2843</span>
<span id="L2844" rel="#L2844">2844</span>
<span id="L2845" rel="#L2845">2845</span>
<span id="L2846" rel="#L2846">2846</span>
<span id="L2847" rel="#L2847">2847</span>
<span id="L2848" rel="#L2848">2848</span>
<span id="L2849" rel="#L2849">2849</span>
<span id="L2850" rel="#L2850">2850</span>
<span id="L2851" rel="#L2851">2851</span>
<span id="L2852" rel="#L2852">2852</span>
<span id="L2853" rel="#L2853">2853</span>
<span id="L2854" rel="#L2854">2854</span>
<span id="L2855" rel="#L2855">2855</span>
<span id="L2856" rel="#L2856">2856</span>
<span id="L2857" rel="#L2857">2857</span>
<span id="L2858" rel="#L2858">2858</span>
<span id="L2859" rel="#L2859">2859</span>
<span id="L2860" rel="#L2860">2860</span>
<span id="L2861" rel="#L2861">2861</span>
<span id="L2862" rel="#L2862">2862</span>
<span id="L2863" rel="#L2863">2863</span>
<span id="L2864" rel="#L2864">2864</span>
<span id="L2865" rel="#L2865">2865</span>
<span id="L2866" rel="#L2866">2866</span>
<span id="L2867" rel="#L2867">2867</span>
<span id="L2868" rel="#L2868">2868</span>
<span id="L2869" rel="#L2869">2869</span>
<span id="L2870" rel="#L2870">2870</span>
<span id="L2871" rel="#L2871">2871</span>
<span id="L2872" rel="#L2872">2872</span>
<span id="L2873" rel="#L2873">2873</span>
<span id="L2874" rel="#L2874">2874</span>
<span id="L2875" rel="#L2875">2875</span>
<span id="L2876" rel="#L2876">2876</span>
<span id="L2877" rel="#L2877">2877</span>
<span id="L2878" rel="#L2878">2878</span>
<span id="L2879" rel="#L2879">2879</span>
<span id="L2880" rel="#L2880">2880</span>
<span id="L2881" rel="#L2881">2881</span>
<span id="L2882" rel="#L2882">2882</span>
<span id="L2883" rel="#L2883">2883</span>
<span id="L2884" rel="#L2884">2884</span>
<span id="L2885" rel="#L2885">2885</span>
<span id="L2886" rel="#L2886">2886</span>
<span id="L2887" rel="#L2887">2887</span>
<span id="L2888" rel="#L2888">2888</span>
<span id="L2889" rel="#L2889">2889</span>
<span id="L2890" rel="#L2890">2890</span>
<span id="L2891" rel="#L2891">2891</span>
<span id="L2892" rel="#L2892">2892</span>
<span id="L2893" rel="#L2893">2893</span>
<span id="L2894" rel="#L2894">2894</span>
<span id="L2895" rel="#L2895">2895</span>
<span id="L2896" rel="#L2896">2896</span>
<span id="L2897" rel="#L2897">2897</span>
<span id="L2898" rel="#L2898">2898</span>
<span id="L2899" rel="#L2899">2899</span>
<span id="L2900" rel="#L2900">2900</span>
<span id="L2901" rel="#L2901">2901</span>
<span id="L2902" rel="#L2902">2902</span>
<span id="L2903" rel="#L2903">2903</span>
<span id="L2904" rel="#L2904">2904</span>
<span id="L2905" rel="#L2905">2905</span>
<span id="L2906" rel="#L2906">2906</span>
<span id="L2907" rel="#L2907">2907</span>
<span id="L2908" rel="#L2908">2908</span>
<span id="L2909" rel="#L2909">2909</span>
<span id="L2910" rel="#L2910">2910</span>
<span id="L2911" rel="#L2911">2911</span>
<span id="L2912" rel="#L2912">2912</span>
<span id="L2913" rel="#L2913">2913</span>
<span id="L2914" rel="#L2914">2914</span>
<span id="L2915" rel="#L2915">2915</span>
<span id="L2916" rel="#L2916">2916</span>
<span id="L2917" rel="#L2917">2917</span>
<span id="L2918" rel="#L2918">2918</span>
<span id="L2919" rel="#L2919">2919</span>
<span id="L2920" rel="#L2920">2920</span>
<span id="L2921" rel="#L2921">2921</span>
<span id="L2922" rel="#L2922">2922</span>
<span id="L2923" rel="#L2923">2923</span>
<span id="L2924" rel="#L2924">2924</span>
<span id="L2925" rel="#L2925">2925</span>
<span id="L2926" rel="#L2926">2926</span>
<span id="L2927" rel="#L2927">2927</span>
<span id="L2928" rel="#L2928">2928</span>
<span id="L2929" rel="#L2929">2929</span>
<span id="L2930" rel="#L2930">2930</span>
<span id="L2931" rel="#L2931">2931</span>
<span id="L2932" rel="#L2932">2932</span>
<span id="L2933" rel="#L2933">2933</span>
<span id="L2934" rel="#L2934">2934</span>
<span id="L2935" rel="#L2935">2935</span>
<span id="L2936" rel="#L2936">2936</span>
<span id="L2937" rel="#L2937">2937</span>
<span id="L2938" rel="#L2938">2938</span>
<span id="L2939" rel="#L2939">2939</span>
<span id="L2940" rel="#L2940">2940</span>
<span id="L2941" rel="#L2941">2941</span>
<span id="L2942" rel="#L2942">2942</span>
<span id="L2943" rel="#L2943">2943</span>
<span id="L2944" rel="#L2944">2944</span>
<span id="L2945" rel="#L2945">2945</span>
<span id="L2946" rel="#L2946">2946</span>
<span id="L2947" rel="#L2947">2947</span>
<span id="L2948" rel="#L2948">2948</span>
<span id="L2949" rel="#L2949">2949</span>
<span id="L2950" rel="#L2950">2950</span>
<span id="L2951" rel="#L2951">2951</span>
<span id="L2952" rel="#L2952">2952</span>
<span id="L2953" rel="#L2953">2953</span>
<span id="L2954" rel="#L2954">2954</span>
<span id="L2955" rel="#L2955">2955</span>
<span id="L2956" rel="#L2956">2956</span>
<span id="L2957" rel="#L2957">2957</span>
<span id="L2958" rel="#L2958">2958</span>
<span id="L2959" rel="#L2959">2959</span>
<span id="L2960" rel="#L2960">2960</span>
<span id="L2961" rel="#L2961">2961</span>
<span id="L2962" rel="#L2962">2962</span>
<span id="L2963" rel="#L2963">2963</span>
<span id="L2964" rel="#L2964">2964</span>
<span id="L2965" rel="#L2965">2965</span>
<span id="L2966" rel="#L2966">2966</span>
<span id="L2967" rel="#L2967">2967</span>
<span id="L2968" rel="#L2968">2968</span>
<span id="L2969" rel="#L2969">2969</span>
<span id="L2970" rel="#L2970">2970</span>
<span id="L2971" rel="#L2971">2971</span>
<span id="L2972" rel="#L2972">2972</span>
<span id="L2973" rel="#L2973">2973</span>
<span id="L2974" rel="#L2974">2974</span>
<span id="L2975" rel="#L2975">2975</span>
<span id="L2976" rel="#L2976">2976</span>
<span id="L2977" rel="#L2977">2977</span>
<span id="L2978" rel="#L2978">2978</span>
<span id="L2979" rel="#L2979">2979</span>
<span id="L2980" rel="#L2980">2980</span>
<span id="L2981" rel="#L2981">2981</span>
<span id="L2982" rel="#L2982">2982</span>
<span id="L2983" rel="#L2983">2983</span>
<span id="L2984" rel="#L2984">2984</span>
<span id="L2985" rel="#L2985">2985</span>
<span id="L2986" rel="#L2986">2986</span>
<span id="L2987" rel="#L2987">2987</span>
<span id="L2988" rel="#L2988">2988</span>
<span id="L2989" rel="#L2989">2989</span>
<span id="L2990" rel="#L2990">2990</span>
<span id="L2991" rel="#L2991">2991</span>
<span id="L2992" rel="#L2992">2992</span>
<span id="L2993" rel="#L2993">2993</span>
<span id="L2994" rel="#L2994">2994</span>
<span id="L2995" rel="#L2995">2995</span>
<span id="L2996" rel="#L2996">2996</span>
<span id="L2997" rel="#L2997">2997</span>
<span id="L2998" rel="#L2998">2998</span>
<span id="L2999" rel="#L2999">2999</span>
<span id="L3000" rel="#L3000">3000</span>
<span id="L3001" rel="#L3001">3001</span>
<span id="L3002" rel="#L3002">3002</span>
<span id="L3003" rel="#L3003">3003</span>
<span id="L3004" rel="#L3004">3004</span>
<span id="L3005" rel="#L3005">3005</span>
<span id="L3006" rel="#L3006">3006</span>
<span id="L3007" rel="#L3007">3007</span>
<span id="L3008" rel="#L3008">3008</span>
<span id="L3009" rel="#L3009">3009</span>
<span id="L3010" rel="#L3010">3010</span>
<span id="L3011" rel="#L3011">3011</span>
<span id="L3012" rel="#L3012">3012</span>
<span id="L3013" rel="#L3013">3013</span>
<span id="L3014" rel="#L3014">3014</span>
<span id="L3015" rel="#L3015">3015</span>
<span id="L3016" rel="#L3016">3016</span>
<span id="L3017" rel="#L3017">3017</span>
<span id="L3018" rel="#L3018">3018</span>
<span id="L3019" rel="#L3019">3019</span>
<span id="L3020" rel="#L3020">3020</span>
<span id="L3021" rel="#L3021">3021</span>
<span id="L3022" rel="#L3022">3022</span>
<span id="L3023" rel="#L3023">3023</span>
<span id="L3024" rel="#L3024">3024</span>
<span id="L3025" rel="#L3025">3025</span>
<span id="L3026" rel="#L3026">3026</span>
<span id="L3027" rel="#L3027">3027</span>
<span id="L3028" rel="#L3028">3028</span>
<span id="L3029" rel="#L3029">3029</span>
<span id="L3030" rel="#L3030">3030</span>
<span id="L3031" rel="#L3031">3031</span>
<span id="L3032" rel="#L3032">3032</span>
<span id="L3033" rel="#L3033">3033</span>
<span id="L3034" rel="#L3034">3034</span>
<span id="L3035" rel="#L3035">3035</span>
<span id="L3036" rel="#L3036">3036</span>
<span id="L3037" rel="#L3037">3037</span>
<span id="L3038" rel="#L3038">3038</span>
<span id="L3039" rel="#L3039">3039</span>
<span id="L3040" rel="#L3040">3040</span>
<span id="L3041" rel="#L3041">3041</span>
<span id="L3042" rel="#L3042">3042</span>
<span id="L3043" rel="#L3043">3043</span>
<span id="L3044" rel="#L3044">3044</span>
<span id="L3045" rel="#L3045">3045</span>
<span id="L3046" rel="#L3046">3046</span>
<span id="L3047" rel="#L3047">3047</span>
<span id="L3048" rel="#L3048">3048</span>
<span id="L3049" rel="#L3049">3049</span>
<span id="L3050" rel="#L3050">3050</span>
<span id="L3051" rel="#L3051">3051</span>
<span id="L3052" rel="#L3052">3052</span>
<span id="L3053" rel="#L3053">3053</span>
<span id="L3054" rel="#L3054">3054</span>
<span id="L3055" rel="#L3055">3055</span>
<span id="L3056" rel="#L3056">3056</span>
<span id="L3057" rel="#L3057">3057</span>
<span id="L3058" rel="#L3058">3058</span>
<span id="L3059" rel="#L3059">3059</span>
<span id="L3060" rel="#L3060">3060</span>
<span id="L3061" rel="#L3061">3061</span>
<span id="L3062" rel="#L3062">3062</span>
<span id="L3063" rel="#L3063">3063</span>
<span id="L3064" rel="#L3064">3064</span>
<span id="L3065" rel="#L3065">3065</span>
<span id="L3066" rel="#L3066">3066</span>
<span id="L3067" rel="#L3067">3067</span>
<span id="L3068" rel="#L3068">3068</span>
<span id="L3069" rel="#L3069">3069</span>
<span id="L3070" rel="#L3070">3070</span>
<span id="L3071" rel="#L3071">3071</span>
<span id="L3072" rel="#L3072">3072</span>
<span id="L3073" rel="#L3073">3073</span>
<span id="L3074" rel="#L3074">3074</span>
<span id="L3075" rel="#L3075">3075</span>
<span id="L3076" rel="#L3076">3076</span>
<span id="L3077" rel="#L3077">3077</span>
<span id="L3078" rel="#L3078">3078</span>
<span id="L3079" rel="#L3079">3079</span>
<span id="L3080" rel="#L3080">3080</span>
<span id="L3081" rel="#L3081">3081</span>
<span id="L3082" rel="#L3082">3082</span>
<span id="L3083" rel="#L3083">3083</span>
<span id="L3084" rel="#L3084">3084</span>
<span id="L3085" rel="#L3085">3085</span>
<span id="L3086" rel="#L3086">3086</span>
<span id="L3087" rel="#L3087">3087</span>
<span id="L3088" rel="#L3088">3088</span>
<span id="L3089" rel="#L3089">3089</span>
<span id="L3090" rel="#L3090">3090</span>
<span id="L3091" rel="#L3091">3091</span>
<span id="L3092" rel="#L3092">3092</span>
<span id="L3093" rel="#L3093">3093</span>
<span id="L3094" rel="#L3094">3094</span>
<span id="L3095" rel="#L3095">3095</span>
<span id="L3096" rel="#L3096">3096</span>
<span id="L3097" rel="#L3097">3097</span>
<span id="L3098" rel="#L3098">3098</span>
<span id="L3099" rel="#L3099">3099</span>
<span id="L3100" rel="#L3100">3100</span>
<span id="L3101" rel="#L3101">3101</span>
<span id="L3102" rel="#L3102">3102</span>
<span id="L3103" rel="#L3103">3103</span>
<span id="L3104" rel="#L3104">3104</span>
<span id="L3105" rel="#L3105">3105</span>
<span id="L3106" rel="#L3106">3106</span>
<span id="L3107" rel="#L3107">3107</span>
<span id="L3108" rel="#L3108">3108</span>
<span id="L3109" rel="#L3109">3109</span>
<span id="L3110" rel="#L3110">3110</span>
<span id="L3111" rel="#L3111">3111</span>
<span id="L3112" rel="#L3112">3112</span>
<span id="L3113" rel="#L3113">3113</span>
<span id="L3114" rel="#L3114">3114</span>
<span id="L3115" rel="#L3115">3115</span>
<span id="L3116" rel="#L3116">3116</span>
<span id="L3117" rel="#L3117">3117</span>
<span id="L3118" rel="#L3118">3118</span>
<span id="L3119" rel="#L3119">3119</span>
<span id="L3120" rel="#L3120">3120</span>
<span id="L3121" rel="#L3121">3121</span>
<span id="L3122" rel="#L3122">3122</span>
<span id="L3123" rel="#L3123">3123</span>
<span id="L3124" rel="#L3124">3124</span>
<span id="L3125" rel="#L3125">3125</span>
<span id="L3126" rel="#L3126">3126</span>
<span id="L3127" rel="#L3127">3127</span>
<span id="L3128" rel="#L3128">3128</span>
<span id="L3129" rel="#L3129">3129</span>
<span id="L3130" rel="#L3130">3130</span>
<span id="L3131" rel="#L3131">3131</span>
<span id="L3132" rel="#L3132">3132</span>
<span id="L3133" rel="#L3133">3133</span>
<span id="L3134" rel="#L3134">3134</span>
<span id="L3135" rel="#L3135">3135</span>
<span id="L3136" rel="#L3136">3136</span>
<span id="L3137" rel="#L3137">3137</span>
<span id="L3138" rel="#L3138">3138</span>
<span id="L3139" rel="#L3139">3139</span>
<span id="L3140" rel="#L3140">3140</span>
<span id="L3141" rel="#L3141">3141</span>
<span id="L3142" rel="#L3142">3142</span>
<span id="L3143" rel="#L3143">3143</span>
<span id="L3144" rel="#L3144">3144</span>
<span id="L3145" rel="#L3145">3145</span>
<span id="L3146" rel="#L3146">3146</span>
<span id="L3147" rel="#L3147">3147</span>
<span id="L3148" rel="#L3148">3148</span>
<span id="L3149" rel="#L3149">3149</span>
<span id="L3150" rel="#L3150">3150</span>
<span id="L3151" rel="#L3151">3151</span>
<span id="L3152" rel="#L3152">3152</span>
<span id="L3153" rel="#L3153">3153</span>
<span id="L3154" rel="#L3154">3154</span>
<span id="L3155" rel="#L3155">3155</span>
<span id="L3156" rel="#L3156">3156</span>
<span id="L3157" rel="#L3157">3157</span>
<span id="L3158" rel="#L3158">3158</span>
<span id="L3159" rel="#L3159">3159</span>
<span id="L3160" rel="#L3160">3160</span>
<span id="L3161" rel="#L3161">3161</span>
<span id="L3162" rel="#L3162">3162</span>
<span id="L3163" rel="#L3163">3163</span>
<span id="L3164" rel="#L3164">3164</span>
<span id="L3165" rel="#L3165">3165</span>
<span id="L3166" rel="#L3166">3166</span>
<span id="L3167" rel="#L3167">3167</span>
<span id="L3168" rel="#L3168">3168</span>
<span id="L3169" rel="#L3169">3169</span>
<span id="L3170" rel="#L3170">3170</span>
<span id="L3171" rel="#L3171">3171</span>
<span id="L3172" rel="#L3172">3172</span>
<span id="L3173" rel="#L3173">3173</span>
<span id="L3174" rel="#L3174">3174</span>
<span id="L3175" rel="#L3175">3175</span>
<span id="L3176" rel="#L3176">3176</span>
<span id="L3177" rel="#L3177">3177</span>
<span id="L3178" rel="#L3178">3178</span>
<span id="L3179" rel="#L3179">3179</span>
<span id="L3180" rel="#L3180">3180</span>
<span id="L3181" rel="#L3181">3181</span>
<span id="L3182" rel="#L3182">3182</span>
<span id="L3183" rel="#L3183">3183</span>
<span id="L3184" rel="#L3184">3184</span>
<span id="L3185" rel="#L3185">3185</span>
<span id="L3186" rel="#L3186">3186</span>
<span id="L3187" rel="#L3187">3187</span>
<span id="L3188" rel="#L3188">3188</span>
<span id="L3189" rel="#L3189">3189</span>
<span id="L3190" rel="#L3190">3190</span>
<span id="L3191" rel="#L3191">3191</span>
<span id="L3192" rel="#L3192">3192</span>
<span id="L3193" rel="#L3193">3193</span>
<span id="L3194" rel="#L3194">3194</span>
<span id="L3195" rel="#L3195">3195</span>
<span id="L3196" rel="#L3196">3196</span>
<span id="L3197" rel="#L3197">3197</span>
<span id="L3198" rel="#L3198">3198</span>
<span id="L3199" rel="#L3199">3199</span>
<span id="L3200" rel="#L3200">3200</span>
<span id="L3201" rel="#L3201">3201</span>
<span id="L3202" rel="#L3202">3202</span>
<span id="L3203" rel="#L3203">3203</span>
<span id="L3204" rel="#L3204">3204</span>
<span id="L3205" rel="#L3205">3205</span>
<span id="L3206" rel="#L3206">3206</span>
<span id="L3207" rel="#L3207">3207</span>
<span id="L3208" rel="#L3208">3208</span>
<span id="L3209" rel="#L3209">3209</span>
<span id="L3210" rel="#L3210">3210</span>
<span id="L3211" rel="#L3211">3211</span>
<span id="L3212" rel="#L3212">3212</span>
<span id="L3213" rel="#L3213">3213</span>
<span id="L3214" rel="#L3214">3214</span>
<span id="L3215" rel="#L3215">3215</span>
<span id="L3216" rel="#L3216">3216</span>
<span id="L3217" rel="#L3217">3217</span>
<span id="L3218" rel="#L3218">3218</span>
<span id="L3219" rel="#L3219">3219</span>
<span id="L3220" rel="#L3220">3220</span>
<span id="L3221" rel="#L3221">3221</span>
<span id="L3222" rel="#L3222">3222</span>
<span id="L3223" rel="#L3223">3223</span>
<span id="L3224" rel="#L3224">3224</span>
<span id="L3225" rel="#L3225">3225</span>
<span id="L3226" rel="#L3226">3226</span>
<span id="L3227" rel="#L3227">3227</span>
<span id="L3228" rel="#L3228">3228</span>
<span id="L3229" rel="#L3229">3229</span>
<span id="L3230" rel="#L3230">3230</span>
<span id="L3231" rel="#L3231">3231</span>
<span id="L3232" rel="#L3232">3232</span>
<span id="L3233" rel="#L3233">3233</span>
<span id="L3234" rel="#L3234">3234</span>
<span id="L3235" rel="#L3235">3235</span>
<span id="L3236" rel="#L3236">3236</span>
<span id="L3237" rel="#L3237">3237</span>
<span id="L3238" rel="#L3238">3238</span>
<span id="L3239" rel="#L3239">3239</span>
<span id="L3240" rel="#L3240">3240</span>
<span id="L3241" rel="#L3241">3241</span>
<span id="L3242" rel="#L3242">3242</span>
<span id="L3243" rel="#L3243">3243</span>
<span id="L3244" rel="#L3244">3244</span>
<span id="L3245" rel="#L3245">3245</span>
<span id="L3246" rel="#L3246">3246</span>
<span id="L3247" rel="#L3247">3247</span>
<span id="L3248" rel="#L3248">3248</span>
<span id="L3249" rel="#L3249">3249</span>
<span id="L3250" rel="#L3250">3250</span>
<span id="L3251" rel="#L3251">3251</span>
<span id="L3252" rel="#L3252">3252</span>
<span id="L3253" rel="#L3253">3253</span>
<span id="L3254" rel="#L3254">3254</span>
<span id="L3255" rel="#L3255">3255</span>
<span id="L3256" rel="#L3256">3256</span>
<span id="L3257" rel="#L3257">3257</span>
<span id="L3258" rel="#L3258">3258</span>
<span id="L3259" rel="#L3259">3259</span>
<span id="L3260" rel="#L3260">3260</span>
<span id="L3261" rel="#L3261">3261</span>
<span id="L3262" rel="#L3262">3262</span>
<span id="L3263" rel="#L3263">3263</span>
<span id="L3264" rel="#L3264">3264</span>
<span id="L3265" rel="#L3265">3265</span>
<span id="L3266" rel="#L3266">3266</span>
<span id="L3267" rel="#L3267">3267</span>
<span id="L3268" rel="#L3268">3268</span>
<span id="L3269" rel="#L3269">3269</span>
<span id="L3270" rel="#L3270">3270</span>
<span id="L3271" rel="#L3271">3271</span>
<span id="L3272" rel="#L3272">3272</span>
<span id="L3273" rel="#L3273">3273</span>
<span id="L3274" rel="#L3274">3274</span>
<span id="L3275" rel="#L3275">3275</span>
<span id="L3276" rel="#L3276">3276</span>
<span id="L3277" rel="#L3277">3277</span>
<span id="L3278" rel="#L3278">3278</span>
<span id="L3279" rel="#L3279">3279</span>
<span id="L3280" rel="#L3280">3280</span>
<span id="L3281" rel="#L3281">3281</span>
<span id="L3282" rel="#L3282">3282</span>
<span id="L3283" rel="#L3283">3283</span>
<span id="L3284" rel="#L3284">3284</span>
<span id="L3285" rel="#L3285">3285</span>
<span id="L3286" rel="#L3286">3286</span>
<span id="L3287" rel="#L3287">3287</span>
<span id="L3288" rel="#L3288">3288</span>
<span id="L3289" rel="#L3289">3289</span>
<span id="L3290" rel="#L3290">3290</span>
<span id="L3291" rel="#L3291">3291</span>
<span id="L3292" rel="#L3292">3292</span>
<span id="L3293" rel="#L3293">3293</span>
<span id="L3294" rel="#L3294">3294</span>
<span id="L3295" rel="#L3295">3295</span>
<span id="L3296" rel="#L3296">3296</span>
<span id="L3297" rel="#L3297">3297</span>
<span id="L3298" rel="#L3298">3298</span>
<span id="L3299" rel="#L3299">3299</span>
<span id="L3300" rel="#L3300">3300</span>
<span id="L3301" rel="#L3301">3301</span>
<span id="L3302" rel="#L3302">3302</span>
<span id="L3303" rel="#L3303">3303</span>
<span id="L3304" rel="#L3304">3304</span>
<span id="L3305" rel="#L3305">3305</span>
<span id="L3306" rel="#L3306">3306</span>
<span id="L3307" rel="#L3307">3307</span>
<span id="L3308" rel="#L3308">3308</span>
<span id="L3309" rel="#L3309">3309</span>
<span id="L3310" rel="#L3310">3310</span>
<span id="L3311" rel="#L3311">3311</span>
<span id="L3312" rel="#L3312">3312</span>
<span id="L3313" rel="#L3313">3313</span>
<span id="L3314" rel="#L3314">3314</span>
<span id="L3315" rel="#L3315">3315</span>
<span id="L3316" rel="#L3316">3316</span>
<span id="L3317" rel="#L3317">3317</span>
<span id="L3318" rel="#L3318">3318</span>
<span id="L3319" rel="#L3319">3319</span>
<span id="L3320" rel="#L3320">3320</span>
<span id="L3321" rel="#L3321">3321</span>
<span id="L3322" rel="#L3322">3322</span>
<span id="L3323" rel="#L3323">3323</span>
<span id="L3324" rel="#L3324">3324</span>
<span id="L3325" rel="#L3325">3325</span>
<span id="L3326" rel="#L3326">3326</span>
<span id="L3327" rel="#L3327">3327</span>
<span id="L3328" rel="#L3328">3328</span>
<span id="L3329" rel="#L3329">3329</span>
<span id="L3330" rel="#L3330">3330</span>
<span id="L3331" rel="#L3331">3331</span>
<span id="L3332" rel="#L3332">3332</span>
<span id="L3333" rel="#L3333">3333</span>
<span id="L3334" rel="#L3334">3334</span>
<span id="L3335" rel="#L3335">3335</span>
<span id="L3336" rel="#L3336">3336</span>
<span id="L3337" rel="#L3337">3337</span>
<span id="L3338" rel="#L3338">3338</span>
<span id="L3339" rel="#L3339">3339</span>
<span id="L3340" rel="#L3340">3340</span>
<span id="L3341" rel="#L3341">3341</span>
<span id="L3342" rel="#L3342">3342</span>
<span id="L3343" rel="#L3343">3343</span>
<span id="L3344" rel="#L3344">3344</span>
<span id="L3345" rel="#L3345">3345</span>
<span id="L3346" rel="#L3346">3346</span>
<span id="L3347" rel="#L3347">3347</span>
<span id="L3348" rel="#L3348">3348</span>
<span id="L3349" rel="#L3349">3349</span>
<span id="L3350" rel="#L3350">3350</span>
<span id="L3351" rel="#L3351">3351</span>
<span id="L3352" rel="#L3352">3352</span>
<span id="L3353" rel="#L3353">3353</span>
<span id="L3354" rel="#L3354">3354</span>
<span id="L3355" rel="#L3355">3355</span>
<span id="L3356" rel="#L3356">3356</span>
<span id="L3357" rel="#L3357">3357</span>
<span id="L3358" rel="#L3358">3358</span>
<span id="L3359" rel="#L3359">3359</span>
<span id="L3360" rel="#L3360">3360</span>
<span id="L3361" rel="#L3361">3361</span>
<span id="L3362" rel="#L3362">3362</span>
<span id="L3363" rel="#L3363">3363</span>
<span id="L3364" rel="#L3364">3364</span>
<span id="L3365" rel="#L3365">3365</span>
<span id="L3366" rel="#L3366">3366</span>
<span id="L3367" rel="#L3367">3367</span>
<span id="L3368" rel="#L3368">3368</span>
<span id="L3369" rel="#L3369">3369</span>
<span id="L3370" rel="#L3370">3370</span>
<span id="L3371" rel="#L3371">3371</span>
<span id="L3372" rel="#L3372">3372</span>
<span id="L3373" rel="#L3373">3373</span>
<span id="L3374" rel="#L3374">3374</span>
<span id="L3375" rel="#L3375">3375</span>
<span id="L3376" rel="#L3376">3376</span>
<span id="L3377" rel="#L3377">3377</span>
<span id="L3378" rel="#L3378">3378</span>
<span id="L3379" rel="#L3379">3379</span>
<span id="L3380" rel="#L3380">3380</span>
<span id="L3381" rel="#L3381">3381</span>
<span id="L3382" rel="#L3382">3382</span>
<span id="L3383" rel="#L3383">3383</span>
<span id="L3384" rel="#L3384">3384</span>
<span id="L3385" rel="#L3385">3385</span>
<span id="L3386" rel="#L3386">3386</span>
<span id="L3387" rel="#L3387">3387</span>
<span id="L3388" rel="#L3388">3388</span>
<span id="L3389" rel="#L3389">3389</span>
<span id="L3390" rel="#L3390">3390</span>
<span id="L3391" rel="#L3391">3391</span>
<span id="L3392" rel="#L3392">3392</span>
<span id="L3393" rel="#L3393">3393</span>
<span id="L3394" rel="#L3394">3394</span>
<span id="L3395" rel="#L3395">3395</span>
<span id="L3396" rel="#L3396">3396</span>
<span id="L3397" rel="#L3397">3397</span>
<span id="L3398" rel="#L3398">3398</span>
<span id="L3399" rel="#L3399">3399</span>
<span id="L3400" rel="#L3400">3400</span>
<span id="L3401" rel="#L3401">3401</span>
<span id="L3402" rel="#L3402">3402</span>
<span id="L3403" rel="#L3403">3403</span>
<span id="L3404" rel="#L3404">3404</span>
<span id="L3405" rel="#L3405">3405</span>
<span id="L3406" rel="#L3406">3406</span>
<span id="L3407" rel="#L3407">3407</span>
<span id="L3408" rel="#L3408">3408</span>
<span id="L3409" rel="#L3409">3409</span>
<span id="L3410" rel="#L3410">3410</span>
<span id="L3411" rel="#L3411">3411</span>
<span id="L3412" rel="#L3412">3412</span>
<span id="L3413" rel="#L3413">3413</span>
<span id="L3414" rel="#L3414">3414</span>
<span id="L3415" rel="#L3415">3415</span>
<span id="L3416" rel="#L3416">3416</span>
<span id="L3417" rel="#L3417">3417</span>
<span id="L3418" rel="#L3418">3418</span>
<span id="L3419" rel="#L3419">3419</span>
<span id="L3420" rel="#L3420">3420</span>
<span id="L3421" rel="#L3421">3421</span>
<span id="L3422" rel="#L3422">3422</span>
<span id="L3423" rel="#L3423">3423</span>
<span id="L3424" rel="#L3424">3424</span>
<span id="L3425" rel="#L3425">3425</span>
<span id="L3426" rel="#L3426">3426</span>
<span id="L3427" rel="#L3427">3427</span>
<span id="L3428" rel="#L3428">3428</span>
<span id="L3429" rel="#L3429">3429</span>
<span id="L3430" rel="#L3430">3430</span>
<span id="L3431" rel="#L3431">3431</span>
<span id="L3432" rel="#L3432">3432</span>
<span id="L3433" rel="#L3433">3433</span>
<span id="L3434" rel="#L3434">3434</span>
<span id="L3435" rel="#L3435">3435</span>
<span id="L3436" rel="#L3436">3436</span>
<span id="L3437" rel="#L3437">3437</span>
<span id="L3438" rel="#L3438">3438</span>
<span id="L3439" rel="#L3439">3439</span>
<span id="L3440" rel="#L3440">3440</span>
<span id="L3441" rel="#L3441">3441</span>
<span id="L3442" rel="#L3442">3442</span>
<span id="L3443" rel="#L3443">3443</span>
<span id="L3444" rel="#L3444">3444</span>
<span id="L3445" rel="#L3445">3445</span>
<span id="L3446" rel="#L3446">3446</span>
<span id="L3447" rel="#L3447">3447</span>
<span id="L3448" rel="#L3448">3448</span>
<span id="L3449" rel="#L3449">3449</span>
<span id="L3450" rel="#L3450">3450</span>
<span id="L3451" rel="#L3451">3451</span>
<span id="L3452" rel="#L3452">3452</span>
<span id="L3453" rel="#L3453">3453</span>
<span id="L3454" rel="#L3454">3454</span>
<span id="L3455" rel="#L3455">3455</span>
<span id="L3456" rel="#L3456">3456</span>
<span id="L3457" rel="#L3457">3457</span>
<span id="L3458" rel="#L3458">3458</span>
<span id="L3459" rel="#L3459">3459</span>
<span id="L3460" rel="#L3460">3460</span>
<span id="L3461" rel="#L3461">3461</span>
<span id="L3462" rel="#L3462">3462</span>
<span id="L3463" rel="#L3463">3463</span>
<span id="L3464" rel="#L3464">3464</span>
<span id="L3465" rel="#L3465">3465</span>
<span id="L3466" rel="#L3466">3466</span>
<span id="L3467" rel="#L3467">3467</span>
<span id="L3468" rel="#L3468">3468</span>
<span id="L3469" rel="#L3469">3469</span>
<span id="L3470" rel="#L3470">3470</span>
<span id="L3471" rel="#L3471">3471</span>
<span id="L3472" rel="#L3472">3472</span>
<span id="L3473" rel="#L3473">3473</span>
<span id="L3474" rel="#L3474">3474</span>
<span id="L3475" rel="#L3475">3475</span>
<span id="L3476" rel="#L3476">3476</span>
<span id="L3477" rel="#L3477">3477</span>
<span id="L3478" rel="#L3478">3478</span>
<span id="L3479" rel="#L3479">3479</span>
<span id="L3480" rel="#L3480">3480</span>
<span id="L3481" rel="#L3481">3481</span>
<span id="L3482" rel="#L3482">3482</span>
<span id="L3483" rel="#L3483">3483</span>
<span id="L3484" rel="#L3484">3484</span>
<span id="L3485" rel="#L3485">3485</span>
<span id="L3486" rel="#L3486">3486</span>
<span id="L3487" rel="#L3487">3487</span>
<span id="L3488" rel="#L3488">3488</span>
<span id="L3489" rel="#L3489">3489</span>
<span id="L3490" rel="#L3490">3490</span>
<span id="L3491" rel="#L3491">3491</span>
<span id="L3492" rel="#L3492">3492</span>
<span id="L3493" rel="#L3493">3493</span>
<span id="L3494" rel="#L3494">3494</span>
<span id="L3495" rel="#L3495">3495</span>
<span id="L3496" rel="#L3496">3496</span>
<span id="L3497" rel="#L3497">3497</span>
<span id="L3498" rel="#L3498">3498</span>
<span id="L3499" rel="#L3499">3499</span>
<span id="L3500" rel="#L3500">3500</span>
<span id="L3501" rel="#L3501">3501</span>
<span id="L3502" rel="#L3502">3502</span>
<span id="L3503" rel="#L3503">3503</span>
<span id="L3504" rel="#L3504">3504</span>
<span id="L3505" rel="#L3505">3505</span>
<span id="L3506" rel="#L3506">3506</span>
<span id="L3507" rel="#L3507">3507</span>
<span id="L3508" rel="#L3508">3508</span>
<span id="L3509" rel="#L3509">3509</span>
<span id="L3510" rel="#L3510">3510</span>
<span id="L3511" rel="#L3511">3511</span>
<span id="L3512" rel="#L3512">3512</span>
<span id="L3513" rel="#L3513">3513</span>
<span id="L3514" rel="#L3514">3514</span>
<span id="L3515" rel="#L3515">3515</span>
<span id="L3516" rel="#L3516">3516</span>
<span id="L3517" rel="#L3517">3517</span>
<span id="L3518" rel="#L3518">3518</span>
<span id="L3519" rel="#L3519">3519</span>
<span id="L3520" rel="#L3520">3520</span>
<span id="L3521" rel="#L3521">3521</span>
<span id="L3522" rel="#L3522">3522</span>
<span id="L3523" rel="#L3523">3523</span>
<span id="L3524" rel="#L3524">3524</span>
<span id="L3525" rel="#L3525">3525</span>
<span id="L3526" rel="#L3526">3526</span>
<span id="L3527" rel="#L3527">3527</span>
<span id="L3528" rel="#L3528">3528</span>
<span id="L3529" rel="#L3529">3529</span>
<span id="L3530" rel="#L3530">3530</span>
<span id="L3531" rel="#L3531">3531</span>
<span id="L3532" rel="#L3532">3532</span>
<span id="L3533" rel="#L3533">3533</span>
<span id="L3534" rel="#L3534">3534</span>
<span id="L3535" rel="#L3535">3535</span>
<span id="L3536" rel="#L3536">3536</span>
<span id="L3537" rel="#L3537">3537</span>
<span id="L3538" rel="#L3538">3538</span>
<span id="L3539" rel="#L3539">3539</span>
<span id="L3540" rel="#L3540">3540</span>
<span id="L3541" rel="#L3541">3541</span>
<span id="L3542" rel="#L3542">3542</span>
<span id="L3543" rel="#L3543">3543</span>
<span id="L3544" rel="#L3544">3544</span>
<span id="L3545" rel="#L3545">3545</span>
<span id="L3546" rel="#L3546">3546</span>
<span id="L3547" rel="#L3547">3547</span>
<span id="L3548" rel="#L3548">3548</span>
<span id="L3549" rel="#L3549">3549</span>
<span id="L3550" rel="#L3550">3550</span>
<span id="L3551" rel="#L3551">3551</span>
<span id="L3552" rel="#L3552">3552</span>
<span id="L3553" rel="#L3553">3553</span>
<span id="L3554" rel="#L3554">3554</span>
<span id="L3555" rel="#L3555">3555</span>
<span id="L3556" rel="#L3556">3556</span>
<span id="L3557" rel="#L3557">3557</span>
<span id="L3558" rel="#L3558">3558</span>
<span id="L3559" rel="#L3559">3559</span>
<span id="L3560" rel="#L3560">3560</span>
<span id="L3561" rel="#L3561">3561</span>
<span id="L3562" rel="#L3562">3562</span>
<span id="L3563" rel="#L3563">3563</span>
<span id="L3564" rel="#L3564">3564</span>
<span id="L3565" rel="#L3565">3565</span>
<span id="L3566" rel="#L3566">3566</span>
<span id="L3567" rel="#L3567">3567</span>
<span id="L3568" rel="#L3568">3568</span>
<span id="L3569" rel="#L3569">3569</span>
<span id="L3570" rel="#L3570">3570</span>
<span id="L3571" rel="#L3571">3571</span>
<span id="L3572" rel="#L3572">3572</span>
<span id="L3573" rel="#L3573">3573</span>
<span id="L3574" rel="#L3574">3574</span>
<span id="L3575" rel="#L3575">3575</span>
<span id="L3576" rel="#L3576">3576</span>
<span id="L3577" rel="#L3577">3577</span>
<span id="L3578" rel="#L3578">3578</span>
<span id="L3579" rel="#L3579">3579</span>
<span id="L3580" rel="#L3580">3580</span>
<span id="L3581" rel="#L3581">3581</span>
<span id="L3582" rel="#L3582">3582</span>
<span id="L3583" rel="#L3583">3583</span>
<span id="L3584" rel="#L3584">3584</span>
<span id="L3585" rel="#L3585">3585</span>
<span id="L3586" rel="#L3586">3586</span>
<span id="L3587" rel="#L3587">3587</span>
<span id="L3588" rel="#L3588">3588</span>
<span id="L3589" rel="#L3589">3589</span>
<span id="L3590" rel="#L3590">3590</span>
<span id="L3591" rel="#L3591">3591</span>
<span id="L3592" rel="#L3592">3592</span>
<span id="L3593" rel="#L3593">3593</span>
<span id="L3594" rel="#L3594">3594</span>
<span id="L3595" rel="#L3595">3595</span>
<span id="L3596" rel="#L3596">3596</span>
<span id="L3597" rel="#L3597">3597</span>
<span id="L3598" rel="#L3598">3598</span>
<span id="L3599" rel="#L3599">3599</span>
<span id="L3600" rel="#L3600">3600</span>
<span id="L3601" rel="#L3601">3601</span>
<span id="L3602" rel="#L3602">3602</span>
<span id="L3603" rel="#L3603">3603</span>
<span id="L3604" rel="#L3604">3604</span>
<span id="L3605" rel="#L3605">3605</span>
<span id="L3606" rel="#L3606">3606</span>
<span id="L3607" rel="#L3607">3607</span>
<span id="L3608" rel="#L3608">3608</span>
<span id="L3609" rel="#L3609">3609</span>
<span id="L3610" rel="#L3610">3610</span>
<span id="L3611" rel="#L3611">3611</span>
<span id="L3612" rel="#L3612">3612</span>
<span id="L3613" rel="#L3613">3613</span>
<span id="L3614" rel="#L3614">3614</span>
<span id="L3615" rel="#L3615">3615</span>
<span id="L3616" rel="#L3616">3616</span>
<span id="L3617" rel="#L3617">3617</span>
<span id="L3618" rel="#L3618">3618</span>
<span id="L3619" rel="#L3619">3619</span>
<span id="L3620" rel="#L3620">3620</span>
<span id="L3621" rel="#L3621">3621</span>
<span id="L3622" rel="#L3622">3622</span>
<span id="L3623" rel="#L3623">3623</span>
<span id="L3624" rel="#L3624">3624</span>
<span id="L3625" rel="#L3625">3625</span>
<span id="L3626" rel="#L3626">3626</span>
<span id="L3627" rel="#L3627">3627</span>
<span id="L3628" rel="#L3628">3628</span>
<span id="L3629" rel="#L3629">3629</span>
<span id="L3630" rel="#L3630">3630</span>
<span id="L3631" rel="#L3631">3631</span>
<span id="L3632" rel="#L3632">3632</span>
<span id="L3633" rel="#L3633">3633</span>
<span id="L3634" rel="#L3634">3634</span>
<span id="L3635" rel="#L3635">3635</span>
<span id="L3636" rel="#L3636">3636</span>
<span id="L3637" rel="#L3637">3637</span>
<span id="L3638" rel="#L3638">3638</span>
<span id="L3639" rel="#L3639">3639</span>
<span id="L3640" rel="#L3640">3640</span>
<span id="L3641" rel="#L3641">3641</span>
<span id="L3642" rel="#L3642">3642</span>
<span id="L3643" rel="#L3643">3643</span>
<span id="L3644" rel="#L3644">3644</span>
<span id="L3645" rel="#L3645">3645</span>
<span id="L3646" rel="#L3646">3646</span>
<span id="L3647" rel="#L3647">3647</span>
<span id="L3648" rel="#L3648">3648</span>
<span id="L3649" rel="#L3649">3649</span>
<span id="L3650" rel="#L3650">3650</span>
<span id="L3651" rel="#L3651">3651</span>
<span id="L3652" rel="#L3652">3652</span>
<span id="L3653" rel="#L3653">3653</span>
<span id="L3654" rel="#L3654">3654</span>
<span id="L3655" rel="#L3655">3655</span>
<span id="L3656" rel="#L3656">3656</span>
<span id="L3657" rel="#L3657">3657</span>
<span id="L3658" rel="#L3658">3658</span>
<span id="L3659" rel="#L3659">3659</span>
<span id="L3660" rel="#L3660">3660</span>
<span id="L3661" rel="#L3661">3661</span>
<span id="L3662" rel="#L3662">3662</span>
<span id="L3663" rel="#L3663">3663</span>
<span id="L3664" rel="#L3664">3664</span>
<span id="L3665" rel="#L3665">3665</span>
<span id="L3666" rel="#L3666">3666</span>
<span id="L3667" rel="#L3667">3667</span>
<span id="L3668" rel="#L3668">3668</span>
<span id="L3669" rel="#L3669">3669</span>
<span id="L3670" rel="#L3670">3670</span>
<span id="L3671" rel="#L3671">3671</span>
<span id="L3672" rel="#L3672">3672</span>
<span id="L3673" rel="#L3673">3673</span>
<span id="L3674" rel="#L3674">3674</span>
<span id="L3675" rel="#L3675">3675</span>
<span id="L3676" rel="#L3676">3676</span>
<span id="L3677" rel="#L3677">3677</span>
<span id="L3678" rel="#L3678">3678</span>
<span id="L3679" rel="#L3679">3679</span>
<span id="L3680" rel="#L3680">3680</span>
<span id="L3681" rel="#L3681">3681</span>
<span id="L3682" rel="#L3682">3682</span>
<span id="L3683" rel="#L3683">3683</span>
<span id="L3684" rel="#L3684">3684</span>
<span id="L3685" rel="#L3685">3685</span>
<span id="L3686" rel="#L3686">3686</span>
<span id="L3687" rel="#L3687">3687</span>
<span id="L3688" rel="#L3688">3688</span>
<span id="L3689" rel="#L3689">3689</span>
<span id="L3690" rel="#L3690">3690</span>
<span id="L3691" rel="#L3691">3691</span>
<span id="L3692" rel="#L3692">3692</span>
<span id="L3693" rel="#L3693">3693</span>
<span id="L3694" rel="#L3694">3694</span>
<span id="L3695" rel="#L3695">3695</span>
<span id="L3696" rel="#L3696">3696</span>
<span id="L3697" rel="#L3697">3697</span>
<span id="L3698" rel="#L3698">3698</span>
<span id="L3699" rel="#L3699">3699</span>
<span id="L3700" rel="#L3700">3700</span>
<span id="L3701" rel="#L3701">3701</span>
<span id="L3702" rel="#L3702">3702</span>
<span id="L3703" rel="#L3703">3703</span>
<span id="L3704" rel="#L3704">3704</span>
<span id="L3705" rel="#L3705">3705</span>
<span id="L3706" rel="#L3706">3706</span>
<span id="L3707" rel="#L3707">3707</span>
<span id="L3708" rel="#L3708">3708</span>
<span id="L3709" rel="#L3709">3709</span>
<span id="L3710" rel="#L3710">3710</span>
<span id="L3711" rel="#L3711">3711</span>
<span id="L3712" rel="#L3712">3712</span>
<span id="L3713" rel="#L3713">3713</span>
<span id="L3714" rel="#L3714">3714</span>
<span id="L3715" rel="#L3715">3715</span>
<span id="L3716" rel="#L3716">3716</span>
<span id="L3717" rel="#L3717">3717</span>
<span id="L3718" rel="#L3718">3718</span>
<span id="L3719" rel="#L3719">3719</span>
<span id="L3720" rel="#L3720">3720</span>
<span id="L3721" rel="#L3721">3721</span>
<span id="L3722" rel="#L3722">3722</span>
<span id="L3723" rel="#L3723">3723</span>
<span id="L3724" rel="#L3724">3724</span>
<span id="L3725" rel="#L3725">3725</span>
<span id="L3726" rel="#L3726">3726</span>
<span id="L3727" rel="#L3727">3727</span>
<span id="L3728" rel="#L3728">3728</span>
<span id="L3729" rel="#L3729">3729</span>
<span id="L3730" rel="#L3730">3730</span>
<span id="L3731" rel="#L3731">3731</span>
<span id="L3732" rel="#L3732">3732</span>
<span id="L3733" rel="#L3733">3733</span>
<span id="L3734" rel="#L3734">3734</span>
<span id="L3735" rel="#L3735">3735</span>
<span id="L3736" rel="#L3736">3736</span>
<span id="L3737" rel="#L3737">3737</span>
<span id="L3738" rel="#L3738">3738</span>
<span id="L3739" rel="#L3739">3739</span>
<span id="L3740" rel="#L3740">3740</span>
<span id="L3741" rel="#L3741">3741</span>
<span id="L3742" rel="#L3742">3742</span>
<span id="L3743" rel="#L3743">3743</span>
<span id="L3744" rel="#L3744">3744</span>
<span id="L3745" rel="#L3745">3745</span>
<span id="L3746" rel="#L3746">3746</span>
<span id="L3747" rel="#L3747">3747</span>
<span id="L3748" rel="#L3748">3748</span>
<span id="L3749" rel="#L3749">3749</span>
<span id="L3750" rel="#L3750">3750</span>
<span id="L3751" rel="#L3751">3751</span>
<span id="L3752" rel="#L3752">3752</span>
<span id="L3753" rel="#L3753">3753</span>
<span id="L3754" rel="#L3754">3754</span>
<span id="L3755" rel="#L3755">3755</span>
<span id="L3756" rel="#L3756">3756</span>
<span id="L3757" rel="#L3757">3757</span>
<span id="L3758" rel="#L3758">3758</span>
<span id="L3759" rel="#L3759">3759</span>
<span id="L3760" rel="#L3760">3760</span>
<span id="L3761" rel="#L3761">3761</span>
<span id="L3762" rel="#L3762">3762</span>
<span id="L3763" rel="#L3763">3763</span>
<span id="L3764" rel="#L3764">3764</span>
<span id="L3765" rel="#L3765">3765</span>
<span id="L3766" rel="#L3766">3766</span>
<span id="L3767" rel="#L3767">3767</span>
<span id="L3768" rel="#L3768">3768</span>
<span id="L3769" rel="#L3769">3769</span>
<span id="L3770" rel="#L3770">3770</span>
<span id="L3771" rel="#L3771">3771</span>
<span id="L3772" rel="#L3772">3772</span>
<span id="L3773" rel="#L3773">3773</span>
<span id="L3774" rel="#L3774">3774</span>
<span id="L3775" rel="#L3775">3775</span>
<span id="L3776" rel="#L3776">3776</span>
<span id="L3777" rel="#L3777">3777</span>
<span id="L3778" rel="#L3778">3778</span>
<span id="L3779" rel="#L3779">3779</span>
<span id="L3780" rel="#L3780">3780</span>
<span id="L3781" rel="#L3781">3781</span>
<span id="L3782" rel="#L3782">3782</span>
<span id="L3783" rel="#L3783">3783</span>
<span id="L3784" rel="#L3784">3784</span>
<span id="L3785" rel="#L3785">3785</span>
<span id="L3786" rel="#L3786">3786</span>
<span id="L3787" rel="#L3787">3787</span>
<span id="L3788" rel="#L3788">3788</span>
<span id="L3789" rel="#L3789">3789</span>
<span id="L3790" rel="#L3790">3790</span>
<span id="L3791" rel="#L3791">3791</span>
<span id="L3792" rel="#L3792">3792</span>
<span id="L3793" rel="#L3793">3793</span>
<span id="L3794" rel="#L3794">3794</span>
<span id="L3795" rel="#L3795">3795</span>
<span id="L3796" rel="#L3796">3796</span>
<span id="L3797" rel="#L3797">3797</span>
<span id="L3798" rel="#L3798">3798</span>
<span id="L3799" rel="#L3799">3799</span>
<span id="L3800" rel="#L3800">3800</span>
<span id="L3801" rel="#L3801">3801</span>
<span id="L3802" rel="#L3802">3802</span>
<span id="L3803" rel="#L3803">3803</span>
<span id="L3804" rel="#L3804">3804</span>
<span id="L3805" rel="#L3805">3805</span>
<span id="L3806" rel="#L3806">3806</span>
<span id="L3807" rel="#L3807">3807</span>
<span id="L3808" rel="#L3808">3808</span>
<span id="L3809" rel="#L3809">3809</span>
<span id="L3810" rel="#L3810">3810</span>
<span id="L3811" rel="#L3811">3811</span>
<span id="L3812" rel="#L3812">3812</span>
<span id="L3813" rel="#L3813">3813</span>
<span id="L3814" rel="#L3814">3814</span>
<span id="L3815" rel="#L3815">3815</span>
<span id="L3816" rel="#L3816">3816</span>
<span id="L3817" rel="#L3817">3817</span>
<span id="L3818" rel="#L3818">3818</span>
<span id="L3819" rel="#L3819">3819</span>
<span id="L3820" rel="#L3820">3820</span>
<span id="L3821" rel="#L3821">3821</span>
<span id="L3822" rel="#L3822">3822</span>
<span id="L3823" rel="#L3823">3823</span>
<span id="L3824" rel="#L3824">3824</span>
<span id="L3825" rel="#L3825">3825</span>
<span id="L3826" rel="#L3826">3826</span>
<span id="L3827" rel="#L3827">3827</span>
<span id="L3828" rel="#L3828">3828</span>
<span id="L3829" rel="#L3829">3829</span>
<span id="L3830" rel="#L3830">3830</span>
<span id="L3831" rel="#L3831">3831</span>
<span id="L3832" rel="#L3832">3832</span>
<span id="L3833" rel="#L3833">3833</span>
<span id="L3834" rel="#L3834">3834</span>
<span id="L3835" rel="#L3835">3835</span>
<span id="L3836" rel="#L3836">3836</span>
<span id="L3837" rel="#L3837">3837</span>
<span id="L3838" rel="#L3838">3838</span>
<span id="L3839" rel="#L3839">3839</span>
<span id="L3840" rel="#L3840">3840</span>
<span id="L3841" rel="#L3841">3841</span>
<span id="L3842" rel="#L3842">3842</span>
<span id="L3843" rel="#L3843">3843</span>
<span id="L3844" rel="#L3844">3844</span>
<span id="L3845" rel="#L3845">3845</span>
<span id="L3846" rel="#L3846">3846</span>
<span id="L3847" rel="#L3847">3847</span>
<span id="L3848" rel="#L3848">3848</span>
<span id="L3849" rel="#L3849">3849</span>
<span id="L3850" rel="#L3850">3850</span>
<span id="L3851" rel="#L3851">3851</span>
<span id="L3852" rel="#L3852">3852</span>
<span id="L3853" rel="#L3853">3853</span>
<span id="L3854" rel="#L3854">3854</span>
<span id="L3855" rel="#L3855">3855</span>
<span id="L3856" rel="#L3856">3856</span>
<span id="L3857" rel="#L3857">3857</span>
<span id="L3858" rel="#L3858">3858</span>
<span id="L3859" rel="#L3859">3859</span>
<span id="L3860" rel="#L3860">3860</span>
<span id="L3861" rel="#L3861">3861</span>
<span id="L3862" rel="#L3862">3862</span>
<span id="L3863" rel="#L3863">3863</span>
<span id="L3864" rel="#L3864">3864</span>
<span id="L3865" rel="#L3865">3865</span>
<span id="L3866" rel="#L3866">3866</span>
<span id="L3867" rel="#L3867">3867</span>
<span id="L3868" rel="#L3868">3868</span>
<span id="L3869" rel="#L3869">3869</span>
<span id="L3870" rel="#L3870">3870</span>
<span id="L3871" rel="#L3871">3871</span>
<span id="L3872" rel="#L3872">3872</span>
<span id="L3873" rel="#L3873">3873</span>
<span id="L3874" rel="#L3874">3874</span>
<span id="L3875" rel="#L3875">3875</span>
<span id="L3876" rel="#L3876">3876</span>
<span id="L3877" rel="#L3877">3877</span>
<span id="L3878" rel="#L3878">3878</span>
<span id="L3879" rel="#L3879">3879</span>
<span id="L3880" rel="#L3880">3880</span>
<span id="L3881" rel="#L3881">3881</span>
<span id="L3882" rel="#L3882">3882</span>
<span id="L3883" rel="#L3883">3883</span>
<span id="L3884" rel="#L3884">3884</span>
<span id="L3885" rel="#L3885">3885</span>
<span id="L3886" rel="#L3886">3886</span>
<span id="L3887" rel="#L3887">3887</span>
<span id="L3888" rel="#L3888">3888</span>
<span id="L3889" rel="#L3889">3889</span>
<span id="L3890" rel="#L3890">3890</span>
<span id="L3891" rel="#L3891">3891</span>
<span id="L3892" rel="#L3892">3892</span>
<span id="L3893" rel="#L3893">3893</span>
<span id="L3894" rel="#L3894">3894</span>
<span id="L3895" rel="#L3895">3895</span>
<span id="L3896" rel="#L3896">3896</span>
<span id="L3897" rel="#L3897">3897</span>
<span id="L3898" rel="#L3898">3898</span>
<span id="L3899" rel="#L3899">3899</span>
<span id="L3900" rel="#L3900">3900</span>
<span id="L3901" rel="#L3901">3901</span>
<span id="L3902" rel="#L3902">3902</span>
<span id="L3903" rel="#L3903">3903</span>
<span id="L3904" rel="#L3904">3904</span>
<span id="L3905" rel="#L3905">3905</span>
<span id="L3906" rel="#L3906">3906</span>
<span id="L3907" rel="#L3907">3907</span>
<span id="L3908" rel="#L3908">3908</span>
<span id="L3909" rel="#L3909">3909</span>
<span id="L3910" rel="#L3910">3910</span>
<span id="L3911" rel="#L3911">3911</span>
<span id="L3912" rel="#L3912">3912</span>
<span id="L3913" rel="#L3913">3913</span>
<span id="L3914" rel="#L3914">3914</span>
<span id="L3915" rel="#L3915">3915</span>
<span id="L3916" rel="#L3916">3916</span>
<span id="L3917" rel="#L3917">3917</span>
<span id="L3918" rel="#L3918">3918</span>
<span id="L3919" rel="#L3919">3919</span>
<span id="L3920" rel="#L3920">3920</span>
<span id="L3921" rel="#L3921">3921</span>
<span id="L3922" rel="#L3922">3922</span>
<span id="L3923" rel="#L3923">3923</span>
<span id="L3924" rel="#L3924">3924</span>
<span id="L3925" rel="#L3925">3925</span>
<span id="L3926" rel="#L3926">3926</span>
<span id="L3927" rel="#L3927">3927</span>
<span id="L3928" rel="#L3928">3928</span>
<span id="L3929" rel="#L3929">3929</span>
<span id="L3930" rel="#L3930">3930</span>
<span id="L3931" rel="#L3931">3931</span>
<span id="L3932" rel="#L3932">3932</span>
<span id="L3933" rel="#L3933">3933</span>
<span id="L3934" rel="#L3934">3934</span>
<span id="L3935" rel="#L3935">3935</span>
<span id="L3936" rel="#L3936">3936</span>
<span id="L3937" rel="#L3937">3937</span>
<span id="L3938" rel="#L3938">3938</span>
<span id="L3939" rel="#L3939">3939</span>
<span id="L3940" rel="#L3940">3940</span>
<span id="L3941" rel="#L3941">3941</span>
<span id="L3942" rel="#L3942">3942</span>
<span id="L3943" rel="#L3943">3943</span>
<span id="L3944" rel="#L3944">3944</span>
<span id="L3945" rel="#L3945">3945</span>
<span id="L3946" rel="#L3946">3946</span>
<span id="L3947" rel="#L3947">3947</span>
<span id="L3948" rel="#L3948">3948</span>
<span id="L3949" rel="#L3949">3949</span>
<span id="L3950" rel="#L3950">3950</span>
<span id="L3951" rel="#L3951">3951</span>
<span id="L3952" rel="#L3952">3952</span>
<span id="L3953" rel="#L3953">3953</span>
<span id="L3954" rel="#L3954">3954</span>
<span id="L3955" rel="#L3955">3955</span>
<span id="L3956" rel="#L3956">3956</span>
<span id="L3957" rel="#L3957">3957</span>
<span id="L3958" rel="#L3958">3958</span>
<span id="L3959" rel="#L3959">3959</span>
<span id="L3960" rel="#L3960">3960</span>
<span id="L3961" rel="#L3961">3961</span>
<span id="L3962" rel="#L3962">3962</span>
<span id="L3963" rel="#L3963">3963</span>
<span id="L3964" rel="#L3964">3964</span>
<span id="L3965" rel="#L3965">3965</span>
<span id="L3966" rel="#L3966">3966</span>
<span id="L3967" rel="#L3967">3967</span>
<span id="L3968" rel="#L3968">3968</span>
<span id="L3969" rel="#L3969">3969</span>
<span id="L3970" rel="#L3970">3970</span>
<span id="L3971" rel="#L3971">3971</span>
<span id="L3972" rel="#L3972">3972</span>
<span id="L3973" rel="#L3973">3973</span>
<span id="L3974" rel="#L3974">3974</span>
<span id="L3975" rel="#L3975">3975</span>
<span id="L3976" rel="#L3976">3976</span>
<span id="L3977" rel="#L3977">3977</span>
<span id="L3978" rel="#L3978">3978</span>
<span id="L3979" rel="#L3979">3979</span>
<span id="L3980" rel="#L3980">3980</span>
<span id="L3981" rel="#L3981">3981</span>
<span id="L3982" rel="#L3982">3982</span>
<span id="L3983" rel="#L3983">3983</span>
<span id="L3984" rel="#L3984">3984</span>
<span id="L3985" rel="#L3985">3985</span>
<span id="L3986" rel="#L3986">3986</span>
<span id="L3987" rel="#L3987">3987</span>
<span id="L3988" rel="#L3988">3988</span>
<span id="L3989" rel="#L3989">3989</span>
<span id="L3990" rel="#L3990">3990</span>
<span id="L3991" rel="#L3991">3991</span>
<span id="L3992" rel="#L3992">3992</span>
<span id="L3993" rel="#L3993">3993</span>
<span id="L3994" rel="#L3994">3994</span>
<span id="L3995" rel="#L3995">3995</span>
<span id="L3996" rel="#L3996">3996</span>
<span id="L3997" rel="#L3997">3997</span>
<span id="L3998" rel="#L3998">3998</span>
<span id="L3999" rel="#L3999">3999</span>
<span id="L4000" rel="#L4000">4000</span>
<span id="L4001" rel="#L4001">4001</span>
<span id="L4002" rel="#L4002">4002</span>
<span id="L4003" rel="#L4003">4003</span>
<span id="L4004" rel="#L4004">4004</span>
<span id="L4005" rel="#L4005">4005</span>
<span id="L4006" rel="#L4006">4006</span>
<span id="L4007" rel="#L4007">4007</span>
<span id="L4008" rel="#L4008">4008</span>
<span id="L4009" rel="#L4009">4009</span>
<span id="L4010" rel="#L4010">4010</span>
<span id="L4011" rel="#L4011">4011</span>
<span id="L4012" rel="#L4012">4012</span>
<span id="L4013" rel="#L4013">4013</span>
<span id="L4014" rel="#L4014">4014</span>
<span id="L4015" rel="#L4015">4015</span>
<span id="L4016" rel="#L4016">4016</span>
<span id="L4017" rel="#L4017">4017</span>
<span id="L4018" rel="#L4018">4018</span>
<span id="L4019" rel="#L4019">4019</span>
<span id="L4020" rel="#L4020">4020</span>
<span id="L4021" rel="#L4021">4021</span>
<span id="L4022" rel="#L4022">4022</span>
<span id="L4023" rel="#L4023">4023</span>
<span id="L4024" rel="#L4024">4024</span>
<span id="L4025" rel="#L4025">4025</span>
<span id="L4026" rel="#L4026">4026</span>
<span id="L4027" rel="#L4027">4027</span>
<span id="L4028" rel="#L4028">4028</span>
<span id="L4029" rel="#L4029">4029</span>
<span id="L4030" rel="#L4030">4030</span>
<span id="L4031" rel="#L4031">4031</span>
<span id="L4032" rel="#L4032">4032</span>
<span id="L4033" rel="#L4033">4033</span>
<span id="L4034" rel="#L4034">4034</span>
<span id="L4035" rel="#L4035">4035</span>
<span id="L4036" rel="#L4036">4036</span>
<span id="L4037" rel="#L4037">4037</span>
<span id="L4038" rel="#L4038">4038</span>
<span id="L4039" rel="#L4039">4039</span>
<span id="L4040" rel="#L4040">4040</span>
<span id="L4041" rel="#L4041">4041</span>
<span id="L4042" rel="#L4042">4042</span>
<span id="L4043" rel="#L4043">4043</span>
<span id="L4044" rel="#L4044">4044</span>
<span id="L4045" rel="#L4045">4045</span>
<span id="L4046" rel="#L4046">4046</span>
<span id="L4047" rel="#L4047">4047</span>
<span id="L4048" rel="#L4048">4048</span>
<span id="L4049" rel="#L4049">4049</span>
<span id="L4050" rel="#L4050">4050</span>
<span id="L4051" rel="#L4051">4051</span>
<span id="L4052" rel="#L4052">4052</span>
<span id="L4053" rel="#L4053">4053</span>
<span id="L4054" rel="#L4054">4054</span>
<span id="L4055" rel="#L4055">4055</span>
<span id="L4056" rel="#L4056">4056</span>
<span id="L4057" rel="#L4057">4057</span>
<span id="L4058" rel="#L4058">4058</span>
<span id="L4059" rel="#L4059">4059</span>
<span id="L4060" rel="#L4060">4060</span>
<span id="L4061" rel="#L4061">4061</span>
<span id="L4062" rel="#L4062">4062</span>
<span id="L4063" rel="#L4063">4063</span>
<span id="L4064" rel="#L4064">4064</span>
<span id="L4065" rel="#L4065">4065</span>
<span id="L4066" rel="#L4066">4066</span>
<span id="L4067" rel="#L4067">4067</span>
<span id="L4068" rel="#L4068">4068</span>
<span id="L4069" rel="#L4069">4069</span>
<span id="L4070" rel="#L4070">4070</span>
<span id="L4071" rel="#L4071">4071</span>
<span id="L4072" rel="#L4072">4072</span>
<span id="L4073" rel="#L4073">4073</span>
<span id="L4074" rel="#L4074">4074</span>
<span id="L4075" rel="#L4075">4075</span>
<span id="L4076" rel="#L4076">4076</span>
<span id="L4077" rel="#L4077">4077</span>
<span id="L4078" rel="#L4078">4078</span>
<span id="L4079" rel="#L4079">4079</span>
<span id="L4080" rel="#L4080">4080</span>
<span id="L4081" rel="#L4081">4081</span>
<span id="L4082" rel="#L4082">4082</span>
<span id="L4083" rel="#L4083">4083</span>
<span id="L4084" rel="#L4084">4084</span>
<span id="L4085" rel="#L4085">4085</span>
<span id="L4086" rel="#L4086">4086</span>
<span id="L4087" rel="#L4087">4087</span>
<span id="L4088" rel="#L4088">4088</span>
<span id="L4089" rel="#L4089">4089</span>
<span id="L4090" rel="#L4090">4090</span>
<span id="L4091" rel="#L4091">4091</span>
<span id="L4092" rel="#L4092">4092</span>
<span id="L4093" rel="#L4093">4093</span>
<span id="L4094" rel="#L4094">4094</span>
<span id="L4095" rel="#L4095">4095</span>
<span id="L4096" rel="#L4096">4096</span>
<span id="L4097" rel="#L4097">4097</span>
<span id="L4098" rel="#L4098">4098</span>
<span id="L4099" rel="#L4099">4099</span>
<span id="L4100" rel="#L4100">4100</span>
<span id="L4101" rel="#L4101">4101</span>
<span id="L4102" rel="#L4102">4102</span>
<span id="L4103" rel="#L4103">4103</span>
<span id="L4104" rel="#L4104">4104</span>
<span id="L4105" rel="#L4105">4105</span>
<span id="L4106" rel="#L4106">4106</span>
<span id="L4107" rel="#L4107">4107</span>
<span id="L4108" rel="#L4108">4108</span>
<span id="L4109" rel="#L4109">4109</span>
<span id="L4110" rel="#L4110">4110</span>
<span id="L4111" rel="#L4111">4111</span>
<span id="L4112" rel="#L4112">4112</span>
<span id="L4113" rel="#L4113">4113</span>
<span id="L4114" rel="#L4114">4114</span>
<span id="L4115" rel="#L4115">4115</span>
<span id="L4116" rel="#L4116">4116</span>
<span id="L4117" rel="#L4117">4117</span>
<span id="L4118" rel="#L4118">4118</span>
<span id="L4119" rel="#L4119">4119</span>
<span id="L4120" rel="#L4120">4120</span>
<span id="L4121" rel="#L4121">4121</span>
<span id="L4122" rel="#L4122">4122</span>
<span id="L4123" rel="#L4123">4123</span>
<span id="L4124" rel="#L4124">4124</span>
<span id="L4125" rel="#L4125">4125</span>
<span id="L4126" rel="#L4126">4126</span>
<span id="L4127" rel="#L4127">4127</span>
<span id="L4128" rel="#L4128">4128</span>
<span id="L4129" rel="#L4129">4129</span>
<span id="L4130" rel="#L4130">4130</span>
<span id="L4131" rel="#L4131">4131</span>
<span id="L4132" rel="#L4132">4132</span>
<span id="L4133" rel="#L4133">4133</span>
<span id="L4134" rel="#L4134">4134</span>
<span id="L4135" rel="#L4135">4135</span>
<span id="L4136" rel="#L4136">4136</span>
<span id="L4137" rel="#L4137">4137</span>
<span id="L4138" rel="#L4138">4138</span>
<span id="L4139" rel="#L4139">4139</span>
<span id="L4140" rel="#L4140">4140</span>
<span id="L4141" rel="#L4141">4141</span>
<span id="L4142" rel="#L4142">4142</span>
<span id="L4143" rel="#L4143">4143</span>
<span id="L4144" rel="#L4144">4144</span>
<span id="L4145" rel="#L4145">4145</span>
<span id="L4146" rel="#L4146">4146</span>
<span id="L4147" rel="#L4147">4147</span>
<span id="L4148" rel="#L4148">4148</span>
<span id="L4149" rel="#L4149">4149</span>
<span id="L4150" rel="#L4150">4150</span>
<span id="L4151" rel="#L4151">4151</span>
<span id="L4152" rel="#L4152">4152</span>
<span id="L4153" rel="#L4153">4153</span>
<span id="L4154" rel="#L4154">4154</span>
<span id="L4155" rel="#L4155">4155</span>
<span id="L4156" rel="#L4156">4156</span>
<span id="L4157" rel="#L4157">4157</span>
<span id="L4158" rel="#L4158">4158</span>
<span id="L4159" rel="#L4159">4159</span>
<span id="L4160" rel="#L4160">4160</span>
<span id="L4161" rel="#L4161">4161</span>
<span id="L4162" rel="#L4162">4162</span>
<span id="L4163" rel="#L4163">4163</span>
<span id="L4164" rel="#L4164">4164</span>
<span id="L4165" rel="#L4165">4165</span>
<span id="L4166" rel="#L4166">4166</span>
<span id="L4167" rel="#L4167">4167</span>
<span id="L4168" rel="#L4168">4168</span>
<span id="L4169" rel="#L4169">4169</span>
<span id="L4170" rel="#L4170">4170</span>
<span id="L4171" rel="#L4171">4171</span>
<span id="L4172" rel="#L4172">4172</span>
<span id="L4173" rel="#L4173">4173</span>
<span id="L4174" rel="#L4174">4174</span>
<span id="L4175" rel="#L4175">4175</span>
<span id="L4176" rel="#L4176">4176</span>
<span id="L4177" rel="#L4177">4177</span>
<span id="L4178" rel="#L4178">4178</span>
<span id="L4179" rel="#L4179">4179</span>
<span id="L4180" rel="#L4180">4180</span>
<span id="L4181" rel="#L4181">4181</span>
<span id="L4182" rel="#L4182">4182</span>
<span id="L4183" rel="#L4183">4183</span>
<span id="L4184" rel="#L4184">4184</span>
<span id="L4185" rel="#L4185">4185</span>
<span id="L4186" rel="#L4186">4186</span>
<span id="L4187" rel="#L4187">4187</span>
<span id="L4188" rel="#L4188">4188</span>
<span id="L4189" rel="#L4189">4189</span>
<span id="L4190" rel="#L4190">4190</span>
<span id="L4191" rel="#L4191">4191</span>
<span id="L4192" rel="#L4192">4192</span>
<span id="L4193" rel="#L4193">4193</span>
<span id="L4194" rel="#L4194">4194</span>
<span id="L4195" rel="#L4195">4195</span>
<span id="L4196" rel="#L4196">4196</span>
<span id="L4197" rel="#L4197">4197</span>
<span id="L4198" rel="#L4198">4198</span>
<span id="L4199" rel="#L4199">4199</span>
<span id="L4200" rel="#L4200">4200</span>
<span id="L4201" rel="#L4201">4201</span>
<span id="L4202" rel="#L4202">4202</span>
<span id="L4203" rel="#L4203">4203</span>
<span id="L4204" rel="#L4204">4204</span>
<span id="L4205" rel="#L4205">4205</span>
<span id="L4206" rel="#L4206">4206</span>
<span id="L4207" rel="#L4207">4207</span>
<span id="L4208" rel="#L4208">4208</span>
<span id="L4209" rel="#L4209">4209</span>
<span id="L4210" rel="#L4210">4210</span>
<span id="L4211" rel="#L4211">4211</span>
<span id="L4212" rel="#L4212">4212</span>
<span id="L4213" rel="#L4213">4213</span>
<span id="L4214" rel="#L4214">4214</span>
<span id="L4215" rel="#L4215">4215</span>
<span id="L4216" rel="#L4216">4216</span>
<span id="L4217" rel="#L4217">4217</span>
<span id="L4218" rel="#L4218">4218</span>
<span id="L4219" rel="#L4219">4219</span>
<span id="L4220" rel="#L4220">4220</span>
<span id="L4221" rel="#L4221">4221</span>
<span id="L4222" rel="#L4222">4222</span>
<span id="L4223" rel="#L4223">4223</span>
<span id="L4224" rel="#L4224">4224</span>
<span id="L4225" rel="#L4225">4225</span>
<span id="L4226" rel="#L4226">4226</span>
<span id="L4227" rel="#L4227">4227</span>
<span id="L4228" rel="#L4228">4228</span>
<span id="L4229" rel="#L4229">4229</span>
<span id="L4230" rel="#L4230">4230</span>
<span id="L4231" rel="#L4231">4231</span>
<span id="L4232" rel="#L4232">4232</span>
<span id="L4233" rel="#L4233">4233</span>
<span id="L4234" rel="#L4234">4234</span>
<span id="L4235" rel="#L4235">4235</span>
<span id="L4236" rel="#L4236">4236</span>
<span id="L4237" rel="#L4237">4237</span>
<span id="L4238" rel="#L4238">4238</span>
<span id="L4239" rel="#L4239">4239</span>
<span id="L4240" rel="#L4240">4240</span>
<span id="L4241" rel="#L4241">4241</span>
<span id="L4242" rel="#L4242">4242</span>
<span id="L4243" rel="#L4243">4243</span>
<span id="L4244" rel="#L4244">4244</span>
<span id="L4245" rel="#L4245">4245</span>
<span id="L4246" rel="#L4246">4246</span>
<span id="L4247" rel="#L4247">4247</span>
<span id="L4248" rel="#L4248">4248</span>
<span id="L4249" rel="#L4249">4249</span>
<span id="L4250" rel="#L4250">4250</span>
<span id="L4251" rel="#L4251">4251</span>
<span id="L4252" rel="#L4252">4252</span>
<span id="L4253" rel="#L4253">4253</span>
<span id="L4254" rel="#L4254">4254</span>
<span id="L4255" rel="#L4255">4255</span>
<span id="L4256" rel="#L4256">4256</span>
<span id="L4257" rel="#L4257">4257</span>
<span id="L4258" rel="#L4258">4258</span>
<span id="L4259" rel="#L4259">4259</span>
<span id="L4260" rel="#L4260">4260</span>
<span id="L4261" rel="#L4261">4261</span>
<span id="L4262" rel="#L4262">4262</span>
<span id="L4263" rel="#L4263">4263</span>
<span id="L4264" rel="#L4264">4264</span>
<span id="L4265" rel="#L4265">4265</span>
<span id="L4266" rel="#L4266">4266</span>
<span id="L4267" rel="#L4267">4267</span>
<span id="L4268" rel="#L4268">4268</span>
<span id="L4269" rel="#L4269">4269</span>
<span id="L4270" rel="#L4270">4270</span>
<span id="L4271" rel="#L4271">4271</span>
<span id="L4272" rel="#L4272">4272</span>
<span id="L4273" rel="#L4273">4273</span>
<span id="L4274" rel="#L4274">4274</span>
<span id="L4275" rel="#L4275">4275</span>
<span id="L4276" rel="#L4276">4276</span>
<span id="L4277" rel="#L4277">4277</span>
<span id="L4278" rel="#L4278">4278</span>
<span id="L4279" rel="#L4279">4279</span>
<span id="L4280" rel="#L4280">4280</span>
<span id="L4281" rel="#L4281">4281</span>
<span id="L4282" rel="#L4282">4282</span>
<span id="L4283" rel="#L4283">4283</span>
<span id="L4284" rel="#L4284">4284</span>
<span id="L4285" rel="#L4285">4285</span>
<span id="L4286" rel="#L4286">4286</span>
<span id="L4287" rel="#L4287">4287</span>
<span id="L4288" rel="#L4288">4288</span>
<span id="L4289" rel="#L4289">4289</span>
<span id="L4290" rel="#L4290">4290</span>
<span id="L4291" rel="#L4291">4291</span>
<span id="L4292" rel="#L4292">4292</span>
<span id="L4293" rel="#L4293">4293</span>
<span id="L4294" rel="#L4294">4294</span>
<span id="L4295" rel="#L4295">4295</span>
<span id="L4296" rel="#L4296">4296</span>
<span id="L4297" rel="#L4297">4297</span>
<span id="L4298" rel="#L4298">4298</span>
<span id="L4299" rel="#L4299">4299</span>
<span id="L4300" rel="#L4300">4300</span>
<span id="L4301" rel="#L4301">4301</span>
<span id="L4302" rel="#L4302">4302</span>
<span id="L4303" rel="#L4303">4303</span>
<span id="L4304" rel="#L4304">4304</span>
<span id="L4305" rel="#L4305">4305</span>
<span id="L4306" rel="#L4306">4306</span>
<span id="L4307" rel="#L4307">4307</span>
<span id="L4308" rel="#L4308">4308</span>
<span id="L4309" rel="#L4309">4309</span>
<span id="L4310" rel="#L4310">4310</span>
<span id="L4311" rel="#L4311">4311</span>
<span id="L4312" rel="#L4312">4312</span>
<span id="L4313" rel="#L4313">4313</span>
<span id="L4314" rel="#L4314">4314</span>
<span id="L4315" rel="#L4315">4315</span>
<span id="L4316" rel="#L4316">4316</span>
<span id="L4317" rel="#L4317">4317</span>
<span id="L4318" rel="#L4318">4318</span>
<span id="L4319" rel="#L4319">4319</span>
<span id="L4320" rel="#L4320">4320</span>
<span id="L4321" rel="#L4321">4321</span>
<span id="L4322" rel="#L4322">4322</span>
<span id="L4323" rel="#L4323">4323</span>
<span id="L4324" rel="#L4324">4324</span>
<span id="L4325" rel="#L4325">4325</span>
<span id="L4326" rel="#L4326">4326</span>
<span id="L4327" rel="#L4327">4327</span>
<span id="L4328" rel="#L4328">4328</span>
<span id="L4329" rel="#L4329">4329</span>
<span id="L4330" rel="#L4330">4330</span>
<span id="L4331" rel="#L4331">4331</span>
<span id="L4332" rel="#L4332">4332</span>
<span id="L4333" rel="#L4333">4333</span>
<span id="L4334" rel="#L4334">4334</span>
<span id="L4335" rel="#L4335">4335</span>
<span id="L4336" rel="#L4336">4336</span>
<span id="L4337" rel="#L4337">4337</span>
<span id="L4338" rel="#L4338">4338</span>
<span id="L4339" rel="#L4339">4339</span>
<span id="L4340" rel="#L4340">4340</span>
<span id="L4341" rel="#L4341">4341</span>
<span id="L4342" rel="#L4342">4342</span>
<span id="L4343" rel="#L4343">4343</span>
<span id="L4344" rel="#L4344">4344</span>
<span id="L4345" rel="#L4345">4345</span>
<span id="L4346" rel="#L4346">4346</span>
<span id="L4347" rel="#L4347">4347</span>
<span id="L4348" rel="#L4348">4348</span>
<span id="L4349" rel="#L4349">4349</span>
<span id="L4350" rel="#L4350">4350</span>
<span id="L4351" rel="#L4351">4351</span>
<span id="L4352" rel="#L4352">4352</span>
<span id="L4353" rel="#L4353">4353</span>
<span id="L4354" rel="#L4354">4354</span>
<span id="L4355" rel="#L4355">4355</span>
<span id="L4356" rel="#L4356">4356</span>
<span id="L4357" rel="#L4357">4357</span>
<span id="L4358" rel="#L4358">4358</span>
<span id="L4359" rel="#L4359">4359</span>
<span id="L4360" rel="#L4360">4360</span>
<span id="L4361" rel="#L4361">4361</span>
<span id="L4362" rel="#L4362">4362</span>
<span id="L4363" rel="#L4363">4363</span>
<span id="L4364" rel="#L4364">4364</span>
<span id="L4365" rel="#L4365">4365</span>
<span id="L4366" rel="#L4366">4366</span>
<span id="L4367" rel="#L4367">4367</span>
<span id="L4368" rel="#L4368">4368</span>
<span id="L4369" rel="#L4369">4369</span>
<span id="L4370" rel="#L4370">4370</span>
<span id="L4371" rel="#L4371">4371</span>
<span id="L4372" rel="#L4372">4372</span>
<span id="L4373" rel="#L4373">4373</span>
<span id="L4374" rel="#L4374">4374</span>
<span id="L4375" rel="#L4375">4375</span>
<span id="L4376" rel="#L4376">4376</span>
<span id="L4377" rel="#L4377">4377</span>
<span id="L4378" rel="#L4378">4378</span>
<span id="L4379" rel="#L4379">4379</span>
<span id="L4380" rel="#L4380">4380</span>
<span id="L4381" rel="#L4381">4381</span>
<span id="L4382" rel="#L4382">4382</span>
<span id="L4383" rel="#L4383">4383</span>
<span id="L4384" rel="#L4384">4384</span>
<span id="L4385" rel="#L4385">4385</span>
<span id="L4386" rel="#L4386">4386</span>
<span id="L4387" rel="#L4387">4387</span>
<span id="L4388" rel="#L4388">4388</span>
<span id="L4389" rel="#L4389">4389</span>
<span id="L4390" rel="#L4390">4390</span>
<span id="L4391" rel="#L4391">4391</span>
<span id="L4392" rel="#L4392">4392</span>
<span id="L4393" rel="#L4393">4393</span>
<span id="L4394" rel="#L4394">4394</span>
<span id="L4395" rel="#L4395">4395</span>
<span id="L4396" rel="#L4396">4396</span>
<span id="L4397" rel="#L4397">4397</span>
<span id="L4398" rel="#L4398">4398</span>
<span id="L4399" rel="#L4399">4399</span>
<span id="L4400" rel="#L4400">4400</span>
<span id="L4401" rel="#L4401">4401</span>
<span id="L4402" rel="#L4402">4402</span>
<span id="L4403" rel="#L4403">4403</span>
<span id="L4404" rel="#L4404">4404</span>
<span id="L4405" rel="#L4405">4405</span>
<span id="L4406" rel="#L4406">4406</span>
<span id="L4407" rel="#L4407">4407</span>
<span id="L4408" rel="#L4408">4408</span>
<span id="L4409" rel="#L4409">4409</span>
<span id="L4410" rel="#L4410">4410</span>
<span id="L4411" rel="#L4411">4411</span>
<span id="L4412" rel="#L4412">4412</span>
<span id="L4413" rel="#L4413">4413</span>
<span id="L4414" rel="#L4414">4414</span>
<span id="L4415" rel="#L4415">4415</span>
<span id="L4416" rel="#L4416">4416</span>
<span id="L4417" rel="#L4417">4417</span>
<span id="L4418" rel="#L4418">4418</span>
<span id="L4419" rel="#L4419">4419</span>
<span id="L4420" rel="#L4420">4420</span>
<span id="L4421" rel="#L4421">4421</span>
<span id="L4422" rel="#L4422">4422</span>
<span id="L4423" rel="#L4423">4423</span>
<span id="L4424" rel="#L4424">4424</span>
<span id="L4425" rel="#L4425">4425</span>
<span id="L4426" rel="#L4426">4426</span>
<span id="L4427" rel="#L4427">4427</span>
<span id="L4428" rel="#L4428">4428</span>
<span id="L4429" rel="#L4429">4429</span>
<span id="L4430" rel="#L4430">4430</span>
<span id="L4431" rel="#L4431">4431</span>
<span id="L4432" rel="#L4432">4432</span>
<span id="L4433" rel="#L4433">4433</span>
<span id="L4434" rel="#L4434">4434</span>
<span id="L4435" rel="#L4435">4435</span>
<span id="L4436" rel="#L4436">4436</span>
<span id="L4437" rel="#L4437">4437</span>
<span id="L4438" rel="#L4438">4438</span>
<span id="L4439" rel="#L4439">4439</span>
<span id="L4440" rel="#L4440">4440</span>
<span id="L4441" rel="#L4441">4441</span>
<span id="L4442" rel="#L4442">4442</span>
<span id="L4443" rel="#L4443">4443</span>
<span id="L4444" rel="#L4444">4444</span>
<span id="L4445" rel="#L4445">4445</span>
<span id="L4446" rel="#L4446">4446</span>
<span id="L4447" rel="#L4447">4447</span>
<span id="L4448" rel="#L4448">4448</span>
<span id="L4449" rel="#L4449">4449</span>
<span id="L4450" rel="#L4450">4450</span>
<span id="L4451" rel="#L4451">4451</span>
<span id="L4452" rel="#L4452">4452</span>
<span id="L4453" rel="#L4453">4453</span>
<span id="L4454" rel="#L4454">4454</span>
<span id="L4455" rel="#L4455">4455</span>
<span id="L4456" rel="#L4456">4456</span>
<span id="L4457" rel="#L4457">4457</span>
<span id="L4458" rel="#L4458">4458</span>
<span id="L4459" rel="#L4459">4459</span>
<span id="L4460" rel="#L4460">4460</span>
<span id="L4461" rel="#L4461">4461</span>
<span id="L4462" rel="#L4462">4462</span>
<span id="L4463" rel="#L4463">4463</span>
<span id="L4464" rel="#L4464">4464</span>
<span id="L4465" rel="#L4465">4465</span>
<span id="L4466" rel="#L4466">4466</span>
<span id="L4467" rel="#L4467">4467</span>
<span id="L4468" rel="#L4468">4468</span>
<span id="L4469" rel="#L4469">4469</span>
<span id="L4470" rel="#L4470">4470</span>
<span id="L4471" rel="#L4471">4471</span>
<span id="L4472" rel="#L4472">4472</span>
<span id="L4473" rel="#L4473">4473</span>
<span id="L4474" rel="#L4474">4474</span>
<span id="L4475" rel="#L4475">4475</span>
<span id="L4476" rel="#L4476">4476</span>
<span id="L4477" rel="#L4477">4477</span>
<span id="L4478" rel="#L4478">4478</span>
<span id="L4479" rel="#L4479">4479</span>
<span id="L4480" rel="#L4480">4480</span>
<span id="L4481" rel="#L4481">4481</span>
<span id="L4482" rel="#L4482">4482</span>
<span id="L4483" rel="#L4483">4483</span>
<span id="L4484" rel="#L4484">4484</span>
<span id="L4485" rel="#L4485">4485</span>
<span id="L4486" rel="#L4486">4486</span>
<span id="L4487" rel="#L4487">4487</span>
<span id="L4488" rel="#L4488">4488</span>
<span id="L4489" rel="#L4489">4489</span>
<span id="L4490" rel="#L4490">4490</span>
<span id="L4491" rel="#L4491">4491</span>
<span id="L4492" rel="#L4492">4492</span>
<span id="L4493" rel="#L4493">4493</span>
<span id="L4494" rel="#L4494">4494</span>
<span id="L4495" rel="#L4495">4495</span>
<span id="L4496" rel="#L4496">4496</span>
<span id="L4497" rel="#L4497">4497</span>
<span id="L4498" rel="#L4498">4498</span>
<span id="L4499" rel="#L4499">4499</span>
<span id="L4500" rel="#L4500">4500</span>
<span id="L4501" rel="#L4501">4501</span>
<span id="L4502" rel="#L4502">4502</span>
<span id="L4503" rel="#L4503">4503</span>
<span id="L4504" rel="#L4504">4504</span>
<span id="L4505" rel="#L4505">4505</span>
<span id="L4506" rel="#L4506">4506</span>
<span id="L4507" rel="#L4507">4507</span>
<span id="L4508" rel="#L4508">4508</span>
<span id="L4509" rel="#L4509">4509</span>
<span id="L4510" rel="#L4510">4510</span>
<span id="L4511" rel="#L4511">4511</span>
<span id="L4512" rel="#L4512">4512</span>
<span id="L4513" rel="#L4513">4513</span>
<span id="L4514" rel="#L4514">4514</span>
<span id="L4515" rel="#L4515">4515</span>
<span id="L4516" rel="#L4516">4516</span>
<span id="L4517" rel="#L4517">4517</span>
<span id="L4518" rel="#L4518">4518</span>
<span id="L4519" rel="#L4519">4519</span>
<span id="L4520" rel="#L4520">4520</span>
<span id="L4521" rel="#L4521">4521</span>
<span id="L4522" rel="#L4522">4522</span>
<span id="L4523" rel="#L4523">4523</span>
<span id="L4524" rel="#L4524">4524</span>
<span id="L4525" rel="#L4525">4525</span>
<span id="L4526" rel="#L4526">4526</span>
<span id="L4527" rel="#L4527">4527</span>
<span id="L4528" rel="#L4528">4528</span>
<span id="L4529" rel="#L4529">4529</span>
<span id="L4530" rel="#L4530">4530</span>
<span id="L4531" rel="#L4531">4531</span>
<span id="L4532" rel="#L4532">4532</span>
<span id="L4533" rel="#L4533">4533</span>
<span id="L4534" rel="#L4534">4534</span>
<span id="L4535" rel="#L4535">4535</span>
<span id="L4536" rel="#L4536">4536</span>
<span id="L4537" rel="#L4537">4537</span>
<span id="L4538" rel="#L4538">4538</span>
<span id="L4539" rel="#L4539">4539</span>
<span id="L4540" rel="#L4540">4540</span>
<span id="L4541" rel="#L4541">4541</span>
<span id="L4542" rel="#L4542">4542</span>
<span id="L4543" rel="#L4543">4543</span>
<span id="L4544" rel="#L4544">4544</span>
<span id="L4545" rel="#L4545">4545</span>
<span id="L4546" rel="#L4546">4546</span>
<span id="L4547" rel="#L4547">4547</span>
<span id="L4548" rel="#L4548">4548</span>
<span id="L4549" rel="#L4549">4549</span>
<span id="L4550" rel="#L4550">4550</span>
<span id="L4551" rel="#L4551">4551</span>
<span id="L4552" rel="#L4552">4552</span>
<span id="L4553" rel="#L4553">4553</span>
<span id="L4554" rel="#L4554">4554</span>
<span id="L4555" rel="#L4555">4555</span>
<span id="L4556" rel="#L4556">4556</span>
<span id="L4557" rel="#L4557">4557</span>
<span id="L4558" rel="#L4558">4558</span>
<span id="L4559" rel="#L4559">4559</span>
<span id="L4560" rel="#L4560">4560</span>
<span id="L4561" rel="#L4561">4561</span>
<span id="L4562" rel="#L4562">4562</span>
<span id="L4563" rel="#L4563">4563</span>
<span id="L4564" rel="#L4564">4564</span>
<span id="L4565" rel="#L4565">4565</span>
<span id="L4566" rel="#L4566">4566</span>
<span id="L4567" rel="#L4567">4567</span>
<span id="L4568" rel="#L4568">4568</span>
<span id="L4569" rel="#L4569">4569</span>
<span id="L4570" rel="#L4570">4570</span>
<span id="L4571" rel="#L4571">4571</span>
<span id="L4572" rel="#L4572">4572</span>
<span id="L4573" rel="#L4573">4573</span>
<span id="L4574" rel="#L4574">4574</span>
<span id="L4575" rel="#L4575">4575</span>
<span id="L4576" rel="#L4576">4576</span>
<span id="L4577" rel="#L4577">4577</span>
<span id="L4578" rel="#L4578">4578</span>
<span id="L4579" rel="#L4579">4579</span>
<span id="L4580" rel="#L4580">4580</span>
<span id="L4581" rel="#L4581">4581</span>
<span id="L4582" rel="#L4582">4582</span>
<span id="L4583" rel="#L4583">4583</span>
<span id="L4584" rel="#L4584">4584</span>
<span id="L4585" rel="#L4585">4585</span>
<span id="L4586" rel="#L4586">4586</span>
<span id="L4587" rel="#L4587">4587</span>
<span id="L4588" rel="#L4588">4588</span>
<span id="L4589" rel="#L4589">4589</span>
<span id="L4590" rel="#L4590">4590</span>
<span id="L4591" rel="#L4591">4591</span>
<span id="L4592" rel="#L4592">4592</span>
<span id="L4593" rel="#L4593">4593</span>
<span id="L4594" rel="#L4594">4594</span>
<span id="L4595" rel="#L4595">4595</span>
<span id="L4596" rel="#L4596">4596</span>
<span id="L4597" rel="#L4597">4597</span>
<span id="L4598" rel="#L4598">4598</span>
<span id="L4599" rel="#L4599">4599</span>
<span id="L4600" rel="#L4600">4600</span>
<span id="L4601" rel="#L4601">4601</span>
<span id="L4602" rel="#L4602">4602</span>
<span id="L4603" rel="#L4603">4603</span>
<span id="L4604" rel="#L4604">4604</span>
<span id="L4605" rel="#L4605">4605</span>
<span id="L4606" rel="#L4606">4606</span>
<span id="L4607" rel="#L4607">4607</span>
<span id="L4608" rel="#L4608">4608</span>
<span id="L4609" rel="#L4609">4609</span>
<span id="L4610" rel="#L4610">4610</span>
<span id="L4611" rel="#L4611">4611</span>
<span id="L4612" rel="#L4612">4612</span>
<span id="L4613" rel="#L4613">4613</span>
<span id="L4614" rel="#L4614">4614</span>
<span id="L4615" rel="#L4615">4615</span>
<span id="L4616" rel="#L4616">4616</span>
<span id="L4617" rel="#L4617">4617</span>
<span id="L4618" rel="#L4618">4618</span>
<span id="L4619" rel="#L4619">4619</span>
<span id="L4620" rel="#L4620">4620</span>
<span id="L4621" rel="#L4621">4621</span>
<span id="L4622" rel="#L4622">4622</span>
<span id="L4623" rel="#L4623">4623</span>
<span id="L4624" rel="#L4624">4624</span>
<span id="L4625" rel="#L4625">4625</span>
<span id="L4626" rel="#L4626">4626</span>
<span id="L4627" rel="#L4627">4627</span>
<span id="L4628" rel="#L4628">4628</span>
<span id="L4629" rel="#L4629">4629</span>
<span id="L4630" rel="#L4630">4630</span>
<span id="L4631" rel="#L4631">4631</span>
<span id="L4632" rel="#L4632">4632</span>
<span id="L4633" rel="#L4633">4633</span>
<span id="L4634" rel="#L4634">4634</span>
<span id="L4635" rel="#L4635">4635</span>
<span id="L4636" rel="#L4636">4636</span>
<span id="L4637" rel="#L4637">4637</span>
<span id="L4638" rel="#L4638">4638</span>
<span id="L4639" rel="#L4639">4639</span>
<span id="L4640" rel="#L4640">4640</span>
<span id="L4641" rel="#L4641">4641</span>
<span id="L4642" rel="#L4642">4642</span>
<span id="L4643" rel="#L4643">4643</span>
<span id="L4644" rel="#L4644">4644</span>
<span id="L4645" rel="#L4645">4645</span>
<span id="L4646" rel="#L4646">4646</span>
<span id="L4647" rel="#L4647">4647</span>
<span id="L4648" rel="#L4648">4648</span>
<span id="L4649" rel="#L4649">4649</span>
<span id="L4650" rel="#L4650">4650</span>
<span id="L4651" rel="#L4651">4651</span>
<span id="L4652" rel="#L4652">4652</span>
<span id="L4653" rel="#L4653">4653</span>
<span id="L4654" rel="#L4654">4654</span>
<span id="L4655" rel="#L4655">4655</span>
<span id="L4656" rel="#L4656">4656</span>
<span id="L4657" rel="#L4657">4657</span>
<span id="L4658" rel="#L4658">4658</span>
<span id="L4659" rel="#L4659">4659</span>
<span id="L4660" rel="#L4660">4660</span>
<span id="L4661" rel="#L4661">4661</span>
<span id="L4662" rel="#L4662">4662</span>
<span id="L4663" rel="#L4663">4663</span>
<span id="L4664" rel="#L4664">4664</span>
<span id="L4665" rel="#L4665">4665</span>
<span id="L4666" rel="#L4666">4666</span>
<span id="L4667" rel="#L4667">4667</span>
<span id="L4668" rel="#L4668">4668</span>
<span id="L4669" rel="#L4669">4669</span>
<span id="L4670" rel="#L4670">4670</span>
<span id="L4671" rel="#L4671">4671</span>
<span id="L4672" rel="#L4672">4672</span>
<span id="L4673" rel="#L4673">4673</span>
<span id="L4674" rel="#L4674">4674</span>
<span id="L4675" rel="#L4675">4675</span>
<span id="L4676" rel="#L4676">4676</span>
<span id="L4677" rel="#L4677">4677</span>
<span id="L4678" rel="#L4678">4678</span>
<span id="L4679" rel="#L4679">4679</span>
<span id="L4680" rel="#L4680">4680</span>
<span id="L4681" rel="#L4681">4681</span>
<span id="L4682" rel="#L4682">4682</span>
<span id="L4683" rel="#L4683">4683</span>
<span id="L4684" rel="#L4684">4684</span>
<span id="L4685" rel="#L4685">4685</span>
<span id="L4686" rel="#L4686">4686</span>
<span id="L4687" rel="#L4687">4687</span>
<span id="L4688" rel="#L4688">4688</span>
<span id="L4689" rel="#L4689">4689</span>
<span id="L4690" rel="#L4690">4690</span>
<span id="L4691" rel="#L4691">4691</span>
<span id="L4692" rel="#L4692">4692</span>
<span id="L4693" rel="#L4693">4693</span>
<span id="L4694" rel="#L4694">4694</span>
<span id="L4695" rel="#L4695">4695</span>
<span id="L4696" rel="#L4696">4696</span>
<span id="L4697" rel="#L4697">4697</span>
<span id="L4698" rel="#L4698">4698</span>
<span id="L4699" rel="#L4699">4699</span>
<span id="L4700" rel="#L4700">4700</span>
<span id="L4701" rel="#L4701">4701</span>
<span id="L4702" rel="#L4702">4702</span>
<span id="L4703" rel="#L4703">4703</span>
<span id="L4704" rel="#L4704">4704</span>
<span id="L4705" rel="#L4705">4705</span>
<span id="L4706" rel="#L4706">4706</span>
<span id="L4707" rel="#L4707">4707</span>
<span id="L4708" rel="#L4708">4708</span>
<span id="L4709" rel="#L4709">4709</span>
<span id="L4710" rel="#L4710">4710</span>
<span id="L4711" rel="#L4711">4711</span>
<span id="L4712" rel="#L4712">4712</span>
<span id="L4713" rel="#L4713">4713</span>
<span id="L4714" rel="#L4714">4714</span>
<span id="L4715" rel="#L4715">4715</span>
<span id="L4716" rel="#L4716">4716</span>
<span id="L4717" rel="#L4717">4717</span>
<span id="L4718" rel="#L4718">4718</span>
<span id="L4719" rel="#L4719">4719</span>
<span id="L4720" rel="#L4720">4720</span>
<span id="L4721" rel="#L4721">4721</span>
<span id="L4722" rel="#L4722">4722</span>
<span id="L4723" rel="#L4723">4723</span>
<span id="L4724" rel="#L4724">4724</span>
<span id="L4725" rel="#L4725">4725</span>
<span id="L4726" rel="#L4726">4726</span>
<span id="L4727" rel="#L4727">4727</span>
<span id="L4728" rel="#L4728">4728</span>
<span id="L4729" rel="#L4729">4729</span>
<span id="L4730" rel="#L4730">4730</span>
<span id="L4731" rel="#L4731">4731</span>
<span id="L4732" rel="#L4732">4732</span>
<span id="L4733" rel="#L4733">4733</span>
<span id="L4734" rel="#L4734">4734</span>
<span id="L4735" rel="#L4735">4735</span>
<span id="L4736" rel="#L4736">4736</span>
<span id="L4737" rel="#L4737">4737</span>
<span id="L4738" rel="#L4738">4738</span>
<span id="L4739" rel="#L4739">4739</span>
<span id="L4740" rel="#L4740">4740</span>
<span id="L4741" rel="#L4741">4741</span>
<span id="L4742" rel="#L4742">4742</span>
<span id="L4743" rel="#L4743">4743</span>
<span id="L4744" rel="#L4744">4744</span>
<span id="L4745" rel="#L4745">4745</span>
<span id="L4746" rel="#L4746">4746</span>
<span id="L4747" rel="#L4747">4747</span>
<span id="L4748" rel="#L4748">4748</span>
<span id="L4749" rel="#L4749">4749</span>
<span id="L4750" rel="#L4750">4750</span>
<span id="L4751" rel="#L4751">4751</span>
<span id="L4752" rel="#L4752">4752</span>
<span id="L4753" rel="#L4753">4753</span>
<span id="L4754" rel="#L4754">4754</span>
<span id="L4755" rel="#L4755">4755</span>
<span id="L4756" rel="#L4756">4756</span>
<span id="L4757" rel="#L4757">4757</span>
<span id="L4758" rel="#L4758">4758</span>
<span id="L4759" rel="#L4759">4759</span>
<span id="L4760" rel="#L4760">4760</span>
<span id="L4761" rel="#L4761">4761</span>
<span id="L4762" rel="#L4762">4762</span>
<span id="L4763" rel="#L4763">4763</span>
<span id="L4764" rel="#L4764">4764</span>
<span id="L4765" rel="#L4765">4765</span>
<span id="L4766" rel="#L4766">4766</span>
<span id="L4767" rel="#L4767">4767</span>
<span id="L4768" rel="#L4768">4768</span>
<span id="L4769" rel="#L4769">4769</span>
<span id="L4770" rel="#L4770">4770</span>
<span id="L4771" rel="#L4771">4771</span>
<span id="L4772" rel="#L4772">4772</span>
<span id="L4773" rel="#L4773">4773</span>
<span id="L4774" rel="#L4774">4774</span>
<span id="L4775" rel="#L4775">4775</span>
<span id="L4776" rel="#L4776">4776</span>
<span id="L4777" rel="#L4777">4777</span>
<span id="L4778" rel="#L4778">4778</span>
<span id="L4779" rel="#L4779">4779</span>
<span id="L4780" rel="#L4780">4780</span>
<span id="L4781" rel="#L4781">4781</span>
<span id="L4782" rel="#L4782">4782</span>
<span id="L4783" rel="#L4783">4783</span>
<span id="L4784" rel="#L4784">4784</span>
<span id="L4785" rel="#L4785">4785</span>
<span id="L4786" rel="#L4786">4786</span>
<span id="L4787" rel="#L4787">4787</span>
<span id="L4788" rel="#L4788">4788</span>
<span id="L4789" rel="#L4789">4789</span>
<span id="L4790" rel="#L4790">4790</span>
<span id="L4791" rel="#L4791">4791</span>
<span id="L4792" rel="#L4792">4792</span>
<span id="L4793" rel="#L4793">4793</span>
<span id="L4794" rel="#L4794">4794</span>
<span id="L4795" rel="#L4795">4795</span>
<span id="L4796" rel="#L4796">4796</span>
<span id="L4797" rel="#L4797">4797</span>
<span id="L4798" rel="#L4798">4798</span>
<span id="L4799" rel="#L4799">4799</span>
<span id="L4800" rel="#L4800">4800</span>
<span id="L4801" rel="#L4801">4801</span>
<span id="L4802" rel="#L4802">4802</span>
<span id="L4803" rel="#L4803">4803</span>
<span id="L4804" rel="#L4804">4804</span>
<span id="L4805" rel="#L4805">4805</span>
<span id="L4806" rel="#L4806">4806</span>
<span id="L4807" rel="#L4807">4807</span>
<span id="L4808" rel="#L4808">4808</span>
<span id="L4809" rel="#L4809">4809</span>
<span id="L4810" rel="#L4810">4810</span>
<span id="L4811" rel="#L4811">4811</span>
<span id="L4812" rel="#L4812">4812</span>
<span id="L4813" rel="#L4813">4813</span>
<span id="L4814" rel="#L4814">4814</span>
<span id="L4815" rel="#L4815">4815</span>
<span id="L4816" rel="#L4816">4816</span>
<span id="L4817" rel="#L4817">4817</span>
<span id="L4818" rel="#L4818">4818</span>
<span id="L4819" rel="#L4819">4819</span>
<span id="L4820" rel="#L4820">4820</span>
<span id="L4821" rel="#L4821">4821</span>
<span id="L4822" rel="#L4822">4822</span>
<span id="L4823" rel="#L4823">4823</span>
<span id="L4824" rel="#L4824">4824</span>
<span id="L4825" rel="#L4825">4825</span>
<span id="L4826" rel="#L4826">4826</span>
<span id="L4827" rel="#L4827">4827</span>
<span id="L4828" rel="#L4828">4828</span>
<span id="L4829" rel="#L4829">4829</span>
<span id="L4830" rel="#L4830">4830</span>
<span id="L4831" rel="#L4831">4831</span>
<span id="L4832" rel="#L4832">4832</span>
<span id="L4833" rel="#L4833">4833</span>
<span id="L4834" rel="#L4834">4834</span>
<span id="L4835" rel="#L4835">4835</span>
<span id="L4836" rel="#L4836">4836</span>
<span id="L4837" rel="#L4837">4837</span>
<span id="L4838" rel="#L4838">4838</span>
<span id="L4839" rel="#L4839">4839</span>
<span id="L4840" rel="#L4840">4840</span>
<span id="L4841" rel="#L4841">4841</span>
<span id="L4842" rel="#L4842">4842</span>
<span id="L4843" rel="#L4843">4843</span>
<span id="L4844" rel="#L4844">4844</span>
<span id="L4845" rel="#L4845">4845</span>
<span id="L4846" rel="#L4846">4846</span>
<span id="L4847" rel="#L4847">4847</span>
<span id="L4848" rel="#L4848">4848</span>
<span id="L4849" rel="#L4849">4849</span>
<span id="L4850" rel="#L4850">4850</span>
<span id="L4851" rel="#L4851">4851</span>
<span id="L4852" rel="#L4852">4852</span>
<span id="L4853" rel="#L4853">4853</span>
<span id="L4854" rel="#L4854">4854</span>
<span id="L4855" rel="#L4855">4855</span>
<span id="L4856" rel="#L4856">4856</span>
<span id="L4857" rel="#L4857">4857</span>
<span id="L4858" rel="#L4858">4858</span>
<span id="L4859" rel="#L4859">4859</span>
<span id="L4860" rel="#L4860">4860</span>
<span id="L4861" rel="#L4861">4861</span>
<span id="L4862" rel="#L4862">4862</span>
<span id="L4863" rel="#L4863">4863</span>
<span id="L4864" rel="#L4864">4864</span>
<span id="L4865" rel="#L4865">4865</span>
<span id="L4866" rel="#L4866">4866</span>
<span id="L4867" rel="#L4867">4867</span>
<span id="L4868" rel="#L4868">4868</span>
<span id="L4869" rel="#L4869">4869</span>
<span id="L4870" rel="#L4870">4870</span>
<span id="L4871" rel="#L4871">4871</span>
<span id="L4872" rel="#L4872">4872</span>
<span id="L4873" rel="#L4873">4873</span>
<span id="L4874" rel="#L4874">4874</span>
<span id="L4875" rel="#L4875">4875</span>
<span id="L4876" rel="#L4876">4876</span>
<span id="L4877" rel="#L4877">4877</span>
<span id="L4878" rel="#L4878">4878</span>
<span id="L4879" rel="#L4879">4879</span>
<span id="L4880" rel="#L4880">4880</span>
<span id="L4881" rel="#L4881">4881</span>
<span id="L4882" rel="#L4882">4882</span>
<span id="L4883" rel="#L4883">4883</span>
<span id="L4884" rel="#L4884">4884</span>
<span id="L4885" rel="#L4885">4885</span>
<span id="L4886" rel="#L4886">4886</span>
<span id="L4887" rel="#L4887">4887</span>
<span id="L4888" rel="#L4888">4888</span>
<span id="L4889" rel="#L4889">4889</span>
<span id="L4890" rel="#L4890">4890</span>
<span id="L4891" rel="#L4891">4891</span>
<span id="L4892" rel="#L4892">4892</span>
<span id="L4893" rel="#L4893">4893</span>
<span id="L4894" rel="#L4894">4894</span>
<span id="L4895" rel="#L4895">4895</span>
<span id="L4896" rel="#L4896">4896</span>
<span id="L4897" rel="#L4897">4897</span>
<span id="L4898" rel="#L4898">4898</span>
<span id="L4899" rel="#L4899">4899</span>
<span id="L4900" rel="#L4900">4900</span>
<span id="L4901" rel="#L4901">4901</span>
<span id="L4902" rel="#L4902">4902</span>
<span id="L4903" rel="#L4903">4903</span>
<span id="L4904" rel="#L4904">4904</span>
<span id="L4905" rel="#L4905">4905</span>
<span id="L4906" rel="#L4906">4906</span>
<span id="L4907" rel="#L4907">4907</span>
<span id="L4908" rel="#L4908">4908</span>
<span id="L4909" rel="#L4909">4909</span>
<span id="L4910" rel="#L4910">4910</span>
<span id="L4911" rel="#L4911">4911</span>
<span id="L4912" rel="#L4912">4912</span>
<span id="L4913" rel="#L4913">4913</span>
<span id="L4914" rel="#L4914">4914</span>
<span id="L4915" rel="#L4915">4915</span>
<span id="L4916" rel="#L4916">4916</span>
<span id="L4917" rel="#L4917">4917</span>
<span id="L4918" rel="#L4918">4918</span>
<span id="L4919" rel="#L4919">4919</span>
<span id="L4920" rel="#L4920">4920</span>
<span id="L4921" rel="#L4921">4921</span>
<span id="L4922" rel="#L4922">4922</span>
<span id="L4923" rel="#L4923">4923</span>
<span id="L4924" rel="#L4924">4924</span>
<span id="L4925" rel="#L4925">4925</span>
<span id="L4926" rel="#L4926">4926</span>
<span id="L4927" rel="#L4927">4927</span>
<span id="L4928" rel="#L4928">4928</span>
<span id="L4929" rel="#L4929">4929</span>
<span id="L4930" rel="#L4930">4930</span>
<span id="L4931" rel="#L4931">4931</span>
<span id="L4932" rel="#L4932">4932</span>
<span id="L4933" rel="#L4933">4933</span>
<span id="L4934" rel="#L4934">4934</span>
<span id="L4935" rel="#L4935">4935</span>
<span id="L4936" rel="#L4936">4936</span>
<span id="L4937" rel="#L4937">4937</span>
<span id="L4938" rel="#L4938">4938</span>
<span id="L4939" rel="#L4939">4939</span>
<span id="L4940" rel="#L4940">4940</span>
<span id="L4941" rel="#L4941">4941</span>
<span id="L4942" rel="#L4942">4942</span>
<span id="L4943" rel="#L4943">4943</span>
<span id="L4944" rel="#L4944">4944</span>
<span id="L4945" rel="#L4945">4945</span>
<span id="L4946" rel="#L4946">4946</span>
<span id="L4947" rel="#L4947">4947</span>
<span id="L4948" rel="#L4948">4948</span>
<span id="L4949" rel="#L4949">4949</span>
<span id="L4950" rel="#L4950">4950</span>
<span id="L4951" rel="#L4951">4951</span>
<span id="L4952" rel="#L4952">4952</span>
<span id="L4953" rel="#L4953">4953</span>
<span id="L4954" rel="#L4954">4954</span>
<span id="L4955" rel="#L4955">4955</span>
<span id="L4956" rel="#L4956">4956</span>
<span id="L4957" rel="#L4957">4957</span>
<span id="L4958" rel="#L4958">4958</span>
<span id="L4959" rel="#L4959">4959</span>
<span id="L4960" rel="#L4960">4960</span>
<span id="L4961" rel="#L4961">4961</span>
<span id="L4962" rel="#L4962">4962</span>
<span id="L4963" rel="#L4963">4963</span>
<span id="L4964" rel="#L4964">4964</span>
<span id="L4965" rel="#L4965">4965</span>
<span id="L4966" rel="#L4966">4966</span>
<span id="L4967" rel="#L4967">4967</span>
<span id="L4968" rel="#L4968">4968</span>
<span id="L4969" rel="#L4969">4969</span>
<span id="L4970" rel="#L4970">4970</span>
<span id="L4971" rel="#L4971">4971</span>
<span id="L4972" rel="#L4972">4972</span>
<span id="L4973" rel="#L4973">4973</span>
<span id="L4974" rel="#L4974">4974</span>
<span id="L4975" rel="#L4975">4975</span>
<span id="L4976" rel="#L4976">4976</span>
<span id="L4977" rel="#L4977">4977</span>
<span id="L4978" rel="#L4978">4978</span>
<span id="L4979" rel="#L4979">4979</span>
<span id="L4980" rel="#L4980">4980</span>
<span id="L4981" rel="#L4981">4981</span>
<span id="L4982" rel="#L4982">4982</span>
<span id="L4983" rel="#L4983">4983</span>
<span id="L4984" rel="#L4984">4984</span>
<span id="L4985" rel="#L4985">4985</span>
<span id="L4986" rel="#L4986">4986</span>
<span id="L4987" rel="#L4987">4987</span>
<span id="L4988" rel="#L4988">4988</span>
<span id="L4989" rel="#L4989">4989</span>
<span id="L4990" rel="#L4990">4990</span>
<span id="L4991" rel="#L4991">4991</span>
<span id="L4992" rel="#L4992">4992</span>
<span id="L4993" rel="#L4993">4993</span>
<span id="L4994" rel="#L4994">4994</span>
<span id="L4995" rel="#L4995">4995</span>
<span id="L4996" rel="#L4996">4996</span>
<span id="L4997" rel="#L4997">4997</span>
<span id="L4998" rel="#L4998">4998</span>
<span id="L4999" rel="#L4999">4999</span>
<span id="L5000" rel="#L5000">5000</span>
<span id="L5001" rel="#L5001">5001</span>
<span id="L5002" rel="#L5002">5002</span>
<span id="L5003" rel="#L5003">5003</span>
<span id="L5004" rel="#L5004">5004</span>
<span id="L5005" rel="#L5005">5005</span>
<span id="L5006" rel="#L5006">5006</span>
<span id="L5007" rel="#L5007">5007</span>
<span id="L5008" rel="#L5008">5008</span>
<span id="L5009" rel="#L5009">5009</span>
<span id="L5010" rel="#L5010">5010</span>
<span id="L5011" rel="#L5011">5011</span>
<span id="L5012" rel="#L5012">5012</span>
<span id="L5013" rel="#L5013">5013</span>
<span id="L5014" rel="#L5014">5014</span>
<span id="L5015" rel="#L5015">5015</span>
<span id="L5016" rel="#L5016">5016</span>
<span id="L5017" rel="#L5017">5017</span>
<span id="L5018" rel="#L5018">5018</span>
<span id="L5019" rel="#L5019">5019</span>
<span id="L5020" rel="#L5020">5020</span>
<span id="L5021" rel="#L5021">5021</span>
<span id="L5022" rel="#L5022">5022</span>
<span id="L5023" rel="#L5023">5023</span>
<span id="L5024" rel="#L5024">5024</span>
<span id="L5025" rel="#L5025">5025</span>
<span id="L5026" rel="#L5026">5026</span>
<span id="L5027" rel="#L5027">5027</span>
<span id="L5028" rel="#L5028">5028</span>
<span id="L5029" rel="#L5029">5029</span>
<span id="L5030" rel="#L5030">5030</span>
<span id="L5031" rel="#L5031">5031</span>
<span id="L5032" rel="#L5032">5032</span>
<span id="L5033" rel="#L5033">5033</span>
<span id="L5034" rel="#L5034">5034</span>
<span id="L5035" rel="#L5035">5035</span>
<span id="L5036" rel="#L5036">5036</span>
<span id="L5037" rel="#L5037">5037</span>
<span id="L5038" rel="#L5038">5038</span>
<span id="L5039" rel="#L5039">5039</span>
<span id="L5040" rel="#L5040">5040</span>
<span id="L5041" rel="#L5041">5041</span>
<span id="L5042" rel="#L5042">5042</span>
<span id="L5043" rel="#L5043">5043</span>
<span id="L5044" rel="#L5044">5044</span>
<span id="L5045" rel="#L5045">5045</span>
<span id="L5046" rel="#L5046">5046</span>
<span id="L5047" rel="#L5047">5047</span>
<span id="L5048" rel="#L5048">5048</span>
<span id="L5049" rel="#L5049">5049</span>
<span id="L5050" rel="#L5050">5050</span>
<span id="L5051" rel="#L5051">5051</span>
<span id="L5052" rel="#L5052">5052</span>
<span id="L5053" rel="#L5053">5053</span>
<span id="L5054" rel="#L5054">5054</span>
<span id="L5055" rel="#L5055">5055</span>
<span id="L5056" rel="#L5056">5056</span>
<span id="L5057" rel="#L5057">5057</span>
<span id="L5058" rel="#L5058">5058</span>
<span id="L5059" rel="#L5059">5059</span>
<span id="L5060" rel="#L5060">5060</span>
<span id="L5061" rel="#L5061">5061</span>
<span id="L5062" rel="#L5062">5062</span>
<span id="L5063" rel="#L5063">5063</span>
<span id="L5064" rel="#L5064">5064</span>
<span id="L5065" rel="#L5065">5065</span>
<span id="L5066" rel="#L5066">5066</span>
<span id="L5067" rel="#L5067">5067</span>
<span id="L5068" rel="#L5068">5068</span>
<span id="L5069" rel="#L5069">5069</span>
<span id="L5070" rel="#L5070">5070</span>
<span id="L5071" rel="#L5071">5071</span>
<span id="L5072" rel="#L5072">5072</span>
<span id="L5073" rel="#L5073">5073</span>
<span id="L5074" rel="#L5074">5074</span>
<span id="L5075" rel="#L5075">5075</span>
<span id="L5076" rel="#L5076">5076</span>
<span id="L5077" rel="#L5077">5077</span>
<span id="L5078" rel="#L5078">5078</span>
<span id="L5079" rel="#L5079">5079</span>
<span id="L5080" rel="#L5080">5080</span>
<span id="L5081" rel="#L5081">5081</span>
<span id="L5082" rel="#L5082">5082</span>
<span id="L5083" rel="#L5083">5083</span>
<span id="L5084" rel="#L5084">5084</span>
<span id="L5085" rel="#L5085">5085</span>
<span id="L5086" rel="#L5086">5086</span>
<span id="L5087" rel="#L5087">5087</span>
<span id="L5088" rel="#L5088">5088</span>
<span id="L5089" rel="#L5089">5089</span>
<span id="L5090" rel="#L5090">5090</span>
<span id="L5091" rel="#L5091">5091</span>
<span id="L5092" rel="#L5092">5092</span>
<span id="L5093" rel="#L5093">5093</span>
<span id="L5094" rel="#L5094">5094</span>
<span id="L5095" rel="#L5095">5095</span>
<span id="L5096" rel="#L5096">5096</span>
<span id="L5097" rel="#L5097">5097</span>
<span id="L5098" rel="#L5098">5098</span>
<span id="L5099" rel="#L5099">5099</span>
<span id="L5100" rel="#L5100">5100</span>
<span id="L5101" rel="#L5101">5101</span>
<span id="L5102" rel="#L5102">5102</span>
<span id="L5103" rel="#L5103">5103</span>
<span id="L5104" rel="#L5104">5104</span>
<span id="L5105" rel="#L5105">5105</span>
<span id="L5106" rel="#L5106">5106</span>
<span id="L5107" rel="#L5107">5107</span>
<span id="L5108" rel="#L5108">5108</span>
<span id="L5109" rel="#L5109">5109</span>
<span id="L5110" rel="#L5110">5110</span>
<span id="L5111" rel="#L5111">5111</span>
<span id="L5112" rel="#L5112">5112</span>
<span id="L5113" rel="#L5113">5113</span>
<span id="L5114" rel="#L5114">5114</span>
<span id="L5115" rel="#L5115">5115</span>
<span id="L5116" rel="#L5116">5116</span>
<span id="L5117" rel="#L5117">5117</span>
<span id="L5118" rel="#L5118">5118</span>
<span id="L5119" rel="#L5119">5119</span>
<span id="L5120" rel="#L5120">5120</span>
<span id="L5121" rel="#L5121">5121</span>
<span id="L5122" rel="#L5122">5122</span>
<span id="L5123" rel="#L5123">5123</span>
<span id="L5124" rel="#L5124">5124</span>
<span id="L5125" rel="#L5125">5125</span>
<span id="L5126" rel="#L5126">5126</span>
<span id="L5127" rel="#L5127">5127</span>
<span id="L5128" rel="#L5128">5128</span>
<span id="L5129" rel="#L5129">5129</span>
<span id="L5130" rel="#L5130">5130</span>
<span id="L5131" rel="#L5131">5131</span>
<span id="L5132" rel="#L5132">5132</span>
<span id="L5133" rel="#L5133">5133</span>
<span id="L5134" rel="#L5134">5134</span>
<span id="L5135" rel="#L5135">5135</span>
<span id="L5136" rel="#L5136">5136</span>
<span id="L5137" rel="#L5137">5137</span>
<span id="L5138" rel="#L5138">5138</span>
<span id="L5139" rel="#L5139">5139</span>
<span id="L5140" rel="#L5140">5140</span>
<span id="L5141" rel="#L5141">5141</span>
<span id="L5142" rel="#L5142">5142</span>
<span id="L5143" rel="#L5143">5143</span>
<span id="L5144" rel="#L5144">5144</span>
<span id="L5145" rel="#L5145">5145</span>
<span id="L5146" rel="#L5146">5146</span>
<span id="L5147" rel="#L5147">5147</span>
<span id="L5148" rel="#L5148">5148</span>
<span id="L5149" rel="#L5149">5149</span>
<span id="L5150" rel="#L5150">5150</span>
<span id="L5151" rel="#L5151">5151</span>
<span id="L5152" rel="#L5152">5152</span>
<span id="L5153" rel="#L5153">5153</span>
<span id="L5154" rel="#L5154">5154</span>
<span id="L5155" rel="#L5155">5155</span>
<span id="L5156" rel="#L5156">5156</span>
<span id="L5157" rel="#L5157">5157</span>
<span id="L5158" rel="#L5158">5158</span>
<span id="L5159" rel="#L5159">5159</span>
<span id="L5160" rel="#L5160">5160</span>
<span id="L5161" rel="#L5161">5161</span>
<span id="L5162" rel="#L5162">5162</span>
<span id="L5163" rel="#L5163">5163</span>
<span id="L5164" rel="#L5164">5164</span>
<span id="L5165" rel="#L5165">5165</span>
<span id="L5166" rel="#L5166">5166</span>
<span id="L5167" rel="#L5167">5167</span>
<span id="L5168" rel="#L5168">5168</span>
<span id="L5169" rel="#L5169">5169</span>
<span id="L5170" rel="#L5170">5170</span>
<span id="L5171" rel="#L5171">5171</span>
<span id="L5172" rel="#L5172">5172</span>
<span id="L5173" rel="#L5173">5173</span>
<span id="L5174" rel="#L5174">5174</span>
<span id="L5175" rel="#L5175">5175</span>
<span id="L5176" rel="#L5176">5176</span>
<span id="L5177" rel="#L5177">5177</span>
<span id="L5178" rel="#L5178">5178</span>
<span id="L5179" rel="#L5179">5179</span>
<span id="L5180" rel="#L5180">5180</span>
<span id="L5181" rel="#L5181">5181</span>
<span id="L5182" rel="#L5182">5182</span>
<span id="L5183" rel="#L5183">5183</span>
<span id="L5184" rel="#L5184">5184</span>
<span id="L5185" rel="#L5185">5185</span>
<span id="L5186" rel="#L5186">5186</span>
<span id="L5187" rel="#L5187">5187</span>
<span id="L5188" rel="#L5188">5188</span>
<span id="L5189" rel="#L5189">5189</span>
<span id="L5190" rel="#L5190">5190</span>
<span id="L5191" rel="#L5191">5191</span>
<span id="L5192" rel="#L5192">5192</span>
<span id="L5193" rel="#L5193">5193</span>
<span id="L5194" rel="#L5194">5194</span>
<span id="L5195" rel="#L5195">5195</span>
<span id="L5196" rel="#L5196">5196</span>
<span id="L5197" rel="#L5197">5197</span>
<span id="L5198" rel="#L5198">5198</span>
<span id="L5199" rel="#L5199">5199</span>
<span id="L5200" rel="#L5200">5200</span>
<span id="L5201" rel="#L5201">5201</span>
<span id="L5202" rel="#L5202">5202</span>
<span id="L5203" rel="#L5203">5203</span>
<span id="L5204" rel="#L5204">5204</span>
<span id="L5205" rel="#L5205">5205</span>
<span id="L5206" rel="#L5206">5206</span>
<span id="L5207" rel="#L5207">5207</span>
<span id="L5208" rel="#L5208">5208</span>
<span id="L5209" rel="#L5209">5209</span>
<span id="L5210" rel="#L5210">5210</span>
<span id="L5211" rel="#L5211">5211</span>
<span id="L5212" rel="#L5212">5212</span>
<span id="L5213" rel="#L5213">5213</span>
<span id="L5214" rel="#L5214">5214</span>
<span id="L5215" rel="#L5215">5215</span>
<span id="L5216" rel="#L5216">5216</span>
<span id="L5217" rel="#L5217">5217</span>
<span id="L5218" rel="#L5218">5218</span>
<span id="L5219" rel="#L5219">5219</span>
<span id="L5220" rel="#L5220">5220</span>
<span id="L5221" rel="#L5221">5221</span>
<span id="L5222" rel="#L5222">5222</span>
<span id="L5223" rel="#L5223">5223</span>
<span id="L5224" rel="#L5224">5224</span>
<span id="L5225" rel="#L5225">5225</span>
<span id="L5226" rel="#L5226">5226</span>
<span id="L5227" rel="#L5227">5227</span>
<span id="L5228" rel="#L5228">5228</span>
<span id="L5229" rel="#L5229">5229</span>
<span id="L5230" rel="#L5230">5230</span>
<span id="L5231" rel="#L5231">5231</span>
<span id="L5232" rel="#L5232">5232</span>
<span id="L5233" rel="#L5233">5233</span>
<span id="L5234" rel="#L5234">5234</span>
<span id="L5235" rel="#L5235">5235</span>
<span id="L5236" rel="#L5236">5236</span>
<span id="L5237" rel="#L5237">5237</span>
<span id="L5238" rel="#L5238">5238</span>
<span id="L5239" rel="#L5239">5239</span>
<span id="L5240" rel="#L5240">5240</span>
<span id="L5241" rel="#L5241">5241</span>
<span id="L5242" rel="#L5242">5242</span>
<span id="L5243" rel="#L5243">5243</span>
<span id="L5244" rel="#L5244">5244</span>
<span id="L5245" rel="#L5245">5245</span>
<span id="L5246" rel="#L5246">5246</span>
<span id="L5247" rel="#L5247">5247</span>
<span id="L5248" rel="#L5248">5248</span>
<span id="L5249" rel="#L5249">5249</span>
<span id="L5250" rel="#L5250">5250</span>
<span id="L5251" rel="#L5251">5251</span>
<span id="L5252" rel="#L5252">5252</span>
<span id="L5253" rel="#L5253">5253</span>
<span id="L5254" rel="#L5254">5254</span>
<span id="L5255" rel="#L5255">5255</span>
<span id="L5256" rel="#L5256">5256</span>
<span id="L5257" rel="#L5257">5257</span>
<span id="L5258" rel="#L5258">5258</span>
<span id="L5259" rel="#L5259">5259</span>
<span id="L5260" rel="#L5260">5260</span>
<span id="L5261" rel="#L5261">5261</span>
<span id="L5262" rel="#L5262">5262</span>
<span id="L5263" rel="#L5263">5263</span>
<span id="L5264" rel="#L5264">5264</span>
<span id="L5265" rel="#L5265">5265</span>
<span id="L5266" rel="#L5266">5266</span>
<span id="L5267" rel="#L5267">5267</span>
<span id="L5268" rel="#L5268">5268</span>
<span id="L5269" rel="#L5269">5269</span>
<span id="L5270" rel="#L5270">5270</span>
<span id="L5271" rel="#L5271">5271</span>
<span id="L5272" rel="#L5272">5272</span>
<span id="L5273" rel="#L5273">5273</span>
<span id="L5274" rel="#L5274">5274</span>
<span id="L5275" rel="#L5275">5275</span>
<span id="L5276" rel="#L5276">5276</span>
<span id="L5277" rel="#L5277">5277</span>
<span id="L5278" rel="#L5278">5278</span>
<span id="L5279" rel="#L5279">5279</span>
<span id="L5280" rel="#L5280">5280</span>
<span id="L5281" rel="#L5281">5281</span>
<span id="L5282" rel="#L5282">5282</span>
<span id="L5283" rel="#L5283">5283</span>
<span id="L5284" rel="#L5284">5284</span>
<span id="L5285" rel="#L5285">5285</span>
<span id="L5286" rel="#L5286">5286</span>
<span id="L5287" rel="#L5287">5287</span>
<span id="L5288" rel="#L5288">5288</span>
<span id="L5289" rel="#L5289">5289</span>
<span id="L5290" rel="#L5290">5290</span>
<span id="L5291" rel="#L5291">5291</span>
<span id="L5292" rel="#L5292">5292</span>
<span id="L5293" rel="#L5293">5293</span>
<span id="L5294" rel="#L5294">5294</span>
<span id="L5295" rel="#L5295">5295</span>
<span id="L5296" rel="#L5296">5296</span>
<span id="L5297" rel="#L5297">5297</span>
<span id="L5298" rel="#L5298">5298</span>
<span id="L5299" rel="#L5299">5299</span>
<span id="L5300" rel="#L5300">5300</span>
<span id="L5301" rel="#L5301">5301</span>
<span id="L5302" rel="#L5302">5302</span>
<span id="L5303" rel="#L5303">5303</span>
<span id="L5304" rel="#L5304">5304</span>
<span id="L5305" rel="#L5305">5305</span>
<span id="L5306" rel="#L5306">5306</span>
<span id="L5307" rel="#L5307">5307</span>
<span id="L5308" rel="#L5308">5308</span>
<span id="L5309" rel="#L5309">5309</span>
<span id="L5310" rel="#L5310">5310</span>
<span id="L5311" rel="#L5311">5311</span>
<span id="L5312" rel="#L5312">5312</span>
<span id="L5313" rel="#L5313">5313</span>
<span id="L5314" rel="#L5314">5314</span>
<span id="L5315" rel="#L5315">5315</span>
<span id="L5316" rel="#L5316">5316</span>
<span id="L5317" rel="#L5317">5317</span>
<span id="L5318" rel="#L5318">5318</span>
<span id="L5319" rel="#L5319">5319</span>
<span id="L5320" rel="#L5320">5320</span>
<span id="L5321" rel="#L5321">5321</span>
<span id="L5322" rel="#L5322">5322</span>
<span id="L5323" rel="#L5323">5323</span>
<span id="L5324" rel="#L5324">5324</span>
<span id="L5325" rel="#L5325">5325</span>
<span id="L5326" rel="#L5326">5326</span>
<span id="L5327" rel="#L5327">5327</span>
<span id="L5328" rel="#L5328">5328</span>
<span id="L5329" rel="#L5329">5329</span>
<span id="L5330" rel="#L5330">5330</span>
<span id="L5331" rel="#L5331">5331</span>
<span id="L5332" rel="#L5332">5332</span>
<span id="L5333" rel="#L5333">5333</span>
<span id="L5334" rel="#L5334">5334</span>
<span id="L5335" rel="#L5335">5335</span>
<span id="L5336" rel="#L5336">5336</span>
<span id="L5337" rel="#L5337">5337</span>
<span id="L5338" rel="#L5338">5338</span>
<span id="L5339" rel="#L5339">5339</span>
<span id="L5340" rel="#L5340">5340</span>
<span id="L5341" rel="#L5341">5341</span>
<span id="L5342" rel="#L5342">5342</span>
<span id="L5343" rel="#L5343">5343</span>
<span id="L5344" rel="#L5344">5344</span>
<span id="L5345" rel="#L5345">5345</span>
<span id="L5346" rel="#L5346">5346</span>
<span id="L5347" rel="#L5347">5347</span>
<span id="L5348" rel="#L5348">5348</span>
<span id="L5349" rel="#L5349">5349</span>
<span id="L5350" rel="#L5350">5350</span>
<span id="L5351" rel="#L5351">5351</span>
<span id="L5352" rel="#L5352">5352</span>
<span id="L5353" rel="#L5353">5353</span>
<span id="L5354" rel="#L5354">5354</span>
<span id="L5355" rel="#L5355">5355</span>
<span id="L5356" rel="#L5356">5356</span>
<span id="L5357" rel="#L5357">5357</span>
<span id="L5358" rel="#L5358">5358</span>
<span id="L5359" rel="#L5359">5359</span>
<span id="L5360" rel="#L5360">5360</span>
<span id="L5361" rel="#L5361">5361</span>
<span id="L5362" rel="#L5362">5362</span>
<span id="L5363" rel="#L5363">5363</span>
<span id="L5364" rel="#L5364">5364</span>
<span id="L5365" rel="#L5365">5365</span>
<span id="L5366" rel="#L5366">5366</span>
<span id="L5367" rel="#L5367">5367</span>
<span id="L5368" rel="#L5368">5368</span>
<span id="L5369" rel="#L5369">5369</span>
<span id="L5370" rel="#L5370">5370</span>
<span id="L5371" rel="#L5371">5371</span>
<span id="L5372" rel="#L5372">5372</span>
<span id="L5373" rel="#L5373">5373</span>
<span id="L5374" rel="#L5374">5374</span>
<span id="L5375" rel="#L5375">5375</span>
<span id="L5376" rel="#L5376">5376</span>
<span id="L5377" rel="#L5377">5377</span>
<span id="L5378" rel="#L5378">5378</span>
<span id="L5379" rel="#L5379">5379</span>
<span id="L5380" rel="#L5380">5380</span>
<span id="L5381" rel="#L5381">5381</span>
<span id="L5382" rel="#L5382">5382</span>
<span id="L5383" rel="#L5383">5383</span>
<span id="L5384" rel="#L5384">5384</span>
<span id="L5385" rel="#L5385">5385</span>
<span id="L5386" rel="#L5386">5386</span>
<span id="L5387" rel="#L5387">5387</span>
<span id="L5388" rel="#L5388">5388</span>
<span id="L5389" rel="#L5389">5389</span>
<span id="L5390" rel="#L5390">5390</span>
<span id="L5391" rel="#L5391">5391</span>
<span id="L5392" rel="#L5392">5392</span>
<span id="L5393" rel="#L5393">5393</span>
<span id="L5394" rel="#L5394">5394</span>
<span id="L5395" rel="#L5395">5395</span>
<span id="L5396" rel="#L5396">5396</span>
<span id="L5397" rel="#L5397">5397</span>
<span id="L5398" rel="#L5398">5398</span>
<span id="L5399" rel="#L5399">5399</span>
<span id="L5400" rel="#L5400">5400</span>
<span id="L5401" rel="#L5401">5401</span>
<span id="L5402" rel="#L5402">5402</span>
<span id="L5403" rel="#L5403">5403</span>
<span id="L5404" rel="#L5404">5404</span>
<span id="L5405" rel="#L5405">5405</span>
<span id="L5406" rel="#L5406">5406</span>
<span id="L5407" rel="#L5407">5407</span>
<span id="L5408" rel="#L5408">5408</span>
<span id="L5409" rel="#L5409">5409</span>
<span id="L5410" rel="#L5410">5410</span>
<span id="L5411" rel="#L5411">5411</span>
<span id="L5412" rel="#L5412">5412</span>
<span id="L5413" rel="#L5413">5413</span>
<span id="L5414" rel="#L5414">5414</span>
<span id="L5415" rel="#L5415">5415</span>
<span id="L5416" rel="#L5416">5416</span>
<span id="L5417" rel="#L5417">5417</span>
<span id="L5418" rel="#L5418">5418</span>
<span id="L5419" rel="#L5419">5419</span>
<span id="L5420" rel="#L5420">5420</span>
<span id="L5421" rel="#L5421">5421</span>
<span id="L5422" rel="#L5422">5422</span>
<span id="L5423" rel="#L5423">5423</span>
<span id="L5424" rel="#L5424">5424</span>
<span id="L5425" rel="#L5425">5425</span>
<span id="L5426" rel="#L5426">5426</span>
<span id="L5427" rel="#L5427">5427</span>
<span id="L5428" rel="#L5428">5428</span>
<span id="L5429" rel="#L5429">5429</span>
<span id="L5430" rel="#L5430">5430</span>
<span id="L5431" rel="#L5431">5431</span>
<span id="L5432" rel="#L5432">5432</span>
<span id="L5433" rel="#L5433">5433</span>
<span id="L5434" rel="#L5434">5434</span>
<span id="L5435" rel="#L5435">5435</span>
<span id="L5436" rel="#L5436">5436</span>
<span id="L5437" rel="#L5437">5437</span>
<span id="L5438" rel="#L5438">5438</span>
<span id="L5439" rel="#L5439">5439</span>
<span id="L5440" rel="#L5440">5440</span>
<span id="L5441" rel="#L5441">5441</span>
<span id="L5442" rel="#L5442">5442</span>
<span id="L5443" rel="#L5443">5443</span>
<span id="L5444" rel="#L5444">5444</span>
<span id="L5445" rel="#L5445">5445</span>
<span id="L5446" rel="#L5446">5446</span>
<span id="L5447" rel="#L5447">5447</span>
<span id="L5448" rel="#L5448">5448</span>
<span id="L5449" rel="#L5449">5449</span>
<span id="L5450" rel="#L5450">5450</span>
<span id="L5451" rel="#L5451">5451</span>
<span id="L5452" rel="#L5452">5452</span>
<span id="L5453" rel="#L5453">5453</span>
<span id="L5454" rel="#L5454">5454</span>
<span id="L5455" rel="#L5455">5455</span>
<span id="L5456" rel="#L5456">5456</span>
<span id="L5457" rel="#L5457">5457</span>
<span id="L5458" rel="#L5458">5458</span>
<span id="L5459" rel="#L5459">5459</span>
<span id="L5460" rel="#L5460">5460</span>
<span id="L5461" rel="#L5461">5461</span>
<span id="L5462" rel="#L5462">5462</span>
<span id="L5463" rel="#L5463">5463</span>
<span id="L5464" rel="#L5464">5464</span>
<span id="L5465" rel="#L5465">5465</span>
<span id="L5466" rel="#L5466">5466</span>
<span id="L5467" rel="#L5467">5467</span>
<span id="L5468" rel="#L5468">5468</span>
<span id="L5469" rel="#L5469">5469</span>
<span id="L5470" rel="#L5470">5470</span>
<span id="L5471" rel="#L5471">5471</span>
<span id="L5472" rel="#L5472">5472</span>
<span id="L5473" rel="#L5473">5473</span>
<span id="L5474" rel="#L5474">5474</span>
<span id="L5475" rel="#L5475">5475</span>
<span id="L5476" rel="#L5476">5476</span>
<span id="L5477" rel="#L5477">5477</span>
<span id="L5478" rel="#L5478">5478</span>
<span id="L5479" rel="#L5479">5479</span>
<span id="L5480" rel="#L5480">5480</span>
<span id="L5481" rel="#L5481">5481</span>
<span id="L5482" rel="#L5482">5482</span>
<span id="L5483" rel="#L5483">5483</span>
<span id="L5484" rel="#L5484">5484</span>
<span id="L5485" rel="#L5485">5485</span>
<span id="L5486" rel="#L5486">5486</span>
<span id="L5487" rel="#L5487">5487</span>
<span id="L5488" rel="#L5488">5488</span>
<span id="L5489" rel="#L5489">5489</span>
<span id="L5490" rel="#L5490">5490</span>
<span id="L5491" rel="#L5491">5491</span>
<span id="L5492" rel="#L5492">5492</span>
<span id="L5493" rel="#L5493">5493</span>
<span id="L5494" rel="#L5494">5494</span>
<span id="L5495" rel="#L5495">5495</span>
<span id="L5496" rel="#L5496">5496</span>
<span id="L5497" rel="#L5497">5497</span>
<span id="L5498" rel="#L5498">5498</span>
<span id="L5499" rel="#L5499">5499</span>
<span id="L5500" rel="#L5500">5500</span>
<span id="L5501" rel="#L5501">5501</span>
<span id="L5502" rel="#L5502">5502</span>
<span id="L5503" rel="#L5503">5503</span>
<span id="L5504" rel="#L5504">5504</span>
<span id="L5505" rel="#L5505">5505</span>
<span id="L5506" rel="#L5506">5506</span>
<span id="L5507" rel="#L5507">5507</span>
<span id="L5508" rel="#L5508">5508</span>
<span id="L5509" rel="#L5509">5509</span>
<span id="L5510" rel="#L5510">5510</span>
<span id="L5511" rel="#L5511">5511</span>
<span id="L5512" rel="#L5512">5512</span>
<span id="L5513" rel="#L5513">5513</span>
<span id="L5514" rel="#L5514">5514</span>
<span id="L5515" rel="#L5515">5515</span>
<span id="L5516" rel="#L5516">5516</span>
<span id="L5517" rel="#L5517">5517</span>
<span id="L5518" rel="#L5518">5518</span>
<span id="L5519" rel="#L5519">5519</span>
<span id="L5520" rel="#L5520">5520</span>
<span id="L5521" rel="#L5521">5521</span>
<span id="L5522" rel="#L5522">5522</span>
<span id="L5523" rel="#L5523">5523</span>
<span id="L5524" rel="#L5524">5524</span>
<span id="L5525" rel="#L5525">5525</span>
<span id="L5526" rel="#L5526">5526</span>
<span id="L5527" rel="#L5527">5527</span>
<span id="L5528" rel="#L5528">5528</span>
<span id="L5529" rel="#L5529">5529</span>
<span id="L5530" rel="#L5530">5530</span>
<span id="L5531" rel="#L5531">5531</span>
<span id="L5532" rel="#L5532">5532</span>
<span id="L5533" rel="#L5533">5533</span>
<span id="L5534" rel="#L5534">5534</span>
<span id="L5535" rel="#L5535">5535</span>
<span id="L5536" rel="#L5536">5536</span>
<span id="L5537" rel="#L5537">5537</span>
<span id="L5538" rel="#L5538">5538</span>
<span id="L5539" rel="#L5539">5539</span>
<span id="L5540" rel="#L5540">5540</span>
<span id="L5541" rel="#L5541">5541</span>
<span id="L5542" rel="#L5542">5542</span>
<span id="L5543" rel="#L5543">5543</span>
<span id="L5544" rel="#L5544">5544</span>
<span id="L5545" rel="#L5545">5545</span>
<span id="L5546" rel="#L5546">5546</span>
<span id="L5547" rel="#L5547">5547</span>
<span id="L5548" rel="#L5548">5548</span>
<span id="L5549" rel="#L5549">5549</span>
<span id="L5550" rel="#L5550">5550</span>
<span id="L5551" rel="#L5551">5551</span>
<span id="L5552" rel="#L5552">5552</span>
<span id="L5553" rel="#L5553">5553</span>
<span id="L5554" rel="#L5554">5554</span>
<span id="L5555" rel="#L5555">5555</span>
<span id="L5556" rel="#L5556">5556</span>
<span id="L5557" rel="#L5557">5557</span>
<span id="L5558" rel="#L5558">5558</span>
<span id="L5559" rel="#L5559">5559</span>
<span id="L5560" rel="#L5560">5560</span>
<span id="L5561" rel="#L5561">5561</span>
<span id="L5562" rel="#L5562">5562</span>
<span id="L5563" rel="#L5563">5563</span>
<span id="L5564" rel="#L5564">5564</span>
<span id="L5565" rel="#L5565">5565</span>
<span id="L5566" rel="#L5566">5566</span>
<span id="L5567" rel="#L5567">5567</span>
<span id="L5568" rel="#L5568">5568</span>
<span id="L5569" rel="#L5569">5569</span>
<span id="L5570" rel="#L5570">5570</span>
<span id="L5571" rel="#L5571">5571</span>
<span id="L5572" rel="#L5572">5572</span>
<span id="L5573" rel="#L5573">5573</span>
<span id="L5574" rel="#L5574">5574</span>
<span id="L5575" rel="#L5575">5575</span>
<span id="L5576" rel="#L5576">5576</span>
<span id="L5577" rel="#L5577">5577</span>
<span id="L5578" rel="#L5578">5578</span>
<span id="L5579" rel="#L5579">5579</span>
<span id="L5580" rel="#L5580">5580</span>
<span id="L5581" rel="#L5581">5581</span>
<span id="L5582" rel="#L5582">5582</span>
<span id="L5583" rel="#L5583">5583</span>
<span id="L5584" rel="#L5584">5584</span>
<span id="L5585" rel="#L5585">5585</span>
<span id="L5586" rel="#L5586">5586</span>
<span id="L5587" rel="#L5587">5587</span>
<span id="L5588" rel="#L5588">5588</span>
<span id="L5589" rel="#L5589">5589</span>
<span id="L5590" rel="#L5590">5590</span>
<span id="L5591" rel="#L5591">5591</span>
<span id="L5592" rel="#L5592">5592</span>
<span id="L5593" rel="#L5593">5593</span>
<span id="L5594" rel="#L5594">5594</span>
<span id="L5595" rel="#L5595">5595</span>
<span id="L5596" rel="#L5596">5596</span>
<span id="L5597" rel="#L5597">5597</span>
<span id="L5598" rel="#L5598">5598</span>
<span id="L5599" rel="#L5599">5599</span>
<span id="L5600" rel="#L5600">5600</span>
<span id="L5601" rel="#L5601">5601</span>
<span id="L5602" rel="#L5602">5602</span>
<span id="L5603" rel="#L5603">5603</span>
<span id="L5604" rel="#L5604">5604</span>
<span id="L5605" rel="#L5605">5605</span>
<span id="L5606" rel="#L5606">5606</span>
<span id="L5607" rel="#L5607">5607</span>
<span id="L5608" rel="#L5608">5608</span>
<span id="L5609" rel="#L5609">5609</span>
<span id="L5610" rel="#L5610">5610</span>
<span id="L5611" rel="#L5611">5611</span>
<span id="L5612" rel="#L5612">5612</span>
<span id="L5613" rel="#L5613">5613</span>
<span id="L5614" rel="#L5614">5614</span>
<span id="L5615" rel="#L5615">5615</span>
<span id="L5616" rel="#L5616">5616</span>
<span id="L5617" rel="#L5617">5617</span>
<span id="L5618" rel="#L5618">5618</span>
<span id="L5619" rel="#L5619">5619</span>
<span id="L5620" rel="#L5620">5620</span>
<span id="L5621" rel="#L5621">5621</span>
<span id="L5622" rel="#L5622">5622</span>
<span id="L5623" rel="#L5623">5623</span>
<span id="L5624" rel="#L5624">5624</span>
<span id="L5625" rel="#L5625">5625</span>
<span id="L5626" rel="#L5626">5626</span>
<span id="L5627" rel="#L5627">5627</span>
<span id="L5628" rel="#L5628">5628</span>
<span id="L5629" rel="#L5629">5629</span>
<span id="L5630" rel="#L5630">5630</span>
<span id="L5631" rel="#L5631">5631</span>
<span id="L5632" rel="#L5632">5632</span>
<span id="L5633" rel="#L5633">5633</span>
<span id="L5634" rel="#L5634">5634</span>
<span id="L5635" rel="#L5635">5635</span>
<span id="L5636" rel="#L5636">5636</span>
<span id="L5637" rel="#L5637">5637</span>
<span id="L5638" rel="#L5638">5638</span>
<span id="L5639" rel="#L5639">5639</span>
<span id="L5640" rel="#L5640">5640</span>
<span id="L5641" rel="#L5641">5641</span>
<span id="L5642" rel="#L5642">5642</span>
<span id="L5643" rel="#L5643">5643</span>
<span id="L5644" rel="#L5644">5644</span>
<span id="L5645" rel="#L5645">5645</span>
<span id="L5646" rel="#L5646">5646</span>
<span id="L5647" rel="#L5647">5647</span>
<span id="L5648" rel="#L5648">5648</span>
<span id="L5649" rel="#L5649">5649</span>
<span id="L5650" rel="#L5650">5650</span>
<span id="L5651" rel="#L5651">5651</span>
<span id="L5652" rel="#L5652">5652</span>
<span id="L5653" rel="#L5653">5653</span>
<span id="L5654" rel="#L5654">5654</span>
<span id="L5655" rel="#L5655">5655</span>
<span id="L5656" rel="#L5656">5656</span>
<span id="L5657" rel="#L5657">5657</span>
<span id="L5658" rel="#L5658">5658</span>
<span id="L5659" rel="#L5659">5659</span>
<span id="L5660" rel="#L5660">5660</span>
<span id="L5661" rel="#L5661">5661</span>
<span id="L5662" rel="#L5662">5662</span>
<span id="L5663" rel="#L5663">5663</span>
<span id="L5664" rel="#L5664">5664</span>
<span id="L5665" rel="#L5665">5665</span>
<span id="L5666" rel="#L5666">5666</span>
<span id="L5667" rel="#L5667">5667</span>
<span id="L5668" rel="#L5668">5668</span>
<span id="L5669" rel="#L5669">5669</span>
<span id="L5670" rel="#L5670">5670</span>
<span id="L5671" rel="#L5671">5671</span>
<span id="L5672" rel="#L5672">5672</span>
<span id="L5673" rel="#L5673">5673</span>
<span id="L5674" rel="#L5674">5674</span>
<span id="L5675" rel="#L5675">5675</span>
<span id="L5676" rel="#L5676">5676</span>
<span id="L5677" rel="#L5677">5677</span>
<span id="L5678" rel="#L5678">5678</span>
<span id="L5679" rel="#L5679">5679</span>
<span id="L5680" rel="#L5680">5680</span>
<span id="L5681" rel="#L5681">5681</span>
<span id="L5682" rel="#L5682">5682</span>
<span id="L5683" rel="#L5683">5683</span>
<span id="L5684" rel="#L5684">5684</span>
<span id="L5685" rel="#L5685">5685</span>
<span id="L5686" rel="#L5686">5686</span>
<span id="L5687" rel="#L5687">5687</span>
<span id="L5688" rel="#L5688">5688</span>
<span id="L5689" rel="#L5689">5689</span>
<span id="L5690" rel="#L5690">5690</span>
<span id="L5691" rel="#L5691">5691</span>
<span id="L5692" rel="#L5692">5692</span>
<span id="L5693" rel="#L5693">5693</span>
<span id="L5694" rel="#L5694">5694</span>
<span id="L5695" rel="#L5695">5695</span>
<span id="L5696" rel="#L5696">5696</span>
<span id="L5697" rel="#L5697">5697</span>
<span id="L5698" rel="#L5698">5698</span>
<span id="L5699" rel="#L5699">5699</span>
<span id="L5700" rel="#L5700">5700</span>
<span id="L5701" rel="#L5701">5701</span>
<span id="L5702" rel="#L5702">5702</span>
<span id="L5703" rel="#L5703">5703</span>
<span id="L5704" rel="#L5704">5704</span>
<span id="L5705" rel="#L5705">5705</span>
<span id="L5706" rel="#L5706">5706</span>
<span id="L5707" rel="#L5707">5707</span>
<span id="L5708" rel="#L5708">5708</span>
<span id="L5709" rel="#L5709">5709</span>
<span id="L5710" rel="#L5710">5710</span>
<span id="L5711" rel="#L5711">5711</span>
<span id="L5712" rel="#L5712">5712</span>
<span id="L5713" rel="#L5713">5713</span>
<span id="L5714" rel="#L5714">5714</span>
<span id="L5715" rel="#L5715">5715</span>
<span id="L5716" rel="#L5716">5716</span>
<span id="L5717" rel="#L5717">5717</span>
<span id="L5718" rel="#L5718">5718</span>
<span id="L5719" rel="#L5719">5719</span>
<span id="L5720" rel="#L5720">5720</span>
<span id="L5721" rel="#L5721">5721</span>
<span id="L5722" rel="#L5722">5722</span>
<span id="L5723" rel="#L5723">5723</span>
<span id="L5724" rel="#L5724">5724</span>
<span id="L5725" rel="#L5725">5725</span>
<span id="L5726" rel="#L5726">5726</span>
<span id="L5727" rel="#L5727">5727</span>
<span id="L5728" rel="#L5728">5728</span>
<span id="L5729" rel="#L5729">5729</span>
<span id="L5730" rel="#L5730">5730</span>
<span id="L5731" rel="#L5731">5731</span>
<span id="L5732" rel="#L5732">5732</span>
<span id="L5733" rel="#L5733">5733</span>
<span id="L5734" rel="#L5734">5734</span>
<span id="L5735" rel="#L5735">5735</span>
<span id="L5736" rel="#L5736">5736</span>
<span id="L5737" rel="#L5737">5737</span>
<span id="L5738" rel="#L5738">5738</span>
<span id="L5739" rel="#L5739">5739</span>
<span id="L5740" rel="#L5740">5740</span>
<span id="L5741" rel="#L5741">5741</span>
<span id="L5742" rel="#L5742">5742</span>
<span id="L5743" rel="#L5743">5743</span>
<span id="L5744" rel="#L5744">5744</span>
<span id="L5745" rel="#L5745">5745</span>
<span id="L5746" rel="#L5746">5746</span>
<span id="L5747" rel="#L5747">5747</span>
<span id="L5748" rel="#L5748">5748</span>
<span id="L5749" rel="#L5749">5749</span>
<span id="L5750" rel="#L5750">5750</span>
<span id="L5751" rel="#L5751">5751</span>
<span id="L5752" rel="#L5752">5752</span>
<span id="L5753" rel="#L5753">5753</span>
<span id="L5754" rel="#L5754">5754</span>
<span id="L5755" rel="#L5755">5755</span>
<span id="L5756" rel="#L5756">5756</span>
<span id="L5757" rel="#L5757">5757</span>
<span id="L5758" rel="#L5758">5758</span>
<span id="L5759" rel="#L5759">5759</span>
<span id="L5760" rel="#L5760">5760</span>
<span id="L5761" rel="#L5761">5761</span>
<span id="L5762" rel="#L5762">5762</span>
<span id="L5763" rel="#L5763">5763</span>
<span id="L5764" rel="#L5764">5764</span>
<span id="L5765" rel="#L5765">5765</span>
<span id="L5766" rel="#L5766">5766</span>
<span id="L5767" rel="#L5767">5767</span>
<span id="L5768" rel="#L5768">5768</span>
<span id="L5769" rel="#L5769">5769</span>
<span id="L5770" rel="#L5770">5770</span>
<span id="L5771" rel="#L5771">5771</span>
<span id="L5772" rel="#L5772">5772</span>
<span id="L5773" rel="#L5773">5773</span>
<span id="L5774" rel="#L5774">5774</span>
<span id="L5775" rel="#L5775">5775</span>
<span id="L5776" rel="#L5776">5776</span>
<span id="L5777" rel="#L5777">5777</span>
<span id="L5778" rel="#L5778">5778</span>
<span id="L5779" rel="#L5779">5779</span>
<span id="L5780" rel="#L5780">5780</span>
<span id="L5781" rel="#L5781">5781</span>
<span id="L5782" rel="#L5782">5782</span>
<span id="L5783" rel="#L5783">5783</span>
<span id="L5784" rel="#L5784">5784</span>
<span id="L5785" rel="#L5785">5785</span>
<span id="L5786" rel="#L5786">5786</span>
<span id="L5787" rel="#L5787">5787</span>
<span id="L5788" rel="#L5788">5788</span>
<span id="L5789" rel="#L5789">5789</span>
<span id="L5790" rel="#L5790">5790</span>
<span id="L5791" rel="#L5791">5791</span>
<span id="L5792" rel="#L5792">5792</span>
<span id="L5793" rel="#L5793">5793</span>
<span id="L5794" rel="#L5794">5794</span>
<span id="L5795" rel="#L5795">5795</span>
<span id="L5796" rel="#L5796">5796</span>
<span id="L5797" rel="#L5797">5797</span>
<span id="L5798" rel="#L5798">5798</span>
<span id="L5799" rel="#L5799">5799</span>
<span id="L5800" rel="#L5800">5800</span>
<span id="L5801" rel="#L5801">5801</span>
<span id="L5802" rel="#L5802">5802</span>
<span id="L5803" rel="#L5803">5803</span>
<span id="L5804" rel="#L5804">5804</span>
<span id="L5805" rel="#L5805">5805</span>
<span id="L5806" rel="#L5806">5806</span>
<span id="L5807" rel="#L5807">5807</span>
<span id="L5808" rel="#L5808">5808</span>
<span id="L5809" rel="#L5809">5809</span>
<span id="L5810" rel="#L5810">5810</span>
<span id="L5811" rel="#L5811">5811</span>
<span id="L5812" rel="#L5812">5812</span>
<span id="L5813" rel="#L5813">5813</span>
<span id="L5814" rel="#L5814">5814</span>
<span id="L5815" rel="#L5815">5815</span>
<span id="L5816" rel="#L5816">5816</span>
<span id="L5817" rel="#L5817">5817</span>
<span id="L5818" rel="#L5818">5818</span>
<span id="L5819" rel="#L5819">5819</span>
<span id="L5820" rel="#L5820">5820</span>
<span id="L5821" rel="#L5821">5821</span>
<span id="L5822" rel="#L5822">5822</span>
<span id="L5823" rel="#L5823">5823</span>
<span id="L5824" rel="#L5824">5824</span>
<span id="L5825" rel="#L5825">5825</span>
<span id="L5826" rel="#L5826">5826</span>
<span id="L5827" rel="#L5827">5827</span>
<span id="L5828" rel="#L5828">5828</span>
<span id="L5829" rel="#L5829">5829</span>
<span id="L5830" rel="#L5830">5830</span>
<span id="L5831" rel="#L5831">5831</span>
<span id="L5832" rel="#L5832">5832</span>
<span id="L5833" rel="#L5833">5833</span>
<span id="L5834" rel="#L5834">5834</span>
<span id="L5835" rel="#L5835">5835</span>
<span id="L5836" rel="#L5836">5836</span>
<span id="L5837" rel="#L5837">5837</span>
<span id="L5838" rel="#L5838">5838</span>
<span id="L5839" rel="#L5839">5839</span>
<span id="L5840" rel="#L5840">5840</span>
<span id="L5841" rel="#L5841">5841</span>
<span id="L5842" rel="#L5842">5842</span>
<span id="L5843" rel="#L5843">5843</span>
<span id="L5844" rel="#L5844">5844</span>
<span id="L5845" rel="#L5845">5845</span>
<span id="L5846" rel="#L5846">5846</span>
<span id="L5847" rel="#L5847">5847</span>
<span id="L5848" rel="#L5848">5848</span>
<span id="L5849" rel="#L5849">5849</span>
<span id="L5850" rel="#L5850">5850</span>
<span id="L5851" rel="#L5851">5851</span>
<span id="L5852" rel="#L5852">5852</span>
<span id="L5853" rel="#L5853">5853</span>
<span id="L5854" rel="#L5854">5854</span>
<span id="L5855" rel="#L5855">5855</span>
<span id="L5856" rel="#L5856">5856</span>
<span id="L5857" rel="#L5857">5857</span>
<span id="L5858" rel="#L5858">5858</span>
<span id="L5859" rel="#L5859">5859</span>
<span id="L5860" rel="#L5860">5860</span>
<span id="L5861" rel="#L5861">5861</span>
<span id="L5862" rel="#L5862">5862</span>
<span id="L5863" rel="#L5863">5863</span>
<span id="L5864" rel="#L5864">5864</span>
<span id="L5865" rel="#L5865">5865</span>
<span id="L5866" rel="#L5866">5866</span>
<span id="L5867" rel="#L5867">5867</span>
<span id="L5868" rel="#L5868">5868</span>
<span id="L5869" rel="#L5869">5869</span>
<span id="L5870" rel="#L5870">5870</span>
<span id="L5871" rel="#L5871">5871</span>
<span id="L5872" rel="#L5872">5872</span>
<span id="L5873" rel="#L5873">5873</span>
<span id="L5874" rel="#L5874">5874</span>
<span id="L5875" rel="#L5875">5875</span>
<span id="L5876" rel="#L5876">5876</span>
<span id="L5877" rel="#L5877">5877</span>
<span id="L5878" rel="#L5878">5878</span>
<span id="L5879" rel="#L5879">5879</span>
<span id="L5880" rel="#L5880">5880</span>
<span id="L5881" rel="#L5881">5881</span>
<span id="L5882" rel="#L5882">5882</span>
<span id="L5883" rel="#L5883">5883</span>
<span id="L5884" rel="#L5884">5884</span>
<span id="L5885" rel="#L5885">5885</span>
<span id="L5886" rel="#L5886">5886</span>
<span id="L5887" rel="#L5887">5887</span>
<span id="L5888" rel="#L5888">5888</span>
<span id="L5889" rel="#L5889">5889</span>
<span id="L5890" rel="#L5890">5890</span>
<span id="L5891" rel="#L5891">5891</span>
<span id="L5892" rel="#L5892">5892</span>
<span id="L5893" rel="#L5893">5893</span>
<span id="L5894" rel="#L5894">5894</span>
<span id="L5895" rel="#L5895">5895</span>
<span id="L5896" rel="#L5896">5896</span>
<span id="L5897" rel="#L5897">5897</span>
<span id="L5898" rel="#L5898">5898</span>
<span id="L5899" rel="#L5899">5899</span>
<span id="L5900" rel="#L5900">5900</span>
<span id="L5901" rel="#L5901">5901</span>
<span id="L5902" rel="#L5902">5902</span>
<span id="L5903" rel="#L5903">5903</span>
<span id="L5904" rel="#L5904">5904</span>
<span id="L5905" rel="#L5905">5905</span>
<span id="L5906" rel="#L5906">5906</span>
<span id="L5907" rel="#L5907">5907</span>
<span id="L5908" rel="#L5908">5908</span>
<span id="L5909" rel="#L5909">5909</span>
<span id="L5910" rel="#L5910">5910</span>
<span id="L5911" rel="#L5911">5911</span>
<span id="L5912" rel="#L5912">5912</span>
<span id="L5913" rel="#L5913">5913</span>
<span id="L5914" rel="#L5914">5914</span>
<span id="L5915" rel="#L5915">5915</span>
<span id="L5916" rel="#L5916">5916</span>
<span id="L5917" rel="#L5917">5917</span>
<span id="L5918" rel="#L5918">5918</span>
<span id="L5919" rel="#L5919">5919</span>
<span id="L5920" rel="#L5920">5920</span>
<span id="L5921" rel="#L5921">5921</span>
<span id="L5922" rel="#L5922">5922</span>
<span id="L5923" rel="#L5923">5923</span>
<span id="L5924" rel="#L5924">5924</span>
<span id="L5925" rel="#L5925">5925</span>
<span id="L5926" rel="#L5926">5926</span>
<span id="L5927" rel="#L5927">5927</span>
<span id="L5928" rel="#L5928">5928</span>
<span id="L5929" rel="#L5929">5929</span>
<span id="L5930" rel="#L5930">5930</span>
<span id="L5931" rel="#L5931">5931</span>
<span id="L5932" rel="#L5932">5932</span>
<span id="L5933" rel="#L5933">5933</span>
<span id="L5934" rel="#L5934">5934</span>
<span id="L5935" rel="#L5935">5935</span>
<span id="L5936" rel="#L5936">5936</span>
<span id="L5937" rel="#L5937">5937</span>
<span id="L5938" rel="#L5938">5938</span>
<span id="L5939" rel="#L5939">5939</span>
<span id="L5940" rel="#L5940">5940</span>
<span id="L5941" rel="#L5941">5941</span>
<span id="L5942" rel="#L5942">5942</span>
<span id="L5943" rel="#L5943">5943</span>
<span id="L5944" rel="#L5944">5944</span>
<span id="L5945" rel="#L5945">5945</span>
<span id="L5946" rel="#L5946">5946</span>
<span id="L5947" rel="#L5947">5947</span>
<span id="L5948" rel="#L5948">5948</span>
<span id="L5949" rel="#L5949">5949</span>
<span id="L5950" rel="#L5950">5950</span>
<span id="L5951" rel="#L5951">5951</span>
<span id="L5952" rel="#L5952">5952</span>
<span id="L5953" rel="#L5953">5953</span>
<span id="L5954" rel="#L5954">5954</span>
<span id="L5955" rel="#L5955">5955</span>
<span id="L5956" rel="#L5956">5956</span>
<span id="L5957" rel="#L5957">5957</span>
<span id="L5958" rel="#L5958">5958</span>
<span id="L5959" rel="#L5959">5959</span>
<span id="L5960" rel="#L5960">5960</span>
<span id="L5961" rel="#L5961">5961</span>
<span id="L5962" rel="#L5962">5962</span>
<span id="L5963" rel="#L5963">5963</span>
<span id="L5964" rel="#L5964">5964</span>
<span id="L5965" rel="#L5965">5965</span>
<span id="L5966" rel="#L5966">5966</span>
<span id="L5967" rel="#L5967">5967</span>
<span id="L5968" rel="#L5968">5968</span>
<span id="L5969" rel="#L5969">5969</span>
<span id="L5970" rel="#L5970">5970</span>
<span id="L5971" rel="#L5971">5971</span>
<span id="L5972" rel="#L5972">5972</span>
<span id="L5973" rel="#L5973">5973</span>
<span id="L5974" rel="#L5974">5974</span>
<span id="L5975" rel="#L5975">5975</span>
<span id="L5976" rel="#L5976">5976</span>
<span id="L5977" rel="#L5977">5977</span>
<span id="L5978" rel="#L5978">5978</span>
<span id="L5979" rel="#L5979">5979</span>
<span id="L5980" rel="#L5980">5980</span>
<span id="L5981" rel="#L5981">5981</span>
<span id="L5982" rel="#L5982">5982</span>
<span id="L5983" rel="#L5983">5983</span>
<span id="L5984" rel="#L5984">5984</span>
<span id="L5985" rel="#L5985">5985</span>
<span id="L5986" rel="#L5986">5986</span>
<span id="L5987" rel="#L5987">5987</span>
<span id="L5988" rel="#L5988">5988</span>
<span id="L5989" rel="#L5989">5989</span>
<span id="L5990" rel="#L5990">5990</span>
<span id="L5991" rel="#L5991">5991</span>
<span id="L5992" rel="#L5992">5992</span>
<span id="L5993" rel="#L5993">5993</span>
<span id="L5994" rel="#L5994">5994</span>
<span id="L5995" rel="#L5995">5995</span>
<span id="L5996" rel="#L5996">5996</span>
<span id="L5997" rel="#L5997">5997</span>
<span id="L5998" rel="#L5998">5998</span>
<span id="L5999" rel="#L5999">5999</span>
<span id="L6000" rel="#L6000">6000</span>
<span id="L6001" rel="#L6001">6001</span>
<span id="L6002" rel="#L6002">6002</span>
<span id="L6003" rel="#L6003">6003</span>
<span id="L6004" rel="#L6004">6004</span>
<span id="L6005" rel="#L6005">6005</span>
<span id="L6006" rel="#L6006">6006</span>
<span id="L6007" rel="#L6007">6007</span>
<span id="L6008" rel="#L6008">6008</span>
<span id="L6009" rel="#L6009">6009</span>
<span id="L6010" rel="#L6010">6010</span>
<span id="L6011" rel="#L6011">6011</span>
<span id="L6012" rel="#L6012">6012</span>
<span id="L6013" rel="#L6013">6013</span>
<span id="L6014" rel="#L6014">6014</span>
<span id="L6015" rel="#L6015">6015</span>
<span id="L6016" rel="#L6016">6016</span>
<span id="L6017" rel="#L6017">6017</span>
<span id="L6018" rel="#L6018">6018</span>
<span id="L6019" rel="#L6019">6019</span>
<span id="L6020" rel="#L6020">6020</span>
<span id="L6021" rel="#L6021">6021</span>
<span id="L6022" rel="#L6022">6022</span>
<span id="L6023" rel="#L6023">6023</span>
<span id="L6024" rel="#L6024">6024</span>
<span id="L6025" rel="#L6025">6025</span>
<span id="L6026" rel="#L6026">6026</span>
<span id="L6027" rel="#L6027">6027</span>
<span id="L6028" rel="#L6028">6028</span>
<span id="L6029" rel="#L6029">6029</span>
<span id="L6030" rel="#L6030">6030</span>
<span id="L6031" rel="#L6031">6031</span>
<span id="L6032" rel="#L6032">6032</span>
<span id="L6033" rel="#L6033">6033</span>
<span id="L6034" rel="#L6034">6034</span>
<span id="L6035" rel="#L6035">6035</span>
<span id="L6036" rel="#L6036">6036</span>
<span id="L6037" rel="#L6037">6037</span>
<span id="L6038" rel="#L6038">6038</span>
<span id="L6039" rel="#L6039">6039</span>
<span id="L6040" rel="#L6040">6040</span>
<span id="L6041" rel="#L6041">6041</span>
<span id="L6042" rel="#L6042">6042</span>
<span id="L6043" rel="#L6043">6043</span>
<span id="L6044" rel="#L6044">6044</span>
<span id="L6045" rel="#L6045">6045</span>
<span id="L6046" rel="#L6046">6046</span>
<span id="L6047" rel="#L6047">6047</span>
<span id="L6048" rel="#L6048">6048</span>
<span id="L6049" rel="#L6049">6049</span>
<span id="L6050" rel="#L6050">6050</span>
<span id="L6051" rel="#L6051">6051</span>
<span id="L6052" rel="#L6052">6052</span>
<span id="L6053" rel="#L6053">6053</span>
<span id="L6054" rel="#L6054">6054</span>
<span id="L6055" rel="#L6055">6055</span>
<span id="L6056" rel="#L6056">6056</span>
<span id="L6057" rel="#L6057">6057</span>
<span id="L6058" rel="#L6058">6058</span>
<span id="L6059" rel="#L6059">6059</span>
<span id="L6060" rel="#L6060">6060</span>
<span id="L6061" rel="#L6061">6061</span>
<span id="L6062" rel="#L6062">6062</span>
<span id="L6063" rel="#L6063">6063</span>
<span id="L6064" rel="#L6064">6064</span>
<span id="L6065" rel="#L6065">6065</span>
<span id="L6066" rel="#L6066">6066</span>
<span id="L6067" rel="#L6067">6067</span>
<span id="L6068" rel="#L6068">6068</span>
<span id="L6069" rel="#L6069">6069</span>
<span id="L6070" rel="#L6070">6070</span>
<span id="L6071" rel="#L6071">6071</span>
<span id="L6072" rel="#L6072">6072</span>
<span id="L6073" rel="#L6073">6073</span>
<span id="L6074" rel="#L6074">6074</span>
<span id="L6075" rel="#L6075">6075</span>
<span id="L6076" rel="#L6076">6076</span>
<span id="L6077" rel="#L6077">6077</span>
<span id="L6078" rel="#L6078">6078</span>
<span id="L6079" rel="#L6079">6079</span>
<span id="L6080" rel="#L6080">6080</span>
<span id="L6081" rel="#L6081">6081</span>
<span id="L6082" rel="#L6082">6082</span>
<span id="L6083" rel="#L6083">6083</span>
<span id="L6084" rel="#L6084">6084</span>
<span id="L6085" rel="#L6085">6085</span>
<span id="L6086" rel="#L6086">6086</span>
<span id="L6087" rel="#L6087">6087</span>
<span id="L6088" rel="#L6088">6088</span>
<span id="L6089" rel="#L6089">6089</span>
<span id="L6090" rel="#L6090">6090</span>
<span id="L6091" rel="#L6091">6091</span>
<span id="L6092" rel="#L6092">6092</span>
<span id="L6093" rel="#L6093">6093</span>
<span id="L6094" rel="#L6094">6094</span>
<span id="L6095" rel="#L6095">6095</span>
<span id="L6096" rel="#L6096">6096</span>
<span id="L6097" rel="#L6097">6097</span>
<span id="L6098" rel="#L6098">6098</span>
<span id="L6099" rel="#L6099">6099</span>
<span id="L6100" rel="#L6100">6100</span>
<span id="L6101" rel="#L6101">6101</span>
<span id="L6102" rel="#L6102">6102</span>
<span id="L6103" rel="#L6103">6103</span>
<span id="L6104" rel="#L6104">6104</span>
<span id="L6105" rel="#L6105">6105</span>
<span id="L6106" rel="#L6106">6106</span>
<span id="L6107" rel="#L6107">6107</span>
<span id="L6108" rel="#L6108">6108</span>
<span id="L6109" rel="#L6109">6109</span>
<span id="L6110" rel="#L6110">6110</span>
<span id="L6111" rel="#L6111">6111</span>
<span id="L6112" rel="#L6112">6112</span>
<span id="L6113" rel="#L6113">6113</span>
<span id="L6114" rel="#L6114">6114</span>
<span id="L6115" rel="#L6115">6115</span>
<span id="L6116" rel="#L6116">6116</span>
<span id="L6117" rel="#L6117">6117</span>
<span id="L6118" rel="#L6118">6118</span>
<span id="L6119" rel="#L6119">6119</span>
<span id="L6120" rel="#L6120">6120</span>
<span id="L6121" rel="#L6121">6121</span>
<span id="L6122" rel="#L6122">6122</span>
<span id="L6123" rel="#L6123">6123</span>
<span id="L6124" rel="#L6124">6124</span>
<span id="L6125" rel="#L6125">6125</span>
<span id="L6126" rel="#L6126">6126</span>
<span id="L6127" rel="#L6127">6127</span>
<span id="L6128" rel="#L6128">6128</span>
<span id="L6129" rel="#L6129">6129</span>
<span id="L6130" rel="#L6130">6130</span>
<span id="L6131" rel="#L6131">6131</span>
<span id="L6132" rel="#L6132">6132</span>
<span id="L6133" rel="#L6133">6133</span>
<span id="L6134" rel="#L6134">6134</span>
<span id="L6135" rel="#L6135">6135</span>
<span id="L6136" rel="#L6136">6136</span>
<span id="L6137" rel="#L6137">6137</span>
<span id="L6138" rel="#L6138">6138</span>
<span id="L6139" rel="#L6139">6139</span>
<span id="L6140" rel="#L6140">6140</span>
<span id="L6141" rel="#L6141">6141</span>
<span id="L6142" rel="#L6142">6142</span>
<span id="L6143" rel="#L6143">6143</span>
<span id="L6144" rel="#L6144">6144</span>
<span id="L6145" rel="#L6145">6145</span>
<span id="L6146" rel="#L6146">6146</span>
<span id="L6147" rel="#L6147">6147</span>
<span id="L6148" rel="#L6148">6148</span>
<span id="L6149" rel="#L6149">6149</span>
<span id="L6150" rel="#L6150">6150</span>
<span id="L6151" rel="#L6151">6151</span>
<span id="L6152" rel="#L6152">6152</span>
<span id="L6153" rel="#L6153">6153</span>
<span id="L6154" rel="#L6154">6154</span>
<span id="L6155" rel="#L6155">6155</span>
<span id="L6156" rel="#L6156">6156</span>
<span id="L6157" rel="#L6157">6157</span>
<span id="L6158" rel="#L6158">6158</span>
<span id="L6159" rel="#L6159">6159</span>
<span id="L6160" rel="#L6160">6160</span>
<span id="L6161" rel="#L6161">6161</span>
<span id="L6162" rel="#L6162">6162</span>
<span id="L6163" rel="#L6163">6163</span>
<span id="L6164" rel="#L6164">6164</span>
<span id="L6165" rel="#L6165">6165</span>
<span id="L6166" rel="#L6166">6166</span>
<span id="L6167" rel="#L6167">6167</span>
<span id="L6168" rel="#L6168">6168</span>
<span id="L6169" rel="#L6169">6169</span>
<span id="L6170" rel="#L6170">6170</span>
<span id="L6171" rel="#L6171">6171</span>
<span id="L6172" rel="#L6172">6172</span>
<span id="L6173" rel="#L6173">6173</span>
<span id="L6174" rel="#L6174">6174</span>
<span id="L6175" rel="#L6175">6175</span>
<span id="L6176" rel="#L6176">6176</span>
<span id="L6177" rel="#L6177">6177</span>
<span id="L6178" rel="#L6178">6178</span>
<span id="L6179" rel="#L6179">6179</span>
<span id="L6180" rel="#L6180">6180</span>
<span id="L6181" rel="#L6181">6181</span>
<span id="L6182" rel="#L6182">6182</span>
<span id="L6183" rel="#L6183">6183</span>
<span id="L6184" rel="#L6184">6184</span>
<span id="L6185" rel="#L6185">6185</span>
<span id="L6186" rel="#L6186">6186</span>
<span id="L6187" rel="#L6187">6187</span>
<span id="L6188" rel="#L6188">6188</span>
<span id="L6189" rel="#L6189">6189</span>
<span id="L6190" rel="#L6190">6190</span>
<span id="L6191" rel="#L6191">6191</span>
<span id="L6192" rel="#L6192">6192</span>
<span id="L6193" rel="#L6193">6193</span>
<span id="L6194" rel="#L6194">6194</span>
<span id="L6195" rel="#L6195">6195</span>
<span id="L6196" rel="#L6196">6196</span>
<span id="L6197" rel="#L6197">6197</span>
<span id="L6198" rel="#L6198">6198</span>
<span id="L6199" rel="#L6199">6199</span>
<span id="L6200" rel="#L6200">6200</span>
<span id="L6201" rel="#L6201">6201</span>
<span id="L6202" rel="#L6202">6202</span>
<span id="L6203" rel="#L6203">6203</span>
<span id="L6204" rel="#L6204">6204</span>
<span id="L6205" rel="#L6205">6205</span>
<span id="L6206" rel="#L6206">6206</span>
<span id="L6207" rel="#L6207">6207</span>
<span id="L6208" rel="#L6208">6208</span>
<span id="L6209" rel="#L6209">6209</span>
<span id="L6210" rel="#L6210">6210</span>
<span id="L6211" rel="#L6211">6211</span>
<span id="L6212" rel="#L6212">6212</span>
<span id="L6213" rel="#L6213">6213</span>
<span id="L6214" rel="#L6214">6214</span>
<span id="L6215" rel="#L6215">6215</span>
<span id="L6216" rel="#L6216">6216</span>
<span id="L6217" rel="#L6217">6217</span>
<span id="L6218" rel="#L6218">6218</span>
<span id="L6219" rel="#L6219">6219</span>
<span id="L6220" rel="#L6220">6220</span>
<span id="L6221" rel="#L6221">6221</span>
<span id="L6222" rel="#L6222">6222</span>
<span id="L6223" rel="#L6223">6223</span>
<span id="L6224" rel="#L6224">6224</span>
<span id="L6225" rel="#L6225">6225</span>
<span id="L6226" rel="#L6226">6226</span>
<span id="L6227" rel="#L6227">6227</span>
<span id="L6228" rel="#L6228">6228</span>
<span id="L6229" rel="#L6229">6229</span>
<span id="L6230" rel="#L6230">6230</span>
<span id="L6231" rel="#L6231">6231</span>
<span id="L6232" rel="#L6232">6232</span>
<span id="L6233" rel="#L6233">6233</span>
<span id="L6234" rel="#L6234">6234</span>
<span id="L6235" rel="#L6235">6235</span>
<span id="L6236" rel="#L6236">6236</span>
<span id="L6237" rel="#L6237">6237</span>
<span id="L6238" rel="#L6238">6238</span>
<span id="L6239" rel="#L6239">6239</span>
<span id="L6240" rel="#L6240">6240</span>
<span id="L6241" rel="#L6241">6241</span>
<span id="L6242" rel="#L6242">6242</span>
<span id="L6243" rel="#L6243">6243</span>
<span id="L6244" rel="#L6244">6244</span>
<span id="L6245" rel="#L6245">6245</span>
<span id="L6246" rel="#L6246">6246</span>
<span id="L6247" rel="#L6247">6247</span>
<span id="L6248" rel="#L6248">6248</span>
<span id="L6249" rel="#L6249">6249</span>
<span id="L6250" rel="#L6250">6250</span>
<span id="L6251" rel="#L6251">6251</span>
<span id="L6252" rel="#L6252">6252</span>
<span id="L6253" rel="#L6253">6253</span>
<span id="L6254" rel="#L6254">6254</span>
<span id="L6255" rel="#L6255">6255</span>
<span id="L6256" rel="#L6256">6256</span>
<span id="L6257" rel="#L6257">6257</span>
<span id="L6258" rel="#L6258">6258</span>
<span id="L6259" rel="#L6259">6259</span>
<span id="L6260" rel="#L6260">6260</span>
<span id="L6261" rel="#L6261">6261</span>
<span id="L6262" rel="#L6262">6262</span>
<span id="L6263" rel="#L6263">6263</span>
<span id="L6264" rel="#L6264">6264</span>
<span id="L6265" rel="#L6265">6265</span>
<span id="L6266" rel="#L6266">6266</span>
<span id="L6267" rel="#L6267">6267</span>
<span id="L6268" rel="#L6268">6268</span>
<span id="L6269" rel="#L6269">6269</span>
<span id="L6270" rel="#L6270">6270</span>
<span id="L6271" rel="#L6271">6271</span>
<span id="L6272" rel="#L6272">6272</span>
<span id="L6273" rel="#L6273">6273</span>
<span id="L6274" rel="#L6274">6274</span>
<span id="L6275" rel="#L6275">6275</span>
<span id="L6276" rel="#L6276">6276</span>
<span id="L6277" rel="#L6277">6277</span>
<span id="L6278" rel="#L6278">6278</span>
<span id="L6279" rel="#L6279">6279</span>
<span id="L6280" rel="#L6280">6280</span>
<span id="L6281" rel="#L6281">6281</span>
<span id="L6282" rel="#L6282">6282</span>
<span id="L6283" rel="#L6283">6283</span>
<span id="L6284" rel="#L6284">6284</span>
<span id="L6285" rel="#L6285">6285</span>
<span id="L6286" rel="#L6286">6286</span>
<span id="L6287" rel="#L6287">6287</span>
<span id="L6288" rel="#L6288">6288</span>
<span id="L6289" rel="#L6289">6289</span>
<span id="L6290" rel="#L6290">6290</span>
<span id="L6291" rel="#L6291">6291</span>
<span id="L6292" rel="#L6292">6292</span>
<span id="L6293" rel="#L6293">6293</span>
<span id="L6294" rel="#L6294">6294</span>
<span id="L6295" rel="#L6295">6295</span>
<span id="L6296" rel="#L6296">6296</span>
<span id="L6297" rel="#L6297">6297</span>
<span id="L6298" rel="#L6298">6298</span>
<span id="L6299" rel="#L6299">6299</span>
<span id="L6300" rel="#L6300">6300</span>
<span id="L6301" rel="#L6301">6301</span>
<span id="L6302" rel="#L6302">6302</span>
<span id="L6303" rel="#L6303">6303</span>
<span id="L6304" rel="#L6304">6304</span>
<span id="L6305" rel="#L6305">6305</span>
<span id="L6306" rel="#L6306">6306</span>
<span id="L6307" rel="#L6307">6307</span>
<span id="L6308" rel="#L6308">6308</span>
<span id="L6309" rel="#L6309">6309</span>
<span id="L6310" rel="#L6310">6310</span>
<span id="L6311" rel="#L6311">6311</span>
<span id="L6312" rel="#L6312">6312</span>
<span id="L6313" rel="#L6313">6313</span>
<span id="L6314" rel="#L6314">6314</span>
<span id="L6315" rel="#L6315">6315</span>
<span id="L6316" rel="#L6316">6316</span>
<span id="L6317" rel="#L6317">6317</span>
<span id="L6318" rel="#L6318">6318</span>
<span id="L6319" rel="#L6319">6319</span>
<span id="L6320" rel="#L6320">6320</span>
<span id="L6321" rel="#L6321">6321</span>
<span id="L6322" rel="#L6322">6322</span>
<span id="L6323" rel="#L6323">6323</span>
<span id="L6324" rel="#L6324">6324</span>
<span id="L6325" rel="#L6325">6325</span>
<span id="L6326" rel="#L6326">6326</span>
<span id="L6327" rel="#L6327">6327</span>
<span id="L6328" rel="#L6328">6328</span>
<span id="L6329" rel="#L6329">6329</span>
<span id="L6330" rel="#L6330">6330</span>
<span id="L6331" rel="#L6331">6331</span>
<span id="L6332" rel="#L6332">6332</span>
<span id="L6333" rel="#L6333">6333</span>
<span id="L6334" rel="#L6334">6334</span>
<span id="L6335" rel="#L6335">6335</span>
<span id="L6336" rel="#L6336">6336</span>
<span id="L6337" rel="#L6337">6337</span>
<span id="L6338" rel="#L6338">6338</span>
<span id="L6339" rel="#L6339">6339</span>
<span id="L6340" rel="#L6340">6340</span>
<span id="L6341" rel="#L6341">6341</span>
<span id="L6342" rel="#L6342">6342</span>
<span id="L6343" rel="#L6343">6343</span>
<span id="L6344" rel="#L6344">6344</span>
<span id="L6345" rel="#L6345">6345</span>
<span id="L6346" rel="#L6346">6346</span>
<span id="L6347" rel="#L6347">6347</span>
<span id="L6348" rel="#L6348">6348</span>
<span id="L6349" rel="#L6349">6349</span>
<span id="L6350" rel="#L6350">6350</span>
<span id="L6351" rel="#L6351">6351</span>
<span id="L6352" rel="#L6352">6352</span>
<span id="L6353" rel="#L6353">6353</span>
<span id="L6354" rel="#L6354">6354</span>
<span id="L6355" rel="#L6355">6355</span>
<span id="L6356" rel="#L6356">6356</span>
<span id="L6357" rel="#L6357">6357</span>
<span id="L6358" rel="#L6358">6358</span>
<span id="L6359" rel="#L6359">6359</span>
<span id="L6360" rel="#L6360">6360</span>
<span id="L6361" rel="#L6361">6361</span>
<span id="L6362" rel="#L6362">6362</span>
<span id="L6363" rel="#L6363">6363</span>
<span id="L6364" rel="#L6364">6364</span>
<span id="L6365" rel="#L6365">6365</span>
<span id="L6366" rel="#L6366">6366</span>
<span id="L6367" rel="#L6367">6367</span>
<span id="L6368" rel="#L6368">6368</span>
<span id="L6369" rel="#L6369">6369</span>
<span id="L6370" rel="#L6370">6370</span>
<span id="L6371" rel="#L6371">6371</span>
<span id="L6372" rel="#L6372">6372</span>
<span id="L6373" rel="#L6373">6373</span>
<span id="L6374" rel="#L6374">6374</span>
<span id="L6375" rel="#L6375">6375</span>
<span id="L6376" rel="#L6376">6376</span>
<span id="L6377" rel="#L6377">6377</span>
<span id="L6378" rel="#L6378">6378</span>
<span id="L6379" rel="#L6379">6379</span>
<span id="L6380" rel="#L6380">6380</span>
<span id="L6381" rel="#L6381">6381</span>
<span id="L6382" rel="#L6382">6382</span>
<span id="L6383" rel="#L6383">6383</span>
<span id="L6384" rel="#L6384">6384</span>
<span id="L6385" rel="#L6385">6385</span>
<span id="L6386" rel="#L6386">6386</span>
<span id="L6387" rel="#L6387">6387</span>
<span id="L6388" rel="#L6388">6388</span>
<span id="L6389" rel="#L6389">6389</span>
<span id="L6390" rel="#L6390">6390</span>
<span id="L6391" rel="#L6391">6391</span>
<span id="L6392" rel="#L6392">6392</span>
<span id="L6393" rel="#L6393">6393</span>
<span id="L6394" rel="#L6394">6394</span>
<span id="L6395" rel="#L6395">6395</span>
<span id="L6396" rel="#L6396">6396</span>
<span id="L6397" rel="#L6397">6397</span>
<span id="L6398" rel="#L6398">6398</span>
<span id="L6399" rel="#L6399">6399</span>
<span id="L6400" rel="#L6400">6400</span>
<span id="L6401" rel="#L6401">6401</span>
<span id="L6402" rel="#L6402">6402</span>
<span id="L6403" rel="#L6403">6403</span>
<span id="L6404" rel="#L6404">6404</span>
<span id="L6405" rel="#L6405">6405</span>
<span id="L6406" rel="#L6406">6406</span>
<span id="L6407" rel="#L6407">6407</span>
<span id="L6408" rel="#L6408">6408</span>
<span id="L6409" rel="#L6409">6409</span>
<span id="L6410" rel="#L6410">6410</span>
<span id="L6411" rel="#L6411">6411</span>
<span id="L6412" rel="#L6412">6412</span>
<span id="L6413" rel="#L6413">6413</span>
<span id="L6414" rel="#L6414">6414</span>
<span id="L6415" rel="#L6415">6415</span>
<span id="L6416" rel="#L6416">6416</span>
<span id="L6417" rel="#L6417">6417</span>
<span id="L6418" rel="#L6418">6418</span>
<span id="L6419" rel="#L6419">6419</span>
<span id="L6420" rel="#L6420">6420</span>
<span id="L6421" rel="#L6421">6421</span>
<span id="L6422" rel="#L6422">6422</span>
<span id="L6423" rel="#L6423">6423</span>
<span id="L6424" rel="#L6424">6424</span>
<span id="L6425" rel="#L6425">6425</span>
<span id="L6426" rel="#L6426">6426</span>
<span id="L6427" rel="#L6427">6427</span>
<span id="L6428" rel="#L6428">6428</span>
<span id="L6429" rel="#L6429">6429</span>
<span id="L6430" rel="#L6430">6430</span>
<span id="L6431" rel="#L6431">6431</span>
<span id="L6432" rel="#L6432">6432</span>
<span id="L6433" rel="#L6433">6433</span>
<span id="L6434" rel="#L6434">6434</span>
<span id="L6435" rel="#L6435">6435</span>
<span id="L6436" rel="#L6436">6436</span>
<span id="L6437" rel="#L6437">6437</span>
<span id="L6438" rel="#L6438">6438</span>
<span id="L6439" rel="#L6439">6439</span>
<span id="L6440" rel="#L6440">6440</span>
<span id="L6441" rel="#L6441">6441</span>
<span id="L6442" rel="#L6442">6442</span>
<span id="L6443" rel="#L6443">6443</span>
<span id="L6444" rel="#L6444">6444</span>
<span id="L6445" rel="#L6445">6445</span>
<span id="L6446" rel="#L6446">6446</span>
<span id="L6447" rel="#L6447">6447</span>
<span id="L6448" rel="#L6448">6448</span>
<span id="L6449" rel="#L6449">6449</span>
<span id="L6450" rel="#L6450">6450</span>
<span id="L6451" rel="#L6451">6451</span>
<span id="L6452" rel="#L6452">6452</span>
<span id="L6453" rel="#L6453">6453</span>
<span id="L6454" rel="#L6454">6454</span>
<span id="L6455" rel="#L6455">6455</span>
<span id="L6456" rel="#L6456">6456</span>
<span id="L6457" rel="#L6457">6457</span>
<span id="L6458" rel="#L6458">6458</span>
<span id="L6459" rel="#L6459">6459</span>
<span id="L6460" rel="#L6460">6460</span>
<span id="L6461" rel="#L6461">6461</span>
<span id="L6462" rel="#L6462">6462</span>
<span id="L6463" rel="#L6463">6463</span>
<span id="L6464" rel="#L6464">6464</span>
<span id="L6465" rel="#L6465">6465</span>
<span id="L6466" rel="#L6466">6466</span>
<span id="L6467" rel="#L6467">6467</span>
<span id="L6468" rel="#L6468">6468</span>
<span id="L6469" rel="#L6469">6469</span>
<span id="L6470" rel="#L6470">6470</span>
<span id="L6471" rel="#L6471">6471</span>
<span id="L6472" rel="#L6472">6472</span>
<span id="L6473" rel="#L6473">6473</span>
<span id="L6474" rel="#L6474">6474</span>
<span id="L6475" rel="#L6475">6475</span>
<span id="L6476" rel="#L6476">6476</span>
<span id="L6477" rel="#L6477">6477</span>
<span id="L6478" rel="#L6478">6478</span>
<span id="L6479" rel="#L6479">6479</span>
<span id="L6480" rel="#L6480">6480</span>
<span id="L6481" rel="#L6481">6481</span>
<span id="L6482" rel="#L6482">6482</span>
<span id="L6483" rel="#L6483">6483</span>
<span id="L6484" rel="#L6484">6484</span>
<span id="L6485" rel="#L6485">6485</span>
<span id="L6486" rel="#L6486">6486</span>
<span id="L6487" rel="#L6487">6487</span>
<span id="L6488" rel="#L6488">6488</span>
<span id="L6489" rel="#L6489">6489</span>
<span id="L6490" rel="#L6490">6490</span>
<span id="L6491" rel="#L6491">6491</span>
<span id="L6492" rel="#L6492">6492</span>
<span id="L6493" rel="#L6493">6493</span>
<span id="L6494" rel="#L6494">6494</span>
<span id="L6495" rel="#L6495">6495</span>
<span id="L6496" rel="#L6496">6496</span>
<span id="L6497" rel="#L6497">6497</span>
<span id="L6498" rel="#L6498">6498</span>
<span id="L6499" rel="#L6499">6499</span>
<span id="L6500" rel="#L6500">6500</span>
<span id="L6501" rel="#L6501">6501</span>
<span id="L6502" rel="#L6502">6502</span>
<span id="L6503" rel="#L6503">6503</span>
<span id="L6504" rel="#L6504">6504</span>
<span id="L6505" rel="#L6505">6505</span>
<span id="L6506" rel="#L6506">6506</span>
<span id="L6507" rel="#L6507">6507</span>
<span id="L6508" rel="#L6508">6508</span>
<span id="L6509" rel="#L6509">6509</span>
<span id="L6510" rel="#L6510">6510</span>
<span id="L6511" rel="#L6511">6511</span>
<span id="L6512" rel="#L6512">6512</span>
<span id="L6513" rel="#L6513">6513</span>
<span id="L6514" rel="#L6514">6514</span>
<span id="L6515" rel="#L6515">6515</span>
<span id="L6516" rel="#L6516">6516</span>
<span id="L6517" rel="#L6517">6517</span>
<span id="L6518" rel="#L6518">6518</span>
<span id="L6519" rel="#L6519">6519</span>
<span id="L6520" rel="#L6520">6520</span>
<span id="L6521" rel="#L6521">6521</span>
<span id="L6522" rel="#L6522">6522</span>
<span id="L6523" rel="#L6523">6523</span>
<span id="L6524" rel="#L6524">6524</span>
<span id="L6525" rel="#L6525">6525</span>
<span id="L6526" rel="#L6526">6526</span>
<span id="L6527" rel="#L6527">6527</span>
<span id="L6528" rel="#L6528">6528</span>
<span id="L6529" rel="#L6529">6529</span>
<span id="L6530" rel="#L6530">6530</span>
<span id="L6531" rel="#L6531">6531</span>
<span id="L6532" rel="#L6532">6532</span>
<span id="L6533" rel="#L6533">6533</span>
<span id="L6534" rel="#L6534">6534</span>
<span id="L6535" rel="#L6535">6535</span>
<span id="L6536" rel="#L6536">6536</span>
<span id="L6537" rel="#L6537">6537</span>
<span id="L6538" rel="#L6538">6538</span>
<span id="L6539" rel="#L6539">6539</span>
<span id="L6540" rel="#L6540">6540</span>
<span id="L6541" rel="#L6541">6541</span>
<span id="L6542" rel="#L6542">6542</span>
<span id="L6543" rel="#L6543">6543</span>
<span id="L6544" rel="#L6544">6544</span>
<span id="L6545" rel="#L6545">6545</span>
<span id="L6546" rel="#L6546">6546</span>
<span id="L6547" rel="#L6547">6547</span>
<span id="L6548" rel="#L6548">6548</span>
<span id="L6549" rel="#L6549">6549</span>
<span id="L6550" rel="#L6550">6550</span>
<span id="L6551" rel="#L6551">6551</span>
<span id="L6552" rel="#L6552">6552</span>
<span id="L6553" rel="#L6553">6553</span>
<span id="L6554" rel="#L6554">6554</span>
<span id="L6555" rel="#L6555">6555</span>
<span id="L6556" rel="#L6556">6556</span>
<span id="L6557" rel="#L6557">6557</span>
<span id="L6558" rel="#L6558">6558</span>
<span id="L6559" rel="#L6559">6559</span>
<span id="L6560" rel="#L6560">6560</span>
<span id="L6561" rel="#L6561">6561</span>
<span id="L6562" rel="#L6562">6562</span>
<span id="L6563" rel="#L6563">6563</span>
<span id="L6564" rel="#L6564">6564</span>
<span id="L6565" rel="#L6565">6565</span>
<span id="L6566" rel="#L6566">6566</span>
<span id="L6567" rel="#L6567">6567</span>
<span id="L6568" rel="#L6568">6568</span>
<span id="L6569" rel="#L6569">6569</span>
<span id="L6570" rel="#L6570">6570</span>
<span id="L6571" rel="#L6571">6571</span>
<span id="L6572" rel="#L6572">6572</span>
<span id="L6573" rel="#L6573">6573</span>
<span id="L6574" rel="#L6574">6574</span>
<span id="L6575" rel="#L6575">6575</span>
<span id="L6576" rel="#L6576">6576</span>
<span id="L6577" rel="#L6577">6577</span>
<span id="L6578" rel="#L6578">6578</span>
<span id="L6579" rel="#L6579">6579</span>
<span id="L6580" rel="#L6580">6580</span>
<span id="L6581" rel="#L6581">6581</span>
<span id="L6582" rel="#L6582">6582</span>
<span id="L6583" rel="#L6583">6583</span>
<span id="L6584" rel="#L6584">6584</span>
<span id="L6585" rel="#L6585">6585</span>
<span id="L6586" rel="#L6586">6586</span>
<span id="L6587" rel="#L6587">6587</span>
<span id="L6588" rel="#L6588">6588</span>
<span id="L6589" rel="#L6589">6589</span>
<span id="L6590" rel="#L6590">6590</span>
<span id="L6591" rel="#L6591">6591</span>
<span id="L6592" rel="#L6592">6592</span>
<span id="L6593" rel="#L6593">6593</span>
<span id="L6594" rel="#L6594">6594</span>
<span id="L6595" rel="#L6595">6595</span>
<span id="L6596" rel="#L6596">6596</span>
<span id="L6597" rel="#L6597">6597</span>
<span id="L6598" rel="#L6598">6598</span>
<span id="L6599" rel="#L6599">6599</span>
<span id="L6600" rel="#L6600">6600</span>
<span id="L6601" rel="#L6601">6601</span>
<span id="L6602" rel="#L6602">6602</span>
<span id="L6603" rel="#L6603">6603</span>
<span id="L6604" rel="#L6604">6604</span>
<span id="L6605" rel="#L6605">6605</span>
<span id="L6606" rel="#L6606">6606</span>
<span id="L6607" rel="#L6607">6607</span>
<span id="L6608" rel="#L6608">6608</span>
<span id="L6609" rel="#L6609">6609</span>
<span id="L6610" rel="#L6610">6610</span>
<span id="L6611" rel="#L6611">6611</span>
<span id="L6612" rel="#L6612">6612</span>
<span id="L6613" rel="#L6613">6613</span>
<span id="L6614" rel="#L6614">6614</span>
<span id="L6615" rel="#L6615">6615</span>
<span id="L6616" rel="#L6616">6616</span>
<span id="L6617" rel="#L6617">6617</span>
<span id="L6618" rel="#L6618">6618</span>
<span id="L6619" rel="#L6619">6619</span>
<span id="L6620" rel="#L6620">6620</span>
<span id="L6621" rel="#L6621">6621</span>
<span id="L6622" rel="#L6622">6622</span>
<span id="L6623" rel="#L6623">6623</span>
<span id="L6624" rel="#L6624">6624</span>
<span id="L6625" rel="#L6625">6625</span>
<span id="L6626" rel="#L6626">6626</span>
<span id="L6627" rel="#L6627">6627</span>
<span id="L6628" rel="#L6628">6628</span>
<span id="L6629" rel="#L6629">6629</span>
<span id="L6630" rel="#L6630">6630</span>
<span id="L6631" rel="#L6631">6631</span>
<span id="L6632" rel="#L6632">6632</span>
<span id="L6633" rel="#L6633">6633</span>
<span id="L6634" rel="#L6634">6634</span>
<span id="L6635" rel="#L6635">6635</span>
<span id="L6636" rel="#L6636">6636</span>
<span id="L6637" rel="#L6637">6637</span>
<span id="L6638" rel="#L6638">6638</span>
<span id="L6639" rel="#L6639">6639</span>
<span id="L6640" rel="#L6640">6640</span>
<span id="L6641" rel="#L6641">6641</span>
<span id="L6642" rel="#L6642">6642</span>
<span id="L6643" rel="#L6643">6643</span>
<span id="L6644" rel="#L6644">6644</span>
<span id="L6645" rel="#L6645">6645</span>
<span id="L6646" rel="#L6646">6646</span>
<span id="L6647" rel="#L6647">6647</span>
<span id="L6648" rel="#L6648">6648</span>
<span id="L6649" rel="#L6649">6649</span>
<span id="L6650" rel="#L6650">6650</span>
<span id="L6651" rel="#L6651">6651</span>
<span id="L6652" rel="#L6652">6652</span>
<span id="L6653" rel="#L6653">6653</span>
<span id="L6654" rel="#L6654">6654</span>
<span id="L6655" rel="#L6655">6655</span>
<span id="L6656" rel="#L6656">6656</span>
<span id="L6657" rel="#L6657">6657</span>
<span id="L6658" rel="#L6658">6658</span>
<span id="L6659" rel="#L6659">6659</span>
<span id="L6660" rel="#L6660">6660</span>
<span id="L6661" rel="#L6661">6661</span>
<span id="L6662" rel="#L6662">6662</span>
<span id="L6663" rel="#L6663">6663</span>
<span id="L6664" rel="#L6664">6664</span>
<span id="L6665" rel="#L6665">6665</span>
<span id="L6666" rel="#L6666">6666</span>
<span id="L6667" rel="#L6667">6667</span>
<span id="L6668" rel="#L6668">6668</span>
<span id="L6669" rel="#L6669">6669</span>
<span id="L6670" rel="#L6670">6670</span>
<span id="L6671" rel="#L6671">6671</span>
<span id="L6672" rel="#L6672">6672</span>
<span id="L6673" rel="#L6673">6673</span>
<span id="L6674" rel="#L6674">6674</span>
<span id="L6675" rel="#L6675">6675</span>
<span id="L6676" rel="#L6676">6676</span>
<span id="L6677" rel="#L6677">6677</span>
<span id="L6678" rel="#L6678">6678</span>
<span id="L6679" rel="#L6679">6679</span>
<span id="L6680" rel="#L6680">6680</span>
<span id="L6681" rel="#L6681">6681</span>
<span id="L6682" rel="#L6682">6682</span>
<span id="L6683" rel="#L6683">6683</span>
<span id="L6684" rel="#L6684">6684</span>
<span id="L6685" rel="#L6685">6685</span>
<span id="L6686" rel="#L6686">6686</span>
<span id="L6687" rel="#L6687">6687</span>
<span id="L6688" rel="#L6688">6688</span>
<span id="L6689" rel="#L6689">6689</span>
<span id="L6690" rel="#L6690">6690</span>
<span id="L6691" rel="#L6691">6691</span>
<span id="L6692" rel="#L6692">6692</span>
<span id="L6693" rel="#L6693">6693</span>
<span id="L6694" rel="#L6694">6694</span>
<span id="L6695" rel="#L6695">6695</span>
<span id="L6696" rel="#L6696">6696</span>
<span id="L6697" rel="#L6697">6697</span>
<span id="L6698" rel="#L6698">6698</span>
<span id="L6699" rel="#L6699">6699</span>
<span id="L6700" rel="#L6700">6700</span>
<span id="L6701" rel="#L6701">6701</span>
<span id="L6702" rel="#L6702">6702</span>
<span id="L6703" rel="#L6703">6703</span>
<span id="L6704" rel="#L6704">6704</span>
<span id="L6705" rel="#L6705">6705</span>
<span id="L6706" rel="#L6706">6706</span>
<span id="L6707" rel="#L6707">6707</span>
<span id="L6708" rel="#L6708">6708</span>
<span id="L6709" rel="#L6709">6709</span>
<span id="L6710" rel="#L6710">6710</span>
<span id="L6711" rel="#L6711">6711</span>
<span id="L6712" rel="#L6712">6712</span>
<span id="L6713" rel="#L6713">6713</span>
<span id="L6714" rel="#L6714">6714</span>
<span id="L6715" rel="#L6715">6715</span>
<span id="L6716" rel="#L6716">6716</span>
<span id="L6717" rel="#L6717">6717</span>
<span id="L6718" rel="#L6718">6718</span>
<span id="L6719" rel="#L6719">6719</span>
<span id="L6720" rel="#L6720">6720</span>
<span id="L6721" rel="#L6721">6721</span>
<span id="L6722" rel="#L6722">6722</span>
<span id="L6723" rel="#L6723">6723</span>
<span id="L6724" rel="#L6724">6724</span>
<span id="L6725" rel="#L6725">6725</span>
<span id="L6726" rel="#L6726">6726</span>
<span id="L6727" rel="#L6727">6727</span>
<span id="L6728" rel="#L6728">6728</span>
<span id="L6729" rel="#L6729">6729</span>
<span id="L6730" rel="#L6730">6730</span>
<span id="L6731" rel="#L6731">6731</span>
<span id="L6732" rel="#L6732">6732</span>
<span id="L6733" rel="#L6733">6733</span>
<span id="L6734" rel="#L6734">6734</span>
<span id="L6735" rel="#L6735">6735</span>
<span id="L6736" rel="#L6736">6736</span>
<span id="L6737" rel="#L6737">6737</span>
<span id="L6738" rel="#L6738">6738</span>
<span id="L6739" rel="#L6739">6739</span>
<span id="L6740" rel="#L6740">6740</span>
<span id="L6741" rel="#L6741">6741</span>
<span id="L6742" rel="#L6742">6742</span>
<span id="L6743" rel="#L6743">6743</span>
<span id="L6744" rel="#L6744">6744</span>
<span id="L6745" rel="#L6745">6745</span>
<span id="L6746" rel="#L6746">6746</span>
<span id="L6747" rel="#L6747">6747</span>
<span id="L6748" rel="#L6748">6748</span>
<span id="L6749" rel="#L6749">6749</span>
<span id="L6750" rel="#L6750">6750</span>
<span id="L6751" rel="#L6751">6751</span>
<span id="L6752" rel="#L6752">6752</span>
<span id="L6753" rel="#L6753">6753</span>
<span id="L6754" rel="#L6754">6754</span>
<span id="L6755" rel="#L6755">6755</span>
<span id="L6756" rel="#L6756">6756</span>
<span id="L6757" rel="#L6757">6757</span>
<span id="L6758" rel="#L6758">6758</span>
<span id="L6759" rel="#L6759">6759</span>
<span id="L6760" rel="#L6760">6760</span>
<span id="L6761" rel="#L6761">6761</span>
<span id="L6762" rel="#L6762">6762</span>
<span id="L6763" rel="#L6763">6763</span>
<span id="L6764" rel="#L6764">6764</span>
<span id="L6765" rel="#L6765">6765</span>
<span id="L6766" rel="#L6766">6766</span>
<span id="L6767" rel="#L6767">6767</span>
<span id="L6768" rel="#L6768">6768</span>
<span id="L6769" rel="#L6769">6769</span>
<span id="L6770" rel="#L6770">6770</span>
<span id="L6771" rel="#L6771">6771</span>
<span id="L6772" rel="#L6772">6772</span>
<span id="L6773" rel="#L6773">6773</span>
<span id="L6774" rel="#L6774">6774</span>
<span id="L6775" rel="#L6775">6775</span>
<span id="L6776" rel="#L6776">6776</span>
<span id="L6777" rel="#L6777">6777</span>
<span id="L6778" rel="#L6778">6778</span>
<span id="L6779" rel="#L6779">6779</span>
<span id="L6780" rel="#L6780">6780</span>
<span id="L6781" rel="#L6781">6781</span>
<span id="L6782" rel="#L6782">6782</span>
<span id="L6783" rel="#L6783">6783</span>
<span id="L6784" rel="#L6784">6784</span>
<span id="L6785" rel="#L6785">6785</span>
<span id="L6786" rel="#L6786">6786</span>
<span id="L6787" rel="#L6787">6787</span>
<span id="L6788" rel="#L6788">6788</span>
<span id="L6789" rel="#L6789">6789</span>
<span id="L6790" rel="#L6790">6790</span>
<span id="L6791" rel="#L6791">6791</span>
<span id="L6792" rel="#L6792">6792</span>
<span id="L6793" rel="#L6793">6793</span>
<span id="L6794" rel="#L6794">6794</span>
<span id="L6795" rel="#L6795">6795</span>
<span id="L6796" rel="#L6796">6796</span>
<span id="L6797" rel="#L6797">6797</span>
<span id="L6798" rel="#L6798">6798</span>
<span id="L6799" rel="#L6799">6799</span>
<span id="L6800" rel="#L6800">6800</span>
<span id="L6801" rel="#L6801">6801</span>
<span id="L6802" rel="#L6802">6802</span>
<span id="L6803" rel="#L6803">6803</span>
<span id="L6804" rel="#L6804">6804</span>
<span id="L6805" rel="#L6805">6805</span>
<span id="L6806" rel="#L6806">6806</span>
<span id="L6807" rel="#L6807">6807</span>
<span id="L6808" rel="#L6808">6808</span>
<span id="L6809" rel="#L6809">6809</span>
<span id="L6810" rel="#L6810">6810</span>
<span id="L6811" rel="#L6811">6811</span>
<span id="L6812" rel="#L6812">6812</span>
<span id="L6813" rel="#L6813">6813</span>
<span id="L6814" rel="#L6814">6814</span>
<span id="L6815" rel="#L6815">6815</span>
<span id="L6816" rel="#L6816">6816</span>
<span id="L6817" rel="#L6817">6817</span>
<span id="L6818" rel="#L6818">6818</span>
<span id="L6819" rel="#L6819">6819</span>
<span id="L6820" rel="#L6820">6820</span>
<span id="L6821" rel="#L6821">6821</span>
<span id="L6822" rel="#L6822">6822</span>
<span id="L6823" rel="#L6823">6823</span>
<span id="L6824" rel="#L6824">6824</span>
<span id="L6825" rel="#L6825">6825</span>
<span id="L6826" rel="#L6826">6826</span>
<span id="L6827" rel="#L6827">6827</span>
<span id="L6828" rel="#L6828">6828</span>
<span id="L6829" rel="#L6829">6829</span>
<span id="L6830" rel="#L6830">6830</span>
<span id="L6831" rel="#L6831">6831</span>
<span id="L6832" rel="#L6832">6832</span>
<span id="L6833" rel="#L6833">6833</span>
<span id="L6834" rel="#L6834">6834</span>
<span id="L6835" rel="#L6835">6835</span>
<span id="L6836" rel="#L6836">6836</span>
<span id="L6837" rel="#L6837">6837</span>
<span id="L6838" rel="#L6838">6838</span>
<span id="L6839" rel="#L6839">6839</span>
<span id="L6840" rel="#L6840">6840</span>
<span id="L6841" rel="#L6841">6841</span>
<span id="L6842" rel="#L6842">6842</span>
<span id="L6843" rel="#L6843">6843</span>
<span id="L6844" rel="#L6844">6844</span>
<span id="L6845" rel="#L6845">6845</span>
<span id="L6846" rel="#L6846">6846</span>
<span id="L6847" rel="#L6847">6847</span>
<span id="L6848" rel="#L6848">6848</span>
<span id="L6849" rel="#L6849">6849</span>
<span id="L6850" rel="#L6850">6850</span>
<span id="L6851" rel="#L6851">6851</span>
<span id="L6852" rel="#L6852">6852</span>
<span id="L6853" rel="#L6853">6853</span>
<span id="L6854" rel="#L6854">6854</span>
<span id="L6855" rel="#L6855">6855</span>
<span id="L6856" rel="#L6856">6856</span>
<span id="L6857" rel="#L6857">6857</span>
<span id="L6858" rel="#L6858">6858</span>
<span id="L6859" rel="#L6859">6859</span>
<span id="L6860" rel="#L6860">6860</span>
<span id="L6861" rel="#L6861">6861</span>
<span id="L6862" rel="#L6862">6862</span>
<span id="L6863" rel="#L6863">6863</span>
<span id="L6864" rel="#L6864">6864</span>
<span id="L6865" rel="#L6865">6865</span>
<span id="L6866" rel="#L6866">6866</span>
<span id="L6867" rel="#L6867">6867</span>
<span id="L6868" rel="#L6868">6868</span>
<span id="L6869" rel="#L6869">6869</span>
<span id="L6870" rel="#L6870">6870</span>
<span id="L6871" rel="#L6871">6871</span>
<span id="L6872" rel="#L6872">6872</span>
<span id="L6873" rel="#L6873">6873</span>
<span id="L6874" rel="#L6874">6874</span>
<span id="L6875" rel="#L6875">6875</span>
<span id="L6876" rel="#L6876">6876</span>
<span id="L6877" rel="#L6877">6877</span>
<span id="L6878" rel="#L6878">6878</span>
<span id="L6879" rel="#L6879">6879</span>
<span id="L6880" rel="#L6880">6880</span>
<span id="L6881" rel="#L6881">6881</span>
<span id="L6882" rel="#L6882">6882</span>
<span id="L6883" rel="#L6883">6883</span>
<span id="L6884" rel="#L6884">6884</span>
<span id="L6885" rel="#L6885">6885</span>
<span id="L6886" rel="#L6886">6886</span>
<span id="L6887" rel="#L6887">6887</span>
<span id="L6888" rel="#L6888">6888</span>
<span id="L6889" rel="#L6889">6889</span>
<span id="L6890" rel="#L6890">6890</span>
<span id="L6891" rel="#L6891">6891</span>
<span id="L6892" rel="#L6892">6892</span>
<span id="L6893" rel="#L6893">6893</span>
<span id="L6894" rel="#L6894">6894</span>
<span id="L6895" rel="#L6895">6895</span>
<span id="L6896" rel="#L6896">6896</span>
<span id="L6897" rel="#L6897">6897</span>
<span id="L6898" rel="#L6898">6898</span>
<span id="L6899" rel="#L6899">6899</span>
<span id="L6900" rel="#L6900">6900</span>
<span id="L6901" rel="#L6901">6901</span>
<span id="L6902" rel="#L6902">6902</span>
<span id="L6903" rel="#L6903">6903</span>
<span id="L6904" rel="#L6904">6904</span>
<span id="L6905" rel="#L6905">6905</span>
<span id="L6906" rel="#L6906">6906</span>
<span id="L6907" rel="#L6907">6907</span>
<span id="L6908" rel="#L6908">6908</span>
<span id="L6909" rel="#L6909">6909</span>
<span id="L6910" rel="#L6910">6910</span>
<span id="L6911" rel="#L6911">6911</span>
<span id="L6912" rel="#L6912">6912</span>
<span id="L6913" rel="#L6913">6913</span>
<span id="L6914" rel="#L6914">6914</span>
<span id="L6915" rel="#L6915">6915</span>
<span id="L6916" rel="#L6916">6916</span>
<span id="L6917" rel="#L6917">6917</span>
<span id="L6918" rel="#L6918">6918</span>
<span id="L6919" rel="#L6919">6919</span>
<span id="L6920" rel="#L6920">6920</span>
<span id="L6921" rel="#L6921">6921</span>
<span id="L6922" rel="#L6922">6922</span>
<span id="L6923" rel="#L6923">6923</span>
<span id="L6924" rel="#L6924">6924</span>
<span id="L6925" rel="#L6925">6925</span>
<span id="L6926" rel="#L6926">6926</span>
<span id="L6927" rel="#L6927">6927</span>
<span id="L6928" rel="#L6928">6928</span>
<span id="L6929" rel="#L6929">6929</span>
<span id="L6930" rel="#L6930">6930</span>
<span id="L6931" rel="#L6931">6931</span>
<span id="L6932" rel="#L6932">6932</span>
<span id="L6933" rel="#L6933">6933</span>
<span id="L6934" rel="#L6934">6934</span>
<span id="L6935" rel="#L6935">6935</span>
<span id="L6936" rel="#L6936">6936</span>
<span id="L6937" rel="#L6937">6937</span>
<span id="L6938" rel="#L6938">6938</span>
<span id="L6939" rel="#L6939">6939</span>
<span id="L6940" rel="#L6940">6940</span>
<span id="L6941" rel="#L6941">6941</span>
<span id="L6942" rel="#L6942">6942</span>
<span id="L6943" rel="#L6943">6943</span>
<span id="L6944" rel="#L6944">6944</span>
<span id="L6945" rel="#L6945">6945</span>
<span id="L6946" rel="#L6946">6946</span>
<span id="L6947" rel="#L6947">6947</span>
<span id="L6948" rel="#L6948">6948</span>
<span id="L6949" rel="#L6949">6949</span>
<span id="L6950" rel="#L6950">6950</span>
<span id="L6951" rel="#L6951">6951</span>
<span id="L6952" rel="#L6952">6952</span>
<span id="L6953" rel="#L6953">6953</span>
<span id="L6954" rel="#L6954">6954</span>
<span id="L6955" rel="#L6955">6955</span>
<span id="L6956" rel="#L6956">6956</span>
<span id="L6957" rel="#L6957">6957</span>
<span id="L6958" rel="#L6958">6958</span>
<span id="L6959" rel="#L6959">6959</span>
<span id="L6960" rel="#L6960">6960</span>
<span id="L6961" rel="#L6961">6961</span>
<span id="L6962" rel="#L6962">6962</span>
<span id="L6963" rel="#L6963">6963</span>
<span id="L6964" rel="#L6964">6964</span>
<span id="L6965" rel="#L6965">6965</span>
<span id="L6966" rel="#L6966">6966</span>
<span id="L6967" rel="#L6967">6967</span>
<span id="L6968" rel="#L6968">6968</span>
<span id="L6969" rel="#L6969">6969</span>
<span id="L6970" rel="#L6970">6970</span>
<span id="L6971" rel="#L6971">6971</span>
<span id="L6972" rel="#L6972">6972</span>
<span id="L6973" rel="#L6973">6973</span>
<span id="L6974" rel="#L6974">6974</span>
<span id="L6975" rel="#L6975">6975</span>
<span id="L6976" rel="#L6976">6976</span>
<span id="L6977" rel="#L6977">6977</span>
<span id="L6978" rel="#L6978">6978</span>
<span id="L6979" rel="#L6979">6979</span>
<span id="L6980" rel="#L6980">6980</span>
<span id="L6981" rel="#L6981">6981</span>
<span id="L6982" rel="#L6982">6982</span>
<span id="L6983" rel="#L6983">6983</span>
<span id="L6984" rel="#L6984">6984</span>
<span id="L6985" rel="#L6985">6985</span>
<span id="L6986" rel="#L6986">6986</span>
<span id="L6987" rel="#L6987">6987</span>
<span id="L6988" rel="#L6988">6988</span>
<span id="L6989" rel="#L6989">6989</span>
<span id="L6990" rel="#L6990">6990</span>
<span id="L6991" rel="#L6991">6991</span>
<span id="L6992" rel="#L6992">6992</span>
<span id="L6993" rel="#L6993">6993</span>
<span id="L6994" rel="#L6994">6994</span>
<span id="L6995" rel="#L6995">6995</span>
<span id="L6996" rel="#L6996">6996</span>
<span id="L6997" rel="#L6997">6997</span>
<span id="L6998" rel="#L6998">6998</span>
<span id="L6999" rel="#L6999">6999</span>
<span id="L7000" rel="#L7000">7000</span>
<span id="L7001" rel="#L7001">7001</span>
<span id="L7002" rel="#L7002">7002</span>
<span id="L7003" rel="#L7003">7003</span>
<span id="L7004" rel="#L7004">7004</span>
<span id="L7005" rel="#L7005">7005</span>
<span id="L7006" rel="#L7006">7006</span>
<span id="L7007" rel="#L7007">7007</span>
<span id="L7008" rel="#L7008">7008</span>
<span id="L7009" rel="#L7009">7009</span>
<span id="L7010" rel="#L7010">7010</span>
<span id="L7011" rel="#L7011">7011</span>
<span id="L7012" rel="#L7012">7012</span>
<span id="L7013" rel="#L7013">7013</span>
<span id="L7014" rel="#L7014">7014</span>
<span id="L7015" rel="#L7015">7015</span>
<span id="L7016" rel="#L7016">7016</span>
<span id="L7017" rel="#L7017">7017</span>
<span id="L7018" rel="#L7018">7018</span>
<span id="L7019" rel="#L7019">7019</span>
<span id="L7020" rel="#L7020">7020</span>
<span id="L7021" rel="#L7021">7021</span>
<span id="L7022" rel="#L7022">7022</span>
<span id="L7023" rel="#L7023">7023</span>
<span id="L7024" rel="#L7024">7024</span>
<span id="L7025" rel="#L7025">7025</span>
<span id="L7026" rel="#L7026">7026</span>
<span id="L7027" rel="#L7027">7027</span>
<span id="L7028" rel="#L7028">7028</span>
<span id="L7029" rel="#L7029">7029</span>
<span id="L7030" rel="#L7030">7030</span>
<span id="L7031" rel="#L7031">7031</span>
<span id="L7032" rel="#L7032">7032</span>
<span id="L7033" rel="#L7033">7033</span>
<span id="L7034" rel="#L7034">7034</span>
<span id="L7035" rel="#L7035">7035</span>
<span id="L7036" rel="#L7036">7036</span>
<span id="L7037" rel="#L7037">7037</span>
<span id="L7038" rel="#L7038">7038</span>
<span id="L7039" rel="#L7039">7039</span>
<span id="L7040" rel="#L7040">7040</span>
<span id="L7041" rel="#L7041">7041</span>
<span id="L7042" rel="#L7042">7042</span>
<span id="L7043" rel="#L7043">7043</span>
<span id="L7044" rel="#L7044">7044</span>
<span id="L7045" rel="#L7045">7045</span>
<span id="L7046" rel="#L7046">7046</span>
<span id="L7047" rel="#L7047">7047</span>
<span id="L7048" rel="#L7048">7048</span>
<span id="L7049" rel="#L7049">7049</span>
<span id="L7050" rel="#L7050">7050</span>
<span id="L7051" rel="#L7051">7051</span>
<span id="L7052" rel="#L7052">7052</span>
<span id="L7053" rel="#L7053">7053</span>
<span id="L7054" rel="#L7054">7054</span>
<span id="L7055" rel="#L7055">7055</span>
<span id="L7056" rel="#L7056">7056</span>
<span id="L7057" rel="#L7057">7057</span>
<span id="L7058" rel="#L7058">7058</span>
<span id="L7059" rel="#L7059">7059</span>
<span id="L7060" rel="#L7060">7060</span>
<span id="L7061" rel="#L7061">7061</span>
<span id="L7062" rel="#L7062">7062</span>
<span id="L7063" rel="#L7063">7063</span>
<span id="L7064" rel="#L7064">7064</span>
<span id="L7065" rel="#L7065">7065</span>
<span id="L7066" rel="#L7066">7066</span>
<span id="L7067" rel="#L7067">7067</span>
<span id="L7068" rel="#L7068">7068</span>
<span id="L7069" rel="#L7069">7069</span>
<span id="L7070" rel="#L7070">7070</span>
<span id="L7071" rel="#L7071">7071</span>
<span id="L7072" rel="#L7072">7072</span>
<span id="L7073" rel="#L7073">7073</span>
<span id="L7074" rel="#L7074">7074</span>
<span id="L7075" rel="#L7075">7075</span>
<span id="L7076" rel="#L7076">7076</span>
<span id="L7077" rel="#L7077">7077</span>
<span id="L7078" rel="#L7078">7078</span>
<span id="L7079" rel="#L7079">7079</span>
<span id="L7080" rel="#L7080">7080</span>
<span id="L7081" rel="#L7081">7081</span>
<span id="L7082" rel="#L7082">7082</span>
<span id="L7083" rel="#L7083">7083</span>
<span id="L7084" rel="#L7084">7084</span>
<span id="L7085" rel="#L7085">7085</span>
<span id="L7086" rel="#L7086">7086</span>
<span id="L7087" rel="#L7087">7087</span>
<span id="L7088" rel="#L7088">7088</span>
<span id="L7089" rel="#L7089">7089</span>
<span id="L7090" rel="#L7090">7090</span>
<span id="L7091" rel="#L7091">7091</span>
<span id="L7092" rel="#L7092">7092</span>
<span id="L7093" rel="#L7093">7093</span>
<span id="L7094" rel="#L7094">7094</span>
<span id="L7095" rel="#L7095">7095</span>
<span id="L7096" rel="#L7096">7096</span>
<span id="L7097" rel="#L7097">7097</span>
<span id="L7098" rel="#L7098">7098</span>
<span id="L7099" rel="#L7099">7099</span>
<span id="L7100" rel="#L7100">7100</span>
<span id="L7101" rel="#L7101">7101</span>
<span id="L7102" rel="#L7102">7102</span>
<span id="L7103" rel="#L7103">7103</span>
<span id="L7104" rel="#L7104">7104</span>
<span id="L7105" rel="#L7105">7105</span>
<span id="L7106" rel="#L7106">7106</span>
<span id="L7107" rel="#L7107">7107</span>
<span id="L7108" rel="#L7108">7108</span>
<span id="L7109" rel="#L7109">7109</span>
<span id="L7110" rel="#L7110">7110</span>
<span id="L7111" rel="#L7111">7111</span>
<span id="L7112" rel="#L7112">7112</span>
<span id="L7113" rel="#L7113">7113</span>
<span id="L7114" rel="#L7114">7114</span>
<span id="L7115" rel="#L7115">7115</span>
<span id="L7116" rel="#L7116">7116</span>
<span id="L7117" rel="#L7117">7117</span>
<span id="L7118" rel="#L7118">7118</span>
<span id="L7119" rel="#L7119">7119</span>
<span id="L7120" rel="#L7120">7120</span>
<span id="L7121" rel="#L7121">7121</span>
<span id="L7122" rel="#L7122">7122</span>
<span id="L7123" rel="#L7123">7123</span>
<span id="L7124" rel="#L7124">7124</span>
<span id="L7125" rel="#L7125">7125</span>
<span id="L7126" rel="#L7126">7126</span>
<span id="L7127" rel="#L7127">7127</span>
<span id="L7128" rel="#L7128">7128</span>
<span id="L7129" rel="#L7129">7129</span>
<span id="L7130" rel="#L7130">7130</span>
<span id="L7131" rel="#L7131">7131</span>
<span id="L7132" rel="#L7132">7132</span>
<span id="L7133" rel="#L7133">7133</span>
<span id="L7134" rel="#L7134">7134</span>
<span id="L7135" rel="#L7135">7135</span>
<span id="L7136" rel="#L7136">7136</span>
<span id="L7137" rel="#L7137">7137</span>
<span id="L7138" rel="#L7138">7138</span>
<span id="L7139" rel="#L7139">7139</span>
<span id="L7140" rel="#L7140">7140</span>
<span id="L7141" rel="#L7141">7141</span>
<span id="L7142" rel="#L7142">7142</span>
<span id="L7143" rel="#L7143">7143</span>
<span id="L7144" rel="#L7144">7144</span>
<span id="L7145" rel="#L7145">7145</span>
<span id="L7146" rel="#L7146">7146</span>
<span id="L7147" rel="#L7147">7147</span>
<span id="L7148" rel="#L7148">7148</span>
<span id="L7149" rel="#L7149">7149</span>
<span id="L7150" rel="#L7150">7150</span>
<span id="L7151" rel="#L7151">7151</span>
<span id="L7152" rel="#L7152">7152</span>
<span id="L7153" rel="#L7153">7153</span>
<span id="L7154" rel="#L7154">7154</span>
<span id="L7155" rel="#L7155">7155</span>
<span id="L7156" rel="#L7156">7156</span>
<span id="L7157" rel="#L7157">7157</span>
<span id="L7158" rel="#L7158">7158</span>
<span id="L7159" rel="#L7159">7159</span>
<span id="L7160" rel="#L7160">7160</span>
<span id="L7161" rel="#L7161">7161</span>
<span id="L7162" rel="#L7162">7162</span>
<span id="L7163" rel="#L7163">7163</span>
<span id="L7164" rel="#L7164">7164</span>
<span id="L7165" rel="#L7165">7165</span>
<span id="L7166" rel="#L7166">7166</span>
<span id="L7167" rel="#L7167">7167</span>
<span id="L7168" rel="#L7168">7168</span>
<span id="L7169" rel="#L7169">7169</span>
<span id="L7170" rel="#L7170">7170</span>
<span id="L7171" rel="#L7171">7171</span>
<span id="L7172" rel="#L7172">7172</span>
<span id="L7173" rel="#L7173">7173</span>
<span id="L7174" rel="#L7174">7174</span>
<span id="L7175" rel="#L7175">7175</span>
<span id="L7176" rel="#L7176">7176</span>
<span id="L7177" rel="#L7177">7177</span>
<span id="L7178" rel="#L7178">7178</span>
<span id="L7179" rel="#L7179">7179</span>
<span id="L7180" rel="#L7180">7180</span>
<span id="L7181" rel="#L7181">7181</span>
<span id="L7182" rel="#L7182">7182</span>
<span id="L7183" rel="#L7183">7183</span>
<span id="L7184" rel="#L7184">7184</span>
<span id="L7185" rel="#L7185">7185</span>
<span id="L7186" rel="#L7186">7186</span>
<span id="L7187" rel="#L7187">7187</span>
<span id="L7188" rel="#L7188">7188</span>
<span id="L7189" rel="#L7189">7189</span>
<span id="L7190" rel="#L7190">7190</span>
<span id="L7191" rel="#L7191">7191</span>
<span id="L7192" rel="#L7192">7192</span>
<span id="L7193" rel="#L7193">7193</span>
<span id="L7194" rel="#L7194">7194</span>
<span id="L7195" rel="#L7195">7195</span>
<span id="L7196" rel="#L7196">7196</span>
<span id="L7197" rel="#L7197">7197</span>
<span id="L7198" rel="#L7198">7198</span>
<span id="L7199" rel="#L7199">7199</span>
<span id="L7200" rel="#L7200">7200</span>
<span id="L7201" rel="#L7201">7201</span>
<span id="L7202" rel="#L7202">7202</span>
<span id="L7203" rel="#L7203">7203</span>
<span id="L7204" rel="#L7204">7204</span>
<span id="L7205" rel="#L7205">7205</span>
<span id="L7206" rel="#L7206">7206</span>
<span id="L7207" rel="#L7207">7207</span>
<span id="L7208" rel="#L7208">7208</span>
<span id="L7209" rel="#L7209">7209</span>
<span id="L7210" rel="#L7210">7210</span>
<span id="L7211" rel="#L7211">7211</span>
<span id="L7212" rel="#L7212">7212</span>
<span id="L7213" rel="#L7213">7213</span>
<span id="L7214" rel="#L7214">7214</span>
<span id="L7215" rel="#L7215">7215</span>
<span id="L7216" rel="#L7216">7216</span>
<span id="L7217" rel="#L7217">7217</span>
<span id="L7218" rel="#L7218">7218</span>
<span id="L7219" rel="#L7219">7219</span>
<span id="L7220" rel="#L7220">7220</span>
<span id="L7221" rel="#L7221">7221</span>
<span id="L7222" rel="#L7222">7222</span>
<span id="L7223" rel="#L7223">7223</span>
<span id="L7224" rel="#L7224">7224</span>
<span id="L7225" rel="#L7225">7225</span>
<span id="L7226" rel="#L7226">7226</span>
<span id="L7227" rel="#L7227">7227</span>
<span id="L7228" rel="#L7228">7228</span>
<span id="L7229" rel="#L7229">7229</span>
<span id="L7230" rel="#L7230">7230</span>
<span id="L7231" rel="#L7231">7231</span>
<span id="L7232" rel="#L7232">7232</span>
<span id="L7233" rel="#L7233">7233</span>
<span id="L7234" rel="#L7234">7234</span>
<span id="L7235" rel="#L7235">7235</span>
<span id="L7236" rel="#L7236">7236</span>
<span id="L7237" rel="#L7237">7237</span>
<span id="L7238" rel="#L7238">7238</span>
<span id="L7239" rel="#L7239">7239</span>
<span id="L7240" rel="#L7240">7240</span>
<span id="L7241" rel="#L7241">7241</span>
<span id="L7242" rel="#L7242">7242</span>
<span id="L7243" rel="#L7243">7243</span>
<span id="L7244" rel="#L7244">7244</span>
<span id="L7245" rel="#L7245">7245</span>
<span id="L7246" rel="#L7246">7246</span>
<span id="L7247" rel="#L7247">7247</span>
<span id="L7248" rel="#L7248">7248</span>
<span id="L7249" rel="#L7249">7249</span>
<span id="L7250" rel="#L7250">7250</span>
<span id="L7251" rel="#L7251">7251</span>
<span id="L7252" rel="#L7252">7252</span>
<span id="L7253" rel="#L7253">7253</span>
<span id="L7254" rel="#L7254">7254</span>
<span id="L7255" rel="#L7255">7255</span>
<span id="L7256" rel="#L7256">7256</span>
<span id="L7257" rel="#L7257">7257</span>
<span id="L7258" rel="#L7258">7258</span>
<span id="L7259" rel="#L7259">7259</span>
<span id="L7260" rel="#L7260">7260</span>
<span id="L7261" rel="#L7261">7261</span>
<span id="L7262" rel="#L7262">7262</span>
<span id="L7263" rel="#L7263">7263</span>
<span id="L7264" rel="#L7264">7264</span>
<span id="L7265" rel="#L7265">7265</span>
<span id="L7266" rel="#L7266">7266</span>
<span id="L7267" rel="#L7267">7267</span>
<span id="L7268" rel="#L7268">7268</span>
<span id="L7269" rel="#L7269">7269</span>
<span id="L7270" rel="#L7270">7270</span>
<span id="L7271" rel="#L7271">7271</span>
<span id="L7272" rel="#L7272">7272</span>
<span id="L7273" rel="#L7273">7273</span>
<span id="L7274" rel="#L7274">7274</span>
<span id="L7275" rel="#L7275">7275</span>
<span id="L7276" rel="#L7276">7276</span>
<span id="L7277" rel="#L7277">7277</span>
<span id="L7278" rel="#L7278">7278</span>
<span id="L7279" rel="#L7279">7279</span>
<span id="L7280" rel="#L7280">7280</span>
<span id="L7281" rel="#L7281">7281</span>
<span id="L7282" rel="#L7282">7282</span>
<span id="L7283" rel="#L7283">7283</span>
<span id="L7284" rel="#L7284">7284</span>
<span id="L7285" rel="#L7285">7285</span>
<span id="L7286" rel="#L7286">7286</span>
<span id="L7287" rel="#L7287">7287</span>
<span id="L7288" rel="#L7288">7288</span>
<span id="L7289" rel="#L7289">7289</span>
<span id="L7290" rel="#L7290">7290</span>
<span id="L7291" rel="#L7291">7291</span>
<span id="L7292" rel="#L7292">7292</span>
<span id="L7293" rel="#L7293">7293</span>
<span id="L7294" rel="#L7294">7294</span>
<span id="L7295" rel="#L7295">7295</span>
<span id="L7296" rel="#L7296">7296</span>
<span id="L7297" rel="#L7297">7297</span>
<span id="L7298" rel="#L7298">7298</span>
<span id="L7299" rel="#L7299">7299</span>
<span id="L7300" rel="#L7300">7300</span>
<span id="L7301" rel="#L7301">7301</span>
<span id="L7302" rel="#L7302">7302</span>
<span id="L7303" rel="#L7303">7303</span>
<span id="L7304" rel="#L7304">7304</span>
<span id="L7305" rel="#L7305">7305</span>
<span id="L7306" rel="#L7306">7306</span>
<span id="L7307" rel="#L7307">7307</span>
<span id="L7308" rel="#L7308">7308</span>
<span id="L7309" rel="#L7309">7309</span>
<span id="L7310" rel="#L7310">7310</span>
<span id="L7311" rel="#L7311">7311</span>
<span id="L7312" rel="#L7312">7312</span>
<span id="L7313" rel="#L7313">7313</span>
<span id="L7314" rel="#L7314">7314</span>
<span id="L7315" rel="#L7315">7315</span>
<span id="L7316" rel="#L7316">7316</span>
<span id="L7317" rel="#L7317">7317</span>
<span id="L7318" rel="#L7318">7318</span>
<span id="L7319" rel="#L7319">7319</span>
<span id="L7320" rel="#L7320">7320</span>
<span id="L7321" rel="#L7321">7321</span>
<span id="L7322" rel="#L7322">7322</span>
<span id="L7323" rel="#L7323">7323</span>
<span id="L7324" rel="#L7324">7324</span>
<span id="L7325" rel="#L7325">7325</span>
<span id="L7326" rel="#L7326">7326</span>
<span id="L7327" rel="#L7327">7327</span>
<span id="L7328" rel="#L7328">7328</span>
<span id="L7329" rel="#L7329">7329</span>
<span id="L7330" rel="#L7330">7330</span>
<span id="L7331" rel="#L7331">7331</span>
<span id="L7332" rel="#L7332">7332</span>
<span id="L7333" rel="#L7333">7333</span>
<span id="L7334" rel="#L7334">7334</span>
<span id="L7335" rel="#L7335">7335</span>
<span id="L7336" rel="#L7336">7336</span>
<span id="L7337" rel="#L7337">7337</span>
<span id="L7338" rel="#L7338">7338</span>
<span id="L7339" rel="#L7339">7339</span>
<span id="L7340" rel="#L7340">7340</span>
<span id="L7341" rel="#L7341">7341</span>
<span id="L7342" rel="#L7342">7342</span>
<span id="L7343" rel="#L7343">7343</span>
<span id="L7344" rel="#L7344">7344</span>
<span id="L7345" rel="#L7345">7345</span>
<span id="L7346" rel="#L7346">7346</span>
<span id="L7347" rel="#L7347">7347</span>
<span id="L7348" rel="#L7348">7348</span>
<span id="L7349" rel="#L7349">7349</span>
<span id="L7350" rel="#L7350">7350</span>
<span id="L7351" rel="#L7351">7351</span>
<span id="L7352" rel="#L7352">7352</span>
<span id="L7353" rel="#L7353">7353</span>
<span id="L7354" rel="#L7354">7354</span>
<span id="L7355" rel="#L7355">7355</span>
<span id="L7356" rel="#L7356">7356</span>
<span id="L7357" rel="#L7357">7357</span>
<span id="L7358" rel="#L7358">7358</span>
<span id="L7359" rel="#L7359">7359</span>
<span id="L7360" rel="#L7360">7360</span>
<span id="L7361" rel="#L7361">7361</span>
<span id="L7362" rel="#L7362">7362</span>
<span id="L7363" rel="#L7363">7363</span>
<span id="L7364" rel="#L7364">7364</span>
<span id="L7365" rel="#L7365">7365</span>
<span id="L7366" rel="#L7366">7366</span>
<span id="L7367" rel="#L7367">7367</span>
<span id="L7368" rel="#L7368">7368</span>
<span id="L7369" rel="#L7369">7369</span>
<span id="L7370" rel="#L7370">7370</span>
<span id="L7371" rel="#L7371">7371</span>
<span id="L7372" rel="#L7372">7372</span>
<span id="L7373" rel="#L7373">7373</span>
<span id="L7374" rel="#L7374">7374</span>
<span id="L7375" rel="#L7375">7375</span>
<span id="L7376" rel="#L7376">7376</span>
<span id="L7377" rel="#L7377">7377</span>
<span id="L7378" rel="#L7378">7378</span>
<span id="L7379" rel="#L7379">7379</span>
<span id="L7380" rel="#L7380">7380</span>
<span id="L7381" rel="#L7381">7381</span>
<span id="L7382" rel="#L7382">7382</span>
<span id="L7383" rel="#L7383">7383</span>
<span id="L7384" rel="#L7384">7384</span>
<span id="L7385" rel="#L7385">7385</span>
<span id="L7386" rel="#L7386">7386</span>
<span id="L7387" rel="#L7387">7387</span>
<span id="L7388" rel="#L7388">7388</span>
<span id="L7389" rel="#L7389">7389</span>
<span id="L7390" rel="#L7390">7390</span>
<span id="L7391" rel="#L7391">7391</span>
<span id="L7392" rel="#L7392">7392</span>
<span id="L7393" rel="#L7393">7393</span>
<span id="L7394" rel="#L7394">7394</span>
<span id="L7395" rel="#L7395">7395</span>
<span id="L7396" rel="#L7396">7396</span>
<span id="L7397" rel="#L7397">7397</span>
<span id="L7398" rel="#L7398">7398</span>
<span id="L7399" rel="#L7399">7399</span>
<span id="L7400" rel="#L7400">7400</span>
<span id="L7401" rel="#L7401">7401</span>
<span id="L7402" rel="#L7402">7402</span>
<span id="L7403" rel="#L7403">7403</span>
<span id="L7404" rel="#L7404">7404</span>
<span id="L7405" rel="#L7405">7405</span>
<span id="L7406" rel="#L7406">7406</span>
<span id="L7407" rel="#L7407">7407</span>
<span id="L7408" rel="#L7408">7408</span>
<span id="L7409" rel="#L7409">7409</span>
<span id="L7410" rel="#L7410">7410</span>
<span id="L7411" rel="#L7411">7411</span>
<span id="L7412" rel="#L7412">7412</span>
<span id="L7413" rel="#L7413">7413</span>
<span id="L7414" rel="#L7414">7414</span>
<span id="L7415" rel="#L7415">7415</span>
<span id="L7416" rel="#L7416">7416</span>
<span id="L7417" rel="#L7417">7417</span>
<span id="L7418" rel="#L7418">7418</span>
<span id="L7419" rel="#L7419">7419</span>
<span id="L7420" rel="#L7420">7420</span>
<span id="L7421" rel="#L7421">7421</span>
<span id="L7422" rel="#L7422">7422</span>
<span id="L7423" rel="#L7423">7423</span>
<span id="L7424" rel="#L7424">7424</span>
<span id="L7425" rel="#L7425">7425</span>
<span id="L7426" rel="#L7426">7426</span>
<span id="L7427" rel="#L7427">7427</span>
<span id="L7428" rel="#L7428">7428</span>
<span id="L7429" rel="#L7429">7429</span>
<span id="L7430" rel="#L7430">7430</span>
<span id="L7431" rel="#L7431">7431</span>
<span id="L7432" rel="#L7432">7432</span>
<span id="L7433" rel="#L7433">7433</span>
<span id="L7434" rel="#L7434">7434</span>
<span id="L7435" rel="#L7435">7435</span>
<span id="L7436" rel="#L7436">7436</span>
<span id="L7437" rel="#L7437">7437</span>
<span id="L7438" rel="#L7438">7438</span>
<span id="L7439" rel="#L7439">7439</span>
<span id="L7440" rel="#L7440">7440</span>
<span id="L7441" rel="#L7441">7441</span>
<span id="L7442" rel="#L7442">7442</span>
<span id="L7443" rel="#L7443">7443</span>
<span id="L7444" rel="#L7444">7444</span>
<span id="L7445" rel="#L7445">7445</span>
<span id="L7446" rel="#L7446">7446</span>
<span id="L7447" rel="#L7447">7447</span>
<span id="L7448" rel="#L7448">7448</span>
<span id="L7449" rel="#L7449">7449</span>
<span id="L7450" rel="#L7450">7450</span>
<span id="L7451" rel="#L7451">7451</span>
<span id="L7452" rel="#L7452">7452</span>
<span id="L7453" rel="#L7453">7453</span>
<span id="L7454" rel="#L7454">7454</span>
<span id="L7455" rel="#L7455">7455</span>
<span id="L7456" rel="#L7456">7456</span>
<span id="L7457" rel="#L7457">7457</span>
<span id="L7458" rel="#L7458">7458</span>
<span id="L7459" rel="#L7459">7459</span>
<span id="L7460" rel="#L7460">7460</span>
<span id="L7461" rel="#L7461">7461</span>
<span id="L7462" rel="#L7462">7462</span>
<span id="L7463" rel="#L7463">7463</span>
<span id="L7464" rel="#L7464">7464</span>
<span id="L7465" rel="#L7465">7465</span>
<span id="L7466" rel="#L7466">7466</span>
<span id="L7467" rel="#L7467">7467</span>
<span id="L7468" rel="#L7468">7468</span>
<span id="L7469" rel="#L7469">7469</span>
<span id="L7470" rel="#L7470">7470</span>
<span id="L7471" rel="#L7471">7471</span>
<span id="L7472" rel="#L7472">7472</span>
<span id="L7473" rel="#L7473">7473</span>
<span id="L7474" rel="#L7474">7474</span>
<span id="L7475" rel="#L7475">7475</span>
<span id="L7476" rel="#L7476">7476</span>
<span id="L7477" rel="#L7477">7477</span>
<span id="L7478" rel="#L7478">7478</span>
<span id="L7479" rel="#L7479">7479</span>
<span id="L7480" rel="#L7480">7480</span>
<span id="L7481" rel="#L7481">7481</span>
<span id="L7482" rel="#L7482">7482</span>
<span id="L7483" rel="#L7483">7483</span>
<span id="L7484" rel="#L7484">7484</span>
<span id="L7485" rel="#L7485">7485</span>
<span id="L7486" rel="#L7486">7486</span>
<span id="L7487" rel="#L7487">7487</span>
<span id="L7488" rel="#L7488">7488</span>
<span id="L7489" rel="#L7489">7489</span>
<span id="L7490" rel="#L7490">7490</span>
<span id="L7491" rel="#L7491">7491</span>
<span id="L7492" rel="#L7492">7492</span>
<span id="L7493" rel="#L7493">7493</span>
<span id="L7494" rel="#L7494">7494</span>
<span id="L7495" rel="#L7495">7495</span>
<span id="L7496" rel="#L7496">7496</span>
<span id="L7497" rel="#L7497">7497</span>
<span id="L7498" rel="#L7498">7498</span>
<span id="L7499" rel="#L7499">7499</span>
<span id="L7500" rel="#L7500">7500</span>
<span id="L7501" rel="#L7501">7501</span>
<span id="L7502" rel="#L7502">7502</span>
<span id="L7503" rel="#L7503">7503</span>
<span id="L7504" rel="#L7504">7504</span>
<span id="L7505" rel="#L7505">7505</span>
<span id="L7506" rel="#L7506">7506</span>
<span id="L7507" rel="#L7507">7507</span>
<span id="L7508" rel="#L7508">7508</span>
<span id="L7509" rel="#L7509">7509</span>
<span id="L7510" rel="#L7510">7510</span>
<span id="L7511" rel="#L7511">7511</span>
<span id="L7512" rel="#L7512">7512</span>
<span id="L7513" rel="#L7513">7513</span>
<span id="L7514" rel="#L7514">7514</span>
<span id="L7515" rel="#L7515">7515</span>
<span id="L7516" rel="#L7516">7516</span>
<span id="L7517" rel="#L7517">7517</span>
<span id="L7518" rel="#L7518">7518</span>
<span id="L7519" rel="#L7519">7519</span>
<span id="L7520" rel="#L7520">7520</span>
<span id="L7521" rel="#L7521">7521</span>
<span id="L7522" rel="#L7522">7522</span>
<span id="L7523" rel="#L7523">7523</span>
<span id="L7524" rel="#L7524">7524</span>
<span id="L7525" rel="#L7525">7525</span>
<span id="L7526" rel="#L7526">7526</span>
<span id="L7527" rel="#L7527">7527</span>
<span id="L7528" rel="#L7528">7528</span>
<span id="L7529" rel="#L7529">7529</span>
<span id="L7530" rel="#L7530">7530</span>
</pre>
          </td>
          <td width="100%">
                <div class="highlight"><pre><div class='line' id='LC1'>##################################################################################</div><div class='line' id='LC2'># Document Properties Section</div><div class='line' id='LC3'><br/></div><div class='line' id='LC4'>SET DOCUMENT Name = &quot;BEL Framework Small Corpus Document&quot;</div><div class='line' id='LC5'>SET DOCUMENT Description = &quot;Approximately 2000 hand curated statements drawn from 57 PubMeds.&quot;</div><div class='line' id='LC6'>SET DOCUMENT Version = &quot;1.6&quot;</div><div class='line' id='LC7'>SET DOCUMENT Copyright = &quot;Copyright (c) 2011-2012, Selventa. All Rights Reserved.&quot;</div><div class='line' id='LC8'>SET DOCUMENT Authors = &quot;Selventa&quot;</div><div class='line' id='LC9'>SET DOCUMENT Licenses = &quot;Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License&quot;</div><div class='line' id='LC10'>SET DOCUMENT ContactInfo = &quot;support@belframework.org&quot;</div><div class='line' id='LC11'><br/></div><div class='line' id='LC12'>##################################################################################</div><div class='line' id='LC13'># Definitions Section</div><div class='line' id='LC14'><br/></div><div class='line' id='LC15'>DEFINE NAMESPACE SDIS AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-diseases.belns&quot;</div><div class='line' id='LC16'>DEFINE NAMESPACE PFR AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/selventa-named-rat-protein-families.belns&quot;</div><div class='line' id='LC17'>DEFINE NAMESPACE MGI AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/mgi-approved-symbols.belns&quot;</div><div class='line' id='LC18'>DEFINE NAMESPACE PFM AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/selventa-named-mouse-protein-families.belns&quot;</div><div class='line' id='LC19'>DEFINE NAMESPACE MESHPP AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/mesh-biological-processes.belns&quot;</div><div class='line' id='LC20'>DEFINE NAMESPACE MESHCL AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/mesh-cellular-locations.belns&quot;</div><div class='line' id='LC21'>DEFINE NAMESPACE NCH AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/selventa-named-human-complexes.belns&quot;</div><div class='line' id='LC22'>DEFINE NAMESPACE CHEBI AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/chebi-names.belns&quot;</div><div class='line' id='LC23'>DEFINE NAMESPACE NCR AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/selventa-named-rat-complexes.belns&quot;</div><div class='line' id='LC24'>DEFINE NAMESPACE HGNC AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/hgnc-approved-symbols.belns&quot;</div><div class='line' id='LC25'>DEFINE NAMESPACE SPAC AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/swissprot-accession-numbers.belns&quot;</div><div class='line' id='LC26'>DEFINE NAMESPACE PFH AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/selventa-named-human-protein-families.belns&quot;</div><div class='line' id='LC27'>DEFINE NAMESPACE NCM AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/selventa-named-mouse-complexes.belns&quot;</div><div class='line' id='LC28'>DEFINE NAMESPACE CHEBIID AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/chebi-ids.belns&quot;</div><div class='line' id='LC29'>DEFINE NAMESPACE RGD AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/rgd-approved-symbols.belns&quot;</div><div class='line' id='LC30'>DEFINE NAMESPACE MESHD AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/mesh-diseases.belns&quot;</div><div class='line' id='LC31'>DEFINE NAMESPACE GO AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/go-biological-processes-names.belns&quot;</div><div class='line' id='LC32'>DEFINE NAMESPACE SCHEM AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-chemical-names.belns&quot;</div><div class='line' id='LC33'>DEFINE NAMESPACE EGID AS URL &quot;http://resource.belframework.org/belframework/1.0/namespace/entrez-gene-ids-hmr.belns&quot;</div><div class='line' id='LC34'><br/></div><div class='line' id='LC35'>DEFINE ANNOTATION HemicAndImmuneSystem AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-hemic-and-immune-system.belanno&quot;</div><div class='line' id='LC36'>DEFINE ANNOTATION UrogenitalSystem AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-urogenital-system.belanno&quot;</div><div class='line' id='LC37'>DEFINE ANNOTATION FluidAndSecretion AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-fluid-and-secretion.belanno&quot;</div><div class='line' id='LC38'>DEFINE ANNOTATION CellStructure AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-cell-structure.belanno&quot;</div><div class='line' id='LC39'>DEFINE ANNOTATION CellLine AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/atcc-cell-line.belanno&quot;</div><div class='line' id='LC40'>DEFINE ANNOTATION TextLocation AS  LIST {&quot;Abstract&quot;,&quot;Results&quot;,&quot;Legend&quot;,&quot;Review&quot;}</div><div class='line' id='LC41'>DEFINE ANNOTATION IntegumentarySystem AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-integumentary-system.belanno&quot;</div><div class='line' id='LC42'>DEFINE ANNOTATION DigestiveSystem AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-digestive-system.belanno&quot;</div><div class='line' id='LC43'>DEFINE ANNOTATION MuskuloskeletalSystem AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-musculoskeletal-system.belanno&quot;</div><div class='line' id='LC44'>DEFINE ANNOTATION Tissue AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-tissue.belanno&quot;</div><div class='line' id='LC45'>DEFINE ANNOTATION BodyRegion AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-body-region.belanno&quot;</div><div class='line' id='LC46'>DEFINE ANNOTATION Cell AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-cell.belanno&quot;</div><div class='line' id='LC47'>DEFINE ANNOTATION NervousSystem AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-nervous-system.belanno&quot;</div><div class='line' id='LC48'>DEFINE ANNOTATION SenseOrgan AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-sense-organ.belanno&quot;</div><div class='line' id='LC49'>DEFINE ANNOTATION Disease AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-disease.belanno&quot;</div><div class='line' id='LC50'>DEFINE ANNOTATION RespiratorySystem AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-respiratory-system.belanno&quot;</div><div class='line' id='LC51'>DEFINE ANNOTATION Species AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/species-taxonomy-id.belanno&quot;</div><div class='line' id='LC52'>DEFINE ANNOTATION CardiovascularSystem AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-cardiovascular-system.belanno&quot;</div><div class='line' id='LC53'>DEFINE ANNOTATION EndocrineSystem AS  URL &quot;http://resource.belframework.org/belframework/1.0/annotation/mesh-endocrine-system.belanno&quot;</div><div class='line' id='LC54'><br/></div><div class='line' id='LC55'>##################################################################################</div><div class='line' id='LC56'># Statements Section</div><div class='line' id='LC57'><br/></div><div class='line' id='LC58'>SET STATEMENT_GROUP = &quot;Group 1&quot;</div><div class='line' id='LC59'><br/></div><div class='line' id='LC60'>SET Disease = &quot;Atherosclerosis&quot;</div><div class='line' id='LC61'>SET CardiovascularSystem = &quot;Arteries&quot;</div><div class='line' id='LC62'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC63'>SET Evidence = &quot;Oxidation and nitration of macromolecules, such as proteins, DNA and lipids, are prominent</div><div class='line' id='LC64'>in atherosclerotic arteries.&quot;</div><div class='line' id='LC65'>SET Citation = {&quot;PubMed&quot;,&quot;Trends in molecular medicine&quot;,&quot;12928037&quot;,&quot;&quot;,&quot;de Nigris F|Lerman A|Ignarro LJ|Williams-Ignarro S|Sica V|Baker AH|Lerman LO|Geng YJ|Napoli C&quot;,&quot;&quot;}</div><div class='line' id='LC66'><br/></div><div class='line' id='LC67'>pathology(MESHD:Atherosclerosis) positiveCorrelation biologicalProcess(GO:&quot;lipid oxidation&quot;)</div><div class='line' id='LC68'>pathology(MESHD:Atherosclerosis) positiveCorrelation biologicalProcess(GO:&quot;protein oxidation&quot;)</div><div class='line' id='LC69'><br/></div><div class='line' id='LC70'>SET Evidence = &quot;Arterial cells are highly susceptible to oxidative stress, which can induce both necrosis</div><div class='line' id='LC71'>and apoptosis (programmed cell death) [1,2]&quot;</div><div class='line' id='LC72'><br/></div><div class='line' id='LC73'>biologicalProcess(GO:&quot;response to oxidative stress&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC74'>biologicalProcess(GO:&quot;response to oxidative stress&quot;) increases biologicalProcess(GO:necrosis)</div><div class='line' id='LC75'><br/></div><div class='line' id='LC76'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC77'>SET Evidence = &quot;One such risk factor is oxLDL, which exert pro-apoptotic effects on a variety of cell</div><div class='line' id='LC78'>lineages, including endothelial cells and VSMCs, both in cultured cells and</div><div class='line' id='LC79'>in arteries [19–26]. Increased formation of oxygen radicals (and other radical</div><div class='line' id='LC80'>species) facilitates LDL oxidation and influences oxidation-sensitive mechanisms</div><div class='line' id='LC81'>[15].&quot;</div><div class='line' id='LC82'><br/></div><div class='line' id='LC83'>abundance(SCHEM:&quot;Oxidized Low Density Lipoprotein&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC84'><br/></div><div class='line' id='LC85'>SET MuskuloskeletalSystem = &quot;Muscle, Smooth, Vascular&quot;</div><div class='line' id='LC86'><br/></div><div class='line' id='LC87'>abundance(SCHEM:&quot;Oxidized Low Density Lipoprotein&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC88'>abundance(CHEBI:&quot;oxygen radical&quot;) increases abundance(SCHEM:&quot;Oxidized Low Density Lipoprotein&quot;)</div><div class='line' id='LC89'><br/></div><div class='line' id='LC90'>SET Evidence = &quot;Not surprisingly, high concentrations of exogenous reactive oxygen species (ROS),</div><div class='line' id='LC91'>generated by enzymatic reactions or by radiation, also stimulate the apoptosis</div><div class='line' id='LC92'>of endothelial cells in vitro [29–31].&quot;</div><div class='line' id='LC93'><br/></div><div class='line' id='LC94'>abundance(CHEBI:&quot;reactive oxygen species&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC95'><br/></div><div class='line' id='LC96'>SET Evidence = &quot;The peptide hormone angiotensin II and pro-inflammatory cytokines also trigger the</div><div class='line' id='LC97'>apoptotic program in endothelial cells [33,34].&quot;</div><div class='line' id='LC98'><br/></div><div class='line' id='LC99'>abundance(CHEBI:&quot;angiotensin II&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC100'><br/></div><div class='line' id='LC101'>SET Evidence = &quot;Aging, one of the major predictors for atherosclerotic lesion formation, increases</div><div class='line' id='LC102'>the sensitivity of endothelial cells to apoptosis induced by in vitro and in vivo</div><div class='line' id='LC103'>stimuli [35–37].&quot;</div><div class='line' id='LC104'><br/></div><div class='line' id='LC105'>biologicalProcess(GO:aging) positiveCorrelation pathology(MESHD:&quot;Plaque, Atherosclerotic&quot;)</div><div class='line' id='LC106'>biologicalProcess(GO:aging) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC107'><br/></div><div class='line' id='LC108'>SET Evidence = &quot;Shear stress enhances expression of the gene encoding the endothelial nitric oxide</div><div class='line' id='LC109'>synthase (eNOS) and further stimulates its enzymatic activity, leading to physiologic</div><div class='line' id='LC110'>low concentrations of nitric oxide (NO) within endothelial cells [44–46].</div><div class='line' id='LC111'>This continuous generation of NO prevents the apoptosis of endothelial cells,</div><div class='line' id='LC112'>thereby protecting the endothelial monolayer from injury [47,48].&quot;</div><div class='line' id='LC113'><br/></div><div class='line' id='LC114'>biologicalProcess(GO:&quot;response to fluid shear stress&quot;) increases rnaAbundance(HGNC:NOS3)</div><div class='line' id='LC115'>biologicalProcess(GO:&quot;response to fluid shear stress&quot;) increases catalyticActivity(proteinAbundance(HGNC:NOS3))</div><div class='line' id='LC116'>catalyticActivity(proteinAbundance(HGNC:NOS3)) directlyIncreases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC117'>abundance(CHEBI:&quot;nitric oxide&quot;) decreases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC118'><br/></div><div class='line' id='LC119'>SET Evidence = &quot;More importantly, intervention with L-arginine has induced beneficial effects on atherosclerosis</div><div class='line' id='LC120'>in experimental and human studies [46,49].&quot;</div><div class='line' id='LC121'><br/></div><div class='line' id='LC122'>abundance(CHEBI:&quot;L-arginine&quot;) decreases pathology(MESHD:Atherosclerosis)</div><div class='line' id='LC123'><br/></div><div class='line' id='LC124'>SET Tissue = &quot;Endothelium, Vascular&quot;</div><div class='line' id='LC125'>SET Evidence = &quot;OxLDL induces the generation of ROS in different vascular cell types [15,58], and</div><div class='line' id='LC126'>might also promote a rise in ROS levels through a decrease in ROS degradation,</div><div class='line' id='LC127'>because oxLDL induces a reduction in the antioxidant enzymes Cu/Zn superoxide dismutase</div><div class='line' id='LC128'>[59] and glutathione peroxidase [60].&quot;</div><div class='line' id='LC129'><br/></div><div class='line' id='LC130'>abundance(SCHEM:&quot;Oxidized Low Density Lipoprotein&quot;) increases abundance(CHEBI:&quot;reactive oxygen species&quot;)</div><div class='line' id='LC131'>abundance(SCHEM:&quot;Oxidized Low Density Lipoprotein&quot;) decreases proteinAbundance(HGNC:SOD1)</div><div class='line' id='LC132'>abundance(SCHEM:&quot;Oxidized Low Density Lipoprotein&quot;) decreases proteinAbundance(PFH:&quot;GPX Family&quot;)</div><div class='line' id='LC133'><br/></div><div class='line' id='LC134'>SET CellLine = &quot;U-937&quot;</div><div class='line' id='LC135'>SET Evidence = &quot;For instance, during 7-ketocholesterol-induced apoptosis of U937 cells, the cellular</div><div class='line' id='LC136'>antioxidant content falls rapidly [64], but administration of two potent antioxidants,</div><div class='line' id='LC137'>the aminothiols glutathione and N-acetylcysteine, can protect themonocytic</div><div class='line' id='LC138'>cells from 7-ketocholesterol-induced apoptotic cell death [64].&quot;</div><div class='line' id='LC139'><br/></div><div class='line' id='LC140'>abundance(SCHEM:&quot;7-Ketocholesterol&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC141'>abundance(SCHEM:&quot;7-Ketocholesterol&quot;) negativeCorrelation abundance(CHEBI:antioxidant)</div><div class='line' id='LC142'>abundance(CHEBI:antioxidant) decreases (abundance(SCHEM:&quot;7-Ketocholesterol&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;))</div><div class='line' id='LC143'><br/></div><div class='line' id='LC144'>SET Tissue = &quot;Muscle, Smooth, Vascular&quot;</div><div class='line' id='LC145'>SET Evidence = &quot;In addition, another oxygen-radical scavenger enzyme, catalase, can prevent VSMC apoptosis</div><div class='line' id='LC146'>triggered by hydrogen peroxide [27,65].&quot;</div><div class='line' id='LC147'><br/></div><div class='line' id='LC148'>abundance(CHEBI:&quot;hydrogen peroxide&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC149'>proteinAbundance(HGNC:CAT) decreases (abundance(CHEBI:&quot;hydrogen peroxide&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;))</div><div class='line' id='LC150'><br/></div><div class='line' id='LC151'>SET Evidence = &quot;The proto-oncogene c-myc can promote cell death (probably mediated through p53) or</div><div class='line' id='LC152'>cell proliferation, depending on its expression level. It functions as a nuclear</div><div class='line' id='LC153'>phosphoprotein with particular properties of a transcription factor [68,69].</div><div class='line' id='LC154'>In serum deprived cultures, cells overexpressing c-myc readily undergo apoptosis.</div><div class='line' id='LC155'>In addition, deregulation of c-myc causes apoptosis of VSMCs deprived of growth</div><div class='line' id='LC156'>factors or treated with cytokines such as interferon-g [70].&quot;</div><div class='line' id='LC157'><br/></div><div class='line' id='LC158'>proteinAbundance(HGNC:MYC) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC159'>proteinAbundance(HGNC:MYC) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC160'><br/></div><div class='line' id='LC161'>SET Evidence = &quot;Tissue factor (TF) is a 47 kDa transmembrane glycoprotein that initiates blood coagulation</div><div class='line' id='LC162'>by binding coagulation factor VII and its activated form (factor VIIa),</div><div class='line' id='LC163'>to produce a high-affinity complex [72] that proteolytically activates factors</div><div class='line' id='LC164'>IX and X, leading to thrombin generation.&quot;</div><div class='line' id='LC165'><br/></div><div class='line' id='LC166'>peptidaseActivity(complexAbundance(proteinAbundance(HGNC:F3),proteinAbundance(HGNC:F7))) directlyIncreases peptidaseActivity(proteinAbundance(HGNC:F9))</div><div class='line' id='LC167'>peptidaseActivity(complexAbundance(proteinAbundance(HGNC:F3),proteinAbundance(HGNC:F7))) directlyIncreases peptidaseActivity(proteinAbundance(HGNC:F10))</div><div class='line' id='LC168'>peptidaseActivity(proteinAbundance(HGNC:F9)) increases peptidaseActivity(proteinAbundance(HGNC:F2))</div><div class='line' id='LC169'>peptidaseActivity(proteinAbundance(HGNC:F10)) increases peptidaseActivity(proteinAbundance(HGNC:F2))</div><div class='line' id='LC170'><br/></div><div class='line' id='LC171'>SET CellStructure = &quot;Cell Membrane&quot;</div><div class='line' id='LC172'>SET Evidence = &quot;TF works at the surface of cell membranes, and its activity is highly dependent on</div><div class='line' id='LC173'>the presence of phosphatidylserine (PS), an anionic phospholipid that is redistributed</div><div class='line' id='LC174'>on the cell surface during apoptotic death and confers a potent pro-coagulant</div><div class='line' id='LC175'>activity to the apoptotic cell [74].&quot;</div><div class='line' id='LC176'><br/></div><div class='line' id='LC177'>abundance(CHEBI:&quot;phosphatidyl-L-serine&quot;) increases peptidaseActivity(proteinAbundance(HGNC:F3))</div><div class='line' id='LC178'>biologicalProcess(GO:&quot;apoptotic process&quot;) increases abundance(CHEBI:&quot;phosphatidyl-L-serine&quot;)</div><div class='line' id='LC179'>abundance(CHEBI:&quot;phosphatidyl-L-serine&quot;) increases biologicalProcess(GO:coagulation)</div><div class='line' id='LC180'><br/></div><div class='line' id='LC181'>SET Evidence = &quot;TIMP-3 can be anti-angiogenic by direct binding to vascular endothelial growth factor</div><div class='line' id='LC182'>(VEGF) receptor 2 in a matrix-metalloproteinase- independent manner [94].&quot;</div><div class='line' id='LC183'><br/></div><div class='line' id='LC184'>proteinAbundance(HGNC:TIMP3) decreases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC185'>complexAbundance(proteinAbundance(HGNC:TIMP3),proteinAbundance(HGNC:KDR)) decreases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC186'><br/></div><div class='line' id='LC187'>UNSET STATEMENT_GROUP</div><div class='line' id='LC188'><br/></div><div class='line' id='LC189'>SET STATEMENT_GROUP = &quot;Group 2&quot;</div><div class='line' id='LC190'><br/></div><div class='line' id='LC191'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC192'>SET Evidence = &quot;Phosphorylation at Ser473, along with Thr308 of its activation loop, is deemed necessary</div><div class='line' id='LC193'>for Akt function, although the regulatory mechanisms and physiological importance</div><div class='line' id='LC194'>of each phosphorylation site remain to be fully understood.&quot;</div><div class='line' id='LC195'>SET Citation = {&quot;PubMed&quot;,&quot;Cell&quot;,&quot;16962653&quot;,&quot;2006-10-07&quot;,&quot;Jacinto E|Facchinetti V|Liu D|Soto N|Wei S|Jung SY|Huang Q|Qin J|Su B&quot;,&quot;&quot;}</div><div class='line' id='LC196'>SET Species = &quot;9606&quot;</div><div class='line' id='LC197'><br/></div><div class='line' id='LC198'>proteinAbundance(HGNC:AKT1,proteinModification(P,T,308)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:AKT1))</div><div class='line' id='LC199'>proteinAbundance(HGNC:AKT1,proteinModification(P,S,473)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:AKT1))</div><div class='line' id='LC200'><br/></div><div class='line' id='LC201'>SET Evidence = &quot;Genetic ablation of sin1 abolished Akt-Ser473 phosphorylation and disrupted rictor-mTOR</div><div class='line' id='LC202'>interaction but maintained Thr308 phosphorylation.&quot;</div><div class='line' id='LC203'><br/></div><div class='line' id='LC204'>proteinAbundance(HGNC:MAPKAP1) increases proteinAbundance(HGNC:AKT1,proteinModification(P,S,473)) //sin1 = MAPKAP1</div><div class='line' id='LC205'><br/></div><div class='line' id='LC206'>SET Cell = &quot;Fibroblasts&quot;</div><div class='line' id='LC207'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC208'>SET Evidence = &quot;We next examined the Akt T-loop Thr308 phosphorylation in wild-type and SIN1−/− cells.</div><div class='line' id='LC209'>We found that although Ser473 phosphorylation was completely abolished in</div><div class='line' id='LC210'>the SIN1−/− cells, Thr308 phosphorylation of Akt was not blocked (Figure 3A).&quot;</div><div class='line' id='LC211'>SET Species = &quot;10090&quot;</div><div class='line' id='LC212'><br/></div><div class='line' id='LC213'>proteinAbundance(MGI:Mapkap1) increases proteinAbundance(MGI:Akt1,proteinModification(P,S,473))</div><div class='line' id='LC214'>proteinAbundance(MGI:Mapkap1) causesNoChange proteinAbundance(MGI:Akt1,proteinModification(P,S,308))</div><div class='line' id='LC215'><br/></div><div class='line' id='LC216'>SET Evidence = &quot;We also examined phosphorylation of TSC2, another Akt target (Manning et al., 2002),</div><div class='line' id='LC217'>at the Akt target sites Ser939 and Thr1462 and found no significant difference</div><div class='line' id='LC218'>between wild-type and SIN1−/− cells upon serum and insulin stimulation (Figure</div><div class='line' id='LC219'>3C).&quot;</div><div class='line' id='LC220'><br/></div><div class='line' id='LC221'>kinaseActivity(proteinAbundance(MGI:Akt1)) directlyIncreases proteinAbundance(MGI:Tsc2,proteinModification(P,S,939))</div><div class='line' id='LC222'>kinaseActivity(proteinAbundance(MGI:Akt1)) directlyIncreases proteinAbundance(MGI:Tsc2,proteinModification(P,T,1462)) //Human T1462 = Mouse T1465</div><div class='line' id='LC223'><br/></div><div class='line' id='LC224'>SET Evidence = &quot;To identify a function that could be linked specifically to Akt-Ser473 phosphorylation,</div><div class='line' id='LC225'>we further examined known Akt substrates that may have defective phosphorylation</div><div class='line' id='LC226'>in SIN1−/− cells. We found that phosphorylation of FoxO1/3a (also called</div><div class='line' id='LC227'>FKHR/FKHRL1) (Greer and Brunet, 2005), was affected in SIN1−/− cells. In particular,</div><div class='line' id='LC228'>phosphorylation of FoxO1/3a at Thr24/Thr32 was significantly decreased in</div><div class='line' id='LC229'>the absence of SIN1 under normal growing and restimulated conditions (Figure 4A).&quot;</div><div class='line' id='LC230'><br/></div><div class='line' id='LC231'>proteinAbundance(MGI:Mapkap1) increases proteinAbundance(MGI:Foxo1,proteinModification(P,T,24))</div><div class='line' id='LC232'>proteinAbundance(MGI:Mapkap1) increases proteinAbundance(MGI:Foxo3,proteinModification(P,T,32))</div><div class='line' id='LC233'>kinaseActivity(proteinAbundance(MGI:Akt1)) directlyIncreases proteinAbundance(MGI:Foxo1,proteinModification(P,T,24))</div><div class='line' id='LC234'>kinaseActivity(proteinAbundance(MGI:Akt1)) directlyIncreases proteinAbundance(MGI:Foxo3,proteinModification(P,T,32))</div><div class='line' id='LC235'><br/></div><div class='line' id='LC236'>SET Evidence = &quot;We also found that the recombinant FoxO1 could not be phosphorylated at Thr24/32 in</div><div class='line' id='LC237'>vitro by an Akt mutant harboring an alanine mutation in either Thr308 or Ser473,</div><div class='line' id='LC238'>whereas a Ser473 to Ala mutated Akt could still phosphorylate recombinant GSK3</div><div class='line' id='LC239'>(Figure S2). These results indicate that Akt-Ser473 phosphorylation is required</div><div class='line' id='LC240'>for FoxO1/3a phosphorylation at Thr24/32.&quot;</div><div class='line' id='LC241'><br/></div><div class='line' id='LC242'>proteinAbundance(MGI:Akt1,proteinModification(P,S,473)) directlyIncreases proteinAbundance(MGI:Foxo1,proteinModification(P,T,24))</div><div class='line' id='LC243'>proteinAbundance(MGI:Akt1,proteinModification(P,S,473)) directlyIncreases proteinAbundance(MGI:Foxo3,proteinModification(P,T,32))</div><div class='line' id='LC244'>kinaseActivity(proteinAbundance(MGI:Akt1)) directlyIncreases proteinAbundance(MGI:Foxo1,proteinModification(P,T,24))</div><div class='line' id='LC245'>kinaseActivity(proteinAbundance(MGI:Akt1)) directlyIncreases proteinAbundance(MGI:Foxo3,proteinModification(P,T,32))</div><div class='line' id='LC246'>proteinAbundance(MGI:Akt1,proteinModification(P,S,473)) directlyIncreases kinaseActivity(proteinAbundance(MGI:Akt1))</div><div class='line' id='LC247'><br/></div><div class='line' id='LC248'>SET Evidence = &quot;In etoposide-treated cells, there was a 2-fold increase in the number of cells that</div><div class='line' id='LC249'>underwent apoptosis after 48 hr in SIN1 knockouts (Figure 4D). Thus, we find</div><div class='line' id='LC250'>that the SIN1−/− cells were more sensitive to stress-induced apoptosis, suggesting</div><div class='line' id='LC251'>that Akt-Ser473 phosphorylation plays an important role in cell survival (Figures</div><div class='line' id='LC252'>4C and 4D).&quot;</div><div class='line' id='LC253'><br/></div><div class='line' id='LC254'>proteinAbundance(MGI:Mapkap1) decreases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC255'><br/></div><div class='line' id='LC256'>SET Evidence = &quot;The phosphorylation of S6K at Thr389, which is the TORC1-mediated site, was not inhibited</div><div class='line' id='LC257'>in the SIN1-/- cells (Figure 5A).&quot;</div><div class='line' id='LC258'><br/></div><div class='line' id='LC259'>kinaseActivity(complexAbundance(NCM:&quot;TORC1 Complex&quot;)) directlyIncreases proteinAbundance(MGI:Rps6kb1,proteinModification(P,T,412))</div><div class='line' id='LC260'><br/></div><div class='line' id='LC261'>SET Evidence = &quot;Likewise, phosphorylation of another translational regulator, 4E-BP1, at the mTOR</div><div class='line' id='LC262'>target site Thr37/46 (Gingras et al., 1999), was also not impaired in SIN1−/− cells</div><div class='line' id='LC263'>(Figure 5A).&quot;</div><div class='line' id='LC264'><br/></div><div class='line' id='LC265'>kinaseActivity(complexAbundance(NCM:&quot;TORC2 Complex&quot;)) directlyIncreases proteinAbundance(MGI:Eif4ebp1,proteinModification(P,T,36))</div><div class='line' id='LC266'>kinaseActivity(complexAbundance(NCM:&quot;TORC2 Complex&quot;)) directlyIncreases proteinAbundance(MGI:Eif4ebp1,proteinModification(P,T,45))</div><div class='line' id='LC267'>kinaseActivity(proteinAbundance(MGI:Mtor)) directlyIncreases proteinAbundance(MGI:Eif4ebp1,proteinModification(P,T,36))</div><div class='line' id='LC268'>kinaseActivity(proteinAbundance(MGI:Mtor)) directlyIncreases proteinAbundance(MGI:Eif4ebp1,proteinModification(P,T,45))</div><div class='line' id='LC269'><br/></div><div class='line' id='LC270'>SET Evidence = &quot;Akt Ser473 was strongly induced in wild-type cells by different growth factors such</div><div class='line' id='LC271'>as the platelet-derived growth factor, epidermal growth factor, and insulin,</div><div class='line' id='LC272'>even in the absence of amino acids and glucose (Figure 5B). In SIN1−/− cells, Akt-Ser473</div><div class='line' id='LC273'>phosphorylation was not induced by any type of stimulus.&quot;</div><div class='line' id='LC274'><br/></div><div class='line' id='LC275'>proteinAbundance(MGI:Mapkap1) increases proteinAbundance(MGI:Akt1,proteinModification(P,S,473))</div><div class='line' id='LC276'>proteinAbundance(PFM:&quot;Pdgf Family&quot;) increases proteinAbundance(MGI:Akt1,proteinModification(P,S,473))</div><div class='line' id='LC277'>proteinAbundance(MGI:Egf) increases proteinAbundance(MGI:Akt1,proteinModification(P,S,473))</div><div class='line' id='LC278'>proteinAbundance(PFM:&quot;Ins Family&quot;) increases proteinAbundance(MGI:Akt1,proteinModification(P,S,473))</div><div class='line' id='LC279'><br/></div><div class='line' id='LC280'>SET Evidence = &quot;As shown in Figures 5E and 5F, SIN1 was able to associate with Akt under normal growth,</div><div class='line' id='LC281'>starvation, or restimulated conditions. Although SIN1 and Akt interacted</div><div class='line' id='LC282'>under starved condition, the SIN1 bound Akt was not phosphorylated on Ser473 (Figure</div><div class='line' id='LC283'>5E).&quot;</div><div class='line' id='LC284'><br/></div><div class='line' id='LC285'>complexAbundance(proteinAbundance(MGI:Akt1),proteinAbundance(MGI:Mapkap1))</div><div class='line' id='LC286'><br/></div><div class='line' id='LC287'>SET Evidence = &quot;Akt has been well characterized as a prosurvival molecule, and part of this function</div><div class='line' id='LC288'>is mediated through its suppression of the activity of the FoxO proteins (Greer</div><div class='line' id='LC289'>and Brunet, 2005).&quot;</div><div class='line' id='LC290'><br/></div><div class='line' id='LC291'>kinaseActivity(proteinAbundance(MGI:Akt1)) directlyDecreases transcriptionalActivity(proteinAbundance(PFM:&quot;Foxo Family&quot;))</div><div class='line' id='LC292'><br/></div><div class='line' id='LC293'>UNSET STATEMENT_GROUP</div><div class='line' id='LC294'><br/></div><div class='line' id='LC295'>SET STATEMENT_GROUP = &quot;Group 3&quot;</div><div class='line' id='LC296'><br/></div><div class='line' id='LC297'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC298'>SET Evidence = &quot;For example, the inactivation of VHL has been demonstrated in 70–80% of all sporadic</div><div class='line' id='LC299'>clear cell RCC, the major form of RCC, which accounts for ~2% of all cancer</div><div class='line' id='LC300'>deaths worldwide [8].&quot;</div><div class='line' id='LC301'>SET Citation = {&quot;PubMed&quot;,&quot;Trends in molecular medicine&quot;,&quot;15350900&quot;,&quot;&quot;,&quot;Barry RE|Krek W&quot;,&quot;&quot;}</div><div class='line' id='LC302'>SET Species = &quot;9606&quot;</div><div class='line' id='LC303'><br/></div><div class='line' id='LC304'>proteinAbundance(HGNC:VHL) negativeCorrelation pathology(MESHD:&quot;Carcinoma, Renal Cell&quot;) //curating to protein, since inactivation of gene may be via mutation, deletion, or hypermethylation and will affect protein levels</div><div class='line' id='LC305'><br/></div><div class='line' id='LC306'>SET Evidence = &quot;The best-established function of pVHL to date has been as a substrate recognition</div><div class='line' id='LC307'>component of an E3 ubiquitinprotein ligase complex, comprising pVHL, Elongin C,</div><div class='line' id='LC308'>Elongin B, Cullin 2 and the RING finger protein, Rbx1, and this is referred to</div><div class='line' id='LC309'>as the VCB–Cul2 complex [17].&quot;</div><div class='line' id='LC310'><br/></div><div class='line' id='LC311'>complexAbundance(proteinAbundance(HGNC:VHL),proteinAbundance(HGNC:TCEB1),proteinAbundance(HGNC:TCEB2),proteinAbundance(HGNC:CUL2),proteinAbundance(HGNC:RBX1))</div><div class='line' id='LC312'><br/></div><div class='line' id='LC313'>SET Evidence = &quot;In this setting, pVHL targets the α-subunits of hypoxiainducible factor (HIF) for</div><div class='line' id='LC314'>ubiquitin-mediated proteolysis under normal oxygen conditions [18].&quot;</div><div class='line' id='LC315'><br/></div><div class='line' id='LC316'>molecularActivity(proteinAbundance(HGNC:VHL)) directlyIncreases degradation(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC317'>molecularActivity(proteinAbundance(HGNC:VHL)) directlyIncreases degradation(proteinAbundance(HGNC:EPAS1))</div><div class='line' id='LC318'>molecularActivity(proteinAbundance(HGNC:VHL)) directlyIncreases degradation(proteinAbundance(HGNC:HIF3A))</div><div class='line' id='LC319'><br/></div><div class='line' id='LC320'>SET Evidence = &quot;The stabilization of HIF in response to hypoxia involves the inactivation of prolylhydroxylases</div><div class='line' id='LC321'>that modify HIF at specific proline residues in an oxygendependent</div><div class='line' id='LC322'>manner. Proline hydroxylation marks HIF for degradation by the VCB–Cul2 E3 ligase</div><div class='line' id='LC323'>complex (Figure 3 and Box 1).&quot;</div><div class='line' id='LC324'><br/></div><div class='line' id='LC325'>abundance(CHEBI:dioxygen) increases proteinAbundance(HGNC:HIF1A,proteinModification(H,P))</div><div class='line' id='LC326'>proteinAbundance(HGNC:HIF1A,proteinModification(H,P)) directlyIncreases degradation(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC327'>proteinAbundance(HGNC:HIF1A,proteinModification(P,H)) directlyIncreases (catalyticActivity(complexAbundance(proteinAbundance(HGNC:VHL),proteinAbundance(HGNC:TCEB1),proteinAbundance(HGNC:TCEB2),proteinAbundance(HGNC:RBX1),proteinAbundance(HGNC:CUL2))) directlyIncreases degradation(proteinAbundance(HGNC:HIF1A)))</div><div class='line' id='LC328'><br/></div><div class='line' id='LC329'>SET Evidence = &quot;The VHL-mediated proteolytic degradation of HIF suppresses a transcription programme</div><div class='line' id='LC330'>that is normally engaged by HIF as part of the adaptive response of the cell</div><div class='line' id='LC331'>to hypoxia, such as the activation of vascular endothelial growth factor (VEGF),</div><div class='line' id='LC332'>which is a potent angiogenic factor that is involved in the formation and differentiation</div><div class='line' id='LC333'>of blood vessels.&quot;</div><div class='line' id='LC334'><br/></div><div class='line' id='LC335'>transcriptionalActivity(proteinAbundance(HGNC:HIF1A)) increases rnaAbundance(HGNC:VEGFA)</div><div class='line' id='LC336'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases rnaAbundance(HGNC:VEGFA)</div><div class='line' id='LC337'>proteinAbundance(HGNC:VEGFA) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC338'><br/></div><div class='line' id='LC339'>SET TextLocation = &quot;Legend&quot;</div><div class='line' id='LC340'>SET Evidence = &quot;Transcriptional control is also maintained by a specific acetylation (Ac) event at</div><div class='line' id='LC341'>lysine 532 and an additional asparagine hydroxylation (OH) event at position 863,</div><div class='line' id='LC342'>both of which act as negative regulators of the transcriptional activity of</div><div class='line' id='LC343'>HIF.&quot;</div><div class='line' id='LC344'><br/></div><div class='line' id='LC345'>proteinAbundance(HGNC:HIF1A,proteinModification(A,K,532)) directlyDecreases transcriptionalActivity(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC346'>proteinAbundance(HGNC:HIF1A,proteinModification(H,N,863)) directlyDecreases transcriptionalActivity(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC347'><br/></div><div class='line' id='LC348'>SET Disease = &quot;Neoplasms&quot;</div><div class='line' id='LC349'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC350'>SET Evidence = &quot;highly vascular phenotype of VHL-null tumours.&quot;</div><div class='line' id='LC351'><br/></div><div class='line' id='LC352'>proteinAbundance(HGNC:VHL) negativeCorrelation biologicalProcess(GO:vasculogenesis)</div><div class='line' id='LC353'><br/></div><div class='line' id='LC354'>SET Disease = &quot;Carcinoma, Renal Cell&quot;</div><div class='line' id='LC355'>SET Evidence = &quot;The inhibition of HIF-2α expression by siRNA inhibits the growth of VHL-negative tumours</div><div class='line' id='LC356'>[20]. Furthermore, the re-introduction of a degradation-resistant mutant</div><div class='line' id='LC357'>of HIF-2α into RCC cells ectopically expressing pVHL abolishes the ability of VHL</div><div class='line' id='LC358'>to suppress the growth of these cell lines [21].&quot;</div><div class='line' id='LC359'><br/></div><div class='line' id='LC360'>proteinAbundance(HGNC:EPAS1) increases biologicalProcess(GO:&quot;cell growth&quot;) //HIF2-alpha = EPAS1</div><div class='line' id='LC361'><br/></div><div class='line' id='LC362'>SET TextLocation = &quot;Legend&quot;</div><div class='line' id='LC363'>SET Evidence = &quot;Hydroxylation at two proline residues on the HIF polypeptide mediates interactions</div><div class='line' id='LC364'>between the b-domain of the von Hippel–Lindau protein (pVHL) and HIF [60]. Each</div><div class='line' id='LC365'>site can interact independently with pVHL, potentially contributing to the extremely</div><div class='line' id='LC366'>rapid proteolysis of HIF-a that is observed under normoxic conditions. These</div><div class='line' id='LC367'>sites contain a conserved LxxLAP motif and are targeted by proline hydroxylases</div><div class='line' id='LC368'>(PHD) that, in mammalian cells, are provided by three isoforms termed PHD 1–3</div><div class='line' id='LC369'>[61].&quot;</div><div class='line' id='LC370'><br/></div><div class='line' id='LC371'>proteinAbundance(HGNC:HIF1A,proteinModification(H,P)) directlyIncreases complexAbundance(proteinAbundance(HGNC:VHL),proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC372'>catalyticActivity(proteinAbundance(HGNC:EGLN1)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,P)) //PHD1-3 = EGLN1 -3</div><div class='line' id='LC373'>catalyticActivity(proteinAbundance(HGNC:EGLN2)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,P))</div><div class='line' id='LC374'>catalyticActivity(proteinAbundance(HGNC:EGLN3)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,P))</div><div class='line' id='LC375'>abundance(CHEBI:dioxygen) increases degradation(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC376'><br/></div><div class='line' id='LC377'>SET Evidence = &quot;In a second hydroxylation-dependent control, b-hydroxylation of an asparaginyl residue</div><div class='line' id='LC378'>in the C-terminal activation domain of HIF-a (N803 in human HIF-1a) is regulated</div><div class='line' id='LC379'>by a HIF asparaginyl hydroxylase called FIH (factor inhibiting HIF) [62,63].</div><div class='line' id='LC380'>Hydroxylation at this site prevents the binding of the transcriptional co-activators</div><div class='line' id='LC381'>p300/CBP (CREB binding protein). Under normoxic conditions, these hydroxylation</div><div class='line' id='LC382'>reactions provide a dual mechanism for HIF inactivation that involves proteolytic</div><div class='line' id='LC383'>destruction and the inhibition of transcriptional activity [64].&quot;</div><div class='line' id='LC384'><br/></div><div class='line' id='LC385'>proteinAbundance(HGNC:HIF1A,proteinModification(H,N,803)) directlyDecreases complexAbundance(proteinAbundance(HGNC:HIF1A),proteinAbundance(HGNC:CREBBP))</div><div class='line' id='LC386'>proteinAbundance(HGNC:HIF1A,proteinModification(H,N,803)) directlyDecreases complexAbundance(proteinAbundance(HGNC:HIF1A),proteinAbundance(HGNC:EP300))</div><div class='line' id='LC387'>catalyticActivity(proteinAbundance(HGNC:HIF1AN)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,N,803)) //FIH = HIF1AN</div><div class='line' id='LC388'>complexAbundance(proteinAbundance(HGNC:HIF1A),proteinAbundance(HGNC:CREBBP)) directlyIncreases transcriptionalActivity(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC389'>complexAbundance(proteinAbundance(HGNC:HIF1A),proteinAbundance(HGNC:EP300)) directlyIncreases transcriptionalActivity(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC390'><br/></div><div class='line' id='LC391'>SET Evidence = &quot;These hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that</div><div class='line' id='LC392'>require molecular oxygen. Therefore, HIFa becomes stabilized under hypoxic conditions</div><div class='line' id='LC393'>in which oxygen availability is low.&quot;</div><div class='line' id='LC394'><br/></div><div class='line' id='LC395'>abundance(CHEBI:dioxygen) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN1))</div><div class='line' id='LC396'>abundance(CHEBI:dioxygen) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN2))</div><div class='line' id='LC397'>abundance(CHEBI:dioxygen) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN3))</div><div class='line' id='LC398'>abundance(CHEBI:dioxygen) directlyIncreases catalyticActivity(proteinAbundance(HGNC:HIF1AN)) //FIH = HIF1AN</div><div class='line' id='LC399'>abundance(CHEBI:&quot;iron(2+)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN1))</div><div class='line' id='LC400'>abundance(CHEBI:&quot;iron(2+)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN2))</div><div class='line' id='LC401'>abundance(CHEBI:&quot;iron(2+)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN3))</div><div class='line' id='LC402'>abundance(CHEBI:&quot;iron(2+)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:HIF1AN))</div><div class='line' id='LC403'>abundance(CHEBIID:16810) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN1))</div><div class='line' id='LC404'>abundance(CHEBIID:16810) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN2))</div><div class='line' id='LC405'>abundance(CHEBIID:16810) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN3))</div><div class='line' id='LC406'>abundance(CHEBIID:16810) directlyIncreases catalyticActivity(proteinAbundance(HGNC:HIF1AN)) //FIH = HIF1AN</div><div class='line' id='LC407'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases proteinAbundance(HGNC:HIF1A)</div><div class='line' id='LC408'><br/></div><div class='line' id='LC409'>SET Evidence = &quot;Furthermore, an acetyltransferase, ARD1, acetylates K532, a residue previously shown</div><div class='line' id='LC410'>to result in HIFa stability, thereby negatively regulating it [65]. Jab1, a</div><div class='line' id='LC411'>transcriptional co-activator, has been shown to positively regulate HIFa [66].&quot;</div><div class='line' id='LC412'><br/></div><div class='line' id='LC413'>catalyticActivity(proteinAbundance(HGNC:NAA10)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(A,K,532)) //AARD1 = NAA10</div><div class='line' id='LC414'>catalyticActivity(proteinAbundance(HGNC:NAA10)) directlyIncreases degradation(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC415'>proteinAbundance(HGNC:HIF1A,proteinModification(A,K,532)) directlyIncreases degradation(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC416'>transcriptionalActivity(proteinAbundance(HGNC:COPS5)) increases proteinAbundance(HGNC:HIF1A)</div><div class='line' id='LC417'><br/></div><div class='line' id='LC418'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC419'>SET Evidence = &quot;RCC cells lacking functional pVHL overexpress various growth factors, including platelet-derived</div><div class='line' id='LC420'>growth factor b (PDGFb), VEGF and transforming growth factor (TGF)-a</div><div class='line' id='LC421'>[25]. The latter is a bona fide renal-cell mitogen that activates the Ras–Raf–MAP</div><div class='line' id='LC422'>kinase signalling cascade through its cognate epidermal growth factor (EGF)</div><div class='line' id='LC423'>cell-surface receptor [26].&quot;</div><div class='line' id='LC424'><br/></div><div class='line' id='LC425'>proteinAbundance(HGNC:VHL) negativeCorrelation proteinAbundance(HGNC:PDGFB)</div><div class='line' id='LC426'>proteinAbundance(HGNC:VHL) negativeCorrelation proteinAbundance(HGNC:VEGFA)</div><div class='line' id='LC427'>proteinAbundance(HGNC:VHL) negativeCorrelation proteinAbundance(HGNC:TGFA)</div><div class='line' id='LC428'>proteinAbundance(HGNC:TGFA) directlyIncreases kinaseActivity(proteinAbundance(HGNC:EGFR))</div><div class='line' id='LC429'>proteinAbundance(HGNC:TGFA) increases gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;))</div><div class='line' id='LC430'>kinaseActivity(proteinAbundance(HGNC:EGFR)) increases gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;))</div><div class='line' id='LC431'><br/></div><div class='line' id='LC432'>SET Evidence = &quot;The overproduction of TGF-a in RCC cells is, at least in part, HIF-dependent and a</div><div class='line' id='LC433'>major contributory event that confers a growth advantage to these cells [25,27].&quot;</div><div class='line' id='LC434'><br/></div><div class='line' id='LC435'>transcriptionalActivity(proteinAbundance(HGNC:HIF1A)) increases proteinAbundance(HGNC:TGFA)</div><div class='line' id='LC436'>proteinAbundance(HGNC:TGFA) increases biologicalProcess(GO:&quot;cell growth&quot;)</div><div class='line' id='LC437'><br/></div><div class='line' id='LC438'>SET Evidence = &quot;tumour necrosis factor (TNF)-a has been shown to promote HIF-1a accumulation, and</div><div class='line' id='LC439'>this might involve a VHL-dependent step [33,34].&quot;</div><div class='line' id='LC440'><br/></div><div class='line' id='LC441'>proteinAbundance(HGNC:TNF) increases proteinAbundance(HGNC:HIF1A)</div><div class='line' id='LC442'><br/></div><div class='line' id='LC443'>SET Evidence = &quot;In particular, it has been reported that RCC cells can be sensitized to TNF-a-induced</div><div class='line' id='LC444'>cytotoxicity by re-introducing wild-type VHL [38]. The authors highlight the</div><div class='line' id='LC445'>fact that TNFreceptor engagement by TNF-a triggers the activation of atypical</div><div class='line' id='LC446'>protein kinase C (aPKC), which, through IKKb phosphorylation, liberates NFkB, thereby</div><div class='line' id='LC447'>initiating the transcription of genes that are involved in apoptosis&quot;</div><div class='line' id='LC448'><br/></div><div class='line' id='LC449'>proteinAbundance(HGNC:VHL) increases (proteinAbundance(HGNC:TNF) increases biologicalProcess(GO:&quot;cell death&quot;))</div><div class='line' id='LC450'>molecularActivity(proteinAbundance(HGNC:TNFRSF1A)) increases kinaseActivity(proteinAbundance(PFH:&quot;PRKC Family&quot;))</div><div class='line' id='LC451'>kinaseActivity(proteinAbundance(PFH:&quot;PRKC Family&quot;)) directlyIncreases proteinAbundance(HGNC:IKBKB,proteinModification(P))</div><div class='line' id='LC452'>proteinAbundance(HGNC:TNF) directlyIncreases molecularActivity(proteinAbundance(HGNC:TNFRSF1A))</div><div class='line' id='LC453'>proteinAbundance(HGNC:IKBKB,proteinModification(P)) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC454'><br/></div><div class='line' id='LC455'>SET Evidence = &quot;pVHL has been shown to bind directly to various aPKC isoforms and to target aPKCl</div><div class='line' id='LC456'>for ubiquitin-mediated degradation [39,40].&quot;</div><div class='line' id='LC457'><br/></div><div class='line' id='LC458'>proteinAbundance(HGNC:VHL) directlyIncreases degradation(proteinAbundance(HGNC:PRKCI)) //PKC lambda = PKC iota</div><div class='line' id='LC459'><br/></div><div class='line' id='LC460'>SET Disease = &quot;Neoplasms&quot;</div><div class='line' id='LC461'>SET Evidence = &quot;pVHL has also been implicated in tumour invasion and metastasis, which represent complex</div><div class='line' id='LC462'>multi-step processes that require the proteolytic degradation of the basement</div><div class='line' id='LC463'>membrane and tissue matrix, changes in cell polarity and motility, and the</div><div class='line' id='LC464'>attachment and detachment of cells to and from the extracellular matrix (ECM) [41].&quot;</div><div class='line' id='LC465'><br/></div><div class='line' id='LC466'>proteinAbundance(HGNC:VHL) association pathology(MESHD:&quot;Neoplasm Invasiveness&quot;)</div><div class='line' id='LC467'>proteinAbundance(HGNC:VHL) association pathology(MESHD:&quot;Neoplasm Metastasis&quot;)</div><div class='line' id='LC468'><br/></div><div class='line' id='LC469'>SET Evidence = &quot;Nevertheless, the restored ability of pVHL-positive transfectants to assemble extracellular</div><div class='line' id='LC470'>fibronectin was mediated by b1 integrins, implying that pVHL controls</div><div class='line' id='LC471'>ECM assembly, at least in part, through integrin signalling [46]. A recent development</div><div class='line' id='LC472'>has demonstrated that an ubiquitin-like molecule, NEDD8, covalently modifies</div><div class='line' id='LC473'>pVHL and that a neddylation- defective pVHL mutant, despite retaining its ability</div><div class='line' id='LC474'>to degrade HIF, fails to promote the assembly of a fibronectin matrix [47].&quot;</div><div class='line' id='LC475'><br/></div><div class='line' id='LC476'>proteinAbundance(HGNC:VHL) increases biologicalProcess(GO:&quot;extracellular matrix assembly&quot;)</div><div class='line' id='LC477'>proteinAbundance(HGNC:VHL) increases (biologicalProcess(GO:&quot;integrin-mediated signaling pathway&quot;) increases biologicalProcess(GO:&quot;extracellular matrix assembly&quot;))</div><div class='line' id='LC478'><br/></div><div class='line' id='LC479'>SET Evidence = &quot;The regulation of insulin growth factor (IGF)-I-mediated cell invasion of RCC cells</div><div class='line' id='LC480'>appears to be dependent upon PKCd inhibition by pVHL. This inhibition is mediated</div><div class='line' id='LC481'>through a protein–protein interaction involving a domain of pVHL that shows</div><div class='line' id='LC482'>similarity to protein kinase inhibitor (PKI), a natural inhibitor of cAMP-dependent</div><div class='line' id='LC483'>protein kinase (PKA) [48]&quot;</div><div class='line' id='LC484'><br/></div><div class='line' id='LC485'>proteinAbundance(HGNC:VHL) directlyDecreases kinaseActivity(proteinAbundance(HGNC:PRKCD))</div><div class='line' id='LC486'><br/></div><div class='line' id='LC487'>SET Disease = &quot;Carcinoma, Renal Cell&quot;</div><div class='line' id='LC488'><br/></div><div class='line' id='LC489'>proteinAbundance(HGNC:IGF1) increases pathology(MESHD:&quot;Neoplasm Invasiveness&quot;)</div><div class='line' id='LC490'><br/></div><div class='line' id='LC491'>SET Evidence = &quot;In contrast to protein-binding inhibition, evidence has shown that pVHL binds to both</div><div class='line' id='LC492'>atypical PKC isoforms (l and z) through its b-domain, and in the case of activated</div><div class='line' id='LC493'>aPKCl, mediates its turnover as part of the E3-ligase function of pVHL [39,40].</div><div class='line' id='LC494'>Although the functional significance of this inhibition remains elusive,</div><div class='line' id='LC495'>given the central role for atypical PKCs (especially aPKCz) in establishing cell</div><div class='line' id='LC496'>polarity in conjunction with PAR6 and the GTPase CDC42 [49], one could envisage</div><div class='line' id='LC497'>a scenario whereby the loss of pVHL leads to altered cell polarity and, by extension,</div><div class='line' id='LC498'>aberrant cell migration.&quot;</div><div class='line' id='LC499'><br/></div><div class='line' id='LC500'>complexAbundance(proteinAbundance(HGNC:VHL),proteinAbundance(HGNC:PRKCZ))</div><div class='line' id='LC501'>complexAbundance(proteinAbundance(HGNC:VHL),proteinAbundance(HGNC:PRKCI)) //PKC lambda = PKC iota (PRKCI)</div><div class='line' id='LC502'>catalyticActivity(proteinAbundance(HGNC:VHL)) directlyIncreases degradation(proteinAbundance(HGNC:PRKCI))</div><div class='line' id='LC503'>kinaseActivity(proteinAbundance(HGNC:PRKCZ)) increases biologicalProcess(GO:&quot;establishment of cell polarity&quot;)</div><div class='line' id='LC504'><br/></div><div class='line' id='LC505'>SET Evidence = &quot;Consistent with this, pVHL30 has been shown to co-localize with the microtubule network</div><div class='line' id='LC506'>in vivo and to promote microtubule stabilization [12]. Because microtubule</div><div class='line' id='LC507'>dynamics have been intimately linked to the process of directed cell migration</div><div class='line' id='LC508'>[49],&quot;</div><div class='line' id='LC509'><br/></div><div class='line' id='LC510'>proteinAbundance(HGNC:VHL) increases biologicalProcess(GO:&quot;negative regulation of microtubule depolymerization&quot;) //microtubule stabilization&quot; synonym = &quot;negative regulation of microtubule depolymerization</div><div class='line' id='LC511'><br/></div><div class='line' id='LC512'>SET Evidence = &quot;This same study demonstrated that the loss of VHL function negatively regulates tissue</div><div class='line' id='LC513'>inhibitor of metalloproteinase 2 (TIMP-2), resulting in the upregulation of</div><div class='line' id='LC514'>matrix metalloproteinase 2 (MMP2) and MMP9, thereby implicating pVHL in the control</div><div class='line' id='LC515'>of these molecules.&quot;</div><div class='line' id='LC516'><br/></div><div class='line' id='LC517'>proteinAbundance(HGNC:VHL) increases peptidaseActivity(proteinAbundance(HGNC:TIMP2))</div><div class='line' id='LC518'>peptidaseActivity(proteinAbundance(HGNC:TIMP2)) decreases proteinAbundance(HGNC:MMP2)</div><div class='line' id='LC519'>peptidaseActivity(proteinAbundance(HGNC:TIMP2)) decreases proteinAbundance(HGNC:MMP9)</div><div class='line' id='LC520'><br/></div><div class='line' id='LC521'>SET Evidence = &quot;Importantly, it has been demonstrated that hypoxia promotes tumour cell invasion by</div><div class='line' id='LC522'>inducing the expression of the Met receptor [54]. This establishes a mechanism</div><div class='line' id='LC523'>whereby transformed cells can be spurred to exit a hypoxic microenvironment and</div><div class='line' id='LC524'>invade the surrounding tissues, which provide more favourable growth conditions.</div><div class='line' id='LC525'>Because HIF-1a is involved in Met gene expression, the constitutive activation</div><div class='line' id='LC526'>of HIF-1a as a consequence of pVHL deregulation provides a mechanism explaining</div><div class='line' id='LC527'>the observation that the expression of HGF and Met receptor is associated with</div><div class='line' id='LC528'>genetic alterations of VHL in primary RCC.&quot;</div><div class='line' id='LC529'><br/></div><div class='line' id='LC530'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases rnaAbundance(HGNC:MET)</div><div class='line' id='LC531'>transcriptionalActivity(proteinAbundance(HGNC:HIF1A)) increases rnaAbundance(HGNC:MET)</div><div class='line' id='LC532'>geneAbundance(HGNC:VHL) association rnaAbundance(HGNC:MET)</div><div class='line' id='LC533'>geneAbundance(HGNC:VHL) association rnaAbundance(HGNC:HGF)</div><div class='line' id='LC534'><br/></div><div class='line' id='LC535'>SET Evidence = &quot;The gene encoding the chemokine receptor CXCR4 has been discovered as a novel HIF</div><div class='line' id='LC536'>target based on a microarray comparison of genetic profiles derived from VHL-null</div><div class='line' id='LC537'>RCC cells and their isogenic wild-type VHLexpressing counterparts [52].&quot;</div><div class='line' id='LC538'><br/></div><div class='line' id='LC539'>proteinAbundance(HGNC:VHL) decreases rnaAbundance(HGNC:CXCR4)</div><div class='line' id='LC540'><br/></div><div class='line' id='LC541'>SET Evidence = &quot;The fact that CXCR4 is a hypoxia-inducible gene provided a potential mechanistic explanation</div><div class='line' id='LC542'>for CXCR4 upregulation during tumour cell evolution. CXCR4- induced</div><div class='line' id='LC543'>cell-surface expression due to the loss of VHL function confers enhanced migratory</div><div class='line' id='LC544'>potential to RCC cells in response to its cognate ligand stromal-derived factor</div><div class='line' id='LC545'>1 (SDF1).&quot;</div><div class='line' id='LC546'><br/></div><div class='line' id='LC547'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases rnaAbundance(HGNC:CXCR4)</div><div class='line' id='LC548'>proteinAbundance(HGNC:VHL) decreases cellSurfaceExpression(proteinAbundance(HGNC:CXCR4))</div><div class='line' id='LC549'>proteinAbundance(HGNC:CXCL12) directlyIncreases molecularActivity(proteinAbundance(HGNC:CXCR4)) //SDF1 = CXCL12</div><div class='line' id='LC550'>molecularActivity(proteinAbundance(HGNC:CXCR4)) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC551'><br/></div><div class='line' id='LC552'>SET TextLocation = &quot;Legend&quot;</div><div class='line' id='LC553'>SET Evidence = &quot;Figure 4. The role of hypoxia-inducible factor (HIF) in conferring tumour growth potential.</div><div class='line' id='LC554'>In solid tumours, HIFa is stabilised under conditions of low oxygen due</div><div class='line' id='LC555'>to a lack of vascularisation and the subsequent evolution of a hypoxic microenvironment.</div><div class='line' id='LC556'>In a VHL-null tumour, HIFa is constitutively active, and can initiate</div><div class='line' id='LC557'>genetic programmes within the entire population of cells that would normally be</div><div class='line' id='LC558'>activated only under hypoxic conditions.&quot;</div><div class='line' id='LC559'><br/></div><div class='line' id='LC560'>biologicalProcess(GO:&quot;response to hypoxia&quot;) decreases degradation(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC561'>proteinAbundance(HGNC:VHL) decreases transcriptionalActivity(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC562'><br/></div><div class='line' id='LC563'>UNSET STATEMENT_GROUP</div><div class='line' id='LC564'><br/></div><div class='line' id='LC565'>SET STATEMENT_GROUP = &quot;Group 4&quot;</div><div class='line' id='LC566'><br/></div><div class='line' id='LC567'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC568'>SET Evidence = &quot;These modifications render Ras functional and capable of localizing to the lipid-rich</div><div class='line' id='LC569'>inner surface of the cell membrane. The first and most critical modification,</div><div class='line' id='LC570'>farnesylation, which is principally catalyzed by protein FTase, adds a 15-carbon</div><div class='line' id='LC571'>hydrobobic farnesyl isoprenyl tail to the carboxyl terminus of Ras.&quot;</div><div class='line' id='LC572'>SET Citation = {&quot;PubMed&quot;,&quot;Journal of clinical oncology : official journal of the American Society of Clinical Oncology&quot;,&quot;16170185&quot;,&quot;&quot;,&quot;Beeram M|Patnaik A|Rowinsky EK&quot;,&quot;&quot;}</div><div class='line' id='LC573'><br/></div><div class='line' id='LC574'>catalyticActivity(complexAbundance(proteinAbundance(HGNC:FNTA),proteinAbundance(HGNC:FNTB))) directlyIncreases proteinAbundance(PFH:&quot;RAS Family&quot;,proteinModification(F))</div><div class='line' id='LC575'>proteinAbundance(PFH:&quot;RAS Family&quot;,proteinModification(F)) directlyIncreases translocation(proteinAbundance(PFH:&quot;RAS Family&quot;),MESHCL:&quot;Intracellular Space&quot;,MESHCL:&quot;Cell Membrane&quot;)</div><div class='line' id='LC576'><br/></div><div class='line' id='LC577'>SET Evidence = &quot;The considerable attention paid to targeting Ras as a therapeutic strategy is based</div><div class='line' id='LC578'>on the high incidence of activating ras mutations in human malignancies, including</div><div class='line' id='LC579'>approximately 22% of non–small-cell lung, 50% of colorectal, and 90% of pancreatic</div><div class='line' id='LC580'>cancers. 53,60,61&quot;</div><div class='line' id='LC581'>SET Species = &quot;9606&quot;</div><div class='line' id='LC582'><br/></div><div class='line' id='LC583'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) positiveCorrelation pathology(MESHD:&quot;Carcinoma, Non-Small-Cell Lung&quot;)</div><div class='line' id='LC584'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) positiveCorrelation pathology(MESHD:&quot;Colorectal Neoplasms&quot;)</div><div class='line' id='LC585'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) positiveCorrelation pathology(MESHD:&quot;Pancreatic Neoplasms&quot;)</div><div class='line' id='LC586'><br/></div><div class='line' id='LC587'>SET Evidence = &quot;Localization of GTP-bound Ras to the inner surface of the cell membrane activates</div><div class='line' id='LC588'>several downstream effectors, most notably the serine/threonine kinase Raf, which</div><div class='line' id='LC589'>is the first signaling element in the MAPK pathway. 2,67,68 As shown in Figure</div><div class='line' id='LC590'>1, other downstream effectors of Ras include the PI3K cell survival pathway, the</div><div class='line' id='LC591'>small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase</div><div class='line' id='LC592'>pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway). 69-71</div><div class='line' id='LC593'>In addition, in response to cellular stress and cytokine stimulation mediated</div><div class='line' id='LC594'>through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases</div><div class='line' id='LC595'>(MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively. 72-76&quot;</div><div class='line' id='LC596'><br/></div><div class='line' id='LC597'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC598'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC599'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases gtpBoundActivity(proteinAbundance(PFH:&quot;RAC Family&quot;))</div><div class='line' id='LC600'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases gtpBoundActivity(proteinAbundance(PFH:&quot;RHO Family&quot;))</div><div class='line' id='LC601'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC602'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases kinaseActivity(proteinAbundance(HGNC:MAP2K3))</div><div class='line' id='LC603'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases kinaseActivity(proteinAbundance(HGNC:MAP2K6))</div><div class='line' id='LC604'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases kinaseActivity(proteinAbundance(HGNC:MAP2K4))</div><div class='line' id='LC605'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases kinaseActivity(proteinAbundance(HGNC:MAP2K7))</div><div class='line' id='LC606'>biologicalProcess(GO:&quot;cellular response to stress&quot;) increases gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;))</div><div class='line' id='LC607'>biologicalProcess(GO:&quot;cellular response to cytokine stimulus&quot;) increases gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;))</div><div class='line' id='LC608'><br/></div><div class='line' id='LC609'>SET CellStructure = &quot;Cell Membrane&quot;</div><div class='line' id='LC610'>SET Evidence = &quot;GTP-bound Ras interacts directly with Raf and mobilizes the inactive protein from</div><div class='line' id='LC611'>the cytoplasm (Figs 1 and 2). Once the Ras-Raf complex is translocated to the cell</div><div class='line' id='LC612'>membrane, Ras activates the serine/threonine kinase function of Raf through</div><div class='line' id='LC613'>an association between its Ras-binding domain (RBD) in the amino-terminal regulatory</div><div class='line' id='LC614'>region and Ras-GTP.&quot;</div><div class='line' id='LC615'><br/></div><div class='line' id='LC616'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) directlyIncreases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC617'><br/></div><div class='line' id='LC618'>SET Evidence = &quot;Raf is also activated by Ras-independent activators, including the soluble non-RTK</div><div class='line' id='LC619'>Src and Janus kinase 1, which are involved in cytokine signaling.86 Other Ras-independent</div><div class='line' id='LC620'>activators of Raf include interferon beta, protein kinase C (PKC) alpha,</div><div class='line' id='LC621'>antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated</div><div class='line' id='LC622'>protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin,</div><div class='line' id='LC623'>and dimerization between Raf isoforms 86-94 (Fig 3).&quot;</div><div class='line' id='LC624'><br/></div><div class='line' id='LC625'>kinaseActivity(proteinAbundance(HGNC:JAK1)) increases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC626'>kinaseActivity(proteinAbundance(HGNC:SRC)) increases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC627'>proteinAbundance(HGNC:IFNB1) increases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC628'>kinaseActivity(proteinAbundance(HGNC:PRKCA)) increases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC629'>proteinAbundance(HGNC:BCL2) increases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC630'>biologicalProcess(GO:&quot;response to UV&quot;) increases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC631'>biologicalProcess(GO:&quot;response to ionizing radiation&quot;) increases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC632'>abundance(CHEBI:retinoid) increases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC633'>proteinAbundance(HGNC:EPO) increases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC634'><br/></div><div class='line' id='LC635'>SET Evidence = &quot;Furthermore, the kinase activity of Raf is inhibited by its interactions with cholesterol-rich</div><div class='line' id='LC636'>lipid rafts in the cell membrane and phosphorylation by protein kinases</div><div class='line' id='LC637'>A (PKA) and B (PKB/Akt), as shown in Figure 2.95-98&quot;</div><div class='line' id='LC638'><br/></div><div class='line' id='LC639'>abundance(MESHCL:&quot;Membrane Microdomains&quot;) directlyDecreases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC640'>kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;)) decreases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC641'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) decreases kinaseActivity(proteinAbundance(PFH:&quot;RAF Family&quot;))</div><div class='line' id='LC642'><br/></div><div class='line' id='LC643'>SET Evidence = &quot;The mammalian raf family consists of the following three genes: A-raf, B-raf, and</div><div class='line' id='LC644'>C-raf, which are located on chromosomes Xp11, 7q32, and 3p25, respectively.&quot;</div><div class='line' id='LC645'><br/></div><div class='line' id='LC646'>proteinAbundance(PFH:&quot;RAF Family&quot;) hasMembers list(proteinAbundance(HGNC:ARAF),proteinAbundance(HGNC:BRAF),proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC647'><br/></div><div class='line' id='LC648'>SET Evidence = &quot;Additional support for the diverse functionality of Raf family members is provided</div><div class='line' id='LC649'>by the disparate responses of B-Raf and C-Raf to identical stimuli, as well as</div><div class='line' id='LC650'>the distinct messages that each isoform relays downstream to Rap1, which is a small</div><div class='line' id='LC651'>GTPase that functions as both an activator and repressor of Raf.115  Rap1-mediated</div><div class='line' id='LC652'>stimulation of B-Raf by cyclic adenosine monophosphate (cAMP) phosphorylates</div><div class='line' id='LC653'>ERK, whereas stimulation of C-Raf inhibits ERK phosphorylation.115&quot;</div><div class='line' id='LC654'><br/></div><div class='line' id='LC655'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;) increases gtpBoundActivity(proteinAbundance(HGNC:RAP1A))</div><div class='line' id='LC656'>gtpBoundActivity(proteinAbundance(HGNC:RAP1A)) increases (kinaseActivity(proteinAbundance(HGNC:BRAF)) increases proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;,proteinModification(P)))</div><div class='line' id='LC657'>gtpBoundActivity(proteinAbundance(HGNC:RAP1A)) decreases kinaseActivity(proteinAbundance(HGNC:RAF1)) //The effect of RAP1A on RAF1 (c-RAF) does not appear to be stimulating</div><div class='line' id='LC658'><br/></div><div class='line' id='LC659'>SET Evidence = &quot;With regard to differences in signaling between the Raf isoforms, A-Raf is a weaker</div><div class='line' id='LC660'>activator of MEK than B-Raf or C-Raf. Furthermore, A-Raf can activate MEK1 only,</div><div class='line' id='LC661'>whereas C-Raf activates both MEK1 and MEK2.123-125&quot;</div><div class='line' id='LC662'><br/></div><div class='line' id='LC663'>kinaseActivity(proteinAbundance(HGNC:ARAF)) causesNoChange kinaseActivity(proteinAbundance(HGNC:MAP2K2))</div><div class='line' id='LC664'>kinaseActivity(proteinAbundance(HGNC:ARAF)) increases kinaseActivity(proteinAbundance(HGNC:MAP2K1))</div><div class='line' id='LC665'>kinaseActivity(proteinAbundance(HGNC:RAF1)) increases kinaseActivity(proteinAbundance(HGNC:MAP2K1))</div><div class='line' id='LC666'>kinaseActivity(proteinAbundance(HGNC:RAF1)) increases kinaseActivity(proteinAbundance(HGNC:MAP2K2))</div><div class='line' id='LC667'><br/></div><div class='line' id='LC668'>SET CellStructure = &quot;Cytoplasm&quot;</div><div class='line' id='LC669'>SET Evidence = &quot;C-Raf exists in the cytoplasm as a 300- to 500-kd protein complex. The complex consists</div><div class='line' id='LC670'>of C-Raf, heat shock protein 90 (Hsp90), and the dimeric protein cofactor</div><div class='line' id='LC671'>14-3-3. 14-3-3 binds to two specific phosphoserine residues of C-Raf, which masks</div><div class='line' id='LC672'>its kinase domain and inactivates the protein. The binding of Ras to C-Raf displaces</div><div class='line' id='LC673'>the 14-3-3 dimer, rendering C-Raf accessible to dephosphorylation by protein</div><div class='line' id='LC674'>phosphatase 2A.126&quot;</div><div class='line' id='LC675'><br/></div><div class='line' id='LC676'>complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(HGNC:HSP90AA1),proteinAbundance(PFH:&quot;14-3-3 Family&quot;))</div><div class='line' id='LC677'>complexAbundance(proteinAbundance(PFH:&quot;RAS Family&quot;),proteinAbundance(HGNC:RAF1)) directlyDecreases complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(PFH:&quot;14-3-3 Family&quot;))</div><div class='line' id='LC678'>proteinAbundance(PFH:&quot;14-3-3 Family&quot;) directlyDecreases kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC679'>phosphataseActivity(complexAbundance(NCH:&quot;PP2A Complex&quot;)) directlyDecreases proteinAbundance(HGNC:RAF1,proteinModification(P,S))</div><div class='line' id='LC680'><br/></div><div class='line' id='LC681'>SET Evidence = &quot;The effector domain of GTP-bound Ras binds to C-Raf through the RBD and CRD in the</div><div class='line' id='LC682'>CR1. Although binding to both sites is required for Raf activation, the most critical</div><div class='line' id='LC683'>interaction is between Ras-GTP and the RBD.127  All Ras isoforms are capable</div><div class='line' id='LC684'>of interacting with Raf, but K-Ras is the most potent activator, whereas N-Ras</div><div class='line' id='LC685'>is much more efficient than H-Ras.128  The interaction between Ras and C-Raf</div><div class='line' id='LC686'>alone is insufficient to activate C-Raf, but it serves to translocate C-Raf to</div><div class='line' id='LC687'>the cell membrane where it can be activated.&quot;</div><div class='line' id='LC688'><br/></div><div class='line' id='LC689'>gtpBoundActivity(proteinAbundance(HGNC:HRAS)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC690'>gtpBoundActivity(proteinAbundance(HGNC:NRAS)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC691'>gtpBoundActivity(proteinAbundance(HGNC:KRAS)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC692'><br/></div><div class='line' id='LC693'>SET Evidence = &quot;The activation of B-Raf by Ras has been less well studied; however, the interacting</div><div class='line' id='LC694'>amino acids in the Ras-Raf interface are identical for B-Raf and C-Raf.129,130</div><div class='line' id='LC695'>&nbsp;The association of Ras with B-Raf also translocates B-Raf to the cell membrane</div><div class='line' id='LC696'>where it is activated.124  Interestingly, a membrane-free complex of B-Raf and</div><div class='line' id='LC697'>14-3-3 can be activated in vitro by recombinant Ras. This is in stark contrast</div><div class='line' id='LC698'>to A-Raf and C-Raf, which must undergo a series of phosphorylation reactions on</div><div class='line' id='LC699'>serine and tyrosine residues in the cell membrane and cannot be activated by Ras</div><div class='line' id='LC700'>alone.124,130  Of the Raf isoforms, B-Raf is activated first, and on stimulation</div><div class='line' id='LC701'>by Ras, it heterodimerizes with C-Raf, the significance of which is not known.94&quot;</div><div class='line' id='LC702'><br/></div><div class='line' id='LC703'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:BRAF))</div><div class='line' id='LC704'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) directlyIncreases translocation(proteinAbundance(HGNC:BRAF),MESHCL:&quot;Intracellular Space&quot;,MESHCL:&quot;Cell Membrane&quot;)</div><div class='line' id='LC705'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(HGNC:BRAF))</div><div class='line' id='LC706'><br/></div><div class='line' id='LC707'>SET Evidence = &quot;Both B-Raf and C-Raf can bind to other small GTPases, most notably Rap1.115,131,132</div><div class='line' id='LC708'>&nbsp;The effector domains of Rap1 and Ras are nearly identical, but activation of</div><div class='line' id='LC709'>these proteins produces vastly different downstream effects. Furthermore, Rap1</div><div class='line' id='LC710'>mediates distinct effects after binding to various Raf isoforms. The B-Raf–Rap1</div><div class='line' id='LC711'>complex activates B-Raf, whereas the C-Raf–Rap1 interaction does not activate C-Raf</div><div class='line' id='LC712'>and, in fact, may be inhibitory.115,132,133  This occurs because Rap1 binds</div><div class='line' id='LC713'>to the CRD of C-Raf with higher affinity than Ras and excludes Ras from binding.&quot;</div><div class='line' id='LC714'><br/></div><div class='line' id='LC715'>gtpBoundActivity(proteinAbundance(HGNC:RAP1A)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:BRAF))</div><div class='line' id='LC716'>gtpBoundActivity(proteinAbundance(HGNC:RAP1A)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC717'><br/></div><div class='line' id='LC718'>SET Evidence = &quot;The Rho family of small GTPases, consisting of Rho, Rac, and cyclin-dependent kinase</div><div class='line' id='LC719'>(Cdc) 42, regulate cytoskeletal organization during the cell cycle and also</div><div class='line' id='LC720'>mediate Ras-induced activation of Raf, especially C-Raf.134-136  These GTPases do</div><div class='line' id='LC721'>not directly bind to Raf but, instead, signal by activating downstream kinases.</div><div class='line' id='LC722'>Rho signals by activating the serine/threonine protein kinases N1 and N2 and Rho-associated</div><div class='line' id='LC723'>kinase 1, whereas Rac and Cdc42 signal through p21-activated kinase</div><div class='line' id='LC724'>(PAK).134-136&quot;</div><div class='line' id='LC725'><br/></div><div class='line' id='LC726'>gtpBoundActivity(proteinAbundance(PFH:&quot;RHO Family&quot;)) increases biologicalProcess(GO:&quot;regulation of cytoskeleton organization&quot;)</div><div class='line' id='LC727'>gtpBoundActivity(proteinAbundance(PFH:&quot;RHO Family&quot;)) increases (gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:RAF1)))</div><div class='line' id='LC728'>gtpBoundActivity(proteinAbundance(PFH:&quot;RHO Family&quot;)) increases kinaseActivity(proteinAbundance(HGNC:PKN1))</div><div class='line' id='LC729'>gtpBoundActivity(proteinAbundance(PFH:&quot;RHO Family&quot;)) increases kinaseActivity(proteinAbundance(HGNC:PKN2))</div><div class='line' id='LC730'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAC Family&quot;)) increases kinaseActivity(proteinAbundance(PFH:&quot;PAK Family&quot;))</div><div class='line' id='LC731'>gtpBoundActivity(proteinAbundance(HGNC:CDC42)) increases kinaseActivity(proteinAbundance(PFH:&quot;PAK Family&quot;))</div><div class='line' id='LC732'>gtpBoundActivity(proteinAbundance(PFH:&quot;RHO Family&quot;)) increases kinaseActivity(proteinAbundance(HGNC:ROCK1))</div><div class='line' id='LC733'><br/></div><div class='line' id='LC734'>SET Evidence = &quot;Phosphorylation.  Raf is principally activated by phosphorylation of specific amino</div><div class='line' id='LC735'>acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint,</div><div class='line' id='LC736'>the Raf activation sites are highly conserved from yeast to humans. Several</div><div class='line' id='LC737'>amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3</div><div class='line' id='LC738'>and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated</div><div class='line' id='LC739'>in the basal state.137  On stimulation, Ras-GTP displaces 14-3-3 from S259, and</div><div class='line' id='LC740'>C-Raf is translocated to the cell membrane, where it can be dephosphorylated at</div><div class='line' id='LC741'>S259 by protein phosphatase 2A or other phosphatases.126  S259 also represents the</div><div class='line' id='LC742'>site of inhibitory phosphorylation by PKB/Akt, PKA, and serum glucocorticoid-inducible</div><div class='line' id='LC743'>kinase.121,138,139  Phosphorylation at S621 seems to have greater significance</div><div class='line' id='LC744'>because mutations at this site inactivate Raf&#39;s kinase activity. Hence,</div><div class='line' id='LC745'>a balance of phosphorylation and dephosphorylation is required to prime Raf in</div><div class='line' id='LC746'>the basal state before stimulation by Ras or mitogens.137&quot;</div><div class='line' id='LC747'><br/></div><div class='line' id='LC748'>proteinAbundance(HGNC:RAF1,proteinModification(P,S,259)) directlyIncreases complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(PFH:&quot;14-3-3 Family&quot;))</div><div class='line' id='LC749'>proteinAbundance(HGNC:RAF1,proteinModification(P,S,259)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC750'>proteinAbundance(HGNC:RAF1,proteinModification(P,S,621)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC751'>proteinAbundance(HGNC:RAF1,proteinModification(P,S,621)) directlyIncreases complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(PFH:&quot;14-3-3 Family&quot;))</div><div class='line' id='LC752'>phosphataseActivity(complexAbundance(NCH:&quot;PP2A Complex&quot;)) directlyDecreases proteinAbundance(HGNC:RAF1,proteinModification(P,S,259))</div><div class='line' id='LC753'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) directlyIncreases proteinAbundance(HGNC:RAF1,proteinModification(P,S,259))</div><div class='line' id='LC754'>kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;)) directlyIncreases proteinAbundance(HGNC:RAF1,proteinModification(P,S,259))</div><div class='line' id='LC755'>kinaseActivity(proteinAbundance(HGNC:SGK1)) directlyIncreases proteinAbundance(HGNC:RAF1,proteinModification(P,S,259))</div><div class='line' id='LC756'><br/></div><div class='line' id='LC757'>SET Evidence = &quot;Raf is also phosphorylated at other serine and threonine residues, the most important</div><div class='line' id='LC758'>of which are S338 and tyrosine (Y) 341, which are situated adjacent to the</div><div class='line' id='LC759'>C-Raf kinase domain.140  Phosphorylation of these residues relieves the inhibitory</div><div class='line' id='LC760'>effects of the regulatory domain on the kinase domain.141  S338, which is the</div><div class='line' id='LC761'>evolutionarily conserved PAK phosphorylation site that resides on the amino-terminal</div><div class='line' id='LC762'>side of the kinase domain, is critical for Raf activation.134-136,140,142</div><div class='line' id='LC763'>&nbsp;This site is also phosphorylated in response to stimulation by growth factors,</div><div class='line' id='LC764'>integrins, Ras, PAK1, and PAK3.78,136,143&quot;</div><div class='line' id='LC765'><br/></div><div class='line' id='LC766'>proteinAbundance(HGNC:RAF1,proteinModification(P,S,338)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC767'>proteinAbundance(HGNC:RAF1,proteinModification(P,Y,341)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC768'>kinaseActivity(proteinAbundance(HGNC:PAK1)) directlyIncreases proteinAbundance(HGNC:RAF1,proteinModification(P,S,338))</div><div class='line' id='LC769'>kinaseActivity(proteinAbundance(HGNC:PAK3)) directlyIncreases proteinAbundance(HGNC:RAF1,proteinModification(P,S,338))</div><div class='line' id='LC770'>biologicalProcess(GO:&quot;integrin activation&quot;) increases proteinAbundance(HGNC:RAF1,proteinModification(P,S,338))</div><div class='line' id='LC771'>biologicalProcess(GO:&quot;cellular response to growth factor stimulus&quot;) increases proteinAbundance(HGNC:RAF1,proteinModification(P,S,338))</div><div class='line' id='LC772'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases proteinAbundance(HGNC:RAF1,proteinModification(P,S,338))</div><div class='line' id='LC773'><br/></div><div class='line' id='LC774'>SET Evidence = &quot;The homologous site on B-Raf, S445, is constitutively phosphorylated, accounting for</div><div class='line' id='LC775'>the higher basal activity of B-Raf. Ras presumably phosphorylates this site</div><div class='line' id='LC776'>by activating PI3K.&quot;</div><div class='line' id='LC777'><br/></div><div class='line' id='LC778'>proteinAbundance(HGNC:BRAF,proteinModification(P,S,445)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:BRAF))</div><div class='line' id='LC779'><br/></div><div class='line' id='LC780'>SET Evidence = &quot;Y341 is phosphorylated by the Src family of non-RTKs, Janus kinase, and erythropoietin.85,92&quot;</div><div class='line' id='LC781'><br/></div><div class='line' id='LC782'>kinaseActivity(proteinAbundance(PFH:&quot;SRC Family&quot;)) directlyIncreases proteinAbundance(HGNC:RAF1,proteinModification(P,Y,341)) //evidence text refers to c-RAF (RAF1)</div><div class='line' id='LC783'>kinaseActivity(proteinAbundance(PFH:&quot;JAK Family&quot;)) directlyIncreases proteinAbundance(HGNC:RAF1,proteinModification(P,Y,341))</div><div class='line' id='LC784'>proteinAbundance(HGNC:EPO) increases proteinAbundance(HGNC:RAF1,proteinModification(P,Y,341))</div><div class='line' id='LC785'><br/></div><div class='line' id='LC786'>SET Evidence = &quot;As shown in Figure 2, C-Raf interacts with a diverse array of scaffolding proteins</div><div class='line' id='LC787'>(kinase suppressor of Ras and MEK partner-1), adaptor proteins (Bcl-2–associated</div><div class='line' id='LC788'>athanogene-1), chaperone proteins (Hsp90 and Hsp70), substrates (retinoblastoma</div><div class='line' id='LC789'>protein [Rb]), lipids (phosphatidic acid, cholesterol-rich caveolae, and cytosolic</div><div class='line' id='LC790'>lipid rafts), and cellular constituents, many of which, in turn, modulate</div><div class='line' id='LC791'>its kinase activity.95&quot;</div><div class='line' id='LC792'><br/></div><div class='line' id='LC793'>complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(HGNC:KSR1)) //kinase suppressor of RAF = KSR1</div><div class='line' id='LC794'>complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(HGNC:LAMTOR3)) //MEK partner 1 = LAMTOR3</div><div class='line' id='LC795'>complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(HGNC:BAG1)) //Bcl-2–associated athanogene-1 = BAG1</div><div class='line' id='LC796'>complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(HGNC:HSP90AA1))</div><div class='line' id='LC797'>complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(PFH:&quot;HSPA Family&quot;))</div><div class='line' id='LC798'>complexAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(HGNC:RB1))</div><div class='line' id='LC799'>complexAbundance(proteinAbundance(HGNC:RAF1),abundance(CHEBI:&quot;phosphatidic acid&quot;))</div><div class='line' id='LC800'><br/></div><div class='line' id='LC801'>SET Evidence = &quot;The Raf isoforms are the best characterized MEK1 and MEK2 activators, and all Raf</div><div class='line' id='LC802'>isoforms activate MEK1, whereas only B-Raf and C-Raf activate MEK2. MEK1 and MEK2</div><div class='line' id='LC803'>contain a proline-rich sequence that enables recognition and activation by Raf.125,146-153.&quot;</div><div class='line' id='LC804'><br/></div><div class='line' id='LC805'>kinaseActivity(proteinAbundance(HGNC:RAF1)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:MAP2K1))</div><div class='line' id='LC806'>kinaseActivity(proteinAbundance(HGNC:BRAF)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:MAP2K1))</div><div class='line' id='LC807'>kinaseActivity(proteinAbundance(HGNC:ARAF)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:MAP2K1))</div><div class='line' id='LC808'>kinaseActivity(proteinAbundance(HGNC:BRAF)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:MAP2K2))</div><div class='line' id='LC809'>kinaseActivity(proteinAbundance(HGNC:RAF1)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:MAP2K2))</div><div class='line' id='LC810'><br/></div><div class='line' id='LC811'>SET Evidence = &quot;the dual-specificity p38MAPK kinases (MKK3 and MKK6) and JNK kinases (MKK4 and MKK7)</div><div class='line' id='LC812'>phosphorylate p38MAPK  and JNK, respectively.72-76&quot;</div><div class='line' id='LC813'><br/></div><div class='line' id='LC814'>kinaseActivity(proteinAbundance(HGNC:MAP2K3)) directlyIncreases kinaseActivity(proteinAbundance(PFH:&quot;MAPK p38 Family&quot;))</div><div class='line' id='LC815'>kinaseActivity(proteinAbundance(HGNC:MAP2K6)) directlyIncreases kinaseActivity(proteinAbundance(PFH:&quot;MAPK p38 Family&quot;))</div><div class='line' id='LC816'>kinaseActivity(proteinAbundance(HGNC:MAP2K4)) directlyIncreases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC817'>kinaseActivity(proteinAbundance(HGNC:MAP2K7)) directlyIncreases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC818'><br/></div><div class='line' id='LC819'>SET Evidence = &quot;Although both A-Raf and C-Raf are capable of activating other signaling elements independent</div><div class='line' id='LC820'>of MAPK pathway activation, such as nuclear factor-kappa B (NF-κB),</div><div class='line' id='LC821'>Rb, and Bcl-2, MEK1 and MEK2 are the only known substrates for B-Raf.154-157&quot;</div><div class='line' id='LC822'><br/></div><div class='line' id='LC823'>kinaseActivity(proteinAbundance(HGNC:ARAF)) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC824'>kinaseActivity(proteinAbundance(HGNC:RAF1)) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC825'><br/></div><div class='line' id='LC826'>SET Evidence = &quot;Cell survival signaling is also regulated by C-Raf, which induces phosphorylation</div><div class='line' id='LC827'>of Iκ B in the NF-κB–Iκ B complex. This action releases activated NF-κB, which</div><div class='line' id='LC828'>is then translocated to the nucleus where it mediates transcription of antiapoptotic</div><div class='line' id='LC829'>factors.155,166&quot;</div><div class='line' id='LC830'><br/></div><div class='line' id='LC831'>kinaseActivity(proteinAbundance(HGNC:RAF1)) increases proteinAbundance(HGNC:NFKBIA,proteinModification(P))</div><div class='line' id='LC832'>proteinAbundance(HGNC:NFKBIA,proteinModification(P)) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC833'><br/></div><div class='line' id='LC834'>SET Evidence = &quot;Other antiapoptotic effects of C-Raf are mediated by a mitochondrial pool of the protein,</div><div class='line' id='LC835'>which, on stimulation, localizes to the mitochondrial membrane where the</div><div class='line' id='LC836'>protein interacts with and phosphorylates Bcl-2, Bcl-2–associated athanogene,</div><div class='line' id='LC837'>and other pro-apoptotic regulators, abrogating their pro-apoptotic effects.157,167</div><div class='line' id='LC838'>The antiapoptotic effects of C-Raf are also mediated through the ankyrin-repeat</div><div class='line' id='LC839'>protein Tvl-1 and apoptosis signal-regulated kinase-1.166,168,169&quot;</div><div class='line' id='LC840'><br/></div><div class='line' id='LC841'>kinaseActivity(proteinAbundance(HGNC:RAF1)) decreases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC842'>kinaseActivity(proteinAbundance(HGNC:RAF1)) directlyIncreases proteinAbundance(HGNC:BCL2,proteinModification(P))</div><div class='line' id='LC843'>kinaseActivity(proteinAbundance(HGNC:RAF1)) directlyIncreases proteinAbundance(HGNC:BAG1,proteinModification(P))</div><div class='line' id='LC844'>kinaseActivity(proteinAbundance(HGNC:RAF1)) directlyIncreases (molecularActivity(proteinAbundance(HGNC:BCL2)) decreases biologicalProcess(GO:&quot;apoptotic process&quot;)) //evidence line is unclear; BCL2 and BAG1 should be anti-apoptotic</div><div class='line' id='LC845'>kinaseActivity(proteinAbundance(HGNC:RAF1)) directlyIncreases (molecularActivity(proteinAbundance(HGNC:BAG1)) decreases biologicalProcess(GO:&quot;apoptotic process&quot;)) //evidence line is unclear; BCL2 and BAG1 should be anti-apoptotic</div><div class='line' id='LC846'>kinaseActivity(proteinAbundance(HGNC:RAF1)) decreases (kinaseActivity(proteinAbundance(HGNC:MAP3K5)) increases biologicalProcess(GO:&quot;apoptotic process&quot;)) //ASK1 = MAP3K5</div><div class='line' id='LC847'><br/></div><div class='line' id='LC848'>SET Evidence = &quot;In addition, C-Raf phosphorylates Rb, p53, Cdc25, and other cell cycle regulatory</div><div class='line' id='LC849'>proteins in metaphase.156,170,171  Lastly, C-Raf induces transcription of the multidrug</div><div class='line' id='LC850'>resistance gene mdr-1,  and its activation has been associated with multidrug</div><div class='line' id='LC851'>resistance.172&quot;</div><div class='line' id='LC852'><br/></div><div class='line' id='LC853'>kinaseActivity(proteinAbundance(HGNC:RAF1)) increases proteinAbundance(HGNC:RB1,proteinModification(P))</div><div class='line' id='LC854'>kinaseActivity(proteinAbundance(HGNC:RAF1)) increases proteinAbundance(HGNC:TP53,proteinModification(P))</div><div class='line' id='LC855'>kinaseActivity(proteinAbundance(HGNC:RAF1)) increases proteinAbundance(PFH:&quot;CDC25 Family&quot;,proteinModification(P))</div><div class='line' id='LC856'>kinaseActivity(proteinAbundance(HGNC:RAF1)) increases rnaAbundance(HGNC:ABCB1) //MDR-1 = ABCB1</div><div class='line' id='LC857'><br/></div><div class='line' id='LC858'>SET Evidence = &quot;Somatic B-raf mutations were demonstrated in 60% to 70% of malignant melanomas and</div><div class='line' id='LC859'>in moderate to high rates in carcinomas of the colon, ovary, and thyroid (papillary),</div><div class='line' id='LC860'>implicating activating oncogenic B-raf mutations as critical promoters of</div><div class='line' id='LC861'>these malignancies.9,14-17&quot;</div><div class='line' id='LC862'><br/></div><div class='line' id='LC863'>kinaseActivity(proteinAbundance(HGNC:BRAF)) positiveCorrelation pathology(MESHD:Melanoma)</div><div class='line' id='LC864'>kinaseActivity(proteinAbundance(HGNC:BRAF)) positiveCorrelation pathology(MESHD:&quot;Colorectal Neoplasms&quot;)</div><div class='line' id='LC865'>kinaseActivity(proteinAbundance(HGNC:BRAF)) positiveCorrelation pathology(MESHD:&quot;Ovarian Neoplasms&quot;)</div><div class='line' id='LC866'>kinaseActivity(proteinAbundance(HGNC:BRAF)) positiveCorrelation pathology(MESHD:&quot;Thyroid Neoplasms&quot;)</div><div class='line' id='LC867'><br/></div><div class='line' id='LC868'>SET Evidence = &quot;V599EB-Raf possesses the hallmarks of a conventional oncogene because the kinase activity</div><div class='line' id='LC869'>of its encoded protein is greatly elevated; it constitutively stimulates</div><div class='line' id='LC870'>ERK in vivo in the absence of Ras activation; and it transforms NIH3T3 cells.144&quot;</div><div class='line' id='LC871'><br/></div><div class='line' id='LC872'>proteinAbundance(HGNC:BRAF,substitution(V,599,E)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:BRAF))</div><div class='line' id='LC873'><br/></div><div class='line' id='LC874'>SET Evidence = &quot;Originally identified by high-throughput screening of small molecules against C-Raf</div><div class='line' id='LC875'>kinase, sorafenib was found to be a potent competitive inhibitor of ATP binding</div><div class='line' id='LC876'>in the catalytic domains of C-Raf, wild-type B-Raf, and V599EB-Raf mutant.&quot;</div><div class='line' id='LC877'><br/></div><div class='line' id='LC878'>abundance(CHEBI:sorafenib) directlyDecreases kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC879'>abundance(CHEBI:sorafenib) directlyDecreases kinaseActivity(proteinAbundance(HGNC:BRAF))</div><div class='line' id='LC880'><br/></div><div class='line' id='LC881'>UNSET STATEMENT_GROUP</div><div class='line' id='LC882'><br/></div><div class='line' id='LC883'>SET STATEMENT_GROUP = &quot;Group 5&quot;</div><div class='line' id='LC884'><br/></div><div class='line' id='LC885'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC886'>SET Evidence = &quot;Originally identified by high-throughput screening of small molecules against C-Raf</div><div class='line' id='LC887'>kinase, sorafenib was found to be a potent competitive inhibitor of ATP binding</div><div class='line' id='LC888'>in the catalytic domains of C-Raf, wild-type B-Raf, and V599EB-Raf mutant.&quot;</div><div class='line' id='LC889'>SET Citation = {&quot;PubMed&quot;,&quot;The Biochemical journal&quot;,&quot;12444918&quot;,&quot;&quot;,&quot;Houslay MD|Adams DR&quot;,&quot;&quot;}</div><div class='line' id='LC890'><br/></div><div class='line' id='LC891'>molecularActivity(proteinAbundance(HGNC:ADRB2)) directlyIncreases complexAbundance(proteinAbundance(HGNC:ADRB2),proteinAbundance(PFH:&quot;PDE4 Family&quot;),proteinAbundance(PFH:&quot;ARRB Family&quot;))</div><div class='line' id='LC892'><br/></div><div class='line' id='LC893'>SET Evidence = &quot;Long PDE4 isoforms from all four subfamilies can be activated through PKA phosphorylation</div><div class='line' id='LC894'>[50,54–57] of a single serine residue[50,56,58–61] found at the extreme</div><div class='line' id='LC895'>N-terminal end of UCR1, within the PKA consensus, RRESF.&quot;</div><div class='line' id='LC896'><br/></div><div class='line' id='LC897'>kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;)) directlyIncreases catalyticActivity(proteinAbundance(PFH:&quot;PDE4 Long Family&quot;))</div><div class='line' id='LC898'>kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;)) directlyIncreases proteinAbundance(PFH:&quot;PDE4 Long Family&quot;,proteinModification(P,S))</div><div class='line' id='LC899'><br/></div><div class='line' id='LC900'>SET Evidence = &quot;Once cAMP is generated, the only way to inactivate it is to degrade it to 5&#39;-AMP,</div><div class='line' id='LC901'>through PDE action&quot;</div><div class='line' id='LC902'><br/></div><div class='line' id='LC903'>catalyticActivity(proteinAbundance(PFH:&quot;PDE Family&quot;)) directlyIncreases reaction(reactants(abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;)),products(abundance(CHEBI:AMP)))</div><div class='line' id='LC904'><br/></div><div class='line' id='LC905'>SET CellStructure = &quot;Cell Membrane&quot;</div><div class='line' id='LC906'>SET Evidence = &quot;cAMP is of pivotal importance in determining many aspects of cellular function [1,2].</div><div class='line' id='LC907'>It is generated at the cytosol surface of the plasma membrane through the action</div><div class='line' id='LC908'>of adenylate cyclases, of which there is a large family. Increased levels</div><div class='line' id='LC909'>of cAMP are translated into cellular responses through the action of cAMP-dependent</div><div class='line' id='LC910'>protein kinase (PKA)&quot;</div><div class='line' id='LC911'><br/></div><div class='line' id='LC912'>catalyticActivity(proteinAbundance(PFH:&quot;ADCY Family&quot;)) directlyIncreases abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;)</div><div class='line' id='LC913'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;) directlyIncreases kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;))</div><div class='line' id='LC914'><br/></div><div class='line' id='LC915'>SET Evidence = &quot;Consistent with this, gene knockout studies have shown that PDE4B(-/-)  mice exhibit</div><div class='line' id='LC916'>a profound attenuation in the ability of lipopolysaccharide (&#39;LPS&#39;) to generate</div><div class='line' id='LC917'>tumour necrosis factor-α (&#39;TNF-α&#39;) [18].&quot;</div><div class='line' id='LC918'>SET Species = &quot;10090&quot;</div><div class='line' id='LC919'><br/></div><div class='line' id='LC920'>proteinAbundance(MGI:Pde4b) increases (abundance(SCHEM:Lipopolysaccharide) increases proteinAbundance(MGI:Tnf))</div><div class='line' id='LC921'><br/></div><div class='line' id='LC922'>SET Evidence = &quot;The third subdomain of the catalytic unit of all PDE4 subfamilies, but not that of</div><div class='line' id='LC923'>PDE4A, contains a single, ERK consensus motif (Pro-Xaa-Ser-Pro). The serine residue</div><div class='line' id='LC924'>in this site can be phosphorylated, both in vitro and in vivo , by ERK [49,70,71].&quot;</div><div class='line' id='LC925'><br/></div><div class='line' id='LC926'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)) directlyIncreases proteinAbundance(HGNC:PDE4B,proteinModification(P,S))</div><div class='line' id='LC927'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)) directlyIncreases proteinAbundance(HGNC:PDE4C,proteinModification(P,S))</div><div class='line' id='LC928'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)) directlyIncreases proteinAbundance(HGNC:PDE4D,proteinModification(P,S))</div><div class='line' id='LC929'><br/></div><div class='line' id='LC930'>SET Evidence = &quot;ERK phosphorylation of PDE4 long isoforms leads to inhibition under conditions where</div><div class='line' id='LC931'>the serine target is the sole residue phosphorylated [49,70,71].&quot;</div><div class='line' id='LC932'><br/></div><div class='line' id='LC933'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)) directlyDecreases catalyticActivity(proteinAbundance(PFH:&quot;PDE4 Long No A Family&quot;))</div><div class='line' id='LC934'><br/></div><div class='line' id='LC935'>SET CardiovascularSystem = &quot;Aorta&quot;</div><div class='line' id='LC936'>SET Tissue = &quot;Muscle, Smooth&quot;</div><div class='line' id='LC937'>SET Evidence = &quot;In these cells ERK causes the autocrine generation of prostaglandin E2  (PGE2) through</div><div class='line' id='LC938'>activation of PKA2 and the production of arachidonic acid. Thus the rapidly</div><div class='line' id='LC939'>generated PGE2 stimulates adenylate cyclase, increasing cAMP levels,&quot;</div><div class='line' id='LC940'>SET Species = &quot;9606&quot;</div><div class='line' id='LC941'><br/></div><div class='line' id='LC942'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)) increases abundance(CHEBI:&quot;prostaglandin E2&quot;)</div><div class='line' id='LC943'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)) increases catalyticActivity(proteinAbundance(PFH:&quot;PLA2 Family&quot;))</div><div class='line' id='LC944'>catalyticActivity(proteinAbundance(PFH:&quot;PLA2 Family&quot;)) increases abundance(CHEBI:&quot;arachidonic acid&quot;)</div><div class='line' id='LC945'>abundance(CHEBI:&quot;prostaglandin E2&quot;) increases catalyticActivity(proteinAbundance(PFH:&quot;ADCY Family&quot;))</div><div class='line' id='LC946'><br/></div><div class='line' id='LC947'>SET Cell = &quot;Myeloid Cells&quot;</div><div class='line' id='LC948'>SET Evidence = &quot;Whether a similar mechanism underpins the ability of interleukin 3 (IL-3) and IL-4</div><div class='line' id='LC949'>to increase PDE4 activity in myeloid cells through an ERK-mediated process [75],</div><div class='line' id='LC950'>or because ERK-activated short forms predominate in such cells (see above), remains</div><div class='line' id='LC951'>to be seen.&quot;</div><div class='line' id='LC952'><br/></div><div class='line' id='LC953'>proteinAbundance(HGNC:IL3) increases catalyticActivity(proteinAbundance(PFH:&quot;PDE4 Family&quot;))</div><div class='line' id='LC954'>proteinAbundance(HGNC:IL4) increases catalyticActivity(proteinAbundance(PFH:&quot;PDE4 Family&quot;))</div><div class='line' id='LC955'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)) directlyIncreases catalyticActivity(proteinAbundance(PFH:&quot;PDE4 Short Family&quot;))</div><div class='line' id='LC956'><br/></div><div class='line' id='LC957'>SET Evidence = &quot;PA causes a marked (0.7-3-fold) activation of various long PDE4 isoforms, but fails</div><div class='line' id='LC958'>to affect short and super-short isoforms [87,91]. Similar activation was seen</div><div class='line' id='LC959'>with the acidic phospholipid phosphatidylserine (PS), but not with neutral phospholipids.&quot;</div><div class='line' id='LC960'><br/></div><div class='line' id='LC961'>abundance(CHEBI:&quot;phosphatidic acid&quot;) increases catalyticActivity(proteinAbundance(PFH:&quot;PDE4 Long Family&quot;))</div><div class='line' id='LC962'>abundance(CHEBI:&quot;phosphatidyl-L-serine&quot;) increases catalyticActivity(proteinAbundance(PFH:&quot;PDE4 Long Family&quot;))</div><div class='line' id='LC963'><br/></div><div class='line' id='LC964'>SET Evidence = &quot;All 3 categories of PDE4 isoforms from all four subfamilies can interact with β-arrestin1/2,</div><div class='line' id='LC965'>implying that a common region in the PDE4 catalytic unit provides a</div><div class='line' id='LC966'>binding site for β-arrestins [65]. Thus challenge of cells with a β-agonist has</div><div class='line' id='LC967'>been shown to cause recruitment of a PDE4–arrestin complex to the β2- AR.&quot;</div><div class='line' id='LC968'><br/></div><div class='line' id='LC969'>complexAbundance(proteinAbundance(PFH:&quot;PDE4 Family&quot;),proteinAbundance(PFH:&quot;ARRB Family&quot;))</div><div class='line' id='LC970'>molecularActivity(proteinAbundance(HGNC:ADRB2)) directlyIncreases complexAbundance(proteinAbundance(HGNC:ADRB2),proteinAbundance(PFH:&quot;PDE4 Family&quot;),proteinAbundance(PFH:&quot;ARRB Family&quot;))</div><div class='line' id='LC971'><br/></div><div class='line' id='LC972'>UNSET STATEMENT_GROUP</div><div class='line' id='LC973'><br/></div><div class='line' id='LC974'>SET STATEMENT_GROUP = &quot;Group 6&quot;</div><div class='line' id='LC975'><br/></div><div class='line' id='LC976'>SET CellLine = &quot;T-47D&quot;</div><div class='line' id='LC977'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC978'>SET BodyRegion = &quot;Mammary Glands, Human&quot;</div><div class='line' id='LC979'>SET Evidence = &quot;Like progesterone receptors (PR), Stat5a and 5b are required for normal mammary gland</div><div class='line' id='LC980'>growth and differentiation. These two proteins are up-regulated during pregnancy,</div><div class='line' id='LC981'>a period dominated by high levels of progesterone.&quot;</div><div class='line' id='LC982'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;9813040&quot;,&quot;&quot;,&quot;Richer JK|Lange CA|Manning NG|Owen G|Powell R|Horwitz KB&quot;,&quot;&quot;}</div><div class='line' id='LC983'>SET Species = &quot;9606&quot;</div><div class='line' id='LC984'><br/></div><div class='line' id='LC985'>proteinAbundance(HGNC:STAT5A) increases biologicalProcess(MESHPP:&quot;Cell Differentiation&quot;)</div><div class='line' id='LC986'>proteinAbundance(HGNC:STAT5B) increases biologicalProcess(MESHPP:&quot;Cell Differentiation&quot;)</div><div class='line' id='LC987'>proteinAbundance(HGNC:PGR) increases biologicalProcess(MESHPP:&quot;Cell Differentiation&quot;)</div><div class='line' id='LC988'>biologicalProcess(MESHPP:Pregnancy) positiveCorrelation proteinAbundance(HGNC:STAT5A)</div><div class='line' id='LC989'>biologicalProcess(MESHPP:Pregnancy) positiveCorrelation proteinAbundance(HGNC:STAT5B)</div><div class='line' id='LC990'><br/></div><div class='line' id='LC991'>SET Disease = &quot;Breast Neoplasms&quot;</div><div class='line' id='LC992'>SET Evidence = &quot;In addition, progestin treatment induces translocation of Stat5 into the nucleus,</div><div class='line' id='LC993'>possibly mediated by the association of PR and Stat5. Last, progesterone pretreatment</div><div class='line' id='LC994'>enhances the phosphorylation of Stat5 on tyrosine 694 induced by epidermal</div><div class='line' id='LC995'>growth factor.&quot;</div><div class='line' id='LC996'><br/></div><div class='line' id='LC997'>abundance(CHEBIID:59826) increases translocation(proteinAbundance(PFH:&quot;STAT5 Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;)</div><div class='line' id='LC998'>abundance(CHEBIID:59826) increases (proteinAbundance(HGNC:EGF) increases proteinAbundance(PFH:&quot;STAT5 Family&quot;,proteinModification(P,Y,694)))</div><div class='line' id='LC999'><br/></div><div class='line' id='LC1000'>SET Evidence = &quot;Functional data show that progestin pretreatment of breast cancer cells enhances the</div><div class='line' id='LC1001'>ability of prolactin to stimulate the transcriptional activity of Stat5 on a</div><div class='line' id='LC1002'>β-casein promoter. Progesterone and epidermal growth factor synergize to control</div><div class='line' id='LC1003'>transcription from p21WAF1 and c-fos promoters.&quot;</div><div class='line' id='LC1004'><br/></div><div class='line' id='LC1005'>compositeAbundance(abundance(CHEBIID:59826),proteinAbundance(HGNC:PRL)) increases (transcriptionalActivity(proteinAbundance(PFH:&quot;STAT5 Family&quot;)) directlyIncreases rnaAbundance(HGNC:CSN2))</div><div class='line' id='LC1006'>compositeAbundance(abundance(CHEBI:progesterone),proteinAbundance(HGNC:EGF)) increases (transcriptionalActivity(proteinAbundance(PFH:&quot;STAT5 Family&quot;)) directlyIncreases rnaAbundance(HGNC:FOS))</div><div class='line' id='LC1007'>compositeAbundance(abundance(CHEBI:progesterone),proteinAbundance(HGNC:EGF)) increases (transcriptionalActivity(proteinAbundance(PFH:&quot;STAT5 Family&quot;)) directlyIncreases rnaAbundance(HGNC:CDKN1A))</div><div class='line' id='LC1008'><br/></div><div class='line' id='LC1009'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC1010'>SET Evidence = &quot;Stat5 protein levels were elevated by 8 h and remained elevated until 72 h after R5020</div><div class='line' id='LC1011'>treatment with increases of 4–7-fold (Fig. 1A). To test the PR dependence</div><div class='line' id='LC1012'>of this effect, the experiment was repeated using PR-negative T47D-Y cells (28)</div><div class='line' id='LC1013'>(Fig. 1B). In the absence of PR, R5020 did not up-regulate Stat5.&quot;</div><div class='line' id='LC1014'><br/></div><div class='line' id='LC1015'>abundance(CHEBIID:59826) increases proteinAbundance(PFH:&quot;STAT5 Family&quot;) //R5020 is a synthetic progestin</div><div class='line' id='LC1016'>proteinAbundance(HGNC:PGR) increases proteinAbundance(PFH:&quot;STAT5 Family&quot;)</div><div class='line' id='LC1017'><br/></div><div class='line' id='LC1018'>SET Evidence = &quot;This study shows that both the longer (95 kDa) Stat5a and the shorter (92 kDa) Stat5b</div><div class='line' id='LC1019'>isoform are up-regulated by progestin treatment.&quot;</div><div class='line' id='LC1020'><br/></div><div class='line' id='LC1021'>abundance(CHEBIID:59826) increases proteinAbundance(HGNC:STAT5A)</div><div class='line' id='LC1022'>abundance(CHEBIID:59826) increases proteinAbundance(HGNC:STAT5B)</div><div class='line' id='LC1023'><br/></div><div class='line' id='LC1024'>SET Evidence = &quot;Similar studies using anti-Stat3 (Fig. 2B) and anti-Stat1 (Fig. 2C) antibodies show</div><div class='line' id='LC1025'>that these STAT family members are also progestin regulated. While Stat3 is clearly</div><div class='line' id='LC1026'>up-regulated by progestin treatment, Stat1 is slightly down-regulated.&quot;</div><div class='line' id='LC1027'><br/></div><div class='line' id='LC1028'>abundance(CHEBIID:59826) increases proteinAbundance(HGNC:STAT3)</div><div class='line' id='LC1029'>abundance(CHEBIID:59826) decreases proteinAbundance(HGNC:STAT1)</div><div class='line' id='LC1030'><br/></div><div class='line' id='LC1031'>SET Evidence = &quot;Northern blot analysis demonstrates hormone-dependent induction of Stat5a message</div><div class='line' id='LC1032'>at 12 and 24 h following progestin treatment (Fig. 3).&quot;</div><div class='line' id='LC1033'><br/></div><div class='line' id='LC1034'>abundance(CHEBIID:59826) increases rnaAbundance(HGNC:STAT5A)</div><div class='line' id='LC1035'><br/></div><div class='line' id='LC1036'>SET Evidence = &quot;In contrast, the same Northern blot hybridized with cDNA for two genes known to be</div><div class='line' id='LC1037'>PR regulated, fatty acid synthetase (30,38) or cyclin D1 (18,39), shows equal</div><div class='line' id='LC1038'>induction of these genes by the two PR isoforms.&quot;</div><div class='line' id='LC1039'><br/></div><div class='line' id='LC1040'>transcriptionalActivity(proteinAbundance(HGNC:PGR)) increases rnaAbundance(HGNC:FASN) //fatty acid synthase = FASN</div><div class='line' id='LC1041'>transcriptionalActivity(proteinAbundance(HGNC:PGR)) increases rnaAbundance(HGNC:CCND1)</div><div class='line' id='LC1042'><br/></div><div class='line' id='LC1043'>SET Evidence = &quot;T47Dco cells were treated for 24 h with 10 nm R5020 or vehicle, then with 10 nm EGF</div><div class='line' id='LC1044'>or vehicle for 5 min. Nuclear and cytosolic extracts were prepared and equal</div><div class='line' id='LC1045'>amounts of protein were probed with antibody recognizing total Stat5 (Fig. 4A).</div><div class='line' id='LC1046'>In untreated cells, Stat5 was exclusively cytoplasmic (lane 1); no Stat5 was found</div><div class='line' id='LC1047'>in the nucleus (lane 2). As expected, EGF treatment promoted nuclear translocation</div><div class='line' id='LC1048'>of a portion of Stat5 (lanes 5 and 6). Surprisingly, R5020 not only increased</div><div class='line' id='LC1049'>total Stat5 levels (lanes 3  and 4; 7and 8), but also promoted extensive nuclear</div><div class='line' id='LC1050'>translocation of Stat5 (compare lanes 2 and 4) independent of EGF treatment.&quot;</div><div class='line' id='LC1051'><br/></div><div class='line' id='LC1052'>abundance(CHEBIID:59826) increases proteinAbundance(PFH:&quot;STAT5 Family&quot;)</div><div class='line' id='LC1053'>abundance(CHEBIID:59826) increases translocation(proteinAbundance(PFH:&quot;STAT5 Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;)</div><div class='line' id='LC1054'>proteinAbundance(HGNC:EGF) increases translocation(proteinAbundance(PFH:&quot;STAT5 Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;)</div><div class='line' id='LC1055'><br/></div><div class='line' id='LC1056'>SET CellLine = &quot;HeLa&quot;</div><div class='line' id='LC1057'>SET Evidence = &quot;These reciprocal studies show that PR and Stat5 are associated, either directly or</div><div class='line' id='LC1058'>in a multiprotein complex.&quot;</div><div class='line' id='LC1059'><br/></div><div class='line' id='LC1060'>complexAbundance(proteinAbundance(HGNC:PGR),proteinAbundance(PFH:&quot;STAT5 Family&quot;))</div><div class='line' id='LC1061'><br/></div><div class='line' id='LC1062'>SET CellLine = &quot;T-47D&quot;</div><div class='line' id='LC1063'>SET Evidence = &quot;In the absence of R5020 pretreatment, JAK2 is immunoprecipitated with the anti-phosphotyrosine</div><div class='line' id='LC1064'>antibody only following EGF treatment (lane 2). Note that JAK2 is</div><div class='line' id='LC1065'>not present in phosphotyrosine immunoprecipitates after 1 h of R5020 treatment (lane</div><div class='line' id='LC1066'>1). However, JAK2 is immunoprecipitated with the anti-phosphotyrosine antibody</div><div class='line' id='LC1067'>as efficiently after 48 h of R5020 treatment (lane 4) as with EGF treatment</div><div class='line' id='LC1068'>(lane 5).&quot;</div><div class='line' id='LC1069'><br/></div><div class='line' id='LC1070'>abundance(CHEBIID:59826) increases proteinAbundance(HGNC:JAK2,proteinModification(P,Y))</div><div class='line' id='LC1071'>proteinAbundance(HGNC:EGF) increases proteinAbundance(HGNC:JAK2,proteinModification(P,Y))</div><div class='line' id='LC1072'><br/></div><div class='line' id='LC1073'>SET Evidence = &quot;However, Stat5 remained unphosphorylated (P-Stat5, lanes 1–5), except in the cells</div><div class='line' id='LC1074'>that were pretreated with R5020 for 48 h, prior to the 10-min prolactin treatment</div><div class='line' id='LC1075'>(P-Stat5, lane 6). Prolactin alone had no effect (lane 3) nor did transient</div><div class='line' id='LC1076'>(1 h) or chronic (48 h) R5020 treatment (lane 2). Thus, in T47Dco cells, Stat5 phosphorylation</div><div class='line' id='LC1077'>by prolactin requires progesterone pretreatment.&quot;</div><div class='line' id='LC1078'><br/></div><div class='line' id='LC1079'>compositeAbundance(proteinAbundance(HGNC:PRL),abundance(CHEBIID:59826)) increases proteinAbundance(PFH:&quot;STAT5 Family&quot;,proteinModification(P))</div><div class='line' id='LC1080'><br/></div><div class='line' id='LC1081'>SET Evidence = &quot;The β-casein promoter, known to be induced by Stat5 when activated by prolactin via</div><div class='line' id='LC1082'>prolactin receptors and JAK2, was next used to test the function of the phosphorylated</div><div class='line' id='LC1083'>Stat5. T47D-YB cells were pretreated with either R5020 or ethanol vehicle</div><div class='line' id='LC1084'>for 48 h. Cells were then washed, transfected with a β-casein promoter-luciferase</div><div class='line' id='LC1085'>reporter, treated with either R5020 or prolactin, and harvested for luciferase</div><div class='line' id='LC1086'>assay 24 h after hormone treatment. We found that in T47D-YB breast cancer</div><div class='line' id='LC1087'>cells, prolactin alone has minimal to no significant effect on the β-casein luciferase</div><div class='line' id='LC1088'>promoter. However, after R5020 pretreatment, a 6–7-fold induction of the</div><div class='line' id='LC1089'>β-casein luciferase promoter was observed (Fig.7B). Thus R5020 sensitized these</div><div class='line' id='LC1090'>breast cancer cells to the transcriptional effects of prolactin mediated through</div><div class='line' id='LC1091'>Stat5.&quot;</div><div class='line' id='LC1092'><br/></div><div class='line' id='LC1093'>compositeAbundance(proteinAbundance(HGNC:PRL),abundance(CHEBIID:59826)) increases transcriptionalActivity(proteinAbundance(PFH:&quot;STAT5 Family&quot;))</div><div class='line' id='LC1094'>compositeAbundance(proteinAbundance(HGNC:PRL),abundance(CHEBIID:59826)) increases rnaAbundance(HGNC:CSN2) //beta casein = CSN2</div><div class='line' id='LC1095'><br/></div><div class='line' id='LC1096'>SET Evidence = &quot;Fig. 8A shows that the p21WAF1 promoter is induced 4.5-fold by progesterone, 2.4-fold</div><div class='line' id='LC1097'>by EGF, and 13.2-fold by both hormones together. The average increase in five</div><div class='line' id='LC1098'>experiments was progesterone, 3.5-fold; EGF, 2.2-fold; both hormones, 11-fold.</div><div class='line' id='LC1099'>Fig. 8B demonstrates the corresponding increases in endogenous p21 levels when</div><div class='line' id='LC1100'>T47D-YB cells are treated for 24 h with ethanol, progesterone, EGF, or both hormones.</div><div class='line' id='LC1101'>Whole cell lysates were probed by immunoblotting with antibody to p21.&quot;</div><div class='line' id='LC1102'><br/></div><div class='line' id='LC1103'>compositeAbundance(proteinAbundance(HGNC:EGF),abundance(CHEBI:progesterone)) increases rnaAbundance(HGNC:CDKN1A)</div><div class='line' id='LC1104'>abundance(CHEBI:progesterone) increases rnaAbundance(HGNC:CDKN1A)</div><div class='line' id='LC1105'>proteinAbundance(HGNC:EGF) increases rnaAbundance(HGNC:CDKN1A)</div><div class='line' id='LC1106'><br/></div><div class='line' id='LC1107'>SET Evidence = &quot;Fig. 8C shows that the c-fos promoter is induced 19.3-fold by R5020 and 6.2-fold by</div><div class='line' id='LC1108'>EGF. Remarkably, together the two hormones produced a 145-fold increase in luciferase</div><div class='line' id='LC1109'>activity.&quot;</div><div class='line' id='LC1110'><br/></div><div class='line' id='LC1111'>compositeAbundance(proteinAbundance(HGNC:EGF),abundance(CHEBIID:59826)) increases rnaAbundance(HGNC:FOS)</div><div class='line' id='LC1112'>proteinAbundance(HGNC:EGF) increases rnaAbundance(HGNC:FOS)</div><div class='line' id='LC1113'>abundance(CHEBIID:59826) increases rnaAbundance(HGNC:FOS)</div><div class='line' id='LC1114'><br/></div><div class='line' id='LC1115'>SET TextLocation = &quot;Legend&quot;</div><div class='line' id='LC1116'>SET Evidence = &quot;Progesterone enhances the ability of EGF to phosphorylate Stat5 on tyrosine 694.&quot;</div><div class='line' id='LC1117'><br/></div><div class='line' id='LC1118'>compositeAbundance(proteinAbundance(HGNC:EGF),abundance(CHEBI:progesterone)) increases proteinAbundance(PFH:&quot;STAT5 Family&quot;,proteinModification(P,Y,694))</div><div class='line' id='LC1119'><br/></div><div class='line' id='LC1120'>UNSET STATEMENT_GROUP</div><div class='line' id='LC1121'><br/></div><div class='line' id='LC1122'>SET STATEMENT_GROUP = &quot;Group 7&quot;</div><div class='line' id='LC1123'><br/></div><div class='line' id='LC1124'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC1125'>SET Evidence = &quot;Mitochondrial dysfunction is a major mechanism whereby drugs can induce liver injury</div><div class='line' id='LC1126'>and other serious side effects such as lactic acidosis and rhabdomyolysis in</div><div class='line' id='LC1127'>some patients.&quot;</div><div class='line' id='LC1128'>SET Citation = {&quot;PubMed&quot;,&quot;Fundamental &amp; clinical pharmacology&quot;,&quot;18705745&quot;,&quot;&quot;,&quot;Labbe G|Pessayre D|Fromenty B&quot;,&quot;&quot;}</div><div class='line' id='LC1129'>SET Species = &quot;9606&quot;</div><div class='line' id='LC1130'><br/></div><div class='line' id='LC1131'>pathology(SDIS:&quot;mitochondrial damage&quot;) increases pathology(MESHD:&quot;Drug-Induced Liver Injury&quot;)</div><div class='line' id='LC1132'><br/></div><div class='line' id='LC1133'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC1134'><br/></div><div class='line' id='LC1135'>pathology(SDIS:&quot;mitochondrial damage&quot;) increases pathology(MESHD:&quot;Acidosis, Lactic&quot;)</div><div class='line' id='LC1136'>pathology(SDIS:&quot;mitochondrial damage&quot;) increases pathology(MESHD:Rhabdomyolysis)</div><div class='line' id='LC1137'><br/></div><div class='line' id='LC1138'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC1139'>SET Evidence = &quot;drugs can induce microvesicular steatosis, a potentially severe lesion that can be</div><div class='line' id='LC1140'>associated with profound hypoglycaemia and encephalopathy&quot;</div><div class='line' id='LC1141'><br/></div><div class='line' id='LC1142'>pathology(SDIS:Steatosis) positiveCorrelation pathology(MESHD:Hypoglycemia)</div><div class='line' id='LC1143'>pathology(SDIS:Steatosis) positiveCorrelation pathology(MESHD:&quot;Hepatic Encephalopathy&quot;)</div><div class='line' id='LC1144'><br/></div><div class='line' id='LC1145'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC1146'><br/></div><div class='line' id='LC1147'>pathology(SDIS:Steatosis) positiveCorrelation pathology(MESHD:&quot;Fatty Liver&quot;)</div><div class='line' id='LC1148'><br/></div><div class='line' id='LC1149'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC1150'>SET DigestiveSystem = &quot;Liver&quot;</div><div class='line' id='LC1151'>SET Evidence = &quot;They can also trigger hepatic necrosis and/or apoptosis, causing cytolytic hepatitis,</div><div class='line' id='LC1152'>which can evolve into liver failure.&quot;</div><div class='line' id='LC1153'><br/></div><div class='line' id='LC1154'>biologicalProcess(GO:necrosis) increases pathology(MESHD:Hepatitis)</div><div class='line' id='LC1155'>biologicalProcess(GO:&quot;apoptotic process&quot;) increases pathology(MESHD:Hepatitis)</div><div class='line' id='LC1156'><br/></div><div class='line' id='LC1157'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC1158'>SET Evidence = &quot;During the fasting state, fatty acid oxidation (FAO) in the liver is incomplete; the</div><div class='line' id='LC1159'>acetyl-CoA that is generated is not oxidized in the liver, but condenses into</div><div class='line' id='LC1160'>ketone bodies (mainly acetoacetate and β-hydroxybutyrate) (Figure 1), which are</div><div class='line' id='LC1161'>released into the plasma for subsequent oxidation in extrahepatic tissues.&quot;</div><div class='line' id='LC1162'><br/></div><div class='line' id='LC1163'>biologicalProcess(GO:&quot;fatty acid oxidation&quot;) increases abundance(CHEBI:&quot;acetyl-CoA&quot;)</div><div class='line' id='LC1164'>reaction(reactants(abundance(CHEBI:&quot;acetyl-CoA&quot;)),products(abundance(CHEBI:acetoacetate),abundance(CHEBI:&quot;3-hydroxybutyrate&quot;)))</div><div class='line' id='LC1165'>cellSecretion(abundance(CHEBI:acetoacetate))</div><div class='line' id='LC1166'>cellSecretion(abundance(CHEBI:&quot;3-hydroxybutyrate&quot;))</div><div class='line' id='LC1167'><br/></div><div class='line' id='LC1168'>SET TextLocation = &quot;Legend&quot;</div><div class='line' id='LC1169'>SET CellStructure = &quot;Mitochondrial Membranes&quot;</div><div class='line' id='LC1170'>SET Evidence = &quot;LCFAs are activated into LCFA-coenzyme A (acyl- CoA) thioesters by long-chain acyl-CoA</div><div class='line' id='LC1171'>synthetases (ACS) located in the outer mitochondrial membrane, microsomes</div><div class='line' id='LC1172'>and peroxisomes&quot;</div><div class='line' id='LC1173'><br/></div><div class='line' id='LC1174'>catalyticActivity(proteinAbundance(PFH:&quot;ACSL Family&quot;)) directlyIncreases reaction(reactants(abundance(SCHEM:&quot;Long-chain fatty acid&quot;)),products(abundance(SCHEM:&quot;Long-chain fatty acyl CoA&quot;)))</div><div class='line' id='LC1175'><br/></div><div class='line' id='LC1176'>SET CellStructure = &quot;Microsomes&quot;</div><div class='line' id='LC1177'><br/></div><div class='line' id='LC1178'>catalyticActivity(proteinAbundance(PFH:&quot;ACSL Family&quot;)) directlyIncreases reaction(reactants(abundance(SCHEM:&quot;Long-chain fatty acid&quot;)),products(abundance(SCHEM:&quot;Long-chain fatty acyl CoA&quot;)))</div><div class='line' id='LC1179'><br/></div><div class='line' id='LC1180'>SET CellStructure = &quot;Peroxisomes&quot;</div><div class='line' id='LC1181'><br/></div><div class='line' id='LC1182'>catalyticActivity(proteinAbundance(PFH:&quot;ACSL Family&quot;)) directlyIncreases reaction(reactants(abundance(SCHEM:&quot;Long-chain fatty acid&quot;)),products(abundance(SCHEM:&quot;Long-chain fatty acyl CoA&quot;)))</div><div class='line' id='LC1183'><br/></div><div class='line' id='LC1184'>SET CellStructure = &quot;Mitochondrial Membranes&quot;</div><div class='line' id='LC1185'>SET Evidence = &quot;The long-chain acyl-CoA is converted into an acyl-carnitine by carnitine palmitoyltransferase-I</div><div class='line' id='LC1186'>(CPT-I) in the outer mitochondrial membrane.&quot;</div><div class='line' id='LC1187'><br/></div><div class='line' id='LC1188'>catalyticActivity(proteinAbundance(HGNC:CPT1A)) directlyIncreases reaction(reactants(abundance(SCHEM:&quot;Long-chain fatty acyl CoA&quot;)),products(abundance(SCHEM:&quot;O-Acylcarnitine&quot;)))</div><div class='line' id='LC1189'><br/></div><div class='line' id='LC1190'>SET CellStructure = &quot;Mitochondria&quot;</div><div class='line' id='LC1191'>SET Evidence = &quot;LCFA-CoA thioesters are then oxidized into acetyl-CoA moieties via the β-oxidation</div><div class='line' id='LC1192'>process.&quot;</div><div class='line' id='LC1193'><br/></div><div class='line' id='LC1194'>biologicalProcess(GO:&quot;fatty acid beta-oxidation&quot;) increases reaction(reactants(abundance(SCHEM:&quot;Long-chain fatty acyl CoA&quot;)),products(abundance(CHEBI:&quot;acetyl-CoA&quot;)))</div><div class='line' id='LC1195'><br/></div><div class='line' id='LC1196'>SET Evidence = &quot;Acetyl-CoA moieties can then generate ketone bodies (mainly acetoacetate and β-hydroxybutyrate)</div><div class='line' id='LC1197'>via ketogenesis, which is stimulated during fasting.&quot;</div><div class='line' id='LC1198'><br/></div><div class='line' id='LC1199'>biologicalProcess(MESHPP:Eating) decreases reaction(reactants(abundance(SCHEM:&quot;Acetyl-CoA&quot;)),products(abundance(SCHEM:acetoacetate),abundance(CHEBI:&quot;3-hydroxybutyrate&quot;)))</div><div class='line' id='LC1200'>abundance(SCHEM:acetoacetate) isA abundance(SCHEM:&quot;Ketone Body&quot;)</div><div class='line' id='LC1201'>abundance(CHEBI:&quot;3-hydroxybutyrate&quot;) isA abundance(SCHEM:&quot;Ketone Body&quot;)</div><div class='line' id='LC1202'><br/></div><div class='line' id='LC1203'>SET CellStructure = &quot;Mitochondria, Liver&quot;</div><div class='line' id='LC1204'>SET Evidence = &quot;Ketone bodies are liberated into the plasma to be used by extrahepatic tissues for</div><div class='line' id='LC1205'>energy production.&quot;</div><div class='line' id='LC1206'><br/></div><div class='line' id='LC1207'>cellSecretion(abundance(SCHEM:&quot;Ketone Body&quot;)) increases biologicalProcess(GO:&quot;energy derivation by oxidation of organic compounds&quot;)</div><div class='line' id='LC1208'><br/></div><div class='line' id='LC1209'>SET Evidence = &quot;After a meal, however, the acetyl-CoA moieties are mainly generated in the liver by</div><div class='line' id='LC1210'>the glycolysis of glucose into pyruvate and the oxidative decarboxylation of</div><div class='line' id='LC1211'>pyruvate.&quot;</div><div class='line' id='LC1212'><br/></div><div class='line' id='LC1213'>biologicalProcess(MESHPP:Eating) increases reaction(reactants(abundance(CHEBI:glucose)),products(abundance(CHEBI:pyruvate)))</div><div class='line' id='LC1214'>reaction(reactants(abundance(CHEBI:glucose)),products(abundance(CHEBI:pyruvate))) subProcessOf biologicalProcess(MESHPP:Glycolysis)</div><div class='line' id='LC1215'><br/></div><div class='line' id='LC1216'>SET Evidence = &quot;The formed acetyl-CoA enters the tricarboxylic acid (TCA) cycle (not shown), to be</div><div class='line' id='LC1217'>fully oxidized or to form citrate, which can leave mitochondria and regenerate</div><div class='line' id='LC1218'>acetyl-CoA in the cytosol for subsequent de novo lipogenesis.&quot;</div><div class='line' id='LC1219'><br/></div><div class='line' id='LC1220'>reaction(reactants(abundance(CHEBI:&quot;acetyl-CoA&quot;)),products(abundance(SCHEM:Citrate))) subProcessOf biologicalProcess(GO:&quot;tricarboxylic acid cycle&quot;)</div><div class='line' id='LC1221'><br/></div><div class='line' id='LC1222'>SET Evidence = &quot;Mitochondrial fatty acid β-oxidation (FAO) and the TCA cycle generate NADH and FADH2,</div><div class='line' id='LC1223'>which transfer their electrons (e-) to the mitochondrial respiratory chain</div><div class='line' id='LC1224'>(MRC), regenerating NAD+ and FAD used for other β-oxidation (or TCA) cycles&quot;</div><div class='line' id='LC1225'><br/></div><div class='line' id='LC1226'>biologicalProcess(GO:&quot;fatty acid beta-oxidation&quot;) increases abundance(CHEBI:NADH)</div><div class='line' id='LC1227'>biologicalProcess(GO:&quot;fatty acid beta-oxidation&quot;) increases abundance(CHEBI:FADH2)</div><div class='line' id='LC1228'>biologicalProcess(GO:&quot;tricarboxylic acid cycle&quot;) increases abundance(CHEBI:NADH)</div><div class='line' id='LC1229'>biologicalProcess(GO:&quot;tricarboxylic acid cycle&quot;) increases abundance(CHEBI:FADH2)</div><div class='line' id='LC1230'><br/></div><div class='line' id='LC1231'>SET Evidence = &quot;When energy is needed (i.e. when ATP levels are low), these protons re-enter the matrix</div><div class='line' id='LC1232'>through ATP synthase (also referred to as complex V), thus liberating energy</div><div class='line' id='LC1233'>that is used to phosphorylate ADP into ATP.&quot;</div><div class='line' id='LC1234'><br/></div><div class='line' id='LC1235'>catalyticActivity(complexAbundance(NCH:&quot;Proton Transporting ATP Synthase Complex&quot;)) directlyIncreases biologicalProcess(GO:&quot;ATP synthesis coupled proton transport&quot;)</div><div class='line' id='LC1236'>abundance(CHEBI:ATP) decreases catalyticActivity(complexAbundance(NCH:&quot;Proton Transporting ATP Synthase Complex&quot;))</div><div class='line' id='LC1237'><br/></div><div class='line' id='LC1238'>SET Evidence = &quot;Cytochrome c release induces caspase activation and cell death via apoptosis or necrosis.&quot;</div><div class='line' id='LC1239'><br/></div><div class='line' id='LC1240'>translocation(proteinAbundance(HGNC:CYCS),MESHCL:Mitochondria,MESHCL:Cytoplasm) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC1241'>translocation(proteinAbundance(HGNC:CYCS),MESHCL:Mitochondria,MESHCL:Cytoplasm) increases biologicalProcess(GO:necrosis)</div><div class='line' id='LC1242'>translocation(proteinAbundance(HGNC:CYCS),MESHCL:Mitochondria,MESHCL:Cytoplasm) increases biologicalProcess(GO:&quot;activation of cysteine-type endopeptidase activity&quot;)</div><div class='line' id='LC1243'><br/></div><div class='line' id='LC1244'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC1245'>SET Evidence = &quot;When cells need energy, the rise in ADP levels within the mitochondria induces the</div><div class='line' id='LC1246'>re-entry of protons into the mitochondrial matrix through the membranespanning</div><div class='line' id='LC1247'>F0 portion of the ATP synthase complex (also referred to as the &#39;complex V of the</div><div class='line' id='LC1248'>MRC&#39;).&quot;</div><div class='line' id='LC1249'><br/></div><div class='line' id='LC1250'>abundance(CHEBI:ADP) increases catalyticActivity(complexAbundance(NCH:&quot;Proton Transporting ATP Synthase Complex&quot;))</div><div class='line' id='LC1251'><br/></div><div class='line' id='LC1252'>SET Evidence = &quot;Classically, it is considered that the number of normal mtDNA copies must fall below</div><div class='line' id='LC1253'>20–40% of basal levels to induce mitochondrial dysfunction and adverse events</div><div class='line' id='LC1254'>[6]. Below this threshold, hepatic mtDNA depletion can impair the MRC. This impairment</div><div class='line' id='LC1255'>can hamper the regeneration of NAD+ and FAD, thus leading to a secondary</div><div class='line' id='LC1256'>inhibition of the oxidation of fatty acids and pyruvate.&quot;</div><div class='line' id='LC1257'><br/></div><div class='line' id='LC1258'>biologicalProcess(SDIS:&quot;mitochondrial DNA damage&quot;) decreases biologicalProcess(GO:&quot;mitochondrial respiratory chain complex assembly&quot;)</div><div class='line' id='LC1259'>biologicalProcess(GO:&quot;mitochondrial respiratory chain complex assembly&quot;) increases abundance(CHEBI:FAD)</div><div class='line' id='LC1260'>abundance(CHEBI:NAD) increases biologicalProcess(GO:&quot;fatty acid beta-oxidation&quot;)</div><div class='line' id='LC1261'>abundance(CHEBI:FAD) increases biologicalProcess(GO:&quot;fatty acid beta-oxidation&quot;)</div><div class='line' id='LC1262'>abundance(CHEBI:NAD) increases biologicalProcess(GO:&quot;pyruvate oxidation&quot;)</div><div class='line' id='LC1263'>abundance(CHEBI:FAD) increases biologicalProcess(GO:&quot;pyruvate oxidation&quot;)</div><div class='line' id='LC1264'><br/></div><div class='line' id='LC1265'>SET Evidence = &quot;a key feature of the mitochondrial genome is its high sensitivity to oxidative damage,</div><div class='line' id='LC1266'>because of its proximity to the inner membrane (the main cellular source of</div><div class='line' id='LC1267'>ROS)&quot;</div><div class='line' id='LC1268'><br/></div><div class='line' id='LC1269'>biologicalProcess(GO:&quot;response to oxidative stress&quot;) increases pathology(SDIS:&quot;mitochondrial DNA damage&quot;)</div><div class='line' id='LC1270'>abundance(CHEBI:&quot;reactive oxygen species&quot;) increases pathology(SDIS:&quot;mitochondrial DNA damage&quot;)</div><div class='line' id='LC1271'><br/></div><div class='line' id='LC1272'>SET Evidence = &quot;However, at several upstream sites of the MRC (most probably complexes I and III),</div><div class='line' id='LC1273'>a small fraction of these electrons can directly react with oxygen, to generate</div><div class='line' id='LC1274'>the superoxide anion radical.&quot;</div><div class='line' id='LC1275'><br/></div><div class='line' id='LC1276'>biologicalProcess(GO:&quot;mitochondrial respiratory chain complex assembly&quot;) increases reaction(reactants(abundance(CHEBI:electron),abundance(CHEBI:dioxygen)),products(abundance(CHEBI:superoxide)))</div><div class='line' id='LC1277'><br/></div><div class='line' id='LC1278'>SET Evidence = &quot;to generate the superoxide anion radical. This radical is then dismutated by the mitochondrial</div><div class='line' id='LC1279'>manganese superoxide dismutase (MnSOD) into hydrogen peroxide (H2O2),</div><div class='line' id='LC1280'>which is detoxified into water by the mitochondrial glutathione peroxidase.&quot;</div><div class='line' id='LC1281'><br/></div><div class='line' id='LC1282'>catalyticActivity(proteinAbundance(HGNC:SOD2)) increases reaction(reactants(abundance(CHEBI:superoxide)),products(abundance(CHEBI:&quot;hydrogen peroxide&quot;)))</div><div class='line' id='LC1283'>catalyticActivity(proteinAbundance(HGNC:GPX1)) increases reaction(reactants(abundance(CHEBI:&quot;hydrogen peroxide&quot;)),products(abundance(CHEBI:water)))</div><div class='line' id='LC1284'><br/></div><div class='line' id='LC1285'>SET Evidence = &quot;Hence, in the normal (non-diseased) state, most of the ROS generated by the MRC is</div><div class='line' id='LC1286'>detoxified by the mitochondrial antioxidant defences.&quot;</div><div class='line' id='LC1287'><br/></div><div class='line' id='LC1288'>biologicalProcess(GO:&quot;mitochondrial respiratory chain complex assembly&quot;) increases abundance(CHEBI:&quot;reactive oxygen species&quot;)</div><div class='line' id='LC1289'><br/></div><div class='line' id='LC1290'>SET CellStructure = {&quot;Mitochondria, Liver&quot;,&quot;Mitochondria, Liver&quot;}</div><div class='line' id='LC1291'>SET Evidence = &quot;However, glutathione peroxidase needs adequate amounts of reduced glutathione in the</div><div class='line' id='LC1292'>mitochondrial matrix to detoxify H2O2.&quot;</div><div class='line' id='LC1293'><br/></div><div class='line' id='LC1294'>abundance(CHEBI:glutathione) increases catalyticActivity(proteinAbundance(HGNC:GPX1))</div><div class='line' id='LC1295'><br/></div><div class='line' id='LC1296'>SET CellStructure = &quot;Mitochondria, Liver&quot;</div><div class='line' id='LC1297'>SET Evidence = &quot;The depletion of mitochondrial glutathione below a critical threshold can impair mitochondrial</div><div class='line' id='LC1298'>H2O2 detoxification, which can trigger mitochondrial dysfunction,</div><div class='line' id='LC1299'>mitochondrial permeability transition (MPT) and cell death [22].&quot;</div><div class='line' id='LC1300'><br/></div><div class='line' id='LC1301'>abundance(CHEBI:glutathione) decreases pathology(SDIS:&quot;mitochondrial DNA damage&quot;)</div><div class='line' id='LC1302'>abundance(CHEBI:glutathione) decreases biologicalProcess(GO:&quot;positive regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1303'>abundance(CHEBI:glutathione) decreases biologicalProcess(GO:&quot;cell death&quot;)</div><div class='line' id='LC1304'><br/></div><div class='line' id='LC1305'>SET Evidence = &quot;rupture of the outer membrane and the release of pro-apoptotic proteins from the intermembrane</div><div class='line' id='LC1306'>space into the cytosol. The release of apoptosis-inducing factor (AIF)</div><div class='line' id='LC1307'>triggers the fragmentation of largesized nuclear DNA.&quot;</div><div class='line' id='LC1308'><br/></div><div class='line' id='LC1309'>translocation(proteinAbundance(HGNC:AIFM1),MESHCL:Mitochondria,MESHCL:Cytoplasm) increases biologicalProcess(GO:&quot;DNA fragmentation involved in apoptotic nuclear change&quot;)</div><div class='line' id='LC1310'><br/></div><div class='line' id='LC1311'>SET Evidence = &quot;The release of a protein called &#39;second mitochondria-derived activator of caspase/</div><div class='line' id='LC1312'>direct inhibitor of apoptosis-binding protein with low pI (Smac/DIABLO)&#39; inactivates</div><div class='line' id='LC1313'>the inhibitor of apoptosis proteins (IAPs).&quot;</div><div class='line' id='LC1314'><br/></div><div class='line' id='LC1315'>translocation(proteinAbundance(HGNC:DIABLO),MESHCL:Mitochondria,MESHCL:Cytoplasm) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC1316'><br/></div><div class='line' id='LC1317'>SET CellStructure = &quot;Cytoplasm&quot;</div><div class='line' id='LC1318'>SET Evidence = &quot;the released cytochrome c binds in the cytosol to Apaf-1 in an ATP-dependent manner</div><div class='line' id='LC1319'>to activate caspase-9.&quot;</div><div class='line' id='LC1320'><br/></div><div class='line' id='LC1321'>abundance(CHEBI:ATP) increases complexAbundance(proteinAbundance(HGNC:CYCS),proteinAbundance(HGNC:APAF1))</div><div class='line' id='LC1322'>complexAbundance(proteinAbundance(HGNC:CYCS),proteinAbundance(HGNC:APAF1)) increases peptidaseActivity(proteinAbundance(HGNC:CASP9))</div><div class='line' id='LC1323'><br/></div><div class='line' id='LC1324'>SET CellStructure = &quot;Mitochondria, Liver&quot;</div><div class='line' id='LC1325'>SET Evidence = &quot;Mitochondrial permeability transition can cause either apoptosis or necrosis.&quot;</div><div class='line' id='LC1326'><br/></div><div class='line' id='LC1327'>biologicalProcess(GO:&quot;positive regulation of mitochondrial membrane permeability&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC1328'>biologicalProcess(GO:&quot;positive regulation of mitochondrial membrane permeability&quot;) increases biologicalProcess(GO:necrosis)</div><div class='line' id='LC1329'><br/></div><div class='line' id='LC1330'>SET Evidence = &quot;In contrast, when MPT occurs in most mitochondria in a single cell, ATP generation</div><div class='line' id='LC1331'>is compromised because of the collapse of the Δψm, and the resulting ATP depletion</div><div class='line' id='LC1332'>triggers cell necrosis [2,24].&quot;</div><div class='line' id='LC1333'><br/></div><div class='line' id='LC1334'>biologicalProcess(GO:&quot;regulation of mitochondrial membrane permeability&quot;) decreases abundance(CHEBI:ATP)</div><div class='line' id='LC1335'><br/></div><div class='line' id='LC1336'>SET Evidence = &quot;Mitochondrial permeability transition pore opening, which is calcium-dependent, can</div><div class='line' id='LC1337'>be triggered by a variety of endogenous compounds such as iron, ROS, nitric oxide,</div><div class='line' id='LC1338'>free fatty acids (and acyl-CoA derivatives), ceramide and bile salts [25,26].&quot;</div><div class='line' id='LC1339'><br/></div><div class='line' id='LC1340'>abundance(CHEBI:&quot;calcium ion&quot;) increases biologicalProcess(GO:&quot;regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1341'>abundance(CHEBIID:24875) increases biologicalProcess(GO:&quot;regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1342'>abundance(CHEBI:&quot;nitric oxide&quot;) increases biologicalProcess(GO:&quot;regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1343'>abundance(CHEBI:&quot;fatty acid&quot;) increases biologicalProcess(GO:&quot;regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1344'>abundance(CHEBI:ceramide) increases biologicalProcess(GO:&quot;regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1345'>abundance(CHEBI:&quot;bile salt&quot;) increases biologicalProcess(GO:&quot;regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1346'><br/></div><div class='line' id='LC1347'>SET Evidence = &quot;MPT can also be triggered by extracellular cytokines such as tumour necrosis factor-a</div><div class='line' id='LC1348'>(TNF-α) and Fas ligand (Fas-L) acting through their plasma membrane receptors</div><div class='line' id='LC1349'>[27,28].&quot;</div><div class='line' id='LC1350'><br/></div><div class='line' id='LC1351'>proteinAbundance(HGNC:TNF) increases biologicalProcess(GO:&quot;regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1352'>proteinAbundance(HGNC:FASLG) increases biologicalProcess(GO:&quot;regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1353'><br/></div><div class='line' id='LC1354'>SET Cell = &quot;Hepatocytes&quot;</div><div class='line' id='LC1355'>SET Evidence = &quot;troglitazone and acetaminophen activate c-Jun N-terminal protein kinase (JNK), thus</div><div class='line' id='LC1356'>inducing the cleavage of Bid, the translocation of this pro-apoptotic protein</div><div class='line' id='LC1357'>to the outer mitochondrial membranes and the release of cytochrome c from mitochondria</div><div class='line' id='LC1358'>[32,33].&quot;</div><div class='line' id='LC1359'><br/></div><div class='line' id='LC1360'>abundance(CHEBI:troglitazone) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC1361'>abundance(CHEBI:paracetamol) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC1362'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;)) increases translocation(proteinAbundance(HGNC:CYCS),MESHCL:&quot;Mitochondrial Membranes&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC1363'><br/></div><div class='line' id='LC1364'>SET Evidence = &quot;Severe inhibition of mitochondrial β-oxidation can lead to microvesicular steatosis</div><div class='line' id='LC1365'>characterized by the presence of many tiny lipid droplets within the cytoplasm</div><div class='line' id='LC1366'>of hepatocytes.&quot;</div><div class='line' id='LC1367'><br/></div><div class='line' id='LC1368'>biologicalProcess(GO:&quot;fatty acid beta-oxidation&quot;) decreases pathology(SDIS:Steatosis)</div><div class='line' id='LC1369'><br/></div><div class='line' id='LC1370'>SET CellStructure = &quot;Cytoplasm&quot;</div><div class='line' id='LC1371'><br/></div><div class='line' id='LC1372'>pathology(SDIS:Steatosis) association biologicalProcess(SDIS:&quot;Lipid Droplet&quot;)</div><div class='line' id='LC1373'><br/></div><div class='line' id='LC1374'>SET Evidence = &quot;ROS overproduction may be a key event in the pathogenesis of drug-induced steatohepatitis</div><div class='line' id='LC1375'>by inducing lipid peroxidation (favoured by lipid accumulation), and possibly</div><div class='line' id='LC1376'>by triggering the generation of proapoptotic (TNF-α) and pro-fibrotic (TGF-β)</div><div class='line' id='LC1377'>cytokines by Kupffer cells and other inflammatory cells [2,4,40].&quot;</div><div class='line' id='LC1378'><br/></div><div class='line' id='LC1379'>abundance(CHEBI:&quot;reactive oxygen species&quot;) increases biologicalProcess(SDIS:&quot;lipid peroxidation&quot;)</div><div class='line' id='LC1380'><br/></div><div class='line' id='LC1381'>SET Cell = &quot;Kupffer Cells&quot;</div><div class='line' id='LC1382'><br/></div><div class='line' id='LC1383'>abundance(CHEBI:&quot;reactive oxygen species&quot;) increases proteinAbundance(HGNC:TNF)</div><div class='line' id='LC1384'>abundance(CHEBI:&quot;reactive oxygen species&quot;) increases proteinAbundance(HGNC:TGFB1)</div><div class='line' id='LC1385'>proteinAbundance(HGNC:TNF) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC1386'>proteinAbundance(HGNC:TGFB1) increases biologicalProcess(SDIS:fibrosis)</div><div class='line' id='LC1387'><br/></div><div class='line' id='LC1388'>SET CellStructure = &quot;Mitochondria, Liver&quot;</div><div class='line' id='LC1389'>SET Evidence = &quot;tamoxifen directly inhibits the transfer of electrons within the MRC, and also progressively</div><div class='line' id='LC1390'>depletes hepatic mtDNA through a mechanism that may involve the inhibition</div><div class='line' id='LC1391'>of mitochondrial topoisomerases and the impairment of mtDNA replication by</div><div class='line' id='LC1392'>this DNA-intercalating drug [41,42].&quot;</div><div class='line' id='LC1393'><br/></div><div class='line' id='LC1394'>abundance(CHEBI:tamoxifen) decreases biologicalProcess(GO:&quot;respiratory electron transport chain&quot;)</div><div class='line' id='LC1395'>abundance(CHEBI:tamoxifen) increases pathology(SDIS:&quot;mitochondrial DNA damage&quot;)</div><div class='line' id='LC1396'>abundance(CHEBI:tamoxifen) decreases biologicalProcess(GO:&quot;mitochondrial DNA replication&quot;)</div><div class='line' id='LC1397'><br/></div><div class='line' id='LC1398'>SET Evidence = &quot;some drugs (e.g. amiodarone, amineptine, pirprofen) also inhibit microsomal triglyceride</div><div class='line' id='LC1399'>transfer protein (MTP), an enzyme playing a major role in the formation</div><div class='line' id='LC1400'>of very-low-density-lipoprotein (VLDL) particles [43]. Such drugs therefore inhibit</div><div class='line' id='LC1401'>the two main pathways removing fat from the liver, namely FAO and hepatic VLDL</div><div class='line' id='LC1402'>secretion.&quot;</div><div class='line' id='LC1403'><br/></div><div class='line' id='LC1404'>abundance(CHEBI:amiodarone) decreases molecularActivity(proteinAbundance(HGNC:MTTP))</div><div class='line' id='LC1405'>abundance(CHEBI:amineptine) decreases molecularActivity(proteinAbundance(HGNC:MTTP))</div><div class='line' id='LC1406'>abundance(CHEBI:amiodarone) decreases biologicalProcess(GO:&quot;fatty acid beta-oxidation&quot;)</div><div class='line' id='LC1407'>abundance(CHEBI:amiodarone) decreases biologicalProcess(SDIS:&quot;VLDL secretion&quot;)</div><div class='line' id='LC1408'>abundance(CHEBI:amineptine) decreases biologicalProcess(GO:&quot;fatty acid beta-oxidation&quot;)</div><div class='line' id='LC1409'>abundance(CHEBI:amineptine) decreases biologicalProcess(SDIS:&quot;VLDL secretion&quot;)</div><div class='line' id='LC1410'><br/></div><div class='line' id='LC1411'>SET Evidence = &quot;Cationic amphiphilic drugs such as amiodarone, perhexiline, diethylaminoethoxyhexestrol</div><div class='line' id='LC1412'>(DEAEH) and tamoxifen can be first protonated in the intermembrane space</div><div class='line' id='LC1413'>of mitochondria, and then electrophoretically transported into the mitochondrial</div><div class='line' id='LC1414'>matrix thanks to the Δψm [3,4,40,42], as discussed in greater detail below. This</div><div class='line' id='LC1415'>transfer across the inner mitochondrial membrane dissipates Δψm (Figure 1) and</div><div class='line' id='LC1416'>increases the basal (state 4) mitochondrial respiration. This phenomenon, which</div><div class='line' id='LC1417'>is called &#39;OXPHOS uncoupling&#39;, can also be observed in the case of some mitochondrial</div><div class='line' id='LC1418'>poisons such as the protonophores 2,4-dinitrophenol (DNP) and carbonylcyanide</div><div class='line' id='LC1419'>p-trifluoromethoxyphenylhydrazone (FCCP).&quot;</div><div class='line' id='LC1420'><br/></div><div class='line' id='LC1421'>abundance(CHEBI:amiodarone) increases biologicalProcess(GO:&quot;regulation of oxidative phosphorylation uncoupler activity&quot;)</div><div class='line' id='LC1422'>abundance(CHEBI:perhexiline) increases biologicalProcess(GO:&quot;regulation of oxidative phosphorylation uncoupler activity&quot;)</div><div class='line' id='LC1423'>abundance(CHEBI:tamoxifen) increases biologicalProcess(GO:&quot;regulation of oxidative phosphorylation uncoupler activity&quot;)</div><div class='line' id='LC1424'>abundance(CHEBI:&quot;2,4-dinitrophenol&quot;) increases biologicalProcess(GO:&quot;regulation of oxidative phosphorylation uncoupler activity&quot;)</div><div class='line' id='LC1425'><br/></div><div class='line' id='LC1426'>SET Evidence = &quot;Finally, it must be pointed out that another important consequence of drug-induced</div><div class='line' id='LC1427'>OXPHOS uncoupling is the reduction of ATP synthesis, as the re-entry of protons</div><div class='line' id='LC1428'>within the mitochondrial matrix bypasses ATP synthase [3,40].&quot;</div><div class='line' id='LC1429'><br/></div><div class='line' id='LC1430'>biologicalProcess(GO:&quot;regulation of oxidative phosphorylation uncoupler activity&quot;) decreases biologicalProcess(GO:&quot;ATP synthesis coupled proton transport&quot;)</div><div class='line' id='LC1431'><br/></div><div class='line' id='LC1432'>SET Evidence = &quot;valproic acid inhibits mitochondrial FAO through the sequestration of coenzyme A (a</div><div class='line' id='LC1433'>cofactor mandatory for FAO),&quot;</div><div class='line' id='LC1434'><br/></div><div class='line' id='LC1435'>abundance(CHEBI:&quot;valproic acid&quot;) decreases biologicalProcess(GO:&quot;fatty acid beta-oxidation&quot;)</div><div class='line' id='LC1436'><br/></div><div class='line' id='LC1437'>SET Evidence = &quot;this antiepileptic drug can induce MPT (Figure 1) [29], which may explain why valproateinduced</div><div class='line' id='LC1438'>microvesicular steatosis can be associated with liver cell death [2].&quot;</div><div class='line' id='LC1439'><br/></div><div class='line' id='LC1440'>abundance(CHEBI:&quot;valproic acid&quot;) increases biologicalProcess(GO:&quot;positive regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1441'><br/></div><div class='line' id='LC1442'>SET Evidence = &quot;ethanol intoxication also increases cytochrome P450 2E1 (CYP2E1) levels, not only</div><div class='line' id='LC1443'>in the endoplasmic reticulum but also in mitochondria [77].&quot;</div><div class='line' id='LC1444'><br/></div><div class='line' id='LC1445'>abundance(CHEBI:ethanol) increases proteinAbundance(HGNC:CYP2E1)</div><div class='line' id='LC1446'><br/></div><div class='line' id='LC1447'>SET CellStructure = &quot;Endoplasmic Reticulum&quot;</div><div class='line' id='LC1448'><br/></div><div class='line' id='LC1449'>abundance(CHEBI:ethanol) increases proteinAbundance(HGNC:CYP2E1)</div><div class='line' id='LC1450'><br/></div><div class='line' id='LC1451'>SET CellStructure = &quot;Mitochondria, Liver&quot;</div><div class='line' id='LC1452'>SET Evidence = &quot;The ectopic localization of CYP2E1 may enhance the mitochondrial generation of N-acetyl-p-benzoquinone</div><div class='line' id='LC1453'>imine (NAPQI), the toxic metabolite of acetaminophen.&quot;</div><div class='line' id='LC1454'><br/></div><div class='line' id='LC1455'>proteinAbundance(HGNC:CYP2E1) increases abundance(CHEBI:&quot;N-acetyl-1,4-benzoquinone imine&quot;)</div><div class='line' id='LC1456'><br/></div><div class='line' id='LC1457'>SET Evidence = &quot;As the reactive NAPQI has a direct toxicity effect on mitochondria, in particular</div><div class='line' id='LC1458'>by triggering MPT [78,79]&quot;</div><div class='line' id='LC1459'><br/></div><div class='line' id='LC1460'>abundance(CHEBI:&quot;N-acetyl-1,4-benzoquinone imine&quot;) increases biologicalProcess(GO:&quot;positive regulation of mitochondrial membrane permeability&quot;)</div><div class='line' id='LC1461'><br/></div><div class='line' id='LC1462'>SET Evidence = &quot;An example is the combined role of aspirin and viral infections in the occurrence</div><div class='line' id='LC1463'>of Reye’s syndrome, a severe post-infectious metabolic disease characterized by</div><div class='line' id='LC1464'>extensive microvesicular steatosis of the liver, severe hypoglycaemia and a non-inflammatory</div><div class='line' id='LC1465'>encephalopathy [3,83].&quot;</div><div class='line' id='LC1466'><br/></div><div class='line' id='LC1467'>pathology(MESHD:&quot;Reye Syndrome&quot;) association pathology(SDIS:Steatosis)</div><div class='line' id='LC1468'>pathology(MESHD:&quot;Reye Syndrome&quot;) association pathology(SDIS:hypoglycemia)</div><div class='line' id='LC1469'>pathology(MESHD:&quot;Reye Syndrome&quot;) association pathology(SDIS:Encephalopathy)</div><div class='line' id='LC1470'><br/></div><div class='line' id='LC1471'>UNSET STATEMENT_GROUP</div><div class='line' id='LC1472'><br/></div><div class='line' id='LC1473'>SET STATEMENT_GROUP = &quot;Group 8&quot;</div><div class='line' id='LC1474'><br/></div><div class='line' id='LC1475'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC1476'>SET Evidence = &quot;In support of a role for PRP4K in pre-mRNA splicing, we identified PRP6, SWAP, and</div><div class='line' id='LC1477'>pinin as interacting proteins and demonstrated that PRP4K is a U5 snRNP-associated</div><div class='line' id='LC1478'>kinase.&quot;</div><div class='line' id='LC1479'>SET Citation = {&quot;PubMed&quot;,&quot;Molecular and cellular biology&quot;,&quot;12077342&quot;,&quot;&quot;,&quot;Dellaire G|Makarov EM|Cowger JJ|Longman D|Sutherland HG|Lührmann R|Torchia J|Bickmore WA&quot;,&quot;&quot;}</div><div class='line' id='LC1480'><br/></div><div class='line' id='LC1481'>complexAbundance(proteinAbundance(HGNC:PRPF4B),proteinAbundance(HGNC:PRPF6)) //disambiguation PRP4K = PRPF4B</div><div class='line' id='LC1482'>complexAbundance(proteinAbundance(HGNC:PRPF4B),proteinAbundance(HGNC:SFSWAP))</div><div class='line' id='LC1483'>complexAbundance(proteinAbundance(HGNC:PRPF4B),proteinAbundance(HGNC:PNN))</div><div class='line' id='LC1484'><br/></div><div class='line' id='LC1485'>SET CellLine = &quot;HT-1080&quot;</div><div class='line' id='LC1486'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC1487'>SET CellStructure = &quot;Cell Nucleus&quot;</div><div class='line' id='LC1488'>SET Evidence = &quot;The subcellular distribution of endogenous PRP4K in human and mouse cells was analyzed</div><div class='line' id='LC1489'>by indirect immunofluorescence (Fig. 2D). PRP4K is distributed throughout</div><div class='line' id='LC1490'>the nucleus, excluding the nucleolus, but is enriched in multiple speckles. In addition,</div><div class='line' id='LC1491'>some endogenous PRP4K is associated with unfixed mitotic chromosomes (Fig.</div><div class='line' id='LC1492'>2D; F9 and HT1080).&quot;</div><div class='line' id='LC1493'>SET Species = &quot;9606&quot;</div><div class='line' id='LC1494'><br/></div><div class='line' id='LC1495'>proteinAbundance(HGNC:PRPF4B)</div><div class='line' id='LC1496'><br/></div><div class='line' id='LC1497'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC1498'>SET Evidence = &quot;In addition, BRG1 and N-CoR, components of nuclear hormone coactivator and corepressor</div><div class='line' id='LC1499'>complexes, also interact with PRP4K.&quot;</div><div class='line' id='LC1500'><br/></div><div class='line' id='LC1501'>complexAbundance(proteinAbundance(HGNC:PRPF4B),proteinAbundance(HGNC:SMARCA4)) //BRG1 = SMARCA4</div><div class='line' id='LC1502'>complexAbundance(proteinAbundance(HGNC:PRPF4B),proteinAbundance(HGNC:NCOR1))</div><div class='line' id='LC1503'><br/></div><div class='line' id='LC1504'>SET CellLine = &quot;HeLa&quot;</div><div class='line' id='LC1505'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC1506'>SET Evidence = &quot;The differentially migrating forms of PRP4K detected by Western blot analysis (Fig.</div><div class='line' id='LC1507'>2C) suggest that it is posttranslationally modified. Phosphatase treatment of</div><div class='line' id='LC1508'>nuclear extracts reduces most PRP4K to the 147-kDa fast-migrating form (Fig. 5D).</div><div class='line' id='LC1509'>Thus, the slower-migrating forms of PRP4K are phosphorylated, and it is only</div><div class='line' id='LC1510'>the hypophosphorylated (147 kDa) form that is coimmunoprecipitated by BRG1 and PRP6</div><div class='line' id='LC1511'>antibodies (Fig. 5B and C).&quot;</div><div class='line' id='LC1512'><br/></div><div class='line' id='LC1513'>proteinAbundance(HGNC:PRPF4B,proteinModification(P)) directlyDecreases complexAbundance(proteinAbundance(HGNC:PRPF4B),proteinAbundance(HGNC:SMARCA4))</div><div class='line' id='LC1514'>proteinAbundance(HGNC:PRPF4B,proteinModification(P)) directlyDecreases complexAbundance(proteinAbundance(HGNC:PRPF4B),proteinAbundance(HGNC:PRPF6))</div><div class='line' id='LC1515'><br/></div><div class='line' id='LC1516'>SET Evidence = &quot;A strongly labeled doublet (Fig. 6, band B) corresponds to the relative position of</div><div class='line' id='LC1517'>PRP4K, a finding consistent with the reported ability of mammalian PRP4K homologues</div><div class='line' id='LC1518'>to autophosphorylate (19, 27). Two other prominently labeled proteins correspond</div><div class='line' id='LC1519'>in size to BRG1 and PRP6 (Fig. 6, bands A and C, respectively). To confirm</div><div class='line' id='LC1520'>that these proteins were indeed BRG1 and PRP6, we carried out kinase assays with</div><div class='line' id='LC1521'>BRG1 and PRP6 IP complexes, which also contain coimmunoprecipitated PRP4K (Fig.</div><div class='line' id='LC1522'>5). These immunoprecipitates do exhibit kinase activity, and both phosphorylated</div><div class='line' id='LC1523'>PRP6 and BRG1 are much more intense in their respective IP reactions, reflecting</div><div class='line' id='LC1524'>the relative increase in each substrate for PRP4K.&quot;</div><div class='line' id='LC1525'><br/></div><div class='line' id='LC1526'>kinaseActivity(proteinAbundance(HGNC:PRPF4B)) directlyIncreases proteinAbundance(HGNC:PRPF4B,proteinModification(P))</div><div class='line' id='LC1527'>kinaseActivity(proteinAbundance(HGNC:PRPF4B)) directlyIncreases proteinAbundance(HGNC:PRPF6,proteinModification(P))</div><div class='line' id='LC1528'>kinaseActivity(proteinAbundance(HGNC:PRPF4B)) directlyIncreases proteinAbundance(HGNC:SMARCA4,proteinModification(P))</div><div class='line' id='LC1529'><br/></div><div class='line' id='LC1530'>UNSET STATEMENT_GROUP</div><div class='line' id='LC1531'><br/></div><div class='line' id='LC1532'>SET STATEMENT_GROUP = &quot;Group 9&quot;</div><div class='line' id='LC1533'><br/></div><div class='line' id='LC1534'>SET Disease = &quot;Breast Neoplasms&quot;</div><div class='line' id='LC1535'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC1536'>SET BodyRegion = &quot;Breast&quot;</div><div class='line' id='LC1537'>SET Evidence = &quot;Residual breast carcinomas that had been surgically removed within 48 days after first</div><div class='line' id='LC1538'>surgery showed a significant increase in proliferation if they were HER2-positive.</div><div class='line' id='LC1539'>Wound drainage fluid and postsurgical serum samples from patients stimulated</div><div class='line' id='LC1540'>in-vitro growth of HER2-overexpressing breast carcinoma cells. Removal of</div><div class='line' id='LC1541'>HER2 from the cell membrane led to a striking reduction of the induced proliferation.&quot;</div><div class='line' id='LC1542'>SET Citation = {&quot;PubMed&quot;,&quot;Lancet&quot;,&quot;12932384&quot;,&quot;&quot;,&quot;Tagliabue E|Agresti R|Carcangiu ML|Ghirelli C|Morelli D|Campiglio M|Martel M|Giovanazzi R|Greco M|Balsari A|Ménard S&quot;,&quot;&quot;}</div><div class='line' id='LC1543'>SET Species = &quot;9606&quot;</div><div class='line' id='LC1544'><br/></div><div class='line' id='LC1545'>pathology(SDIS:&quot;tissue damage&quot;) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC1546'>proteinAbundance(HGNC:ERBB2) increases (pathology(SDIS:&quot;tissue damage&quot;) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC1547'><br/></div><div class='line' id='LC1548'>SET CellLine = &quot;MDA-MB-453&quot;</div><div class='line' id='LC1549'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC1550'>SET Evidence = &quot;To determine the potential role of these growth factors in cell growth induced by</div><div class='line' id='LC1551'>drainage fluid, MDAMB453 cells were treated with drainage fluids in the presence</div><div class='line' id='LC1552'>of neutralising antibodies against HB-EGF or TGFα. Cell proliferation induced</div><div class='line' id='LC1553'>by all drainage fluids was found to decrease by about 50% and 30%, respectively,</div><div class='line' id='LC1554'>and no further decrease was noted in the presence of both antibodies together,</div><div class='line' id='LC1555'>as shown by selected data shown for two drainage fluids in figure 3.&quot;</div><div class='line' id='LC1556'><br/></div><div class='line' id='LC1557'>proteinAbundance(HGNC:TGFA) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC1558'>proteinAbundance(HGNC:HBEGF) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC1559'><br/></div><div class='line' id='LC1560'>SET Evidence = &quot;In the other five cases, the concentrations of EGF-like factors were below the detection</div><div class='line' id='LC1561'>limits in both presurgical and postsurgical serum samples. A highly significant</div><div class='line' id='LC1562'>direct correlation (r=0.77, 95% CI 0.49–0.92, p=0.002) was found between</div><div class='line' id='LC1563'>EGF in postsurgical serum and cellular damage induced by surgery, measured on the</div><div class='line' id='LC1564'>basis of creatine phosphokinase concentration in drainage fluids obtained 1 day</div><div class='line' id='LC1565'>after surgery (figure 4). The degree of drainage-fluid-induced MDAMB453 cell</div><div class='line' id='LC1566'>proliferation also directly correlated with creatine phosphokinase concentration</div><div class='line' id='LC1567'>(r=0.69, 95% CI 0.25–0·91, p=0.009; figure 4).&quot;</div><div class='line' id='LC1568'><br/></div><div class='line' id='LC1569'>proteinAbundance(PFH:&quot;EGFR Ligand Family&quot;) positiveCorrelation pathology(SDIS:&quot;tissue damage&quot;)</div><div class='line' id='LC1570'>biologicalProcess(GO:&quot;cell proliferation&quot;) positiveCorrelation pathology(SDIS:&quot;tissue damage&quot;)</div><div class='line' id='LC1571'><br/></div><div class='line' id='LC1572'>UNSET STATEMENT_GROUP</div><div class='line' id='LC1573'><br/></div><div class='line' id='LC1574'>SET STATEMENT_GROUP = &quot;Group 10&quot;</div><div class='line' id='LC1575'><br/></div><div class='line' id='LC1576'>SET Disease = &quot;Multiple Myeloma&quot;</div><div class='line' id='LC1577'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC1578'>SET Evidence = &quot;We show that protein kinase C (PKC) alpha is translocated to the plasma membrane and</div><div class='line' id='LC1579'>activated by adhesion of MM cells to fibronectin and VEGF. We identify beta(1)</div><div class='line' id='LC1580'>integrin modulating VEGF-triggered MM cell migration on fibronectin. We show</div><div class='line' id='LC1581'>that transient enhancement of MM cell adhesion to fibronectin triggered by VEGF</div><div class='line' id='LC1582'>is dependent on the activity of both PKC and beta(1) integrin. Moreover, we demonstrate</div><div class='line' id='LC1583'>that PKC alpha is constitutively associated with beta(1) integrin.&quot;</div><div class='line' id='LC1584'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;11751905&quot;,&quot;2002-01-20&quot;,&quot;Podar K|Tai YT|Lin BK|Narsimhan RP|Sattler M|Kijima T|Salgia R|Gupta D|Chauhan D|Anderson KC&quot;,&quot;&quot;}</div><div class='line' id='LC1585'>SET Species = &quot;9606&quot;</div><div class='line' id='LC1586'><br/></div><div class='line' id='LC1587'>biologicalProcess(GO:&quot;cell-matrix adhesion&quot;) increases translocation(proteinAbundance(HGNC:PRKCA),MESHCL:&quot;Intracellular Space&quot;,MESHCL:&quot;Cell Membrane&quot;)</div><div class='line' id='LC1588'>compositeAbundance(proteinAbundance(HGNC:FN1),proteinAbundance(HGNC:VEGFA)) increases translocation(proteinAbundance(HGNC:PRKCA),MESHCL:&quot;Intracellular Space&quot;,MESHCL:&quot;Cell Membrane&quot;)</div><div class='line' id='LC1589'>biologicalProcess(GO:&quot;cell-matrix adhesion&quot;) increases kinaseActivity(proteinAbundance(HGNC:PRKCA))</div><div class='line' id='LC1590'>compositeAbundance(proteinAbundance(HGNC:FN1),proteinAbundance(HGNC:VEGFA)) increases kinaseActivity(proteinAbundance(HGNC:PRKCA))</div><div class='line' id='LC1591'>proteinAbundance(HGNC:VEGFA) increases (proteinAbundance(HGNC:ITGB1) increases biologicalProcess(GO:&quot;cell migration&quot;))</div><div class='line' id='LC1592'>proteinAbundance(HGNC:VEGFA) increases (compositeAbundance(molecularActivity(proteinAbundance(HGNC:ITGB1)),kinaseActivity(proteinAbundance(HGNC:PRKCA))) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;))</div><div class='line' id='LC1593'>complexAbundance(proteinAbundance(HGNC:PRKCA),proteinAbundance(HGNC:ITGB1))</div><div class='line' id='LC1594'><br/></div><div class='line' id='LC1595'>SET Evidence = &quot;These data are consistent with PKC alpha-dependent exocytosis of activated beta(1)</div><div class='line' id='LC1596'>integrin to the plasma membrane, where its increased surface expression mediates</div><div class='line' id='LC1597'>binding to fibronectin; conversely, catalytically active PKC alpha-driven internalization</div><div class='line' id='LC1598'>of beta(1) integrin results in MM cell de-adhesion.&quot;</div><div class='line' id='LC1599'><br/></div><div class='line' id='LC1600'>kinaseActivity(proteinAbundance(HGNC:PRKCA)) decreases cellSurfaceExpression(proteinAbundance(HGNC:ITGB1))</div><div class='line' id='LC1601'>kinaseActivity(proteinAbundance(HGNC:PRKCA)) increases cellSurfaceExpression(proteinAbundance(HGNC:ITGB1))</div><div class='line' id='LC1602'>cellSurfaceExpression(proteinAbundance(HGNC:ITGB1)) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC1603'><br/></div><div class='line' id='LC1604'>SET Evidence = &quot;We show that the regulatory subunit of phosphatidylinositol (PI) 3-kinase (p85) is</div><div class='line' id='LC1605'>constitutively associated with FMS-like tyrosine kinase-1 (Flt-1). VEGF stimulates</div><div class='line' id='LC1606'>activation of PI 3-kinase, and both MM cell adhesion and migration are PI 3-kinase-dependent.</div><div class='line' id='LC1607'>Moreover, both VEGF-induced PI 3-kinase activation and beta(1)</div><div class='line' id='LC1608'>integrin-mediated binding to fibronectin are required for the recruitment and</div><div class='line' id='LC1609'>activation of PKC alpha.&quot;</div><div class='line' id='LC1610'><br/></div><div class='line' id='LC1611'>complexAbundance(proteinAbundance(HGNC:FLT1),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC1612'>proteinAbundance(HGNC:VEGFA) increases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC1613'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC1614'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC1615'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) increases kinaseActivity(proteinAbundance(HGNC:PRKCA))</div><div class='line' id='LC1616'>biologicalProcess(GO:&quot;cell-matrix adhesion&quot;) increases kinaseActivity(proteinAbundance(HGNC:PRKCA))</div><div class='line' id='LC1617'>molecularActivity(proteinAbundance(HGNC:ITGB1)) increases kinaseActivity(proteinAbundance(HGNC:PRKCA))</div><div class='line' id='LC1618'><br/></div><div class='line' id='LC1619'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC1620'>SET Evidence = &quot;After VEGF stimulation of cells seeded on fibronectin, PKCα translocated into the</div><div class='line' id='LC1621'>membrane fraction after 30 min (Fig. 2a), whereas no significant changes in distribution</div><div class='line' id='LC1622'>of PKC isoforms as PKCγ, PKCε, and PKCξ were observed.&quot;</div><div class='line' id='LC1623'><br/></div><div class='line' id='LC1624'>compositeAbundance(proteinAbundance(HGNC:VEGFA),proteinAbundance(HGNC:FN1)) increases cellSurfaceExpression(proteinAbundance(HGNC:PRKCA))</div><div class='line' id='LC1625'>compositeAbundance(proteinAbundance(HGNC:VEGFA),proteinAbundance(HGNC:FN1)) causesNoChange cellSurfaceExpression(proteinAbundance(HGNC:PRKCG))</div><div class='line' id='LC1626'>compositeAbundance(proteinAbundance(HGNC:VEGFA),proteinAbundance(HGNC:FN1)) causesNoChange cellSurfaceExpression(proteinAbundance(HGNC:PRKCE))</div><div class='line' id='LC1627'>compositeAbundance(proteinAbundance(HGNC:VEGFA),proteinAbundance(HGNC:FN1)) causesNoChange cellSurfaceExpression(proteinAbundance(HGNC:PRKCZ))</div><div class='line' id='LC1628'><br/></div><div class='line' id='LC1629'>SET Evidence = &quot;The activation of PKCα after VEGF treatment of cells attached to fibronectin was further</div><div class='line' id='LC1630'>supported by a 2-fold increase in PKCα-IP kinase activity;&quot;</div><div class='line' id='LC1631'><br/></div><div class='line' id='LC1632'>compositeAbundance(proteinAbundance(HGNC:VEGFA),proteinAbundance(HGNC:FN1)) increases kinaseActivity(proteinAbundance(HGNC:PRKCA))</div><div class='line' id='LC1633'><br/></div><div class='line' id='LC1634'>SET Evidence = &quot;As shown previously, MM cells spontaneously adhered to fibronectin, and this adhesion</div><div class='line' id='LC1635'>was increased upon stimulation with VEGF (Fig.3a).&quot;</div><div class='line' id='LC1636'><br/></div><div class='line' id='LC1637'>proteinAbundance(HGNC:VEGFA) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC1638'><br/></div><div class='line' id='LC1639'>SET Evidence = &quot;As shown in Fig. 3,d–e, incubation with the PKC inhibitor BIM I (as well as with the</div><div class='line' id='LC1640'>β1-neutralizing mAb) blocked dose-dependent VEGF-induced cell adhesion to fibronectin.</div><div class='line' id='LC1641'>This involvement of PKC in MM cell adhesion to fibronectin was further</div><div class='line' id='LC1642'>confirmed by a dose-dependent increment of adhesion triggered by PMA stimulation</div><div class='line' id='LC1643'>(Fig. 3d) similar to that induced by VEGF. Taken together, our results show that</div><div class='line' id='LC1644'>VEGF transiently enhances MM cell adhesion to fibronectin, dependent on both</div><div class='line' id='LC1645'>PKC and β1 integrin activity.&quot;</div><div class='line' id='LC1646'><br/></div><div class='line' id='LC1647'>abundance(CHEBI:&quot;phorbol 13-acetate 12-myristate&quot;) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC1648'>proteinAbundance(HGNC:ITGB1) increases (proteinAbundance(HGNC:VEGFA) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;))</div><div class='line' id='LC1649'>kinaseActivity(proteinAbundance(HGNC:PRKCA)) increases (proteinAbundance(HGNC:VEGFA) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;))</div><div class='line' id='LC1650'><br/></div><div class='line' id='LC1651'>SET Evidence = &quot;These data confirm that β1 integrin (CD29) is the integrin primarily associated with</div><div class='line' id='LC1652'>VEGF-triggered MM cell migration on fibronectin.&quot;</div><div class='line' id='LC1653'><br/></div><div class='line' id='LC1654'>proteinAbundance(HGNC:ITGB1) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC1655'>proteinAbundance(HGNC:ITGB1) increases (compositeAbundance(proteinAbundance(HGNC:VEGFA),proteinAbundance(HGNC:FN1)) increases biologicalProcess(GO:&quot;cell migration&quot;))</div><div class='line' id='LC1656'><br/></div><div class='line' id='LC1657'>SET TextLocation = &quot;Legend&quot;</div><div class='line' id='LC1658'>SET Evidence = &quot;Figure 4.  VEGFR-1/Flt-1 associates with β1-integrin and CADTK and enhances CADTK-phosphorylation,</div><div class='line' id='LC1659'>dependent on PKC- and β1-integrin activation.&quot;</div><div class='line' id='LC1660'><br/></div><div class='line' id='LC1661'>complexAbundance(proteinAbundance(HGNC:FLT1),proteinAbundance(HGNC:ITGB1),proteinAbundance(HGNC:PTK2B))</div><div class='line' id='LC1662'>kinaseActivity(proteinAbundance(HGNC:FLT1)) increases proteinAbundance(HGNC:PTK2B,proteinModification(P))</div><div class='line' id='LC1663'>kinaseActivity(proteinAbundance(PFH:&quot;PRKC Family&quot;)) increases proteinAbundance(HGNC:PTK2B,proteinModification(P))</div><div class='line' id='LC1664'>molecularActivity(proteinAbundance(HGNC:ITGB1)) increases proteinAbundance(HGNC:PTK2B,proteinModification(P))</div><div class='line' id='LC1665'><br/></div><div class='line' id='LC1666'>SET Evidence = &quot;(a) Co-immunoprecipitation of CADTK and β1-integrin with PKCα. (b) constitutive association</div><div class='line' id='LC1667'>of Flt-1 and CADTK. (c) activation of CADTK upon treatment with PMA (300nM),</div><div class='line' id='LC1668'>20 min. (d) Additional increase of CADTK-phosphorylation in the presence</div><div class='line' id='LC1669'>of VEGF (100ng/mL). (e) Dependency of VEGF-induced CADTK activation on PKC and</div><div class='line' id='LC1670'>β1-integrin. β1, β1-integrin; pY, phosphotyrosine; C, IP control&quot;</div><div class='line' id='LC1671'><br/></div><div class='line' id='LC1672'>complexAbundance(proteinAbundance(HGNC:FLT1),proteinAbundance(HGNC:PTK2B))</div><div class='line' id='LC1673'>abundance(CHEBI:&quot;phorbol 13-acetate 12-myristate&quot;) increases kinaseActivity(proteinAbundance(HGNC:PTK2B))</div><div class='line' id='LC1674'>proteinAbundance(HGNC:VEGFA) increases proteinAbundance(HGNC:PTK2B,proteinModification(P))</div><div class='line' id='LC1675'>proteinAbundance(HGNC:ITGB1) increases (proteinAbundance(HGNC:VEGFA) increases kinaseActivity(proteinAbundance(HGNC:PTK2B)))</div><div class='line' id='LC1676'>kinaseActivity(proteinAbundance(PFH:&quot;PRKC Family&quot;)) increases (proteinAbundance(HGNC:VEGFA) increases kinaseActivity(proteinAbundance(HGNC:PTK2B)))</div><div class='line' id='LC1677'>complexAbundance(proteinAbundance(HGNC:PTK2B),proteinAbundance(HGNC:ITGB1),proteinAbundance(PFH:&quot;PRKC Family&quot;))</div><div class='line' id='LC1678'><br/></div><div class='line' id='LC1679'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC1680'>SET Evidence = &quot;we have previously shown that CADTK is activated upon dex-treatment,suggesting its</div><div class='line' id='LC1681'>role in dex-induced apoptosis (47).&quot;</div><div class='line' id='LC1682'><br/></div><div class='line' id='LC1683'>abundance(CHEBI:dexamethasone) increases kinaseActivity(proteinAbundance(HGNC:PTK2B))</div><div class='line' id='LC1684'><br/></div><div class='line' id='LC1685'>SET Evidence = &quot;Our results show that VEGF induces the association of CADTK with the β1  integrin/PKCα</div><div class='line' id='LC1686'>protein complex (Fig. 4a).&quot;</div><div class='line' id='LC1687'><br/></div><div class='line' id='LC1688'>proteinAbundance(HGNC:VEGFA) increases complexAbundance(proteinAbundance(HGNC:ITGB1),proteinAbundance(HGNC:PRKCA),proteinAbundance(HGNC:PTK2B))</div><div class='line' id='LC1689'><br/></div><div class='line' id='LC1690'>SET Evidence = &quot;We have shown recently that Flt-1 VEGFR is expressed in the human MM cell line and</div><div class='line' id='LC1691'>patient MM cells and is tyrosine-phosphorylated upon VEGF stimulation (12). Because</div><div class='line' id='LC1692'>Flt-1 and the p85 subunit of PI 3-kinase were associated when overexpressed</div><div class='line' id='LC1693'>in yeast cells (54), we next determined whether this interaction is biologically</div><div class='line' id='LC1694'>significant in MM cells. Flt-1 was immunoprecipitated from VEGF treated and non-treated</div><div class='line' id='LC1695'>MM.1S cells followed by immunoblotting with anti-p85 Ab. As illustrated</div><div class='line' id='LC1696'>in Fig.5a, p85 is constitutively associated with Flt-1, suggesting that PI 3-kinase</div><div class='line' id='LC1697'>participates in Flt-1-mediated VEGF signal transduction.&quot;</div><div class='line' id='LC1698'><br/></div><div class='line' id='LC1699'>proteinAbundance(HGNC:VEGFA) increases proteinAbundance(HGNC:FLT1,proteinModification(P,Y))</div><div class='line' id='LC1700'>complexAbundance(proteinAbundance(HGNC:FLT1),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC1701'><br/></div><div class='line' id='LC1702'>SET Evidence = &quot;VEGF induced tyrosine phosphorylation of the regulatory p85 subunit of PI 3-kinase,</div><div class='line' id='LC1703'>evidenced by immunoblotting of anti-p85 immunoprecipitates with an anti-pY mAb</div><div class='line' id='LC1704'>(Fig. 5b). Moreover, immunoblotting of anti-pY immunoprecipitates with specific</div><div class='line' id='LC1705'>p85 mAb showed an increased association of p85 with tyrosine-phosphorylated proteins,</div><div class='line' id='LC1706'>which was maximal after 5 min of VEGF treatment (Fig. 5c). To determine</div><div class='line' id='LC1707'>whether VEGF-induced p85 phosphorylation regulates p110, the catalytic counterpart</div><div class='line' id='LC1708'>of PI 3-kinase, we performed in vitrokinase assays using PI 4,5-bisphosphate</div><div class='line' id='LC1709'>as a substrate. As shown in Fig. 5d, VEGF induced peak activation (6-fold) of PI</div><div class='line' id='LC1710'>3-kinase activity at 5 min.&quot;</div><div class='line' id='LC1711'><br/></div><div class='line' id='LC1712'>proteinAbundance(HGNC:VEGFA) increases proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;,proteinModification(P,Y))</div><div class='line' id='LC1713'>proteinAbundance(HGNC:VEGFA) increases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC1714'><br/></div><div class='line' id='LC1715'>SET Evidence = &quot;When PI 3-kinase activation in MM cells seeded on fibronectin was inhibited by LY294002,</div><div class='line' id='LC1716'>PKCα recruitment to the plasma membrane was also abrogated (Fig. 6). These</div><div class='line' id='LC1717'>results indicate that VEGF-induced PI 3-kinase activation along with β1 integrin</div><div class='line' id='LC1718'>binding to fibronectin activate PKCα.&quot;</div><div class='line' id='LC1719'><br/></div><div class='line' id='LC1720'>abundance(SCHEM:&quot;LY 294002&quot;) decreases translocation(proteinAbundance(HGNC:PRKCA),MESHCL:&quot;Intracellular Space&quot;,MESHCL:&quot;Cell Membrane&quot;)</div><div class='line' id='LC1721'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) increases kinaseActivity(proteinAbundance(HGNC:PRKCA))</div><div class='line' id='LC1722'>complexAbundance(proteinAbundance(HGNC:ITGB1),proteinAbundance(HGNC:FN1)) increases kinaseActivity(proteinAbundance(HGNC:PRKCA))</div><div class='line' id='LC1723'><br/></div><div class='line' id='LC1724'>SET Evidence = &quot;As seen in Fig. 7a, VEGF added to the conditioned medium in the lower chamber induced</div><div class='line' id='LC1725'>a dose-dependent migration of growth-factor-deprived MM.1S cells seeded on</div><div class='line' id='LC1726'>fibronectin in the upper chamber, which was totally inhibited by the PKC inhibitor</div><div class='line' id='LC1727'>BIM I. Pre-incubation with the PI3-kinase inhibitor LY294002 (20μM) at 37°C for</div><div class='line' id='LC1728'>45min prior to VEGF stimulation similarly inhibited MM cell migration.&quot;</div><div class='line' id='LC1729'><br/></div><div class='line' id='LC1730'>compositeAbundance(proteinAbundance(HGNC:VEGFA),proteinAbundance(HGNC:FN1)) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC1731'>abundance(SCHEM:&quot;LY 294002&quot;) decreases (compositeAbundance(proteinAbundance(HGNC:VEGFA),proteinAbundance(HGNC:FN1)) increases biologicalProcess(GO:&quot;cell migration&quot;))</div><div class='line' id='LC1732'><br/></div><div class='line' id='LC1733'>UNSET STATEMENT_GROUP</div><div class='line' id='LC1734'><br/></div><div class='line' id='LC1735'>SET STATEMENT_GROUP = &quot;Group 11&quot;</div><div class='line' id='LC1736'><br/></div><div class='line' id='LC1737'>SET Tissue = &quot;Muscle Fibers, Slow-Twitch&quot;</div><div class='line' id='LC1738'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC1739'>SET Evidence = &quot;Here, we show that repetitive slow fiber type electrical stimulation, but not fast</div><div class='line' id='LC1740'>fiber type stimulation, caused HDAC4-GFP, but not HDAC5-GFP, to translocate from</div><div class='line' id='LC1741'>the nucleus to the cytoplasm in cultured adult skeletal muscle fibers. HDAC4-GFP</div><div class='line' id='LC1742'>translocation was blocked by calmodulin-dependent protein kinase (CaMK) inhibitor</div><div class='line' id='LC1743'>KN-62.&quot;</div><div class='line' id='LC1744'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of cell biology&quot;,&quot;15767461&quot;,&quot;&quot;,&quot;Liu Y|Randall WR|Schneider MF&quot;,&quot;&quot;}</div><div class='line' id='LC1745'>SET Species = &quot;10090&quot;</div><div class='line' id='LC1746'><br/></div><div class='line' id='LC1747'>biologicalProcess(GO:&quot;cellular response to electrical stimulus&quot;) increases translocation(proteinAbundance(MGI:Hdac4),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC1748'>biologicalProcess(GO:&quot;cellular response to electrical stimulus&quot;) causesNoChange translocation(proteinAbundance(MGI:Hdac5),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC1749'>abundance(SCHEM:&quot;KN 62&quot;) directlyDecreases kinaseActivity(proteinAbundance(PFM:&quot;Camk Family&quot;))</div><div class='line' id='LC1750'>abundance(SCHEM:&quot;KN 62&quot;) decreases (biologicalProcess(GO:&quot;cellular response to electrical stimulus&quot;) increases translocation(proteinAbundance(MGI:Hdac4),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm))</div><div class='line' id='LC1751'><br/></div><div class='line' id='LC1752'>SET CellStructure = &quot;Cell Nucleus&quot;</div><div class='line' id='LC1753'>SET Evidence = &quot;Slow fiber type stimulation increased MEF2 transcriptional activity, nuclear Ca2+</div><div class='line' id='LC1754'>concentration, and nuclear levels of activated CaMKII, but not total nuclear CaMKII</div><div class='line' id='LC1755'>or CaM-YFP. Thus, calcium transients for slow, but not fast, fiber stimulation</div><div class='line' id='LC1756'>patterns appear to provide sufficient Ca2+-dependent activation of nuclear CaMKII</div><div class='line' id='LC1757'>to result in net nuclear efflux of HDAC4.&quot;</div><div class='line' id='LC1758'><br/></div><div class='line' id='LC1759'>biologicalProcess(GO:&quot;cellular response to electrical stimulus&quot;) increases transcriptionalActivity(proteinAbundance(PFM:&quot;Mef2 Family&quot;))</div><div class='line' id='LC1760'>biologicalProcess(GO:&quot;cellular response to electrical stimulus&quot;) increases abundance(CHEBI:&quot;calcium(2+)&quot;)</div><div class='line' id='LC1761'>biologicalProcess(GO:&quot;cellular response to electrical stimulus&quot;) increases kinaseActivity(proteinAbundance(PFM:&quot;Camk2 Family&quot;))</div><div class='line' id='LC1762'>abundance(CHEBI:&quot;calcium(2+)&quot;) directlyIncreases kinaseActivity(proteinAbundance(PFM:&quot;Camk2 Family&quot;))</div><div class='line' id='LC1763'><br/></div><div class='line' id='LC1764'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC1765'>SET Evidence = &quot;It is known that CaMK can phosphorylate class II HDACs (Grozinger and Schreiber, 2000;</div><div class='line' id='LC1766'>Wang et al., 2000). Phosphorylated intranuclear HDACs bind to 14-3-3 proteins</div><div class='line' id='LC1767'>(McKinsey et al., 2001), exposing a nuclear export signal at the HDAC COOH terminus</div><div class='line' id='LC1768'>and thus allowing HDAC translocation to the cytoplasm.&quot;</div><div class='line' id='LC1769'><br/></div><div class='line' id='LC1770'>kinaseActivity(proteinAbundance(PFM:&quot;Camk2 Family&quot;)) directlyIncreases proteinAbundance(PFM:&quot;Hdac Class II Family&quot;,proteinModification(P))</div><div class='line' id='LC1771'>proteinAbundance(PFM:&quot;Hdac Class II Family&quot;,proteinModification(P)) directlyIncreases complexAbundance(proteinAbundance(PFM:&quot;Hdac Class II Family&quot;),proteinAbundance(PFM:&quot;14-3-3 Family&quot;))</div><div class='line' id='LC1772'>complexAbundance(proteinAbundance(PFM:&quot;Hdac Class II Family&quot;),proteinAbundance(PFM:&quot;14-3-3 Family&quot;)) directlyIncreases translocation(proteinAbundance(PFM:&quot;Hdac Class II Family&quot;),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC1773'><br/></div><div class='line' id='LC1774'>SET Evidence = &quot;In the presence of 5 μM KN-62, there was no change in either nuclear or cytoplasmic</div><div class='line' id='LC1775'>fluorescence either at rest or in response to 10-Hz train stimulation (Fig. 2</div><div class='line' id='LC1776'>C; nine nuclei from four fibers). The results in Fig. 2 (A and C) strongly suggest</div><div class='line' id='LC1777'>that electrical stimulation resulted in HDAC4-GFP phosphorylation by CaMK before</div><div class='line' id='LC1778'>translocation.&quot;</div><div class='line' id='LC1779'><br/></div><div class='line' id='LC1780'>biologicalProcess(GO:&quot;cellular response to electrical stimulus&quot;) increases (kinaseActivity(proteinAbundance(PFM:&quot;Camk Family&quot;)) increases proteinAbundance(MGI:Hdac4,proteinModification(P)))</div><div class='line' id='LC1781'><br/></div><div class='line' id='LC1782'>SET Evidence = &quot;1 h of 10-Hz train stimulation significantly increased (P &lt; 0.01) the mean nuclear</div><div class='line' id='LC1783'>stain of activated CaMKII compared with unstimulated fibers, and KN-62 (5 μM)</div><div class='line' id='LC1784'>blocked the increase in activated CaMKII staining after stimulation (Fig. 3 A).</div><div class='line' id='LC1785'>In parallel experiments, in which the fibers were stained with antibody directed</div><div class='line' id='LC1786'>against total CaMKII, there was no difference in mean nuclear antibody stain between</div><div class='line' id='LC1787'>stimulated and unstimulated fibers (P &gt; 0.05; Fig. 3 A). These results are</div><div class='line' id='LC1788'>consistent with activation of nuclear CaMKII by fiber electrical stimulation without</div><div class='line' id='LC1789'>any appreciable translocation of CaMKII from the cytoplasm to the nucleus.&quot;</div><div class='line' id='LC1790'><br/></div><div class='line' id='LC1791'>biologicalProcess(GO:&quot;cellular response to electrical stimulus&quot;) increases kinaseActivity(proteinAbundance(PFM:&quot;Camk2 Family&quot;))</div><div class='line' id='LC1792'><br/></div><div class='line' id='LC1793'>SET Evidence = &quot;The same stimulation (5 h, followed by 19 h without stimulation) in the presence of</div><div class='line' id='LC1794'>the CaMK inhibitor KN-62 gave the same luciferase activity as control. Thus,</div><div class='line' id='LC1795'>KN-62 completely blocked the stimulation-dependent increase in MEF2 reporter activity,</div><div class='line' id='LC1796'>just as KN-62 completely blocked the stimulation-dependent efflux of HDAC4</div><div class='line' id='LC1797'>from the nucleus (Fig. 2).&quot;</div><div class='line' id='LC1798'><br/></div><div class='line' id='LC1799'>kinaseActivity(proteinAbundance(PFM:&quot;Camk Family&quot;)) increases transcriptionalActivity(proteinAbundance(PFM:&quot;Mef2 Family&quot;))</div><div class='line' id='LC1800'>abundance(SCHEM:&quot;KN 62&quot;) decreases transcriptionalActivity(proteinAbundance(PFM:&quot;Mef2 Family&quot;))</div><div class='line' id='LC1801'><br/></div><div class='line' id='LC1802'>SET Evidence = &quot;In contrast to the lack of effect of electrical stimulation on the distribution of</div><div class='line' id='LC1803'>CaM, prolonged continuous elevation of Ca2+ concentration by addition of ionomycin</div><div class='line' id='LC1804'>(2 μM) to the bathing solution (presumably elevating both cytosolic and nuclear</div><div class='line' id='LC1805'>Ca2+ concentration) did give rise to a delayed redistribution of CaM from the</div><div class='line' id='LC1806'>cytoplasm to the nucleus,&quot;</div><div class='line' id='LC1807'><br/></div><div class='line' id='LC1808'>abundance(SCHEM:Ionomycin) increases abundance(CHEBI:&quot;calcium(2+)&quot;)</div><div class='line' id='LC1809'>abundance(SCHEM:Ionomycin) increases translocation(proteinAbundance(PFM:&quot;Calm Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;)</div><div class='line' id='LC1810'><br/></div><div class='line' id='LC1811'>SET Evidence = &quot;Nuclear and cytoplasmic calcium is elevated during electrical stimulation&quot;</div><div class='line' id='LC1812'><br/></div><div class='line' id='LC1813'>biologicalProcess(GO:&quot;cellular response to electrical stimulus&quot;) increases abundance(CHEBI:&quot;calcium(2+)&quot;)</div><div class='line' id='LC1814'><br/></div><div class='line' id='LC1815'>SET Evidence = &quot;Leptomycin B binds to the nuclear export mediator protein CRM1, thereby blocking the</div><div class='line' id='LC1816'>binding of CRM1 to proteins containing the nuclear export signal (Fukuda et</div><div class='line' id='LC1817'>al., 1997) and preventing their nuclear export. During exposure to leptomycin B</div><div class='line' id='LC1818'>(40 nM), nuclear HDAC4-GFP continuously increased over a 60-min experimental period,</div><div class='line' id='LC1819'>whereas the cytoplasmic fluorescence signal was stable (Fig. 8 A).&quot;</div><div class='line' id='LC1820'><br/></div><div class='line' id='LC1821'>abundance(CHEBIID:52646) directlyDecreases transportActivity(proteinAbundance(MGI:Xpo1))</div><div class='line' id='LC1822'>abundance(CHEBIID:52646) increases translocation(proteinAbundance(MGI:Hdac4),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;)</div><div class='line' id='LC1823'><br/></div><div class='line' id='LC1824'>SET Evidence = &quot;Over a 60-min period of treatment with 1 μM calyculin A (a PP1 and PP2A phosphatase</div><div class='line' id='LC1825'>inhibitor that does not affect PP2B; Ishihara et al., 1989), the nuclear HDAC4-GFP</div><div class='line' id='LC1826'>fluorescence decreased linearly with a mean net export rate of -0.71 ± 0.07%/min</div><div class='line' id='LC1827'>(Fig. 9 A, 13 nuclei from 5 fibers).&quot;</div><div class='line' id='LC1828'><br/></div><div class='line' id='LC1829'>abundance(SCHEM:&quot;Calyculin A&quot;) directlyDecreases phosphataseActivity(proteinAbundance(PFM:&quot;Ppp1c Family&quot;))</div><div class='line' id='LC1830'>abundance(SCHEM:&quot;Calyculin A&quot;) directlyDecreases phosphataseActivity(complexAbundance(NCM:&quot;PP2A Complex&quot;))</div><div class='line' id='LC1831'>abundance(SCHEM:&quot;Calyculin A&quot;) increases translocation(proteinAbundance(MGI:Hdac4),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC1832'>abundance(SCHEM:&quot;Calyculin A&quot;) causesNoChange phosphataseActivity(proteinAbundance(PFM:&quot;Ppp3 Family&quot;))</div><div class='line' id='LC1833'><br/></div><div class='line' id='LC1834'>SET Evidence = &quot;Interestingly, calyculin A also caused a similar rate of efflux of HDAC5-GFP (-0.62</div><div class='line' id='LC1835'>± 0.05, nine nuclei from six fibers) from nuclei as observed for HDAC4, establishing</div><div class='line' id='LC1836'>the ability of HDAC5 to move out of the nucleus even though it did not translocate</div><div class='line' id='LC1837'>in response to electrical stimulation.&quot;</div><div class='line' id='LC1838'><br/></div><div class='line' id='LC1839'>abundance(SCHEM:&quot;Calyculin A&quot;) increases translocation(proteinAbundance(MGI:Hdac5),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC1840'>biologicalProcess(GO:&quot;cellular response to electrical stimulus&quot;) causesNoChange translocation(proteinAbundance(MGI:Hdac5),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC1841'><br/></div><div class='line' id='LC1842'>UNSET STATEMENT_GROUP</div><div class='line' id='LC1843'><br/></div><div class='line' id='LC1844'>SET STATEMENT_GROUP = &quot;Group 12&quot;</div><div class='line' id='LC1845'><br/></div><div class='line' id='LC1846'>SET Tissue = &quot;Endothelium&quot;</div><div class='line' id='LC1847'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC1848'>SET Evidence = &quot;LPS + IFNγ caused an increase in monolayer permeability, induction of iNOS and NADPH</div><div class='line' id='LC1849'>oxidase type 1 (Nox1) proteins, formation of superoxide, nitric oxide and 3-nitrotyrosine,</div><div class='line' id='LC1850'>and increase in PP2A activity in endothelial cells. These effects</div><div class='line' id='LC1851'>of LPS + IFNγ were diminished by tripterine (50-200 nM).&quot;</div><div class='line' id='LC1852'>SET Citation = {&quot;PubMed&quot;,&quot;British journal of pharmacology&quot;,&quot;19508391&quot;,&quot;2009-07-05&quot;,&quot;Wu F|Han M|Wilson JX&quot;,&quot;&quot;}</div><div class='line' id='LC1853'>SET Species = &quot;10090&quot;</div><div class='line' id='LC1854'><br/></div><div class='line' id='LC1855'>compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases biologicalProcess(MESHPP:&quot;Capillary Permeability&quot;)</div><div class='line' id='LC1856'>compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases proteinAbundance(MGI:Nos2)</div><div class='line' id='LC1857'>compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases proteinAbundance(MGI:Nox1)</div><div class='line' id='LC1858'>compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases abundance(CHEBI:superoxide)</div><div class='line' id='LC1859'>compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC1860'>compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases abundance(CHEBI:&quot;3-nitro-L-tyrosine&quot;)</div><div class='line' id='LC1861'>compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases phosphataseActivity(complexAbundance(NCM:&quot;PP2A Complex&quot;))</div><div class='line' id='LC1862'>abundance(SCHEM:Tripterine) decreases (compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases biologicalProcess(MESHPP:&quot;Capillary Permeability&quot;))</div><div class='line' id='LC1863'>abundance(SCHEM:Tripterine) decreases (compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases proteinAbundance(MGI:Nos2))</div><div class='line' id='LC1864'>abundance(SCHEM:Tripterine) decreases (compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases proteinAbundance(MGI:Nox1))</div><div class='line' id='LC1865'>abundance(SCHEM:Tripterine) decreases (compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases abundance(CHEBI:superoxide))</div><div class='line' id='LC1866'>abundance(SCHEM:Tripterine) decreases (compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases abundance(CHEBI:&quot;nitric oxide&quot;))</div><div class='line' id='LC1867'>abundance(SCHEM:Tripterine) decreases (compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases abundance(CHEBI:&quot;3-nitro-L-tyrosine&quot;))</div><div class='line' id='LC1868'>abundance(SCHEM:Tripterine) decreases (compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases phosphataseActivity(complexAbundance(NCM:&quot;PP2A Complex&quot;)))</div><div class='line' id='LC1869'><br/></div><div class='line' id='LC1870'>SET Evidence = &quot;Further, LPS + IFNγ -induced expression of iNOS and Nox1 was attenuated by the mitogen-activated</div><div class='line' id='LC1871'>protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor</div><div class='line' id='LC1872'>SP600125, the Jak2 inhibitor AG490 and the NFκB inhibitor MG132, but not</div><div class='line' id='LC1873'>by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNγ stimulated</div><div class='line' id='LC1874'>phosphorylation of ERK, JNK and Jak2, and degradation of IκB, but only Jak2</div><div class='line' id='LC1875'>phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine</div><div class='line' id='LC1876'>diminished the increased vascular permeability in inflamed air pouches.&quot;</div><div class='line' id='LC1877'><br/></div><div class='line' id='LC1878'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases (compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(MGI:Nos2))</div><div class='line' id='LC1879'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases (compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(MGI:Nox1))</div><div class='line' id='LC1880'>abundance(SCHEM:&quot;PD 98,059&quot;) directlyDecreases kinaseActivity(proteinAbundance(MGI:Map2k1))</div><div class='line' id='LC1881'>abundance(SCHEM:&quot;PD 98,059&quot;) directlyDecreases kinaseActivity(proteinAbundance(MGI:Map2k2))</div><div class='line' id='LC1882'>abundance(SCHEM:SP600125) directlyDecreases kinaseActivity(proteinAbundance(PFM:&quot;Mapk JNK Family&quot;))</div><div class='line' id='LC1883'>abundance(SCHEM:SP600125) decreases (compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(MGI:Nos2))</div><div class='line' id='LC1884'>abundance(SCHEM:SP600125) decreases (compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(MGI:Nox1))</div><div class='line' id='LC1885'>abundance(SCHEM:&quot;AG-490&quot;) directlyDecreases kinaseActivity(proteinAbundance(MGI:Jak2))</div><div class='line' id='LC1886'>abundance(SCHEM:&quot;AG-490&quot;) decreases (compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(MGI:Nos2))</div><div class='line' id='LC1887'>abundance(SCHEM:&quot;AG-490&quot;) decreases (compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(MGI:Nox1))</div><div class='line' id='LC1888'>abundance(SCHEM:&quot;Benzyloxycarbonylleucyl-leucyl-leucine aldehyde&quot;) decreases (compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(MGI:Nos2)) //MG132 = &quot;Benzyloxycarbonylleucyl-leucyl-leucine aldehyde&quot;</div><div class='line' id='LC1889'>abundance(SCHEM:&quot;Benzyloxycarbonylleucyl-leucyl-leucine aldehyde&quot;) decreases (compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(MGI:Nox1))</div><div class='line' id='LC1890'>abundance(SCHEM:&quot;SB-203580&quot;) directlyDecreases kinaseActivity(proteinAbundance(PFM:&quot;Mapk p38 Family&quot;))</div><div class='line' id='LC1891'>abundance(SCHEM:Tripterine) decreases proteinAbundance(MGI:Jak2,proteinModification(P))</div><div class='line' id='LC1892'>compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(PFM:&quot;MAPK Erk1/3 Family&quot;,proteinModification(P))</div><div class='line' id='LC1893'>compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(PFM:&quot;Mapk JNK Family&quot;,proteinModification(P))</div><div class='line' id='LC1894'>compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases proteinAbundance(MGI:Jak2,proteinModification(P))</div><div class='line' id='LC1895'>compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases degradation(proteinAbundance(MGI:Nfkbia))</div><div class='line' id='LC1896'>abundance(SCHEM:&quot;Benzyloxycarbonylleucyl-leucyl-leucine aldehyde&quot;) decreases transcriptionalActivity(complexAbundance(NCM:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC1897'><br/></div><div class='line' id='LC1898'>SET Evidence = &quot;Our results indicate that, by preventing Jak2-dependent induction of iNOS and Nox1,</div><div class='line' id='LC1899'>tripterine inhibits peroxynitrite precursor synthesis, attenuates the increased</div><div class='line' id='LC1900'>activity of PP2A and consequently protects endothelial barrier function.&quot;</div><div class='line' id='LC1901'><br/></div><div class='line' id='LC1902'>abundance(SCHEM:Tripterine) decreases abundance(CHEBI:peroxynitrite)</div><div class='line' id='LC1903'><br/></div><div class='line' id='LC1904'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC1905'>SET Evidence = &quot;The increased endothelial permeability induced by LPS + IFNγ was attenuated by the</div><div class='line' id='LC1906'>NADPH oxidase inhibitor apocynin (250 µM; based on Coyle and Kader, 2007), iNOS</div><div class='line' id='LC1907'>inhibitor 1400W (50 µM; based on Hortelano et al., 2000), and tripterine (50 nM</div><div class='line' id='LC1908'>and 200 nM; based on Allison et al., 2001) (Figure 1B). Neither apocynin, 1400W</div><div class='line' id='LC1909'>nor tripterine (50 nM and 200 nM) altered the endothelial permeability in the</div><div class='line' id='LC1910'>absence of a pro-inflammatory stimulus (Figure 1B).&quot;</div><div class='line' id='LC1911'><br/></div><div class='line' id='LC1912'>abundance(CHEBI:apocynin) directlyDecreases catalyticActivity(complexAbundance(NCM:&quot;NADPH Oxidase Complex&quot;))</div><div class='line' id='LC1913'>abundance(CHEBI:apocynin) decreases (compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases biologicalProcess(MESHPP:&quot;Capillary Permeability&quot;))</div><div class='line' id='LC1914'>catalyticActivity(proteinAbundance(MGI:Nos2)) increases biologicalProcess(MESHPP:&quot;Capillary Permeability&quot;) //No term for 1400W</div><div class='line' id='LC1915'>abundance(SCHEM:Tripterine) decreases (compositeAbundance(proteinAbundance(MGI:Ifng),abundance(SCHEM:Lipopolysaccharide)) increases biologicalProcess(MESHPP:&quot;Capillary Permeability&quot;))</div><div class='line' id='LC1916'><br/></div><div class='line' id='LC1917'>SET Evidence = &quot;However, tripterine at a concentration of 1 µM (based on Allison et al., 2001), either</div><div class='line' id='LC1918'>alone or together with LPS + IFNγ, significantly decreased cell viability,</div><div class='line' id='LC1919'>which may have caused the permeability increase observed for this high dose (Figure</div><div class='line' id='LC1920'>1B,C).&quot;</div><div class='line' id='LC1921'><br/></div><div class='line' id='LC1922'>abundance(SCHEM:Tripterine) increases biologicalProcess(GO:&quot;cell death&quot;)</div><div class='line' id='LC1923'><br/></div><div class='line' id='LC1924'>SET Evidence = &quot;LPS + IFNγ induces NO and superoxide production in microvascular endothelial cells</div><div class='line' id='LC1925'>(Wu et al., 2001; 2002; 2008).&quot;</div><div class='line' id='LC1926'><br/></div><div class='line' id='LC1927'>compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC1928'>compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases abundance(CHEBI:superoxide)</div><div class='line' id='LC1929'><br/></div><div class='line' id='LC1930'>SET Evidence = &quot;Our previous study identified NADPH oxidase activity as the principal source of superoxide</div><div class='line' id='LC1931'>in LPS + IFNγ-stimulated microvascular endothelial cells (Wu et al., 2007;</div><div class='line' id='LC1932'>2008).&quot;</div><div class='line' id='LC1933'><br/></div><div class='line' id='LC1934'>compositeAbundance(abundance(SCHEM:Lipopolysaccharide),proteinAbundance(MGI:Ifng)) increases catalyticActivity(complexAbundance(NCM:&quot;NADPH Oxidase Complex&quot;))</div><div class='line' id='LC1935'>catalyticActivity(complexAbundance(NCM:&quot;NADPH Oxidase Complex&quot;)) directlyIncreases abundance(CHEBI:superoxide)</div><div class='line' id='LC1936'><br/></div><div class='line' id='LC1937'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC1938'>SET Evidence = &quot;Nox1 is a catalytic subunit of NADPH oxidase that is expressed in endothelial cells</div><div class='line' id='LC1939'>(Sorescu et al., 2004; Wu et al., 2008).&quot;</div><div class='line' id='LC1940'><br/></div><div class='line' id='LC1941'>complexAbundance(NCM:&quot;NADPH Oxidase Complex&quot;) hasComponent proteinAbundance(MGI:Nox1)</div><div class='line' id='LC1942'><br/></div><div class='line' id='LC1943'>SET Evidence = &quot;Tripterine alone also decreased the basal production of NO in endothelial cells, in</div><div class='line' id='LC1944'>the absence of LPS + IFNγ stimulation (Figure 4D).&quot;</div><div class='line' id='LC1945'><br/></div><div class='line' id='LC1946'>abundance(SCHEM:Tripterine) decreases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC1947'><br/></div><div class='line' id='LC1948'>SET Evidence = &quot;iNOS-derived NO and NADPH oxidase-derived superoxide react to form peroxynitrite that</div><div class='line' id='LC1949'>can nitrate the tyrosine residues of target proteins, leading to the formation</div><div class='line' id='LC1950'>of 3-nitrotyrosine.&quot;</div><div class='line' id='LC1951'><br/></div><div class='line' id='LC1952'>catalyticActivity(proteinAbundance(MGI:Nos2)) directlyIncreases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC1953'>catalyticActivity(complexAbundance(NCM:&quot;NADPH Oxidase Complex&quot;)) directlyIncreases abundance(CHEBI:superoxide)</div><div class='line' id='LC1954'>reaction(reactants(abundance(CHEBI:superoxide),abundance(CHEBI:&quot;nitric oxide&quot;)),products(abundance(CHEBI:peroxynitrite)))</div><div class='line' id='LC1955'>abundance(CHEBI:peroxynitrite) increases abundance(CHEBI:&quot;3-nitro-L-tyrosine&quot;)</div><div class='line' id='LC1956'><br/></div><div class='line' id='LC1957'>SET Evidence = &quot;Increased production of peroxynitrite is associated with the activation of PP2A; this</div><div class='line' id='LC1958'>causes an increase in the permeability of the endothelial cell monolayer (Wu</div><div class='line' id='LC1959'>and Wilson, 2009).&quot;</div><div class='line' id='LC1960'><br/></div><div class='line' id='LC1961'>abundance(CHEBI:peroxynitrite) increases phosphataseActivity(complexAbundance(NCM:&quot;PP2A Complex&quot;))</div><div class='line' id='LC1962'>phosphataseActivity(complexAbundance(NCM:&quot;PP2A Complex&quot;)) increases biologicalProcess(MESHPP:&quot;Capillary Permeability&quot;)</div><div class='line' id='LC1963'><br/></div><div class='line' id='LC1964'>UNSET STATEMENT_GROUP</div><div class='line' id='LC1965'><br/></div><div class='line' id='LC1966'>SET STATEMENT_GROUP = &quot;Group 13&quot;</div><div class='line' id='LC1967'><br/></div><div class='line' id='LC1968'>SET Disease = &quot;Carcinoma, Non-Small-Cell Lung&quot;</div><div class='line' id='LC1969'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC1970'>SET Evidence = &quot;Constitutive Akt/protein kinase B (PKB) activity was demonstrated in 16 of 17 cell</div><div class='line' id='LC1971'>lines by maintenance of S473 phosphorylation with serum deprivation. Additional</div><div class='line' id='LC1972'>analysis of five of 2these NSCLC lines revealed that phosphorylation of S473 and</div><div class='line' id='LC1973'>T308 correlated with in vitro kinase activity.&quot;</div><div class='line' id='LC1974'>SET Citation = {&quot;PubMed&quot;,&quot;Cancer research&quot;,&quot;11358816&quot;,&quot;&quot;,&quot;Brognard J|Clark AS|Ni Y|Dennis PA&quot;,&quot;&quot;}</div><div class='line' id='LC1975'>SET Species = &quot;9606&quot;</div><div class='line' id='LC1976'><br/></div><div class='line' id='LC1977'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) positiveCorrelation pathology(MESHD:&quot;Carcinoma, Non-Small-Cell Lung&quot;)</div><div class='line' id='LC1978'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473)) positiveCorrelation pathology(MESHD:&quot;Carcinoma, Non-Small-Cell Lung&quot;)</div><div class='line' id='LC1979'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473)) positiveCorrelation kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC1980'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308)) positiveCorrelation pathology(MESHD:&quot;Carcinoma, Non-Small-Cell Lung&quot;)</div><div class='line' id='LC1981'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308)) positiveCorrelation kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC1982'><br/></div><div class='line' id='LC1983'>SET Evidence = &quot;Akt/PKB activation was phosphatidylinositol 3-kinase-dependent and promoted survival</div><div class='line' id='LC1984'>because the phosphatidylinositol 3 inhibitors LY294002 and wortmannin inhibited</div><div class='line' id='LC1985'>Akt/PKB phosphorylation, Akt/PKB activity, and increased apoptosis only in cells</div><div class='line' id='LC1986'>with active Akt/PKB.&quot;</div><div class='line' id='LC1987'><br/></div><div class='line' id='LC1988'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) increases biologicalProcess(MESHPP:&quot;Cell Survival&quot;)</div><div class='line' id='LC1989'>abundance(SCHEM:&quot;LY 294002&quot;) decreases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473))</div><div class='line' id='LC1990'>abundance(CHEBIID:52289) decreases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473))</div><div class='line' id='LC1991'>abundance(SCHEM:&quot;LY 294002&quot;) decreases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC1992'>abundance(CHEBIID:52289) decreases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC1993'>abundance(CHEBIID:52289) decreases (kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) decreases biologicalProcess(GO:&quot;apoptotic process&quot;))</div><div class='line' id='LC1994'>abundance(SCHEM:&quot;LY 294002&quot;) decreases (kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) decreases biologicalProcess(GO:&quot;apoptotic process&quot;))</div><div class='line' id='LC1995'><br/></div><div class='line' id='LC1996'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC1997'>SET Evidence = &quot;Table 1  shows that under normal growth conditions, 17 of 19 NSCLC cell lines (89%)</div><div class='line' id='LC1998'>exhibit phosphorylation of S473. Phosphorylation of S473 was maintained in 16</div><div class='line' id='LC1999'>of 17 positive cell lines (94%) when cells were deprived of serum.&quot;</div><div class='line' id='LC2000'><br/></div><div class='line' id='LC2001'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473)) positiveCorrelation pathology(MESHD:&quot;Carcinoma, Non-Small-Cell Lung&quot;)</div><div class='line' id='LC2002'><br/></div><div class='line' id='LC2003'>SET Evidence = &quot;In all 10 cell lines tested, IGF-I increased S473 phosphorylation irrespective of</div><div class='line' id='LC2004'>endogenous levels, indicating that NSCLC cell lines phosphorylate Akt/PKB in response</div><div class='line' id='LC2005'>to IGF-I, and that the IGF-IR signaling pathway that leads to Akt/PKB activation</div><div class='line' id='LC2006'>is intact, even in cells that exhibit no Akt/PKB phosphorylation (H1355).&quot;</div><div class='line' id='LC2007'><br/></div><div class='line' id='LC2008'>proteinAbundance(HGNC:IGF1) increases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473))</div><div class='line' id='LC2009'><br/></div><div class='line' id='LC2010'>SET CellLine = &quot;NCI-H1155&quot;</div><div class='line' id='LC2011'>SET Evidence = &quot;Fig. 1A shows that the H1155, H157, and H1703 cells exhibit S473 phosphorylation under</div><div class='line' id='LC2012'>normal growth conditions and serum deprivation, but A549 and H1355 cells show</div><div class='line' id='LC2013'>little S473 phosphorylation in low-serum conditions. Levels of phosphorylated</div><div class='line' id='LC2014'>S473 were greatest in the H1155 cells. Regulation of S473 phosphorylation by serum</div><div class='line' id='LC2015'>withdrawal was only observed with the A549 cells.&quot;</div><div class='line' id='LC2016'><br/></div><div class='line' id='LC2017'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473))</div><div class='line' id='LC2018'><br/></div><div class='line' id='LC2019'>SET CellLine = &quot;NCI-H1703&quot;</div><div class='line' id='LC2020'><br/></div><div class='line' id='LC2021'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473))</div><div class='line' id='LC2022'><br/></div><div class='line' id='LC2023'>SET CellLine = &quot;A549&quot;</div><div class='line' id='LC2024'><br/></div><div class='line' id='LC2025'>biologicalProcess(GO:&quot;cellular response to starvation&quot;) decreases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473))</div><div class='line' id='LC2026'><br/></div><div class='line' id='LC2027'>SET Evidence = &quot;Phosphorylation patterns for T308, the PDK1 site (Fig. 1B), generally correlated with</div><div class='line' id='LC2028'>the S473 pattern; only the H1155, H157, and H1703 cells displayed phosphorylation</div><div class='line' id='LC2029'>of Akt/PKB at T308.&quot;</div><div class='line' id='LC2030'><br/></div><div class='line' id='LC2031'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473)) positiveCorrelation proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308))</div><div class='line' id='LC2032'>kinaseActivity(proteinAbundance(HGNC:PDPK1)) directlyIncreases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308))</div><div class='line' id='LC2033'><br/></div><div class='line' id='LC2034'>SET CellLine = &quot;NCI-H1155&quot;</div><div class='line' id='LC2035'><br/></div><div class='line' id='LC2036'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308))</div><div class='line' id='LC2037'><br/></div><div class='line' id='LC2038'>SET CellLine = &quot;NCI-H1703&quot;</div><div class='line' id='LC2039'><br/></div><div class='line' id='LC2040'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308))</div><div class='line' id='LC2041'><br/></div><div class='line' id='LC2042'>SET Evidence = &quot;Interestingly, both H1703 and H1155 cells increased T308 phosphorylation when transitioned</div><div class='line' id='LC2043'>from normal growth conditions to serum deprivation, indicating that increased</div><div class='line' id='LC2044'>T308 phosphorylation might be an adaptive response to the stress of serum</div><div class='line' id='LC2045'>deprivation in these cells.&quot;</div><div class='line' id='LC2046'><br/></div><div class='line' id='LC2047'>biologicalProcess(GO:&quot;cellular response to starvation&quot;) increases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308))</div><div class='line' id='LC2048'><br/></div><div class='line' id='LC2049'>SET CellLine = &quot;NCI-H1155&quot;</div><div class='line' id='LC2050'><br/></div><div class='line' id='LC2051'>biologicalProcess(GO:&quot;cellular response to starvation&quot;) increases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308))</div><div class='line' id='LC2052'><br/></div><div class='line' id='LC2053'>SET Evidence = &quot;In contrast to the low or absent PTEN in cells with phosphorylated Akt/PKB, the cell</div><div class='line' id='LC2054'>lines with the lowest levels of phosphorylated Akt had the highest level of</div><div class='line' id='LC2055'>PTEN protein expression (A549 and H1355). Both A549 and H1355 cells have wild-type</div><div class='line' id='LC2056'>PTEN (Ref. 69  and data not shown, respectively). Taken together, these data</div><div class='line' id='LC2057'>show that Akt/PKB phosphorylation and mutations in PTEN are inversely correlated</div><div class='line' id='LC2058'>in four of five NSCLC cell lines.&quot;</div><div class='line' id='LC2059'><br/></div><div class='line' id='LC2060'>proteinAbundance(HGNC:PTEN) negativeCorrelation proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P))</div><div class='line' id='LC2061'><br/></div><div class='line' id='LC2062'>SET Evidence = &quot;we tested the ability of two PI3-K inhibitors, LY294002 and wortmannin, to inhibit</div><div class='line' id='LC2063'>Akt/PKB phosphorylation. Fig. 2A shows that both LY294002 and wortmannin completely</div><div class='line' id='LC2064'>inhibited phosphorylation of S473 in the three NSCLC cell lines that maintain</div><div class='line' id='LC2065'>S473 phosphorylation under serum deprivation. Native Akt/PKB levels did not</div><div class='line' id='LC2066'>change. Similar results were obtained for T308 phosphorylation (Fig. 2B).&quot;</div><div class='line' id='LC2067'><br/></div><div class='line' id='LC2068'>abundance(SCHEM:&quot;LY 294002&quot;) decreases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308))</div><div class='line' id='LC2069'>abundance(SCHEM:&quot;LY 294002&quot;) decreases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473))</div><div class='line' id='LC2070'>abundance(CHEBI:wortmannin) decreases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308))</div><div class='line' id='LC2071'>abundance(CHEBI:wortmannin) decreases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473))</div><div class='line' id='LC2072'>abundance(CHEBI:wortmannin) directlyDecreases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC2073'>abundance(SCHEM:&quot;LY 294002&quot;) directlyDecreases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC2074'><br/></div><div class='line' id='LC2075'>SET Evidence = &quot;These data demonstrate that Akt/PKB phosphorylation in the three positive cell lines</div><div class='line' id='LC2076'>is PI3-K-dependent, making it unlikely that other kinases are directly involved</div><div class='line' id='LC2077'>in activating Akt/PKB.&quot;</div><div class='line' id='LC2078'><br/></div><div class='line' id='LC2079'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) increases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P))</div><div class='line' id='LC2080'><br/></div><div class='line' id='LC2081'>SET Evidence = &quot;Fig. 5A shows that in the three cell lines with high Akt/PKB activity, basal levels</div><div class='line' id='LC2082'>of apoptosis were potentiated 6–16-fold by LY294002 (Lanes 1).&quot;</div><div class='line' id='LC2083'><br/></div><div class='line' id='LC2084'>abundance(SCHEM:&quot;LY 294002&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC2085'><br/></div><div class='line' id='LC2086'>SET Evidence = &quot;we transiently cotransfected NSCLC cell lines with HA-tagged dominant negative Akt/PKB</div><div class='line' id='LC2087'>(K179M Akt/PKB) and GFP and assessed apoptosis in the GFP-positive cells.</div><div class='line' id='LC2088'>Fig. 6 shows that in the cell lines with high Akt/PKB activity, transfection of</div><div class='line' id='LC2089'>K179M Akt/PKB resulted in a 2–5-fold increase in basal apoptosis.&quot;</div><div class='line' id='LC2090'><br/></div><div class='line' id='LC2091'>proteinAbundance(PFH:&quot;AKT Family&quot;,substitution(K,179,M)) directlyDecreases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC2092'>proteinAbundance(PFH:&quot;AKT Family&quot;,substitution(K,179,M)) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC2093'><br/></div><div class='line' id='LC2094'>UNSET STATEMENT_GROUP</div><div class='line' id='LC2095'><br/></div><div class='line' id='LC2096'>SET STATEMENT_GROUP = &quot;Group 14&quot;</div><div class='line' id='LC2097'><br/></div><div class='line' id='LC2098'>SET Cell = &quot;Blood Platelets&quot;</div><div class='line' id='LC2099'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC2100'>SET Evidence = &quot;platelet adhesion is an essential function in response to vascular injury and is generally</div><div class='line' id='LC2101'>viewed as the first step during which single platelets bind through specific</div><div class='line' id='LC2102'>membrane receptors to cellular and extracellular matrix constituents of the</div><div class='line' id='LC2103'>vessel wall and tissues. This response initiates thrombus formation that arrests</div><div class='line' id='LC2104'>hemorrhage and permits wound healing&quot;</div><div class='line' id='LC2105'>SET Citation = {&quot;PubMed&quot;,&quot;Circulation research&quot;,&quot;17585075&quot;,&quot;&quot;,&quot;Ruggeri ZM|Mendolicchio GL&quot;,&quot;&quot;}</div><div class='line' id='LC2106'><br/></div><div class='line' id='LC2107'>biologicalProcess(MESHPP:&quot;Platelet Adhesiveness&quot;) decreases pathology(SDIS:hemorrhage)</div><div class='line' id='LC2108'>biologicalProcess(MESHPP:&quot;Platelet Adhesiveness&quot;) increases biologicalProcess(MESHPP:&quot;Wound Healing&quot;)</div><div class='line' id='LC2109'><br/></div><div class='line' id='LC2110'>SET Disease = &quot;Atherosclerosis&quot;</div><div class='line' id='LC2111'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC2112'>SET Evidence = &quot;In pathological conditions, platelets are a major contributor to arterial thrombosis,</div><div class='line' id='LC2113'>which typically occurs at sites of atherosclerosis with stenosis of the vessel</div><div class='line' id='LC2114'>lumen, where shear-stress values are considerably higher than in the normal</div><div class='line' id='LC2115'>circulation.11–13&quot;</div><div class='line' id='LC2116'><br/></div><div class='line' id='LC2117'>biologicalProcess(GO:&quot;response to fluid shear stress&quot;) increases pathology(MESHD:Thrombosis)</div><div class='line' id='LC2118'><br/></div><div class='line' id='LC2119'>SET Cell = &quot;Leukocytes&quot;</div><div class='line' id='LC2120'>SET Evidence = &quot;Shear stress, in contrast, influences the lifetime of an adhesive bond once formed,</div><div class='line' id='LC2121'>thus the off-rate of the interaction, and the consequence is decreased efficiency</div><div class='line' id='LC2122'>caused by detachment of adherent cells with increasing shear stress. The point</div><div class='line' id='LC2123'>has been well documented for leukocyte adhesion.14&quot;</div><div class='line' id='LC2124'><br/></div><div class='line' id='LC2125'>biologicalProcess(GO:&quot;response to fluid shear stress&quot;) decreases biologicalProcess(GO:&quot;leukocyte cell-cell adhesion&quot;)</div><div class='line' id='LC2126'><br/></div><div class='line' id='LC2127'>SET Cell = &quot;Blood Platelets&quot;</div><div class='line' id='LC2128'>SET TextLocation = &quot;Legend&quot;</div><div class='line' id='LC2129'>SET Evidence = &quot;The results demonstrate that the adhesive function of GPIbα is as necessary as that</div><div class='line' id='LC2130'>of αIIbβ3 to sustain platelet aggregation at the edge of a growing thrombus&quot;</div><div class='line' id='LC2131'><br/></div><div class='line' id='LC2132'>molecularActivity(proteinAbundance(HGNC:GP1BA)) increases biologicalProcess(GO:&quot;platelet aggregation&quot;)</div><div class='line' id='LC2133'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3))) increases biologicalProcess(GO:&quot;platelet aggregation&quot;)</div><div class='line' id='LC2134'><br/></div><div class='line' id='LC2135'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC2136'>SET Evidence = &quot;Among the substrates required for normal thrombus formation, VWF is unique for its</div><div class='line' id='LC2137'>role in initiating platelet adhesion and sustaining platelet aggregation under</div><div class='line' id='LC2138'>conditions of elevated shear stress.16,18&quot;</div><div class='line' id='LC2139'><br/></div><div class='line' id='LC2140'>proteinAbundance(HGNC:VWF) increases biologicalProcess(GO:&quot;platelet aggregation&quot;)</div><div class='line' id='LC2141'>proteinAbundance(HGNC:VWF) increases biologicalProcess(MESHPP:&quot;Platelet Adhesiveness&quot;)</div><div class='line' id='LC2142'><br/></div><div class='line' id='LC2143'>SET Evidence = &quot;Platelets have 2 main binding sites for VWF,57,58 GPIbα in the GPIβ-IX-V complex26</div><div class='line' id='LC2144'>and the integrin αIIbβ3.59&quot;</div><div class='line' id='LC2145'><br/></div><div class='line' id='LC2146'>complexAbundance(proteinAbundance(HGNC:VWF),proteinAbundance(HGNC:GP1BA))</div><div class='line' id='LC2147'>complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3),proteinAbundance(HGNC:VWF))</div><div class='line' id='LC2148'><br/></div><div class='line' id='LC2149'>SET Evidence = &quot;The integrin αIIbβ3, on the other hand, binds several ligands, in addition to VWF,</div><div class='line' id='LC2150'>that are key to the process of platelet adhesion and aggregation, primarily fibrinogen,64</div><div class='line' id='LC2151'>fibronectin, 65 and CD40 ligand.66&quot;</div><div class='line' id='LC2152'><br/></div><div class='line' id='LC2153'>complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3),proteinAbundance(HGNC:VWF)) increases biologicalProcess(MESHPP:&quot;Platelet Adhesiveness&quot;)</div><div class='line' id='LC2154'>complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3),proteinAbundance(HGNC:VWF)) increases biologicalProcess(GO:&quot;platelet aggregation&quot;)</div><div class='line' id='LC2155'>complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3),abundance(SCHEM:Fibrinogen)) increases biologicalProcess(MESHPP:&quot;Platelet Adhesiveness&quot;)</div><div class='line' id='LC2156'>complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3),abundance(SCHEM:Fibrinogen)) increases biologicalProcess(GO:&quot;platelet aggregation&quot;)</div><div class='line' id='LC2157'>complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3),proteinAbundance(HGNC:FN1)) increases biologicalProcess(MESHPP:&quot;Platelet Adhesiveness&quot;)</div><div class='line' id='LC2158'>complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3),proteinAbundance(HGNC:FN1)) increases biologicalProcess(GO:&quot;platelet aggregation&quot;)</div><div class='line' id='LC2159'>complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3),proteinAbundance(HGNC:CD40LG)) increases biologicalProcess(MESHPP:&quot;Platelet Adhesiveness&quot;)</div><div class='line' id='LC2160'>complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3),proteinAbundance(HGNC:CD40LG)) increases biologicalProcess(GO:&quot;platelet aggregation&quot;)</div><div class='line' id='LC2161'><br/></div><div class='line' id='LC2162'>SET Evidence = &quot;ADAMTS-13 can cleave circulating VWF multimers while they mediate activationindependent</div><div class='line' id='LC2163'>interplatelet cohesion under high shear stress, thus dispersing the aggregates.73&quot;</div><div class='line' id='LC2164'><br/></div><div class='line' id='LC2165'>peptidaseActivity(proteinAbundance(HGNC:ADAMTS13)) increases degradation(proteinAbundance(HGNC:VWF))</div><div class='line' id='LC2166'><br/></div><div class='line' id='LC2167'>SET Evidence = &quot;In contrast, blocking the other receptor, GPVI, impairs thrombus formation on all</div><div class='line' id='LC2168'>types of collagen fibers.77,78&quot;</div><div class='line' id='LC2169'><br/></div><div class='line' id='LC2170'>molecularActivity(proteinAbundance(HGNC:GP6)) increases pathology(MESHD:Thrombosis)</div><div class='line' id='LC2171'><br/></div><div class='line' id='LC2172'>SET Evidence = &quot;The expression of alpha2beta1 on normal platelets varies by as much as 1 order of</div><div class='line' id='LC2173'>magnitude,92 and may positively correlate to the rapidity of the initial phase</div><div class='line' id='LC2174'>of platelet adhesion to collagen&quot;</div><div class='line' id='LC2175'><br/></div><div class='line' id='LC2176'>cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGA2),proteinAbundance(HGNC:ITGB1))) positiveCorrelation biologicalProcess(GO:&quot;regulation of collagen binding&quot;)</div><div class='line' id='LC2177'><br/></div><div class='line' id='LC2178'>SET Evidence = &quot;In the latter study, with blood perfused over fibrillar collagen type I at shear rates</div><div class='line' id='LC2179'>between 400 and 1300 sec-1, the isolated deficiency of α2β1 or GPVI-Fc receptor</div><div class='line' id='LC2180'>-chain (FcR-g) complex caused an equivalent partial defect of platelet thrombus</div><div class='line' id='LC2181'>formation, whereas the combined deficiency caused complete inhibition.97&quot;</div><div class='line' id='LC2182'>SET Species = &quot;10090&quot;</div><div class='line' id='LC2183'><br/></div><div class='line' id='LC2184'>complexAbundance(proteinAbundance(MGI:Itga2),proteinAbundance(MGI:Itgb1)) increases pathology(MESHD:Thrombosis)</div><div class='line' id='LC2185'>complexAbundance(proteinAbundance(MGI:Gp6),complexAbundance(NCM:&quot;FcR Gamma Chain Complex&quot;)) increases pathology(MESHD:Thrombosis)</div><div class='line' id='LC2186'><br/></div><div class='line' id='LC2187'>SET Evidence = &quot;Fibronectin is an essential adhesive substrate in many fundamental biological processes.24</div><div class='line' id='LC2188'>Platelets possess 2 main receptors for this protein, α5β1 and αIIbβ3,114</div><div class='line' id='LC2189'>the latter of which requires activation to function.65&quot;</div><div class='line' id='LC2190'><br/></div><div class='line' id='LC2191'>complexAbundance(proteinAbundance(HGNC:ITGA5),proteinAbundance(HGNC:ITGB1),proteinAbundance(HGNC:FN1))</div><div class='line' id='LC2192'>complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3),proteinAbundance(HGNC:FN1))</div><div class='line' id='LC2193'>proteinAbundance(HGNC:FN1) directlyIncreases molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA5),proteinAbundance(HGNC:ITGB1)))</div><div class='line' id='LC2194'>proteinAbundance(HGNC:FN1) directlyIncreases molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3)))</div><div class='line' id='LC2195'><br/></div><div class='line' id='LC2196'>SET Evidence = &quot;α5β1 supports platelet adhesion to endothelial extracellular matrix&quot;</div><div class='line' id='LC2197'><br/></div><div class='line' id='LC2198'>complexAbundance(proteinAbundance(HGNC:ITGA5),proteinAbundance(HGNC:ITGB1)) increases biologicalProcess(MESHPP:&quot;Platelet Adhesiveness&quot;)</div><div class='line' id='LC2199'><br/></div><div class='line' id='LC2200'>SET CellStructure = &quot;Cell Membrane&quot;</div><div class='line' id='LC2201'>SET Evidence = &quot;thrombospondin-1 binds to the platelet membrane and mediates adhesion&quot;</div><div class='line' id='LC2202'><br/></div><div class='line' id='LC2203'>proteinAbundance(HGNC:THBS1) increases biologicalProcess(MESHPP:&quot;Platelet Adhesiveness&quot;)</div><div class='line' id='LC2204'><br/></div><div class='line' id='LC2205'>SET Disease = &quot;Plaque, Atherosclerotic&quot;</div><div class='line' id='LC2206'>SET Evidence = &quot;The significance of thrombospondin-1 in platelet thrombus formation is still unclear,</div><div class='line' id='LC2207'>although it is intriguing to note that this glycoprotein is abundant in atherosclerotic</div><div class='line' id='LC2208'>plaques&quot;</div><div class='line' id='LC2209'><br/></div><div class='line' id='LC2210'>proteinAbundance(HGNC:THBS1) positiveCorrelation pathology(MESHD:&quot;Plaque, Atherosclerotic&quot;)</div><div class='line' id='LC2211'><br/></div><div class='line' id='LC2212'>SET Evidence = &quot;These findings delineate a synergistic role for α5β1 and GPVI as laminin receptors,</div><div class='line' id='LC2213'>coupled to distinct activation pathways convergent on the function of the Syk</div><div class='line' id='LC2214'>tyrosine kinase&quot;</div><div class='line' id='LC2215'><br/></div><div class='line' id='LC2216'>complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB1)) increases kinaseActivity(proteinAbundance(HGNC:SYK))</div><div class='line' id='LC2217'>proteinAbundance(HGNC:GP6) increases kinaseActivity(proteinAbundance(HGNC:SYK))</div><div class='line' id='LC2218'><br/></div><div class='line' id='LC2219'>SET CardiovascularSystem = &quot;Blood Vessels&quot;</div><div class='line' id='LC2220'>SET Evidence = &quot;The main substrate capable of binding VWF is collagen,36 particularly types I and</div><div class='line' id='LC2221'>III in deeper layers of the vessel wall and microfibrillar collagen type VI in</div><div class='line' id='LC2222'>the subendothelial matrix,30,37–39 with heparin, sulfatides, and fibrin providing</div><div class='line' id='LC2223'>additional interaction sites (see the online data supplement).&quot;</div><div class='line' id='LC2224'><br/></div><div class='line' id='LC2225'>complexAbundance(proteinAbundance(HGNC:VWF),proteinAbundance(PFH:&quot;COL1 Family&quot;))</div><div class='line' id='LC2226'><br/></div><div class='line' id='LC2227'>SET Evidence = &quot;The platelet membrane is endowed with several collagen receptors, including the integrin</div><div class='line' id='LC2228'>α2β1,79–81 GPVI,82,83 GPIV (CD-36),84–86 and the 65-kDa protein (p65) reportedly</div><div class='line' id='LC2229'>specific specific for type I collagen.87&quot;</div><div class='line' id='LC2230'><br/></div><div class='line' id='LC2231'>complexAbundance(proteinAbundance(HGNC:ITGA2),proteinAbundance(HGNC:ITGB1),proteinAbundance(PFH:&quot;COL1 Family&quot;))</div><div class='line' id='LC2232'>complexAbundance(proteinAbundance(HGNC:GP6),proteinAbundance(PFH:&quot;COL1 Family&quot;))</div><div class='line' id='LC2233'>complexAbundance(proteinAbundance(HGNC:CD36),proteinAbundance(PFH:&quot;COL1 Family&quot;))</div><div class='line' id='LC2234'>proteinAbundance(PFH:&quot;COL1 Family&quot;) directlyIncreases molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA2),proteinAbundance(HGNC:ITGB1)))</div><div class='line' id='LC2235'>proteinAbundance(PFH:&quot;COL1 Family&quot;) directlyIncreases molecularActivity(proteinAbundance(HGNC:GP6))</div><div class='line' id='LC2236'>proteinAbundance(PFH:&quot;COL1 Family&quot;) directlyIncreases molecularActivity(proteinAbundance(HGNC:CD36))</div><div class='line' id='LC2237'><br/></div><div class='line' id='LC2238'>UNSET STATEMENT_GROUP</div><div class='line' id='LC2239'><br/></div><div class='line' id='LC2240'>SET STATEMENT_GROUP = &quot;Group 15&quot;</div><div class='line' id='LC2241'><br/></div><div class='line' id='LC2242'>SET Cell = {&quot;Cells, Cultured&quot;,&quot;Endothelial Cells&quot;}</div><div class='line' id='LC2243'>SET CardiovascularSystem = &quot;Umbilical Veins&quot;</div><div class='line' id='LC2244'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC2245'>SET Evidence = &quot;In human umbilical vein endothelial cells (HUVECs), cigarette smoke extracts (CSE)</div><div class='line' id='LC2246'>inhibited VEGF induced tube formation in the matrigel assay. CSE did not affect</div><div class='line' id='LC2247'>HUVECs proliferation, but significantly reduced cellular migration in response</div><div class='line' id='LC2248'>to VEGF.&quot;</div><div class='line' id='LC2249'>SET Citation = {&quot;PubMed&quot;,&quot;Journal of molecular and cellular cardiology&quot;,&quot;16806264&quot;,&quot;2006-07-27&quot;,&quot;Michaud SE|Dussault S|Groleau J|Haddad P|Rivard A&quot;,&quot;&quot;}</div><div class='line' id='LC2250'><br/></div><div class='line' id='LC2251'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;))</div><div class='line' id='LC2252'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;blood vessel endothelial cell migration&quot;))</div><div class='line' id='LC2253'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) causesNoChange (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC2254'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;epithelial tube formation&quot;))</div><div class='line' id='LC2255'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;))</div><div class='line' id='LC2256'><br/></div><div class='line' id='LC2257'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC2258'><br/></div><div class='line' id='LC2259'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases catalyticActivity(proteinAbundance(HGNC:NOS3)))</div><div class='line' id='LC2260'><br/></div><div class='line' id='LC2261'>SET Evidence = &quot;We studied the effect of CSE exposure on tube formation in vitro. As determined using</div><div class='line' id='LC2262'>the Matrigel assay, VEGF significantly increased capillary-like tube formation</div><div class='line' id='LC2263'>in HUVECs. However, the induction of tube formation by VEGF was almost completely</div><div class='line' id='LC2264'>abolished when HUVECs were exposed to 10% CSE (Fig. 1 and Table 1).&quot;</div><div class='line' id='LC2265'><br/></div><div class='line' id='LC2266'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;blood vessel endothelial cell migration&quot;))</div><div class='line' id='LC2267'><br/></div><div class='line' id='LC2268'>SET Evidence = &quot;As expected, VEGF treatment significantly induced both migration and proliferation</div><div class='line' id='LC2269'>in HUVECs (Figs. 2A–B and Table 1). Interestingly, CSE exposure was associated</div><div class='line' id='LC2270'>with a selective inhibition of VEGF-induced HUVEC migration, whereas cellular proliferation</div><div class='line' id='LC2271'>was not significantly affected (Figs. 2A– B and Table 1).&quot;</div><div class='line' id='LC2272'><br/></div><div class='line' id='LC2273'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC2274'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC2275'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;))</div><div class='line' id='LC2276'><br/></div><div class='line' id='LC2277'>SET Evidence = &quot;Surface integrins have been shown to be critical regulators of endothelial cell migration</div><div class='line' id='LC2278'>in response to VEGF and NO. Here we found that VEGF-stimulated HUVECs exposed</div><div class='line' id='LC2279'>to CSE had a significant reduction in the expression of several surface integrins</div><div class='line' id='LC2280'>including αvβ3, αvβ5, α5β1 and α2β1 (Fig. 2C). Moreover, the adhesion of</div><div class='line' id='LC2281'>VEGF-stimulated HUVECs was significantly reduced following exposure to 10% CSE,</div><div class='line' id='LC2282'>suggesting an impairment of integrin activity/function (Fig. 2D).&quot;</div><div class='line' id='LC2283'><br/></div><div class='line' id='LC2284'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3)))</div><div class='line' id='LC2285'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB5)))</div><div class='line' id='LC2286'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGA5),proteinAbundance(HGNC:ITGB1)))</div><div class='line' id='LC2287'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGA2),proteinAbundance(HGNC:ITGB1)))</div><div class='line' id='LC2288'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases biologicalProcess(GO:&quot;cell adhesion&quot;)</div><div class='line' id='LC2289'><br/></div><div class='line' id='LC2290'>SET Evidence = &quot;CSE show an important increase of intracellular ROS, as assessed by 2&#39;,7&#39;-dichlorofluorescin</div><div class='line' id='LC2291'>diacetate (DCFH-DA) (Fig. 3). Importantly, antioxidants such as NAC</div><div class='line' id='LC2292'>and vitamin C can significantly reduce the generation of ROS in HUVECs exposed to</div><div class='line' id='LC2293'>CSE (Fig. 3).&quot;</div><div class='line' id='LC2294'><br/></div><div class='line' id='LC2295'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) increases abundance(CHEBI:&quot;reactive oxygen species&quot;)</div><div class='line' id='LC2296'>abundance(CHEBI:&quot;vitamin C&quot;) decreases (abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) increases abundance(CHEBI:&quot;reactive oxygen species&quot;))</div><div class='line' id='LC2297'>abundance(CHEBI:&quot;N-acetyl-L-cysteine&quot;) decreases (abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) increases abundance(CHEBI:&quot;reactive oxygen species&quot;))</div><div class='line' id='LC2298'><br/></div><div class='line' id='LC2299'>SET CellLine = &quot;HUV-EC-C&quot;</div><div class='line' id='LC2300'>SET Evidence = &quot;Because NO is an essential mediator of endothelial cell migration and VEGF-induced</div><div class='line' id='LC2301'>angiogenesis, we investigated the effect of CSE exposure on VEGF-dependent Akt/eNOS/NO</div><div class='line' id='LC2302'>pathway. VEGF-stimulated HUVECs exposed to CSE show a dose-dependent inhibition</div><div class='line' id='LC2303'>of phosphorylated Akt and eNOS (Fig. 4A). Importantly, the activation of</div><div class='line' id='LC2304'>Akt and eNOS by VEGF can be rescued following treatment with the antioxidants</div><div class='line' id='LC2305'>NAC and vitamin C (Fig. 4B). Similarly, we found that the induction of NO by VEGF</div><div class='line' id='LC2306'>in endothelial cell cultures was severely compromised in the presence of CSE,</div><div class='line' id='LC2307'>but that NO levels could be normalized with antioxidants (Fig. 4C). Globally, these</div><div class='line' id='LC2308'>data suggest that ROS are involved in the impairment of VEGF-induced Akt/eNOS/NO</div><div class='line' id='LC2309'>pathway by CSE.&quot;</div><div class='line' id='LC2310'><br/></div><div class='line' id='LC2311'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)))</div><div class='line' id='LC2312'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases catalyticActivity(proteinAbundance(HGNC:NOS3)))</div><div class='line' id='LC2313'><br/></div><div class='line' id='LC2314'>SET Evidence = &quot;Similarly, we found that the induction of NO by VEGF in endothelial cell cultures</div><div class='line' id='LC2315'>was severely compromised in the presence of CSE, but that NO levels could be normalized</div><div class='line' id='LC2316'>with antioxidants (Fig. 4C). Globally, these data suggest that ROS are</div><div class='line' id='LC2317'>involved in the impairment of VEGF-induced Akt/eNOS/NO pathway by CSE.&quot;</div><div class='line' id='LC2318'><br/></div><div class='line' id='LC2319'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases abundance(CHEBI:&quot;nitric oxide&quot;))</div><div class='line' id='LC2320'>abundance(CHEBI:&quot;reactive oxygen species&quot;) decreases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC2321'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases catalyticActivity(proteinAbundance(HGNC:NOS3))</div><div class='line' id='LC2322'><br/></div><div class='line' id='LC2323'>SET Evidence = &quot;Because NO is an essential mediator of endothelial cell migration and VEGF-induced</div><div class='line' id='LC2324'>angiogenesis, we investigated the effect of CSE exposure on VEGF-dependent Akt/eNOS/NO</div><div class='line' id='LC2325'>pathway. VEGF-stimulated HUVECs exposed to CSE show a dose-dependent inhibition</div><div class='line' id='LC2326'>of phosphorylated Akt and eNOS (Fig. 4A). Importantly, the activation of</div><div class='line' id='LC2327'>Akt and eNOS by VEGF can be rescued following treatment with the antioxidants</div><div class='line' id='LC2328'>NAC and vitamin C (Fig. 4B).&quot;</div><div class='line' id='LC2329'><br/></div><div class='line' id='LC2330'>abundance(CHEBI:&quot;nitric oxide&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC2331'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC2332'>abundance(CHEBI:&quot;nitric oxide&quot;) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC2333'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)))</div><div class='line' id='LC2334'>abundance(SCHEM:&quot;Smoke extract, cigarette&quot;) decreases (proteinAbundance(PFH:&quot;VEGF Family&quot;) increases catalyticActivity(proteinAbundance(HGNC:NOS3)))</div><div class='line' id='LC2335'><br/></div><div class='line' id='LC2336'>SET Evidence = &quot;These data suggest that CSE prevents VEGF-induced endothelial cell migration and tube</div><div class='line' id='LC2337'>formation by increasing oxidative stress. The importance of NO in that physiopathology</div><div class='line' id='LC2338'>was demonstrated by showing that NO donors (SNAP 75 μM, SNP 0.1 mM)</div><div class='line' id='LC2339'>or a cGMP analog (8-Br-cGMP 2 mM) rescued integrin expression (Fig. 5A), cellular</div><div class='line' id='LC2340'>migration (Fig. 5B) and tube formation (Fig. 5C) in endothelial cells exposed</div><div class='line' id='LC2341'>to CSE.&quot;</div><div class='line' id='LC2342'><br/></div><div class='line' id='LC2343'>abundance(CHEBI:&quot;nitric oxide&quot;) increases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3)))</div><div class='line' id='LC2344'>abundance(CHEBI:&quot;nitric oxide&quot;) increases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB5)))</div><div class='line' id='LC2345'>abundance(CHEBI:&quot;nitric oxide&quot;) increases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGA5),proteinAbundance(HGNC:ITGB1)))</div><div class='line' id='LC2346'>abundance(CHEBI:&quot;nitric oxide&quot;) increases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGA2),proteinAbundance(HGNC:ITGB1)))</div><div class='line' id='LC2347'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic GMP&quot;) increases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3)))</div><div class='line' id='LC2348'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic GMP&quot;) increases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB5)))</div><div class='line' id='LC2349'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic GMP&quot;) increases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGA5),proteinAbundance(HGNC:ITGB1)))</div><div class='line' id='LC2350'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic GMP&quot;) increases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGA2),proteinAbundance(HGNC:ITGB1)))</div><div class='line' id='LC2351'>abundance(CHEBI:&quot;nitric oxide&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC2352'>abundance(CHEBI:&quot;nitric oxide&quot;) increases biologicalProcess(GO:&quot;blood vessel endothelial cell migration&quot;)</div><div class='line' id='LC2353'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic GMP&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;) //Making the inference here that 8-Br-cGMP acts as cGMP. c-Br-cGMP is extensively characterized and a very specific cGMP mimetic.</div><div class='line' id='LC2354'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic GMP&quot;) increases biologicalProcess(GO:&quot;blood vessel endothelial cell migration&quot;)</div><div class='line' id='LC2355'><br/></div><div class='line' id='LC2356'>UNSET STATEMENT_GROUP</div><div class='line' id='LC2357'><br/></div><div class='line' id='LC2358'>SET STATEMENT_GROUP = &quot;Group 16&quot;</div><div class='line' id='LC2359'><br/></div><div class='line' id='LC2360'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC2361'>SET Evidence = &quot;Here we examine the nature of the physical interaction between the αvβ3 integrin and</div><div class='line' id='LC2362'>two receptor tyrosine kinases (RTKs), the platelet-derived growth factor receptor</div><div class='line' id='LC2363'>β (PDGF-Rβ) and the vascular endothelial growth factor receptor 2 (VEGF-R2,</div><div class='line' id='LC2364'>also known as KDR and flk-1). Both of these RTKs associate with the αvβ3 integrin</div><div class='line' id='LC2365'>but do not associate with β1 integrins. Furthermore, growth factor stimulation</div><div class='line' id='LC2366'>of these RTKs promotes increased cell proliferation and migration when cells</div><div class='line' id='LC2367'>are attached to the αvβ3 ligand, vitronectin.&quot;</div><div class='line' id='LC2368'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;10964931&quot;,&quot;&quot;,&quot;Borges E|Jan Y|Ruoslahti E&quot;,&quot;&quot;}</div><div class='line' id='LC2369'>SET Species = &quot;9606&quot;</div><div class='line' id='LC2370'><br/></div><div class='line' id='LC2371'>proteinAbundance(HGNC:VTN) directlyIncreases molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3)))</div><div class='line' id='LC2372'>complexAbundance(proteinAbundance(HGNC:PDGFRB),proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3))</div><div class='line' id='LC2373'>complexAbundance(proteinAbundance(HGNC:KDR),proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3))</div><div class='line' id='LC2374'>complexAbundance(proteinAbundance(HGNC:VTN),proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3)) increases (kinaseActivity(proteinAbundance(HGNC:PDGFRB)) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC2375'>complexAbundance(proteinAbundance(HGNC:VTN),proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3)) increases (kinaseActivity(proteinAbundance(HGNC:PDGFRB)) increases biologicalProcess(GO:&quot;cell migration&quot;))</div><div class='line' id='LC2376'>complexAbundance(proteinAbundance(HGNC:VTN),proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3)) increases (kinaseActivity(proteinAbundance(HGNC:KDR)) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC2377'>complexAbundance(proteinAbundance(HGNC:VTN),proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3)) increases (kinaseActivity(proteinAbundance(HGNC:KDR)) increases biologicalProcess(GO:&quot;cell migration&quot;))</div><div class='line' id='LC2378'><br/></div><div class='line' id='LC2379'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC2380'>SET Evidence = &quot;Previous studies have shown that PDGF-Rβ (9,10) and VEGF-R2 (12) associate with the</div><div class='line' id='LC2381'>αvβ3 integrin but not with β1 integrins. The association was detected after cells</div><div class='line' id='LC2382'>were stimulated with the respective growth factor.&quot;</div><div class='line' id='LC2383'><br/></div><div class='line' id='LC2384'>proteinAbundance(PFH:&quot;PDGF Family&quot;) directlyIncreases complexAbundance(proteinAbundance(HGNC:PDGFRB),proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3))</div><div class='line' id='LC2385'>proteinAbundance(PFH:&quot;VEGF Family&quot;) directlyIncreases complexAbundance(proteinAbundance(HGNC:KDR),proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3))</div><div class='line' id='LC2386'><br/></div><div class='line' id='LC2387'>SET Evidence = &quot;To study the role of αv in the formation of the RTK-integrin complex, we transfected</div><div class='line' id='LC2388'>PDGF-Rβ into CHO cells that overexpress the platelet integrin αIIbβ3. As shown</div><div class='line' id='LC2389'>in Fig. 5A, equal amounts of PDGF-Rb were coprecipitated with both anti-αIIb</div><div class='line' id='LC2390'>and anti-β3 antibodies.&quot;</div><div class='line' id='LC2391'><br/></div><div class='line' id='LC2392'>complexAbundance(proteinAbundance(HGNC:PDGFRB),proteinAbundance(HGNC:ITGA2B),proteinAbundance(HGNC:ITGB3))</div><div class='line' id='LC2393'><br/></div><div class='line' id='LC2394'>SET Evidence = &quot;We have previously shown that the attachment of cells to a substrate through the αvβ3</div><div class='line' id='LC2395'>integrin enhances the ability of insulin and PDGF to stimulate cell proliferation</div><div class='line' id='LC2396'>and migration (9,11).&quot;</div><div class='line' id='LC2397'><br/></div><div class='line' id='LC2398'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3))) increases (proteinAbundance(PFH:&quot;PDGF Family&quot;) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC2399'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3))) increases (proteinAbundance(HGNC:INS) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC2400'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3))) increases (proteinAbundance(PFH:&quot;PDGF Family&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;))</div><div class='line' id='LC2401'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGAV),proteinAbundance(HGNC:ITGB3))) increases (proteinAbundance(HGNC:INS) increases biologicalProcess(GO:&quot;cell migration&quot;))</div><div class='line' id='LC2402'><br/></div><div class='line' id='LC2403'>UNSET STATEMENT_GROUP</div><div class='line' id='LC2404'><br/></div><div class='line' id='LC2405'>SET STATEMENT_GROUP = &quot;Group 17&quot;</div><div class='line' id='LC2406'><br/></div><div class='line' id='LC2407'>SET Cell = &quot;Keratinocytes&quot;</div><div class='line' id='LC2408'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC2409'>SET Evidence = &quot;Ligation of α6β4  in primary human keratinocytes caused tyrosine phosphorylation of</div><div class='line' id='LC2410'>Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases</div><div class='line' id='LC2411'>Erk and Jnk.&quot;</div><div class='line' id='LC2412'>SET Citation = {&quot;PubMed&quot;,&quot;The EMBO journal&quot;,&quot;9171350&quot;,&quot;&quot;,&quot;Mainiero F|Murgia C|Wary KK|Curatola AM|Pepe A|Blumemberg M|Westwick JK|Der CJ|Giancotti FG&quot;,&quot;&quot;}</div><div class='line' id='LC2413'>SET Species = &quot;9606&quot;</div><div class='line' id='LC2414'><br/></div><div class='line' id='LC2415'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases proteinAbundance(HGNC:SHC1,proteinModification(P,Y))</div><div class='line' id='LC2416'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases complexAbundance(proteinAbundance(HGNC:SHC1),proteinAbundance(HGNC:GRB2))</div><div class='line' id='LC2417'>complexAbundance(proteinAbundance(HGNC:SHC1),proteinAbundance(HGNC:GRB2)) increases gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;))</div><div class='line' id='LC2418'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;))</div><div class='line' id='LC2419'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC2420'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;))</div><div class='line' id='LC2421'><br/></div><div class='line' id='LC2422'>SET Evidence = &quot;Ligation of α6β4 in primary human keratinocytes caused tyrosine phosphorylation of</div><div class='line' id='LC2423'>Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases</div><div class='line' id='LC2424'>Erk and Jnk. In contrast, ligation of the laminin- and collagen-binding integrins</div><div class='line' id='LC2425'>α3β1  and α2β1  did not cause these events.&quot;</div><div class='line' id='LC2426'><br/></div><div class='line' id='LC2427'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA3),proteinAbundance(HGNC:ITGB1))) causesNoChange complexAbundance(proteinAbundance(HGNC:SHC1),proteinAbundance(HGNC:GRB2))</div><div class='line' id='LC2428'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA2),proteinAbundance(HGNC:ITGB1))) causesNoChange complexAbundance(proteinAbundance(HGNC:SHC1),proteinAbundance(HGNC:GRB2))</div><div class='line' id='LC2429'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA3),proteinAbundance(HGNC:ITGB1))) causesNoChange proteinAbundance(HGNC:SHC1,proteinModification(P,Y))</div><div class='line' id='LC2430'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA2),proteinAbundance(HGNC:ITGB1))) increases proteinAbundance(HGNC:SHC1,proteinModification(P,Y))</div><div class='line' id='LC2431'>complexAbundance(proteinAbundance(PFH:&quot;LAM Family&quot;),complexAbundance(proteinAbundance(HGNC:ITGA3),proteinAbundance(HGNC:ITGB1)))</div><div class='line' id='LC2432'>complexAbundance(proteinAbundance(PFH:&quot;LAM Family&quot;),complexAbundance(proteinAbundance(HGNC:ITGA2),proteinAbundance(HGNC:ITGB1)))</div><div class='line' id='LC2433'><br/></div><div class='line' id='LC2434'>SET CellLine = &quot;HeLa&quot;</div><div class='line' id='LC2435'>SET Evidence = &quot;While the stimulation of Erk by α6β4 was suppressed by dominant-negative Shc, Ras</div><div class='line' id='LC2436'>and RhoA, the activation of Jnk was inhibited by dominant-negative Ras and Rac1</div><div class='line' id='LC2437'>and by the phosphoinositide 3-kinase inhibitor Wortmannin.&quot;</div><div class='line' id='LC2438'><br/></div><div class='line' id='LC2439'>molecularActivity(proteinAbundance(HGNC:SHC1)) increases (molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)))</div><div class='line' id='LC2440'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases (molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)))</div><div class='line' id='LC2441'>gtpBoundActivity(proteinAbundance(HGNC:RHOA)) increases (molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)))</div><div class='line' id='LC2442'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases (molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;)))</div><div class='line' id='LC2443'>gtpBoundActivity(proteinAbundance(HGNC:RAC1)) increases (molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;)))</div><div class='line' id='LC2444'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) increases (molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;)))</div><div class='line' id='LC2445'>abundance(SCHEM:Wortmannin) directlyDecreases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC2446'><br/></div><div class='line' id='LC2447'>SET Evidence = &quot;Adhesion mediated by α6β4 induced transcription from the Fos serum response element</div><div class='line' id='LC2448'>and promoted cell cycle progression in response to mitogens.&quot;</div><div class='line' id='LC2449'><br/></div><div class='line' id='LC2450'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC2451'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA6),proteinAbundance(HGNC:ITGB4))) increases rnaAbundance(HGNC:FOS)</div><div class='line' id='LC2452'><br/></div><div class='line' id='LC2453'>SET Cell = &quot;Cells, Cultured&quot;</div><div class='line' id='LC2454'>SET TextLocation = {&quot;Results&quot;,&quot;Results&quot;}</div><div class='line' id='LC2455'>SET UrogenitalSystem = &quot;Urinary Bladder&quot;</div><div class='line' id='LC2456'>SET Evidence = &quot;These results are consistent with the hypothesis that the recruitment of Shc to activated</div><div class='line' id='LC2457'>α6β4 is mediated by tyrosine phosphorylation of the cytoplasmic domain</div><div class='line' id='LC2458'>of β4.&quot;</div><div class='line' id='LC2459'>SET Species = &quot;10116&quot;</div><div class='line' id='LC2460'><br/></div><div class='line' id='LC2461'>proteinAbundance(RGD:Itgb4,proteinModification(P,Y)) directlyIncreases complexAbundance(proteinAbundance(RGD:Itga6),proteinAbundance(RGD:Itgb4),proteinAbundance(RGD:Shc1))</div><div class='line' id='LC2462'><br/></div><div class='line' id='LC2463'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC2464'>SET Evidence = &quot;This suggests that ligation of α6β4, but not α2β1, is sufficient to promote transcription</div><div class='line' id='LC2465'>from the Fos SRE in the absence of mitogens.&quot;</div><div class='line' id='LC2466'>SET Species = &quot;9606&quot;</div><div class='line' id='LC2467'><br/></div><div class='line' id='LC2468'>molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGA2),proteinAbundance(HGNC:ITGB1))) causesNoChange rnaAbundance(HGNC:FOS)</div><div class='line' id='LC2469'><br/></div><div class='line' id='LC2470'>UNSET STATEMENT_GROUP</div><div class='line' id='LC2471'><br/></div><div class='line' id='LC2472'>SET STATEMENT_GROUP = &quot;Group 18&quot;</div><div class='line' id='LC2473'><br/></div><div class='line' id='LC2474'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC2475'>SET Evidence = &quot;secreted proteins such as Norrin and R-Spondin were shown to be activators of the</div><div class='line' id='LC2476'>canonical Wnt pathway owing to their interaction with Frizzled–LRP receptors79,80&quot;</div><div class='line' id='LC2477'>SET Citation = {&quot;PubMed&quot;,&quot;Nature reviews. Cancer&quot;,&quot;18432252&quot;,&quot;&quot;,&quot;Klaus A|Birchmeier W&quot;,&quot;&quot;}</div><div class='line' id='LC2478'><br/></div><div class='line' id='LC2479'>proteinAbundance(HGNC:NDP) increases biologicalProcess(GO:&quot;Wnt receptor signaling pathway&quot;)</div><div class='line' id='LC2480'>proteinAbundance(HGNC:RSPO1) increases biologicalProcess(GO:&quot;Wnt receptor signaling pathway&quot;)</div><div class='line' id='LC2481'><br/></div><div class='line' id='LC2482'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC2483'>SET Evidence = &quot;Following phosphorylation, β-catenin is targeted for proteasome-dependent degradation</div><div class='line' id='LC2484'>involving interaction with β-TrCP (β-transducin repeat-containing protein),</div><div class='line' id='LC2485'>a component of the E3 ubiquitin ligase complex89–92&quot;</div><div class='line' id='LC2486'><br/></div><div class='line' id='LC2487'>proteinAbundance(HGNC:CTNNB1,proteinModification(P)) directlyIncreases degradation(proteinAbundance(HGNC:CTNNB1))</div><div class='line' id='LC2488'>proteinAbundance(HGNC:CTNNB1,proteinModification(P)) directlyIncreases complexAbundance(proteinAbundance(HGNC:CTNNB1),proteinAbundance(HGNC:BTRC))</div><div class='line' id='LC2489'>complexAbundance(proteinAbundance(HGNC:CTNNB1),proteinAbundance(HGNC:BTRC)) directlyIncreases degradation(proteinAbundance(HGNC:CTNNB1))</div><div class='line' id='LC2490'><br/></div><div class='line' id='LC2491'>SET Disease = &quot;Fibrosis&quot;</div><div class='line' id='LC2492'>SET RespiratorySystem = &quot;Lung&quot;</div><div class='line' id='LC2493'>SET Evidence = &quot;Moreover, uncontrolled Wnt-β-catenin signalling that is associated with elevated β-catenin</div><div class='line' id='LC2494'>levels is also linked to aggressive fibromatosis and pulmonary fibrosis140,141&quot;</div><div class='line' id='LC2495'><br/></div><div class='line' id='LC2496'>proteinAbundance(HGNC:CTNNB1) positiveCorrelation pathology(MESHD:&quot;Pulmonary Fibrosis&quot;)</div><div class='line' id='LC2497'><br/></div><div class='line' id='LC2498'>SET Cell = &quot;Stem Cells&quot;</div><div class='line' id='LC2499'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC2500'>SET BodyRegion = &quot;Breast&quot;</div><div class='line' id='LC2501'>SET Evidence = &quot;It was shown that the frequency of CD29+CD24+ stem cells in the mammary gland increases</div><div class='line' id='LC2502'>by a factor of 6.4 following activation of WNT1 (REF. 201).&quot;</div><div class='line' id='LC2503'><br/></div><div class='line' id='LC2504'>molecularActivity(proteinAbundance(HGNC:WNT1)) increases biologicalProcess(GO:&quot;stem cell development&quot;)</div><div class='line' id='LC2505'>molecularActivity(proteinAbundance(HGNC:WNT1)) increases cellSurfaceExpression(proteinAbundance(HGNC:ITGB1))</div><div class='line' id='LC2506'>molecularActivity(proteinAbundance(HGNC:WNT1)) increases cellSurfaceExpression(proteinAbundance(HGNC:CD24))</div><div class='line' id='LC2507'><br/></div><div class='line' id='LC2508'>SET Disease = &quot;Neoplasms&quot;</div><div class='line' id='LC2509'>SET Evidence = &quot;In recent years, other mechanisms of activation of the canonical Wnt pathway in tumours</div><div class='line' id='LC2510'>have been discovered; for example, silencing of the genes that encode the</div><div class='line' id='LC2511'>inhibitory Wnt ligands SFRPs and DKKs by hypermethylation, or by overexpression</div><div class='line' id='LC2512'>of Wnt proteins (WNT2B for example), Frizzleds (FZD10 for example) or Dishevelled142-149&quot;</div><div class='line' id='LC2513'><br/></div><div class='line' id='LC2514'>proteinAbundance(HGNC:WNT2B) increases biologicalProcess(GO:&quot;Wnt receptor signaling pathway&quot;)</div><div class='line' id='LC2515'>proteinAbundance(HGNC:FZD10) increases biologicalProcess(GO:&quot;Wnt receptor signaling pathway&quot;)</div><div class='line' id='LC2516'>proteinAbundance(PFH:&quot;DVL Family&quot;) increases biologicalProcess(GO:&quot;Wnt receptor signaling pathway&quot;)</div><div class='line' id='LC2517'><br/></div><div class='line' id='LC2518'>SET HemicAndImmuneSystem = &quot;Hematopoietic Stem Cells&quot;</div><div class='line' id='LC2519'>SET Evidence = &quot;Wnt-β-catenin signalling has been proposed to increase haematopoietic stem cell renewal58,185-187&quot;</div><div class='line' id='LC2520'><br/></div><div class='line' id='LC2521'>molecularActivity(proteinAbundance(PFH:&quot;WNT Family&quot;)) increases biologicalProcess(GO:&quot;stem cell division&quot;)</div><div class='line' id='LC2522'>transcriptionalActivity(proteinAbundance(HGNC:CTNNB1)) increases biologicalProcess(GO:&quot;stem cell division&quot;)</div><div class='line' id='LC2523'><br/></div><div class='line' id='LC2524'>SET BodyRegion = &quot;Head&quot;</div><div class='line' id='LC2525'>SET Evidence = &quot;DKK1 antagonizes Wnt signalling during head formation in mice77. An additional DKK-receptor,</div><div class='line' id='LC2526'>Kremen, was shown to inhibit the Wnt signalling pathway by internalization</div><div class='line' id='LC2527'>of LRP&quot;</div><div class='line' id='LC2528'>SET Species = &quot;10090&quot;</div><div class='line' id='LC2529'><br/></div><div class='line' id='LC2530'>proteinAbundance(MGI:Dkk1) decreases biologicalProcess(GO:&quot;Wnt receptor signaling pathway&quot;)</div><div class='line' id='LC2531'>complexAbundance(proteinAbundance(MGI:Kremen1),proteinAbundance(MGI:Dkk1))</div><div class='line' id='LC2532'>proteinAbundance(MGI:Kremen1) decreases biologicalProcess(GO:&quot;Wnt receptor signaling pathway&quot;)</div><div class='line' id='LC2533'><br/></div><div class='line' id='LC2534'>SET DigestiveSystem = &quot;Colon&quot;</div><div class='line' id='LC2535'>SET Evidence = &quot;axin1 and axin2 loss-of-function mutations have also been detected in rare cases of</div><div class='line' id='LC2536'>colorectal cancer124,125.&quot;</div><div class='line' id='LC2537'>SET Species = &quot;9606&quot;</div><div class='line' id='LC2538'><br/></div><div class='line' id='LC2539'>proteinAbundance(HGNC:AXIN1) negativeCorrelation pathology(MESHD:Neoplasms)</div><div class='line' id='LC2540'>proteinAbundance(HGNC:AXIN2) negativeCorrelation pathology(MESHD:Neoplasms)</div><div class='line' id='LC2541'><br/></div><div class='line' id='LC2542'>SET Evidence = &quot;loss of Indian hedgehog, also contribute to the progression of colorectal cancer157&quot;</div><div class='line' id='LC2543'><br/></div><div class='line' id='LC2544'>proteinAbundance(HGNC:IHH) negativeCorrelation pathology(MESHD:Neoplasms)</div><div class='line' id='LC2545'><br/></div><div class='line' id='LC2546'>SET Evidence = &quot;In the presence of canonical Wnt ligands (FIG. 1b), LRP5-LRP6 is phosphorylated by</div><div class='line' id='LC2547'>CK1γ and GSK3β96,97 (and possibly other protein kinases yet to be identified),</div><div class='line' id='LC2548'>and Dishevelled is recruited to the plasma membrane, where it interacts with Frizzled</div><div class='line' id='LC2549'>receptors and polymerizes with other Dishevelled molecules98,99.&quot;</div><div class='line' id='LC2550'><br/></div><div class='line' id='LC2551'>proteinAbundance(PFH:&quot;WNT Family&quot;) increases (kinaseActivity(proteinAbundance(HGNC:CSNK1G2)) directlyIncreases proteinAbundance(HGNC:LRP5,proteinModification(P)))</div><div class='line' id='LC2552'>proteinAbundance(PFH:&quot;WNT Family&quot;) increases (kinaseActivity(proteinAbundance(HGNC:GSK3B)) directlyIncreases proteinAbundance(HGNC:LRP5,proteinModification(P)))</div><div class='line' id='LC2553'>proteinAbundance(PFH:&quot;WNT Family&quot;) increases (kinaseActivity(proteinAbundance(HGNC:CSNK1G2)) directlyIncreases proteinAbundance(HGNC:LRP6,proteinModification(P)))</div><div class='line' id='LC2554'>proteinAbundance(PFH:&quot;WNT Family&quot;) increases (kinaseActivity(proteinAbundance(HGNC:GSK3B)) directlyIncreases proteinAbundance(HGNC:LRP6,proteinModification(P)))</div><div class='line' id='LC2555'>proteinAbundance(HGNC:LRP6,proteinModification(P)) increases translocation(proteinAbundance(PFH:&quot;DVL Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Membrane&quot;)</div><div class='line' id='LC2556'><br/></div><div class='line' id='LC2557'>SET CellStructure = &quot;Cell Membrane&quot;</div><div class='line' id='LC2558'><br/></div><div class='line' id='LC2559'>translocation(proteinAbundance(PFH:&quot;DVL Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Membrane&quot;) increases complexAbundance(proteinAbundance(PFH:&quot;DVL Family&quot;),proteinAbundance(PFH:&quot;FZD Family&quot;))</div><div class='line' id='LC2560'>translocation(proteinAbundance(PFH:&quot;DVL Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Membrane&quot;) increases complexAbundance(proteinAbundance(PFH:&quot;DVL Family&quot;),proteinAbundance(PFH:&quot;DVL Family&quot;))</div><div class='line' id='LC2561'><br/></div><div class='line' id='LC2562'>SET Evidence = &quot;Surplus β-catenin then translocates to the nucleus, interacts with the LEF and TCF</div><div class='line' id='LC2563'>transcription factors, and persistently transactivates genes associated with the</div><div class='line' id='LC2564'>regulation of cell proliferation, such as MYC and cyclin D1 (Refs 30,32,106,135-137).&quot;</div><div class='line' id='LC2565'><br/></div><div class='line' id='LC2566'>translocation(proteinAbundance(HGNC:CTNNB1),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;) increases complexAbundance(proteinAbundance(HGNC:CTNNB1),proteinAbundance(HGNC:LEF1))</div><div class='line' id='LC2567'>complexAbundance(proteinAbundance(HGNC:CTNNB1),proteinAbundance(HGNC:LEF1)) directlyIncreases transcriptionalActivity(proteinAbundance(HGNC:CTNNB1))</div><div class='line' id='LC2568'>transcriptionalActivity(proteinAbundance(HGNC:CTNNB1)) directlyIncreases rnaAbundance(HGNC:CCND1)</div><div class='line' id='LC2569'>transcriptionalActivity(proteinAbundance(HGNC:CTNNB1)) directlyIncreases rnaAbundance(HGNC:MYC)</div><div class='line' id='LC2570'><br/></div><div class='line' id='LC2571'>SET Evidence = &quot;N-terminal phosphorylation of β-catenin by the kinases CK1α (casein kinase 1α) and</div><div class='line' id='LC2572'>GSK3β (glycogen synthase kinase 3β), and subsequent ubiquitylation by β-TrCP (β</div><div class='line' id='LC2573'>-transducin repeat-containing protein, an E3 ubiquitin ligase), β -catenin is</div><div class='line' id='LC2574'>proteasomally degraded&quot;</div><div class='line' id='LC2575'><br/></div><div class='line' id='LC2576'>kinaseActivity(proteinAbundance(HGNC:CSNK1A1)) directlyIncreases proteinAbundance(HGNC:CTNNB1,proteinModification(P))</div><div class='line' id='LC2577'><br/></div><div class='line' id='LC2578'>SET TextLocation = {&quot;Review&quot;,&quot;Review&quot;}</div><div class='line' id='LC2579'>SET Evidence = &quot;In the nucleus, β-catenin forms a transcriptionally active complex with LEF and TCF</div><div class='line' id='LC2580'>transcription factors30–32 by displacing Grouchos and interacting with other</div><div class='line' id='LC2581'>co-activators such as BCL9, Pygopus, CBP (CREB-binding protein) or Hyrax47–51,101–105</div><div class='line' id='LC2582'>(TIMELINE).&quot;</div><div class='line' id='LC2583'><br/></div><div class='line' id='LC2584'>complexAbundance(proteinAbundance(HGNC:CTNNB1),proteinAbundance(HGNC:LEF1))</div><div class='line' id='LC2585'>complexAbundance(proteinAbundance(HGNC:CTNNB1),proteinAbundance(HGNC:BCL9))</div><div class='line' id='LC2586'>complexAbundance(proteinAbundance(HGNC:CTNNB1),proteinAbundance(HGNC:CREBBP))</div><div class='line' id='LC2587'>translocation(proteinAbundance(HGNC:CTNNB1),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;) increases complexAbundance(proteinAbundance(HGNC:CTNNB1),proteinAbundance(HGNC:BCL9))</div><div class='line' id='LC2588'>translocation(proteinAbundance(HGNC:CTNNB1),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;) increases complexAbundance(proteinAbundance(HGNC:CTNNB1),proteinAbundance(HGNC:CREBBP))</div><div class='line' id='LC2589'><br/></div><div class='line' id='LC2590'>UNSET STATEMENT_GROUP</div><div class='line' id='LC2591'><br/></div><div class='line' id='LC2592'>SET STATEMENT_GROUP = &quot;Group 19&quot;</div><div class='line' id='LC2593'><br/></div><div class='line' id='LC2594'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC2595'>SET Evidence = &quot;Here, we show that Wnt/β-catenin signaling regulates proximal-distal differentiation</div><div class='line' id='LC2596'>of airway epithelium. Inhibition of Wnt/β-catenin signaling, either by expression</div><div class='line' id='LC2597'>of Dkk1 or by tissue-specific deletion of β-catenin, results in disruption</div><div class='line' id='LC2598'>of distal airway development and expansion of proximal airways.&quot;</div><div class='line' id='LC2599'>SET Citation = {&quot;PubMed&quot;,&quot;Developmental biology&quot;,&quot;15907834&quot;,&quot;&quot;,&quot;Shu W|Guttentag S|Wang Z|Andl T|Ballard P|Lu MM|Piccolo S|Birchmeier W|Whitsett JA|Millar SE|Morrisey EE&quot;,&quot;&quot;}</div><div class='line' id='LC2600'>SET Species = &quot;10090&quot;</div><div class='line' id='LC2601'><br/></div><div class='line' id='LC2602'>proteinAbundance(PFM:&quot;Wnt Family&quot;) increases biologicalProcess(GO:&quot;lung pattern specification process&quot;)</div><div class='line' id='LC2603'>proteinAbundance(MGI:Ctnnb1) increases biologicalProcess(GO:&quot;lung pattern specification process&quot;)</div><div class='line' id='LC2604'><br/></div><div class='line' id='LC2605'>SET Evidence = &quot;Moreover, we show that β-catenin and LEF/TCF activate the promoters of BMP4 and N-myc.&quot;</div><div class='line' id='LC2606'><br/></div><div class='line' id='LC2607'>transcriptionalActivity(proteinAbundance(MGI:Ctnnb1)) directlyIncreases rnaAbundance(MGI:Bmp4)</div><div class='line' id='LC2608'>transcriptionalActivity(proteinAbundance(PFM:&quot;Tcf/Lef Family&quot;)) directlyIncreases rnaAbundance(MGI:Bmp4)</div><div class='line' id='LC2609'>transcriptionalActivity(proteinAbundance(MGI:Ctnnb1)) directlyIncreases rnaAbundance(MGI:Mycn)</div><div class='line' id='LC2610'>transcriptionalActivity(proteinAbundance(PFM:&quot;Tcf/Lef Family&quot;)) directlyIncreases rnaAbundance(MGI:Mycn)</div><div class='line' id='LC2611'><br/></div><div class='line' id='LC2612'>SET RespiratorySystem = &quot;Lung&quot;</div><div class='line' id='LC2613'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC2614'>SET Evidence = &quot;This pattern of activity and expression overlaps extensively with that of Wnt7b, which</div><div class='line' id='LC2615'>is known to play a key role in lung epithelial differentiation (Shu et al.,</div><div class='line' id='LC2616'>2002).&quot;</div><div class='line' id='LC2617'><br/></div><div class='line' id='LC2618'>proteinAbundance(MGI:Wnt7b) increases biologicalProcess(GO:&quot;lung epithelium development&quot;)</div><div class='line' id='LC2619'><br/></div><div class='line' id='LC2620'>SET Evidence = &quot;These data suggest that, along with airway epithelium, the proximal– distal expression</div><div class='line' id='LC2621'>of smooth muscle in lung mesoderm is disrupted in SP-C/rtTA X tetO-Dkk1 double</div><div class='line' id='LC2622'>transgenic embryos and that Wnt signaling lies upstream of signals regulating</div><div class='line' id='LC2623'>proximal–distal patterning of both endodermal (airway epithelium) and mesodermal</div><div class='line' id='LC2624'>(airway smooth muscle) cell lineages.&quot;</div><div class='line' id='LC2625'><br/></div><div class='line' id='LC2626'>proteinAbundance(MGI:Dkk1) decreases biologicalProcess(GO:&quot;lung epithelium development&quot;)</div><div class='line' id='LC2627'>proteinAbundance(MGI:Dkk1) decreases biologicalProcess(GO:&quot;lung smooth muscle development&quot;)</div><div class='line' id='LC2628'>proteinAbundance(PFM:&quot;Wnt Family&quot;) increases biologicalProcess(GO:&quot;lung smooth muscle development&quot;)</div><div class='line' id='LC2629'>proteinAbundance(PFM:&quot;Wnt Family&quot;) increases biologicalProcess(GO:&quot;lung epithelium development&quot;)</div><div class='line' id='LC2630'><br/></div><div class='line' id='LC2631'>SET Evidence = &quot;Wnt signaling has been directly associated with cell proliferation in a multitude</div><div class='line' id='LC2632'>of tissues and cell types including colon epithelium and in stem cell self renewal</div><div class='line' id='LC2633'>(Pinto et al., 2003; Reya et al., 2003; van de Wetering et al., 2002).&quot;</div><div class='line' id='LC2634'><br/></div><div class='line' id='LC2635'>proteinAbundance(PFM:&quot;Wnt Family&quot;) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC2636'><br/></div><div class='line' id='LC2637'>SET Evidence = &quot;Loss of N-myc function has been shown to result in defective branching morphogenesis</div><div class='line' id='LC2638'>in the lung (Moens et al., 1993; Okubo et al., 2005; Sawai et al., 1993; Stanton</div><div class='line' id='LC2639'>et al., 1992). Furthermore, N-myc has been recently implicated in the regulation</div><div class='line' id='LC2640'>of distal airway progenitor development (Okubo et al., 2005). c-myc, a highly</div><div class='line' id='LC2641'>related myc gene, is a well-established down-stream target of Wnt/β-catenin</div><div class='line' id='LC2642'>signaling in several tissues including intestinal epithelium (Anna et al., 2003;</div><div class='line' id='LC2643'>Cong et al., 2003; Pinto et al., 2003).&quot;</div><div class='line' id='LC2644'><br/></div><div class='line' id='LC2645'>proteinAbundance(MGI:Mycn) increases biologicalProcess(GO:&quot;lung proximal/distal axis specification&quot;)</div><div class='line' id='LC2646'>proteinAbundance(PFM:&quot;Wnt Family&quot;) increases rnaAbundance(MGI:Myc)</div><div class='line' id='LC2647'>transcriptionalActivity(proteinAbundance(MGI:Ctnnb1)) increases rnaAbundance(MGI:Myc)</div><div class='line' id='LC2648'><br/></div><div class='line' id='LC2649'>SET Evidence = &quot;As expected, N-myc is expressed at high levels in distal airway epithelium in wild-type</div><div class='line' id='LC2650'>lung tissue at E12.5 and E16.5 (Figs. 5A and C). However, N-myc expression</div><div class='line' id='LC2651'>in E12.5 SP-C/rtTA:tetO-cre X β-cateninflox and E16.5 SP-C/ Dkk1 lung tissue was</div><div class='line' id='LC2652'>severely attenuated (Figs. 5B and D).  These data indicate that N-myc is down-stream</div><div class='line' id='LC2653'>of Wnt/β-catenin signaling in airway epithelium.&quot;</div><div class='line' id='LC2654'><br/></div><div class='line' id='LC2655'>proteinAbundance(MGI:Dkk1) decreases rnaAbundance(MGI:Mycn)</div><div class='line' id='LC2656'>proteinAbundance(MGI:Ctnnb1) increases rnaAbundance(MGI:Mycn)</div><div class='line' id='LC2657'><br/></div><div class='line' id='LC2658'>SET Evidence = &quot;Previous studies have implicated BMP signaling in the regulation of lung airway morphogenesis,</div><div class='line' id='LC2659'>specifically proximal–distal patterning of the airways (Lu et al.,</div><div class='line' id='LC2660'>2001; Weaver et al., 1999).&quot;</div><div class='line' id='LC2661'><br/></div><div class='line' id='LC2662'>proteinAbundance(PFM:&quot;Bmp Family&quot;) increases biologicalProcess(GO:&quot;lung proximal/distal axis specification&quot;)</div><div class='line' id='LC2663'><br/></div><div class='line' id='LC2664'>SET Evidence = &quot;In SP-C/Dkk1 embryos, however, BMP4 expression is significantly reduced (Fig. 5J).</div><div class='line' id='LC2665'>As discussed above, at E12.5, the efficiency of β-catenin excision in many SP-C/rtTA:tetO-cre</div><div class='line' id='LC2666'>X β-cateninflox embryos is less than 100% in some embryos resulting</div><div class='line' id='LC2667'>in a mosaic pattern of β-catenin expression in the lung airway epithelium. However,</div><div class='line' id='LC2668'>this result proves advantageous since we can determine in a precise cell</div><div class='line' id='LC2669'>specific manner whether loss of β-catenin leads to a loss of BMP4. As expected,</div><div class='line' id='LC2670'>BMP4 and β-catenin are expressed at high levels in distal airway epithelium in</div><div class='line' id='LC2671'>wild-type lungs at E12.5 (Figs. 5K– M). Lungs exhibiting mosaic expression of β-catenin</div><div class='line' id='LC2672'>also express BMP4 in a mosaic pattern that closely correlates with presence</div><div class='line' id='LC2673'>of β-catenin (Figs. 5N–P). Complete loss of β-catenin leads to a complete loss</div><div class='line' id='LC2674'>of BMP4 expression (Figs. 5Q–S).&quot;</div><div class='line' id='LC2675'><br/></div><div class='line' id='LC2676'>proteinAbundance(MGI:Dkk1) decreases rnaAbundance(MGI:Bmp4)</div><div class='line' id='LC2677'>proteinAbundance(MGI:Ctnnb1) increases rnaAbundance(MGI:Bmp4)</div><div class='line' id='LC2678'><br/></div><div class='line' id='LC2679'>SET Evidence = &quot;FGF signaling is known to be a critical regulator of lung airway development. Loss</div><div class='line' id='LC2680'>of FGF signaling in the lung, either through loss of FGF10 expression or expression</div><div class='line' id='LC2681'>of a dominant-negative FGF receptor, results in a severe abrogation of lung</div><div class='line' id='LC2682'>airway branching (Bellusci et al., 1997; Min et al., 1998; Peters et al., 1994;</div><div class='line' id='LC2683'>Sekine et al., 1999).&quot;</div><div class='line' id='LC2684'><br/></div><div class='line' id='LC2685'>proteinAbundance(MGI:Fgf10) increases biologicalProcess(GO:&quot;respiratory tube development&quot;)</div><div class='line' id='LC2686'><br/></div><div class='line' id='LC2687'>SET Evidence = &quot;In situ hybridization demonstrates that FGFR2 expression is dramatically reduced in</div><div class='line' id='LC2688'>lung airway epithelium but not tracheal epithelium of SP-C/rtTA:tetO-cre X h-cateninflox</div><div class='line' id='LC2689'>(Figs. 6A and B).&quot;</div><div class='line' id='LC2690'><br/></div><div class='line' id='LC2691'>proteinAbundance(MGI:Ctnnb1) increases rnaAbundance(MGI:Fgfr2)</div><div class='line' id='LC2692'><br/></div><div class='line' id='LC2693'>SET Evidence = &quot;Loss of h-catenin expression leads to a dramatic reduction in ERK1/2 activity (Figs.</div><div class='line' id='LC2694'>6C and D).&quot;</div><div class='line' id='LC2695'><br/></div><div class='line' id='LC2696'>proteinAbundance(MGI:Ctnnb1) increases kinaseActivity(proteinAbundance(MGI:Mapk1))</div><div class='line' id='LC2697'>proteinAbundance(MGI:Ctnnb1) increases kinaseActivity(proteinAbundance(MGI:Mapk3))</div><div class='line' id='LC2698'><br/></div><div class='line' id='LC2699'>SET Evidence = &quot;Co-transfection of luciferase reporter plasmids containing these sequences along with</div><div class='line' id='LC2700'>expression plasmids encoding either an activated β-catenin containing mutations</div><div class='line' id='LC2701'>in the GSK-3h phosphorylation sites (β-catenin/4145) or with a TCF3-VP16 fusion</div><div class='line' id='LC2702'>protein demonstrated that both promoter sequences could be activated by transcriptional</div><div class='line' id='LC2703'>mediators of Wnt signaling (Figs. 7A and B). Addition of both h-catenin/4154</div><div class='line' id='LC2704'>and TCF3-VP16 resulted in cooperative activation of both promoters (Figs.</div><div class='line' id='LC2705'>7A and B). Furthermore, a dominantnegative TCF3 construct repressed both BMP4</div><div class='line' id='LC2706'>and N-myc promoters (Figs. 7C and D). Chromatin immunoprecipitation assays show</div><div class='line' id='LC2707'>that β-catenin associates with the conserved LEF/TCF DNA binding sites located</div><div class='line' id='LC2708'>in the BMP4 and N-myc promoters, indicating direct regulation of these promoters</div><div class='line' id='LC2709'>by canonical Wnt signaling (Figs. 7E and F). Together, these results demonstrate</div><div class='line' id='LC2710'>that BMP4 and Nmyc are targets of Wnt/β-catenin signaling in lung airway epithelium.&quot;</div><div class='line' id='LC2711'><br/></div><div class='line' id='LC2712'>transcriptionalActivity(proteinAbundance(MGI:Ctnnb1)) directlyIncreases rnaAbundance(MGI:Bmp4)</div><div class='line' id='LC2713'>transcriptionalActivity(proteinAbundance(MGI:Ctnnb1)) directlyIncreases rnaAbundance(MGI:Mycn)</div><div class='line' id='LC2714'>transcriptionalActivity(proteinAbundance(MGI:Tcf3)) directlyIncreases rnaAbundance(MGI:Mycn)</div><div class='line' id='LC2715'>transcriptionalActivity(proteinAbundance(MGI:Tcf3)) directlyIncreases rnaAbundance(MGI:Bmp4)</div><div class='line' id='LC2716'><br/></div><div class='line' id='LC2717'>UNSET STATEMENT_GROUP</div><div class='line' id='LC2718'><br/></div><div class='line' id='LC2719'>SET STATEMENT_GROUP = &quot;Group 20&quot;</div><div class='line' id='LC2720'><br/></div><div class='line' id='LC2721'>SET RespiratorySystem = &quot;Lung&quot;</div><div class='line' id='LC2722'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC2723'>SET Evidence = &quot;Exposure of rats to 80 mg/m3 tobacco smoke significantly induced apoptosis in the</div><div class='line' id='LC2724'>lungs. Tobacco smoke resulted in inhibition of NF-κB activity, noted by suppression</div><div class='line' id='LC2725'>of inhibitor of κB (IκB) kinase (IKK), accumulation of IκBα, decrease of NF-κB</div><div class='line' id='LC2726'>DNA binding activity, and downregulation of NF-κB-dependent anti-apoptotic proteins,</div><div class='line' id='LC2727'>including Bcl-2, Bcl-xl, and inhibitors of apoptosis.&quot;</div><div class='line' id='LC2728'>SET Citation = {&quot;PubMed&quot;,&quot;Toxicology and applied pharmacology&quot;,&quot;18355884&quot;,&quot;2008-03-15&quot;,&quot;Zhong CY|Zhou YM|Pinkerton KE&quot;,&quot;&quot;}</div><div class='line' id='LC2729'>SET Species = &quot;10116&quot;</div><div class='line' id='LC2730'><br/></div><div class='line' id='LC2731'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC2732'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases transcriptionalActivity(complexAbundance(NCR:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC2733'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases kinaseActivity(complexAbundance(NCR:&quot;IkappaB Kinase Complex&quot;))</div><div class='line' id='LC2734'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) increases proteinAbundance(RGD:Nfkbia)</div><div class='line' id='LC2735'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Bcl2)</div><div class='line' id='LC2736'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Bcl2l1)</div><div class='line' id='LC2737'><br/></div><div class='line' id='LC2738'>SET Evidence = &quot;Initiator caspases for the death receptor pathway (caspase 8) and the mitochondrial</div><div class='line' id='LC2739'>pathway (caspase 9) as well as effector caspase 3 were activated following tobacco</div><div class='line' id='LC2740'>smoke exposure.&quot;</div><div class='line' id='LC2741'><br/></div><div class='line' id='LC2742'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) increases peptidaseActivity(proteinAbundance(RGD:Casp8))</div><div class='line' id='LC2743'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) increases peptidaseActivity(proteinAbundance(RGD:Casp9))</div><div class='line' id='LC2744'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) increases peptidaseActivity(proteinAbundance(RGD:Casp3))</div><div class='line' id='LC2745'><br/></div><div class='line' id='LC2746'>SET Cell = &quot;Epithelial Cells&quot;</div><div class='line' id='LC2747'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC2748'>SET Evidence = &quot;In contrast, exposure of animals to 80 mg/m3 tobacco smoke resulted in a significant</div><div class='line' id='LC2749'>decrease of NFκ-B -DNA binding activity. In addition to NF-κB –DNA binding activity,</div><div class='line' id='LC2750'>the level of NF-κB subunits, including p65 and p50 in the nucleus, were</div><div class='line' id='LC2751'>measure by Western blot analyses. Consistent with the EMSA results, the nuclear</div><div class='line' id='LC2752'>protein levels of both NF-κB p65 and p50 were significantly reduced in the lungs</div><div class='line' id='LC2753'>of rats exposed to 80 mg/m3 with respect to FA control animals (Fig. 3).&quot;</div><div class='line' id='LC2754'><br/></div><div class='line' id='LC2755'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases transcriptionalActivity(complexAbundance(NCR:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC2756'><br/></div><div class='line' id='LC2757'>SET Evidence = &quot;In order to better understand the underlying mechanisms of tobacco smoke on NF-κB</div><div class='line' id='LC2758'>activity, the NF-κB activation pathway was examined. Fig. 4B demonstrates that</div><div class='line' id='LC2759'>the levels of the inhibitor of NF-κB (IκB)-α in cytoplasm were significantly elevated</div><div class='line' id='LC2760'>in rats exposed to 80 mg/m3 tobacco smoke, whereas the cytoplasmic levels</div><div class='line' id='LC2761'>of IκB-α was not changed by tobacco smoke exposure, regardless of concentration.&quot;</div><div class='line' id='LC2762'><br/></div><div class='line' id='LC2763'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) increases proteinAbundance(RGD:Nfkbia)</div><div class='line' id='LC2764'><br/></div><div class='line' id='LC2765'>SET Evidence = &quot;Examination of IκB kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed</div><div class='line' id='LC2766'>the levels of IKKα and IKKβ phosphorylation (activation). No significant changes</div><div class='line' id='LC2767'>were observed for the levels of IKKα and IKKβ activation from rats exposed to</div><div class='line' id='LC2768'>30 mg/m3 tobacco smoke.&quot;</div><div class='line' id='LC2769'><br/></div><div class='line' id='LC2770'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Chuk,proteinModification(P,S,176))</div><div class='line' id='LC2771'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Ikbkb,proteinModification(P,S,177))</div><div class='line' id='LC2772'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Ikbkb,proteinModification(P,S,181))</div><div class='line' id='LC2773'>proteinAbundance(RGD:Chuk,proteinModification(P,S,180)) directlyIncreases kinaseActivity(proteinAbundance(RGD:Chuk))</div><div class='line' id='LC2774'>proteinAbundance(RGD:Ikbkb,proteinModification(P,S,177)) directlyIncreases kinaseActivity(proteinAbundance(RGD:Ikbkb))</div><div class='line' id='LC2775'>proteinAbundance(RGD:Ikbkb,proteinModification(P,S,181)) directlyIncreases kinaseActivity(proteinAbundance(RGD:Ikbkb))</div><div class='line' id='LC2776'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases kinaseActivity(proteinAbundance(RGD:Chuk))</div><div class='line' id='LC2777'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases kinaseActivity(proteinAbundance(RGD:Ikbkb))</div><div class='line' id='LC2778'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Chuk,proteinModification(P,S,180))</div><div class='line' id='LC2779'>proteinAbundance(RGD:Chuk,proteinModification(P,S,176)) directlyIncreases kinaseActivity(proteinAbundance(RGD:Chuk))</div><div class='line' id='LC2780'><br/></div><div class='line' id='LC2781'>SET Evidence = &quot;Because of their molecular chaperone property, heat shock proteins (HSP), HSP70 in</div><div class='line' id='LC2782'>particular, can exert an inhibitory effect on NF-κB as a partial substitute for</div><div class='line' id='LC2783'>IκB. Therefore, the effect of tobacco smoke on HSP70 induction was examined. The</div><div class='line' id='LC2784'>level of HSP70 was significantly greater (152%) in animals exposed to 80 mg/m3</div><div class='line' id='LC2785'>tobacco smoke compared to animals exposed to FA (Fig. 4D).&quot;</div><div class='line' id='LC2786'><br/></div><div class='line' id='LC2787'>abundance(PFR:&quot;Hspa Family&quot;) directlyDecreases transcriptionalActivity(complexAbundance(NCR:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC2788'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) increases proteinAbundance(PFR:&quot;Hspa Family&quot;)</div><div class='line' id='LC2789'><br/></div><div class='line' id='LC2790'>SET Evidence = &quot;In line with the NF-κB activity described above, exposure to 80 mg/m3 tobacco smoke</div><div class='line' id='LC2791'>significantly down regulated the expression levels of Bcl-2, Bcl-xl, c-IAP1,</div><div class='line' id='LC2792'>c-IA2 and XIAP by 49.7%, 67%, 75.9%, 57.1%, and 63.2%, respectively (Fig. 5B).&quot;</div><div class='line' id='LC2793'><br/></div><div class='line' id='LC2794'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Bcl2)</div><div class='line' id='LC2795'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Bcl2l1)</div><div class='line' id='LC2796'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Birc3)</div><div class='line' id='LC2797'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Ptprn)</div><div class='line' id='LC2798'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) decreases proteinAbundance(RGD:Xiap)</div><div class='line' id='LC2799'><br/></div><div class='line' id='LC2800'>SET Evidence = &quot;Apoptosis is executed through the activation of caspases. To further verify the effect</div><div class='line' id='LC2801'>of tobacco smoke in the induction of apoptosis, the levels of cleaved caspases</div><div class='line' id='LC2802'>8, 9, and 3 in rat lungs were determined. In agreement with the apoptotic results</div><div class='line' id='LC2803'>described above, exposure of rats to 80 mg/m3 tobacco smoke resulted in significantly</div><div class='line' id='LC2804'>increased levels of cleaved caspases 8, 9, and 3, indicating the activation</div><div class='line' id='LC2805'>of these caspases (Fig. 7B). Compared to FA control animals, the cleaved</div><div class='line' id='LC2806'>caspases 8, 9, and 3 were elevated by 98.1%, 113.9%, and 84.7 %, respectively.&quot;</div><div class='line' id='LC2807'><br/></div><div class='line' id='LC2808'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) increases peptidaseActivity(proteinAbundance(RGD:Casp8))</div><div class='line' id='LC2809'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) increases peptidaseActivity(proteinAbundance(RGD:Casp9))</div><div class='line' id='LC2810'>abundance(SCHEM:&quot;Smoke, cigarette&quot;) increases peptidaseActivity(proteinAbundance(RGD:Casp3))</div><div class='line' id='LC2811'><br/></div><div class='line' id='LC2812'>UNSET STATEMENT_GROUP</div><div class='line' id='LC2813'><br/></div><div class='line' id='LC2814'>SET STATEMENT_GROUP = &quot;Group 21&quot;</div><div class='line' id='LC2815'><br/></div><div class='line' id='LC2816'>SET Cell = &quot;Cells, Cultured&quot;</div><div class='line' id='LC2817'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC2818'>SET Evidence = &quot;Following the molecular characterization of several angiogenic growth factors, landmark</div><div class='line' id='LC2819'>studies in the early 1990s showed that hypoxia could induce expression of</div><div class='line' id='LC2820'>platelet-derived growth factor mRNA9 and vascular endothelial growth factor (VEGF)</div><div class='line' id='LC2821'>mRNA in tissue culture10.&quot;</div><div class='line' id='LC2822'>SET Citation = {&quot;PubMed&quot;,&quot;Nature medicine&quot;,&quot;12778166&quot;,&quot;&quot;,&quot;Pugh CW|Ratcliffe PJ&quot;,&quot;&quot;}</div><div class='line' id='LC2823'><br/></div><div class='line' id='LC2824'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases rnaAbundance(HGNC:VEGFA)</div><div class='line' id='LC2825'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases rnaAbundance(HGNC:PDGFA)</div><div class='line' id='LC2826'><br/></div><div class='line' id='LC2827'>SET HemicAndImmuneSystem = &quot;Blood&quot;</div><div class='line' id='LC2828'>SET Evidence = &quot;Circulating erythropoietin increases several hundred fold within hours of hypoxic</div><div class='line' id='LC2829'>stimulation (reviewed in ref. 13).&quot;</div><div class='line' id='LC2830'><br/></div><div class='line' id='LC2831'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases proteinAbundance(HGNC:EPO)</div><div class='line' id='LC2832'><br/></div><div class='line' id='LC2833'>SET Evidence = &quot;Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1α) mediates</div><div class='line' id='LC2834'>interactions with the von Hippel-Lindau (VHL) E3 ubiquitin ligase complex that</div><div class='line' id='LC2835'>targets HIF-α for proteasomal destruction28, 29, 30, 34. Each site can interact</div><div class='line' id='LC2836'>independently with VHL E3, potentially contributing to the extremely rapid proteolysis</div><div class='line' id='LC2837'>of HIF-α that is observed in oxygenated cells34. These sites contain a conserved</div><div class='line' id='LC2838'>LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity,</div><div class='line' id='LC2839'>that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase</div><div class='line' id='LC2840'>domain) 1-3 (refs. 31,32).&quot;</div><div class='line' id='LC2841'><br/></div><div class='line' id='LC2842'>proteinAbundance(HGNC:HIF1A,proteinModification(H,P,402)) directlyIncreases complexAbundance(proteinAbundance(HGNC:VHL),proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC2843'>proteinAbundance(HGNC:HIF1A,proteinModification(H,P,402)) directlyIncreases degradation(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC2844'>proteinAbundance(HGNC:HIF1A,proteinModification(H,P,564)) directlyIncreases complexAbundance(proteinAbundance(HGNC:VHL),proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC2845'>proteinAbundance(HGNC:HIF1A,proteinModification(H,P,564)) directlyIncreases degradation(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC2846'>proteinAbundance(HGNC:VHL) directlyIncreases degradation(proteinAbundance(HGNC:HIF1A))</div><div class='line' id='LC2847'>catalyticActivity(proteinAbundance(HGNC:EGLN1)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,P,402))</div><div class='line' id='LC2848'>catalyticActivity(proteinAbundance(HGNC:EGLN1)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,P,564))</div><div class='line' id='LC2849'>catalyticActivity(proteinAbundance(HGNC:EGLN2)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,P,402))</div><div class='line' id='LC2850'>catalyticActivity(proteinAbundance(HGNC:EGLN2)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,P,564))</div><div class='line' id='LC2851'>catalyticActivity(proteinAbundance(HGNC:EGLN3)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,P,402))</div><div class='line' id='LC2852'>catalyticActivity(proteinAbundance(HGNC:EGLN3)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,P,564))</div><div class='line' id='LC2853'><br/></div><div class='line' id='LC2854'>SET Evidence = &quot;In a second hydroxylation-dependent control, β-hydroxylation of an asparaginyl residue</div><div class='line' id='LC2855'>in the C-terminal activation domain of HIF-α (Asn803 in human HIF-1α)35 is</div><div class='line' id='LC2856'>regulated by a HIF asparaginyl hydroxylase33,36 termed FIH (factor inhibiting HIF)37.</div><div class='line' id='LC2857'>Hydroxylation at this site blocks interaction of the HIF-α C-terminal activation</div><div class='line' id='LC2858'>domain with the transcriptional coactivator p300.&quot;</div><div class='line' id='LC2859'><br/></div><div class='line' id='LC2860'>catalyticActivity(proteinAbundance(HGNC:HIF1AN)) directlyIncreases proteinAbundance(HGNC:HIF1A,proteinModification(H,N,803))</div><div class='line' id='LC2861'>proteinAbundance(HGNC:HIF1A,proteinModification(H,N,803)) directlyDecreases complexAbundance(proteinAbundance(HGNC:HIF1A),proteinAbundance(HGNC:EP300))</div><div class='line' id='LC2862'><br/></div><div class='line' id='LC2863'>SET Evidence = &quot;In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF</div><div class='line' id='LC2864'>inactivation that involves proteolytic destruction and inhibition of transcriptional</div><div class='line' id='LC2865'>activity (Fig.1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent</div><div class='line' id='LC2866'>dioxygenases that have an absolute requirement for molecular oxygen,</div><div class='line' id='LC2867'>allowing HIF to escape inactivation in hypoxia.&quot;</div><div class='line' id='LC2868'><br/></div><div class='line' id='LC2869'>abundance(CHEBI:&quot;iron(2+)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN1))</div><div class='line' id='LC2870'>abundance(CHEBI:&quot;iron(2+)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN2))</div><div class='line' id='LC2871'>abundance(CHEBI:&quot;iron(2+)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN3))</div><div class='line' id='LC2872'>abundance(CHEBI:&quot;iron(2+)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:HIF1AN))</div><div class='line' id='LC2873'>abundance(CHEBI:&quot;2-oxoglutarate(2-)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN1))</div><div class='line' id='LC2874'>abundance(CHEBI:&quot;2-oxoglutarate(2-)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN2))</div><div class='line' id='LC2875'>abundance(CHEBI:&quot;2-oxoglutarate(2-)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN3))</div><div class='line' id='LC2876'>abundance(CHEBI:&quot;2-oxoglutarate(2-)&quot;) directlyIncreases catalyticActivity(proteinAbundance(HGNC:HIF1AN))</div><div class='line' id='LC2877'>abundance(CHEBI:dioxygen) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN1))</div><div class='line' id='LC2878'>abundance(CHEBI:dioxygen) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN2))</div><div class='line' id='LC2879'>abundance(CHEBI:dioxygen) directlyIncreases catalyticActivity(proteinAbundance(HGNC:EGLN3))</div><div class='line' id='LC2880'>abundance(CHEBI:dioxygen) directlyIncreases catalyticActivity(proteinAbundance(HGNC:HIF1AN))</div><div class='line' id='LC2881'><br/></div><div class='line' id='LC2882'>SET Evidence = &quot;In hypoxia, VEGF transcription is upregulated by HIF18, 19, mRNA stability is increased</div><div class='line' id='LC2883'>by binding of proteins to specific sequences in the 3&#39; UTR71, and an internal</div><div class='line' id='LC2884'>ribosomal entry site allows preserved translation in the face of normal cellular</div><div class='line' id='LC2885'>hypoxic shutdown72. The biological activity of secreted VEGF is further influenced</div><div class='line' id='LC2886'>by hypoxia-inducible expression of the Flt-1 receptor49,&quot;</div><div class='line' id='LC2887'><br/></div><div class='line' id='LC2888'>transcriptionalActivity(proteinAbundance(HGNC:HIF1A)) directlyIncreases rnaAbundance(HGNC:VEGFA)</div><div class='line' id='LC2889'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases proteinAbundance(HGNC:VEGFA)</div><div class='line' id='LC2890'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases rnaAbundance(HGNC:FLT1)</div><div class='line' id='LC2891'><br/></div><div class='line' id='LC2892'>SET Evidence = &quot;In keeping with the central role of HIF in responses to hypoxia observed in tissue</div><div class='line' id='LC2893'>culture, targeted inactivation of either Hif1a (refs. 68,70,74) or Arnt (encoding</div><div class='line' id='LC2894'>HIF-1β)75 in the mouse results in abnormal vascular development and embryonic</div><div class='line' id='LC2895'>lethality.&quot;</div><div class='line' id='LC2896'>SET Species = &quot;10090&quot;</div><div class='line' id='LC2897'><br/></div><div class='line' id='LC2898'>transcriptionalActivity(proteinAbundance(MGI:Hif1a)) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC2899'>transcriptionalActivity(proteinAbundance(MGI:Arnt)) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC2900'><br/></div><div class='line' id='LC2901'>SET Evidence = &quot;In addition to activation by hypoxia, the HIF system is also induced or amplified</div><div class='line' id='LC2902'>by a wide range of growth-promoting stimuli and oncogenic pathways such as the</div><div class='line' id='LC2903'>insulin, insulin-like growth factor-1, epidermal growth factor and mutant Ras and</div><div class='line' id='LC2904'>Src kinase pathways.&quot;</div><div class='line' id='LC2905'><br/></div><div class='line' id='LC2906'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases proteinAbundance(HGNC:HIF1A)</div><div class='line' id='LC2907'>biologicalProcess(GO:&quot;insulin receptor signaling pathway&quot;) increases proteinAbundance(HGNC:HIF1A)</div><div class='line' id='LC2908'>biologicalProcess(GO:&quot;insulin-like growth factor receptor signaling pathway&quot;) increases proteinAbundance(HGNC:HIF1A)</div><div class='line' id='LC2909'>biologicalProcess(GO:&quot;epidermal growth factor receptor signaling pathway&quot;) increases proteinAbundance(HGNC:HIF1A)</div><div class='line' id='LC2910'>gtpBoundActivity(proteinAbundance(PFH:&quot;RAS Family&quot;)) increases proteinAbundance(HGNC:HIF1A)</div><div class='line' id='LC2911'>kinaseActivity(proteinAbundance(PFH:&quot;SRC Family&quot;)) increases proteinAbundance(HGNC:HIF1A)</div><div class='line' id='LC2912'><br/></div><div class='line' id='LC2913'>UNSET STATEMENT_GROUP</div><div class='line' id='LC2914'><br/></div><div class='line' id='LC2915'>SET STATEMENT_GROUP = &quot;Group 22&quot;</div><div class='line' id='LC2916'><br/></div><div class='line' id='LC2917'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC2918'>SET Evidence = &quot;Numerous studies have shown that the RB protein is an inhibitor of cell proliferation&quot;</div><div class='line' id='LC2919'>SET Citation = {&quot;PubMed&quot;,&quot;Gene&quot;,&quot;15225871&quot;,&quot;&quot;,&quot;Yee AS|Paulson EK|McDevitt MA|Rieger-Christ K|Summerhayes I|Berasi SP|Kim J|Huang CY|Zhang X&quot;,&quot;&quot;}</div><div class='line' id='LC2920'><br/></div><div class='line' id='LC2921'>proteinAbundance(HGNC:RB1) decreases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC2922'><br/></div><div class='line' id='LC2923'>SET Evidence = &quot;RB and the related family members p107 and p130 can each bind E2F to repress genes</div><div class='line' id='LC2924'>that are otherwise important for progression from G1 to S phase.&quot;</div><div class='line' id='LC2925'><br/></div><div class='line' id='LC2926'>complexAbundance(proteinAbundance(HGNC:RB1),proteinAbundance(PFH:&quot;E2F Family&quot;)) decreases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;)</div><div class='line' id='LC2927'>complexAbundance(proteinAbundance(HGNC:RBL1),proteinAbundance(PFH:&quot;E2F Family&quot;)) decreases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;)</div><div class='line' id='LC2928'>complexAbundance(proteinAbundance(HGNC:RBL2),proteinAbundance(PFH:&quot;E2F Family&quot;)) decreases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;)</div><div class='line' id='LC2929'>proteinAbundance(HGNC:RB1) directlyDecreases transcriptionalActivity(proteinAbundance(PFH:&quot;E2F Family&quot;))</div><div class='line' id='LC2930'><br/></div><div class='line' id='LC2931'>SET Evidence = &quot;The binding of RB, p107, or p130 has two simultaneous consequences: (1) binding prevents</div><div class='line' id='LC2932'>E2F from interacting with transcriptional co-activators (e.g., p300);&quot;</div><div class='line' id='LC2933'><br/></div><div class='line' id='LC2934'>complexAbundance(proteinAbundance(HGNC:RB1),proteinAbundance(PFH:&quot;E2F Family&quot;)) directlyDecreases complexAbundance(proteinAbundance(PFH:&quot;E2F Family&quot;),proteinAbundance(HGNC:EP300))</div><div class='line' id='LC2935'>complexAbundance(proteinAbundance(HGNC:RBL1),proteinAbundance(PFH:&quot;E2F Family&quot;)) directlyDecreases complexAbundance(proteinAbundance(PFH:&quot;E2F Family&quot;),proteinAbundance(HGNC:EP300))</div><div class='line' id='LC2936'>complexAbundance(proteinAbundance(HGNC:RBL2),proteinAbundance(PFH:&quot;E2F Family&quot;)) directlyDecreases complexAbundance(proteinAbundance(PFH:&quot;E2F Family&quot;),proteinAbundance(HGNC:EP300))</div><div class='line' id='LC2937'><br/></div><div class='line' id='LC2938'>SET Evidence = &quot;In normal G1 progression, the Cyclin D1/CDK4 kinase phosphorylates RB, triggers disruption</div><div class='line' id='LC2939'>of the RB/ E2F complex, and frees E2F to activate genes that are necessary</div><div class='line' id='LC2940'>for S-phase progression.&quot;</div><div class='line' id='LC2941'><br/></div><div class='line' id='LC2942'>kinaseActivity(complexAbundance(proteinAbundance(HGNC:CCND1),proteinAbundance(HGNC:CDK4))) directlyIncreases proteinAbundance(HGNC:RB1,proteinModification(P))</div><div class='line' id='LC2943'>proteinAbundance(HGNC:RB1,proteinModification(P)) directlyDecreases complexAbundance(proteinAbundance(HGNC:RB1),proteinAbundance(PFH:&quot;E2F Family&quot;))</div><div class='line' id='LC2944'><br/></div><div class='line' id='LC2945'>SET Evidence = &quot;The p16 protein is a CDK4 inhibitor that restrains the activity of Cyclin D1/CDK4</div><div class='line' id='LC2946'>and thus inhibits G1 progression.&quot;</div><div class='line' id='LC2947'><br/></div><div class='line' id='LC2948'>proteinAbundance(HGNC:CDKN2A) directlyDecreases kinaseActivity(complexAbundance(proteinAbundance(HGNC:CCND1),proteinAbundance(HGNC:CDK4)))</div><div class='line' id='LC2949'>proteinAbundance(HGNC:CDKN2A) decreases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;)</div><div class='line' id='LC2950'><br/></div><div class='line' id='LC2951'>SET Disease = &quot;Neoplasms&quot;</div><div class='line' id='LC2952'>SET Evidence = &quot;Cyclin D1 overexpression/amplification is associated with numerous cancers.&quot;</div><div class='line' id='LC2953'><br/></div><div class='line' id='LC2954'>geneAbundance(HGNC:CCND1) positiveCorrelation pathology(MESHD:Neoplasms)</div><div class='line' id='LC2955'><br/></div><div class='line' id='LC2956'>SET Evidence = &quot;As described below, we and other groups reisolated HBP1 as an RB and p130 interacting</div><div class='line' id='LC2957'>protein (Lavender et al., 1997; Tevosian et al., 1997&quot;</div><div class='line' id='LC2958'><br/></div><div class='line' id='LC2959'>complexAbundance(proteinAbundance(HGNC:HBP1),proteinAbundance(HGNC:RB1))</div><div class='line' id='LC2960'>complexAbundance(proteinAbundance(HGNC:HBP1),proteinAbundance(HGNC:RBL2))</div><div class='line' id='LC2961'><br/></div><div class='line' id='LC2962'>SET MuskuloskeletalSystem = &quot;Muscles&quot;</div><div class='line' id='LC2963'>SET Evidence = &quot;HBP1 is consistently up regulated in differentiation and under conditions of cell</div><div class='line' id='LC2964'>cycle arrest in muscle, adipocyte, erythroid, and other cell types&quot;</div><div class='line' id='LC2965'><br/></div><div class='line' id='LC2966'>proteinAbundance(HGNC:HBP1) positiveCorrelation biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC2967'><br/></div><div class='line' id='LC2968'>SET Cell = &quot;Adipocytes&quot;</div><div class='line' id='LC2969'><br/></div><div class='line' id='LC2970'>proteinAbundance(HGNC:HBP1) positiveCorrelation biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC2971'><br/></div><div class='line' id='LC2972'>SET Cell = &quot;Erythroid Cells&quot;</div><div class='line' id='LC2973'><br/></div><div class='line' id='LC2974'>proteinAbundance(HGNC:HBP1) positiveCorrelation biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC2975'>proteinAbundance(HGNC:HBP1) positiveCorrelation biologicalProcess(GO:&quot;cell cycle arrest&quot;)</div><div class='line' id='LC2976'><br/></div><div class='line' id='LC2977'>SET Cell = &quot;Adipocytes&quot;</div><div class='line' id='LC2978'><br/></div><div class='line' id='LC2979'>proteinAbundance(HGNC:HBP1) positiveCorrelation biologicalProcess(GO:&quot;cell cycle arrest&quot;)</div><div class='line' id='LC2980'><br/></div><div class='line' id='LC2981'>SET Cell = &quot;Erythroid Cells&quot;</div><div class='line' id='LC2982'><br/></div><div class='line' id='LC2983'>proteinAbundance(HGNC:HBP1) positiveCorrelation biologicalProcess(GO:&quot;cell cycle arrest&quot;)</div><div class='line' id='LC2984'><br/></div><div class='line' id='LC2985'>SET Evidence = &quot;Consistent with these results, we showed that overexpression of HBP1 in cells inhibited</div><div class='line' id='LC2986'>G1 and S-phase progression (Tevosian et al., 1997).&quot;</div><div class='line' id='LC2987'><br/></div><div class='line' id='LC2988'>proteinAbundance(HGNC:HBP1) decreases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;)</div><div class='line' id='LC2989'><br/></div><div class='line' id='LC2990'>SET Evidence = &quot;HDAC4, a Class II histone deacetylase binds within a region from amino acids 220–250,</div><div class='line' id='LC2991'>which resides within the Ataxin homology region (see Fig. 3).&quot;</div><div class='line' id='LC2992'><br/></div><div class='line' id='LC2993'>complexAbundance(proteinAbundance(HGNC:HDAC4),proteinAbundance(HGNC:HBP1))</div><div class='line' id='LC2994'><br/></div><div class='line' id='LC2995'>SET Evidence = &quot;Our detailed investigation showed that both Cyclin D1 and c-MYC expression was extinguished</div><div class='line' id='LC2996'>upon HBP1 expression.&quot;</div><div class='line' id='LC2997'><br/></div><div class='line' id='LC2998'>proteinAbundance(HGNC:HBP1) decreases rnaAbundance(HGNC:CCND1)</div><div class='line' id='LC2999'>proteinAbundance(HGNC:HBP1) decreases rnaAbundance(HGNC:MYC)</div><div class='line' id='LC3000'><br/></div><div class='line' id='LC3001'>SET Evidence = &quot;Specifically, HBP1 inhibited the activity of LEF/TCFs.&quot;</div><div class='line' id='LC3002'><br/></div><div class='line' id='LC3003'>proteinAbundance(HGNC:HBP1) decreases transcriptionalActivity(proteinAbundance(HGNC:LEF1))</div><div class='line' id='LC3004'><br/></div><div class='line' id='LC3005'>SET BodyRegion = &quot;Breast&quot;</div><div class='line' id='LC3006'>SET Evidence = &quot;A constitutive Wnt signaling pathway has been linked to breast, colon, and other cancers</div><div class='line' id='LC3007'>(for reviews, see Bienz and Clevers, 2000; Polakis, 2000).&quot;</div><div class='line' id='LC3008'><br/></div><div class='line' id='LC3009'>biologicalProcess(GO:&quot;Wnt receptor signaling pathway&quot;) positiveCorrelation pathology(MESHD:Neoplasms)</div><div class='line' id='LC3010'><br/></div><div class='line' id='LC3011'>SET DigestiveSystem = &quot;Colon&quot;</div><div class='line' id='LC3012'><br/></div><div class='line' id='LC3013'>biologicalProcess(GO:&quot;Wnt receptor signaling pathway&quot;) positiveCorrelation pathology(MESHD:Neoplasms)</div><div class='line' id='LC3014'><br/></div><div class='line' id='LC3015'>SET Evidence = &quot;The accumulation of β-catenin results from the inhibition of the GSK3β kinase, which</div><div class='line' id='LC3016'>normally would phosphorylate β-catenin as a degradation signal.&quot;</div><div class='line' id='LC3017'><br/></div><div class='line' id='LC3018'>kinaseActivity(proteinAbundance(HGNC:GSK3B)) directlyIncreases proteinAbundance(HGNC:CTNNB1,proteinModification(P))</div><div class='line' id='LC3019'>proteinAbundance(HGNC:CTNNB1,proteinModification(P)) increases degradation(proteinAbundance(HGNC:CTNNB1))</div><div class='line' id='LC3020'><br/></div><div class='line' id='LC3021'>SET Evidence = &quot;Wild-type APC and Axin trigger β-catenin degradation through recruitment of GSK3b</div><div class='line' id='LC3022'>to the Axin- APC scaffold, which provides for potent activation of GSK3β.&quot;</div><div class='line' id='LC3023'><br/></div><div class='line' id='LC3024'>complexAbundance(proteinAbundance(HGNC:APC),proteinAbundance(PFH:&quot;AXIN Family&quot;)) directlyIncreases (kinaseActivity(proteinAbundance(HGNC:GSK3B)) increases degradation(proteinAbundance(HGNC:CTNNB1)))</div><div class='line' id='LC3025'><br/></div><div class='line' id='LC3026'>SET Evidence = &quot;high β-catenin levels correlate with poor prognosis in human breast cancer and result</div><div class='line' id='LC3027'>from biochemical, not genetic, dysregulation (Ryo et al., 2001; Wulf et al.,</div><div class='line' id='LC3028'>2001, 2003).&quot;</div><div class='line' id='LC3029'><br/></div><div class='line' id='LC3030'>proteinAbundance(HGNC:CTNNB1) prognosticBiomarkerFor pathology(MESHD:&quot;Breast Neoplasms&quot;)</div><div class='line' id='LC3031'><br/></div><div class='line' id='LC3032'>SET Evidence = &quot;Cyclin D1, MYC, and Cox-2 are three clinically relevant Wnt target genes that are</div><div class='line' id='LC3033'>overexpressed in breast and many other cancers (e.g., Weinstat-Saslow et al., 1995;</div><div class='line' id='LC3034'>Naidu et al., 2002a,b; Singh and Luci, 2002; Spizzo et al., 2003).&quot;</div><div class='line' id='LC3035'><br/></div><div class='line' id='LC3036'>proteinAbundance(HGNC:CCND1) positiveCorrelation pathology(MESHD:&quot;Breast Neoplasms&quot;)</div><div class='line' id='LC3037'>proteinAbundance(HGNC:MYC) positiveCorrelation pathology(MESHD:&quot;Breast Neoplasms&quot;)</div><div class='line' id='LC3038'>proteinAbundance(HGNC:PTGS2) positiveCorrelation pathology(MESHD:&quot;Breast Neoplasms&quot;)</div><div class='line' id='LC3039'><br/></div><div class='line' id='LC3040'>SET Evidence = &quot;Cyclin D1 and MYC are examples of direct Wnt target genes in proliferation and whose</div><div class='line' id='LC3041'>activation requires the LEF/TCF sites in the respective promoters (He et al.,</div><div class='line' id='LC3042'>1998; Tetsu and McCormick, 1999).&quot;</div><div class='line' id='LC3043'><br/></div><div class='line' id='LC3044'>transcriptionalActivity(proteinAbundance(HGNC:LEF1)) directlyIncreases rnaAbundance(HGNC:CCND1)</div><div class='line' id='LC3045'>transcriptionalActivity(proteinAbundance(HGNC:LEF1)) directlyIncreases rnaAbundance(HGNC:MYC)</div><div class='line' id='LC3046'><br/></div><div class='line' id='LC3047'>SET Evidence = &quot;Cyclin D1 expression best correlates with breast proliferation.&quot;</div><div class='line' id='LC3048'><br/></div><div class='line' id='LC3049'>proteinAbundance(HGNC:CCND1) positiveCorrelation biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC3050'><br/></div><div class='line' id='LC3051'>SET Evidence = &quot;Increased Cyclin D1 levels in breast cancer cell lines and tumors have been correlated</div><div class='line' id='LC3052'>with increased β-catenin accumulation and constitutive Wnt signaling (Lin</div><div class='line' id='LC3053'>et al., 2000).&quot;</div><div class='line' id='LC3054'><br/></div><div class='line' id='LC3055'>proteinAbundance(HGNC:CCND1) positiveCorrelation proteinAbundance(HGNC:CTNNB1)</div><div class='line' id='LC3056'>proteinAbundance(HGNC:CCND1) positiveCorrelation biologicalProcess(GO:&quot;Wnt receptor signaling pathway&quot;)</div><div class='line' id='LC3057'><br/></div><div class='line' id='LC3058'>SET Evidence = &quot;The NADPH oxidase is the principle source of intracellular reactive oxygen species</div><div class='line' id='LC3059'>(ROS) that is generated by mitogenic signaling.&quot;</div><div class='line' id='LC3060'><br/></div><div class='line' id='LC3061'>complexAbundance(NCH:&quot;NADPH Oxidase Complex&quot;) directlyIncreases abundance(CHEBI:&quot;reactive oxygen species&quot;)</div><div class='line' id='LC3062'><br/></div><div class='line' id='LC3063'>SET Evidence = &quot;The importance of a functional NADPH oxidase is underscored by the observation that</div><div class='line' id='LC3064'>mutations of the p47phox and gp91phox genes are associated with chronic granulomatosis,</div><div class='line' id='LC3065'>in which patients have increased susceptibility to bacterial and fungal</div><div class='line' id='LC3066'>infections (reviewed in Cheng et al., 2001).&quot;</div><div class='line' id='LC3067'><br/></div><div class='line' id='LC3068'>complexAbundance(NCH:&quot;NADPH Oxidase Complex&quot;) hasComponents list(proteinAbundance(HGNC:NCF1),proteinAbundance(HGNC:CYBB))</div><div class='line' id='LC3069'><br/></div><div class='line' id='LC3070'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC3071'>SET Evidence = &quot;Stable transfection of NIH/3T3 fibroblasts with active Ras (H-RasV12) results in transformation</div><div class='line' id='LC3072'>and in significant intracellular ROS generation. The importance of</div><div class='line' id='LC3073'>intracellular ROS in RAS-mediated transformation is highlighted by the observation</div><div class='line' id='LC3074'>that pharmacological inhibition of the NADPH oxidase reverses transformation</div><div class='line' id='LC3075'>(Irani et al., 1997).&quot;</div><div class='line' id='LC3076'>SET Species = &quot;10090&quot;</div><div class='line' id='LC3077'><br/></div><div class='line' id='LC3078'>gtpBoundActivity(proteinAbundance(MGI:Hras1,substitution(G,12,V))) increases catalyticActivity(complexAbundance(NCM:&quot;NADPH Oxidase Complex&quot;))</div><div class='line' id='LC3079'>catalyticActivity(complexAbundance(NCM:&quot;NADPH Oxidase Complex&quot;)) directlyIncreases abundance(CHEBI:&quot;reactive oxygen species&quot;)</div><div class='line' id='LC3080'><br/></div><div class='line' id='LC3081'>SET Evidence = &quot;the expression of the Nox1/Mox1 catalytic subunit of the NADPH oxidase in NIH/3T3</div><div class='line' id='LC3082'>fibroblasts not only triggered increased superoxide production, but also oncogenic</div><div class='line' id='LC3083'>transformation (Suh et al., 1999; Arnold et al., 2001).&quot;</div><div class='line' id='LC3084'><br/></div><div class='line' id='LC3085'>proteinAbundance(MGI:Nox1) increases abundance(CHEBI:superoxide)</div><div class='line' id='LC3086'><br/></div><div class='line' id='LC3087'>SET Evidence = &quot;RAC itself is also an obligate subunit of the cellular NADPH oxidase&quot;</div><div class='line' id='LC3088'><br/></div><div class='line' id='LC3089'>complexAbundance(NCH:&quot;NADPH Oxidase Complex&quot;) hasComponent proteinAbundance(HGNC:RAC1)</div><div class='line' id='LC3090'><br/></div><div class='line' id='LC3091'>SET Evidence = &quot;The expression of active Rac1 in many cell types causes increased superoxide production,</div><div class='line' id='LC3092'>while expression of a dominant-negative Rac1 block superoxide production....superoxide</div><div class='line' id='LC3093'>production is necessary for Rac dependent G1 progression and cellular</div><div class='line' id='LC3094'>shape changes&quot;</div><div class='line' id='LC3095'><br/></div><div class='line' id='LC3096'>proteinAbundance(HGNC:RAC1) increases abundance(CHEBI:superoxide)</div><div class='line' id='LC3097'>abundance(CHEBI:superoxide) increases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;)</div><div class='line' id='LC3098'>abundance(CHEBI:superoxide) increases biologicalProcess(GO:&quot;cell morphogenesis&quot;)</div><div class='line' id='LC3099'><br/></div><div class='line' id='LC3100'>SET Evidence = &quot;The promoter of the p47phox gene contains six tandem high-affinity HBP1 DNA binding</div><div class='line' id='LC3101'>elements at -1243 to -1318 bp from the transcriptional start site and which were</div><div class='line' id='LC3102'>required for repression.&quot;</div><div class='line' id='LC3103'><br/></div><div class='line' id='LC3104'>complexAbundance(proteinAbundance(HGNC:HBP1),geneAbundance(HGNC:NCF1))</div><div class='line' id='LC3105'>transcriptionalActivity(proteinAbundance(HGNC:HBP1)) directlyDecreases rnaAbundance(HGNC:NCF1)</div><div class='line' id='LC3106'><br/></div><div class='line' id='LC3107'>SET Disease = &quot;Neuroblastoma&quot;</div><div class='line' id='LC3108'>SET Evidence = &quot;We identified the N-MYC gene as a new HBP1 target (Tevosian et al., 1997). The expression</div><div class='line' id='LC3109'>of NMYC is increased in neuroblastomas.&quot;</div><div class='line' id='LC3110'><br/></div><div class='line' id='LC3111'>proteinAbundance(HGNC:MYCN) positiveCorrelation pathology(MESHD:Neuroblastoma)</div><div class='line' id='LC3112'>complexAbundance(proteinAbundance(HGNC:HBP1),geneAbundance(HGNC:MYCN))</div><div class='line' id='LC3113'><br/></div><div class='line' id='LC3114'>SET Evidence = &quot;Histone H10 gene as another RB-regulated HBP1 target that is also cell cycle regulated.&quot;</div><div class='line' id='LC3115'><br/></div><div class='line' id='LC3116'>complexAbundance(proteinAbundance(HGNC:HBP1),geneAbundance(HGNC:H1F0))</div><div class='line' id='LC3117'><br/></div><div class='line' id='LC3118'>SET Evidence = &quot;HBP1 was identified as a regulator of the Histone H10 gene. HBP1 appears to be an</div><div class='line' id='LC3119'>activator for this gene.&quot;</div><div class='line' id='LC3120'><br/></div><div class='line' id='LC3121'>transcriptionalActivity(proteinAbundance(HGNC:HBP1)) directlyIncreases rnaAbundance(HGNC:H1F0)</div><div class='line' id='LC3122'><br/></div><div class='line' id='LC3123'>SET Evidence = &quot;Lin et al. (2001) have shown that myeloperoxidase (MPO) gene is another HBP1 target.&quot;</div><div class='line' id='LC3124'><br/></div><div class='line' id='LC3125'>complexAbundance(proteinAbundance(HGNC:HBP1),geneAbundance(HGNC:MPO))</div><div class='line' id='LC3126'><br/></div><div class='line' id='LC3127'>SET Disease = &quot;Leukemia, Myeloid&quot;</div><div class='line' id='LC3128'>SET Evidence = &quot;Myeloperoxidase is a clinical prognostic marker for the progression of myeloid leukemia&quot;</div><div class='line' id='LC3129'><br/></div><div class='line' id='LC3130'>proteinAbundance(HGNC:MPO) prognosticBiomarkerFor pathology(MESHD:&quot;Leukemia, Myeloid&quot;)</div><div class='line' id='LC3131'><br/></div><div class='line' id='LC3132'>SET Evidence = &quot;p38 MAPK activity is also linked with differentiation and recently, with senescence</div><div class='line' id='LC3133'>and tumor suppression (reviewed in Kyriakis and Avruch, 2001 and see below).&quot;</div><div class='line' id='LC3134'><br/></div><div class='line' id='LC3135'>proteinAbundance(PFH:&quot;MAPK p38 Family&quot;) positiveCorrelation biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC3136'>proteinAbundance(PFH:&quot;MAPK p38 Family&quot;) positiveCorrelation biologicalProcess(GO:&quot;cell aging&quot;)</div><div class='line' id='LC3137'>proteinAbundance(PFH:&quot;MAPK p38 Family&quot;) negativeCorrelation biologicalProcess(SDIS:&quot;tumor growth&quot;)</div><div class='line' id='LC3138'><br/></div><div class='line' id='LC3139'>SET Evidence = &quot;p21 protein levels increased by a post-transcriptional mechanism and concluded that</div><div class='line' id='LC3140'>the SAPKs p38 MAPK and JNK were involved in stabilizing the p21 protein. A specific</div><div class='line' id='LC3141'>site on p21 (serine 190) was defined for p38 MAPK-mediated stabilization</div><div class='line' id='LC3142'>(Kim et al., 2002).&quot;</div><div class='line' id='LC3143'><br/></div><div class='line' id='LC3144'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK p38 Family&quot;)) directlyIncreases proteinAbundance(HGNC:CDKN1A,proteinModification(P,S,190))</div><div class='line' id='LC3145'>proteinAbundance(HGNC:CDKN1A,proteinModification(P,S,190)) decreases degradation(proteinAbundance(HGNC:CDKN1A))</div><div class='line' id='LC3146'><br/></div><div class='line' id='LC3147'>SET Evidence = &quot;the apparent mechanism was that p38 MAPK-mediated phosphorylation of the HBP1 led</div><div class='line' id='LC3148'>to increased protein stability and a G1 arrest&quot;</div><div class='line' id='LC3149'><br/></div><div class='line' id='LC3150'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK p38 Family&quot;)) directlyIncreases proteinAbundance(HGNC:HBP1,proteinModification(P))</div><div class='line' id='LC3151'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK p38 Family&quot;)) decreases degradation(proteinAbundance(HGNC:HBP1))</div><div class='line' id='LC3152'><br/></div><div class='line' id='LC3153'>SET Evidence = &quot;the activation of the upstream kinases MKK 6 and MKK 3 lead to a senescent phenotype</div><div class='line' id='LC3154'>that was dependent on p38 MAPK activity&quot;</div><div class='line' id='LC3155'><br/></div><div class='line' id='LC3156'>kinaseActivity(proteinAbundance(HGNC:MAP2K6)) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK p38 Family&quot;))</div><div class='line' id='LC3157'>kinaseActivity(proteinAbundance(HGNC:MAP2K3)) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK p38 Family&quot;))</div><div class='line' id='LC3158'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK p38 Family&quot;)) increases biologicalProcess(GO:&quot;cell aging&quot;)</div><div class='line' id='LC3159'><br/></div><div class='line' id='LC3160'>SET Evidence = &quot;A loss of both MKK6 and MKK3 resulted in cells with increased proliferation and susceptibility</div><div class='line' id='LC3161'>to tumorigenic conversion (Brancho et al., 2003).&quot;</div><div class='line' id='LC3162'><br/></div><div class='line' id='LC3163'>proteinAbundance(HGNC:MAP2K6) decreases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC3164'>proteinAbundance(HGNC:MAP2K3) decreases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC3165'>proteinAbundance(HGNC:MAP2K6) decreases biologicalProcess(SDIS:&quot;tumor growth&quot;)</div><div class='line' id='LC3166'>proteinAbundance(HGNC:MAP2K3) decreases biologicalProcess(SDIS:&quot;tumor growth&quot;)</div><div class='line' id='LC3167'><br/></div><div class='line' id='LC3168'>SET Evidence = &quot;deletion of the p38a (mapk14) isoform also resulted in cells with increased susceptibility</div><div class='line' id='LC3169'>to tumorigenic conversion (Bulavin et al., 2002).&quot;</div><div class='line' id='LC3170'><br/></div><div class='line' id='LC3171'>proteinAbundance(HGNC:MAPK14) decreases biologicalProcess(SDIS:&quot;tumor growth&quot;)</div><div class='line' id='LC3172'><br/></div><div class='line' id='LC3173'>SET Disease = &quot;Neoplasms&quot;</div><div class='line' id='LC3174'>SET Evidence = &quot;In breast cancer, amplification of the human epidermal growth factor receptor- 2 (Her-2)</div><div class='line' id='LC3175'>is associated with aggressively proliferating breast cancers.&quot;</div><div class='line' id='LC3176'><br/></div><div class='line' id='LC3177'>geneAbundance(HGNC:ERBB2) positiveCorrelation biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC3178'>kinaseActivity(proteinAbundance(HGNC:EGFR)) negativeCorrelation proteinAbundance(PFH:&quot;ESR Family&quot;)</div><div class='line' id='LC3179'><br/></div><div class='line' id='LC3180'>SET Evidence = &quot;In addition, excessive EGFR signaling is a common scenario in breast cancer, specifically</div><div class='line' id='LC3181'>in estrogen receptor-negative subtypes&quot;</div><div class='line' id='LC3182'><br/></div><div class='line' id='LC3183'>kinaseActivity(proteinAbundance(HGNC:EGFR)) negativeCorrelation proteinAbundance(PFH:&quot;ESR Family&quot;)</div><div class='line' id='LC3184'><br/></div><div class='line' id='LC3185'>SET Evidence = &quot;Herceptin therapy is blocking the Her-2 receptor and its resulting signaling.&quot;</div><div class='line' id='LC3186'><br/></div><div class='line' id='LC3187'>abundance(SCHEM:Trastuzumab) directlyDecreases kinaseActivity(proteinAbundance(HGNC:ERBB2))</div><div class='line' id='LC3188'><br/></div><div class='line' id='LC3189'>UNSET STATEMENT_GROUP</div><div class='line' id='LC3190'><br/></div><div class='line' id='LC3191'>SET STATEMENT_GROUP = &quot;Group 23&quot;</div><div class='line' id='LC3192'><br/></div><div class='line' id='LC3193'>SET Cell = &quot;Adipocytes, Brown&quot;</div><div class='line' id='LC3194'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC3195'>SET Evidence = &quot;UCP-1 allows the re-entry of protons and, as a consequence, energy liberated from</div><div class='line' id='LC3196'>substrate oxidation is dissipated as heat (Fig. 1).&quot;</div><div class='line' id='LC3197'>SET Citation = {&quot;PubMed&quot;,&quot;Mini reviews in medicinal chemistry&quot;,&quot;15777261&quot;,&quot;&quot;,&quot;Valverde AM|Benito M&quot;,&quot;&quot;}</div><div class='line' id='LC3198'><br/></div><div class='line' id='LC3199'>proteinAbundance(HGNC:UCP1) increases biologicalProcess(GO:&quot;heat dissipation&quot;)</div><div class='line' id='LC3200'><br/></div><div class='line' id='LC3201'>SET Evidence = &quot;UCP-1 allows the re-entry of protons and, as a consequence, energy liberated from</div><div class='line' id='LC3202'>substrate oxidation is dissipated as heat (Fig. 1). This mechanism is reversible,</div><div class='line' id='LC3203'>since it can be inhibited by purine nucleotides such as GDP [5].&quot;</div><div class='line' id='LC3204'><br/></div><div class='line' id='LC3205'>abundance(CHEBI:GDP) decreases (proteinAbundance(HGNC:UCP1) increases biologicalProcess(GO:&quot;heat dissipation&quot;))</div><div class='line' id='LC3206'><br/></div><div class='line' id='LC3207'>SET Evidence = &quot;Acute activation of BAT thermogenesis appears to be mediated by noradrenaline (NA)</div><div class='line' id='LC3208'>liberated from the sympathetic nervous system&quot;</div><div class='line' id='LC3209'><br/></div><div class='line' id='LC3210'>abundance(CHEBI:noradrenaline) increases biologicalProcess(MESHPP:Thermogenesis)</div><div class='line' id='LC3211'><br/></div><div class='line' id='LC3212'>SET Evidence = &quot;By acting through β-receptors, NA increases intracellular cAMP levels, which in turn</div><div class='line' id='LC3213'>activate lipolysis (Fig. 1).&quot;</div><div class='line' id='LC3214'><br/></div><div class='line' id='LC3215'>abundance(CHEBI:noradrenaline) directlyIncreases molecularActivity(proteinAbundance(PFH:&quot;ADRB Family&quot;))</div><div class='line' id='LC3216'>molecularActivity(proteinAbundance(PFH:&quot;ADRB Family&quot;)) increases abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;)</div><div class='line' id='LC3217'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;) increases biologicalProcess(MESHPP:Lipolysis)</div><div class='line' id='LC3218'><br/></div><div class='line' id='LC3219'>SET Evidence = &quot;The resulting free fatty acids are used as substrates for mitochondrial respiration</div><div class='line' id='LC3220'>and as activators of UCP-1 [5].&quot;</div><div class='line' id='LC3221'><br/></div><div class='line' id='LC3222'>biologicalProcess(MESHPP:Lipolysis) increases abundance(CHEBI:&quot;fatty acid&quot;)</div><div class='line' id='LC3223'>abundance(CHEBI:&quot;fatty acid&quot;) increases biologicalProcess(GO:&quot;cellular respiration&quot;)</div><div class='line' id='LC3224'>abundance(CHEBI:&quot;fatty acid&quot;) increases molecularActivity(proteinAbundance(HGNC:UCP1))</div><div class='line' id='LC3225'><br/></div><div class='line' id='LC3226'>SET Evidence = &quot;They found an A/C transition in the 5&#39; untranslated region of exon 1 (112 bp upstream</div><div class='line' id='LC3227'>of the translation initiation codon) and also a Met229/Leu variant. Interestingly,</div><div class='line' id='LC3228'>the allele frequencies for the C variant and for the Leu229 variant were</div><div class='line' id='LC3229'>higher in the Type 2 diabetic group than in the control group.&quot;</div><div class='line' id='LC3230'>SET Species = &quot;9606&quot;</div><div class='line' id='LC3231'><br/></div><div class='line' id='LC3232'>proteinAbundance(HGNC:UCP1,substitution(M,229,L)) positiveCorrelation pathology(MESHD:&quot;Diabetes Mellitus, Type 2&quot;)</div><div class='line' id='LC3233'>proteinAbundance(HGNC:UCP1,substitution(M,229,L)) positiveCorrelation pathology(MESHD:&quot;Diabetes Mellitus, Type 2&quot;)</div><div class='line' id='LC3234'><br/></div><div class='line' id='LC3235'>SET Evidence = &quot;Insulin and IGF-I initiate the biological effects in target cells by binding to and</div><div class='line' id='LC3236'>activating its endogenous tyrosine kinase receptors [23,24]. These receptors</div><div class='line' id='LC3237'>are believed to transduce signals by phosphorylation on tyrosine residues of several</div><div class='line' id='LC3238'>cellular substrates including IRS proteins (IRS-1,-2,- 3 and –4) [25-28].&quot;</div><div class='line' id='LC3239'><br/></div><div class='line' id='LC3240'>proteinAbundance(HGNC:INS) directlyIncreases kinaseActivity(proteinAbundance(HGNC:INSR))</div><div class='line' id='LC3241'>proteinAbundance(HGNC:IGF1) directlyIncreases kinaseActivity(proteinAbundance(HGNC:IGF1R))</div><div class='line' id='LC3242'>kinaseActivity(proteinAbundance(HGNC:INSR)) directlyIncreases proteinAbundance(HGNC:IRS1,proteinModification(P,Y))</div><div class='line' id='LC3243'>kinaseActivity(proteinAbundance(HGNC:INSR)) directlyIncreases proteinAbundance(HGNC:IRS2,proteinModification(P,Y))</div><div class='line' id='LC3244'>kinaseActivity(proteinAbundance(HGNC:INSR)) directlyIncreases proteinAbundance(HGNC:IRS4,proteinModification(P,Y))</div><div class='line' id='LC3245'>kinaseActivity(proteinAbundance(HGNC:IGF1R)) directlyIncreases proteinAbundance(HGNC:IRS1,proteinModification(P,Y))</div><div class='line' id='LC3246'>kinaseActivity(proteinAbundance(HGNC:IGF1R)) directlyIncreases proteinAbundance(HGNC:IRS2,proteinModification(P,Y))</div><div class='line' id='LC3247'>kinaseActivity(proteinAbundance(HGNC:IGF1R)) directlyIncreases proteinAbundance(HGNC:IRS4,proteinModification(P,Y))</div><div class='line' id='LC3248'><br/></div><div class='line' id='LC3249'>SET Evidence = &quot;The p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase) contains</div><div class='line' id='LC3250'>two SH2 domains that allow its binding to the IRS proteins [29].&quot;</div><div class='line' id='LC3251'><br/></div><div class='line' id='LC3252'>proteinAbundance(PFH:&quot;IRS Family&quot;,proteinModification(P)) directlyIncreases complexAbundance(proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;),proteinAbundance(PFH:&quot;IRS Family&quot;))</div><div class='line' id='LC3253'><br/></div><div class='line' id='LC3254'>SET Evidence = &quot;PI 3-kinase is a heterodimer composed of an 85-kDa regulatory subunit and a 110-kDa</div><div class='line' id='LC3255'>catalytic subunit, capable of phosphorylating phosphoinositides at the 3&#39;-position</div><div class='line' id='LC3256'>of the inositol ring, thus initiating phospholipid turnover [29].&quot;</div><div class='line' id='LC3257'><br/></div><div class='line' id='LC3258'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) directlyIncreases abundance(CHEBI:&quot;phosphatidylinositol trisphosphate&quot;)</div><div class='line' id='LC3259'><br/></div><div class='line' id='LC3260'>SET Evidence = &quot;The phosphoinositides produced by PI 3-kinase activate the phosphoinositide-dependent</div><div class='line' id='LC3261'>kinases 1 and 2. These kinases phosphorylate and activate the serine/threonine</div><div class='line' id='LC3262'>kinase PKB/Akt [32].&quot;</div><div class='line' id='LC3263'><br/></div><div class='line' id='LC3264'>abundance(CHEBI:&quot;phosphatidylinositol trisphosphate&quot;) increases kinaseActivity(proteinAbundance(HGNC:PDPK1))</div><div class='line' id='LC3265'>kinaseActivity(proteinAbundance(HGNC:PDPK1)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:AKT1))</div><div class='line' id='LC3266'><br/></div><div class='line' id='LC3267'>SET Evidence = &quot;The mammalian target of rapamycin (mTOR), a 290 kDa serine/threonine kinase and aminoacid</div><div class='line' id='LC3268'>sensor, is a direct target for Akt [33].&quot;</div><div class='line' id='LC3269'><br/></div><div class='line' id='LC3270'>kinaseActivity(proteinAbundance(HGNC:AKT1)) directlyIncreases proteinAbundance(HGNC:MTOR,proteinModification(P))</div><div class='line' id='LC3271'><br/></div><div class='line' id='LC3272'>SET Evidence = &quot;mTOR can phosphorylate and activate the prototypical p70s6k, a process which is blocked</div><div class='line' id='LC3273'>by rapamycin.&quot;</div><div class='line' id='LC3274'><br/></div><div class='line' id='LC3275'>abundance(CHEBI:rapamycin) directlyDecreases (kinaseActivity(proteinAbundance(HGNC:MTOR)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:RPS6KB2)))</div><div class='line' id='LC3276'><br/></div><div class='line' id='LC3277'>SET Evidence = &quot;P70s6k is involved in the phosphorylation of ribosomal protein S6&quot;</div><div class='line' id='LC3278'><br/></div><div class='line' id='LC3279'>kinaseActivity(proteinAbundance(HGNC:RPS6KB2)) directlyIncreases proteinAbundance(HGNC:RPS6,proteinModification(P))</div><div class='line' id='LC3280'><br/></div><div class='line' id='LC3281'>SET Evidence = &quot;One of the well-known downstream targets of MAPK is p90 RSK (ribosomal S6 kinase).&quot;</div><div class='line' id='LC3282'><br/></div><div class='line' id='LC3283'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;)) directlyIncreases proteinAbundance(PFH:&quot;RPS6KA Family&quot;,proteinModification(P))</div><div class='line' id='LC3284'><br/></div><div class='line' id='LC3285'>SET Evidence = &quot;Fetal brown adipocytes primary cultures offer an excellent cell model to study the</div><div class='line' id='LC3286'>molecular mechanisms of insulin/IGF-I-mediated differentiation processes. In these</div><div class='line' id='LC3287'>cells insulin and IGF-I, acting independently, up-regulate the expression of</div><div class='line' id='LC3288'>adipogenic-related genes (fatty acid synthase, glycerol-3-phosphate dehydrogenase,</div><div class='line' id='LC3289'>malic enzyme, glucose- 6-phosphate dehydrogenase) in a dose and time-dependent</div><div class='line' id='LC3290'>manner at the transcriptional level, resulting in an increase of cytosolic lipid</div><div class='line' id='LC3291'>content [20,40].&quot;</div><div class='line' id='LC3292'><br/></div><div class='line' id='LC3293'>proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:FASN)</div><div class='line' id='LC3294'>proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:G6PD)</div><div class='line' id='LC3295'>proteinAbundance(HGNC:IGF1) increases rnaAbundance(HGNC:FASN)</div><div class='line' id='LC3296'>proteinAbundance(HGNC:IGF1) increases rnaAbundance(HGNC:G6PD)</div><div class='line' id='LC3297'><br/></div><div class='line' id='LC3298'>SET CellStructure = &quot;Cytoplasm&quot;</div><div class='line' id='LC3299'><br/></div><div class='line' id='LC3300'>proteinAbundance(HGNC:INS) increases abundance(CHEBI:lipid)</div><div class='line' id='LC3301'>proteinAbundance(HGNC:IGF1) increases abundance(CHEBI:lipid)</div><div class='line' id='LC3302'><br/></div><div class='line' id='LC3303'>SET Evidence = &quot;Activation of PI 3- kinase mediates GLUT4 redistribution from an intracellular compartment</div><div class='line' id='LC3304'>to the plasma membrane upon insulin stimulation [47]&quot;</div><div class='line' id='LC3305'><br/></div><div class='line' id='LC3306'>proteinAbundance(HGNC:INS) increases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC3307'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) increases translocation(proteinAbundance(HGNC:SLC2A4),MESHCL:&quot;Intracellular Space&quot;,MESHCL:&quot;Cell Membrane&quot;)</div><div class='line' id='LC3308'><br/></div><div class='line' id='LC3309'>SET Evidence = &quot;In primary cultures of brown adipocytes, insulin and IGF-I transactivated the GLUT4</div><div class='line' id='LC3310'>promoter and upregulated the expression of the GLUT4 gene, producing a time-dependent</div><div class='line' id='LC3311'>mRNA accumulation and significantly increasing the amount of protein located</div><div class='line' id='LC3312'>in total membrane fraction.&quot;</div><div class='line' id='LC3313'><br/></div><div class='line' id='LC3314'>proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:SLC2A4)</div><div class='line' id='LC3315'>proteinAbundance(HGNC:IGF1) increases rnaAbundance(HGNC:SLC2A4)</div><div class='line' id='LC3316'><br/></div><div class='line' id='LC3317'>SET CellStructure = &quot;Cell Membrane&quot;</div><div class='line' id='LC3318'><br/></div><div class='line' id='LC3319'>proteinAbundance(HGNC:INS) increases proteinAbundance(HGNC:SLC2A4)</div><div class='line' id='LC3320'>proteinAbundance(HGNC:IGF1) increases proteinAbundance(HGNC:SLC2A4)</div><div class='line' id='LC3321'><br/></div><div class='line' id='LC3322'>SET Evidence = &quot;insulin and IGF-I transactivated the GLUT4 promoter and upregulated the expression</div><div class='line' id='LC3323'>of the GLUT4 gene, producing a time-dependent mRNA accumulation and significantly</div><div class='line' id='LC3324'>increasing the amount of protein located in total membrane fraction. Consequently,</div><div class='line' id='LC3325'>glucose uptake was augmented [49].&quot;</div><div class='line' id='LC3326'><br/></div><div class='line' id='LC3327'>transportActivity(proteinAbundance(HGNC:SLC2A4)) increases biologicalProcess(GO:&quot;glucose import&quot;)</div><div class='line' id='LC3328'><br/></div><div class='line' id='LC3329'>SET Evidence = &quot;Inhibition of PI 3-kinase with either wortmannin or LY294002 down-regulated insulin-induced</div><div class='line' id='LC3330'>GLUT4 mRNA accumulation or GLUT4 protein content as well as precluded</div><div class='line' id='LC3331'>the transactivation of the GLUT4 promoter&quot;</div><div class='line' id='LC3332'><br/></div><div class='line' id='LC3333'>abundance(CHEBI:wortmannin) decreases (proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:SLC2A4))</div><div class='line' id='LC3334'>abundance(CHEBI:wortmannin) decreases (proteinAbundance(HGNC:INS) increases proteinAbundance(HGNC:SLC2A4))</div><div class='line' id='LC3335'>abundance(SCHEM:&quot;LY 294002&quot;) decreases (proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:SLC2A4))</div><div class='line' id='LC3336'>abundance(SCHEM:&quot;LY 294002&quot;) decreases (proteinAbundance(HGNC:INS) increases proteinAbundance(HGNC:SLC2A4))</div><div class='line' id='LC3337'><br/></div><div class='line' id='LC3338'>SET Evidence = &quot;LY294002 down-regulated insulin-induced GLUT4 mRNA accumulation or GLUT4 protein content</div><div class='line' id='LC3339'>as well as precluded the transactivation of the GLUT4 promoter. Similar</div><div class='line' id='LC3340'>results have been obtained by transient transfection of primary brown adipocytes</div><div class='line' id='LC3341'>with constructs encoding dominant negative p85 (Dp85).&quot;</div><div class='line' id='LC3342'><br/></div><div class='line' id='LC3343'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) increases rnaAbundance(HGNC:SLC2A4)</div><div class='line' id='LC3344'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) increases proteinAbundance(HGNC:SLC2A4)</div><div class='line' id='LC3345'><br/></div><div class='line' id='LC3346'>SET Evidence = &quot;Conversely, the use of 1-(5-Chloronaphthalene-1-sulfonyl) homopiperazine (ML-9) compound</div><div class='line' id='LC3347'>(Fig. 5) as an inhibitor of PKB/Akt enzymatic activity (IC50=10-50 mM) [50]</div><div class='line' id='LC3348'>has revealed that activation of PKB/Akt is necessary for the acute (GLUT4 translocation)</div><div class='line' id='LC3349'>and chronic (GLUT4 gene expression) insulin effects that lead to glucose</div><div class='line' id='LC3350'>uptake [51]&quot;</div><div class='line' id='LC3351'><br/></div><div class='line' id='LC3352'>abundance(SCHEM:&quot;ML 9&quot;) directlyDecreases kinaseActivity(proteinAbundance(HGNC:AKT1))</div><div class='line' id='LC3353'>abundance(SCHEM:&quot;ML 9&quot;) decreases (proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:SLC2A4))</div><div class='line' id='LC3354'>abundance(SCHEM:&quot;ML 9&quot;) decreases (proteinAbundance(HGNC:INS) increases translocation(proteinAbundance(HGNC:SLC2A4),MESHCL:&quot;Intracellular Space&quot;,MESHCL:&quot;Cell Membrane&quot;))</div><div class='line' id='LC3355'><br/></div><div class='line' id='LC3356'>SET Evidence = &quot;Okadaic acid is an ionophore-like polyether derivate of a C38 fatty acid compound</div><div class='line' id='LC3357'>that has tumor promoting properties (Fig. 6) [52]. It is a potent inhibitor of</div><div class='line' id='LC3358'>protein serine/threonine phosphatase 1 (IC50=10-15 nM) and protein serine/threonine</div><div class='line' id='LC3359'>phosphatase 2A (IC50=0.1 nM) without any inhibitory effect on the activity of</div><div class='line' id='LC3360'>tyrosine phosphatases.&quot;</div><div class='line' id='LC3361'><br/></div><div class='line' id='LC3362'>abundance(CHEBI:&quot;okadaic acid&quot;) directlyDecreases phosphataseActivity(complexAbundance(NCH:&quot;PP2A Complex&quot;))</div><div class='line' id='LC3363'><br/></div><div class='line' id='LC3364'>SET Evidence = &quot;Primary brown adipocytes pretreated with this compound before insulin stimulation</div><div class='line' id='LC3365'>showed a marked increase in IRS-1/2 serine phosphorylation with a concomitant decrease</div><div class='line' id='LC3366'>in tyrosine phosphorylation of these molecules and a partial inhibition</div><div class='line' id='LC3367'>of IRS-1- and IRS-2-associated PI 3-kinase activity [53].&quot;</div><div class='line' id='LC3368'><br/></div><div class='line' id='LC3369'>abundance(CHEBI:&quot;okadaic acid&quot;) increases proteinAbundance(HGNC:IRS1,proteinModification(P,S))</div><div class='line' id='LC3370'>abundance(CHEBI:&quot;okadaic acid&quot;) increases proteinAbundance(HGNC:IRS2,proteinModification(P,S))</div><div class='line' id='LC3371'>proteinAbundance(HGNC:IRS1,proteinModification(P,S)) negativeCorrelation proteinAbundance(HGNC:IRS1,proteinModification(P,Y))</div><div class='line' id='LC3372'>proteinAbundance(HGNC:IRS2,proteinModification(P,S)) negativeCorrelation proteinAbundance(HGNC:IRS2,proteinModification(P,Y))</div><div class='line' id='LC3373'><br/></div><div class='line' id='LC3374'>SET Evidence = &quot;Downstream PI 3-kinase, okadaic acid blunted insulin induced PKCz activity, but not</div><div class='line' id='LC3375'>PKB/Akt or p70s6k phosphorylation.&quot;</div><div class='line' id='LC3376'><br/></div><div class='line' id='LC3377'>abundance(CHEBI:&quot;okadaic acid&quot;) decreases (proteinAbundance(HGNC:INS) increases kinaseActivity(proteinAbundance(HGNC:PRKCZ)))</div><div class='line' id='LC3378'><br/></div><div class='line' id='LC3379'>SET Evidence = &quot;The metabolic consequence of PKCz inhibition is a blockade of insulin-induced glucose</div><div class='line' id='LC3380'>uptake.&quot;</div><div class='line' id='LC3381'><br/></div><div class='line' id='LC3382'>kinaseActivity(proteinAbundance(HGNC:PRKCZ)) increases (proteinAbundance(HGNC:INS) increases biologicalProcess(GO:&quot;glucose import&quot;))</div><div class='line' id='LC3383'><br/></div><div class='line' id='LC3384'>SET Evidence = &quot;PD098059 blocks the activity of MEK and not that of MAPK. In addition, PD098059 did</div><div class='line' id='LC3385'>not inhibit a number of other kinase activities both in vitro and in cultured</div><div class='line' id='LC3386'>cells. These include Raf kinase, PKC, cyclic AMP-dependent kinase, vsrc kinase,</div><div class='line' id='LC3387'>PDGF receptor tyrosine kinase and PI 3-kinase&quot;</div><div class='line' id='LC3388'><br/></div><div class='line' id='LC3389'>abundance(SCHEM:&quot;PD 98,059&quot;) directlyDecreases kinaseActivity(proteinAbundance(PFH:&quot;MEK1/2 Family&quot;))</div><div class='line' id='LC3390'>abundance(SCHEM:&quot;PD 98,059&quot;) causesNoChange kinaseActivity(proteinAbundance(HGNC:RAF1))</div><div class='line' id='LC3391'>abundance(SCHEM:&quot;PD 98,059&quot;) causesNoChange kinaseActivity(proteinAbundance(PFH:&quot;PRKC Family&quot;))</div><div class='line' id='LC3392'>abundance(SCHEM:&quot;PD 98,059&quot;) causesNoChange kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;))</div><div class='line' id='LC3393'>abundance(SCHEM:&quot;PD 98,059&quot;) causesNoChange kinaseActivity(proteinAbundance(PFH:&quot;SRC Family&quot;))</div><div class='line' id='LC3394'>abundance(SCHEM:&quot;PD 98,059&quot;) causesNoChange kinaseActivity(proteinAbundance(PFH:&quot;PDGFR Family&quot;))</div><div class='line' id='LC3395'>abundance(SCHEM:&quot;PD 98,059&quot;) causesNoChange kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC3396'><br/></div><div class='line' id='LC3397'>SET Evidence = &quot;insulin and IGF-I are novel thermogenic factors through the ability to increase UCP-1</div><div class='line' id='LC3398'>gene transcription rate and also UCP-1 mRNA accumulation [19,21].&quot;</div><div class='line' id='LC3399'><br/></div><div class='line' id='LC3400'>proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:UCP1)</div><div class='line' id='LC3401'>proteinAbundance(HGNC:IGF1) increases rnaAbundance(HGNC:UCP1)</div><div class='line' id='LC3402'><br/></div><div class='line' id='LC3403'>SET Evidence = &quot;Inhibition of PI 3-kinase with wortmannin or LY294002, completely blocked insulin/IGF-I</div><div class='line' id='LC3404'>induced transactivation of the UCP-1 promoter and UCP-1 mRNA accumulation</div><div class='line' id='LC3405'>[21,41].&quot;</div><div class='line' id='LC3406'><br/></div><div class='line' id='LC3407'>abundance(CHEBI:wortmannin) decreases (proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:UCP1))</div><div class='line' id='LC3408'>abundance(CHEBI:wortmannin) decreases (proteinAbundance(HGNC:IGF1) increases rnaAbundance(HGNC:UCP1))</div><div class='line' id='LC3409'>abundance(SCHEM:&quot;LY 294002&quot;) decreases (proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:UCP1))</div><div class='line' id='LC3410'>abundance(SCHEM:&quot;LY 294002&quot;) decreases (proteinAbundance(HGNC:IGF1) increases rnaAbundance(HGNC:UCP1))</div><div class='line' id='LC3411'><br/></div><div class='line' id='LC3412'>SET Evidence = &quot;transient transfection of primary brown adipocytes with a dominantnegative form of</div><div class='line' id='LC3413'>p21 Ras completely abolished insulininduced UCP-1-CAT transactivation [58].&quot;</div><div class='line' id='LC3414'><br/></div><div class='line' id='LC3415'>proteinAbundance(PFH:&quot;RAS Family&quot;) increases (proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:UCP1))</div><div class='line' id='LC3416'><br/></div><div class='line' id='LC3417'>SET Evidence = &quot;The first reported action of TNFa in brown adipocytes was the induction of insulin</div><div class='line' id='LC3418'>resistance [62].&quot;</div><div class='line' id='LC3419'><br/></div><div class='line' id='LC3420'>proteinAbundance(HGNC:TNF) increases pathology(MESHD:&quot;Insulin Resistance&quot;)</div><div class='line' id='LC3421'><br/></div><div class='line' id='LC3422'>SET Evidence = &quot;pretreatment of rat fetal brown adipocytes in primary culture with TNFα inhibited</div><div class='line' id='LC3423'>insulin-induced expression of several adipogenic differentiation mRNAs markers</div><div class='line' id='LC3424'>such as FAS and G3PD&quot;</div><div class='line' id='LC3425'>SET Species = &quot;10116&quot;</div><div class='line' id='LC3426'><br/></div><div class='line' id='LC3427'>proteinAbundance(RGD:Tnf) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases rnaAbundance(RGD:Fasn))</div><div class='line' id='LC3428'><br/></div><div class='line' id='LC3429'>SET Evidence = &quot;The antiadipogenic effect of TNFα was accompanied by a down-regulation of the mRNAs</div><div class='line' id='LC3430'>for the transcription factors C/EBPα and β.&quot;</div><div class='line' id='LC3431'><br/></div><div class='line' id='LC3432'>proteinAbundance(HGNC:TNF) decreases rnaAbundance(HGNC:CEBPA)</div><div class='line' id='LC3433'>proteinAbundance(HGNC:TNF) decreases rnaAbundance(HGNC:CEBPB)</div><div class='line' id='LC3434'><br/></div><div class='line' id='LC3435'>SET Evidence = &quot;TNFα caused an insulin resistance on the insulin-induced glucose uptake in brown adipocytes.&quot;</div><div class='line' id='LC3436'><br/></div><div class='line' id='LC3437'>proteinAbundance(HGNC:TNF) increases pathology(MESHD:&quot;Insulin Resistance&quot;)</div><div class='line' id='LC3438'><br/></div><div class='line' id='LC3439'>SET Evidence = &quot;TNFα on brown adipocytes seemed to be due to the hypophosphorylation of the insulin</div><div class='line' id='LC3440'>receptor in response to insulin as well as the hypophosphorylation of IRS-2,</div><div class='line' id='LC3441'>resulting in an impairment of IRS-2-associated PI 3-kinase activity [62].&quot;</div><div class='line' id='LC3442'><br/></div><div class='line' id='LC3443'>proteinAbundance(HGNC:TNF) decreases (proteinAbundance(HGNC:INS) increases proteinAbundance(HGNC:INSR,proteinModification(P)))</div><div class='line' id='LC3444'>proteinAbundance(HGNC:TNF) decreases (proteinAbundance(HGNC:INS) increases proteinAbundance(HGNC:IRS2,proteinModification(P)))</div><div class='line' id='LC3445'>proteinAbundance(HGNC:TNF) decreases (proteinAbundance(HGNC:INS) increases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)))</div><div class='line' id='LC3446'><br/></div><div class='line' id='LC3447'>SET Evidence = &quot;TNFα mediates the production of ceramide which triggers PKB/Akt dephosphorylation</div><div class='line' id='LC3448'>through the activation of a protein phosphatase [63].&quot;</div><div class='line' id='LC3449'><br/></div><div class='line' id='LC3450'>proteinAbundance(HGNC:TNF) increases abundance(CHEBI:ceramide)</div><div class='line' id='LC3451'>abundance(CHEBI:ceramide) decreases proteinAbundance(HGNC:AKT1,proteinModification(P))</div><div class='line' id='LC3452'><br/></div><div class='line' id='LC3453'>SET Cell = {&quot;Adipocytes, Brown&quot;,&quot;Adipocytes, Brown&quot;}</div><div class='line' id='LC3454'>SET TextLocation = {&quot;Review&quot;,&quot;Review&quot;}</div><div class='line' id='LC3455'>SET Evidence = &quot;TNFα is also a direct inhibitor of adipogenic genes and UCP-1 expression acting through</div><div class='line' id='LC3456'>mechanisms mediated by TNFα receptors, but unrelated with the induction of</div><div class='line' id='LC3457'>insulin resistance [64,65].&quot;</div><div class='line' id='LC3458'><br/></div><div class='line' id='LC3459'>proteinAbundance(HGNC:TNF) decreases proteinAbundance(HGNC:UCP1)</div><div class='line' id='LC3460'><br/></div><div class='line' id='LC3461'>SET Cell = &quot;Adipocytes, Brown&quot;</div><div class='line' id='LC3462'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC3463'>SET Evidence = &quot;IRS-1 has recently been described as an essential signaling molecule, acting through</div><div class='line' id='LC3464'>PI 3-kinase, in the  differentiation of brown adipocytes in vitro based on protocols</div><div class='line' id='LC3465'>developed in mouse fibroblasts [67] and in brown fat preadipocytes [56].&quot;</div><div class='line' id='LC3466'>SET Species = &quot;10090&quot;</div><div class='line' id='LC3467'><br/></div><div class='line' id='LC3468'>proteinAbundance(MGI:Irs1) increases biologicalProcess(GO:&quot;brown fat cell differentiation&quot;)</div><div class='line' id='LC3469'><br/></div><div class='line' id='LC3470'>SET Evidence = &quot;Moreover, the loss of insulin-induced PI 3- kinase activity in IRS-1-/- brown adipocytes</div><div class='line' id='LC3471'>was accompanied by a decrease in the phosphorylation of PKB/Akt, without</div><div class='line' id='LC3472'>changes in the phospho-70s6k content&quot;</div><div class='line' id='LC3473'><br/></div><div class='line' id='LC3474'>proteinAbundance(MGI:Irs1) increases (proteinAbundance(PFM:&quot;Ins Family&quot;) increases kinaseActivity(complexAbundance(NCM:&quot;p85/p110 PI3Kinase Complex&quot;)))</div><div class='line' id='LC3475'>proteinAbundance(MGI:Irs1) increases proteinAbundance(MGI:Akt1,proteinModification(P))</div><div class='line' id='LC3476'>proteinAbundance(MGI:Irs1) causesNoChange proteinAbundance(MGI:Rps6kb2,proteinModification(P))</div><div class='line' id='LC3477'><br/></div><div class='line' id='LC3478'>SET CellStructure = &quot;Cytoplasm&quot;</div><div class='line' id='LC3479'>SET Evidence = &quot;IRS-1 diminished the cytosolic lipid content in serum-starved homozygous and heterozygous</div><div class='line' id='LC3480'>IRS-1-deficient brown adipocytes, as compared to wild-type cells.&quot;</div><div class='line' id='LC3481'><br/></div><div class='line' id='LC3482'>proteinAbundance(MGI:Irs1) increases abundance(CHEBI:lipid)</div><div class='line' id='LC3483'><br/></div><div class='line' id='LC3484'>SET Evidence = &quot;Moreover, insulin induced a significant increase in FAS mRNA in wild-type cells, but</div><div class='line' id='LC3485'>not in IRS-1-/- cells.&quot;</div><div class='line' id='LC3486'><br/></div><div class='line' id='LC3487'>proteinAbundance(MGI:Irs1) increases (proteinAbundance(PFM:&quot;Ins Family&quot;) increases rnaAbundance(MGI:Fasn))</div><div class='line' id='LC3488'><br/></div><div class='line' id='LC3489'>SET Cell = {&quot;Adipocytes, Brown&quot;,&quot;Adipocytes, Brown&quot;}</div><div class='line' id='LC3490'>SET TextLocation = {&quot;Review&quot;,&quot;Review&quot;}</div><div class='line' id='LC3491'>SET Evidence = &quot;Insulin fails to induce UCP-1 expression and to transactivate the UCP-1 promoter in</div><div class='line' id='LC3492'>IRS-1-deficient fetal brown adipocytes due to the lack of IRS-1-associated/Akt</div><div class='line' id='LC3493'>signaling in response to insulin (Fig. 7).&quot;</div><div class='line' id='LC3494'><br/></div><div class='line' id='LC3495'>proteinAbundance(HGNC:IRS1) increases (proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:UCP1))</div><div class='line' id='LC3496'><br/></div><div class='line' id='LC3497'>SET Cell = &quot;Adipocytes, Brown&quot;</div><div class='line' id='LC3498'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC3499'>SET Evidence = &quot;IRS- 2 seems to be crucial in mediating insulin-induced glucose uptake since insulin-stimulated</div><div class='line' id='LC3500'>glucose uptake was impaired in immortalized brown adipocytes derived</div><div class='line' id='LC3501'>from IRS-2- deficient mice [76].&quot;</div><div class='line' id='LC3502'><br/></div><div class='line' id='LC3503'>proteinAbundance(MGI:Irs2) increases (proteinAbundance(PFM:&quot;Ins Family&quot;) increases biologicalProcess(GO:&quot;glucose import&quot;))</div><div class='line' id='LC3504'><br/></div><div class='line' id='LC3505'>SET Evidence = &quot;IRS-2-deficient brown adipocytes insulin-induced effect on GLUT4 translocation to</div><div class='line' id='LC3506'>the plasma membrane was impaired [76].&quot;</div><div class='line' id='LC3507'><br/></div><div class='line' id='LC3508'>proteinAbundance(HGNC:IRS2) increases (proteinAbundance(HGNC:INS) increases translocation(proteinAbundance(HGNC:SLC2A4),MESHCL:&quot;Intracellular Space&quot;,MESHCL:&quot;Cell Membrane&quot;))</div><div class='line' id='LC3509'><br/></div><div class='line' id='LC3510'>SET Evidence = &quot;PI 3- kinase/PKCξ, but not PI 3-kinase/Akt signaling pathway, is inhibited in IRS-2-deficient</div><div class='line' id='LC3511'>brown adipocytes upon insulin stimulation&quot;</div><div class='line' id='LC3512'><br/></div><div class='line' id='LC3513'>proteinAbundance(HGNC:IRS2) increases kinaseActivity(proteinAbundance(HGNC:PRKCZ))</div><div class='line' id='LC3514'>proteinAbundance(HGNC:IRS2) causesNoChange kinaseActivity(proteinAbundance(HGNC:AKT1))</div><div class='line' id='LC3515'><br/></div><div class='line' id='LC3516'>SET Evidence = &quot;wild-type cells expressing a kinase inactive (KI) mutant of PKCξ lack insulin responsiveness</div><div class='line' id='LC3517'>in induce GLUT4 translocation and glucose uptake [78].&quot;</div><div class='line' id='LC3518'><br/></div><div class='line' id='LC3519'>kinaseActivity(proteinAbundance(HGNC:PRKCZ)) increases translocation(proteinAbundance(HGNC:SLC2A4),MESHCL:&quot;Intracellular Space&quot;,MESHCL:&quot;Cell Membrane&quot;)</div><div class='line' id='LC3520'>kinaseActivity(proteinAbundance(HGNC:PRKCZ)) increases biologicalProcess(GO:&quot;glucose import&quot;)</div><div class='line' id='LC3521'><br/></div><div class='line' id='LC3522'>SET Evidence = &quot;TZD induce their diverse effects by binding to and activating the peroxisome proliferator-</div><div class='line' id='LC3523'>activated receptor (PPAR)γ [79].&quot;</div><div class='line' id='LC3524'><br/></div><div class='line' id='LC3525'>abundance(SCHEM:Thiazolidinedione) directlyIncreases transcriptionalActivity(proteinAbundance(HGNC:PPARG))</div><div class='line' id='LC3526'><br/></div><div class='line' id='LC3527'>SET Cell = &quot;Adipocytes&quot;</div><div class='line' id='LC3528'>SET Evidence = &quot;increased GLUT4 expression has been reported in adipocytes treated with TZD [82].&quot;</div><div class='line' id='LC3529'><br/></div><div class='line' id='LC3530'>abundance(SCHEM:Thiazolidinedione) increases proteinAbundance(HGNC:SLC2A4)</div><div class='line' id='LC3531'><br/></div><div class='line' id='LC3532'>SET Cell = &quot;Adipocytes, Brown&quot;</div><div class='line' id='LC3533'>SET Evidence = &quot;In brown adipocytes, TZD increase UCP-1 expression [83,84].&quot;</div><div class='line' id='LC3534'><br/></div><div class='line' id='LC3535'>abundance(SCHEM:Thiazolidinedione) increases proteinAbundance(HGNC:UCP1)</div><div class='line' id='LC3536'><br/></div><div class='line' id='LC3537'>SET CellLine = &quot;3T3-L1&quot;</div><div class='line' id='LC3538'>SET Evidence = &quot;IRS-2 protein expression increased after TZD treatment in murine 3T3-L1 and human</div><div class='line' id='LC3539'>adipocytes [85].&quot;</div><div class='line' id='LC3540'><br/></div><div class='line' id='LC3541'>abundance(SCHEM:Thiazolidinedione) increases proteinAbundance(MGI:Irs2)</div><div class='line' id='LC3542'><br/></div><div class='line' id='LC3543'>SET Cell = &quot;Adipocytes&quot;</div><div class='line' id='LC3544'>SET Species = &quot;9606&quot;</div><div class='line' id='LC3545'><br/></div><div class='line' id='LC3546'>abundance(SCHEM:Thiazolidinedione) increases proteinAbundance(HGNC:IRS2)</div><div class='line' id='LC3547'><br/></div><div class='line' id='LC3548'>SET Cell = {&quot;Adipocytes, Brown&quot;,&quot;Adipocytes, White&quot;}</div><div class='line' id='LC3549'>SET Evidence = &quot;Previous work reported by Angel et al. [94] demonstrated that GLUT4 mRNA and protein</div><div class='line' id='LC3550'>levels are decreased in WAT and BAT of Type 2 diabetic rats.&quot;</div><div class='line' id='LC3551'>SET Species = &quot;10116&quot;</div><div class='line' id='LC3552'><br/></div><div class='line' id='LC3553'>proteinAbundance(RGD:Slc2a4) negativeCorrelation pathology(MESHD:&quot;Diabetes Mellitus, Type 2&quot;)</div><div class='line' id='LC3554'><br/></div><div class='line' id='LC3555'>UNSET STATEMENT_GROUP</div><div class='line' id='LC3556'><br/></div><div class='line' id='LC3557'>SET STATEMENT_GROUP = &quot;Group 24&quot;</div><div class='line' id='LC3558'><br/></div><div class='line' id='LC3559'>SET CellLine = &quot;MCF 10A&quot;</div><div class='line' id='LC3560'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC3561'>SET Evidence = &quot;USF1 and USF2 bound the IGF2R promoter in vitro, and both USF1 and USF2, but not c-Myc,</div><div class='line' id='LC3562'>were present within the IGF2R promoter-associated chromatin in vivo. Overexpressed</div><div class='line' id='LC3563'>USF2, but not USF1, transactivated the IGF2R promoter, and IGF2R mRNA</div><div class='line' id='LC3564'>was markedly decreased by expression of a USF-specific dominant negative mutant,</div><div class='line' id='LC3565'>identifying IGF2R as a USF2 target.&quot;</div><div class='line' id='LC3566'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;12857727&quot;,&quot;2003-08-11&quot;,&quot;Szentirmay MN|Yang HX|Pawar SA|Vinson C|Sawadogo M&quot;,&quot;&quot;}</div><div class='line' id='LC3567'><br/></div><div class='line' id='LC3568'>complexAbundance(proteinAbundance(HGNC:USF1),geneAbundance(HGNC:IGF2R))</div><div class='line' id='LC3569'>complexAbundance(proteinAbundance(HGNC:USF2),geneAbundance(HGNC:IGF2R))</div><div class='line' id='LC3570'>transcriptionalActivity(proteinAbundance(HGNC:USF2)) directlyIncreases rnaAbundance(HGNC:IGF2R)</div><div class='line' id='LC3571'>transcriptionalActivity(proteinAbundance(HGNC:USF1)) causesNoChange rnaAbundance(HGNC:IGF2R)</div><div class='line' id='LC3572'><br/></div><div class='line' id='LC3573'>SET Evidence = &quot;c-Myc was present on the CDK4 promoter to the small extent expected in nontumorigenic</div><div class='line' id='LC3574'>cells (8). ChIP with c-Myc antibodies was repeated in the MCF-7 breast cancer</div><div class='line' id='LC3575'>cell line, where c-Myc is more abundant (8), to rule out a problem of detection</div><div class='line' id='LC3576'>sensitivity. This analysis clearly demonstrated the presence of c-Myc at the</div><div class='line' id='LC3577'>CDK4 promoter.&quot;</div><div class='line' id='LC3578'><br/></div><div class='line' id='LC3579'>complexAbundance(proteinAbundance(HGNC:MYC),geneAbundance(HGNC:CDK4))</div><div class='line' id='LC3580'><br/></div><div class='line' id='LC3581'>UNSET STATEMENT_GROUP</div><div class='line' id='LC3582'><br/></div><div class='line' id='LC3583'>SET STATEMENT_GROUP = &quot;Group 25&quot;</div><div class='line' id='LC3584'><br/></div><div class='line' id='LC3585'>SET Cell = &quot;Keratinocytes&quot;</div><div class='line' id='LC3586'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC3587'>SET Evidence = &quot;The epidermis develops depending on the transcription factor p63, a member of the</div><div class='line' id='LC3588'>p53 family of transcription factors.&quot;</div><div class='line' id='LC3589'>SET Citation = {&quot;PubMed&quot;,&quot;Cell death and differentiation&quot;,&quot;18483491&quot;,&quot;2008-06-16&quot;,&quot;Lena AM|Shalom-Feuerstein R|Rivetti di Val Cervo P|Aberdam D|Knight RA|Melino G|Candi E&quot;,&quot;&quot;}</div><div class='line' id='LC3590'><br/></div><div class='line' id='LC3591'>transcriptionalActivity(proteinAbundance(HGNC:TP63)) increases biologicalProcess(GO:&quot;epidermis development&quot;)</div><div class='line' id='LC3592'><br/></div><div class='line' id='LC3593'>SET Cell = {&quot;Keratinocytes&quot;,&quot;Cells, Cultured&quot;}</div><div class='line' id='LC3594'>SET Evidence = &quot;Here we report that microRNA (miR)-203 is induced in vitro in primary keratinocytes</div><div class='line' id='LC3595'>in parallel with differentiation. We found that miR-203 specifically targets</div><div class='line' id='LC3596'>human and mouse p63 3&#39;-UTRs and not SOCS-3, despite bioinformatics alignment between</div><div class='line' id='LC3597'>miR-203 and SOCS-3 3&#39;-UTR.&quot;</div><div class='line' id='LC3598'>SET Species = &quot;9606&quot;</div><div class='line' id='LC3599'><br/></div><div class='line' id='LC3600'>microRNAAbundance(HGNC:MIR203) positiveCorrelation biologicalProcess(GO:&quot;keratinocyte differentiation&quot;)</div><div class='line' id='LC3601'><br/></div><div class='line' id='LC3602'>SET Species = &quot;10090&quot;</div><div class='line' id='LC3603'><br/></div><div class='line' id='LC3604'>microRNAAbundance(MGI:Mir203) positiveCorrelation biologicalProcess(GO:&quot;keratinocyte differentiation&quot;)</div><div class='line' id='LC3605'>microRNAAbundance(MGI:Mir203) directlyDecreases rnaAbundance(MGI:Trp63)</div><div class='line' id='LC3606'><br/></div><div class='line' id='LC3607'>SET Cell = &quot;Keratinocytes&quot;</div><div class='line' id='LC3608'>SET Evidence = &quot;In addition, we demonstrate that miR-203 is downregulated during the epithelial commitment</div><div class='line' id='LC3609'>of embryonic stem cells, and that overexpression of miR-203 in rapidly</div><div class='line' id='LC3610'>proliferating human primary keratinocytes significantly reduces their clonogenic</div><div class='line' id='LC3611'>capacity. The results suggest that miR-203, by regulating the ΔNp63 expression</div><div class='line' id='LC3612'>level, is a key molecule controlling the p63-dependent proliferative potential</div><div class='line' id='LC3613'>of epithelial precursor cells both during keratinocyte differentiation and in epithelial</div><div class='line' id='LC3614'>development.&quot;</div><div class='line' id='LC3615'><br/></div><div class='line' id='LC3616'>microRNAAbundance(MGI:Mir203) decreases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC3617'>microRNAAbundance(MGI:Mir203) decreases (proteinAbundance(MGI:Trp63) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC3618'><br/></div><div class='line' id='LC3619'>SET Evidence = &quot;As shown in Figure 1a and b, miR-203 was rapidly upregulated (about 12-fold in mouse</div><div class='line' id='LC3620'>keratinocytes upon 24 h calcium treatment) when cells where induced by calcium</div><div class='line' id='LC3621'>to differentiate in vitro. Concurrently, with miR-203 upregulation, we observed</div><div class='line' id='LC3622'>DNp63 downregulation in differentiating cells (Figure 1a and b).&quot;</div><div class='line' id='LC3623'><br/></div><div class='line' id='LC3624'>microRNAAbundance(MGI:Mir203) positiveCorrelation biologicalProcess(GO:&quot;keratinocyte differentiation&quot;)</div><div class='line' id='LC3625'>proteinAbundance(MGI:Trp63) negativeCorrelation biologicalProcess(GO:&quot;keratinocyte differentiation&quot;)</div><div class='line' id='LC3626'><br/></div><div class='line' id='LC3627'>SET Evidence = &quot;To further evaluate directly if SOCS-3 is indeed a genuine target of miR-203, we exogenously</div><div class='line' id='LC3628'>expressed miR-203 in mouse keratinocytes by infection with adenovirus</div><div class='line' id='LC3629'>containing miR-203. Figure 1c (lanes 4–6) shows a slight upregulation of SOCS-3</div><div class='line' id='LC3630'>as compared with keratinocytes infected with adenovirus containing scrambled sequence</div><div class='line' id='LC3631'>(lanes 1–3). These data indicate that SOSC-3 is not repressed by miR- 203;</div><div class='line' id='LC3632'>conversely its upregulation is presumably independent of miR-203.&quot;</div><div class='line' id='LC3633'><br/></div><div class='line' id='LC3634'>microRNAAbundance(MGI:Mir203) causesNoChange proteinAbundance(MGI:Socs3)</div><div class='line' id='LC3635'><br/></div><div class='line' id='LC3636'>SET Evidence = &quot;As control, Figure 2d also shows p63 mRNA levels in keratinocytes induced to differentiate</div><div class='line' id='LC3637'>by calcium treatment. p63 protein expression was also markedly diminished</div><div class='line' id='LC3638'>in mouse keratinocytes infected with adenovirus containing miR-203 (Figure 2e,</div><div class='line' id='LC3639'>lanes 3–4) compared with mouse keratinocytes infected with adenovirus containing</div><div class='line' id='LC3640'>a scrambled sequence (lanes 1–2). Together, these results indicate that effect</div><div class='line' id='LC3641'>of miR-203 on p63 is direct and is mediated by a specific 30-UTR target site.&quot;</div><div class='line' id='LC3642'><br/></div><div class='line' id='LC3643'>microRNAAbundance(MGI:Mir203) directlyDecreases rnaAbundance(MGI:Trp63)</div><div class='line' id='LC3644'><br/></div><div class='line' id='LC3645'>SET Evidence = &quot;Indeed, we have previously shown that the ubiquitin E3 ligase, Itch, contributes to</div><div class='line' id='LC3646'>the reduction in DNp63 protein levels.21&quot;</div><div class='line' id='LC3647'><br/></div><div class='line' id='LC3648'>catalyticActivity(proteinAbundance(MGI:Itch)) directlyIncreases degradation(proteinAbundance(MGI:Trp63))</div><div class='line' id='LC3649'><br/></div><div class='line' id='LC3650'>SET Evidence = &quot;As expected, pre-miR-transfected cells showed reduced cell growth when compared to</div><div class='line' id='LC3651'>cells transfected with scrambled oligonucleotides. In contrast, overexpression</div><div class='line' id='LC3652'>of antagomiR- 203 resulted in an increase in cell growth (Figure 4).&quot;</div><div class='line' id='LC3653'><br/></div><div class='line' id='LC3654'>microRNAAbundance(MGI:Mir203) decreases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC3655'><br/></div><div class='line' id='LC3656'>SET Evidence = &quot;This suggests that overexpression of miR-203 triggers cells toward differentiation</div><div class='line' id='LC3657'>by interfering with the proliferative potential of proliferating keratinocytes</div><div class='line' id='LC3658'>through ΔNp63 downregulation. This result is consistent with a requirement for</div><div class='line' id='LC3659'>ΔNp63 in maintaining proliferative potential of epidermal stem cells.&quot;</div><div class='line' id='LC3660'><br/></div><div class='line' id='LC3661'>proteinAbundance(MGI:Trp63) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC3662'><br/></div><div class='line' id='LC3663'>SET Cell = &quot;Embryonic Stem Cells&quot;</div><div class='line' id='LC3664'>SET Evidence = &quot;Embryonic stem cells can recapitulate in vitro the main steps of embryonic epidermal</div><div class='line' id='LC3665'>differentiation upon exogenous addition of bone morphogenic protein (BMP)-4.&quot;</div><div class='line' id='LC3666'><br/></div><div class='line' id='LC3667'>proteinAbundance(MGI:Bmp4) increases biologicalProcess(GO:&quot;epidermal cell differentiation&quot;)</div><div class='line' id='LC3668'><br/></div><div class='line' id='LC3669'>SET Evidence = &quot;Soon after BMP-4 treatment, the ΔNp63 gene is activated and remains strongly expressed</div><div class='line' id='LC3670'>until the cells undergo terminal epidermal differentiation.28 Using these</div><div class='line' id='LC3671'>experimental conditions, and concomitant with DNp63 mRNA upregulation, we observed</div><div class='line' id='LC3672'>that miR-203 expression is downregulated (Figure 5c).&quot;</div><div class='line' id='LC3673'><br/></div><div class='line' id='LC3674'>proteinAbundance(MGI:Bmp4) increases rnaAbundance(MGI:Trp63)</div><div class='line' id='LC3675'>proteinAbundance(MGI:Bmp4) decreases rnaAbundance(MGI:Mir203)</div><div class='line' id='LC3676'><br/></div><div class='line' id='LC3677'>SET Disease = {&quot;Head and Neck Neoplasms&quot;,&quot;Carcinoma, Squamous Cell&quot;}</div><div class='line' id='LC3678'>SET Evidence = &quot;Besides the epidermis and other stratified squamous epithelia, ΔNp63 is commonly overexpressed</div><div class='line' id='LC3679'>in up to 80% of primary head and neck squamous cell carcinomas (HNSCCs).29&quot;</div><div class='line' id='LC3680'>SET Species = &quot;9606&quot;</div><div class='line' id='LC3681'><br/></div><div class='line' id='LC3682'>proteinAbundance(HGNC:TP63) positiveCorrelation pathology(MESHD:&quot;Carcinoma, Squamous Cell&quot;)</div><div class='line' id='LC3683'>proteinAbundance(HGNC:TP63) positiveCorrelation pathology(MESHD:&quot;Head and Neck Neoplasms&quot;)</div><div class='line' id='LC3684'><br/></div><div class='line' id='LC3685'>SET Evidence = &quot;Recently, it has been shown that ΔNp63a is also overexpressed in HNSCC cell lines</div><div class='line' id='LC3686'>(including JHU-012) and in these cells, it acts as a crucial survival factor by</div><div class='line' id='LC3687'>suppressing p73-dependent apoptosis.29,32–34 Knockdown of ΔNp63 induces the proapoptotic</div><div class='line' id='LC3688'>bcl-2-family members Puma and Noxa, and both their induction and cell</div><div class='line' id='LC3689'>death are p53-independent, but require transactivating isoforms of p73. The inhibition</div><div class='line' id='LC3690'>of p73-dependent transcription by DNp63a involves both direct promoter binding</div><div class='line' id='LC3691'>and physical sequestration of p73 by protein–protein interaction.29,34–35&quot;</div><div class='line' id='LC3692'><br/></div><div class='line' id='LC3693'>proteinAbundance(HGNC:TP63) decreases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC3694'>proteinAbundance(HGNC:TP63) decreases (proteinAbundance(HGNC:TP73) increases biologicalProcess(GO:&quot;apoptotic process&quot;))</div><div class='line' id='LC3695'>proteinAbundance(HGNC:TP63) decreases proteinAbundance(HGNC:BBC3)</div><div class='line' id='LC3696'>proteinAbundance(HGNC:TP63) decreases proteinAbundance(HGNC:PMAIP1)</div><div class='line' id='LC3697'>transcriptionalActivity(proteinAbundance(HGNC:TP73)) increases proteinAbundance(HGNC:BBC3)</div><div class='line' id='LC3698'>transcriptionalActivity(proteinAbundance(HGNC:TP73)) increases proteinAbundance(HGNC:PMAIP1)</div><div class='line' id='LC3699'>proteinAbundance(HGNC:TP63) directlyDecreases transcriptionalActivity(proteinAbundance(HGNC:TP73))</div><div class='line' id='LC3700'><br/></div><div class='line' id='LC3701'>SET Cell = &quot;Cell Line, Tumor&quot;</div><div class='line' id='LC3702'>SET Evidence = &quot;As shown in Figure 6a, ΔNp63 expression was already decreased in JHU-012 cells 12</div><div class='line' id='LC3703'>h after UVC treatment. Simultaneously, with DNp63 downregulation, miR-203 was significantly</div><div class='line' id='LC3704'>upregulated as evaluated by real-time PCR (Figure 6b).&quot;</div><div class='line' id='LC3705'><br/></div><div class='line' id='LC3706'>biologicalProcess(GO:&quot;response to UV-C&quot;) decreases proteinAbundance(HGNC:TP63)</div><div class='line' id='LC3707'>biologicalProcess(GO:&quot;response to UV-C&quot;) increases rnaAbundance(HGNC:MIR203)</div><div class='line' id='LC3708'><br/></div><div class='line' id='LC3709'>SET Evidence = &quot;To verify that the observed effect on apoptosis and cell cycle is, at least in part,</div><div class='line' id='LC3710'>mediated by miR-203, we infected JHU-012 cells with adenoviruses containing</div><div class='line' id='LC3711'>miR-203 or scrambled sequence. ΔNp63 protein expression was markedly diminished</div><div class='line' id='LC3712'>(about 50%) in JHU-012 cells infected with adenovirus containing miR-203 as compared</div><div class='line' id='LC3713'>with cells infected with adenovirus containing scrambled sequence (Figure 7a).</div><div class='line' id='LC3714'>In addition, we observed a significant increase of cell death (from 5 to 17%,</div><div class='line' id='LC3715'>Figure 7b), an increased number of cells in G1 and a reduction in the proportion</div><div class='line' id='LC3716'>of cells in G2 (Figure 7c).&quot;</div><div class='line' id='LC3717'><br/></div><div class='line' id='LC3718'>microRNAAbundance(HGNC:MIR203) decreases proteinAbundance(HGNC:TP63)</div><div class='line' id='LC3719'>microRNAAbundance(HGNC:MIR203) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC3720'><br/></div><div class='line' id='LC3721'>UNSET STATEMENT_GROUP</div><div class='line' id='LC3722'><br/></div><div class='line' id='LC3723'>SET STATEMENT_GROUP = &quot;Group 26&quot;</div><div class='line' id='LC3724'><br/></div><div class='line' id='LC3725'>SET Disease = &quot;Neoplasms&quot;</div><div class='line' id='LC3726'>SET CardiovascularSystem = &quot;Blood Vessels&quot;</div><div class='line' id='LC3727'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC3728'>SET Evidence = &quot;intravital microscopy failed to demonstrate that targeting of VEGFR-2 (by the tyrosine</div><div class='line' id='LC3729'>kinase inhibitor SU5416) induces significant regression of experimental tumor</div><div class='line' id='LC3730'>blood vessels.&quot;</div><div class='line' id='LC3731'>SET Citation = {&quot;PubMed&quot;,&quot;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&quot;,&quot;14657001&quot;,&quot;2004-01-04&quot;,&quot;Erber R|Thurnher A|Katsen AD|Groth G|Kerger H|Hammes HP|Menger MD|Ullrich A|Vajkoczy P&quot;,&quot;&quot;}</div><div class='line' id='LC3732'>SET Species = &quot;10090&quot;</div><div class='line' id='LC3733'><br/></div><div class='line' id='LC3734'>abundance(SCHEM:&quot;SU 5416&quot;) directlyDecreases kinaseActivity(proteinAbundance(MGI:Kdr))</div><div class='line' id='LC3735'><br/></div><div class='line' id='LC3736'>SET Cell = &quot;Pericytes&quot;</div><div class='line' id='LC3737'>SET Evidence = &quot;this resistance of tumor blood vessels to VEGFR-2 targeting is conferred by pericytes</div><div class='line' id='LC3738'>that stabilize blood vessels and provide endothelial cell survival signals</div><div class='line' id='LC3739'>via the Ang-1/Tie2 pathway.&quot;</div><div class='line' id='LC3740'><br/></div><div class='line' id='LC3741'>proteinAbundance(MGI:Angpt1) directlyIncreases kinaseActivity(proteinAbundance(MGI:Tek))</div><div class='line' id='LC3742'>kinaseActivity(proteinAbundance(MGI:Tek)) increases biologicalProcess(GO:&quot;blood vessel development&quot;)</div><div class='line' id='LC3743'><br/></div><div class='line' id='LC3744'>SET Evidence = &quot;targeting VEGFR-2 plus the platelet- derived growth factor receptor (PDGFR)-β system</div><div class='line' id='LC3745'>(PDGFR- β) signaling (by SU6668) rapidly forced 40% of tumor blood vessels into</div><div class='line' id='LC3746'>regression, rendering these tumors hypoxic as shown by phosphorescence quenching.&quot;</div><div class='line' id='LC3747'><br/></div><div class='line' id='LC3748'>abundance(SCHEM:&quot;SU 6668&quot;) directlyDecreases kinaseActivity(proteinAbundance(MGI:Pdgfrb))</div><div class='line' id='LC3749'>compositeAbundance(abundance(SCHEM:&quot;SU 5416&quot;),abundance(SCHEM:&quot;SU 6668&quot;)) increases biologicalProcess(MESHPP:&quot;Cell Hypoxia&quot;)</div><div class='line' id='LC3750'>compositeAbundance(abundance(SCHEM:&quot;SU 5416&quot;),abundance(SCHEM:&quot;SU 6668&quot;)) increases biologicalProcess(GO:&quot;blood vessel development&quot;)</div><div class='line' id='LC3751'><br/></div><div class='line' id='LC3752'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC3753'>SET Evidence = &quot;VEGFR-2 plus PDGFR-β targeting enforced tumor blood vessel regression by inducing</div><div class='line' id='LC3754'>endothelial cell apoptosis.&quot;</div><div class='line' id='LC3755'><br/></div><div class='line' id='LC3756'>compositeAbundance(abundance(SCHEM:&quot;SU 5416&quot;),abundance(SCHEM:&quot;SU 6668&quot;)) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC3757'><br/></div><div class='line' id='LC3758'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC3759'>SET Evidence = &quot;Whereas expression of the VEGF and FGF systems remained largely unchanged, expression</div><div class='line' id='LC3760'>of PDGFR-β and Tie2 were nearly doubled and expression of Ang-1 was increased</div><div class='line' id='LC3761'>by nine fold in SU5416- treated tumors (Fig. 3A-C).&quot;</div><div class='line' id='LC3762'><br/></div><div class='line' id='LC3763'>abundance(SCHEM:&quot;SU 5416&quot;) increases rnaAbundance(MGI:Pdgfrb)</div><div class='line' id='LC3764'>abundance(SCHEM:&quot;SU 5416&quot;) increases rnaAbundance(MGI:Tek)</div><div class='line' id='LC3765'>abundance(SCHEM:&quot;SU 5416&quot;) increases rnaAbundance(MGI:Angpt1)</div><div class='line' id='LC3766'><br/></div><div class='line' id='LC3767'>SET Cell = &quot;Pericytes&quot;</div><div class='line' id='LC3768'>SET Evidence = &quot;the increased expression of PDGFR- β and Tie2 was clearly attributable to pericytes</div><div class='line' id='LC3769'>and endothelial cells (i.e., cells of mouse origin), respectively.&quot;</div><div class='line' id='LC3770'><br/></div><div class='line' id='LC3771'>abundance(SCHEM:&quot;SU 5416&quot;) increases rnaAbundance(MGI:Pdgfrb)</div><div class='line' id='LC3772'><br/></div><div class='line' id='LC3773'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC3774'><br/></div><div class='line' id='LC3775'>abundance(SCHEM:&quot;SU 5416&quot;) increases rnaAbundance(MGI:Tek)</div><div class='line' id='LC3776'><br/></div><div class='line' id='LC3777'>SET IntegumentarySystem = &quot;Skin&quot;</div><div class='line' id='LC3778'>SET Evidence = &quot;However, by none of these means we could detect significant Ang-1 mRNA levels in normal</div><div class='line' id='LC3779'>skin, neither in control nor in treated tissue.&quot;</div><div class='line' id='LC3780'><br/></div><div class='line' id='LC3781'>abundance(SCHEM:&quot;SU 5416&quot;) causesNoChange rnaAbundance(MGI:Angpt1)</div><div class='line' id='LC3782'><br/></div><div class='line' id='LC3783'>SET Disease = &quot;Hyperplasia&quot;</div><div class='line' id='LC3784'>SET Evidence = &quot;tumor blood vessels in SU6668-treated tumors presented with endothelial hyperplasia</div><div class='line' id='LC3785'>and an increased number of luminal folds (Fig. 5C and D; compare with Fig. 2D).&quot;</div><div class='line' id='LC3786'><br/></div><div class='line' id='LC3787'>abundance(SCHEM:&quot;SU 6668&quot;) increases pathology(MESHD:Hyperplasia)</div><div class='line' id='LC3788'><br/></div><div class='line' id='LC3789'>UNSET STATEMENT_GROUP</div><div class='line' id='LC3790'><br/></div><div class='line' id='LC3791'>SET STATEMENT_GROUP = &quot;Group 27&quot;</div><div class='line' id='LC3792'><br/></div><div class='line' id='LC3793'>SET CardiovascularSystem = &quot;Carotid Arteries&quot;</div><div class='line' id='LC3794'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC3795'>SET Evidence = &quot;In situ hybridization of injured and control carotid arteries also revealed marked</div><div class='line' id='LC3796'>downregulation of miR-143 and miR-145 expression in the thickened vascular wall,</div><div class='line' id='LC3797'>coincident with decreased expression of the differentiation marker, smooth muscle</div><div class='line' id='LC3798'>α-actin (Sm- α actin) (Supplementary Fig. 4a).&quot;</div><div class='line' id='LC3799'>SET Citation = {&quot;PubMed&quot;,&quot;Nature&quot;,&quot;19578358&quot;,&quot;2009-08-05&quot;,&quot;Cordes KR|Sheehy NT|White MP|Berry EC|Morton SU|Muth AN|Lee TH|Miano JM|Ivey KN|Srivastava D&quot;,&quot;&quot;}</div><div class='line' id='LC3800'>SET Species = &quot;10090&quot;</div><div class='line' id='LC3801'><br/></div><div class='line' id='LC3802'>pathology(SDIS:&quot;tissue damage&quot;) decreases microRNAAbundance(MGI:Mir143)</div><div class='line' id='LC3803'>pathology(SDIS:&quot;tissue damage&quot;) decreases microRNAAbundance(MGI:Mir145)</div><div class='line' id='LC3804'>microRNAAbundance(MGI:Mir143) positiveCorrelation rnaAbundance(MGI:Acta2)</div><div class='line' id='LC3805'>microRNAAbundance(MGI:Mir145) positiveCorrelation rnaAbundance(MGI:Acta2)</div><div class='line' id='LC3806'><br/></div><div class='line' id='LC3807'>SET CardiovascularSystem = &quot;Heart&quot;</div><div class='line' id='LC3808'>SET Evidence = &quot;miR-143 and miR-145 expression was also decreased in hearts of Nkx2.5 mutant mouse</div><div class='line' id='LC3809'>embryos in a dose-dependent fashion (Fig. 2h).&quot;</div><div class='line' id='LC3810'><br/></div><div class='line' id='LC3811'>proteinAbundance(MGI:&quot;Nkx2-5&quot;) increases microRNAAbundance(MGI:Mir143)</div><div class='line' id='LC3812'>proteinAbundance(MGI:&quot;Nkx2-5&quot;) increases rnaAbundance(MGI:Mir145)</div><div class='line' id='LC3813'><br/></div><div class='line' id='LC3814'>SET CardiovascularSystem = &quot;Carotid Arteries&quot;</div><div class='line' id='LC3815'>SET Evidence = &quot;lentiviral-mediated introduction of miR-145 into ligated mouse carotid arteries in</div><div class='line' id='LC3816'>vivo increased expression of markers of VSMC differentiation (e.g., Calponin and</div><div class='line' id='LC3817'>Sm-α-actin), as well as Myocd, compared to control-infected injured carotid arteries</div><div class='line' id='LC3818'>(Supplementary Fig. 7).&quot;</div><div class='line' id='LC3819'><br/></div><div class='line' id='LC3820'>microRNAAbundance(MGI:Mir145) increases proteinAbundance(MGI:Cnn1)</div><div class='line' id='LC3821'>rnaAbundance(MGI:Mir145) increases proteinAbundance(MGI:Acta2)</div><div class='line' id='LC3822'>rnaAbundance(MGI:Mir145) increases proteinAbundance(MGI:Myocd)</div><div class='line' id='LC3823'><br/></div><div class='line' id='LC3824'>SET Cell = &quot;Embryoid Bodies&quot;</div><div class='line' id='LC3825'>SET Evidence = &quot;miR-143 and miR-145 were each expressed at lower levels in SRF-null embryoid bodies</div><div class='line' id='LC3826'>(EBs) compared to wildtype EBs derived from the respective ES cells (Fig. 2g)&quot;</div><div class='line' id='LC3827'><br/></div><div class='line' id='LC3828'>proteinAbundance(MGI:Srf) increases microRNAAbundance(MGI:Mir143)</div><div class='line' id='LC3829'>proteinAbundance(MGI:Srf) increases rnaAbundance(MGI:Mir145)</div><div class='line' id='LC3830'><br/></div><div class='line' id='LC3831'>SET Cell = &quot;COS Cells&quot;</div><div class='line' id='LC3832'>SET Evidence = &quot;Nkx2.5 could also independently activate this enhancer (miR-143/145 enhancer), and</div><div class='line' id='LC3833'>the combination of SRF, Myocd, and Nkx2.5, which also interacts with SRF26, had</div><div class='line' id='LC3834'>additive effects on luciferase activity. Mutation of each binding site progressively</div><div class='line' id='LC3835'>decreased luciferase activity (Fig. 2f).&quot;</div><div class='line' id='LC3836'>SET Species = &quot;9606&quot;</div><div class='line' id='LC3837'><br/></div><div class='line' id='LC3838'>transcriptionalActivity(proteinAbundance(HGNC:&quot;NKX2-5&quot;)) directlyIncreases microRNAAbundance(HGNC:MIR145)</div><div class='line' id='LC3839'>transcriptionalActivity(proteinAbundance(HGNC:SRF)) directlyIncreases microRNAAbundance(HGNC:MIR145)</div><div class='line' id='LC3840'>transcriptionalActivity(proteinAbundance(HGNC:MYOCD)) directlyIncreases microRNAAbundance(HGNC:MIR145)</div><div class='line' id='LC3841'>transcriptionalActivity(proteinAbundance(HGNC:&quot;NKX2-5&quot;)) directlyIncreases microRNAAbundance(HGNC:MIR143)</div><div class='line' id='LC3842'>transcriptionalActivity(proteinAbundance(HGNC:SRF)) directlyIncreases microRNAAbundance(HGNC:MIR143)</div><div class='line' id='LC3843'>transcriptionalActivity(proteinAbundance(HGNC:MYOCD)) directlyIncreases microRNAAbundance(HGNC:MIR143)</div><div class='line' id='LC3844'>compositeAbundance(proteinAbundance(HGNC:&quot;NKX2-5&quot;),proteinAbundance(HGNC:SRF),proteinAbundance(HGNC:MYOCD)) directlyIncreases microRNAAbundance(HGNC:MIR145)</div><div class='line' id='LC3845'>compositeAbundance(proteinAbundance(HGNC:&quot;NKX2-5&quot;),proteinAbundance(HGNC:SRF),proteinAbundance(HGNC:MYOCD)) directlyIncreases microRNAAbundance(HGNC:MIR143)</div><div class='line' id='LC3846'><br/></div><div class='line' id='LC3847'>SET CardiovascularSystem = &quot;Muscle, Smooth, Vascular&quot;</div><div class='line' id='LC3848'>SET Evidence = &quot;These findings suggest that miR-145 may promote VSMC differentiation by directly repressing</div><div class='line' id='LC3849'>numerous transcription factors that promote the proliferative state while</div><div class='line' id='LC3850'>stabilizing factors that promote the differentiated state of VSMCs (Fig. 5).&quot;</div><div class='line' id='LC3851'>SET Species = &quot;10090&quot;</div><div class='line' id='LC3852'><br/></div><div class='line' id='LC3853'>microRNAAbundance(MGI:Mir145) increases biologicalProcess(GO:&quot;cardiac vascular smooth muscle cell differentiation&quot;)</div><div class='line' id='LC3854'><br/></div><div class='line' id='LC3855'>SET Evidence = &quot;introduction of miR-145, but not miR-143, with the luciferase vector in Cos cells</div><div class='line' id='LC3856'>resulted in relief of the repression and an ~150-fold increase in luciferase activity</div><div class='line' id='LC3857'>compared to the CMV-luciferase- Myocd 3&#39; UTR-luciferase vector alone (Fig.</div><div class='line' id='LC3858'>4d).&quot;</div><div class='line' id='LC3859'>SET Species = &quot;9606&quot;</div><div class='line' id='LC3860'><br/></div><div class='line' id='LC3861'>microRNAAbundance(HGNC:MIR145) increases proteinAbundance(HGNC:MYOCD)</div><div class='line' id='LC3862'>microRNAAbundance(HGNC:MIR143) causesNoChange proteinAbundance(HGNC:MYOCD)</div><div class='line' id='LC3863'><br/></div><div class='line' id='LC3864'>SET Evidence = &quot;In the presence of the Elk-1 3&#39; UTR, miR-143 repressed luciferase activity; this repression</div><div class='line' id='LC3865'>was diminished upon mutation of one of the two miR-143 binding sites</div><div class='line' id='LC3866'>(Fig. 4a).&quot;</div><div class='line' id='LC3867'><br/></div><div class='line' id='LC3868'>microRNAAbundance(HGNC:MIR143) directlyDecreases proteinAbundance(HGNC:ELK1)</div><div class='line' id='LC3869'><br/></div><div class='line' id='LC3870'>SET Evidence = &quot;SRF weakly activated the miR-143/145 enhancer upstream of a luciferase reporter, but</div><div class='line' id='LC3871'>co-transfection of Myocd synergistically and robustly activated luciferase activity</div><div class='line' id='LC3872'>in Cos cells (Fig. 2f).&quot;</div><div class='line' id='LC3873'><br/></div><div class='line' id='LC3874'>compositeAbundance(proteinAbundance(HGNC:SRF),proteinAbundance(HGNC:MYOCD)) increases microRNAAbundance(HGNC:MIR145)</div><div class='line' id='LC3875'>compositeAbundance(proteinAbundance(HGNC:SRF),proteinAbundance(HGNC:MYOCD)) increases microRNAAbundance(HGNC:MIR143)</div><div class='line' id='LC3876'><br/></div><div class='line' id='LC3877'>SET Evidence = &quot;The miR-145 binding site in the 3&#39; UTR of Klf4 specifically mediated miR-145- dependent</div><div class='line' id='LC3878'>repression in luciferase assays (Fig. 4e and Supplementary Fig. 6c).&quot;</div><div class='line' id='LC3879'><br/></div><div class='line' id='LC3880'>microRNAAbundance(HGNC:MIR145) directlyDecreases proteinAbundance(HGNC:KLF4)</div><div class='line' id='LC3881'><br/></div><div class='line' id='LC3882'>SET Disease = &quot;Atherosclerosis&quot;</div><div class='line' id='LC3883'>SET CardiovascularSystem = &quot;Blood Vessels&quot;</div><div class='line' id='LC3884'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC3885'>SET Evidence = &quot;miR-145 and miR-143 were direct transcriptional targets of serum response factor,</div><div class='line' id='LC3886'>myocardin and Nkx2-5 (NK2 transcription factor related, locus 5) and were downregulated</div><div class='line' id='LC3887'>in injured or atherosclerotic vessels containing proliferating, less differentiated</div><div class='line' id='LC3888'>smooth muscle cells&quot;</div><div class='line' id='LC3889'><br/></div><div class='line' id='LC3890'>microRNAAbundance(MGI:Mir145) negativeCorrelation pathology(MESHD:Atherosclerosis)</div><div class='line' id='LC3891'>microRNAAbundance(MGI:Mir143) negativeCorrelation pathology(MESHD:Atherosclerosis)</div><div class='line' id='LC3892'><br/></div><div class='line' id='LC3893'>UNSET STATEMENT_GROUP</div><div class='line' id='LC3894'><br/></div><div class='line' id='LC3895'>SET STATEMENT_GROUP = &quot;Group 28&quot;</div><div class='line' id='LC3896'><br/></div><div class='line' id='LC3897'>SET CellLine = &quot;293&quot;</div><div class='line' id='LC3898'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC3899'>SET Evidence = &quot;In human embryonic kidney 293 cells, IL-1β induces IκB kinase β (IKKβ) activation,</div><div class='line' id='LC3900'>IκBα degradation, NF-κB transactivation, and weak Akt activation.&quot;</div><div class='line' id='LC3901'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;11976320&quot;,&quot;2002-05-25&quot;,&quot;Chen BC|Wu WT|Ho FM|Lin WW&quot;,&quot;&quot;}</div><div class='line' id='LC3902'>SET Species = &quot;9606&quot;</div><div class='line' id='LC3903'><br/></div><div class='line' id='LC3904'>proteinAbundance(HGNC:IL1B) increases kinaseActivity(proteinAbundance(HGNC:IKBKB))</div><div class='line' id='LC3905'>proteinAbundance(HGNC:IL1B) increases degradation(proteinAbundance(HGNC:NFKBIA))</div><div class='line' id='LC3906'>proteinAbundance(HGNC:IL1B) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC3907'>proteinAbundance(HGNC:IL1B) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC3908'><br/></div><div class='line' id='LC3909'>SET Evidence = &quot;However, IL-1β-induced NF-κB activity is attenuated by increased intracellular calcium</div><div class='line' id='LC3910'>in response to ionomycin, UTP, or thapsigargin or by overexpression of CaMKKc</div><div class='line' id='LC3911'>and/or Akt. Ionomycin and CaMKKc overexpression increases Akt phosphorylation</div><div class='line' id='LC3912'>on Thr308 and enzyme activity. Under these conditions or upon overexpression of</div><div class='line' id='LC3913'>wild type Akt, IL-1β-induced IKKβ activity is diminished. Furthermore, a dominant</div><div class='line' id='LC3914'>negative mutant of Akt abolishes IKKβ inhibition by CaMKKc and ionomycin, suggesting</div><div class='line' id='LC3915'>that Akt acts as a mediator of CaMKK signaling to inhibit IL-1β-induced</div><div class='line' id='LC3916'>IKK activity at an upstream target site.&quot;</div><div class='line' id='LC3917'><br/></div><div class='line' id='LC3918'>abundance(SCHEM:Ionomycin) increases abundance(CHEBI:&quot;calcium(2+)&quot;)</div><div class='line' id='LC3919'>abundance(CHEBI:UTP) increases abundance(CHEBI:&quot;calcium(2+)&quot;)</div><div class='line' id='LC3920'>abundance(CHEBI:thapsigargin) increases abundance(CHEBI:&quot;calcium(2+)&quot;)</div><div class='line' id='LC3921'>abundance(CHEBI:&quot;calcium(2+)&quot;) decreases (proteinAbundance(HGNC:IL1B) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;)))</div><div class='line' id='LC3922'>kinaseActivity(proteinAbundance(PFH:&quot;CAMK Family&quot;)) decreases (proteinAbundance(HGNC:IL1B) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))) //Do not have a CAMKK Family (CAMKK1 and CAMKK2)</div><div class='line' id='LC3923'>proteinAbundance(PFH:&quot;AKT Family&quot;) decreases (proteinAbundance(HGNC:IL1B) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;)))</div><div class='line' id='LC3924'>kinaseActivity(proteinAbundance(PFH:&quot;CAMK Family&quot;)) increases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308)) //CAMKKc is constitutively active CAMKK</div><div class='line' id='LC3925'>kinaseActivity(proteinAbundance(PFH:&quot;CAMK Family&quot;)) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC3926'>abundance(SCHEM:Ionomycin) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC3927'>abundance(SCHEM:Ionomycin) increases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308))</div><div class='line' id='LC3928'>abundance(SCHEM:Ionomycin) decreases (proteinAbundance(HGNC:IL1B) increases kinaseActivity(proteinAbundance(HGNC:IKBKB)))</div><div class='line' id='LC3929'>kinaseActivity(proteinAbundance(PFH:&quot;CAMK Family&quot;)) decreases (proteinAbundance(HGNC:IL1B) increases kinaseActivity(proteinAbundance(HGNC:IKBKB)))</div><div class='line' id='LC3930'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) decreases (proteinAbundance(HGNC:IL1B) increases kinaseActivity(proteinAbundance(HGNC:IKBKB)))</div><div class='line' id='LC3931'><br/></div><div class='line' id='LC3932'>SET Evidence = &quot;CaMKKc and Akt overexpression decreases IRAK1-mediated NF-κB activity and its association</div><div class='line' id='LC3933'>with MyD88 in response to IL-1β stimulation. Furthermore, CaMKKc and Akt</div><div class='line' id='LC3934'>overexpression increases IRAK1 phosphorylation at Thr100, and point mutation of</div><div class='line' id='LC3935'>this site abrogates the inhibitory effect of Akt on IRAK1-mediated NF-κB activation.&quot;</div><div class='line' id='LC3936'><br/></div><div class='line' id='LC3937'>proteinAbundance(HGNC:IRAK1) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC3938'>kinaseActivity(proteinAbundance(PFH:&quot;CAMK Family&quot;)) decreases (proteinAbundance(HGNC:IRAK1) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;)))</div><div class='line' id='LC3939'>proteinAbundance(PFH:&quot;AKT Family&quot;) decreases (proteinAbundance(HGNC:IRAK1) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;)))</div><div class='line' id='LC3940'>kinaseActivity(proteinAbundance(PFH:&quot;CAMK Family&quot;)) increases proteinAbundance(HGNC:IRAK1,proteinModification(P,T,100))</div><div class='line' id='LC3941'>proteinAbundance(PFH:&quot;AKT Family&quot;) increases proteinAbundance(HGNC:IRAK1,proteinModification(P,T,100))</div><div class='line' id='LC3942'>proteinAbundance(HGNC:IRAK1,proteinModification(P,T,100)) directlyDecreases (proteinAbundance(HGNC:IRAK1) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;)))</div><div class='line' id='LC3943'><br/></div><div class='line' id='LC3944'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC3945'>SET Evidence = &quot;In cells transfected with negative mutants of IKKα, IKKβ, and NIK, IL-1β-induced κB</div><div class='line' id='LC3946'>luciferase activity were inhibited by 32 ± 7%, 70 ± 11%, and 33 ± 8%, respectively</div><div class='line' id='LC3947'>(Fig. 1D). Compared with the distinct selectivity for IL-1β action, IKKα and</div><div class='line' id='LC3948'>IKKβ mutants reduced the NIK-induced κB response to a similar extent (Fig. 1D).&quot;</div><div class='line' id='LC3949'><br/></div><div class='line' id='LC3950'>kinaseActivity(proteinAbundance(HGNC:IKBKB)) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC3951'>kinaseActivity(proteinAbundance(HGNC:CHUK)) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;)) //IKK alpha = CHUK</div><div class='line' id='LC3952'>kinaseActivity(proteinAbundance(HGNC:MAP3K14)) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC3953'><br/></div><div class='line' id='LC3954'>SET Evidence = &quot;Probing of immunoblots with antibodies specific for phosphorylated Akt showed that</div><div class='line' id='LC3955'>10 ng/ml of IL-1β slightly increased Akt Thr308 and Ser473 phosphorylation within</div><div class='line' id='LC3956'>60 min (Fig.2). Using histone H2B as an Akt substrate, a slight increase in</div><div class='line' id='LC3957'>Akt kinase activity was noted within the same time interval as Akt phosphorylation</div><div class='line' id='LC3958'>(Fig. 2).&quot;</div><div class='line' id='LC3959'><br/></div><div class='line' id='LC3960'>proteinAbundance(HGNC:IL1B) increases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,308))</div><div class='line' id='LC3961'>proteinAbundance(HGNC:IL1B) increases proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473))</div><div class='line' id='LC3962'>proteinAbundance(HGNC:IL1B) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC3963'><br/></div><div class='line' id='LC3964'>SET Evidence = &quot;A shows that IL-1β at 10 ng/ml increased IRAK1 activity, which reached a maximum after</div><div class='line' id='LC3965'>10 min and was sustained for at least 90 min.&quot;</div><div class='line' id='LC3966'><br/></div><div class='line' id='LC3967'>proteinAbundance(HGNC:IL1B) increases kinaseActivity(proteinAbundance(HGNC:IRAK1)) //IRAK1 is a kinase</div><div class='line' id='LC3968'><br/></div><div class='line' id='LC3969'>SET Evidence = &quot;IL-1β-induced IRAK1 activity was inhibited by treatment with ionomycin or overexpression</div><div class='line' id='LC3970'>of CaMKKc and Akt.&quot;</div><div class='line' id='LC3971'><br/></div><div class='line' id='LC3972'>kinaseActivity(proteinAbundance(PFH:&quot;CAMK Family&quot;)) decreases (proteinAbundance(HGNC:IL1B) increases kinaseActivity(proteinAbundance(HGNC:IRAK1)))</div><div class='line' id='LC3973'>proteinAbundance(PFH:&quot;AKT Family&quot;) decreases (proteinAbundance(HGNC:IL1B) increases kinaseActivity(proteinAbundance(HGNC:IRAK1)))</div><div class='line' id='LC3974'>abundance(SCHEM:Ionomycin) decreases (proteinAbundance(HGNC:IL1B) increases kinaseActivity(proteinAbundance(HGNC:IRAK1)))</div><div class='line' id='LC3975'><br/></div><div class='line' id='LC3976'>SET Evidence = &quot;In support of previous findings, kinase-dead IRAK1 (K239A) transfection efficiently</div><div class='line' id='LC3977'>triggered κB luciferase activity at a level equivalent to that of wild type IRAK1,</div><div class='line' id='LC3978'>and this activity was similarly reduced by CaMKKc and Akt (Fig. 9C). These</div><div class='line' id='LC3979'>results suggest that the inhibition of IRAK1-dependent signaling by Akt is unrelated</div><div class='line' id='LC3980'>to the kinase activity of IRAK1.&quot;</div><div class='line' id='LC3981'><br/></div><div class='line' id='LC3982'>kinaseActivity(proteinAbundance(HGNC:IRAK1)) causesNoChange transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC3983'><br/></div><div class='line' id='LC3984'>SET Evidence = &quot;These results confirm that IRAK1 and Akt can interact in vivo, particularly following</div><div class='line' id='LC3985'>Akt activation.&quot;</div><div class='line' id='LC3986'><br/></div><div class='line' id='LC3987'>complexAbundance(proteinAbundance(PFH:&quot;AKT Family&quot;),proteinAbundance(HGNC:IRAK1))</div><div class='line' id='LC3988'><br/></div><div class='line' id='LC3989'>SET Evidence = &quot;Upon stimulation with 10 ng/ml IL-1β for 15 or 30 min, IRAK1 co-immunoprecipitation</div><div class='line' id='LC3990'>with MyD88 was enhanced, whereas it was reduced by the overexpression of Akt</div><div class='line' id='LC3991'>and CaMKKc (Fig.10,C and D).&quot;</div><div class='line' id='LC3992'><br/></div><div class='line' id='LC3993'>proteinAbundance(HGNC:IL1B) increases complexAbundance(proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:MYD88))</div><div class='line' id='LC3994'>proteinAbundance(PFH:&quot;AKT Family&quot;) decreases complexAbundance(proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:MYD88))</div><div class='line' id='LC3995'>kinaseActivity(proteinAbundance(PFH:&quot;CAMK Family&quot;)) decreases complexAbundance(proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:MYD88))</div><div class='line' id='LC3996'><br/></div><div class='line' id='LC3997'>UNSET STATEMENT_GROUP</div><div class='line' id='LC3998'><br/></div><div class='line' id='LC3999'>SET STATEMENT_GROUP = &quot;Group 29&quot;</div><div class='line' id='LC4000'><br/></div><div class='line' id='LC4001'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC4002'>SET Evidence = &quot;From yeast two-hybrid experiments we are able to show that the SR3-SR4 domains of</div><div class='line' id='LC4003'>α-actinin 2 are required to bind the COOH-terminal region of the FATZ as does γ-filamin/ABP-L.</div><div class='line' id='LC4004'>Furthermore, by using a glutathione S-transferase overlay assay</div><div class='line' id='LC4005'>we find that FATZ also binds telethonin&quot;</div><div class='line' id='LC4006'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;10984498&quot;,&quot;&quot;,&quot;Faulkner G|Pallavicini A|Comelli A|Salamon M|Bortoletto G|Ievolella C|Trevisan S|Kojic&#39; S|Dalla Vecchia F|Laveder P|Valle G|Lanfranchi G&quot;,&quot;&quot;}</div><div class='line' id='LC4007'><br/></div><div class='line' id='LC4008'>complexAbundance(proteinAbundance(HGNC:MYOZ1),proteinAbundance(HGNC:ACTN2))</div><div class='line' id='LC4009'>complexAbundance(proteinAbundance(HGNC:MYOZ1),proteinAbundance(HGNC:FLNC))</div><div class='line' id='LC4010'>complexAbundance(proteinAbundance(HGNC:MYOZ1),proteinAbundance(HGNC:TCAP))</div><div class='line' id='LC4011'><br/></div><div class='line' id='LC4012'>SET Cell = &quot;Muscle Cells&quot;</div><div class='line' id='LC4013'>SET Evidence = &quot;The level of FATZ protein in muscle cells increases during differentiation, being</div><div class='line' id='LC4014'>clearly detectable before the onset of myosin&quot;</div><div class='line' id='LC4015'><br/></div><div class='line' id='LC4016'>proteinAbundance(HGNC:MYOZ1) positiveCorrelation biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC4017'><br/></div><div class='line' id='LC4018'>UNSET STATEMENT_GROUP</div><div class='line' id='LC4019'><br/></div><div class='line' id='LC4020'>SET STATEMENT_GROUP = &quot;Group 30&quot;</div><div class='line' id='LC4021'><br/></div><div class='line' id='LC4022'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC4023'>SET Evidence = &quot;The tumor necrosis factor α receptor (TNFR1) activates downstream effectors that include</div><div class='line' id='LC4024'>the mitogen-activated protein kinase kinase 7 (MKK7)/c-Jun-NH2-kinase (JNK)/activator</div><div class='line' id='LC4025'>protein 1 (AP1) cascade. Here, we report that JNK is activated in</div><div class='line' id='LC4026'>a majority of spontaneous human squamous cell carcinomas (SCC).&quot;</div><div class='line' id='LC4027'>SET Citation = {&quot;PubMed&quot;,&quot;Cancer research&quot;,&quot;17440097&quot;,&quot;&quot;,&quot;Zhang JY|Adams AE|Ridky TW|Tao S|Khavari PA&quot;,&quot;&quot;}</div><div class='line' id='LC4028'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4029'><br/></div><div class='line' id='LC4030'>molecularActivity(proteinAbundance(HGNC:TNFRSF1A)) increases kinaseActivity(proteinAbundance(HGNC:MAP2K7))</div><div class='line' id='LC4031'>molecularActivity(proteinAbundance(HGNC:TNFRSF1A)) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC4032'>molecularActivity(proteinAbundance(HGNC:TNFRSF1A)) increases transcriptionalActivity(complexAbundance(NCH:&quot;AP-1 Complex&quot;))</div><div class='line' id='LC4033'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;)) positiveCorrelation pathology(MESHD:&quot;Carcinoma, Squamous Cell&quot;)</div><div class='line' id='LC4034'><br/></div><div class='line' id='LC4035'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC4036'>SET Evidence = &quot;To study the frequency of JNK induction in human SCC, we probed tissue microarrays</div><div class='line' id='LC4037'>of spontaneous human SCC samples (n=52) with antibodies directed against the phosphorylated</div><div class='line' id='LC4038'>active forms of JNK. Eighty-one percent of SCCs examined exhibited</div><div class='line' id='LC4039'>either strong or moderately strong induction of phosphorylated JNK (pJNK) over</div><div class='line' id='LC4040'>normal tissues (Fig. 1A).&quot;</div><div class='line' id='LC4041'><br/></div><div class='line' id='LC4042'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;)) positiveCorrelation pathology(MESHD:&quot;Carcinoma, Squamous Cell&quot;)</div><div class='line' id='LC4043'><br/></div><div class='line' id='LC4044'>SET Evidence = &quot;To address this, we first studied the effect of a JNK-specific inhibitor, SP600125</div><div class='line' id='LC4045'>(30), which has been shown to inhibit JNK function and epidermal hyperplasia in</div><div class='line' id='LC4046'>epidermis expressing IκBα or deficient in relA (16).&quot;</div><div class='line' id='LC4047'><br/></div><div class='line' id='LC4048'>abundance(SCHEM:SP600125) directlyDecreases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC4049'><br/></div><div class='line' id='LC4050'>SET Evidence = &quot;Ras-driven epidermal neoplasias generated on the surface of immunodeficient SCID mice</div><div class='line' id='LC4051'>were treated topically with DMSO vehicle or SP600125 daily for 5 weeks. DMSO</div><div class='line' id='LC4052'>and untreated control tissues displayed typical findings of neoplasia, including</div><div class='line' id='LC4053'>invasion and disruption of the BMZ, as visualized by type VII collagen staining</div><div class='line' id='LC4054'>(Fig. 2A). In contrast, tissues treated with SP600125 lacked invasive neoplasia</div><div class='line' id='LC4055'>and retained sharp delineation of the BMZ, with a humanspecific desmoglein-3</div><div class='line' id='LC4056'>antibody confirming the human origin of these tissues (Fig. 2A).&quot;</div><div class='line' id='LC4057'><br/></div><div class='line' id='LC4058'>gtpBoundActivity(proteinAbundance(HGNC:HRAS)) increases pathology(MESHD:Neoplasms)</div><div class='line' id='LC4059'>abundance(SCHEM:SP600125) decreases (gtpBoundActivity(proteinAbundance(HGNC:HRAS)) increases pathology(MESHD:Neoplasms))</div><div class='line' id='LC4060'><br/></div><div class='line' id='LC4061'>SET Evidence = &quot;To investigate whether JNK/AP1 dependency is a general process common to other SCC</div><div class='line' id='LC4062'>cell types, we expressed DNc-Jun in spontaneous human SCC cell lines, A431 and</div><div class='line' id='LC4063'>SCC25, and found that DNc-Jun significantly inhibited their s.c. tumor growth as</div><div class='line' id='LC4064'>well (Fig. 2B–C). Furthermore, retroviral-mediated RNA interference knockdown</div><div class='line' id='LC4065'>of MKK7, the upstream activator of JNK, also prevented s.c. tumor growth of A431,</div><div class='line' id='LC4066'>SCC25, and primary keratinocytes transformed by Ras and IκBα (Fig. 2B–D).&quot;</div><div class='line' id='LC4067'><br/></div><div class='line' id='LC4068'>transcriptionalActivity(proteinAbundance(HGNC:JUN)) increases pathology(MESHD:&quot;Carcinoma, Squamous Cell&quot;)</div><div class='line' id='LC4069'>kinaseActivity(proteinAbundance(HGNC:MAP2K7)) increases pathology(MESHD:&quot;Carcinoma, Squamous Cell&quot;)</div><div class='line' id='LC4070'>transcriptionalActivity(proteinAbundance(HGNC:JUN)) increases pathology(SDIS:&quot;tumor growth&quot;)</div><div class='line' id='LC4071'>kinaseActivity(proteinAbundance(HGNC:MAPK7)) increases pathology(SDIS:&quot;tumor growth&quot;)</div><div class='line' id='LC4072'><br/></div><div class='line' id='LC4073'>SET Evidence = &quot;We next asked whether components of the JNK cascade could directly promote human epidermal</div><div class='line' id='LC4074'>neoplasia. We expressed either active MKK7 or c-Jun in primary keratinocytes</div><div class='line' id='LC4075'>and examined their capacity to promote tumorigenesis in combination with</div><div class='line' id='LC4076'>Ras in the absence of IκBα. First, we confirmed induction of AP1-dependent gene</div><div class='line' id='LC4077'>reporter activity by MKK7 in vitro (Supplementary Fig. S4). Surface skin grafts</div><div class='line' id='LC4078'>were then regenerated with primary keratinocytes expressing MKK7 and Ras; these</div><div class='line' id='LC4079'>developed into clinical tumors resembling SCC (Fig. 3A). Dermal invasion, one of</div><div class='line' id='LC4080'>the hallmarks of spontaneous human SCC, is apparent in tumors induced by MKK7 and</div><div class='line' id='LC4081'>Ras as revealed by both histologic appearance and BMZ disruption (Fig. 3B–C).</div><div class='line' id='LC4082'>MKK7 and Ras-induced neoplasia depends on intact AP1 function as concurrent expression</div><div class='line' id='LC4083'>of DNc-Jun prevents tumorigenesis (Fig. 3A–C).&quot;</div><div class='line' id='LC4084'><br/></div><div class='line' id='LC4085'>proteinAbundance(HGNC:MAP2K7) increases pathology(MESHD:&quot;Carcinoma, Squamous Cell&quot;)</div><div class='line' id='LC4086'>proteinAbundance(HGNC:JUN) increases pathology(MESHD:&quot;Carcinoma, Squamous Cell&quot;)</div><div class='line' id='LC4087'>compositeAbundance(proteinAbundance(HGNC:HRAS),proteinAbundance(HGNC:MAP2K7)) increases pathology(MESHD:&quot;Carcinoma, Squamous Cell&quot;)</div><div class='line' id='LC4088'><br/></div><div class='line' id='LC4089'>SET Evidence = &quot;Of interest, although Ras by itself activates AP1, coexpression of Ras with MKK7 induces</div><div class='line' id='LC4090'>significantly higher levels of AP1 activity in primary human keratinocytes</div><div class='line' id='LC4091'>than either one alone (Supplementary Fig. S5), indicating that Ras and MKK7 act</div><div class='line' id='LC4092'>in synergy to induce downstream signaling.&quot;</div><div class='line' id='LC4093'><br/></div><div class='line' id='LC4094'>kinaseActivity(proteinAbundance(HGNC:MAP2K7)) increases transcriptionalActivity(complexAbundance(NCH:&quot;AP-1 Complex&quot;))</div><div class='line' id='LC4095'>gtpBoundActivity(proteinAbundance(HGNC:HRAS)) increases transcriptionalActivity(complexAbundance(NCH:&quot;AP-1 Complex&quot;))</div><div class='line' id='LC4096'>compositeAbundance(proteinAbundance(HGNC:HRAS),proteinAbundance(HGNC:MAP2K7)) increases transcriptionalActivity(complexAbundance(NCH:&quot;AP-1 Complex&quot;))</div><div class='line' id='LC4097'><br/></div><div class='line' id='LC4098'>SET Cell = &quot;Keratinocytes&quot;</div><div class='line' id='LC4099'>SET Evidence = &quot;Oncogenic Ras alone induces growth arrest in primary human keratinocytes in the G1</div><div class='line' id='LC4100'>phase of the cell cycle (19,31).&quot;</div><div class='line' id='LC4101'><br/></div><div class='line' id='LC4102'>proteinAbundance(HGNC:HRAS,substitution(G,12,V)) decreases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;)</div><div class='line' id='LC4103'><br/></div><div class='line' id='LC4104'>SET Evidence = &quot;MKK7 bypassed cell cycle G1 arrest induced by Ras, as shown by flow cytometry (Fig.</div><div class='line' id='LC4105'>4B). Thus, MKK7 promotes epidermal cell proliferation and rescues Ras-induced</div><div class='line' id='LC4106'>cell cycle arrest.&quot;</div><div class='line' id='LC4107'><br/></div><div class='line' id='LC4108'>kinaseActivity(proteinAbundance(HGNC:MAP2K7)) decreases (gtpBoundActivity(proteinAbundance(HGNC:HRAS)) decreases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;))</div><div class='line' id='LC4109'><br/></div><div class='line' id='LC4110'>SET Evidence = &quot;CDK4 is a cyclin-dependent kinase promoting G1 progression previously shown to be</div><div class='line' id='LC4111'>posttranscriptionally down-regulated by Ras, a finding whose functional importance</div><div class='line' id='LC4112'>has been confirmed because CDK4 can bypass Ras-induced growth arrest (31). CDK4</div><div class='line' id='LC4113'>protein was also restored to near-normal levels by MKK7.&quot;</div><div class='line' id='LC4114'><br/></div><div class='line' id='LC4115'>kinaseActivity(proteinAbundance(HGNC:CDK4)) increases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;)</div><div class='line' id='LC4116'>gtpBoundActivity(proteinAbundance(HGNC:HRAS)) decreases proteinAbundance(HGNC:CDK4)</div><div class='line' id='LC4117'>kinaseActivity(proteinAbundance(HGNC:CDK4)) decreases (proteinAbundance(HGNC:HRAS,substitution(G,12,V)) decreases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;))</div><div class='line' id='LC4118'><br/></div><div class='line' id='LC4119'>SET Evidence = &quot;In support of this, TNFR1 has recently been implicated in murine epidermal tumorigenesis.</div><div class='line' id='LC4120'>Genetic deletion of Tnfr1 diminished occurrence of neoplasia in mice induced</div><div class='line' id='LC4121'>by both NF-κB blockade and chemical carcinogenesis (33,34).&quot;</div><div class='line' id='LC4122'><br/></div><div class='line' id='LC4123'>proteinAbundance(HGNC:TNFRSF1A) increases pathology(MESHD:Neoplasms)</div><div class='line' id='LC4124'><br/></div><div class='line' id='LC4125'>SET Evidence = &quot;Moreover, recent findings showed that epidermal NF-κB blockade relieves constitutive</div><div class='line' id='LC4126'>repression of JNK activity by the NF-κB RelA subunit and that TNFR1 is required</div><div class='line' id='LC4127'>both for the JNK induction as well as the epidermal hyperplasia that occurs</div><div class='line' id='LC4128'>in this setting (16,17).&quot;</div><div class='line' id='LC4129'><br/></div><div class='line' id='LC4130'>proteinAbundance(HGNC:RELA) decreases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC4131'><br/></div><div class='line' id='LC4132'>SET Evidence = &quot;In contrast, tissues treated with TNFR1 antibody, although hyperplastic, retained</div><div class='line' id='LC4133'>BMZ structure and proper desmoglein-3 expression, indicating intact tissue polarity</div><div class='line' id='LC4134'>(Fig. 5A and B). Blockade of TNFR1 signaling was accompanied by the absence</div><div class='line' id='LC4135'>of detectable pJNK in the tissues treated by the TNFR1 antibody (Supplementary</div><div class='line' id='LC4136'>Fig. S7). In addition, TNFR1 blockade reduced the mitotic index and limited mitotic</div><div class='line' id='LC4137'>cells to the basal layer, whereas proliferating cells were widespread and abundant</div><div class='line' id='LC4138'>in the control tumor tissue (Fig. 5C and D). These findings indicate that</div><div class='line' id='LC4139'>antagonizing TNFR1 function prevents Ras-driven tumorigenesis.&quot;</div><div class='line' id='LC4140'><br/></div><div class='line' id='LC4141'>molecularActivity(proteinAbundance(HGNC:TNFRSF1A)) increases pathology(MESHD:Neoplasms)</div><div class='line' id='LC4142'><br/></div><div class='line' id='LC4143'>SET Evidence = &quot;In agreement with this, antibody-mediated TNFR1 blockade significantly inhibited s.c.</div><div class='line' id='LC4144'>tumor growth of three independent SCC tumor lines, A431, SCC25, and CAL27 (Supplementary</div><div class='line' id='LC4145'>Fig. S8A). To determine if TNFR1 action in this context is tumor cell</div><div class='line' id='LC4146'>intrinsic, we used retroviral-mediated RNA interference to decrease TNFR1 expression.</div><div class='line' id='LC4147'>Reduced levels of TNFR1, as confirmed by immunoblotting, significantly</div><div class='line' id='LC4148'>inhibited s.c. growth of Ras-driven tumors and SCC lines (Supplementary Fig. S8B).&quot;</div><div class='line' id='LC4149'><br/></div><div class='line' id='LC4150'>molecularActivity(proteinAbundance(HGNC:TNFRSF1A)) increases pathology(MESHD:&quot;Carcinoma, Squamous Cell&quot;)</div><div class='line' id='LC4151'><br/></div><div class='line' id='LC4152'>UNSET STATEMENT_GROUP</div><div class='line' id='LC4153'><br/></div><div class='line' id='LC4154'>SET STATEMENT_GROUP = &quot;Group 31&quot;</div><div class='line' id='LC4155'><br/></div><div class='line' id='LC4156'>SET RespiratorySystem = &quot;Lung&quot;</div><div class='line' id='LC4157'>SET Evidence = &quot;Based on these observations, a mouse model of lung adenocarcinoma has been generated</div><div class='line' id='LC4158'>in which nasal instillation of Ad-Cre to the lungs of K-Ras+/LSL-G12D  conditional</div><div class='line' id='LC4159'>mutant mice (Figure 1a) results in the expression of oncogenic K-RasG12D</div><div class='line' id='LC4160'>and the development of lesions that resemble human tumors (Jackson et al., 2001).&quot;</div><div class='line' id='LC4161'>SET Citation = {&quot;PubMed&quot;,&quot;Oncogene&quot;,&quot;19151761&quot;,&quot;2009-02-19&quot;,&quot;Ho VM|Schaffer BE|Karnezis AN|Park KS|Sage J&quot;,&quot;&quot;}</div><div class='line' id='LC4162'>SET Species = &quot;10090&quot;</div><div class='line' id='LC4163'><br/></div><div class='line' id='LC4164'>proteinAbundance(MGI:Kras,substitution(G,12,D)) increases pathology(MESHD:Neoplasms)</div><div class='line' id='LC4165'><br/></div><div class='line' id='LC4166'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC4167'>SET Evidence = &quot;The RB tumor suppressor is inactivated in a broad range of human tumors (Classon and</div><div class='line' id='LC4168'>Harlow, 2002; Sherr and McCormick, 2002), including pediatric retinoblastomas</div><div class='line' id='LC4169'>and ~90% of human small cell lung carcinomas (SCLCs).&quot;</div><div class='line' id='LC4170'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4171'><br/></div><div class='line' id='LC4172'>proteinAbundance(HGNC:RB1) negativeCorrelation pathology(MESHD:&quot;Small Cell Lung Carcinoma&quot;)</div><div class='line' id='LC4173'>proteinAbundance(HGNC:RB1) negativeCorrelation pathology(MESHD:Retinoblastoma)</div><div class='line' id='LC4174'><br/></div><div class='line' id='LC4175'>SET Evidence = &quot;For instance, RB is rarely found mutated in lung adeno-carcinomas whereas p16INK4α,</div><div class='line' id='LC4176'>an upstream activator of the pRb protein and the two related proteins p107 and</div><div class='line' id='LC4177'>p130, is frequently inactivated in this tumor type (Wistuba et al., 2001).&quot;</div><div class='line' id='LC4178'><br/></div><div class='line' id='LC4179'>proteinAbundance(SPAC:P42771) negativeCorrelation pathology(MESHD:Adenocarcinoma)</div><div class='line' id='LC4180'><br/></div><div class='line' id='LC4181'>SET Evidence = &quot;In addition, loss of function of the pRb family member p130 may be part of tumor progression</div><div class='line' id='LC4182'>in several types of human cancers, including lung adenocarcinomas (Claudio</div><div class='line' id='LC4183'>et al., 2000; Cinti et al., 2005), but a causal role for loss of p130 in</div><div class='line' id='LC4184'>lung cancer progression also remains to be determined.&quot;</div><div class='line' id='LC4185'><br/></div><div class='line' id='LC4186'>proteinAbundance(HGNC:RBL2) negativeCorrelation pathology(MESHD:Adenocarcinoma)</div><div class='line' id='LC4187'><br/></div><div class='line' id='LC4188'>UNSET STATEMENT_GROUP</div><div class='line' id='LC4189'><br/></div><div class='line' id='LC4190'>SET STATEMENT_GROUP = &quot;Group 32&quot;</div><div class='line' id='LC4191'><br/></div><div class='line' id='LC4192'>SET CellLine = &quot;IMR-90&quot;</div><div class='line' id='LC4193'>SET Cell = &quot;Fibroblasts&quot;</div><div class='line' id='LC4194'>SET RespiratorySystem = &quot;Lung&quot;</div><div class='line' id='LC4195'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC4196'>SET Evidence = &quot;inhibition of fibroblast proliferation was mediated exclusively by activation of Epac-1.</div><div class='line' id='LC4197'>PGE2 and Epac-1 inhibited cell proliferation through activation of the small</div><div class='line' id='LC4198'>GTPase Rap1, since decreasing Rap1 activity by transfection with Rap1GAP or</div><div class='line' id='LC4199'>the dominant-negative Rap1N17 prevented, and transfection with the constitutively</div><div class='line' id='LC4200'>active Rap1V12 mimicked, the anti-proliferative effects of PGE2&quot;</div><div class='line' id='LC4201'>SET Citation = {&quot;PubMed&quot;,&quot;American journal of respiratory cell and molecular biology&quot;,&quot;18421013&quot;,&quot;2008-05-17&quot;,&quot;Huang SK|Wettlaufer SH|Chung J|Peters-Golden M&quot;,&quot;&quot;}</div><div class='line' id='LC4202'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4203'><br/></div><div class='line' id='LC4204'>abundance(CHEBI:&quot;prostaglandin E2&quot;) increases molecularActivity(proteinAbundance(HGNC:RAPGEF3))</div><div class='line' id='LC4205'>molecularActivity(proteinAbundance(HGNC:RAPGEF3)) increases gtpBoundActivity(proteinAbundance(HGNC:RAP1A))</div><div class='line' id='LC4206'>gtpBoundActivity(proteinAbundance(HGNC:RAP1A)) decreases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC4207'><br/></div><div class='line' id='LC4208'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC4209'>SET Evidence = &quot;Work in our laboratory (13) and others (14) has shown that the inhibitory actions</div><div class='line' id='LC4210'>of PGE2 in lung fibroblasts are a result of increases in cAMP, mediated through</div><div class='line' id='LC4211'>the Gas-coupled EP2 receptor;&quot;</div><div class='line' id='LC4212'><br/></div><div class='line' id='LC4213'>abundance(CHEBI:&quot;prostaglandin E2&quot;) directlyIncreases molecularActivity(proteinAbundance(HGNC:PTGER2))</div><div class='line' id='LC4214'>molecularActivity(proteinAbundance(HGNC:PTGER2)) increases abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;)</div><div class='line' id='LC4215'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;) decreases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC4216'><br/></div><div class='line' id='LC4217'>SET Evidence = &quot;To determine which cAMP effector-PKA or Epac-is capable of inhibiting collagen expression</div><div class='line' id='LC4218'>and proliferation, fibroblasts were treated with varying concentrations</div><div class='line' id='LC4219'>of the selective PKA agonist 6-bnz-cAMP or the selective Epac agonist 8-pCPT-2&#39;-ο-Me-cAMP.&quot;</div><div class='line' id='LC4220'><br/></div><div class='line' id='LC4221'>abundance(SCHEM:&quot;N(6)-Benzoyl-cyclic amp&quot;) directlyIncreases kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;))</div><div class='line' id='LC4222'>abundance(SCHEM:&quot;8-(4-chloro-phenylthio)-2&#39;-O-methyladenosine-3&#39;-5&#39;-cyclic monophosphate&quot;) directlyIncreases molecularActivity(proteinAbundance(HGNC:RAPGEF3))</div><div class='line' id='LC4223'><br/></div><div class='line' id='LC4224'>SET Evidence = &quot;the Epac agonist elicited a dose-dependent decrease in proliferation but had no effect</div><div class='line' id='LC4225'>on collagen expression (Figure 1D)&quot;</div><div class='line' id='LC4226'><br/></div><div class='line' id='LC4227'>abundance(SCHEM:&quot;8-(4-chloro-phenylthio)-2&#39;-O-methyladenosine-3&#39;-5&#39;-cyclic monophosphate&quot;) decreases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC4228'>abundance(SCHEM:&quot;8-(4-chloro-phenylthio)-2&#39;-O-methyladenosine-3&#39;-5&#39;-cyclic monophosphate&quot;) causesNoChange proteinAbundance(PFH:&quot;COL1 Family&quot;)</div><div class='line' id='LC4229'><br/></div><div class='line' id='LC4230'>SET Evidence = &quot;cells expressing PKACα exhibited a reduction in collagen expression, but not in proliferation</div><div class='line' id='LC4231'>(Figure 2A)&quot;</div><div class='line' id='LC4232'><br/></div><div class='line' id='LC4233'>proteinAbundance(HGNC:PRKACA) causesNoChange biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC4234'>proteinAbundance(HGNC:PRKACA) decreases proteinAbundance(PFH:&quot;COL1 Family&quot;)</div><div class='line' id='LC4235'><br/></div><div class='line' id='LC4236'>SET Evidence = &quot;We found that both PGE2 and the Epac agonist stimulated Rap1 activity, as measured</div><div class='line' id='LC4237'>by the RalGDS pulldown of active GTP-loaded Rap1, whereas the PKA agonist actually</div><div class='line' id='LC4238'>had an inhibitory effect on Rap1 activity (Figure 4A).&quot;</div><div class='line' id='LC4239'><br/></div><div class='line' id='LC4240'>abundance(CHEBI:&quot;prostaglandin E2&quot;) increases gtpBoundActivity(proteinAbundance(HGNC:RAP1A))</div><div class='line' id='LC4241'>abundance(SCHEM:&quot;8-(4-chloro-phenylthio)-2&#39;-O-methyladenosine-3&#39;-5&#39;-cyclic monophosphate&quot;) increases gtpBoundActivity(proteinAbundance(HGNC:RAP1A))</div><div class='line' id='LC4242'>abundance(SCHEM:&quot;N(6)-Benzoyl-cyclic amp&quot;) decreases gtpBoundActivity(proteinAbundance(HGNC:RAP1A))</div><div class='line' id='LC4243'><br/></div><div class='line' id='LC4244'>SET Evidence = &quot;PGE2 and the PKA agonist, but not the Epac agonist, inhibited PKC-δ phosphorylation</div><div class='line' id='LC4245'>(Figure 5A)&quot;</div><div class='line' id='LC4246'><br/></div><div class='line' id='LC4247'>abundance(CHEBI:&quot;prostaglandin E2&quot;) decreases proteinAbundance(HGNC:PRKCD,proteinModification(P))</div><div class='line' id='LC4248'>abundance(SCHEM:&quot;N(6)-Benzoyl-cyclic amp&quot;) decreases proteinAbundance(HGNC:PRKCD,proteinModification(P))</div><div class='line' id='LC4249'><br/></div><div class='line' id='LC4250'>SET Evidence = &quot;Cells transfected with the catalytic subunit of PKA also showed diminished PKC-δ phosphorylation</div><div class='line' id='LC4251'>(Figure 5B).&quot;</div><div class='line' id='LC4252'><br/></div><div class='line' id='LC4253'>proteinAbundance(HGNC:PRKACA) decreases proteinAbundance(HGNC:PRKCD,proteinModification(P))</div><div class='line' id='LC4254'><br/></div><div class='line' id='LC4255'>SET Evidence = &quot;Inhibition with the specific PKC-δ inhibitor rottlerin resulted in decreased collagen</div><div class='line' id='LC4256'>expression (Figure 5C)&quot;</div><div class='line' id='LC4257'><br/></div><div class='line' id='LC4258'>abundance(SCHEM:Rottlerin) directlyDecreases kinaseActivity(proteinAbundance(HGNC:PRKCD))</div><div class='line' id='LC4259'>abundance(SCHEM:Rottlerin) decreases proteinAbundance(PFH:&quot;COL1 Family&quot;)</div><div class='line' id='LC4260'><br/></div><div class='line' id='LC4261'>SET Evidence = &quot;The PKA agonist dose-dependently inhibited collagen expression but had no effect on</div><div class='line' id='LC4262'>proliferation (Figure 1C)&quot;</div><div class='line' id='LC4263'><br/></div><div class='line' id='LC4264'>abundance(SCHEM:&quot;N(6)-Benzoyl-cyclic amp&quot;) decreases kinaseActivity(proteinAbundance(PFH:&quot;COL1 Family&quot;))</div><div class='line' id='LC4265'>abundance(SCHEM:&quot;N(6)-Benzoyl-cyclic amp&quot;) causesNoChange biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC4266'><br/></div><div class='line' id='LC4267'>SET Evidence = &quot;In keeping with the agonist data, cells expressing PKACα exhibited a reduction in</div><div class='line' id='LC4268'>collagen expression, but not in proliferation (Figure 2A)&quot;</div><div class='line' id='LC4269'><br/></div><div class='line' id='LC4270'>proteinAbundance(HGNC:PRKACA) decreases proteinAbundance(PFH:&quot;COL1 Family&quot;)</div><div class='line' id='LC4271'>proteinAbundance(HGNC:PRKACA) causesNoChange biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC4272'><br/></div><div class='line' id='LC4273'>UNSET STATEMENT_GROUP</div><div class='line' id='LC4274'><br/></div><div class='line' id='LC4275'>SET STATEMENT_GROUP = &quot;Group 33&quot;</div><div class='line' id='LC4276'><br/></div><div class='line' id='LC4277'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC4278'>SET Evidence = &quot;Rin1 is a Rab5 guanine nucleotide exchange factor that plays an important role in</div><div class='line' id='LC4279'>Ras-activated endocytosis and growth factor receptor trafficking in fibroblasts.&quot;</div><div class='line' id='LC4280'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;19570984&quot;,&quot;2009-08-01&quot;,&quot;Tomshine JC|Severson SR|Wigle DA|Sun Z|Beleford DA|Shridhar V|Horazdovsky BF&quot;,&quot;&quot;}</div><div class='line' id='LC4281'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4282'><br/></div><div class='line' id='LC4283'>molecularActivity(proteinAbundance(HGNC:RIN1)) directlyDecreases gtpBoundActivity(proteinAbundance(HGNC:RAB5A))</div><div class='line' id='LC4284'><br/></div><div class='line' id='LC4285'>SET CellLine = &quot;A549&quot;</div><div class='line' id='LC4286'>SET Evidence = &quot;Rin1 depletion from A549 cells resulted in a decrease in cell proliferation that was</div><div class='line' id='LC4287'>correlated to a decrease in epidermal growth factor receptor (EGFR) signaling.</div><div class='line' id='LC4288'>Expression of wild type Rin1 but not the Rab5 guanine nucleotide exchange factor-deficient</div><div class='line' id='LC4289'>Rin1 (Rin1Δ) complemented the Rin1 depletion effects, and overexpression</div><div class='line' id='LC4290'>of Rin1Δ had a dominant negative effect on cell proliferation.&quot;</div><div class='line' id='LC4291'><br/></div><div class='line' id='LC4292'>molecularActivity(proteinAbundance(HGNC:RIN1)) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC4293'><br/></div><div class='line' id='LC4294'>SET Evidence = &quot;Rin1 depletion stabilized the cell surface levels of EGFR, suggesting that internalization</div><div class='line' id='LC4295'>was necessary for robust signaling in A549 cells. In support of this conclusion,</div><div class='line' id='LC4296'>introduction of either dominant negative Rab5 or dominant negative dynamin</div><div class='line' id='LC4297'>decreased A549 proliferation and EGFR signaling.&quot;</div><div class='line' id='LC4298'><br/></div><div class='line' id='LC4299'>proteinAbundance(HGNC:RIN1) increases cellSurfaceExpression(proteinAbundance(HGNC:EGFR))</div><div class='line' id='LC4300'>gtpBoundActivity(proteinAbundance(PFH:&quot;DNM Family&quot;)) increases (proteinAbundance(HGNC:EGF) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC4301'><br/></div><div class='line' id='LC4302'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC4303'>SET Evidence = &quot;To test whether the cell proliferation defect observed with Rin1 depletion was because</div><div class='line' id='LC4304'>of altered EGFR signaling, A549 cells were transfected with control or Rin1-specific</div><div class='line' id='LC4305'>morpholinos, serum-starved, and then stimulated with EGF. The levels</div><div class='line' id='LC4306'>of phosphorylated ERK1/2 (pERK) were used to assess EGF signaling (Fig. 2C). Depletion</div><div class='line' id='LC4307'>of Rin1 from A549 cells resulted in at least a 2-fold decrease in pERK levels</div><div class='line' id='LC4308'>(Fig. 2, C and D), but not total ERK levels (supplemental Fig. 2), indicating</div><div class='line' id='LC4309'>that the decrease in cell proliferation correlated with a decrease in EGF signaling.&quot;</div><div class='line' id='LC4310'><br/></div><div class='line' id='LC4311'>proteinAbundance(HGNC:RIN1) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;))</div><div class='line' id='LC4312'><br/></div><div class='line' id='LC4313'>SET Evidence = &quot;Rin1 depletion resulted in a decrease in cell proliferation as measured by the percent</div><div class='line' id='LC4314'>change in proliferation between 24 and 72 h (Fig. 3). This decrease in cell</div><div class='line' id='LC4315'>proliferation was not because of any initial morpholino toxicity because 24 h</div><div class='line' id='LC4316'>after electroporation cells receiving control or Rin1 targeting morpholinos showed</div><div class='line' id='LC4317'>no difference in proliferation (supplemental Fig. 3). These data confirmed a</div><div class='line' id='LC4318'>participatory role of Rin1 in EGF-mediated cell proliferation.&quot;</div><div class='line' id='LC4319'><br/></div><div class='line' id='LC4320'>proteinAbundance(HGNC:RIN1) increases (proteinAbundance(HGNC:EGF) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC4321'><br/></div><div class='line' id='LC4322'>SET Evidence = &quot;However, Rin1Δ expression did not complement Rin1 knockdown defects but instead caused</div><div class='line' id='LC4323'>further inhibition of cell proliferation (Fig. 4E). These results suggest</div><div class='line' id='LC4324'>that a functional Vps9 domain is critical for Rin1 activity in EGFR-mediated cell</div><div class='line' id='LC4325'>proliferation. To verify that the Rin1 Vps9 domain was important for A549 cell</div><div class='line' id='LC4326'>proliferation, Rin1Δ or wild type Rin1 expression constructs were transfected into</div><div class='line' id='LC4327'>A549 cells and assayed for colony formation (Fig. 5, A and B). Only Rin1Δ expression</div><div class='line' id='LC4328'>but not wild type Rin1 expression resulted in decreased cell proliferation.</div><div class='line' id='LC4329'>These results indicated that Rin1 lacking a functional Vps9 domain acted as</div><div class='line' id='LC4330'>a dominant negative, suggesting that the trafficking roles of Rin1 were mediating</div><div class='line' id='LC4331'>EGFR proliferative signaling in A549 cells.&quot;</div><div class='line' id='LC4332'><br/></div><div class='line' id='LC4333'>molecularActivity(proteinAbundance(HGNC:RIN1)) increases (kinaseActivity(proteinAbundance(HGNC:EGFR)) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC4334'><br/></div><div class='line' id='LC4335'>SET Evidence = &quot;After 10 min of EGF treatment, EGFR levels dropped ~2-fold in cells transfected with</div><div class='line' id='LC4336'>the control morpholino (Fig. 6, A and B), whereas cells depleted of Rin1 showed</div><div class='line' id='LC4337'>very little receptor loss following EGF stimulation.&quot;</div><div class='line' id='LC4338'><br/></div><div class='line' id='LC4339'>proteinAbundance(HGNC:RIN1) increases degradation(proteinAbundance(HGNC:EGFR))</div><div class='line' id='LC4340'><br/></div><div class='line' id='LC4341'>SET Evidence = &quot;To confirm that EGFR internalization was critical for potentiating EGFR signaling,</div><div class='line' id='LC4342'>a GFP-tagged dominant negative dynamin (dn-dynamin) K44A expression construct</div><div class='line' id='LC4343'>was transiently transfected into A549 cells, and the impact of its expression on</div><div class='line' id='LC4344'>EGF-stimulated signaling was determined (Fig. 7A). The expression of dn-dynamin</div><div class='line' id='LC4345'>(Fig. 7B) resulted in a ~2-fold decrease in ERK1/2 activation in response to EGF</div><div class='line' id='LC4346'>stimulation (Fig. 7, A and C); this observation supports the conclusion that internalization</div><div class='line' id='LC4347'>of EGFR is critical for proper signaling in A549 cells.&quot;</div><div class='line' id='LC4348'><br/></div><div class='line' id='LC4349'>gtpBoundActivity(proteinAbundance(PFH:&quot;DNM Family&quot;)) increases kinaseActivity(proteinAbundance(HGNC:EGFR))</div><div class='line' id='LC4350'>gtpBoundActivity(proteinAbundance(PFH:&quot;DNM Family&quot;)) increases biologicalProcess(GO:&quot;epidermal growth factor receptor signaling pathway&quot;)</div><div class='line' id='LC4351'>gtpBoundActivity(proteinAbundance(PFH:&quot;DNM Family&quot;)) increases (biologicalProcess(GO:&quot;receptor internalization&quot;) increases biologicalProcess(GO:&quot;epidermal growth factor receptor signaling pathway&quot;))</div><div class='line' id='LC4352'>gtpBoundActivity(proteinAbundance(PFH:&quot;DNM Family&quot;)) increases translocation(proteinAbundance(HGNC:EGFR),MESHCL:&quot;Cell Membrane&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC4353'><br/></div><div class='line' id='LC4354'>SET Evidence = &quot;To test the role of Rab5 in these processes, A549 cells were transfected with a GFP-tagged</div><div class='line' id='LC4355'>dominant negative Rab5 S34N (GFP-dnRab5) expression construct (Fig. 7A).</div><div class='line' id='LC4356'>Similar to the results with Rin1 depletion, expression of GFP-dnRab5 resulted</div><div class='line' id='LC4357'>in a ~2-fold decrease in pERK levels when compared with control cells expressing</div><div class='line' id='LC4358'>GFP alone.&quot;</div><div class='line' id='LC4359'><br/></div><div class='line' id='LC4360'>gtpBoundActivity(proteinAbundance(HGNC:RAB5A)) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK Erk1/3 Family&quot;))</div><div class='line' id='LC4361'><br/></div><div class='line' id='LC4362'>SET Evidence = &quot;Finally, to confirm that dnRab5 and dn-dynamin expression impacted cell proliferation</div><div class='line' id='LC4363'>in a manner similar to Rin1 depletion, A549 cells transiently transfected with</div><div class='line' id='LC4364'>expression constructs encoding GFP-dnRab5, GFP-dn-dynamin, or GFP alone were</div><div class='line' id='LC4365'>tested for their ability to form colonies (Fig. 8). Cells transfected with GFP-dnRab5</div><div class='line' id='LC4366'>or GFP-dn-dynamin expression constructs showed decreased cell proliferation,</div><div class='line' id='LC4367'>supporting the conclusion that proper EGFR internalization and Rab5-mediated</div><div class='line' id='LC4368'>endosomal trafficking of EGFR are critical for potentiating proliferative signaling</div><div class='line' id='LC4369'>in A549 cells.&quot;</div><div class='line' id='LC4370'><br/></div><div class='line' id='LC4371'>gtpBoundActivity(proteinAbundance(PFH:&quot;DNM Family&quot;)) increases (proteinAbundance(HGNC:EGF) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC4372'>gtpBoundActivity(proteinAbundance(HGNC:RAB5A)) increases (proteinAbundance(HGNC:EGF) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC4373'>gtpBoundActivity(proteinAbundance(HGNC:RAB5A)) increases translocation(proteinAbundance(HGNC:EGFR),MESHCL:&quot;Cell Membrane&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC4374'><br/></div><div class='line' id='LC4375'>SET Disease = &quot;Carcinoma, Non-Small-Cell Lung&quot;</div><div class='line' id='LC4376'>SET Evidence = &quot;Gene expression from 186 human lung tumors with associated clinical information were</div><div class='line' id='LC4377'>surveyed for statistically significant variations in RIN1 mRNA levels (34).</div><div class='line' id='LC4378'>Of three Rin1 probe sets on the Affymetrix U95 array, one probe set (1777_at) was</div><div class='line' id='LC4379'>significantly up-regulated in adenocarcinoma, bronchioalveolar carcinoma, metastatic</div><div class='line' id='LC4380'>adenocarcinoma, and carcinoid and squamous cell carcinoma compared with normal</div><div class='line' id='LC4381'>lung (Fig. 9). The other two probe sets demonstrated statistically significant</div><div class='line' id='LC4382'>up-regulation in both squamous cell carcinoma and metastatic adenocarcinoma</div><div class='line' id='LC4383'>of the lung.&quot;</div><div class='line' id='LC4384'><br/></div><div class='line' id='LC4385'>rnaAbundance(HGNC:RIN1) positiveCorrelation pathology(MESHD:Adenocarcinoma)</div><div class='line' id='LC4386'>rnaAbundance(HGNC:RIN1) positiveCorrelation pathology(MESHD:&quot;Carcinoma, Squamous Cell&quot;)</div><div class='line' id='LC4387'>rnaAbundance(HGNC:RIN1) positiveCorrelation pathology(MESHD:&quot;Adenocarcinoma, Bronchiolo-Alveolar&quot;)</div><div class='line' id='LC4388'>rnaAbundance(HGNC:RIN1) positiveCorrelation pathology(MESHD:&quot;Carcinoid Tumor&quot;)</div><div class='line' id='LC4389'><br/></div><div class='line' id='LC4390'>UNSET STATEMENT_GROUP</div><div class='line' id='LC4391'><br/></div><div class='line' id='LC4392'>SET STATEMENT_GROUP = &quot;Group 34&quot;</div><div class='line' id='LC4393'><br/></div><div class='line' id='LC4394'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC4395'>SET Evidence = &quot;In human pancreatic islets, specific insulin biosynthesis, i.e. after normalization</div><div class='line' id='LC4396'>to total protein biosynthesis, increased by 2-fold (P &lt; 0.01) upon stimulation</div><div class='line' id='LC4397'>with glucose and by 2.3-fold (P &lt; 0.01) upon stimulation with insulin (Fig.1)&quot;</div><div class='line' id='LC4398'>SET Citation = {&quot;PubMed&quot;,&quot;Endocrinology&quot;,&quot;15001544&quot;,&quot;2004-04-04&quot;,&quot;Andreozzi F|D&#39;Alessandris C|Federici M|Laratta E|Del Guerra S|Del Prato S|Marchetti P|Lauro R|Perticone F|Sesti G&quot;,&quot;&quot;}</div><div class='line' id='LC4399'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4400'>SET EndocrineSystem = &quot;Islets of Langerhans&quot;</div><div class='line' id='LC4401'><br/></div><div class='line' id='LC4402'>abundance(CHEBI:glucose) increases proteinAbundance(HGNC:INS)</div><div class='line' id='LC4403'><br/></div><div class='line' id='LC4404'>SET Evidence = &quot;Insulin biosynthesis in human pancreatic islets exposed to glucosamine was reduced</div><div class='line' id='LC4405'>by 39% upon glucose stimulation (P &lt; 0.01) and by 24% upon insulin stimulation</div><div class='line' id='LC4406'>(P &lt; 0.01) as compared with untreated control human islets.&quot;</div><div class='line' id='LC4407'><br/></div><div class='line' id='LC4408'>abundance(CHEBI:glucosamine) decreases (abundance(CHEBI:glucose) increases proteinAbundance(HGNC:INS))</div><div class='line' id='LC4409'><br/></div><div class='line' id='LC4410'>SET CellLine = &quot;RIN-m&quot;</div><div class='line' id='LC4411'>SET Evidence = &quot;in control RIN β-cells, specific insulin biosynthesis increased by 1.9-fold (P &lt; 0.001)</div><div class='line' id='LC4412'>upon stimulation with glucose and by 2.0-fold (P &lt; 0.001) upon stimulation</div><div class='line' id='LC4413'>with insulin (Fig.2). Insulin biosynthesis in RIN β-cells exposed to glucosamine</div><div class='line' id='LC4414'>was reduced by 40% upon glucose stimulation (P &lt; 0.001) and by 45% upon insulin</div><div class='line' id='LC4415'>stimulation (P &lt; 0.01) as compared with untreated control β-cells.&quot;</div><div class='line' id='LC4416'>SET Species = &quot;10116&quot;</div><div class='line' id='LC4417'><br/></div><div class='line' id='LC4418'>abundance(CHEBI:glucosamine) decreases (abundance(CHEBI:glucose) increases proteinAbundance(HGNC:INS))</div><div class='line' id='LC4419'><br/></div><div class='line' id='LC4420'>SET DigestiveSystem = &quot;Islets of Langerhans&quot;</div><div class='line' id='LC4421'>SET Evidence = &quot;we combined the stimulation with glucose or insulin with the cotreatment with inhibitors</div><div class='line' id='LC4422'>of the insulin receptor tyrosine kinase [hydroxy-2-naphthalenylmethylphosphonic</div><div class='line' id='LC4423'>acid trisacetoxymethyl ester (HNMPA)], PI 3-kinase (wortmannin and LY294002),</div><div class='line' id='LC4424'>and mTOR (rapamycin). As shown in Figs. 1 and 2, HNMPA, wortmannin, LY294002,</div><div class='line' id='LC4425'>and rapamycin inhibited both glucose- and insulin-stimulated insulin biosynthesis</div><div class='line' id='LC4426'>in both human pancreatic islets and RIN β-cells.&quot;</div><div class='line' id='LC4427'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4428'><br/></div><div class='line' id='LC4429'>kinaseActivity(proteinAbundance(HGNC:INSR)) increases (abundance(CHEBI:glucose) increases proteinAbundance(HGNC:INS))</div><div class='line' id='LC4430'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) increases (abundance(CHEBI:glucose) increases proteinAbundance(HGNC:INS))</div><div class='line' id='LC4431'>kinaseActivity(proteinAbundance(HGNC:MTOR)) increases (abundance(CHEBI:glucose) increases proteinAbundance(HGNC:INS))</div><div class='line' id='LC4432'>abundance(CHEBI:wortmannin) directlyDecreases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC4433'>abundance(CHEBI:rapamycin) directlyDecreases kinaseActivity(proteinAbundance(HGNC:MTOR))</div><div class='line' id='LC4434'><br/></div><div class='line' id='LC4435'>SET Evidence = &quot;As shown in Fig. 3A, exposure of the cells to high glucose concentrations resulted</div><div class='line' id='LC4436'>in a 47% reduction of insulin-stimulated tyrosine phosphorylation of IRS-1 as</div><div class='line' id='LC4437'>compared with control RIN β-cells.&quot;</div><div class='line' id='LC4438'>SET Species = &quot;10116&quot;</div><div class='line' id='LC4439'><br/></div><div class='line' id='LC4440'>abundance(CHEBI:glucose) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases proteinAbundance(RGD:Irs1,proteinModification(P,Y)))</div><div class='line' id='LC4441'><br/></div><div class='line' id='LC4442'>SET Evidence = &quot;insulin-stimulated PI 3-kinase activity associated with IRS-1 was reduced by 36% in</div><div class='line' id='LC4443'>RIN β-cells exposed to high glucose concentrations as compared with control RIN</div><div class='line' id='LC4444'>β-cells (Fig. 3B).&quot;</div><div class='line' id='LC4445'><br/></div><div class='line' id='LC4446'>abundance(CHEBI:glucose) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases kinaseActivity(complexAbundance(NCR:&quot;p85/p110 PI3Kinase Complex&quot;)))</div><div class='line' id='LC4447'><br/></div><div class='line' id='LC4448'>SET Evidence = &quot;exposure of the cells to glucosamine resulted in a 38% reduction of insulin-stimulated</div><div class='line' id='LC4449'>tyrosine phosphorylation of IRS-1 as compared with control RIN β-cells.&quot;</div><div class='line' id='LC4450'><br/></div><div class='line' id='LC4451'>abundance(CHEBI:glucosamine) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases proteinAbundance(RGD:Irs1,proteinModification(P,Y)))</div><div class='line' id='LC4452'><br/></div><div class='line' id='LC4453'>SET Evidence = &quot;Insulin-stimulated PI 3-kinase activity associated with IRS-1 was reduced by 40% in</div><div class='line' id='LC4454'>RIN β-cells exposed to glucosamine as compared with control RIN β-cells (Fig.</div><div class='line' id='LC4455'>3B)&quot;</div><div class='line' id='LC4456'><br/></div><div class='line' id='LC4457'>abundance(CHEBI:glucosamine) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases kinaseActivity(complexAbundance(NCR:&quot;p85/p110 PI3Kinase Complex&quot;)))</div><div class='line' id='LC4458'><br/></div><div class='line' id='LC4459'>SET Evidence = &quot;As shown in Fig. 4, insulin-stimulated Tyr608 and Tyr628 phosphorylation of IRS-1</div><div class='line' id='LC4460'>was decreased by 30 and 46%, respectively, in RIN β-cells exposed to glucosamine</div><div class='line' id='LC4461'>as compared with control RIN β-cells.&quot;</div><div class='line' id='LC4462'><br/></div><div class='line' id='LC4463'>abundance(CHEBI:glucosamine) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases proteinAbundance(RGD:Irs1,proteinModification(P,Y,608)))</div><div class='line' id='LC4464'>abundance(CHEBI:glucosamine) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases proteinAbundance(RGD:Irs1,proteinModification(P,Y,628)))</div><div class='line' id='LC4465'><br/></div><div class='line' id='LC4466'>SET Evidence = &quot;Exposure of cells to glucosamine also resulted in a 39% reduction of insulin-stimulated</div><div class='line' id='LC4467'>tyrosine phosphorylation of IRS-2 as compared with control RIN β-cells (Fig.</div><div class='line' id='LC4468'>5A).&quot;</div><div class='line' id='LC4469'><br/></div><div class='line' id='LC4470'>abundance(CHEBI:glucosamine) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases proteinAbundance(RGD:Irs2,proteinModification(P,Y)))</div><div class='line' id='LC4471'><br/></div><div class='line' id='LC4472'>SET Evidence = &quot;To determine whether alterations in insulin-stimulated PI 3-kinase activation induced</div><div class='line' id='LC4473'>by exposure of RIN β-cells to glucosamine affected Akt phosphorylation, lysates</div><div class='line' id='LC4474'>from insulin-treated RIN cells were immunoblotted with phospho-specific anti-Ser473</div><div class='line' id='LC4475'>antibody. Insulin-induced Ser473 Akt phosphorylation was reduced by 37%</div><div class='line' id='LC4476'>(Fig. 6).&quot;</div><div class='line' id='LC4477'><br/></div><div class='line' id='LC4478'>abundance(CHEBI:glucosamine) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases proteinAbundance(RGD:Akt1,proteinModification(P,S,473)))</div><div class='line' id='LC4479'><br/></div><div class='line' id='LC4480'>SET Evidence = &quot;As shown in Fig. 7A, insulin-stimulated phosphorylation of mTOR at Ser2248 was decreased</div><div class='line' id='LC4481'>by 30%, whereas phosphorylation of tuberin at Thr1462 was decreased by 36%</div><div class='line' id='LC4482'>in RIN β-cells exposed to glucosamine as compared with control RIN β-cells (Fig.</div><div class='line' id='LC4483'>7B).&quot;</div><div class='line' id='LC4484'><br/></div><div class='line' id='LC4485'>abundance(CHEBI:glucosamine) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases proteinAbundance(RGD:Mtor,proteinModification(P,S,2448)))</div><div class='line' id='LC4486'>abundance(CHEBI:glucosamine) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases proteinAbundance(RGD:Tsc2,proteinModification(P,S,1462)))</div><div class='line' id='LC4487'><br/></div><div class='line' id='LC4488'>SET Evidence = &quot;As shown in Fig. 8A, insulin-stimulated p70S6 kinase Thr389  phosphorylation was decreased</div><div class='line' id='LC4489'>by 50% in RIN β-cells exposed to glucosamine as compared with control</div><div class='line' id='LC4490'>RIN β-cells, whereas expression of p70S6 kinase did not differ between glucosamine-treated</div><div class='line' id='LC4491'>and -untreated RIN β-cells as detected by immunoblotting.&quot;</div><div class='line' id='LC4492'><br/></div><div class='line' id='LC4493'>abundance(CHEBI:glucosamine) decreases (proteinAbundance(PFR:&quot;Ins Family&quot;) increases proteinAbundance(RGD:Rps6kb2,proteinModification(P,T,389)))</div><div class='line' id='LC4494'><br/></div><div class='line' id='LC4495'>SET Evidence = &quot;As shown in Fig. 9, A–C, exposure of RIN β-cells to high glucose resulted in an increased</div><div class='line' id='LC4496'>phosphorylation of both JNK and the transcription factor c-Jun, a physiological</div><div class='line' id='LC4497'>substrate of JNK as well as the ERK-1 and -2 members of MAPK family.&quot;</div><div class='line' id='LC4498'><br/></div><div class='line' id='LC4499'>abundance(CHEBI:glucose) increases proteinAbundance(PFR:&quot;Mapk JNK Family&quot;,proteinModification(P))</div><div class='line' id='LC4500'>proteinAbundance(PFR:&quot;Mapk JNK Family&quot;,proteinModification(P)) directlyIncreases kinaseActivity(proteinAbundance(PFR:&quot;Mapk JNK Family&quot;))</div><div class='line' id='LC4501'>kinaseActivity(proteinAbundance(PFR:&quot;Mapk JNK Family&quot;)) directlyIncreases proteinAbundance(RGD:Jun,proteinModification(P))</div><div class='line' id='LC4502'><br/></div><div class='line' id='LC4503'>SET Evidence = &quot;exposure of RIN β-cells to high glucose increased phosphorylation of both IRS-1 Ser307</div><div class='line' id='LC4504'>and IRS-1 Ser612 (Fig. 10, A and B)&quot;</div><div class='line' id='LC4505'><br/></div><div class='line' id='LC4506'>abundance(CHEBI:glucose) increases proteinAbundance(RGD:Irs1,proteinModification(P,S,307))</div><div class='line' id='LC4507'>abundance(CHEBI:glucose) increases proteinAbundance(RGD:Irs1,proteinModification(P,S,612))</div><div class='line' id='LC4508'><br/></div><div class='line' id='LC4509'>SET Evidence = &quot;Inhibition of hexosamine biosynthesis by the GFAT inhibitor azaserine reversed the</div><div class='line' id='LC4510'>stimulatory effects of glucose on JNK, c-Jun, and ERK1/2 activation (Fig. 9, A–C)</div><div class='line' id='LC4511'>as well as IRS-1 phosphorylation at Ser307 and Ser612 (Fig. 10, A and B).&quot;</div><div class='line' id='LC4512'><br/></div><div class='line' id='LC4513'>abundance(SCHEM:Azaserine) directlyDecreases catalyticActivity(proteinAbundance(RGD:Gfpt1))</div><div class='line' id='LC4514'>abundance(SCHEM:Azaserine) decreases (abundance(CHEBI:glucose) increases kinaseActivity(proteinAbundance(PFR:&quot;Mapk JNK Family&quot;)))</div><div class='line' id='LC4515'>abundance(SCHEM:Azaserine) decreases (abundance(CHEBI:glucose) increases transcriptionalActivity(proteinAbundance(RGD:Jun)))</div><div class='line' id='LC4516'>abundance(SCHEM:Azaserine) decreases (abundance(CHEBI:glucose) increases kinaseActivity(proteinAbundance(RGD:Mapk1)))</div><div class='line' id='LC4517'>abundance(SCHEM:Azaserine) decreases (abundance(CHEBI:glucose) increases kinaseActivity(proteinAbundance(RGD:Mapk3)))</div><div class='line' id='LC4518'><br/></div><div class='line' id='LC4519'>SET Evidence = &quot;exposure of RIN β-cells to glucosamine resulted in an increased phosphorylation of</div><div class='line' id='LC4520'>JNK, c-Jun, and ERK1/2 as compared with control RIN β-cells (Fig. 9, A–C).&quot;</div><div class='line' id='LC4521'><br/></div><div class='line' id='LC4522'>abundance(CHEBI:glucosamine) increases kinaseActivity(proteinAbundance(PFR:&quot;Mapk JNK Family&quot;))</div><div class='line' id='LC4523'>abundance(CHEBI:glucosamine) increases proteinAbundance(RGD:Jun,proteinModification(P))</div><div class='line' id='LC4524'>abundance(CHEBI:glucosamine) increases kinaseActivity(proteinAbundance(RGD:Mapk1))</div><div class='line' id='LC4525'>abundance(CHEBI:glucosamine) increases kinaseActivity(proteinAbundance(RGD:Mapk3))</div><div class='line' id='LC4526'><br/></div><div class='line' id='LC4527'>SET Evidence = &quot;Exposure of RIN β-cells to glucosamine increased phosphorylation of both IRS-1 Ser307</div><div class='line' id='LC4528'>and IRS-1 Ser612, which was reversed by treatment with either a cell-permeable</div><div class='line' id='LC4529'>JNK inhibitor or PD98059, a reversible MAPK kinase (MEK)1 inhibitor, the enzyme</div><div class='line' id='LC4530'>that directly activates ERK1/2, respectively (Fig. 10, A and B)&quot;</div><div class='line' id='LC4531'><br/></div><div class='line' id='LC4532'>abundance(CHEBI:glucosamine) increases proteinAbundance(RGD:Irs1,proteinModification(P,S,307))</div><div class='line' id='LC4533'>abundance(CHEBI:glucosamine) increases proteinAbundance(RGD:Irs1,proteinModification(P,S,612))</div><div class='line' id='LC4534'>kinaseActivity(proteinAbundance(PFR:&quot;Mapk JNK Family&quot;)) increases (abundance(CHEBI:glucosamine) increases proteinAbundance(RGD:Irs1,proteinModification(P,S,307)))</div><div class='line' id='LC4535'>kinaseActivity(proteinAbundance(PFR:&quot;Mapk JNK Family&quot;)) increases (abundance(CHEBI:glucosamine) increases proteinAbundance(RGD:Irs1,proteinModification(P,S,612)))</div><div class='line' id='LC4536'>kinaseActivity(proteinAbundance(RGD:Map2k1)) increases (abundance(CHEBI:glucosamine) increases proteinAbundance(RGD:Irs1,proteinModification(P,S,307)))</div><div class='line' id='LC4537'>kinaseActivity(proteinAbundance(RGD:Map2k1)) increases (abundance(CHEBI:glucosamine) increases proteinAbundance(RGD:Irs1,proteinModification(P,S,612)))</div><div class='line' id='LC4538'>abundance(SCHEM:&quot;PD 98,059&quot;) directlyDecreases kinaseActivity(proteinAbundance(RGD:Map2k1))</div><div class='line' id='LC4539'><br/></div><div class='line' id='LC4540'>UNSET STATEMENT_GROUP</div><div class='line' id='LC4541'><br/></div><div class='line' id='LC4542'>SET STATEMENT_GROUP = &quot;Group 35&quot;</div><div class='line' id='LC4543'><br/></div><div class='line' id='LC4544'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC4545'>SET Evidence = &quot;Triggering of the IL-1R or TLR causes the adaptor protein MyD88 to be recruited to</div><div class='line' id='LC4546'>the receptor complex, which in turn promotes association with the IL-1R-associated</div><div class='line' id='LC4547'>kinases IRAK4 and IRAK1. During the formation of this complex, IRAK4 is activated,</div><div class='line' id='LC4548'>leading to the hyperphosphorylation of IRAK-1, which then induces the interaction</div><div class='line' id='LC4549'>of TRAF6 with the complex.&quot;</div><div class='line' id='LC4550'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;12893815&quot;,&quot;2003-08-30&quot;,&quot;Akira S&quot;,&quot;&quot;}</div><div class='line' id='LC4551'><br/></div><div class='line' id='LC4552'>molecularActivity(proteinAbundance(HGNC:MYD88)) directlyIncreases complexAbundance(proteinAbundance(HGNC:MYD88),proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:IRAK4))</div><div class='line' id='LC4553'>complexAbundance(proteinAbundance(HGNC:MYD88),proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:IRAK4)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:IRAK4))</div><div class='line' id='LC4554'>kinaseActivity(proteinAbundance(HGNC:IRAK4)) directlyIncreases proteinAbundance(HGNC:IRAK1,proteinModification(P))</div><div class='line' id='LC4555'>proteinAbundance(HGNC:IRAK1,proteinModification(P)) directlyIncreases complexAbundance(proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:TRAF6))</div><div class='line' id='LC4556'><br/></div><div class='line' id='LC4557'>SET CellStructure = &quot;Cell Membrane&quot;</div><div class='line' id='LC4558'>SET Evidence = &quot;The IRAK-4·IRAK-1·TRAF6 complex then interacts at the membrane with another preformed</div><div class='line' id='LC4559'>complex consisting of TAK1, TAB1, and TAB2. This interaction induces phosphorylation</div><div class='line' id='LC4560'>of TAB2 and TAK1, which then translocate together with TRAF6 and TAB1</div><div class='line' id='LC4561'>to the cytosol.&quot;</div><div class='line' id='LC4562'><br/></div><div class='line' id='LC4563'>complexAbundance(proteinAbundance(HGNC:IRAK4),proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:TRAF6),proteinAbundance(HGNC:MAP3K7),proteinAbundance(HGNC:TAB1),proteinAbundance(HGNC:TAB2))</div><div class='line' id='LC4564'>complexAbundance(proteinAbundance(HGNC:IRAK4),proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:TRAF6),proteinAbundance(HGNC:MAP3K7),proteinAbundance(HGNC:TAB1),proteinAbundance(HGNC:TAB2)) directlyIncreases proteinAbundance(HGNC:MAP3K7,proteinModification(P))</div><div class='line' id='LC4565'>complexAbundance(proteinAbundance(HGNC:IRAK4),proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:TRAF6),proteinAbundance(HGNC:MAP3K7),proteinAbundance(HGNC:TAB1),proteinAbundance(HGNC:TAB2)) directlyIncreases proteinAbundance(HGNC:TAB2,proteinModification(P))</div><div class='line' id='LC4566'><br/></div><div class='line' id='LC4567'>SET CellStructure = &quot;Cytoplasm&quot;</div><div class='line' id='LC4568'><br/></div><div class='line' id='LC4569'>complexAbundance(proteinAbundance(HGNC:TAB1),proteinAbundance(HGNC:TAB2),proteinAbundance(HGNC:TRAF6),proteinAbundance(HGNC:MAP3K7))</div><div class='line' id='LC4570'><br/></div><div class='line' id='LC4571'>SET Evidence = &quot;TAK1 is subsequently activated in the cytoplasm, leading to the activation of IKK.</div><div class='line' id='LC4572'>Inactive IKK sequesters NF-κB in the cytoplasm, but activation leads to phosphorylation</div><div class='line' id='LC4573'>and degradation of IκB and consequent release of NF-κB. Activation of</div><div class='line' id='LC4574'>TAK1 also results in the activation of MAP kinases and c-Jun NH2-terminal kinase</div><div class='line' id='LC4575'>(JNK).&quot;</div><div class='line' id='LC4576'><br/></div><div class='line' id='LC4577'>kinaseActivity(proteinAbundance(HGNC:MAP3K7)) increases kinaseActivity(complexAbundance(NCH:&quot;IkappaB Kinase Complex&quot;))</div><div class='line' id='LC4578'>kinaseActivity(complexAbundance(NCH:&quot;IkappaB Kinase Complex&quot;)) directlyIncreases degradation(proteinAbundance(HGNC:NFKBIA))</div><div class='line' id='LC4579'>kinaseActivity(complexAbundance(NCH:&quot;IkappaB Kinase Complex&quot;)) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC4580'>kinaseActivity(proteinAbundance(HGNC:MAP3K7)) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC4581'><br/></div><div class='line' id='LC4582'>SET CellLine = &quot;M1&quot;</div><div class='line' id='LC4583'>SET Evidence = &quot;MyD88 was originally isolated as a myeloid differentiation primary response gene that</div><div class='line' id='LC4584'>is rapidly induced upon IL-6-stimulated differentiation of M1 myeloleukemic</div><div class='line' id='LC4585'>cells into macrophages&quot;</div><div class='line' id='LC4586'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4587'><br/></div><div class='line' id='LC4588'>proteinAbundance(HGNC:IL6) increases rnaAbundance(HGNC:MYD88)</div><div class='line' id='LC4589'><br/></div><div class='line' id='LC4590'>SET Evidence = &quot;Although the kinase activity of IRAK-1 increases strongly following IL-1 stimulation,</div><div class='line' id='LC4591'>IRAK-1 kinase activity is not required for its signaling function, because</div><div class='line' id='LC4592'>overexpression of a kinase-defective mutant of IRAK-1 is observed to strongly induce</div><div class='line' id='LC4593'>NF-κB activation in cells otherwise deficient for IRAK-1. Upon stimulation,</div><div class='line' id='LC4594'>IRAK-1 is recruited to the receptor through a homophilic interaction with the DD</div><div class='line' id='LC4595'>of MyD88.&quot;</div><div class='line' id='LC4596'><br/></div><div class='line' id='LC4597'>proteinAbundance(PFH:&quot;IL1 Family&quot;) increases kinaseActivity(proteinAbundance(HGNC:IRAK1))</div><div class='line' id='LC4598'>proteinAbundance(HGNC:IRAK1) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC4599'>proteinAbundance(PFH:&quot;IL1 Family&quot;) increases complexAbundance(proteinAbundance(HGNC:MYD88),proteinAbundance(HGNC:IRAK1))</div><div class='line' id='LC4600'><br/></div><div class='line' id='LC4601'>SET Evidence = &quot;MyD88 also binds to IRAK-4 and thereby facilitates IRAK-4 phosphorylation of critical</div><div class='line' id='LC4602'>residue(s) in the kinase activation loop of IRAK-1, triggering IRAK-1&#39;s own</div><div class='line' id='LC4603'>kinase activity. Once activated, IRAK-1 likely autophosphorylates residues in its</div><div class='line' id='LC4604'>N terminus. TRAF6 is also recruited to the receptor complex via interaction with</div><div class='line' id='LC4605'>IRAK-1.&quot;</div><div class='line' id='LC4606'><br/></div><div class='line' id='LC4607'>proteinAbundance(HGNC:MYD88) directlyIncreases (kinaseActivity(proteinAbundance(HGNC:IRAK4)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:IRAK1)))</div><div class='line' id='LC4608'>complexAbundance(proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:TRAF6))</div><div class='line' id='LC4609'><br/></div><div class='line' id='LC4610'>SET Evidence = &quot;IRAK-1-deficient mice and cell lines showed diminished cytokine production in response</div><div class='line' id='LC4611'>to IL-1 and LPS;&quot;</div><div class='line' id='LC4612'>SET Species = &quot;10090&quot;</div><div class='line' id='LC4613'><br/></div><div class='line' id='LC4614'>proteinAbundance(PFM:&quot;Il1 Family&quot;) increases biologicalProcess(GO:&quot;cytokine production&quot;)</div><div class='line' id='LC4615'>abundance(SCHEM:Lipopolysaccharide) increases biologicalProcess(GO:&quot;cytokine production&quot;)</div><div class='line' id='LC4616'>proteinAbundance(MGI:Irak1) increases (proteinAbundance(PFM:&quot;Il1 Family&quot;) increases biologicalProcess(GO:&quot;cytokine production&quot;))</div><div class='line' id='LC4617'>proteinAbundance(MGI:Irak1) increases (abundance(SCHEM:Lipopolysaccharide) increases biologicalProcess(GO:&quot;cytokine production&quot;))</div><div class='line' id='LC4618'><br/></div><div class='line' id='LC4619'>SET Cell = &quot;Macrophages&quot;</div><div class='line' id='LC4620'>SET Evidence = &quot;Data with IRAK-M knock-out mice have revealed that IRAK-M serves as a negative regulator</div><div class='line' id='LC4621'>of IL-1R/TLR signaling (19). IRAK-M-deficient macrophages produced significantly</div><div class='line' id='LC4622'>higher cytokine levels in response to a variety of IL-1R/TLR ligands.&quot;</div><div class='line' id='LC4623'><br/></div><div class='line' id='LC4624'>proteinAbundance(MGI:Irak3) decreases biologicalProcess(GO:&quot;toll-like receptor signaling pathway&quot;)</div><div class='line' id='LC4625'>proteinAbundance(MGI:Irak3) decreases biologicalProcess(GO:&quot;cytokine production&quot;)</div><div class='line' id='LC4626'><br/></div><div class='line' id='LC4627'>SET Evidence = &quot;TRAF6 directly interacts with CD40 and TRANCE-R&quot;</div><div class='line' id='LC4628'><br/></div><div class='line' id='LC4629'>complexAbundance(proteinAbundance(HGNC:TRAF6),proteinAbundance(HGNC:CD40))</div><div class='line' id='LC4630'>complexAbundance(proteinAbundance(HGNC:TRAF6),proteinAbundance(HGNC:TNFRSF11A))</div><div class='line' id='LC4631'><br/></div><div class='line' id='LC4632'>SET Evidence = &quot;Studies using small interfering RNA (siRNA) to inhibit TAK1 expression show that TAK1</div><div class='line' id='LC4633'>is essential for both IL-1- and TNF-α-induced NF-κB activation. Two TAK1-binding</div><div class='line' id='LC4634'>proteins, TAB1 and TAB2, have been identified (24, 25). When ectopically co-expressed,</div><div class='line' id='LC4635'>TAB1 augments the kinase activity of TAK1, indicating that TAB1 functions</div><div class='line' id='LC4636'>as an activator of TAK1.&quot;</div><div class='line' id='LC4637'><br/></div><div class='line' id='LC4638'>proteinAbundance(PFH:&quot;IL1 Family&quot;) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC4639'>proteinAbundance(HGNC:TNF) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC4640'>proteinAbundance(HGNC:MAP3K7) increases (proteinAbundance(PFH:&quot;IL1 Family&quot;) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;)))</div><div class='line' id='LC4641'>proteinAbundance(HGNC:MAP3K7) increases (proteinAbundance(HGNC:TNF) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;)))</div><div class='line' id='LC4642'>proteinAbundance(HGNC:TAB1) directlyIncreases kinaseActivity(proteinAbundance(HGNC:MAP3K7))</div><div class='line' id='LC4643'>complexAbundance(proteinAbundance(HGNC:TAB2),proteinAbundance(HGNC:MAP3K7))</div><div class='line' id='LC4644'><br/></div><div class='line' id='LC4645'>SET Evidence = &quot;TAB2 is associated with the cell membrane in unstimulated conditions, but upon stimulation</div><div class='line' id='LC4646'>it translocates to the cytosol, where it functions as an adaptor linking</div><div class='line' id='LC4647'>TAK1 to TRAF6, thereby facilitating TAK1 activation.&quot;</div><div class='line' id='LC4648'><br/></div><div class='line' id='LC4649'>complexAbundance(proteinAbundance(HGNC:TAB2),proteinAbundance(HGNC:TRAF6),proteinAbundance(HGNC:MAP3K7))</div><div class='line' id='LC4650'>proteinAbundance(HGNC:TAB2) directlyIncreases kinaseActivity(proteinAbundance(HGNC:MAP3K7))</div><div class='line' id='LC4651'><br/></div><div class='line' id='LC4652'>SET Evidence = &quot;It has been shown recently that ubiquitination plays an important role in TAK1 activation</div><div class='line' id='LC4653'>(26, 27). IKK activation by TRAF6 requires a dimeric ubiquitin-conjugating</div><div class='line' id='LC4654'>enzyme complex composed of Ubc13 and Uev1A as well as the TAK1·kinase complex.</div><div class='line' id='LC4655'>TRAF6 can interact through its RING finger domain with Ubc13 in the Ubc13·Uev1A</div><div class='line' id='LC4656'>complex. This Ubc·TRAF6 complex catalyzes the formation of a Lys-63-linked polyubiquitin</div><div class='line' id='LC4657'>chain, which triggers TAK1 activation through a unique proteasome-independent</div><div class='line' id='LC4658'>mechanism.&quot;</div><div class='line' id='LC4659'><br/></div><div class='line' id='LC4660'>proteinAbundance(HGNC:TRAF6) increases kinaseActivity(complexAbundance(NCH:&quot;IkappaB Kinase Complex&quot;))</div><div class='line' id='LC4661'>catalyticActivity(complexAbundance(proteinAbundance(HGNC:UBE2N),proteinAbundance(HGNC:UBE2V1),proteinAbundance(HGNC:TRAF6))) increases kinaseActivity(proteinAbundance(HGNC:MAP3K7))</div><div class='line' id='LC4662'><br/></div><div class='line' id='LC4663'>SET Evidence = &quot;Tollip—Tollip (Toll-interacting protein) was originally cloned as a protein interacting</div><div class='line' id='LC4664'>with the IL-1 receptor accessory protein (28). Tollip also associates with</div><div class='line' id='LC4665'>TLR2 and TLR4. In resting cells, Tollip forms a complex with members of the IRAK</div><div class='line' id='LC4666'>family, thereby preventing NF-κB activation. Upon activation Tollip·IRAK-1 complexes</div><div class='line' id='LC4667'>are recruited to the cognate receptor, resulting in the rapid autophosphorylation</div><div class='line' id='LC4668'>of IRAK-1 and its dissociation from the receptor.&quot;</div><div class='line' id='LC4669'><br/></div><div class='line' id='LC4670'>complexAbundance(proteinAbundance(HGNC:TOLLIP),proteinAbundance(HGNC:IL1RAP))</div><div class='line' id='LC4671'>complexAbundance(proteinAbundance(HGNC:TOLLIP),proteinAbundance(HGNC:TLR2))</div><div class='line' id='LC4672'>complexAbundance(proteinAbundance(HGNC:TOLLIP),proteinAbundance(HGNC:TLR4))</div><div class='line' id='LC4673'>complexAbundance(proteinAbundance(HGNC:TOLLIP),proteinAbundance(HGNC:IRAK1))</div><div class='line' id='LC4674'>proteinAbundance(HGNC:TOLLIP) decreases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC4675'><br/></div><div class='line' id='LC4676'>SET Evidence = &quot;Pellino 1 is required for IL-1-induced NF-κB activation and IL-8 gene expression (30).</div><div class='line' id='LC4677'>Pellino 2 has also been shown to be involved in IL-1R/TLR signaling pathways</div><div class='line' id='LC4678'>(31). Following IL-1 stimulation, IRAK-1 and Pellino 2 associate to form complexes.</div><div class='line' id='LC4679'>Ectopic expression of a Pellino 2 antisense construct was shown to inhibit</div><div class='line' id='LC4680'>IL-1- and LPS-dependent but not TNF-α-dependent activation of the IL-8 promoter.&quot;</div><div class='line' id='LC4681'><br/></div><div class='line' id='LC4682'>proteinAbundance(HGNC:PELI1) increases (proteinAbundance(PFH:&quot;IL1 Family&quot;) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;)))</div><div class='line' id='LC4683'>proteinAbundance(PFH:&quot;IL1 Family&quot;) increases complexAbundance(proteinAbundance(HGNC:IRAK1),proteinAbundance(HGNC:PELI2))</div><div class='line' id='LC4684'>proteinAbundance(HGNC:PELI2) increases (proteinAbundance(PFH:&quot;IL1 Family&quot;) increases rnaAbundance(HGNC:IL8))</div><div class='line' id='LC4685'>proteinAbundance(HGNC:PELI2) increases (abundance(SCHEM:Lipopolysaccharide) increases rnaAbundance(HGNC:IL8))</div><div class='line' id='LC4686'><br/></div><div class='line' id='LC4687'>SET Evidence = &quot;TLR2 has been shown to bind directly to the regulatory p85 subunit of the PI 3-kinase</div><div class='line' id='LC4688'>(32).&quot;</div><div class='line' id='LC4689'><br/></div><div class='line' id='LC4690'>complexAbundance(proteinAbundance(HGNC:TLR2),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC4691'><br/></div><div class='line' id='LC4692'>SET Evidence = &quot;LPS stimulation has been shown to result in tyrosine phosphorylation of MyD88 and</div><div class='line' id='LC4693'>formation of a PI 3-kinase·MyD88 complex (33).&quot;</div><div class='line' id='LC4694'><br/></div><div class='line' id='LC4695'>abundance(SCHEM:Lipopolysaccharide) increases complexAbundance(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;),proteinAbundance(HGNC:MYD88))</div><div class='line' id='LC4696'>abundance(SCHEM:Lipopolysaccharide) increases proteinAbundance(HGNC:MYD88,proteinModification(P,Y))</div><div class='line' id='LC4697'><br/></div><div class='line' id='LC4698'>SET Evidence = &quot;it is noteworthy that, compared with other TLR ligands, poly(I-C) stimulation induces</div><div class='line' id='LC4699'>the production of relatively large amounts of type I interferons and interferon-inducible</div><div class='line' id='LC4700'>genes but smaller amounts of inflammatory cytokines such as TNF-α</div><div class='line' id='LC4701'>and IL-6, further suggesting that TLR3 does not utilize the MyD88-dependent pathway</div><div class='line' id='LC4702'>for signaling.&quot;</div><div class='line' id='LC4703'><br/></div><div class='line' id='LC4704'>abundance(SCHEM:&quot;Poly I-C&quot;) directlyIncreases molecularActivity(proteinAbundance(HGNC:TLR3))</div><div class='line' id='LC4705'>abundance(SCHEM:&quot;Poly I-C&quot;) increases biologicalProcess(GO:&quot;type I interferon secretion&quot;)</div><div class='line' id='LC4706'><br/></div><div class='line' id='LC4707'>SET Evidence = &quot;Following virus infection, double-stranded RNA, or LPS treatment, IRF-3 undergoes</div><div class='line' id='LC4708'>phosphorylation and translocates from the cytoplasm to the nucleus, resulting in</div><div class='line' id='LC4709'>the transcriptional activation of type I interferons.&quot;</div><div class='line' id='LC4710'><br/></div><div class='line' id='LC4711'>biologicalProcess(GO:&quot;response to virus&quot;) increases proteinAbundance(HGNC:IRF3,proteinModification(P))</div><div class='line' id='LC4712'>biologicalProcess(GO:&quot;response to virus&quot;) increases translocation(proteinAbundance(HGNC:IRF3),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;)</div><div class='line' id='LC4713'>translocation(proteinAbundance(HGNC:IRF3),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;) increases biologicalProcess(GO:&quot;type I interferon production&quot;)</div><div class='line' id='LC4714'><br/></div><div class='line' id='LC4715'>SET Evidence = &quot;TIRAP was shown to associate with TLR-4 but not with other TLRs. Overexpression of</div><div class='line' id='LC4716'>a dominant-negative form of TIRAP was shown to inhibit LPS-induced NF-κB activation</div><div class='line' id='LC4717'>and dendritic cell maturation. Blockage of TIRAP using a cell-permeable inhibitory</div><div class='line' id='LC4718'>peptide also prevented induction of IP-10 by LPS.&quot;</div><div class='line' id='LC4719'><br/></div><div class='line' id='LC4720'>complexAbundance(proteinAbundance(HGNC:TIRAP),proteinAbundance(HGNC:TLR4))</div><div class='line' id='LC4721'>molecularActivity(proteinAbundance(HGNC:TIRAP)) increases (abundance(SCHEM:Lipopolysaccharide) increases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;)))</div><div class='line' id='LC4722'><br/></div><div class='line' id='LC4723'>SET Cell = &quot;Dendritic Cells&quot;</div><div class='line' id='LC4724'><br/></div><div class='line' id='LC4725'>molecularActivity(proteinAbundance(HGNC:TIRAP)) increases (abundance(SCHEM:Lipopolysaccharide) increases biologicalProcess(GO:&quot;dendritic cell differentiation&quot;))</div><div class='line' id='LC4726'>molecularActivity(proteinAbundance(HGNC:TIRAP)) increases (abundance(SCHEM:Lipopolysaccharide) increases proteinAbundance(HGNC:CXCL10))</div><div class='line' id='LC4727'><br/></div><div class='line' id='LC4728'>SET Evidence = &quot;Overexpression of TRIF, but not MyD88 or TIRAP, preferentially activates the IFN-β</div><div class='line' id='LC4729'>promoter. A dominant-negative form (DN) of TRIF, but not MyD88DN or TIRAPDN, blocked</div><div class='line' id='LC4730'>the TLR3-mediated response to poly(I-C),&quot;</div><div class='line' id='LC4731'><br/></div><div class='line' id='LC4732'>proteinAbundance(HGNC:TICAM1) increases rnaAbundance(HGNC:IFNB1)</div><div class='line' id='LC4733'>molecularActivity(proteinAbundance(HGNC:TICAM1)) increases biologicalProcess(GO:&quot;toll-like receptor 3 signaling pathway&quot;)</div><div class='line' id='LC4734'>proteinAbundance(HGNC:MYD88) causesNoChange rnaAbundance(HGNC:IFNB1)</div><div class='line' id='LC4735'>proteinAbundance(HGNC:TIRAP) causesNoChange rnaAbundance(HGNC:IFNB1)</div><div class='line' id='LC4736'><br/></div><div class='line' id='LC4737'>SET Evidence = &quot;Interestingly, TRIF-deficient mice abolished the response to LPS in terms of cytokine</div><div class='line' id='LC4738'>production that was considered to be mediated by the MyD88-dependent pathway.&quot;</div><div class='line' id='LC4739'><br/></div><div class='line' id='LC4740'>proteinAbundance(MGI:Ticam1) increases (abundance(SCHEM:Lipopolysaccharide) increases biologicalProcess(GO:&quot;cytokine production&quot;))</div><div class='line' id='LC4741'><br/></div><div class='line' id='LC4742'>UNSET STATEMENT_GROUP</div><div class='line' id='LC4743'><br/></div><div class='line' id='LC4744'>SET STATEMENT_GROUP = &quot;Group 36&quot;</div><div class='line' id='LC4745'><br/></div><div class='line' id='LC4746'>SET Tissue = &quot;Mammary Glands, Human&quot;</div><div class='line' id='LC4747'>SET Evidence = &quot;We have observed previously that adhesion of normal HB2 cells to collagen I is accompanied</div><div class='line' id='LC4748'>by a collagen-induced phosphorylation of DDR1.9 The present experiments</div><div class='line' id='LC4749'>show that adhesion to collagen IV also causes a phosphorylation of DDR1 in mammary</div><div class='line' id='LC4750'>epithelial cells (Fig.1b).&quot;</div><div class='line' id='LC4751'>SET Citation = {&quot;PubMed&quot;,&quot;International journal of cancer. Journal international du cancer&quot;,&quot;12471617&quot;,&quot;&quot;,&quot;Dejmek J|Dib K|Jönsson M|Andersson T&quot;,&quot;&quot;}</div><div class='line' id='LC4752'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4753'><br/></div><div class='line' id='LC4754'>proteinAbundance(PFH:&quot;COL1 Family&quot;) increases proteinAbundance(HGNC:DDR1,proteinModification(P))</div><div class='line' id='LC4755'>proteinAbundance(PFH:&quot;COL4 Family&quot;) increases proteinAbundance(HGNC:DDR1,proteinModification(P))</div><div class='line' id='LC4756'><br/></div><div class='line' id='LC4757'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC4758'>SET Evidence = &quot;To explore the mechanism(s) involved in the Wnt-5a-dependent effects on collagen-induced</div><div class='line' id='LC4759'>phosphorylation of DDR1 in mammary epithelial cells and on adhesion of such</div><div class='line' id='LC4760'>cells to collagen,9 we first tested the impact of pertussis and cholera toxins</div><div class='line' id='LC4761'>on the collagen-induced phosphorylation of DDR1 in normal HB2 cells. We found</div><div class='line' id='LC4762'>that the phosphorylation was almost abolished by pertussis toxin (Fig. 2a,b), but</div><div class='line' id='LC4763'>was not affected by cholera toxin (Fig. 2c).&quot;</div><div class='line' id='LC4764'><br/></div><div class='line' id='LC4765'>abundance(SCHEM:&quot;Pertussis toxins&quot;) decreases (proteinAbundance(PFH:&quot;COL1 Family&quot;) increases proteinAbundance(HGNC:DDR1,proteinModification(P)))</div><div class='line' id='LC4766'><br/></div><div class='line' id='LC4767'>SET Evidence = &quot;In accordance with the observed effects on phosphorylation of DDR1in HB2 cells (Fig.</div><div class='line' id='LC4768'>2), we subsequently found that pertussis toxin, but not cholera toxin, impaired</div><div class='line' id='LC4769'>the adhesion of normal HB2 cells to collagen (Fig. 3a,b respectively).&quot;</div><div class='line' id='LC4770'><br/></div><div class='line' id='LC4771'>abundance(SCHEM:&quot;Pertussis toxins&quot;) decreases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC4772'>abundance(SCHEM:&quot;Cholera toxin&quot;) causesNoChange biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC4773'><br/></div><div class='line' id='LC4774'>SET Evidence = &quot;α2β1 integrins have been reported to be the major receptor responsible for attachment</div><div class='line' id='LC4775'>of HB2 cells to collagen.9,24 We found, however, that adhesion of HB2 cells</div><div class='line' id='LC4776'>to collagen was decreased by less than 50% in the presence of an anti-β1 integrin</div><div class='line' id='LC4777'>Ab (Fig. 3a), which indicates that, in addition to engagement of β1 integrins,</div><div class='line' id='LC4778'>at least 1 other mechanism must be involved in adherence of these cells to collagen.&quot;</div><div class='line' id='LC4779'><br/></div><div class='line' id='LC4780'>proteinAbundance(HGNC:ITGB1) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC4781'><br/></div><div class='line' id='LC4782'>SET CellLine = &quot;MCF7&quot;</div><div class='line' id='LC4783'>SET Evidence = &quot;Furthermore, we tested the effects of pertussis toxin on Wnt-5a-deficient HB2 (Fig.</div><div class='line' id='LC4784'>4a) and MCF-7 mammary tumor (Fig. 4b) cells. As expected, both of these Wnt-5a-deficient</div><div class='line' id='LC4785'>cell lines exhibited significantly less adhesion that reached a maximum</div><div class='line' id='LC4786'>(50–60% of the plated cells) after 90–120 min (Fig. 4), which is nearly half</div><div class='line' id='LC4787'>of the adhesive capacity of Wnt-5a-expressing HB2 cells (Fig. 3).&quot;</div><div class='line' id='LC4788'><br/></div><div class='line' id='LC4789'>proteinAbundance(HGNC:WNT5A) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC4790'>abundance(SCHEM:&quot;Pertussis toxins&quot;) decreases (proteinAbundance(HGNC:WNT5A) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;))</div><div class='line' id='LC4791'><br/></div><div class='line' id='LC4792'>SET Evidence = &quot;We found that treatment with 7.5 μM mastoparan enabled a marked collagen-induced phosphorylation</div><div class='line' id='LC4793'>of DDR1 after only 30 min (Fig. 5a) and a concomitant increase in</div><div class='line' id='LC4794'>adhesion after 60 and 90 min (Fig. 5b). Other investigators have previously reported</div><div class='line' id='LC4795'>that the indicated concentration of mastoparan primarily activates Gi/o-proteins,</div><div class='line' id='LC4796'>whereas a significantly higher concentration is needed to stimulate transducin</div><div class='line' id='LC4797'>and Gs-proteins.27&quot;</div><div class='line' id='LC4798'><br/></div><div class='line' id='LC4799'>abundance(SCHEM:Mastoparan) increases gtpBoundActivity(proteinAbundance(PFH:&quot;GNAI Family&quot;))</div><div class='line' id='LC4800'>abundance(SCHEM:Mastoparan) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC4801'>abundance(SCHEM:Mastoparan) increases (proteinAbundance(PFH:&quot;COL1 Family&quot;) increases proteinAbundance(HGNC:DDR1,proteinModification(P)))</div><div class='line' id='LC4802'><br/></div><div class='line' id='LC4803'>SET Evidence = &quot;To further ascertain whether such a link exists between Wnt-5a signaling, collagen-induced</div><div class='line' id='LC4804'>DDR1 activation, and the adhesiveness of HB2 cells, we tested the effects</div><div class='line' id='LC4805'>of PP1, a specific inhibitor of Src family tyrosine kinases. We found that PP1</div><div class='line' id='LC4806'>abolished the collagen-induced phosphorylation of DDR1 (Fig. 6a), and that it</div><div class='line' id='LC4807'>also decreased adhesion of normal HB2 cells by about 50% (Fig. 6b).&quot;</div><div class='line' id='LC4808'><br/></div><div class='line' id='LC4809'>abundance(SCHEM:&quot;PP1 tyrosine kinase inhibitor&quot;) directlyDecreases kinaseActivity(proteinAbundance(PFH:&quot;SRC Family&quot;))</div><div class='line' id='LC4810'>abundance(SCHEM:&quot;PP1 tyrosine kinase inhibitor&quot;) decreases (proteinAbundance(PFH:&quot;COL1 Family&quot;) increases proteinAbundance(HGNC:DDR1,proteinModification(P))) //Full text of paper states that type I collagen was used</div><div class='line' id='LC4811'>abundance(SCHEM:&quot;PP1 tyrosine kinase inhibitor&quot;) decreases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC4812'><br/></div><div class='line' id='LC4813'>SET Evidence = &quot;Furthermore, we noted that collagen-stimulated DDR1 interacted with the p85 subunit</div><div class='line' id='LC4814'>of PI3K (Fig. 7b), and we also observed that adherence of HB2 cells to collagen</div><div class='line' id='LC4815'>caused tyrosine phosphorylation of the p85 of PI3K (Fig. 7c), a phenomenon associated</div><div class='line' id='LC4816'>with activation of this enzyme. Neither of these events was observed in</div><div class='line' id='LC4817'>cells pretreated with pertussis toxin (Fig. 7a,b,c).&quot;</div><div class='line' id='LC4818'><br/></div><div class='line' id='LC4819'>proteinAbundance(PFH:&quot;COL1 Family&quot;) increases complexAbundance(proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;),proteinAbundance(HGNC:DDR1))</div><div class='line' id='LC4820'>biologicalProcess(GO:&quot;cell-matrix adhesion&quot;) increases proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;,proteinModification(P,Y))</div><div class='line' id='LC4821'>proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;,proteinModification(P,Y)) directlyIncreases kinaseActivity(proteinAbundance(PFH:&quot;PIK3C Class IA Family&quot;))</div><div class='line' id='LC4822'>abundance(SCHEM:&quot;Pertussis toxins&quot;) decreases (proteinAbundance(PFH:&quot;COL1 Family&quot;) increases complexAbundance(proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;),proteinAbundance(HGNC:DDR1)))</div><div class='line' id='LC4823'>abundance(SCHEM:&quot;Pertussis toxins&quot;) decreases (biologicalProcess(GO:&quot;cell-matrix adhesion&quot;) increases proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;,proteinModification(P,Y)))</div><div class='line' id='LC4824'><br/></div><div class='line' id='LC4825'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC4826'>SET Evidence = &quot;Thus, a Gi/o-protein signaling pathway mediates the effect of Wnt-5a expression by</div><div class='line' id='LC4827'>enabling collagen-induced activation of DDR1, which, in parallel with β1 integrins,</div><div class='line' id='LC4828'>regulates adhesion of mammary cells.&quot;</div><div class='line' id='LC4829'><br/></div><div class='line' id='LC4830'>proteinAbundance(HGNC:WNT5A) increases (gtpBoundActivity(proteinAbundance(PFH:&quot;GNAI Family&quot;)) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;))</div><div class='line' id='LC4831'>proteinAbundance(HGNC:WNT5A) increases (gtpBoundActivity(proteinAbundance(PFH:&quot;GNAI Family&quot;)) increases kinaseActivity(proteinAbundance(HGNC:DDR1)))</div><div class='line' id='LC4832'>kinaseActivity(proteinAbundance(HGNC:DDR1)) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC4833'><br/></div><div class='line' id='LC4834'>UNSET STATEMENT_GROUP</div><div class='line' id='LC4835'><br/></div><div class='line' id='LC4836'>SET STATEMENT_GROUP = &quot;Group 37&quot;</div><div class='line' id='LC4837'><br/></div><div class='line' id='LC4838'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC4839'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC4840'>SET Evidence = &quot;Tumor necrosis factor α (TNFα) strongly increased the expression of E-selectin in</div><div class='line' id='LC4841'>human umbilical vein endothelial cells (HUVEC). This effect was independent of</div><div class='line' id='LC4842'>the activation of SAPK2/p38 induced by TNFα.&quot;</div><div class='line' id='LC4843'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;11448946&quot;,&quot;2001-08-11&quot;,&quot;Laferriere J|Houle F|Taher MM|Valerie K|Huot J&quot;,&quot;&quot;}</div><div class='line' id='LC4844'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4845'><br/></div><div class='line' id='LC4846'>proteinAbundance(HGNC:TNF) increases proteinAbundance(HGNC:SELE)</div><div class='line' id='LC4847'>proteinAbundance(HGNC:TNF) increases kinaseActivity(proteinAbundance(HGNC:MAPK11))</div><div class='line' id='LC4848'><br/></div><div class='line' id='LC4849'>SET Evidence = &quot;Adhesion of HT-29 cells on a monolayer of HUVEC pretreated with TNFα was dependent</div><div class='line' id='LC4850'>on E-selectin expression but was independent of SAPK2/p38 activity of both HUVEC</div><div class='line' id='LC4851'>and tumor cells. The adhesion of HT-29 cells to E-selectin-expressing HUVEC led</div><div class='line' id='LC4852'>to the activation of SAPK2/p38 in the tumor cells as reflected by the increased</div><div class='line' id='LC4853'>phosphorylation of the actin-polymerizing factor HSP27 by mitogen-activated protein</div><div class='line' id='LC4854'>kinase 2/3, a direct target of SAPK2/p38. Moreover, a recombinant E-selectin/Fc</div><div class='line' id='LC4855'>chimera quickly increased the activation of SAPK2/p38 in HT-29 cells. Blocking</div><div class='line' id='LC4856'>the increased activity of SAPK2/p38 of HT-29 cells by SB203580 or by expressing</div><div class='line' id='LC4857'>a dominant negative form of SAPK2/p38 inhibited their transendothelial migration.&quot;</div><div class='line' id='LC4858'><br/></div><div class='line' id='LC4859'>proteinAbundance(HGNC:TNF) increases biologicalProcess(GO:&quot;heterotypic cell-cell adhesion&quot;)</div><div class='line' id='LC4860'>proteinAbundance(HGNC:SELE) increases biologicalProcess(GO:&quot;heterotypic cell-cell adhesion&quot;)</div><div class='line' id='LC4861'><br/></div><div class='line' id='LC4862'>SET Cell = &quot;Tumor Cells, Cultured&quot;</div><div class='line' id='LC4863'><br/></div><div class='line' id='LC4864'>biologicalProcess(GO:&quot;heterotypic cell-cell adhesion&quot;) increases proteinAbundance(HGNC:HSPB1,proteinModification(P))</div><div class='line' id='LC4865'>biologicalProcess(GO:&quot;heterotypic cell-cell adhesion&quot;) increases kinaseActivity(proteinAbundance(HGNC:MAPK11))</div><div class='line' id='LC4866'>proteinAbundance(HGNC:SELE) increases kinaseActivity(proteinAbundance(HGNC:MAPK11))</div><div class='line' id='LC4867'><br/></div><div class='line' id='LC4868'>SET CellLine = &quot;HT-29&quot;</div><div class='line' id='LC4869'><br/></div><div class='line' id='LC4870'>kinaseActivity(proteinAbundance(HGNC:MAPK11)) increases biologicalProcess(MESHPP:&quot;Transendothelial and Transepithelial Migration&quot;)</div><div class='line' id='LC4871'>kinaseActivity(proteinAbundance(HGNC:MAPK11)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:MAPKAPK2))</div><div class='line' id='LC4872'>abundance(SCHEM:&quot;SB-203580&quot;) decreases biologicalProcess(MESHPP:&quot;Transendothelial and Transepithelial Migration&quot;)</div><div class='line' id='LC4873'><br/></div><div class='line' id='LC4874'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC4875'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC4876'>SET Evidence = &quot;In primary cultures of HUVEC, TNFα induced a strong activation of the expression of</div><div class='line' id='LC4877'>endothelial adhesion proteins that include E-selectin and ICAM (Fig.1, A—D, and</div><div class='line' id='LC4878'>data not shown). This induction was maximal after 4 h and required de novo protein</div><div class='line' id='LC4879'>synthesis being inhibited by cycloheximide (Fig. 1,E and F).&quot;</div><div class='line' id='LC4880'><br/></div><div class='line' id='LC4881'>proteinAbundance(HGNC:TNF) increases proteinAbundance(HGNC:ICAM1)</div><div class='line' id='LC4882'>proteinAbundance(HGNC:TNF) increases proteinAbundance(HGNC:SELE)</div><div class='line' id='LC4883'><br/></div><div class='line' id='LC4884'>SET Evidence = &quot;As illustrated in Fig.2, A–C, the expression of E-selectin correlated with an increased</div><div class='line' id='LC4885'>adhesion of both colon carcinoma HT-29 cells and HL-60 leukemia cells to</div><div class='line' id='LC4886'>a monolayer of HUVEC. After 30 min, the number of HT-29 cells that adhered to HUVEC-expressing</div><div class='line' id='LC4887'>E-selectin, following activation with TNFα, was 5-fold higher than</div><div class='line' id='LC4888'>when adhering to inactivated HUVEC. Similarly, HT-29 cells quickly adhered to</div><div class='line' id='LC4889'>immobilized recombinant human E-selectin/Fc chimera (data not shown). An anti-E-selectin</div><div class='line' id='LC4890'>neutralizing antibody, but not a matched isotype antibody, decreased the</div><div class='line' id='LC4891'>adhesion of both cancer cell types to the activated endothelium (Fig. 2, A–C).&quot;</div><div class='line' id='LC4892'><br/></div><div class='line' id='LC4893'>proteinAbundance(HGNC:TNF) increases biologicalProcess(GO:&quot;heterotypic cell-cell adhesion&quot;)</div><div class='line' id='LC4894'>proteinAbundance(HGNC:SELE) increases biologicalProcess(GO:&quot;heterotypic cell-cell adhesion&quot;)</div><div class='line' id='LC4895'><br/></div><div class='line' id='LC4896'>SET Evidence = &quot;TNFα also induced in HUVEC, a marked time- and dose-dependent stimulation of SAPK2/p38</div><div class='line' id='LC4897'>that is characterized by an increased activity of MAPKAP K2/3, a direct physiological</div><div class='line' id='LC4898'>target of SAPK2/p38(21).&quot;</div><div class='line' id='LC4899'><br/></div><div class='line' id='LC4900'>proteinAbundance(HGNC:TNF) increases kinaseActivity(proteinAbundance(HGNC:MAPK11))</div><div class='line' id='LC4901'>kinaseActivity(proteinAbundance(HGNC:MAPK11)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:MAPKAPK2))</div><div class='line' id='LC4902'>kinaseActivity(proteinAbundance(HGNC:MAPK11)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:MAPKAPK3))</div><div class='line' id='LC4903'><br/></div><div class='line' id='LC4904'>SET Evidence = &quot;inhibiting the TNFα-induced increase in SAPK2/p38 activity by SB203580 did not impair</div><div class='line' id='LC4905'>the expression of E-selectin, which suggested that activation of SAPK2/p38</div><div class='line' id='LC4906'>was not required for the expression of this adhesion molecule (Fig. 1,G and H).</div><div class='line' id='LC4907'>Accordingly, blocking the SAPK2/p38 activity of HUVEC with SB203580 did not inhibit</div><div class='line' id='LC4908'>the adhesion of HT-29 cells to HUVEC (Fig. 2A).&quot;</div><div class='line' id='LC4909'><br/></div><div class='line' id='LC4910'>abundance(SCHEM:&quot;SB-203580&quot;) directlyDecreases kinaseActivity(proteinAbundance(HGNC:MAPK11))</div><div class='line' id='LC4911'>abundance(SCHEM:&quot;SB-203580&quot;) causesNoChange proteinAbundance(HGNC:SELE)</div><div class='line' id='LC4912'>abundance(SCHEM:&quot;SB-203580&quot;) causesNoChange biologicalProcess(GO:&quot;heterotypic cell-cell adhesion&quot;)</div><div class='line' id='LC4913'><br/></div><div class='line' id='LC4914'>SET Evidence = &quot;However, HT-29 cells migrated across an endothelial layer of HUVEC, and this migration</div><div class='line' id='LC4915'>was enhanced by pretreating HUVEC with TNFα (Fig.4A). This increase in cell</div><div class='line' id='LC4916'>migration was reduced down to control levels by pretreating HUVEC with the anti-E-selectin</div><div class='line' id='LC4917'>antibody indicating the requirement of E-selectin expression and E-selectin-dependent</div><div class='line' id='LC4918'>adhesion for HT-29 cell migration across an endothelial cell</div><div class='line' id='LC4919'>layer (Fig. 4A).&quot;</div><div class='line' id='LC4920'><br/></div><div class='line' id='LC4921'>proteinAbundance(HGNC:TNF) increases biologicalProcess(MESHPP:&quot;Transendothelial and Transepithelial Migration&quot;)</div><div class='line' id='LC4922'>proteinAbundance(HGNC:SELE) increases biologicalProcess(MESHPP:&quot;Transendothelial and Transepithelial Migration&quot;)</div><div class='line' id='LC4923'><br/></div><div class='line' id='LC4924'>SET Evidence = &quot;Impairing E-selectin-mediated activation of SAPK2p38 and HSP27 phosphorylation of</div><div class='line' id='LC4925'>HT-29 cells with SB203580 (Fig. 4A and data not shown) or by expressing a dominant</div><div class='line' id='LC4926'>negative form of SAPK2/p38 inhibited their migration across activated HUVEC</div><div class='line' id='LC4927'>(Fig.4B).&quot;</div><div class='line' id='LC4928'><br/></div><div class='line' id='LC4929'>proteinAbundance(HGNC:SELE) increases proteinAbundance(HGNC:HSPB1,proteinModification(P))</div><div class='line' id='LC4930'>proteinAbundance(HGNC:SELE) increases kinaseActivity(proteinAbundance(HGNC:MAPK11))</div><div class='line' id='LC4931'>abundance(SCHEM:&quot;SB-203580&quot;) decreases biologicalProcess(MESHPP:&quot;Transendothelial and Transepithelial Migration&quot;)</div><div class='line' id='LC4932'><br/></div><div class='line' id='LC4933'>UNSET STATEMENT_GROUP</div><div class='line' id='LC4934'><br/></div><div class='line' id='LC4935'>SET STATEMENT_GROUP = &quot;Group 38&quot;</div><div class='line' id='LC4936'><br/></div><div class='line' id='LC4937'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC4938'>SET Evidence = &quot;Impairing E-selectin-mediated activation of SAPK2p38 and HSP27 phosphorylation of</div><div class='line' id='LC4939'>HT-29 cells with SB203580 (Fig. 4A and data not shown) or by expressing a dominant</div><div class='line' id='LC4940'>negative form of SAPK2/p38 inhibited their migration across activated HUVEC</div><div class='line' id='LC4941'>(Fig.4B).&quot;</div><div class='line' id='LC4942'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;10207013&quot;,&quot;&quot;,&quot;Rajavashisth TB|Liao JK|Galis ZS|Tripathi S|Laufs U|Tripathi J|Chai NN|Xu XP|Jovinge S|Shah PK|Libby P&quot;,&quot;&quot;}</div><div class='line' id='LC4943'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4944'><br/></div><div class='line' id='LC4945'>proteinAbundance(HGNC:IL1B) increases rnaAbundance(HGNC:MMP14)</div><div class='line' id='LC4946'>abundance(CHEBI:&quot;oxidised LDL&quot;) increases rnaAbundance(HGNC:MMP14)</div><div class='line' id='LC4947'><br/></div><div class='line' id='LC4948'>SET Evidence = &quot;Incubation of medium conditioned by human smooth muscle cells that contained pro-MMP-2,</div><div class='line' id='LC4949'>with plasma membrane extracts prepared from EC treated with TNF-α, interleukin-1β,</div><div class='line' id='LC4950'>or OxLDL, increased the proteolytic conversion of 72-kDa proMMP-2 to new</div><div class='line' id='LC4951'>gelatinolytic bands of 70- and 68-kDa corresponding to the processed active MMP-2</div><div class='line' id='LC4952'>(Fig. 7A). Proteolytic processing of pro-MMP-2 was reduced in membrane extracts</div><div class='line' id='LC4953'>incubated with anti-MT1-MMP antibody (Fig. 7A and B).&quot;</div><div class='line' id='LC4954'><br/></div><div class='line' id='LC4955'>proteinAbundance(HGNC:TNF) increases catalyticActivity(proteinAbundance(HGNC:MMP2))</div><div class='line' id='LC4956'>proteinAbundance(HGNC:IL1B) increases catalyticActivity(proteinAbundance(HGNC:MMP2))</div><div class='line' id='LC4957'>abundance(CHEBI:&quot;oxidised LDL&quot;) increases catalyticActivity(proteinAbundance(HGNC:MMP2))</div><div class='line' id='LC4958'>catalyticActivity(proteinAbundance(HGNC:MMP14)) increases catalyticActivity(proteinAbundance(HGNC:MMP2))</div><div class='line' id='LC4959'><br/></div><div class='line' id='LC4960'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC4961'>SET Evidence = &quot;Northern analyses and RNase protection assays revealed that exposure of cultured EC</div><div class='line' id='LC4962'>to TNF-α, interleukin-1β, or Ox-LDL results in the accumulation of MT1- MMP mRNA&quot;</div><div class='line' id='LC4963'><br/></div><div class='line' id='LC4964'>proteinAbundance(HGNC:TNF) increases rnaAbundance(HGNC:MMP14)</div><div class='line' id='LC4965'>proteinAbundance(HGNC:IL1A) increases rnaAbundance(HGNC:MMP14)</div><div class='line' id='LC4966'>proteinAbundance(HGNC:IL1B) increases rnaAbundance(HGNC:MMP14)</div><div class='line' id='LC4967'>abundance(CHEBI:&quot;oxidised LDL&quot;) increases rnaAbundance(HGNC:MMP14)</div><div class='line' id='LC4968'><br/></div><div class='line' id='LC4969'>SET Evidence = &quot;Stimulation of EC with TNF-α and/or Ox-LDL for 24 h increased the number of MT1-MMP-bearing</div><div class='line' id='LC4970'>cells to about 1.8-fold (Ox-LDL), 1.7-fold (TNF-α), or 2.5-fold (TNF-α</div><div class='line' id='LC4971'>and Ox-LDL together) as compared with unstimulated cells&quot;</div><div class='line' id='LC4972'><br/></div><div class='line' id='LC4973'>abundance(CHEBI:&quot;oxidised LDL&quot;) increases cellSurfaceExpression(proteinAbundance(HGNC:MMP14))</div><div class='line' id='LC4974'>proteinAbundance(HGNC:TNF) increases cellSurfaceExpression(proteinAbundance(HGNC:MMP14))</div><div class='line' id='LC4975'><br/></div><div class='line' id='LC4976'>UNSET STATEMENT_GROUP</div><div class='line' id='LC4977'><br/></div><div class='line' id='LC4978'>SET STATEMENT_GROUP = &quot;Group 39&quot;</div><div class='line' id='LC4979'><br/></div><div class='line' id='LC4980'>SET CellLine = &quot;Calu-6&quot;</div><div class='line' id='LC4981'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC4982'>SET Evidence = &quot;TSC exposure dramatically increased the tumorigenicity of Calu-6cells (Fig. 1B).&quot;</div><div class='line' id='LC4983'>SET Citation = {&quot;PubMed&quot;,&quot;Cancer research&quot;,&quot;19351856&quot;,&quot;2009-05-07&quot;,&quot;Hussain M|Rao M|Humphries AE|Hong JA|Liu F|Yang M|Caragacianu D|Schrump DS&quot;,&quot;&quot;}</div><div class='line' id='LC4984'>SET Species = &quot;9606&quot;</div><div class='line' id='LC4985'><br/></div><div class='line' id='LC4986'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) increases pathology(SDIS:&quot;tumor growth&quot;)</div><div class='line' id='LC4987'><br/></div><div class='line' id='LC4988'>SET CellLine = &quot;A549&quot;</div><div class='line' id='LC4989'>SET Evidence = &quot;Tumors arising from TSC-treated A549 cells tended to be somewhat larger than those</div><div class='line' id='LC4990'>developing from untreated cells (364 F 333 versus 200 F 329 mg; P = 0.25, two-tailed</div><div class='line' id='LC4991'>t test; data not shown).&quot;</div><div class='line' id='LC4992'><br/></div><div class='line' id='LC4993'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) increases biologicalProcess(SDIS:&quot;tumor growth&quot;)</div><div class='line' id='LC4994'><br/></div><div class='line' id='LC4995'>SET Evidence = &quot;Interestingly, Dkk-1, encoding a Wnt signaling antagonist frequently silenced by DNA</div><div class='line' id='LC4996'>methylation in cancer cells (20, 26), was down-regulated in a dose-dependent</div><div class='line' id='LC4997'>manner in both cell lines. Quantitative RT-PCR experiments (Fig. 1C) confirmed</div><div class='line' id='LC4998'>that TSC mediated dose-dependent decreases in Dkk-1 mRNA copy numbers in A549 and</div><div class='line' id='LC4999'>Calu-6cells, which exhibited relatively high Dkk-1 expression.&quot;</div><div class='line' id='LC5000'><br/></div><div class='line' id='LC5001'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) decreases rnaAbundance(HGNC:DKK1)</div><div class='line' id='LC5002'><br/></div><div class='line' id='LC5003'>SET CellLine = &quot;Calu-6&quot;</div><div class='line' id='LC5004'><br/></div><div class='line' id='LC5005'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) decreases rnaAbundance(HGNC:DKK1)</div><div class='line' id='LC5006'><br/></div><div class='line' id='LC5007'>SET CellLine = &quot;A549&quot;</div><div class='line' id='LC5008'>SET Evidence = &quot;Diminished Dkk-1 expression coincided with reduced Dkk-1 protein levels in A549 and</div><div class='line' id='LC5009'>Calu-6 cells following TSC exposure (Fig. 1D).&quot;</div><div class='line' id='LC5010'><br/></div><div class='line' id='LC5011'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) decreases proteinAbundance(HGNC:DKK1)</div><div class='line' id='LC5012'><br/></div><div class='line' id='LC5013'>SET CellLine = &quot;Calu-6&quot;</div><div class='line' id='LC5014'><br/></div><div class='line' id='LC5015'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) decreases proteinAbundance(HGNC:DKK1)</div><div class='line' id='LC5016'><br/></div><div class='line' id='LC5017'>SET CellLine = &quot;A549&quot;</div><div class='line' id='LC5018'>SET Evidence = &quot;Interestingly, TSC exposure decreased H4K16Ac and increased H3K27me3 levels within</div><div class='line' id='LC5019'>the Dkk-1 promoter region in both lung cancer lines.&quot;</div><div class='line' id='LC5020'><br/></div><div class='line' id='LC5021'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) decreases complexAbundance(proteinAbundance(PFH:&quot;Histone H4 Family&quot;,proteinModification(A,K,16)),geneAbundance(HGNC:DKK1))</div><div class='line' id='LC5022'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) increases complexAbundance(proteinAbundance(PFH:&quot;Histone H3 Family&quot;,proteinModification(M,K,27)),geneAbundance(HGNC:DKK1))</div><div class='line' id='LC5023'><br/></div><div class='line' id='LC5024'>SET CellLine = &quot;Calu-6&quot;</div><div class='line' id='LC5025'><br/></div><div class='line' id='LC5026'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) decreases complexAbundance(proteinAbundance(PFH:&quot;Histone H4 Family&quot;,proteinModification(A,K,16)),geneAbundance(HGNC:DKK1))</div><div class='line' id='LC5027'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) increases complexAbundance(proteinAbundance(PFH:&quot;Histone H3 Family&quot;,proteinModification(M,K,27)),geneAbundance(HGNC:DKK1))</div><div class='line' id='LC5028'><br/></div><div class='line' id='LC5029'>SET Evidence = &quot;Chromatin immunoprecipitation analysis (Fig. 3B) revealed a dose-dependent increase</div><div class='line' id='LC5030'>in H3K27me3, which coincided with recruitment of EZH2 and SUZ12 (components of</div><div class='line' id='LC5031'>the “initiation” polycomb repressor complex 2 that catalyze H3K27me3), as well</div><div class='line' id='LC5032'>as Bmi1, a member of “maintenance” polycomb repressor complex 1 (27). Additional</div><div class='line' id='LC5033'>analysis confirmed the dose-dependent deacetylation of H4K16, which coincided</div><div class='line' id='LC5034'>with recruitment of SirT1, a class III histone deacetylase that mediates H4K16deacet</div><div class='line' id='LC5035'>ylation (28).&quot;</div><div class='line' id='LC5036'><br/></div><div class='line' id='LC5037'>proteinAbundance(HGNC:EZH2) positiveCorrelation complexAbundance(proteinAbundance(PFH:&quot;Histone H3 Family&quot;,proteinModification(M,K,27)),geneAbundance(HGNC:DKK1))</div><div class='line' id='LC5038'>complexAbundance(proteinAbundance(HGNC:EZH2),geneAbundance(HGNC:DKK1))</div><div class='line' id='LC5039'>proteinAbundance(HGNC:SUZ12) positiveCorrelation complexAbundance(proteinAbundance(PFH:&quot;Histone H3 Family&quot;,proteinModification(M,K,27)),geneAbundance(HGNC:DKK1))</div><div class='line' id='LC5040'>complexAbundance(proteinAbundance(HGNC:SUZ12),geneAbundance(HGNC:DKK1))</div><div class='line' id='LC5041'>complexAbundance(proteinAbundance(HGNC:BMI1),geneAbundance(HGNC:DKK1))</div><div class='line' id='LC5042'><br/></div><div class='line' id='LC5043'>SET Evidence = &quot;Quantitative RT-PCR analysis showed that knockdown of EZH2 increased Dkk-1 expression</div><div class='line' id='LC5044'>in untreated Calu-6cells and partially abrogated TSC-mediated repression of</div><div class='line' id='LC5045'>Dkk-1 (Fig. 4C)&quot;</div><div class='line' id='LC5046'><br/></div><div class='line' id='LC5047'>proteinAbundance(HGNC:EZH2) directlyDecreases rnaAbundance(HGNC:DKK1)</div><div class='line' id='LC5048'><br/></div><div class='line' id='LC5049'>SET Evidence = &quot;Knockdown of SirT1 also seemed to somewhat increase Dkk-1 expression in untreated</div><div class='line' id='LC5050'>Calu-6cells and partially abrogate TSC-mediated repression of Dkk-1 (Fig. 4C).&quot;</div><div class='line' id='LC5051'><br/></div><div class='line' id='LC5052'>proteinAbundance(HGNC:SIRT1) decreases rnaAbundance(HGNC:DKK1)</div><div class='line' id='LC5053'><br/></div><div class='line' id='LC5054'>SET Evidence = &quot;Western blot analysis (Fig. 5B) revealed that TSC-mediated repression of Dkk-1 coincided</div><div class='line' id='LC5055'>with dose-dependent phosphorylation of LDL receptor related protein 6(LRP-6)</div><div class='line' id='LC5056'>and dishevelled-2 (Dvl-2) indicative of activation of Wnt receptor complex,</div><div class='line' id='LC5057'>as well as JNK, a downstream effector of noncanonical Wnt signaling.&quot;</div><div class='line' id='LC5058'><br/></div><div class='line' id='LC5059'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) increases proteinAbundance(HGNC:LRP6,proteinModification(P))</div><div class='line' id='LC5060'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) increases proteinAbundance(HGNC:DVL2,proteinModification(P))</div><div class='line' id='LC5061'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) increases molecularActivity(proteinAbundance(PFH:&quot;WNT Family&quot;))</div><div class='line' id='LC5062'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC5063'><br/></div><div class='line' id='LC5064'>SET Evidence = &quot;shRNA-mediated knockdown of Dkk-1 enhanced phosphorylation of JNK in Calu-6cells (Fig.</div><div class='line' id='LC5065'>5C), suggesting that activation of JNK in these cells following TSC exposure</div><div class='line' id='LC5066'>was due, at least in part, to activation of Wnt signaling, rather than nonspecific</div><div class='line' id='LC5067'>responses to genotoxic stress.&quot;</div><div class='line' id='LC5068'><br/></div><div class='line' id='LC5069'>proteinAbundance(HGNC:DKK1) decreases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC5070'><br/></div><div class='line' id='LC5071'>SET Evidence = &quot;Wnt5a (which encodes a ligand implicated in noncanonical Wnt signaling; ref. 32) was</div><div class='line' id='LC5072'>markedly induced in TSC-treated Calu-6cells as well as Calu-6cells transfected</div><div class='line' id='LC5073'>with shRNA targeting Dkk-1.&quot;</div><div class='line' id='LC5074'><br/></div><div class='line' id='LC5075'>abundance(SCHEM:&quot;smoke condensate, cigarette (gas phase)&quot;) increases proteinAbundance(HGNC:WNT5A)</div><div class='line' id='LC5076'>proteinAbundance(HGNC:DKK1) decreases proteinAbundance(HGNC:WNT5A)</div><div class='line' id='LC5077'><br/></div><div class='line' id='LC5078'>SET Evidence = &quot;Additional analysis confirmed the dose-dependent deacetylation of H4K16, which coincided</div><div class='line' id='LC5079'>with recruitment of SirT1, a class III histone deacetylase that mediates</div><div class='line' id='LC5080'>H4K16deacet ylation (28).&quot;</div><div class='line' id='LC5081'><br/></div><div class='line' id='LC5082'>proteinAbundance(HGNC:SIRT1) negativeCorrelation complexAbundance(proteinAbundance(PFH:&quot;Histone H4 Family&quot;,proteinModification(A,K,16)),geneAbundance(HGNC:DKK1))</div><div class='line' id='LC5083'><br/></div><div class='line' id='LC5084'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC5085'>SET Evidence = &quot;Knockdown of Dkk-1 recapitulated the dramatic protumorigenic effects of TSC exposure</div><div class='line' id='LC5086'>in Calu-6 cells.&quot;</div><div class='line' id='LC5087'><br/></div><div class='line' id='LC5088'>proteinAbundance(HGNC:DKK1) decreases pathology(SDIS:&quot;tumor growth&quot;)</div><div class='line' id='LC5089'><br/></div><div class='line' id='LC5090'>UNSET STATEMENT_GROUP</div><div class='line' id='LC5091'><br/></div><div class='line' id='LC5092'>SET STATEMENT_GROUP = &quot;Group 40&quot;</div><div class='line' id='LC5093'><br/></div><div class='line' id='LC5094'>SET Cell = &quot;T-Lymphocytes&quot;</div><div class='line' id='LC5095'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC5096'>SET Evidence = &quot;IL-6 is produced by various types of lymphoid and nonlymphoid cells, such as T cells,</div><div class='line' id='LC5097'>B cells, monocytes, fibroblasts, keratinocytes, endothelial cells, mesangial</div><div class='line' id='LC5098'>cells, and several tumor cells [14]. It induces growth of T cells and differentiation</div><div class='line' id='LC5099'>of cytotoxic T cells [15-19] by augmenting the expression of IL-2 receptor</div><div class='line' id='LC5100'>[15] and the production of IL-2 [20].&quot;</div><div class='line' id='LC5101'>SET Citation = {&quot;PubMed&quot;,&quot;Arthritis research&quot;,&quot;12110143&quot;,&quot;2002-06-09&quot;,&quot;Naka T|Nishimoto N|Kishimoto T&quot;,&quot;&quot;}</div><div class='line' id='LC5102'><br/></div><div class='line' id='LC5103'>proteinAbundance(HGNC:IL6) increases biologicalProcess(GO:&quot;cell growth&quot;)</div><div class='line' id='LC5104'><br/></div><div class='line' id='LC5105'>SET Cell = &quot;T-Lymphocytes, Cytotoxic&quot;</div><div class='line' id='LC5106'><br/></div><div class='line' id='LC5107'>proteinAbundance(HGNC:IL6) increases biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC5108'><br/></div><div class='line' id='LC5109'>SET Cell = &quot;T-Lymphocytes&quot;</div><div class='line' id='LC5110'><br/></div><div class='line' id='LC5111'>proteinAbundance(HGNC:IL6) increases rnaAbundance(HGNC:IL2RA)</div><div class='line' id='LC5112'>proteinAbundance(HGNC:IL6) increases proteinAbundance(HGNC:IL2)</div><div class='line' id='LC5113'><br/></div><div class='line' id='LC5114'>SET Cell = &quot;Macrophages&quot;</div><div class='line' id='LC5115'>SET Evidence = &quot;IL-6 also induces differentiation of macrophages [26], megakaryocytes [27-29], and</div><div class='line' id='LC5116'>osteoclasts [30].&quot;</div><div class='line' id='LC5117'><br/></div><div class='line' id='LC5118'>proteinAbundance(HGNC:IL6) increases biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC5119'><br/></div><div class='line' id='LC5120'>SET Cell = &quot;Megakaryocytes&quot;</div><div class='line' id='LC5121'><br/></div><div class='line' id='LC5122'>proteinAbundance(HGNC:IL6) increases biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC5123'><br/></div><div class='line' id='LC5124'>SET Cell = &quot;Osteoclasts&quot;</div><div class='line' id='LC5125'><br/></div><div class='line' id='LC5126'>proteinAbundance(HGNC:IL6) increases biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC5127'><br/></div><div class='line' id='LC5128'>SET Cell = &quot;Hepatocytes&quot;</div><div class='line' id='LC5129'>SET Evidence = &quot;In the acute-phase reaction, this cytokine stimulates hepatocytes to produce acute-phase</div><div class='line' id='LC5130'>proteins such as C-reactive protein (CRP), fibrinogen, α1-antitrypsin, and</div><div class='line' id='LC5131'>serum amyloid A [12,13], and it simultaneously suppresses albumin production</div><div class='line' id='LC5132'>[11].&quot;</div><div class='line' id='LC5133'><br/></div><div class='line' id='LC5134'>proteinAbundance(HGNC:IL6) increases proteinAbundance(HGNC:CRP)</div><div class='line' id='LC5135'>proteinAbundance(HGNC:IL6) increases proteinAbundance(HGNC:SERPINA1)</div><div class='line' id='LC5136'>proteinAbundance(HGNC:IL6) increases complexAbundance(NCH:&quot;Fibrinogen Complex&quot;)</div><div class='line' id='LC5137'>proteinAbundance(HGNC:IL6) increases proteinAbundance(HGNC:SAA1)</div><div class='line' id='LC5138'>proteinAbundance(HGNC:IL6) decreases proteinAbundance(HGNC:ALB)</div><div class='line' id='LC5139'><br/></div><div class='line' id='LC5140'>SET Evidence = &quot;It causes leukocytosis and fever when administered in vivo[31] and also acts as a</div><div class='line' id='LC5141'>growth factor for renal mesangial cells [32], epidermal keratinocytes [33,34],</div><div class='line' id='LC5142'>and various types of tumor cells, for example, in plasmacytoma[8], multiple myeloma[35],</div><div class='line' id='LC5143'>and renal cell carcinoma[36].&quot;</div><div class='line' id='LC5144'><br/></div><div class='line' id='LC5145'>proteinAbundance(HGNC:IL6) increases pathology(MESHD:Leukocytosis)</div><div class='line' id='LC5146'>proteinAbundance(HGNC:IL6) increases pathology(MESHD:Fever)</div><div class='line' id='LC5147'><br/></div><div class='line' id='LC5148'>SET Cell = &quot;Mesangial Cells&quot;</div><div class='line' id='LC5149'><br/></div><div class='line' id='LC5150'>proteinAbundance(HGNC:IL6) increases biologicalProcess(GO:&quot;cell growth&quot;)</div><div class='line' id='LC5151'><br/></div><div class='line' id='LC5152'>SET Cell = &quot;Keratinocytes&quot;</div><div class='line' id='LC5153'><br/></div><div class='line' id='LC5154'>proteinAbundance(HGNC:IL6) increases biologicalProcess(GO:&quot;cell growth&quot;)</div><div class='line' id='LC5155'><br/></div><div class='line' id='LC5156'>SET Cell = &quot;Tumor Cells, Cultured&quot;</div><div class='line' id='LC5157'>SET Disease = &quot;Neoplasms&quot;</div><div class='line' id='LC5158'><br/></div><div class='line' id='LC5159'>proteinAbundance(HGNC:IL6) increases biologicalProcess(GO:&quot;cell growth&quot;)</div><div class='line' id='LC5160'><br/></div><div class='line' id='LC5161'>SET Evidence = &quot;We and our colleagues identified the two components of IL-6 receptor (IL-6R), an 80-kDa</div><div class='line' id='LC5162'>IL-6-binding protein (α chain) and a 130-kDa signal transducer known as gp130</div><div class='line' id='LC5163'>(β chain), in 1988 and 1990[37-39], respectively. Although IL-6 cannot directly</div><div class='line' id='LC5164'>bind to gp130, it can bind to IL-6R to generate the high-affinity complex of</div><div class='line' id='LC5165'>IL-6/IL-6R/gp130.&quot;</div><div class='line' id='LC5166'><br/></div><div class='line' id='LC5167'>complexAbundance(proteinAbundance(HGNC:IL6),proteinAbundance(HGNC:IL6R),proteinAbundance(HGNC:IL6ST))</div><div class='line' id='LC5168'><br/></div><div class='line' id='LC5169'>SET Evidence = &quot;Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated</div><div class='line' id='LC5170'>in response to IL-6, CNTF, LIF, and OSM[14]&quot;</div><div class='line' id='LC5171'><br/></div><div class='line' id='LC5172'>proteinAbundance(HGNC:IL6) increases kinaseActivity(proteinAbundance(HGNC:JAK1))</div><div class='line' id='LC5173'>proteinAbundance(HGNC:CNTF) increases kinaseActivity(proteinAbundance(HGNC:JAK1))</div><div class='line' id='LC5174'>proteinAbundance(HGNC:LIF) increases kinaseActivity(proteinAbundance(HGNC:JAK1))</div><div class='line' id='LC5175'>proteinAbundance(HGNC:OSM) increases kinaseActivity(proteinAbundance(HGNC:JAK1))</div><div class='line' id='LC5176'>proteinAbundance(HGNC:IL6) increases kinaseActivity(proteinAbundance(HGNC:JAK2))</div><div class='line' id='LC5177'>proteinAbundance(HGNC:CNTF) increases kinaseActivity(proteinAbundance(HGNC:JAK2))</div><div class='line' id='LC5178'>proteinAbundance(HGNC:LIF) increases kinaseActivity(proteinAbundance(HGNC:JAK2))</div><div class='line' id='LC5179'>proteinAbundance(HGNC:OSM) increases kinaseActivity(proteinAbundance(HGNC:JAK2))</div><div class='line' id='LC5180'>proteinAbundance(HGNC:IL6) increases kinaseActivity(proteinAbundance(HGNC:TYK2))</div><div class='line' id='LC5181'>proteinAbundance(HGNC:CNTF) increases kinaseActivity(proteinAbundance(HGNC:TYK2))</div><div class='line' id='LC5182'>proteinAbundance(HGNC:LIF) increases kinaseActivity(proteinAbundance(HGNC:TYK2))</div><div class='line' id='LC5183'>proteinAbundance(HGNC:OSM) increases kinaseActivity(proteinAbundance(HGNC:TYK2))</div><div class='line' id='LC5184'><br/></div><div class='line' id='LC5185'>SET Evidence = &quot;IL-6 activates STAT1 and STAT5 in addition to STAT3.&quot;</div><div class='line' id='LC5186'><br/></div><div class='line' id='LC5187'>proteinAbundance(HGNC:IL6) increases transcriptionalActivity(proteinAbundance(HGNC:STAT3))</div><div class='line' id='LC5188'>proteinAbundance(HGNC:IL6) increases transcriptionalActivity(proteinAbundance(HGNC:STAT1))</div><div class='line' id='LC5189'>proteinAbundance(HGNC:IL6) increases transcriptionalActivity(proteinAbundance(PFH:&quot;STAT5 Family&quot;))</div><div class='line' id='LC5190'><br/></div><div class='line' id='LC5191'>SET Evidence = &quot;The binding activity of NF-IL-6 is probably induced by IL-6 through the increased</div><div class='line' id='LC5192'>expression of the NF-IL-6 gene rather than through its post-translational modification.&quot;</div><div class='line' id='LC5193'><br/></div><div class='line' id='LC5194'>proteinAbundance(HGNC:IL6) increases rnaAbundance(HGNC:CEBPB) //NF-IL-6 = CEBPB</div><div class='line' id='LC5195'><br/></div><div class='line' id='LC5196'>SET CellLine = &quot;M1&quot;</div><div class='line' id='LC5197'>SET Evidence = &quot;It is known that IL-6 induces growth arrest and macrophage differentiation in the</div><div class='line' id='LC5198'>murine myeloid leukemic cell line M1. The essential role of STAT3 in the IL-6-induced</div><div class='line' id='LC5199'>macrophage differentiation of M1 cells was demonstrated by using dominant</div><div class='line' id='LC5200'>negative forms of STAT3 [67], which inhibit both IL-6-induced growth arrest and</div><div class='line' id='LC5201'>macrophage differentiation in M1 transformants. Blocking STAT3 activation inhibits</div><div class='line' id='LC5202'>IL-6-induced repression of c-Myb and c-Myc, but not EGR-1 induction [68], while</div><div class='line' id='LC5203'>IL-6 enhances the growth of M1 cells when STAT3 is suppressed.&quot;</div><div class='line' id='LC5204'>SET Species = &quot;10090&quot;</div><div class='line' id='LC5205'><br/></div><div class='line' id='LC5206'>proteinAbundance(HGNC:IL6) decreases biologicalProcess(GO:&quot;cell growth&quot;)</div><div class='line' id='LC5207'>proteinAbundance(HGNC:IL6) increases biologicalProcess(GO:&quot;macrophage differentiation&quot;)</div><div class='line' id='LC5208'>transcriptionalActivity(proteinAbundance(HGNC:STAT3)) increases biologicalProcess(GO:&quot;macrophage differentiation&quot;)</div><div class='line' id='LC5209'>transcriptionalActivity(proteinAbundance(HGNC:STAT3)) decreases biologicalProcess(GO:&quot;cell growth&quot;)</div><div class='line' id='LC5210'>proteinAbundance(HGNC:IL6) decreases rnaAbundance(HGNC:MYB)</div><div class='line' id='LC5211'>proteinAbundance(HGNC:IL6) decreases rnaAbundance(HGNC:MYC)</div><div class='line' id='LC5212'>proteinAbundance(HGNC:IL6) increases rnaAbundance(HGNC:EGR1)</div><div class='line' id='LC5213'>transcriptionalActivity(proteinAbundance(HGNC:STAT3)) decreases rnaAbundance(HGNC:MYB)</div><div class='line' id='LC5214'>transcriptionalActivity(proteinAbundance(HGNC:STAT3)) decreases rnaAbundance(HGNC:MYC)</div><div class='line' id='LC5215'><br/></div><div class='line' id='LC5216'>SET Evidence = &quot;Furthermore, nonreceptor tyrosine kinases, such as Btk, Tec, Fes, and Hck[72,73] are</div><div class='line' id='LC5217'>activated through the IL-6 receptor, as well as through a variety of other cytokine</div><div class='line' id='LC5218'>receptors [74], although the biological significance of these signal transduction</div><div class='line' id='LC5219'>pathways remains to be clarified.&quot;</div><div class='line' id='LC5220'><br/></div><div class='line' id='LC5221'>molecularActivity(proteinAbundance(HGNC:IL6R)) increases kinaseActivity(proteinAbundance(HGNC:BTK))</div><div class='line' id='LC5222'>molecularActivity(proteinAbundance(HGNC:IL6R)) increases kinaseActivity(proteinAbundance(HGNC:TEC))</div><div class='line' id='LC5223'>molecularActivity(proteinAbundance(HGNC:IL6R)) increases kinaseActivity(proteinAbundance(HGNC:FES))</div><div class='line' id='LC5224'>molecularActivity(proteinAbundance(HGNC:IL6R)) increases kinaseActivity(proteinAbundance(HGNC:HCK))</div><div class='line' id='LC5225'><br/></div><div class='line' id='LC5226'>SET Evidence = &quot;In fact, a recent study reported that knock-in mutation mice lacking SHP-2 signal</div><div class='line' id='LC5227'>showed sustained gp130-induced STAT3 activation; this finding indicates a negative</div><div class='line' id='LC5228'>regulatory role of SHP-2 for STAT3 activation[75] .&quot;</div><div class='line' id='LC5229'><br/></div><div class='line' id='LC5230'>proteinAbundance(MGI:Ptpn11) decreases (molecularActivity(proteinAbundance(MGI:Il6st)) increases transcriptionalActivity(proteinAbundance(MGI:Stat3)))</div><div class='line' id='LC5231'><br/></div><div class='line' id='LC5232'>SET Evidence = &quot;SOCS-1 directly interacts with JAKs, and thus inhibits their catalytic activity. SOCS-3</div><div class='line' id='LC5233'>also inhibits JAK activity (but only partially in comparison with SOCS-1)</div><div class='line' id='LC5234'>although the augmentation of its effect in the presence of receptors suggests that</div><div class='line' id='LC5235'>SOCS-3 inhibits cytokine signaling by binding to the receptor complex.&quot;</div><div class='line' id='LC5236'><br/></div><div class='line' id='LC5237'>proteinAbundance(HGNC:SOCS1) directlyDecreases kinaseActivity(proteinAbundance(PFH:&quot;JAK Family&quot;))</div><div class='line' id='LC5238'>proteinAbundance(HGNC:SOCS3) decreases kinaseActivity(proteinAbundance(PFH:&quot;JAK Family&quot;))</div><div class='line' id='LC5239'><br/></div><div class='line' id='LC5240'>SET Evidence = &quot;Overexpression studies have shown that PIAS-1 associates only with activated STAT1</div><div class='line' id='LC5241'>dimers and inhibits their DNA-binding activity, but that no monomeric forms of</div><div class='line' id='LC5242'>STAT1 are present [99]. Similarly, PIAS-3 associates specifically with activated</div><div class='line' id='LC5243'>STAT3 but not with STAT1, resulting in the blocking of all STAT3-mediated gene</div><div class='line' id='LC5244'>transcriptions, and is especially well known as an inhibitor of IL-6 signaling</div><div class='line' id='LC5245'>in M1 cell lines [98].&quot;</div><div class='line' id='LC5246'><br/></div><div class='line' id='LC5247'>proteinAbundance(MGI:Pias1) directlyDecreases transcriptionalActivity(proteinAbundance(MGI:Stat1))</div><div class='line' id='LC5248'>proteinAbundance(MGI:Pias3) directlyDecreases transcriptionalActivity(proteinAbundance(HGNC:STAT3))</div><div class='line' id='LC5249'><br/></div><div class='line' id='LC5250'>UNSET STATEMENT_GROUP</div><div class='line' id='LC5251'><br/></div><div class='line' id='LC5252'>SET STATEMENT_GROUP = &quot;Group 41&quot;</div><div class='line' id='LC5253'><br/></div><div class='line' id='LC5254'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC5255'>SET Evidence = &quot;Vascular endothelial growth factor (VEGF) is one of the key angiogenic growth factors</div><div class='line' id='LC5256'>and stimulates migration, proliferation, and tube formation of ECs primarily</div><div class='line' id='LC5257'>through the VEGF receptor type2 (VEGR2, KDR/Flk1) (76).&quot;</div><div class='line' id='LC5258'>SET Citation = {&quot;PubMed&quot;,&quot;Antioxidants &amp; redox signaling&quot;,&quot;17511588&quot;,&quot;&quot;,&quot;Ushio-Fukai M&quot;,&quot;&quot;}</div><div class='line' id='LC5259'>SET Species = &quot;9606&quot;</div><div class='line' id='LC5260'><br/></div><div class='line' id='LC5261'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases kinaseActivity(proteinAbundance(HGNC:KDR))</div><div class='line' id='LC5262'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC5263'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC5264'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC5265'><br/></div><div class='line' id='LC5266'>SET Evidence = &quot;Excess amounts of reactive oxygen species (ROS) such as O2.- and H2O2 have deleterious</div><div class='line' id='LC5267'>effects on cells and contribute to various cardiovascular diseases including</div><div class='line' id='LC5268'>hypertension, heart failure, atherosclerosis, and diabetes (41), while physiological</div><div class='line' id='LC5269'>concentrations of ROS are involved in signaling to mediate cell migration,</div><div class='line' id='LC5270'>growth, and differentiation (32).&quot;</div><div class='line' id='LC5271'><br/></div><div class='line' id='LC5272'>abundance(CHEBI:&quot;reactive oxygen species&quot;) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC5273'>abundance(CHEBI:&quot;reactive oxygen species&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC5274'>abundance(CHEBI:&quot;reactive oxygen species&quot;) increases biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC5275'><br/></div><div class='line' id='LC5276'>SET Evidence = &quot;ROS stimulate induction of VEGF, which in turn increases ROS through activation of</div><div class='line' id='LC5277'>NADPH oxidases that are involved in VEGFR2 autophosphorylation, EC migration,</div><div class='line' id='LC5278'>and proliferation (49, 100, 111).&quot;</div><div class='line' id='LC5279'><br/></div><div class='line' id='LC5280'>abundance(CHEBI:&quot;reactive oxygen species&quot;) increases proteinAbundance(PFH:&quot;VEGF Family&quot;)</div><div class='line' id='LC5281'><br/></div><div class='line' id='LC5282'>SET Evidence = &quot;Nox2 is a critical component of endothelial NADPH oxidase (38), and its expression</div><div class='line' id='LC5283'>and Nox2-dependent ROS production are increased by oxidized LDL, endothelin-1,</div><div class='line' id='LC5284'>angiotensin II, VEGF, and angiopoietin-2 in ECs (99). Nox1 is involved in shear</div><div class='line' id='LC5285'>stressinduced ROS production which is required for monocyte adhesion (93) and stimulates</div><div class='line' id='LC5286'>branching morphogenesis in sinusoidal ECs (55). Nox4 is most abundantly</div><div class='line' id='LC5287'>expressed in ECs, and involved in basal- (2) and Ang II-induced (109) O2- production.</div><div class='line' id='LC5288'>Moreover, p47phox is involved in cytokine, growth factor, or shear stress-stimulated</div><div class='line' id='LC5289'>ROS production in ECs (48, 67, 107).&quot;</div><div class='line' id='LC5290'><br/></div><div class='line' id='LC5291'>abundance(SCHEM:&quot;Oxidized Low Density Lipoprotein&quot;) increases proteinAbundance(HGNC:CYBB)</div><div class='line' id='LC5292'>abundance(SCHEM:&quot;Oxidized Low Density Lipoprotein&quot;) increases catalyticActivity(proteinAbundance(HGNC:CYBB))</div><div class='line' id='LC5293'>catalyticActivity(proteinAbundance(HGNC:CYBB)) directlyIncreases abundance(CHEBI:&quot;reactive oxygen species&quot;)</div><div class='line' id='LC5294'>proteinAbundance(HGNC:EDN1) increases catalyticActivity(proteinAbundance(HGNC:CYBB))</div><div class='line' id='LC5295'>abundance(SCHEM:&quot;Angiotensin ii&quot;) increases catalyticActivity(proteinAbundance(HGNC:CYBB))</div><div class='line' id='LC5296'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases catalyticActivity(proteinAbundance(HGNC:CYBB))</div><div class='line' id='LC5297'>proteinAbundance(HGNC:ANGPT2) increases catalyticActivity(proteinAbundance(HGNC:CYBB))</div><div class='line' id='LC5298'>biologicalProcess(GO:&quot;response to fluid shear stress&quot;) increases catalyticActivity(proteinAbundance(HGNC:NOX1))</div><div class='line' id='LC5299'>biologicalProcess(GO:&quot;response to fluid shear stress&quot;) increases (molecularActivity(proteinAbundance(HGNC:NOX1)) increases abundance(CHEBI:&quot;reactive oxygen species&quot;))</div><div class='line' id='LC5300'>catalyticActivity(proteinAbundance(HGNC:NOX4)) increases abundance(CHEBI:superoxide)</div><div class='line' id='LC5301'>biologicalProcess(GO:&quot;response to fluid shear stress&quot;) increases catalyticActivity(proteinAbundance(HGNC:NCF1))</div><div class='line' id='LC5302'><br/></div><div class='line' id='LC5303'>SET Evidence = &quot;After agonist stimulation or during active EC migration, p47phox translocates to the</div><div class='line' id='LC5304'>membrane ruffles through association with WAVE1 and Rac1/PAK1 (107), as well</div><div class='line' id='LC5305'>as to the focal complexes in lamellar protrusions through binding to adaptor TRAF4</div><div class='line' id='LC5306'>and Hic-5, a focal contact scaffold (108).&quot;</div><div class='line' id='LC5307'><br/></div><div class='line' id='LC5308'>complexAbundance(proteinAbundance(HGNC:NCF1),proteinAbundance(HGNC:WASF1))</div><div class='line' id='LC5309'>complexAbundance(proteinAbundance(HGNC:NCF1),proteinAbundance(HGNC:RAC1))</div><div class='line' id='LC5310'>complexAbundance(proteinAbundance(HGNC:NCF1),proteinAbundance(HGNC:TRAF4))</div><div class='line' id='LC5311'>complexAbundance(proteinAbundance(HGNC:NCF1),proteinAbundance(HGNC:TGFB1I1))</div><div class='line' id='LC5312'><br/></div><div class='line' id='LC5313'>SET Evidence = &quot;Exogenous H2O2 stimulates induction of HIF1α and VEGF by various cell types including</div><div class='line' id='LC5314'>ECs, and promote cell proliferation and migration, cytoskeletal reorganization,</div><div class='line' id='LC5315'>and tube formation in ECs (99).&quot;</div><div class='line' id='LC5316'><br/></div><div class='line' id='LC5317'>abundance(CHEBI:&quot;hydrogen peroxide&quot;) increases proteinAbundance(HGNC:HIF1A)</div><div class='line' id='LC5318'>abundance(CHEBI:&quot;hydrogen peroxide&quot;) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC5319'>abundance(CHEBI:&quot;hydrogen peroxide&quot;) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC5320'>abundance(CHEBI:&quot;hydrogen peroxide&quot;) increases biologicalProcess(GO:&quot;epithelial tube formation&quot;)</div><div class='line' id='LC5321'>abundance(CHEBI:&quot;hydrogen peroxide&quot;) increases proteinAbundance(HGNC:VEGFA)</div><div class='line' id='LC5322'><br/></div><div class='line' id='LC5323'>SET Evidence = &quot;VEGF and angiopoietin-1 stimulate ROS production via activation of Nox2-based NADPH</div><div class='line' id='LC5324'>oxidase and oxidase-derived ROS are involved in EC migration and/or proliferation</div><div class='line' id='LC5325'>(43, 49, 100, 111) (Fig. 1). Thus, many of angiogenic responses in ECs are</div><div class='line' id='LC5326'>dependent on ROS.&quot;</div><div class='line' id='LC5327'><br/></div><div class='line' id='LC5328'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases (molecularActivity(proteinAbundance(HGNC:CYBB)) increases abundance(CHEBI:&quot;reactive oxygen species&quot;))</div><div class='line' id='LC5329'>proteinAbundance(HGNC:ANGPT2) increases (molecularActivity(proteinAbundance(HGNC:CYBB)) increases abundance(CHEBI:&quot;reactive oxygen species&quot;))</div><div class='line' id='LC5330'><br/></div><div class='line' id='LC5331'>SET Evidence = &quot;The mitogenic and chemotactic effects of VEGF in ECs are mediated mainly through VEGFR2</div><div class='line' id='LC5332'>(76). VEGFR2 is activated through ligandstimulated receptor dimerization</div><div class='line' id='LC5333'>and transphosphorylation (autophosphorylation) of tyrosine residues in the cytoplasmic</div><div class='line' id='LC5334'>kinase domain. At present, tyrosine residues 951 and 996 in the kinase insert</div><div class='line' id='LC5335'>domain, and 1054 and 1059 in the kinase catalytic domain, have been identified</div><div class='line' id='LC5336'>as autophosphorylation sites for VEGFR2 in a bacterial expression system (30).</div><div class='line' id='LC5337'>This event is followed by activation of downstream signaling pathways such as</div><div class='line' id='LC5338'>Src, PI3 kinase, MAP kinases, and Akt, which is essential for VEGF-induced actin</div><div class='line' id='LC5339'>reorganization, cell migration, and proliferation of ECs.&quot;</div><div class='line' id='LC5340'><br/></div><div class='line' id='LC5341'>proteinAbundance(PFH:&quot;VEGF Family&quot;) directlyIncreases kinaseActivity(proteinAbundance(HGNC:KDR))</div><div class='line' id='LC5342'>kinaseActivity(proteinAbundance(HGNC:KDR)) directlyIncreases proteinAbundance(HGNC:KDR,proteinModification(P,Y,951))</div><div class='line' id='LC5343'>kinaseActivity(proteinAbundance(HGNC:KDR)) directlyIncreases proteinAbundance(HGNC:KDR,proteinModification(P,Y,996))</div><div class='line' id='LC5344'>proteinAbundance(PFH:&quot;VEGF Family&quot;) directlyIncreases proteinAbundance(HGNC:KDR,proteinModification(P,Y,1054))</div><div class='line' id='LC5345'>proteinAbundance(PFH:&quot;VEGF Family&quot;) directlyIncreases proteinAbundance(HGNC:KDR,proteinModification(P,Y,1059))</div><div class='line' id='LC5346'>kinaseActivity(proteinAbundance(HGNC:KDR)) directlyIncreases kinaseActivity(proteinAbundance(HGNC:SRC))</div><div class='line' id='LC5347'>kinaseActivity(proteinAbundance(HGNC:KDR)) directlyIncreases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC5348'>kinaseActivity(proteinAbundance(HGNC:KDR)) directlyIncreases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC5349'><br/></div><div class='line' id='LC5350'>SET Evidence = &quot;Several PTPs, including SHP-1, SHP-2, and LMW-PTP (HCPTPA), inducibly associate with</div><div class='line' id='LC5351'>VEGFR2 after VEGF stimulation (42, 46, 57).&quot;</div><div class='line' id='LC5352'><br/></div><div class='line' id='LC5353'>proteinAbundance(PFH:&quot;VEGF Family&quot;) directlyIncreases complexAbundance(proteinAbundance(HGNC:KDR),proteinAbundance(HGNC:PTPN6))</div><div class='line' id='LC5354'>proteinAbundance(PFH:&quot;VEGF Family&quot;) directlyIncreases complexAbundance(proteinAbundance(HGNC:KDR),proteinAbundance(HGNC:PTPN11))</div><div class='line' id='LC5355'>proteinAbundance(PFH:&quot;VEGF Family&quot;) directlyIncreases complexAbundance(proteinAbundance(HGNC:KDR),proteinAbundance(HGNC:ACP1))</div><div class='line' id='LC5356'><br/></div><div class='line' id='LC5357'>SET Evidence = &quot;HCPTPA overexpression inhibits VEGFinduced VEGFR2 autophosphorylation, EC migration,</div><div class='line' id='LC5358'>and proliferation (46). High cell density-enhanced PTP1 (DEP- 1)/CD148 attenuates</div><div class='line' id='LC5359'>phosphorylation of VEGFR2 in contact-inhibited confluent ECs (40). A small</div><div class='line' id='LC5360'>molecule inhibitor of PTP1B enhances VEGF-induced VEGFR2 autophosphoryla- tion,</div><div class='line' id='LC5361'>migration, and proliferation of EC, as well as neovascularization in a mouse matrigel</div><div class='line' id='LC5362'>model (92). Angiopoietin-1 stimulates association of SHP-2 to the phosphorylated</div><div class='line' id='LC5363'>Tie-2 receptor (47), which in turn inhibits PI3 kinase-dependent signaling</div><div class='line' id='LC5364'>pathways leading to EC migration.&quot;</div><div class='line' id='LC5365'><br/></div><div class='line' id='LC5366'>proteinAbundance(HGNC:ACP1) decreases kinaseActivity(proteinAbundance(HGNC:KDR))</div><div class='line' id='LC5367'>phosphataseActivity(proteinAbundance(HGNC:PTPRJ)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:KDR))</div><div class='line' id='LC5368'>proteinAbundance(HGNC:PTPN11) directlyDecreases kinaseActivity(proteinAbundance(HGNC:TEK))</div><div class='line' id='LC5369'><br/></div><div class='line' id='LC5370'>SET Evidence = &quot;TNF-α inhibits VEGF signaling by recruiting SHP-2 to the VEGFR2 in ECs (42).&quot;</div><div class='line' id='LC5371'><br/></div><div class='line' id='LC5372'>proteinAbundance(HGNC:TNF) increases (phosphataseActivity(proteinAbundance(HGNC:PTPN11)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:KDR)))</div><div class='line' id='LC5373'><br/></div><div class='line' id='LC5374'>SET Evidence = &quot;The SHP-2 is oxidatively inactivated by PDGF-induced ROS when it binds to PDGFR (78).</div><div class='line' id='LC5375'>Thus, it is essential to identify the PTPs which are reversibly oxidized and</div><div class='line' id='LC5376'>inactivated after VEGF stimulation in ECs (Fig. 1).&quot;</div><div class='line' id='LC5377'><br/></div><div class='line' id='LC5378'>abundance(CHEBI:&quot;reactive oxygen species&quot;) directlyDecreases phosphataseActivity(proteinAbundance(HGNC:PTPN11))</div><div class='line' id='LC5379'><br/></div><div class='line' id='LC5380'>SET Evidence = &quot;VEGF rapidly activates Rac1 and promotes translocation of Rac1 from the cytosol to</div><div class='line' id='LC5381'>the membrane, thereby activating NADPH oxidase in ECs (100). Overexpression of</div><div class='line' id='LC5382'>dominant negative N17Rac1 significantly inhibits VEGF-induced ROS production that</div><div class='line' id='LC5383'>is involved in VEGFR2 activation, EC migration, and proliferation (100).&quot;</div><div class='line' id='LC5384'><br/></div><div class='line' id='LC5385'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases gtpBoundActivity(proteinAbundance(HGNC:RAC1))</div><div class='line' id='LC5386'>gtpBoundActivity(proteinAbundance(HGNC:RAC1)) directlyIncreases catalyticActivity(complexAbundance(NCH:&quot;NADPH Oxidase Complex&quot;))</div><div class='line' id='LC5387'><br/></div><div class='line' id='LC5388'>SET CellStructure = &quot;Caveolae&quot;</div><div class='line' id='LC5389'>SET Evidence = &quot;VEGFR2 is present in endothelial caveolae through association with Cav1 which negatively</div><div class='line' id='LC5390'>regulates receptor activity in basal state (Fig. 1)(61). Dissociation of</div><div class='line' id='LC5391'>VEGFR2 from caveolae/Cav1 seems to be essential for VEGFR2 autophosphorylation</div><div class='line' id='LC5392'>and activation of downstream signaling events(61).&quot;</div><div class='line' id='LC5393'><br/></div><div class='line' id='LC5394'>proteinAbundance(HGNC:CAV1) directlyDecreases kinaseActivity(proteinAbundance(HGNC:KDR))</div><div class='line' id='LC5395'>complexAbundance(proteinAbundance(HGNC:CAV1),proteinAbundance(HGNC:KDR))</div><div class='line' id='LC5396'><br/></div><div class='line' id='LC5397'>SET Evidence = &quot;Cav1 is tyrosine phosphorylated by ROS (14, 17)and by various growth factors(54, 70),</div><div class='line' id='LC5398'>including VEGF(61). We have demonstrated that VEGF promotes the release of</div><div class='line' id='LC5399'>VEGFR2 from caveolae/lipid rafts, which is contemporaneous with the tyrosine phosphorylation</div><div class='line' id='LC5400'>of Cav1(Tyr14) and VEGFR2 and their colocalization at focal complexes,</div><div class='line' id='LC5401'>appearing as small-dot like structures at the edge of lamellipodia (Figs. 1</div><div class='line' id='LC5402'>and 2)(52).&quot;</div><div class='line' id='LC5403'><br/></div><div class='line' id='LC5404'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases proteinAbundance(HGNC:CAV1,proteinModification(P,Y,14))</div><div class='line' id='LC5405'>proteinAbundance(HGNC:CAV1,proteinModification(P,Y,14)) directlyDecreases complexAbundance(proteinAbundance(HGNC:CAV1),proteinAbundance(HGNC:KDR))</div><div class='line' id='LC5406'><br/></div><div class='line' id='LC5407'>SET Evidence = &quot;Phospho-caveolin interacts with Grb7 (63), low molecular weight protein tyrosine phosphatase</div><div class='line' id='LC5408'>(16), and Csk, a negative regulator for Src (13).&quot;</div><div class='line' id='LC5409'><br/></div><div class='line' id='LC5410'>proteinAbundance(HGNC:CAV1,proteinModification(P,Y,14)) directlyIncreases complexAbundance(proteinAbundance(HGNC:CAV1),proteinAbundance(HGNC:GRB7))</div><div class='line' id='LC5411'>proteinAbundance(HGNC:CAV1,proteinModification(P,Y,14)) directlyIncreases complexAbundance(proteinAbundance(HGNC:CAV1),proteinAbundance(HGNC:ACP1))</div><div class='line' id='LC5412'>proteinAbundance(HGNC:CAV1,proteinModification(P,Y,14)) directlyIncreases complexAbundance(proteinAbundance(HGNC:CAV1),proteinAbundance(HGNC:CSK))</div><div class='line' id='LC5413'><br/></div><div class='line' id='LC5414'>SET Evidence = &quot;Of note, overexpression of mutant Cav1 (Y14F) blocks VEGF-stimulated localization</div><div class='line' id='LC5415'>of phospho-VEGFR2 at focal complexes as well as EC migration and proliferation.&quot;</div><div class='line' id='LC5416'><br/></div><div class='line' id='LC5417'>proteinAbundance(HGNC:CAV1) decreases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC5418'>proteinAbundance(HGNC:CAV1) decreases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC5419'><br/></div><div class='line' id='LC5420'>SET Evidence = &quot;In ECs, VEGF stimulates ARF6 association with Rac1, which is cotemporaneous with Rac1</div><div class='line' id='LC5421'>activation. The dominant negative ARF6 (T27N),inhibits VEGF-stimulated GTP-loading</div><div class='line' id='LC5422'>of Rac1, ROS production, and VEGFR2 autophosphorylation. These results suggest</div><div class='line' id='LC5423'>that ARF6 is an upstream mediator for Rac1, which may contribute to ROS production</div><div class='line' id='LC5424'>that mediates VEGFR2 autophosphorylation in ECs (Fig. 1).&quot;</div><div class='line' id='LC5425'><br/></div><div class='line' id='LC5426'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases gtpBoundActivity(proteinAbundance(HGNC:ARF6))</div><div class='line' id='LC5427'>proteinAbundance(PFH:&quot;VEGF Family&quot;) increases complexAbundance(proteinAbundance(HGNC:ARF6),proteinAbundance(HGNC:RAC1))</div><div class='line' id='LC5428'>gtpBoundActivity(proteinAbundance(HGNC:ARF6)) increases gtpBoundActivity(proteinAbundance(HGNC:RAC1))</div><div class='line' id='LC5429'><br/></div><div class='line' id='LC5430'>SET Evidence = &quot;Tyrosine phosphorylation of VE-cadherin is required for reducing cell–cell adhesions</div><div class='line' id='LC5431'>and is mediated through cSrc which is dependent on ROS (69,103).&quot;</div><div class='line' id='LC5432'><br/></div><div class='line' id='LC5433'>proteinAbundance(HGNC:CDH5,proteinModification(P,Y)) directlyDecreases biologicalProcess(GO:&quot;cell-cell adhesion&quot;)</div><div class='line' id='LC5434'>kinaseActivity(proteinAbundance(HGNC:SRC)) directlyIncreases proteinAbundance(HGNC:CDH5,proteinModification(P,Y))</div><div class='line' id='LC5435'><br/></div><div class='line' id='LC5436'>SET Evidence = &quot;IQGAP1 captures and stabilizes microtubules by interacting with CLIP-170, a microtubule</div><div class='line' id='LC5437'>plus end binding protein, near the cell cortical regions (83). Activated</div><div class='line' id='LC5438'>Rac1 promotes capture of CLIP-170-capped microtubules in lamellipodia(75).&quot;</div><div class='line' id='LC5439'><br/></div><div class='line' id='LC5440'>complexAbundance(proteinAbundance(HGNC:IQGAP1),proteinAbundance(HGNC:CLIP1))</div><div class='line' id='LC5441'>gtpBoundActivity(proteinAbundance(HGNC:RAC1)) increases complexAbundance(proteinAbundance(HGNC:IQGAP1),proteinAbundance(HGNC:CLIP1))</div><div class='line' id='LC5442'><br/></div><div class='line' id='LC5443'>SET Evidence = &quot;At the leading edge of cells, Rac1 also links the adenomatous polyposis coli (APC)</div><div class='line' id='LC5444'>protein to actin filaments through binding to IQGAP1, thereby regulating polarization</div><div class='line' id='LC5445'>and directional migration by forming a complex with APC and CLIP-170. Of</div><div class='line' id='LC5446'>note, Nox2 also binds to and colocalizes with IQGAP1 at the leading edge in actively</div><div class='line' id='LC5447'>migrating ECs (Fig. 2)(50).&quot;</div><div class='line' id='LC5448'><br/></div><div class='line' id='LC5449'>gtpBoundActivity(proteinAbundance(HGNC:RAC1)) increases complexAbundance(proteinAbundance(HGNC:APC),proteinAbundance(HGNC:IQGAP1))</div><div class='line' id='LC5450'>gtpBoundActivity(proteinAbundance(HGNC:RAC1)) increases complexAbundance(proteinAbundance(HGNC:CLIP1),proteinAbundance(HGNC:APC))</div><div class='line' id='LC5451'>complexAbundance(proteinAbundance(HGNC:CYBB),proteinAbundance(HGNC:IQGAP1))</div><div class='line' id='LC5452'><br/></div><div class='line' id='LC5453'>SET Evidence = &quot;We also demonstrated that VEGF-induced capillary tube formation in three-dimensional</div><div class='line' id='LC5454'>culture in type I collagen gels is impaired in IQGAP1 knocked down ECs.&quot;</div><div class='line' id='LC5455'><br/></div><div class='line' id='LC5456'>proteinAbundance(HGNC:IQGAP1) increases biologicalProcess(GO:&quot;epithelial tube formation&quot;)</div><div class='line' id='LC5457'><br/></div><div class='line' id='LC5458'>UNSET STATEMENT_GROUP</div><div class='line' id='LC5459'><br/></div><div class='line' id='LC5460'>SET STATEMENT_GROUP = &quot;Group 42&quot;</div><div class='line' id='LC5461'><br/></div><div class='line' id='LC5462'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC5463'>SET Evidence = &quot;The model was appropriate for testing the effects of desaturase inhibition because,</div><div class='line' id='LC5464'>after subplantar injection of carrageenan, an acute and localized inflammatory</div><div class='line' id='LC5465'>response occurs in the footpad, characterized by increased edema and neutrophil</div><div class='line' id='LC5466'>infiltration. Inhibition of edema was obtained with aspirin and indomethacin and</div><div class='line' id='LC5467'>was comparable to that obtained in the rat model.&quot;</div><div class='line' id='LC5468'>SET Citation = {&quot;PubMed&quot;,&quot;Lipids&quot;,&quot;10419129&quot;,&quot;&quot;,&quot;Obukowicz M|Welsch D|Salsgiver W|Martin-Berger C|Chinn K|Duffin K|Raz A|Needleman P&quot;,&quot;&quot;}</div><div class='line' id='LC5469'>SET Species = &quot;10090&quot;</div><div class='line' id='LC5470'><br/></div><div class='line' id='LC5471'>abundance(CHEBI:&quot;acetylsalicylic acid&quot;) decreases pathology(MESHD:Edema)</div><div class='line' id='LC5472'>abundance(CHEBI:indomethacin) decreases pathology(MESHD:Edema)</div><div class='line' id='LC5473'>pathology(MESHD:Edema) subProcessOf biologicalProcess(GO:&quot;inflammatory response&quot;)</div><div class='line' id='LC5474'>biologicalProcess(MESHPP:&quot;Neutrophil Infiltration&quot;) subProcessOf biologicalProcess(GO:&quot;inflammatory response&quot;)</div><div class='line' id='LC5475'><br/></div><div class='line' id='LC5476'>SET TextLocation = &quot;Legend&quot;</div><div class='line' id='LC5477'>SET DigestiveSystem = &quot;Liver&quot;</div><div class='line' id='LC5478'>SET Evidence = &quot;Desaturase activity was determined directly in mouse liver by quantifying the conversion</div><div class='line' id='LC5479'>of 14C-DGLA → 14C-AA (Δ5 desaturase activity) or 14C-LA → 14C-AA (combined</div><div class='line' id='LC5480'>Δ6 desaturase + elongase + Δ5 desaturase activities).&quot;</div><div class='line' id='LC5481'><br/></div><div class='line' id='LC5482'>catalyticActivity(proteinAbundance(MGI:Fads1)) directlyIncreases reaction(reactants(abundance(CHEBI:&quot;all-cis-eicosa-8,11,14-trienoic acid&quot;)),products(abundance(CHEBI:&quot;arachidonic acid&quot;)))</div><div class='line' id='LC5483'><br/></div><div class='line' id='LC5484'>SET Evidence = &quot;A. SC-26196 inhibited Δ6 desaturase activity and decreased edema.  SC-26196 inhibited</div><div class='line' id='LC5485'>desaturase activity in vivo(ED50 = 20 mpk) and decreased edema dose-dependently</div><div class='line' id='LC5486'>(fig.3). Nearly complete inhibition of the conversion of 14C-LA to 14C-GLA</div><div class='line' id='LC5487'>+14C-DGLA + 14C-AA in mouse liver was obtained with a single 100 mpk i.p. or i.g.</div><div class='line' id='LC5488'>dose (90–100% inhibition).&quot;</div><div class='line' id='LC5489'><br/></div><div class='line' id='LC5490'>catalyticActivity(proteinAbundance(MGI:Fads2)) increases abundance(CHEBI:&quot;arachidonic acid&quot;)</div><div class='line' id='LC5491'>catalyticActivity(proteinAbundance(MGI:Fads2)) increases pathology(MESHD:Edema)</div><div class='line' id='LC5492'><br/></div><div class='line' id='LC5493'>SET Evidence = &quot;D. Dietary AA restored edema and MPO activity.&quot;</div><div class='line' id='LC5494'><br/></div><div class='line' id='LC5495'>abundance(CHEBI:&quot;arachidonic acid&quot;) increases pathology(MESHD:Edema)</div><div class='line' id='LC5496'>abundance(CHEBI:&quot;arachidonic acid&quot;) increases catalyticActivity(proteinAbundance(MGI:Mpo))</div><div class='line' id='LC5497'><br/></div><div class='line' id='LC5498'>UNSET STATEMENT_GROUP</div><div class='line' id='LC5499'><br/></div><div class='line' id='LC5500'>SET STATEMENT_GROUP = &quot;Group 43&quot;</div><div class='line' id='LC5501'><br/></div><div class='line' id='LC5502'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC5503'>SET CellStructure = &quot;Cytoplasm&quot;</div><div class='line' id='LC5504'>SET Evidence = &quot;Phosphorylation of cytoplasmic FOXO at specific sites by JNK initiates translocation</div><div class='line' id='LC5505'>into the nucleus&quot;</div><div class='line' id='LC5506'>SET Citation = {&quot;PubMed&quot;,&quot;Cell cycle (Georgetown, Tex.)&quot;,&quot;15917664&quot;,&quot;2005-08-03&quot;,&quot;Vogt PK|Jiang H|Aoki M&quot;,&quot;&quot;}</div><div class='line' id='LC5507'><br/></div><div class='line' id='LC5508'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;)) directlyIncreases proteinAbundance(PFH:&quot;FOXO Family&quot;,proteinModification(P))</div><div class='line' id='LC5509'>proteinAbundance(PFH:&quot;FOXO Family&quot;,proteinModification(P)) increases translocation(proteinAbundance(PFH:&quot;FOXO Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;)</div><div class='line' id='LC5510'><br/></div><div class='line' id='LC5511'>SET Evidence = &quot;Akt-dependent phosphorylation reduces the DNA-binding activity of FOXO, interferes</div><div class='line' id='LC5512'>with binding to the co-activators p300/CBP, and inactivates the FOXO nuclear translocation</div><div class='line' id='LC5513'>signal&quot;</div><div class='line' id='LC5514'><br/></div><div class='line' id='LC5515'>kinaseActivity(proteinAbundance(HGNC:AKT1)) directlyIncreases proteinAbundance(PFH:&quot;FOXO Family&quot;,proteinModification(P))</div><div class='line' id='LC5516'>kinaseActivity(proteinAbundance(HGNC:AKT1)) directlyDecreases transcriptionalActivity(proteinAbundance(PFH:&quot;FOXO Family&quot;))</div><div class='line' id='LC5517'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases complexAbundance(proteinAbundance(HGNC:AKT1),proteinAbundance(HGNC:EP300))</div><div class='line' id='LC5518'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases complexAbundance(proteinAbundance(HGNC:AKT1),proteinAbundance(HGNC:CREBBP))</div><div class='line' id='LC5519'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases translocation(proteinAbundance(PFH:&quot;FOXO Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;)</div><div class='line' id='LC5520'>proteinAbundance(PFH:&quot;FOXO Family&quot;,proteinModification(P)) directlyDecreases transcriptionalActivity(proteinAbundance(PFH:&quot;FOXO Family&quot;))</div><div class='line' id='LC5521'><br/></div><div class='line' id='LC5522'>SET Evidence = &quot;The Akt-phosphorylated FOXO is exported from the nucleus in a CRM1- and 14-3-3-dependent</div><div class='line' id='LC5523'>process&quot;</div><div class='line' id='LC5524'><br/></div><div class='line' id='LC5525'>molecularActivity(proteinAbundance(HGNC:XPO1)) directlyIncreases translocation(proteinAbundance(PFH:&quot;FOXO Family&quot;),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC5526'>molecularActivity(proteinAbundance(PFH:&quot;14-3-3 Family&quot;)) directlyIncreases translocation(proteinAbundance(PFH:&quot;FOXO Family&quot;),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC5527'>kinaseActivity(proteinAbundance(HGNC:AKT1)) increases (molecularActivity(proteinAbundance(HGNC:XPO1)) directlyIncreases translocation(proteinAbundance(PFH:&quot;FOXO Family&quot;),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm))</div><div class='line' id='LC5528'>kinaseActivity(proteinAbundance(HGNC:AKT1)) increases (molecularActivity(proteinAbundance(PFH:&quot;14-3-3 Family&quot;)) directlyIncreases translocation(proteinAbundance(PFH:&quot;FOXO Family&quot;),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm))</div><div class='line' id='LC5529'><br/></div><div class='line' id='LC5530'>SET Evidence = &quot;Akt-phosphorylated FOXO interacts with the ubiquitin ligase Skp2 and is targeted for</div><div class='line' id='LC5531'>proteasomal degradation.&quot;</div><div class='line' id='LC5532'><br/></div><div class='line' id='LC5533'>kinaseActivity(proteinAbundance(HGNC:AKT1)) increases complexAbundance(proteinAbundance(HGNC:SKP2),proteinAbundance(PFH:&quot;FOXO Family&quot;))</div><div class='line' id='LC5534'>catalyticActivity(proteinAbundance(HGNC:SKP2)) directlyIncreases degradation(proteinAbundance(PFH:&quot;FOXO Family&quot;))</div><div class='line' id='LC5535'>kinaseActivity(proteinAbundance(HGNC:AKT1)) increases (catalyticActivity(proteinAbundance(HGNC:SKP2)) directlyIncreases degradation(proteinAbundance(PFH:&quot;FOXO Family&quot;)))</div><div class='line' id='LC5536'><br/></div><div class='line' id='LC5537'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC5538'>SET Evidence = &quot;FOXO proteins intervene in the cell cycle by activating the cyclin-dependent kinase</div><div class='line' id='LC5539'>(CDK) inhibitors p27kip1 and p21cip1.&quot;</div><div class='line' id='LC5540'><br/></div><div class='line' id='LC5541'>kinaseActivity(proteinAbundance(PFH:&quot;FOXO Family&quot;)) increases proteinAbundance(HGNC:CDKN1A)</div><div class='line' id='LC5542'>kinaseActivity(proteinAbundance(PFH:&quot;FOXO Family&quot;)) increases proteinAbundance(HGNC:CDKN1B)</div><div class='line' id='LC5543'><br/></div><div class='line' id='LC5544'>SET Evidence = &quot;They also repress transcription of cyclin D1 and D2, which results in an attenuation</div><div class='line' id='LC5545'>of CDK4 activity and reduced phosphorylation of Rb protein, and hence increased</div><div class='line' id='LC5546'>binding activity of E2F family members to Rb.&quot;</div><div class='line' id='LC5547'><br/></div><div class='line' id='LC5548'>transcriptionalActivity(proteinAbundance(PFH:&quot;FOXO Family&quot;)) directlyDecreases rnaAbundance(HGNC:CCND1)</div><div class='line' id='LC5549'>transcriptionalActivity(proteinAbundance(PFH:&quot;FOXO Family&quot;)) directlyDecreases rnaAbundance(HGNC:CCND2)</div><div class='line' id='LC5550'>proteinAbundance(HGNC:CCND1) directlyIncreases kinaseActivity(proteinAbundance(HGNC:CDK4))</div><div class='line' id='LC5551'>proteinAbundance(HGNC:CCND2) directlyIncreases kinaseActivity(proteinAbundance(HGNC:CDK4))</div><div class='line' id='LC5552'>kinaseActivity(proteinAbundance(HGNC:CDK4)) directlyIncreases proteinAbundance(HGNC:RB1,proteinModification(P))</div><div class='line' id='LC5553'>proteinAbundance(HGNC:RB1,proteinModification(P)) directlyDecreases complexAbundance(proteinAbundance(PFH:&quot;E2F Family&quot;),proteinAbundance(HGNC:RB1))</div><div class='line' id='LC5554'><br/></div><div class='line' id='LC5555'>SET Evidence = &quot;The overall effect of FOXO on cell cycle control is G1 arrest&quot;</div><div class='line' id='LC5556'><br/></div><div class='line' id='LC5557'>transcriptionalActivity(proteinAbundance(PFH:&quot;FOXO Family&quot;)) decreases biologicalProcess(GO:&quot;G1/S transition of mitotic cell cycle&quot;)</div><div class='line' id='LC5558'><br/></div><div class='line' id='LC5559'>SET Evidence = &quot;Phosphorylation of the N-terminal Akt motif disrupts the interaction of this domain</div><div class='line' id='LC5560'>with the transcriptional co-activators p300/CBP and facilitates binding of FOXO</div><div class='line' id='LC5561'>to a 14-3-3 protein instead&quot;</div><div class='line' id='LC5562'><br/></div><div class='line' id='LC5563'>kinaseActivity(proteinAbundance(HGNC:AKT1)) directlyIncreases complexAbundance(proteinAbundance(PFH:&quot;FOXO Family&quot;),proteinAbundance(PFH:&quot;14-3-3 Family&quot;))</div><div class='line' id='LC5564'><br/></div><div class='line' id='LC5565'>SET Evidence = &quot;Oxidative stress, for instance a low concentration of hydrogen peroxide (H2O2),leads</div><div class='line' id='LC5566'>to an activation of the small GTPase Ral, which in turn is instrumental in the</div><div class='line' id='LC5567'>phosphorylation and activation of the Jun N-terminal kinase JNK.&quot;</div><div class='line' id='LC5568'><br/></div><div class='line' id='LC5569'>biologicalProcess(GO:&quot;response to oxidative stress&quot;) increases gtpBoundActivity(proteinAbundance(HGNC:RALA))</div><div class='line' id='LC5570'>gtpBoundActivity(proteinAbundance(HGNC:RALA)) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC5571'><br/></div><div class='line' id='LC5572'>SET Evidence = &quot;JNK-induced phosphorylation initiates nuclear import of FOXO proteins and activation</div><div class='line' id='LC5573'>of their transcriptional regulatory potential.&quot;</div><div class='line' id='LC5574'><br/></div><div class='line' id='LC5575'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;)) increases translocation(proteinAbundance(PFH:&quot;FOXO Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;)</div><div class='line' id='LC5576'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;)) increases transcriptionalActivity(proteinAbundance(PFH:&quot;FOXO Family&quot;))</div><div class='line' id='LC5577'><br/></div><div class='line' id='LC5578'>SET Evidence = &quot;Nuclear import triggered by oxidative stress results in association of FOXO proteins</div><div class='line' id='LC5579'>with proteins that have histone acetylase activity, such as p300/CBP and p300/CBP-associated</div><div class='line' id='LC5580'>factor (PCAF).&quot;</div><div class='line' id='LC5581'><br/></div><div class='line' id='LC5582'>biologicalProcess(GO:&quot;response to oxidative stress&quot;) increases translocation(proteinAbundance(PFH:&quot;FOXO Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;)</div><div class='line' id='LC5583'><br/></div><div class='line' id='LC5584'>SET CellStructure = &quot;Cell Nucleus&quot;</div><div class='line' id='LC5585'><br/></div><div class='line' id='LC5586'>biologicalProcess(GO:&quot;response to oxidative stress&quot;) increases complexAbundance(proteinAbundance(PFH:&quot;FOXO Family&quot;),proteinAbundance(HGNC:EP300))</div><div class='line' id='LC5587'>biologicalProcess(GO:&quot;response to oxidative stress&quot;) increases complexAbundance(proteinAbundance(PFH:&quot;FOXO Family&quot;),proteinAbundance(HGNC:CREBBP))</div><div class='line' id='LC5588'>biologicalProcess(GO:&quot;response to oxidative stress&quot;) increases complexAbundance(proteinAbundance(PFH:&quot;FOXO Family&quot;),proteinAbundance(HGNC:KAT2B))</div><div class='line' id='LC5589'>translocation(proteinAbundance(PFH:&quot;FOXO Family&quot;),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;) increases transcriptionalActivity(proteinAbundance(PFH:&quot;FOXO Family&quot;))</div><div class='line' id='LC5590'><br/></div><div class='line' id='LC5591'>SET TextLocation = {&quot;Review&quot;,&quot;Review&quot;}</div><div class='line' id='LC5592'>SET Evidence = &quot;acetylation of FOXO appears to reduce transcriptional activity&quot;</div><div class='line' id='LC5593'><br/></div><div class='line' id='LC5594'>proteinAbundance(PFH:&quot;FOXO Family&quot;,proteinModification(A)) directlyDecreases transcriptionalActivity(proteinAbundance(PFH:&quot;FOXO Family&quot;))</div><div class='line' id='LC5595'><br/></div><div class='line' id='LC5596'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC5597'>SET Evidence = &quot;Acetylated and JNK-phosphorylated nuclear FOXO then recruits SIRT1, a constitutively</div><div class='line' id='LC5598'>nuclear, nicotinamide adenine dinucleotide-dependent protein deacetylase. This</div><div class='line' id='LC5599'>recruitment, like the nuclear import, is dependent on oxidative stress signals.&quot;</div><div class='line' id='LC5600'><br/></div><div class='line' id='LC5601'>biologicalProcess(GO:&quot;response to oxidative stress&quot;) increases complexAbundance(proteinAbundance(PFH:&quot;FOXO Family&quot;),proteinAbundance(HGNC:SIRT1))</div><div class='line' id='LC5602'><br/></div><div class='line' id='LC5603'>SET Evidence = &quot;For FOXO3a, the critical kinase is IKKβ rather than Akt, and the relevant target residue</div><div class='line' id='LC5604'>is serine 644, attracting an as yet unidentified ubiquitin ligase.16&quot;</div><div class='line' id='LC5605'><br/></div><div class='line' id='LC5606'>kinaseActivity(proteinAbundance(HGNC:IKBKB)) directlyIncreases proteinAbundance(HGNC:FOXO3,proteinModification(P,S,644))</div><div class='line' id='LC5607'><br/></div><div class='line' id='LC5608'>UNSET STATEMENT_GROUP</div><div class='line' id='LC5609'><br/></div><div class='line' id='LC5610'>SET STATEMENT_GROUP = &quot;Group 44&quot;</div><div class='line' id='LC5611'><br/></div><div class='line' id='LC5612'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC5613'>SET Evidence = &quot;Therapies that target the EGF receptor (EGFR), such as gefitinib (IRESSA), are effective</div><div class='line' id='LC5614'>in a subset of patients with advanced non-small cell lung cancer (NSCLC).&quot;</div><div class='line' id='LC5615'>SET Citation = {&quot;PubMed&quot;,&quot;Proceedings of the National Academy of Sciences of the United States of America&quot;,&quot;15731348&quot;,&quot;2005-03-24&quot;,&quot;Engelman JA|Jänne PA|Mermel C|Pearlberg J|Mukohara T|Fleet C|Cichowski K|Johnson BE|Cantley LC&quot;,&quot;&quot;}</div><div class='line' id='LC5616'>SET Species = &quot;9606&quot;</div><div class='line' id='LC5617'><br/></div><div class='line' id='LC5618'>abundance(SCHEM:Gefitinib) directlyDecreases kinaseActivity(proteinAbundance(HGNC:EGFR))</div><div class='line' id='LC5619'><br/></div><div class='line' id='LC5620'>SET Disease = &quot;Carcinoma, Non-Small-Cell Lung&quot;</div><div class='line' id='LC5621'>SET Evidence = &quot;In this study, we observe that gefitinib reduces phospho-Akt levels only in NSCLC</div><div class='line' id='LC5622'>cell lines in which it inhibits growth.&quot;</div><div class='line' id='LC5623'><br/></div><div class='line' id='LC5624'>abundance(SCHEM:Gefitinib) decreases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC5625'>proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,S,473)) directlyIncreases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC5626'><br/></div><div class='line' id='LC5627'>SET Evidence = &quot;We observe that PI3K associates with ErbB-3 exclusively in gefitinib-sensitive NSCLC</div><div class='line' id='LC5628'>cell lines. Gefitinib dissociates this complex, thereby linking EGFR inhibition</div><div class='line' id='LC5629'>to decreased Akt activity.&quot;</div><div class='line' id='LC5630'><br/></div><div class='line' id='LC5631'>complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC5632'>abundance(SCHEM:Gefitinib) decreases complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC5633'>kinaseActivity(proteinAbundance(HGNC:EGFR)) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC5634'><br/></div><div class='line' id='LC5635'>SET CellLine = &quot;Calu-3&quot;</div><div class='line' id='LC5636'>SET Evidence = &quot;Down-regulation of ErbB-3 by means of short hairpin RNA leads to decreased phospho-Akt</div><div class='line' id='LC5637'>levels in the gefitinib-sensitive NSCLC cell lines, Calu-3 (WT EGFR) and H3255</div><div class='line' id='LC5638'>(L858R EGFR), but has no effect on Akt activation in the gefitinib-resistant</div><div class='line' id='LC5639'>cell lines, A549 and H522.&quot;</div><div class='line' id='LC5640'><br/></div><div class='line' id='LC5641'>proteinAbundance(HGNC:ERBB3) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC5642'><br/></div><div class='line' id='LC5643'>SET CellLine = &quot;A549&quot;</div><div class='line' id='LC5644'>SET Cell = &quot;Acrosome&quot;</div><div class='line' id='LC5645'><br/></div><div class='line' id='LC5646'>proteinAbundance(HGNC:ERBB3) causesNoChange kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC5647'><br/></div><div class='line' id='LC5648'>SET CellLine = &quot;NCI-H522&quot;</div><div class='line' id='LC5649'><br/></div><div class='line' id='LC5650'>proteinAbundance(HGNC:ERBB3) causesNoChange proteinAbundance(PFH:&quot;AKT Family&quot;,proteinModification(P,T,493))</div><div class='line' id='LC5651'><br/></div><div class='line' id='LC5652'>SET CellLine = &quot;Calu-3&quot;</div><div class='line' id='LC5653'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC5654'>SET Evidence = &quot;Therefore, the p85 IPs were probed with anti-ErbB-3 antibodies. In the gefitinib-sensitive</div><div class='line' id='LC5655'>NSCLC cell lines, there is indeed a gefitinib-labile interaction between</div><div class='line' id='LC5656'>p85 and ErbB-3 (Fig. 2A Bottom Right).&quot;</div><div class='line' id='LC5657'><br/></div><div class='line' id='LC5658'>complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC5659'>abundance(SCHEM:Gefitinib) decreases complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC5660'><br/></div><div class='line' id='LC5661'>SET CellLine = &quot;A-431&quot;</div><div class='line' id='LC5662'><br/></div><div class='line' id='LC5663'>complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC5664'>abundance(SCHEM:Gefitinib) decreases complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC5665'><br/></div><div class='line' id='LC5666'>SET Evidence = &quot;As shown in Fig. 3A, EGF stimulated an association between p85 and ErbB-3 (also observed</div><div class='line' id='LC5667'>as the 210-kDa PTyr protein). This association was blocked by exposing the</div><div class='line' id='LC5668'>cells to 1 μM gefitinib. Assessment of ErbB-3 immunoprecipitations reveals that</div><div class='line' id='LC5669'>gefitinib leads to a decrease in ErbB-3 tyrosine phosphorylation (Fig. 3B Top)</div><div class='line' id='LC5670'>and the amount of coprecipitated p85 (Fig. 3B Middle).&quot;</div><div class='line' id='LC5671'><br/></div><div class='line' id='LC5672'>proteinAbundance(HGNC:EGF) increases complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC5673'>abundance(SCHEM:Gefitinib) decreases (proteinAbundance(HGNC:EGF) increases complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;)))</div><div class='line' id='LC5674'><br/></div><div class='line' id='LC5675'>SET CellLine = &quot;Calu-3&quot;</div><div class='line' id='LC5676'>SET Evidence = &quot;As shown in Fig. 5, the ErbB-3 shRNA efficiently down-regulated ErbB-3 in both the</div><div class='line' id='LC5677'>Calu-3 and H3255 cells, leading to a marked reduction in phospho-Akt levels and</div><div class='line' id='LC5678'>demonstrating that ErbB-3 couples to the PI3K/Akt pathway in these cells. In contrast,</div><div class='line' id='LC5679'>the amount of phospho-Akt was unchanged in the A549 and H522 cell lines</div><div class='line' id='LC5680'>infected with ErbB-3 shRNA.&quot;</div><div class='line' id='LC5681'><br/></div><div class='line' id='LC5682'>proteinAbundance(HGNC:ERBB3) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC5683'><br/></div><div class='line' id='LC5684'>SET CellLine = &quot;A549&quot;</div><div class='line' id='LC5685'><br/></div><div class='line' id='LC5686'>proteinAbundance(HGNC:ERBB3) causesNoChange kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC5687'><br/></div><div class='line' id='LC5688'>SET CellLine = &quot;NCI-H522&quot;</div><div class='line' id='LC5689'><br/></div><div class='line' id='LC5690'>proteinAbundance(HGNC:ERBB3) causesNoChange kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC5691'><br/></div><div class='line' id='LC5692'>SET CellLine = &quot;Calu-3&quot;</div><div class='line' id='LC5693'>SET Evidence = &quot;As shown in Fig. 3A, EGF stimulated an association between p85 and ErbB-3 (also observed</div><div class='line' id='LC5694'>as the 210-kDa PTyr protein). This association was blocked by exposing the</div><div class='line' id='LC5695'>cells to 1 μM gefitinib. Assessment of ErbB-3 immunoprecipitations reveals that</div><div class='line' id='LC5696'>gefitinib leads to a decrease in ErbB-3 tyrosine phosphorylation (Fig. 3B Top)</div><div class='line' id='LC5697'>and the amount of coprecipitated p85 (Fig. 3B Middle).&quot;</div><div class='line' id='LC5698'><br/></div><div class='line' id='LC5699'>proteinAbundance(HGNC:EGF) increases complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC5700'>abundance(SCHEM:Gefitinib) decreases complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC5701'>abundance(SCHEM:Gefitinib) decreases proteinAbundance(HGNC:ERBB3,proteinModification(P,Y))</div><div class='line' id='LC5702'><br/></div><div class='line' id='LC5703'>SET Evidence = &quot;As shown in Fig. 3C, phosphorylated Akt levels are dramatically reduced by 0.25 μM</div><div class='line' id='LC5704'>gefitinib. At this concentration, we also observe a reduction in the amount of</div><div class='line' id='LC5705'>ErbB-3 associated with p85 and decreased levels of phosphorylated ErbB-3 and phosphorylated</div><div class='line' id='LC5706'>EGFR. In contrast, phosphorylated ErbB-2 levels are not significantly</div><div class='line' id='LC5707'>reduced until concentrations of 4 μM are used.&quot;</div><div class='line' id='LC5708'><br/></div><div class='line' id='LC5709'>abundance(SCHEM:Gefitinib) decreases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC5710'>abundance(SCHEM:Gefitinib) decreases complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(PFH:&quot;PIK3R Class IA Family&quot;))</div><div class='line' id='LC5711'>abundance(SCHEM:Gefitinib) decreases kinaseActivity(proteinAbundance(HGNC:EGFR))</div><div class='line' id='LC5712'>abundance(SCHEM:Gefitinib) causesNoChange kinaseActivity(proteinAbundance(HGNC:ERBB2))</div><div class='line' id='LC5713'><br/></div><div class='line' id='LC5714'>UNSET STATEMENT_GROUP</div><div class='line' id='LC5715'><br/></div><div class='line' id='LC5716'>SET STATEMENT_GROUP = &quot;Group 45&quot;</div><div class='line' id='LC5717'><br/></div><div class='line' id='LC5718'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC5719'>SET Evidence = &quot;Vascular endothelial growth factor (VEGF) stimulates angiogenesis by activating VEGF</div><div class='line' id='LC5720'>receptor-2 (VEGFR-2).&quot;</div><div class='line' id='LC5721'>SET Citation = {&quot;PubMed&quot;,&quot;Nature medicine&quot;,&quot;11329059&quot;,&quot;&quot;,&quot;Carmeliet P|Moons L|Luttun A|Vincenti V|Compernolle V|De Mol M|Wu Y|Bono F|Devy L|Beck H|Scholz D|Acker T|DiPalma T|Dewerchin M|Noel A|Stalmans I|Barra A|Blacher S|Vandendriessche T|Ponten A|Eriksson U|Plate KH|Foidart JM|Schaper W|Charnock-Jones DS|Hicklin DJ|Herbert JM|Collen D|Persico MG&quot;,&quot;&quot;}</div><div class='line' id='LC5722'>SET Species = &quot;10090&quot;</div><div class='line' id='LC5723'><br/></div><div class='line' id='LC5724'>proteinAbundance(MGI:Vegfa) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC5725'>proteinAbundance(MGI:Vegfa) directlyIncreases kinaseActivity(proteinAbundance(MGI:Kdr))</div><div class='line' id='LC5726'>kinaseActivity(proteinAbundance(MGI:Kdr)) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC5727'><br/></div><div class='line' id='LC5728'>SET Evidence = &quot;Both VEGF and PlGF bind to VEGF receptor-1 (VEGFR-1), but it is unknown whether VEGFR-1,</div><div class='line' id='LC5729'>which exists as a soluble or a membrane-bound type, is an inert decoy or</div><div class='line' id='LC5730'>a signaling receptor for PlGF during angiogenesis.&quot;</div><div class='line' id='LC5731'><br/></div><div class='line' id='LC5732'>complexAbundance(proteinAbundance(MGI:Flt1),proteinAbundance(MGI:Pgf))</div><div class='line' id='LC5733'>complexAbundance(proteinAbundance(MGI:Vegfa),proteinAbundance(MGI:Flt1))</div><div class='line' id='LC5734'><br/></div><div class='line' id='LC5735'>SET Evidence = &quot;However, loss of PlGF impaired angiogenesis, plasma extravasation and collateral growth</div><div class='line' id='LC5736'>during ischemia, inflammation, wound healing and cancer. Transplantation</div><div class='line' id='LC5737'>of wild-type bone marrow rescued the impaired angiogenesis and collateral growth</div><div class='line' id='LC5738'>in Pgf-/- mice, indicating that PlGF might have contributed to vessel growth in</div><div class='line' id='LC5739'>the adult by mobilizing bone-marrow-derived cells.&quot;</div><div class='line' id='LC5740'><br/></div><div class='line' id='LC5741'>proteinAbundance(MGI:Pgf) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC5742'><br/></div><div class='line' id='LC5743'>SET Evidence = &quot;The synergism between PlGF and VEGF was specific, as PlGF deficiency impaired the</div><div class='line' id='LC5744'>response to VEGF, but not to bFGF or histamine. VEGFR-1 was activated by PlGF,</div><div class='line' id='LC5745'>given that anti-VEGFR-1 antibodies and a Src-kinase inhibitor blocked the endothelial</div><div class='line' id='LC5746'>response to PlGF or VEGF/PlGF.&quot;</div><div class='line' id='LC5747'><br/></div><div class='line' id='LC5748'>proteinAbundance(MGI:Pgf) directlyIncreases kinaseActivity(proteinAbundance(MGI:Flt1))</div><div class='line' id='LC5749'><br/></div><div class='line' id='LC5750'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC5751'>SET Evidence = &quot;To examine the role of PlGF in angiogenesis, we inactivated the gene expressing PlGF</div><div class='line' id='LC5752'>(Pgf) in mice. Unexpectedly, the absence of PlGF—even in combination with a</div><div class='line' id='LC5753'>loss of VEGF-B—had a negligible effect on vascular development.&quot;</div><div class='line' id='LC5754'><br/></div><div class='line' id='LC5755'>proteinAbundance(MGI:Pgf) causesNoChange biologicalProcess(GO:&quot;vasculature development&quot;)</div><div class='line' id='LC5756'><br/></div><div class='line' id='LC5757'>SET Evidence = &quot;VEGF-B is another ligand of VEGFR-1 (ref. 18), but loss of VEGF-B (Vegfb–/–) does</div><div class='line' id='LC5758'>not affect vascular development19.&quot;</div><div class='line' id='LC5759'><br/></div><div class='line' id='LC5760'>proteinAbundance(MGI:Vegfb) causesNoChange biologicalProcess(GO:&quot;vasculature development&quot;)</div><div class='line' id='LC5761'>complexAbundance(proteinAbundance(MGI:Vegfb),proteinAbundance(MGI:Flt1))</div><div class='line' id='LC5762'><br/></div><div class='line' id='LC5763'>SET UrogenitalSystem = &quot;Corpus Luteum&quot;</div><div class='line' id='LC5764'>SET Evidence = &quot;Fewer vessels developed in corpora lutea at 4.5 days of pregnancy in Pgf–/– mice (vessels/mm2:</div><div class='line' id='LC5765'>910 ± 62 in 6 wildtype mice versus 430 ± 80 in 6 Pgf–/– mice; P &lt;</div><div class='line' id='LC5766'>0.005; Fig. 1e and f), but did not impair reproduction. Thus, loss of PlGF impaired</div><div class='line' id='LC5767'>VEGF-dependent retinal and luteal angiogenesis.&quot;</div><div class='line' id='LC5768'><br/></div><div class='line' id='LC5769'>proteinAbundance(MGI:Pgf) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC5770'><br/></div><div class='line' id='LC5771'>SET SenseOrgan = &quot;Retina&quot;</div><div class='line' id='LC5772'><br/></div><div class='line' id='LC5773'>proteinAbundance(MGI:Pgf) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC5774'><br/></div><div class='line' id='LC5775'>SET Disease = &quot;Neoplasms&quot;</div><div class='line' id='LC5776'>SET Evidence = &quot;When both tumor and host expressed PlGF, tumors were large and highly vascularized</div><div class='line' id='LC5777'>(4 ± 1 g; n = 8; Fig. 1g and j). In contrast, when they both lacked PlGF, tumors</div><div class='line' id='LC5778'>remained small and poorly vascularized (1.0 ± 0.3 g; n = 8; Fig. 1h and j),&quot;</div><div class='line' id='LC5779'><br/></div><div class='line' id='LC5780'>proteinAbundance(MGI:Pgf) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC5781'>proteinAbundance(MGI:Pgf) increases pathology(MESHD:&quot;Neovascularization, Pathologic&quot;)</div><div class='line' id='LC5782'><br/></div><div class='line' id='LC5783'>SET Disease = &quot;Infarction&quot;</div><div class='line' id='LC5784'>SET CardiovascularSystem = &quot;Coronary Vessels&quot;</div><div class='line' id='LC5785'>SET Evidence = &quot;We analyzed revascularization of myocardial infarcts after ligating the left anterior</div><div class='line' id='LC5786'>descending coronary artery 25. Compared with wild type mice, Pgf–/– infarcts</div><div class='line' id='LC5787'>contained approximately 20% fewer vessels (vessels/mm2: 134 ± 9 in wild-type mice</div><div class='line' id='LC5788'>versus 111 ± 5 in Pgf–/– mice; n = 12 to 24; P &lt; 0.05; Fig. 2f and g).&quot;</div><div class='line' id='LC5789'><br/></div><div class='line' id='LC5790'>proteinAbundance(MGI:Pgf) increases biologicalProcess(GO:angiogenesis)</div><div class='line' id='LC5791'><br/></div><div class='line' id='LC5792'>SET IntegumentarySystem = &quot;Skin&quot;</div><div class='line' id='LC5793'>SET Evidence = &quot;Healing of skin incisions progressed more slowly in Pgf–/–  mice versus wild-type</div><div class='line' id='LC5794'>(Fig. 3a–c)&quot;</div><div class='line' id='LC5795'><br/></div><div class='line' id='LC5796'>proteinAbundance(MGI:Pgf) increases biologicalProcess(MESHPP:&quot;Wound Healing&quot;)</div><div class='line' id='LC5797'><br/></div><div class='line' id='LC5798'>SET TextLocation = &quot;Legend&quot;</div><div class='line' id='LC5799'>SET Evidence = &quot;In pathological conditions, PlGF is upregulated and stimulates angiogenesis via displacement</div><div class='line' id='LC5800'>of VEGF from VEGF-R1 to VEGFR2 and via activation of VEGFR-1, of which</div><div class='line' id='LC5801'>a larger fraction is membraneassociated.&quot;</div><div class='line' id='LC5802'><br/></div><div class='line' id='LC5803'>proteinAbundance(MGI:Pgf) increases (proteinAbundance(MGI:Vegfa) directlyIncreases kinaseActivity(proteinAbundance(MGI:Kdr)))</div><div class='line' id='LC5804'>proteinAbundance(MGI:Pgf) decreases complexAbundance(proteinAbundance(MGI:Vegfa),proteinAbundance(MGI:Flt1))</div><div class='line' id='LC5805'><br/></div><div class='line' id='LC5806'>UNSET STATEMENT_GROUP</div><div class='line' id='LC5807'><br/></div><div class='line' id='LC5808'>SET STATEMENT_GROUP = &quot;Group 46&quot;</div><div class='line' id='LC5809'><br/></div><div class='line' id='LC5810'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC5811'>SET Evidence = &quot;In pathological conditions, PlGF is upregulated and stimulates angiogenesis via displacement</div><div class='line' id='LC5812'>of VEGF from VEGF-R1 to VEGFR2 and via activation of VEGFR-1, of which</div><div class='line' id='LC5813'>a larger fraction is membraneassociated.&quot;</div><div class='line' id='LC5814'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;15345710&quot;,&quot;2004-10-01&quot;,&quot;Laederich MB|Funes-Duran M|Yen L|Ingalla E|Wu X|Carraway KL|Sweeney C&quot;,&quot;&quot;}</div><div class='line' id='LC5815'><br/></div><div class='line' id='LC5816'>proteinAbundance(HGNC:LRIG1) increases proteinAbundance(HGNC:EGFR,proteinModification(U,K))</div><div class='line' id='LC5817'><br/></div><div class='line' id='LC5818'>SET CellLine = &quot;293T/17&quot;</div><div class='line' id='LC5819'>SET Evidence = &quot;Here we tested whether the related human LRIG1 (also called Lig-1) protein can act</div><div class='line' id='LC5820'>as a negative regulator of EGF receptor and its relatives, ErbB2, ErbB3, and ErbB4.</div><div class='line' id='LC5821'>We observed that in co-transfected 293T cells, LRIG1 forms a complex with</div><div class='line' id='LC5822'>each of the ErbB receptors independent of growth factor binding. We further observed</div><div class='line' id='LC5823'>that co-expression of LRIG1 with EGF receptor suppresses cellular receptor</div><div class='line' id='LC5824'>levels, shortens receptor half-life, and enhances ligand-stimulated receptor ubiquitination.&quot;</div><div class='line' id='LC5825'>SET Species = &quot;9606&quot;</div><div class='line' id='LC5826'><br/></div><div class='line' id='LC5827'>complexAbundance(proteinAbundance(HGNC:EGFR),proteinAbundance(HGNC:LRIG1))</div><div class='line' id='LC5828'>complexAbundance(proteinAbundance(HGNC:ERBB2),proteinAbundance(HGNC:LRIG1))</div><div class='line' id='LC5829'>complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(HGNC:LRIG1))</div><div class='line' id='LC5830'>complexAbundance(proteinAbundance(HGNC:ERBB4),proteinAbundance(HGNC:LRIG1))</div><div class='line' id='LC5831'>proteinAbundance(HGNC:LRIG1) decreases proteinAbundance(HGNC:EGFR)</div><div class='line' id='LC5832'>proteinAbundance(HGNC:LRIG1) increases proteinAbundance(HGNC:EGFR,proteinModification(U,K))</div><div class='line' id='LC5833'>proteinAbundance(HGNC:EGFR,proteinModification(U,K)) directlyIncreases degradation(proteinAbundance(HGNC:EGFR))</div><div class='line' id='LC5834'><br/></div><div class='line' id='LC5835'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC5836'>SET Evidence = &quot;Finally, we observed that co-expression of LRIG1 suppresses EGF-stimulated transformation</div><div class='line' id='LC5837'>of NIH3T3 fibroblasts and that the inducible expression of LRIG1 in PC3</div><div class='line' id='LC5838'>prostate tumor cells suppresses EGF- and neuregulin-1-stimulated cell cycle progression.&quot;</div><div class='line' id='LC5839'>SET Species = &quot;10090&quot;</div><div class='line' id='LC5840'><br/></div><div class='line' id='LC5841'>proteinAbundance(MGI:Lrig1) decreases (proteinAbundance(MGI:Egf) increases biologicalProcess(GO:&quot;immortalization of host cell&quot;))</div><div class='line' id='LC5842'><br/></div><div class='line' id='LC5843'>SET CellLine = &quot;PC-3&quot;</div><div class='line' id='LC5844'>SET Species = &quot;9606&quot;</div><div class='line' id='LC5845'><br/></div><div class='line' id='LC5846'>proteinAbundance(HGNC:LRIG1) decreases (proteinAbundance(HGNC:EGF) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC5847'>proteinAbundance(HGNC:LRIG1) decreases (proteinAbundance(HGNC:NRG1) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC5848'><br/></div><div class='line' id='LC5849'>SET CellLine = &quot;293T/17&quot;</div><div class='line' id='LC5850'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC5851'>SET Evidence = &quot;We observed that EGFR, ErbB2, ErbB3, and ErbB4 each co-immunoprecipitated with the</div><div class='line' id='LC5852'>145- kDa LRIG1, but co-immunoprecipitation of endogenous insulin receptor was</div><div class='line' id='LC5853'>not observed. These observations indicate that LRIG1 is capable of forming a specific</div><div class='line' id='LC5854'>complex with each of the receptors of the ErbB family.&quot;</div><div class='line' id='LC5855'><br/></div><div class='line' id='LC5856'>complexAbundance(proteinAbundance(HGNC:EGFR),proteinAbundance(HGNC:LRIG1))</div><div class='line' id='LC5857'>complexAbundance(proteinAbundance(HGNC:ERBB2),proteinAbundance(HGNC:LRIG1))</div><div class='line' id='LC5858'>complexAbundance(proteinAbundance(HGNC:ERBB3),proteinAbundance(HGNC:LRIG1))</div><div class='line' id='LC5859'>complexAbundance(proteinAbundance(HGNC:ERBB4),proteinAbundance(HGNC:LRIG1))</div><div class='line' id='LC5860'><br/></div><div class='line' id='LC5861'>SET NervousSystem = &quot;Brain&quot;</div><div class='line' id='LC5862'>SET Evidence = &quot;Because previous studies have demonstrated that LRIG1 is prominently expressed in</div><div class='line' id='LC5863'>glial cells of mouse brain (14), we used the co-immunoprecipitation assay to examine</div><div class='line' id='LC5864'>the association of LRIG1 and EGFR in mouse brain lysates. We observed that</div><div class='line' id='LC5865'>EGFR could be specifically co-immunoprecipitated with LRIG1 (Fig. 1B), indicating</div><div class='line' id='LC5866'>that the two proteins are associated in a complex in vivo.&quot;</div><div class='line' id='LC5867'>SET Species = &quot;10090&quot;</div><div class='line' id='LC5868'><br/></div><div class='line' id='LC5869'>complexAbundance(proteinAbundance(MGI:Egfr),proteinAbundance(MGI:Lrig1))</div><div class='line' id='LC5870'><br/></div><div class='line' id='LC5871'>SET Evidence = &quot;Interestingly, when lysates from co-transfection experiments were blotted with anti-receptor</div><div class='line' id='LC5872'>antibodies, a loss of EGFR, ErbB2, ErbB3, and ErbB4 was observed in</div><div class='line' id='LC5873'>the presence of LRIG1, but no loss of insulin receptor was observed despite very</div><div class='line' id='LC5874'>efficient transfection of these cells (Fig. 1C, compare lanes 1 and 3 in all panels).</div><div class='line' id='LC5875'>These observations suggest that a functional consequence of LRIG1 interaction</div><div class='line' id='LC5876'>with receptor tyrosine kinases may be suppression of receptor levels to lower</div><div class='line' id='LC5877'>the efficiency of signaling.&quot;</div><div class='line' id='LC5878'>SET Species = &quot;9606&quot;</div><div class='line' id='LC5879'><br/></div><div class='line' id='LC5880'>proteinAbundance(HGNC:LRIG1) decreases proteinAbundance(HGNC:EGFR)</div><div class='line' id='LC5881'>proteinAbundance(HGNC:LRIG1) decreases proteinAbundance(HGNC:ERBB2)</div><div class='line' id='LC5882'>proteinAbundance(HGNC:LRIG1) decreases proteinAbundance(HGNC:ERBB3)</div><div class='line' id='LC5883'>proteinAbundance(HGNC:LRIG1) decreases proteinAbundance(HGNC:ERBB4)</div><div class='line' id='LC5884'><br/></div><div class='line' id='LC5885'>SET Evidence = &quot;Consistent with previous reports, we observed that growth factor treatment promoted</div><div class='line' id='LC5886'>the rapid ubiquitination of receptors. Interestingly, for both receptors LRIG1</div><div class='line' id='LC5887'>markedly potentiated the ratio of ubiquitinated receptor to total receptor following</div><div class='line' id='LC5888'>growth factor stimulation.&quot;</div><div class='line' id='LC5889'><br/></div><div class='line' id='LC5890'>proteinAbundance(HGNC:LRIG1) increases (proteinAbundance(HGNC:EGF) directlyIncreases proteinAbundance(HGNC:EGFR,proteinModification(U,K)))</div><div class='line' id='LC5891'>proteinAbundance(HGNC:LRIG1) increases (proteinAbundance(HGNC:EGF) directlyIncreases proteinAbundance(HGNC:ERBB4,proteinModification(U,K)))</div><div class='line' id='LC5892'><br/></div><div class='line' id='LC5893'>SET Evidence = &quot;To determine whether LRIG1 expression influences the ubiquitination and degradation</div><div class='line' id='LC5894'>rate of ErbB receptors in the inducible expression system, we focused on the</div><div class='line' id='LC5895'>effect of LRIG1 expression on the properties of EGFR in the PC3-LRIG1 cells. Similar</div><div class='line' id='LC5896'>to the results with transfected 293T cells (Fig. 3), we observed that the induction</div><div class='line' id='LC5897'>of LRIG1 expression markedly augmented the ubiquitination of EGFR in response</div><div class='line' id='LC5898'>to EGF treatment (Fig. 5A). This potentiation of ligand-stimulated EGFR ubiquitination</div><div class='line' id='LC5899'>correlated with a suppression of EGFR tyrosine phosphorylation and</div><div class='line' id='LC5900'>receptor levels after growth factor treatment.&quot;</div><div class='line' id='LC5901'><br/></div><div class='line' id='LC5902'>proteinAbundance(HGNC:LRIG1) increases proteinAbundance(HGNC:EGFR,proteinModification(U,K))</div><div class='line' id='LC5903'>proteinAbundance(HGNC:LRIG1) decreases kinaseActivity(proteinAbundance(HGNC:EGFR))</div><div class='line' id='LC5904'><br/></div><div class='line' id='LC5905'>SET CellLine = &quot;PC-3&quot;</div><div class='line' id='LC5906'>SET Evidence = &quot;In the experiment illustrated in Fig. 5B, PC3-LRIG1 cells were treated with and without</div><div class='line' id='LC5907'>tetracycline to induce LRIG1 expression, and a time course of EGF stimulation</div><div class='line' id='LC5908'>of the cells was carried out. Lysates were immunoblotted with anti-phosphotyrosine</div><div class='line' id='LC5909'>and anti-EGFR antibodies. In the presence of LRIG1, EGFR responded less</div><div class='line' id='LC5910'>efficiently to EGF as determined by blotting autophosphorylated receptors with anti-phosphotyrosine.</div><div class='line' id='LC5911'>Interestingly, LRIG1 expression also resulted in an accelerated</div><div class='line' id='LC5912'>loss of EGFR.&quot;</div><div class='line' id='LC5913'><br/></div><div class='line' id='LC5914'>proteinAbundance(HGNC:LRIG1) decreases kinaseActivity(proteinAbundance(HGNC:EGFR))</div><div class='line' id='LC5915'>proteinAbundance(HGNC:LRIG1) decreases proteinAbundance(HGNC:EGFR)</div><div class='line' id='LC5916'><br/></div><div class='line' id='LC5917'>SET Evidence = &quot;As shown in Fig. 5C, the presence of LRIG1 accelerated the rate at which EGF receptor</div><div class='line' id='LC5918'>was degraded by cells. Taken together, the results depicted in Fig. 5 suggest</div><div class='line' id='LC5919'>that LRIG1 negatively regulates ErbB receptors by promoting receptor ubiquitination</div><div class='line' id='LC5920'>and increasing the basal and ligand-stimulated rates of receptor degradation.&quot;</div><div class='line' id='LC5921'><br/></div><div class='line' id='LC5922'>proteinAbundance(HGNC:LRIG1) increases proteinAbundance(HGNC:EGFR,proteinModification(U,K))</div><div class='line' id='LC5923'><br/></div><div class='line' id='LC5924'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC5925'>SET Evidence = &quot;In the experiment depicted in Fig. 6A, NIH3T3 cells were transfected with control</div><div class='line' id='LC5926'>vector alone, EGF receptor, or EGF receptor together with LRIG1. Cells were treated</div><div class='line' id='LC5927'>without or with EGF, and colonies were counted after 3.5 weeks of growth. Consistent</div><div class='line' id='LC5928'>with numerous previous reports, we observed that EGF stimulated colony</div><div class='line' id='LC5929'>formation in this assay. This effect was completely blocked when LRIG1 was co-expressed,</div><div class='line' id='LC5930'>but LRIG1 expression was not able to suppress transformation induced by</div><div class='line' id='LC5931'>H-Ras (not shown).&quot;</div><div class='line' id='LC5932'>SET Species = &quot;10090&quot;</div><div class='line' id='LC5933'><br/></div><div class='line' id='LC5934'>proteinAbundance(MGI:Lrig1) decreases (proteinAbundance(MGI:Egf) increases biologicalProcess(GO:&quot;immortalization of host cell&quot;))</div><div class='line' id='LC5935'><br/></div><div class='line' id='LC5936'>SET CellLine = &quot;PC-3&quot;</div><div class='line' id='LC5937'>SET Evidence = &quot;Stimulation with EGF or NRG1β resulted in a dramatic shift of cells into S-phase in</div><div class='line' id='LC5938'>the absence of LRIG1 expression. However, the presence of LRIG1 markedly suppressed</div><div class='line' id='LC5939'>these effects.&quot;</div><div class='line' id='LC5940'>SET Species = &quot;9606&quot;</div><div class='line' id='LC5941'><br/></div><div class='line' id='LC5942'>proteinAbundance(HGNC:LRIG1) decreases (proteinAbundance(HGNC:EGF) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC5943'>proteinAbundance(HGNC:LRIG1) decreases (proteinAbundance(HGNC:NRG1) increases biologicalProcess(GO:&quot;cell proliferation&quot;))</div><div class='line' id='LC5944'><br/></div><div class='line' id='LC5945'>SET Evidence = &quot;Interestingly, other LRR domain-containing proteins have also been demonstrated to</div><div class='line' id='LC5946'>interact with receptor tyrosine kinases. Decorin, a secreted proteoglycan containing</div><div class='line' id='LC5947'>nine LRRs, has been shown to interact with the EGF receptor and ErbB2 to</div><div class='line' id='LC5948'>initially enhance their activities (27, 28). Decorin interaction with receptors</div><div class='line' id='LC5949'>has been suggested to mediate prolonged receptor down-regulation and the inhibition</div><div class='line' id='LC5950'>of cellular growth through enhanced expression of p21waf1 (29).&quot;</div><div class='line' id='LC5951'><br/></div><div class='line' id='LC5952'>proteinAbundance(HGNC:DCN) directlyIncreases kinaseActivity(proteinAbundance(HGNC:EGFR))</div><div class='line' id='LC5953'>proteinAbundance(HGNC:DCN) directlyIncreases kinaseActivity(proteinAbundance(HGNC:ERBB2))</div><div class='line' id='LC5954'>proteinAbundance(HGNC:DCN) decreases proteinAbundance(HGNC:EGFR)</div><div class='line' id='LC5955'>proteinAbundance(HGNC:DCN) decreases proteinAbundance(HGNC:ERBB2)</div><div class='line' id='LC5956'><br/></div><div class='line' id='LC5957'>UNSET STATEMENT_GROUP</div><div class='line' id='LC5958'><br/></div><div class='line' id='LC5959'>SET STATEMENT_GROUP = &quot;Group 47&quot;</div><div class='line' id='LC5960'><br/></div><div class='line' id='LC5961'>SET MuskuloskeletalSystem = &quot;Muscle, Skeletal&quot;</div><div class='line' id='LC5962'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC5963'>SET Evidence = &quot;The most notable impact on IGF-I signaling was a significant blunting of IGF-I induced</div><div class='line' id='LC5964'>increase in S6K1 phosphorylation by PD-98059 coinfusion (~ 5-fold, P &lt; 0.001</div><div class='line' id='LC5965'>vs. 3-fold, P &lt; 0.01).&quot;</div><div class='line' id='LC5966'>SET Citation = {&quot;PubMed&quot;,&quot;Journal of applied physiology (Bethesda, Md. : 1985)&quot;,&quot;12959952&quot;,&quot;2003-10-05&quot;,&quot;Haddad F|Adams GR&quot;,&quot;&quot;}</div><div class='line' id='LC5967'>SET Species = &quot;10116&quot;</div><div class='line' id='LC5968'><br/></div><div class='line' id='LC5969'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases (proteinAbundance(RGD:Igf1) increases kinaseActivity(proteinAbundance(PFR:&quot;Rps6kb Family&quot;)))</div><div class='line' id='LC5970'><br/></div><div class='line' id='LC5971'>SET Evidence = &quot;Insulin-like growth factor-I (IGF-I) has been shown to stimulate a hypertrophy response</div><div class='line' id='LC5972'>in skeletal muscles in vivo. In vitro studies have delineated two primary</div><div class='line' id='LC5973'>intracellular pathways that appear to mediate the effects of IGF-I in skeletal</div><div class='line' id='LC5974'>muscle: the Ras-ERK pathway and the phosphoinositide-3 kinase pathway.&quot;</div><div class='line' id='LC5975'><br/></div><div class='line' id='LC5976'>proteinAbundance(RGD:Igf1) increases biologicalProcess(GO:&quot;skeletal muscle hypertrophy&quot;)</div><div class='line' id='LC5977'>gtpBoundActivity(proteinAbundance(PFR:&quot;Ras Family&quot;)) increases biologicalProcess(GO:&quot;skeletal muscle hypertrophy&quot;)</div><div class='line' id='LC5978'>kinaseActivity(proteinAbundance(PFR:&quot;MAPK Erk1/3 Family&quot;)) increases biologicalProcess(GO:&quot;skeletal muscle hypertrophy&quot;)</div><div class='line' id='LC5979'>kinaseActivity(complexAbundance(NCR:&quot;p85/p110 PI3Kinase Complex&quot;)) increases biologicalProcess(GO:&quot;skeletal muscle hypertrophy&quot;)</div><div class='line' id='LC5980'><br/></div><div class='line' id='LC5981'>SET Cell = &quot;Cell Line&quot;</div><div class='line' id='LC5982'>SET Evidence = &quot;In vitro, the Ras pathway appears to regulate the mitogenic effects of IGF-I signaling,</div><div class='line' id='LC5983'>whereas the phosphoinositide-3 kinase pathway is associated with cellular</div><div class='line' id='LC5984'>differentiation.&quot;</div><div class='line' id='LC5985'><br/></div><div class='line' id='LC5986'>gtpBoundActivity(proteinAbundance(PFR:&quot;Ras Family&quot;)) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC5987'>kinaseActivity(complexAbundance(NCR:&quot;p85/p110 PI3Kinase Complex&quot;)) increases biologicalProcess(GO:&quot;cell differentiation&quot;)</div><div class='line' id='LC5988'>proteinAbundance(RGD:Igf1) increases gtpBoundActivity(proteinAbundance(PFR:&quot;Ras Family&quot;))</div><div class='line' id='LC5989'>proteinAbundance(RGD:Igf1) increases kinaseActivity(complexAbundance(NCR:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC5990'><br/></div><div class='line' id='LC5991'>SET Evidence = &quot;Our results show that 14 days of coinfusion of MAPK/ERK kinase inhibitor PD-098059</div><div class='line' id='LC5992'>(PD) limited the phosphorylation of ERK and prevented IGF-I induced increases</div><div class='line' id='LC5993'>in protein (18%, P &lt; 0.05 vs. 7%, not significant) or myofibrillar protein (23%,</div><div class='line' id='LC5994'>P &lt; 0.01 vs. 5%, not significant).&quot;</div><div class='line' id='LC5995'><br/></div><div class='line' id='LC5996'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases (proteinAbundance(RGD:Igf1) increases biologicalProcess(GO:&quot;skeletal muscle hypertrophy&quot;))</div><div class='line' id='LC5997'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases kinaseActivity(proteinAbundance(PFR:&quot;MAPK Erk1/3 Family&quot;))</div><div class='line' id='LC5998'><br/></div><div class='line' id='LC5999'>SET Evidence = &quot;The most notable impact on IGF-I signaling was a significant blunting of IGF-I induced</div><div class='line' id='LC6000'>increase in S6K1 phosphorylation by PD-98059 coinfusion (~ 5-fold, P &lt; 0.001</div><div class='line' id='LC6001'>vs. 3-fold, P &lt; 0.01).&quot;</div><div class='line' id='LC6002'><br/></div><div class='line' id='LC6003'>proteinAbundance(RGD:Igf1) increases proteinAbundance(PFR:&quot;Rps6kb Family&quot;,proteinModification(P,T,412))</div><div class='line' id='LC6004'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases (proteinAbundance(RGD:Igf1) increases proteinAbundance(PFR:&quot;Rps6kb Family&quot;,proteinModification(P,T,412)))</div><div class='line' id='LC6005'>proteinAbundance(RGD:Igf1) increases kinaseActivity(proteinAbundance(PFR:&quot;Rps6kb Family&quot;))</div><div class='line' id='LC6006'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases (proteinAbundance(RGD:Igf1) increases kinaseActivity(proteinAbundance(PFR:&quot;Rps6kb Family&quot;)))</div><div class='line' id='LC6007'><br/></div><div class='line' id='LC6008'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC6009'><br/></div><div class='line' id='LC6010'>rnaAbundance(RGD:Myog) positiveCorrelation biologicalProcess(GO:&quot;muscle cell differentiation&quot;)</div><div class='line' id='LC6011'><br/></div><div class='line' id='LC6012'>SET Evidence = &quot;Muscle hypertrophy. Local infusion of IGF-I for 14 days resulted in a 19% increase</div><div class='line' id='LC6013'>in muscle wet weight and an 18% increase in the total protein content of the IGF</div><div class='line' id='LC6014'>but not the IGF+PD plantaris muscles (Fig. 1A, Table 1). Total protein concentration</div><div class='line' id='LC6015'>was unchanged in both treatment groups (Table 1). IGF-I infusion resulted</div><div class='line' id='LC6016'>in a 23% increase in myofibrillar protein content (IGF group) that was completely</div><div class='line' id='LC6017'>blunted by coinfusion of MEK inhibitor PD-098059 (Fig. 1B).&quot;</div><div class='line' id='LC6018'><br/></div><div class='line' id='LC6019'>proteinAbundance(RGD:Igf1) increases biologicalProcess(GO:&quot;skeletal muscle hypertrophy&quot;)</div><div class='line' id='LC6020'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases (proteinAbundance(RGD:Igf1) increases biologicalProcess(GO:&quot;skeletal muscle hypertrophy&quot;))</div><div class='line' id='LC6021'><br/></div><div class='line' id='LC6022'>SET Evidence = &quot;Mitogenic indicators. The DNA content of the IGF and IGF+PD infused muscles increased</div><div class='line' id='LC6023'>~50% compared with the contralateral muscles (Fig. 2A). The concentration of</div><div class='line' id='LC6024'>DNA was also increased by both treatments (Table 1). Similarly, there was a significant</div><div class='line' id='LC6025'>increase in the expression and/or accumulation of cyclin D1 mRNA in the</div><div class='line' id='LC6026'>IGF and IGF+PD muscles (Fig. 2B).&quot;</div><div class='line' id='LC6027'><br/></div><div class='line' id='LC6028'>proteinAbundance(RGD:Igf1) increases biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC6029'>proteinAbundance(RGD:Igf1) increases rnaAbundance(RGD:Ccnd1)</div><div class='line' id='LC6030'><br/></div><div class='line' id='LC6031'>SET Evidence = &quot;Myogenic processes. The mRNA for myogenin, a putative marker of myogenic differentiation,</div><div class='line' id='LC6032'>increased significantly in the IGF+PD muscles, whereas this change was</div><div class='line' id='LC6033'>not significant after IGF-I infusion alone (Fig. 3).&quot;</div><div class='line' id='LC6034'><br/></div><div class='line' id='LC6035'>compositeAbundance(proteinAbundance(RGD:Igf1),abundance(SCHEM:&quot;PD 98,059&quot;)) increases rnaAbundance(RGD:Myog)</div><div class='line' id='LC6036'>proteinAbundance(RGD:Igf1) causesNoChange rnaAbundance(RGD:Myog)</div><div class='line' id='LC6037'>rnaAbundance(RGD:Myog) positiveCorrelation biologicalProcess(GO:&quot;muscle cell differentiation&quot;)</div><div class='line' id='LC6038'><br/></div><div class='line' id='LC6039'>SET Evidence = &quot;Intracellular signaling. Infusion of IGF-I resulted in an approximate fivefold increase</div><div class='line' id='LC6040'>in the phosphorylation of ERKs 1 and 2 (Fig. 4), whereas the total ERK levels</div><div class='line' id='LC6041'>were unchanged vs. contralateral muscles (data not shown). Coinfusion (IGF+PD)</div><div class='line' id='LC6042'>completely blunted the increase in ERK1 phosphorylation and significantly reduced</div><div class='line' id='LC6043'>the increase in ERK2 phosphorylation (Fig. 4B). Similar to ERK2, the phosphorylation</div><div class='line' id='LC6044'>of S6K1 was increased fivefold in the IGF and 2.8-fold in the IGF+PD</div><div class='line' id='LC6045'>muscles (Fig. 5). The infusion protocols did not impact the total amount of S6K1</div><div class='line' id='LC6046'>(data not shown).&quot;</div><div class='line' id='LC6047'><br/></div><div class='line' id='LC6048'>proteinAbundance(RGD:Igf1) increases kinaseActivity(proteinAbundance(PFR:&quot;MAPK Erk1/3 Family&quot;))</div><div class='line' id='LC6049'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases (proteinAbundance(RGD:Igf1) increases kinaseActivity(proteinAbundance(PFR:&quot;MAPK Erk1/3 Family&quot;)))</div><div class='line' id='LC6050'>proteinAbundance(RGD:Igf1) increases kinaseActivity(proteinAbundance(PFR:&quot;Rps6kb Family&quot;))</div><div class='line' id='LC6051'><br/></div><div class='line' id='LC6052'>SET Evidence = &quot;IGF-I-related mRNA. IGF-I infusion resulted in a 48 and 63% increase in IGFBP-5 mRNA</div><div class='line' id='LC6053'>in the IGF and IGFPD muscles, respectively (Fig. 7A). The mRNA for IGFBP-4 increased</div><div class='line' id='LC6054'>significantly (4-fold) in the IGFPD but not IGF muscles (Fig. 7B).&quot;</div><div class='line' id='LC6055'><br/></div><div class='line' id='LC6056'>proteinAbundance(RGD:Igf1) increases rnaAbundance(RGD:Igfbp5)</div><div class='line' id='LC6057'>compositeAbundance(proteinAbundance(RGD:Igf1),abundance(SCHEM:&quot;PD 98,059&quot;)) increases rnaAbundance(RGD:Igfbp5)</div><div class='line' id='LC6058'>compositeAbundance(proteinAbundance(RGD:Igf1),abundance(SCHEM:&quot;PD 98,059&quot;)) increases rnaAbundance(RGD:Igfbp4)</div><div class='line' id='LC6059'><br/></div><div class='line' id='LC6060'>UNSET STATEMENT_GROUP</div><div class='line' id='LC6061'><br/></div><div class='line' id='LC6062'>SET STATEMENT_GROUP = &quot;Group 48&quot;</div><div class='line' id='LC6063'><br/></div><div class='line' id='LC6064'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC6065'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC6066'>SET Evidence = &quot;Under conditions where activation of neither RAF nor AKT alone was sufficient to induce</div><div class='line' id='LC6067'>DNA synthesis, coactivation of both kinases elicited a strong cooperative</div><div class='line' id='LC6068'>response.&quot;</div><div class='line' id='LC6069'>SET Citation = {&quot;PubMed&quot;,&quot;Molecular and cellular biology&quot;,&quot;15572689&quot;,&quot;&quot;,&quot;Mirza AM|Gysin S|Malek N|Nakayama K|Roberts JM|McMahon M&quot;,&quot;&quot;}</div><div class='line' id='LC6070'>SET Species = &quot;10090&quot;</div><div class='line' id='LC6071'><br/></div><div class='line' id='LC6072'>compositeAbundance(proteinAbundance(MGI:Raf1),proteinAbundance(MGI:Akt1)) increases biologicalProcess(MESHPP:&quot;DNA Replication&quot;)</div><div class='line' id='LC6073'><br/></div><div class='line' id='LC6074'>SET Evidence = &quot;Activation of AKT or RAF alone led to a two- or threefold induction of cyclin D1 expression,</div><div class='line' id='LC6075'>respectively (Fig. 2A). However, coactivation of both signaling pathways</div><div class='line' id='LC6076'>led to a sixfold induction of cyclin D1.&quot;</div><div class='line' id='LC6077'><br/></div><div class='line' id='LC6078'>compositeAbundance(proteinAbundance(MGI:Raf1),proteinAbundance(MGI:Akt1)) increases proteinAbundance(MGI:Ccnd1)</div><div class='line' id='LC6079'><br/></div><div class='line' id='LC6080'>SET Evidence = &quot;Strikingly, coactivation of RAF and AKT led to a rapid and profound repression of</div><div class='line' id='LC6081'>p27Kip1 expression that was clearly evident at 6 h and continued up to 24 h (Fig.</div><div class='line' id='LC6082'>2A).&quot;</div><div class='line' id='LC6083'><br/></div><div class='line' id='LC6084'>compositeAbundance(proteinAbundance(MGI:Raf1),proteinAbundance(MGI:Akt1)) decreases proteinAbundance(MGI:Cdkn1b)</div><div class='line' id='LC6085'><br/></div><div class='line' id='LC6086'>SET Evidence = &quot;Consistent with previous observations, activation of AKT alone led to a ~50% reduction</div><div class='line' id='LC6087'>of KIP1 mRNA that was evident after 24 h (38). Activation of RAF alone led</div><div class='line' id='LC6088'>to a ~65% reduction of KIP1 mRNA that was best evident after 24 h.&quot;</div><div class='line' id='LC6089'><br/></div><div class='line' id='LC6090'>kinaseActivity(proteinAbundance(MGI:Akt1)) decreases rnaAbundance(MGI:Cdkn1b)</div><div class='line' id='LC6091'>kinaseActivity(proteinAbundance(MGI:Raf1)) decreases rnaAbundance(MGI:Cdkn1b)</div><div class='line' id='LC6092'><br/></div><div class='line' id='LC6093'>SET Evidence = &quot;PDGF stimulation of quiescent NIH 3T3 cells leads to activation of both the PI3&#39;-kinase3→PDK1→AKT</div><div class='line' id='LC6094'>and the RAF→MEK→ERK signaling pathways and repression of p27Kip1</div><div class='line' id='LC6095'>expression (Fig. 3A).&quot;</div><div class='line' id='LC6096'><br/></div><div class='line' id='LC6097'>proteinAbundance(PFM:&quot;Pdgf Family&quot;) increases kinaseActivity(proteinAbundance(MGI:Akt1))</div><div class='line' id='LC6098'>proteinAbundance(PFM:&quot;Pdgf Family&quot;) increases kinaseActivity(proteinAbundance(PFM:&quot;MAPK Erk1/3 Family&quot;))</div><div class='line' id='LC6099'>proteinAbundance(PFM:&quot;Pdgf Family&quot;) decreases proteinAbundance(MGI:Cdkn1b)</div><div class='line' id='LC6100'><br/></div><div class='line' id='LC6101'>SET Evidence = &quot;Consistent with observations described above, PDGF repressed KIP1 mRNA by ~60%.&quot;</div><div class='line' id='LC6102'><br/></div><div class='line' id='LC6103'>proteinAbundance(PFM:&quot;Pdgf Family&quot;) decreases rnaAbundance(MGI:Cdkn1b)</div><div class='line' id='LC6104'><br/></div><div class='line' id='LC6105'>SET Evidence = &quot;Inhibition of either the PI3&#39;-kinase→PDK1→AKT or the RAF→ MEK→ERK pathway alone partially</div><div class='line' id='LC6106'>inhibited the effects of PDGF on KIP1 mRNA expression.&quot;</div><div class='line' id='LC6107'><br/></div><div class='line' id='LC6108'>abundance(SCHEM:&quot;LY 294002&quot;) decreases (proteinAbundance(PFM:&quot;Pdgf Family&quot;) decreases rnaAbundance(MGI:Cdkn1b))</div><div class='line' id='LC6109'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases (proteinAbundance(PFM:&quot;Pdgf Family&quot;) decreases rnaAbundance(MGI:Cdkn1b))</div><div class='line' id='LC6110'><br/></div><div class='line' id='LC6111'>SET TextLocation = &quot;Legend&quot;</div><div class='line' id='LC6112'>SET Evidence = &quot;RAF and AKT cooperate to promote cell cycle progression&quot;</div><div class='line' id='LC6113'><br/></div><div class='line' id='LC6114'>compositeAbundance(proteinAbundance(MGI:Raf1),proteinAbundance(MGI:Akt1)) increases biologicalProcess(GO:&quot;cell cycle&quot;)</div><div class='line' id='LC6115'><br/></div><div class='line' id='LC6116'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC6117'>SET Evidence = &quot;Serum deprivation of parental NIH 3T3 cells leads to elevated p27Kip1 expression and</div><div class='line' id='LC6118'>cell cycle arrest (Fig. 4A).&quot;</div><div class='line' id='LC6119'><br/></div><div class='line' id='LC6120'>biologicalProcess(GO:&quot;cellular response to starvation&quot;) increases proteinAbundance(MGI:Cdkn1b)</div><div class='line' id='LC6121'>biologicalProcess(GO:&quot;cellular response to starvation&quot;) increases biologicalProcess(GO:&quot;cell cycle arrest&quot;)</div><div class='line' id='LC6122'><br/></div><div class='line' id='LC6123'>SET Evidence = &quot;Serum-deprived 3T3:iRAS cells displayed elevated p27Kip1 that was reduced by subsequent</div><div class='line' id='LC6124'>induction of H-RASG12V expression by addition of IPTG (Fig. 4B).&quot;</div><div class='line' id='LC6125'><br/></div><div class='line' id='LC6126'>proteinAbundance(MGI:Hras1,substitution(G,12,V)) decreases (biologicalProcess(GO:&quot;cellular response to starvation&quot;) increases proteinAbundance(MGI:Cdkn1b))</div><div class='line' id='LC6127'><br/></div><div class='line' id='LC6128'>SET Evidence = &quot;Pharmacological inhibition of the PI3&#39;-kinase→PDK1→AKT pathway, the RAF→MEK→ERK signaling</div><div class='line' id='LC6129'>pathway, or both pathways together prevented the H-RASG12V-mediated reduction</div><div class='line' id='LC6130'>of p27Kip1 expression. Cumulatively, these data suggest that the level of</div><div class='line' id='LC6131'>p27Kip1 expression in RAS-transformed cells is under the dual control of the PI3&#39;-kinase→PDK1→AKT</div><div class='line' id='LC6132'>and RAF→MEK→ERK pathways.&quot;</div><div class='line' id='LC6133'><br/></div><div class='line' id='LC6134'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases (proteinAbundance(MGI:Hras1,substitution(G,12,V)) decreases proteinAbundance(MGI:Cdkn1b))</div><div class='line' id='LC6135'>abundance(SCHEM:&quot;LY 294002&quot;) decreases (proteinAbundance(MGI:Hras1,substitution(G,12,V)) decreases proteinAbundance(MGI:Cdkn1b))</div><div class='line' id='LC6136'><br/></div><div class='line' id='LC6137'>SET CellLine = &quot;Hs 766T&quot;</div><div class='line' id='LC6138'>SET Disease = &quot;Carcinoma, Pancreatic Ductal&quot;</div><div class='line' id='LC6139'>SET Evidence = &quot;Hs766T cells express activated KRAS and display elevated levels of pERK1/2 and pAKT</div><div class='line' id='LC6140'>(Fig. 4C).&quot;</div><div class='line' id='LC6141'>SET Species = &quot;9606&quot;</div><div class='line' id='LC6142'><br/></div><div class='line' id='LC6143'>gtpBoundActivity(proteinAbundance(HGNC:KRAS)) increases kinaseActivity(proteinAbundance(HGNC:MAPK1))</div><div class='line' id='LC6144'>gtpBoundActivity(proteinAbundance(HGNC:KRAS)) increases kinaseActivity(proteinAbundance(HGNC:MAPK3))</div><div class='line' id='LC6145'>gtpBoundActivity(proteinAbundance(HGNC:KRAS)) increases kinaseActivity(proteinAbundance(HGNC:AKT1))</div><div class='line' id='LC6146'><br/></div><div class='line' id='LC6147'>SET Evidence = &quot;Treatment of Hs766T cells with the PI3&#39;-kinase inhibitor LY294002 led to a selective</div><div class='line' id='LC6148'>decrease in pAKT with little or no effect on pERK1/2.&quot;</div><div class='line' id='LC6149'><br/></div><div class='line' id='LC6150'>abundance(SCHEM:&quot;LY 294002&quot;) decreases kinaseActivity(proteinAbundance(HGNC:AKT1))</div><div class='line' id='LC6151'>abundance(SCHEM:&quot;LY 294002&quot;) causesNoChange kinaseActivity(proteinAbundance(HGNC:MAPK1))</div><div class='line' id='LC6152'>abundance(SCHEM:&quot;LY 294002&quot;) causesNoChange kinaseActivity(proteinAbundance(HGNC:MAPK3))</div><div class='line' id='LC6153'><br/></div><div class='line' id='LC6154'>SET Evidence = &quot;By contrast, treatment of the cells with the MEK inhibitor U0126 or CI-1040 led to</div><div class='line' id='LC6155'>a selective decrease in pERK1/2 with little or no effect on pAKT&quot;</div><div class='line' id='LC6156'><br/></div><div class='line' id='LC6157'>abundance(SCHEM:U0126) decreases kinaseActivity(proteinAbundance(HGNC:MAPK1))</div><div class='line' id='LC6158'>abundance(SCHEM:U0126) decreases kinaseActivity(proteinAbundance(HGNC:MAPK3))</div><div class='line' id='LC6159'>abundance(SCHEM:U0126) causesNoChange kinaseActivity(proteinAbundance(HGNC:AKT1))</div><div class='line' id='LC6160'><br/></div><div class='line' id='LC6161'>SET Evidence = &quot;both the PI3&#39;-kinase and the MEK inhibitors led to accumulation of p27Kip1 expression.&quot;</div><div class='line' id='LC6162'><br/></div><div class='line' id='LC6163'>abundance(SCHEM:&quot;LY 294002&quot;) directlyDecreases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC6164'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases kinaseActivity(proteinAbundance(HGNC:MAPK1))</div><div class='line' id='LC6165'>abundance(SCHEM:&quot;PD 98,059&quot;) decreases kinaseActivity(proteinAbundance(HGNC:MAPK3))</div><div class='line' id='LC6166'>abundance(SCHEM:&quot;LY 294002&quot;) increases proteinAbundance(HGNC:CDKN1B)</div><div class='line' id='LC6167'>abundance(SCHEM:&quot;PD 98,059&quot;) increases proteinAbundance(HGNC:CDKN1B)</div><div class='line' id='LC6168'><br/></div><div class='line' id='LC6169'>SET Evidence = &quot;Phosphorylation of p27Kip1 on threonine 187 (T187) by active cdk2 leads to its recognition</div><div class='line' id='LC6170'>by the F-box protein SCFSkp2, thereby promoting p27Kip1 ubiquitination</div><div class='line' id='LC6171'>and destruction by the 26S proteasome (45).&quot;</div><div class='line' id='LC6172'><br/></div><div class='line' id='LC6173'>kinaseActivity(proteinAbundance(HGNC:CDK2)) directlyIncreases proteinAbundance(HGNC:CDKN1B,proteinModification(P,T,187))</div><div class='line' id='LC6174'>proteinAbundance(HGNC:CDKN1B,proteinModification(P,T,187)) directlyIncreases complexAbundance(proteinAbundance(HGNC:SKP2),proteinAbundance(HGNC:CDKN1B))</div><div class='line' id='LC6175'>catalyticActivity(proteinAbundance(HGNC:SKP2)) directlyIncreases proteinAbundance(HGNC:CDKN1B,proteinModification(U))</div><div class='line' id='LC6176'>proteinAbundance(HGNC:CDKN1B,proteinModification(U)) directlyIncreases degradation(proteinAbundance(HGNC:CDKN1B))</div><div class='line' id='LC6177'>proteinAbundance(HGNC:CDKN1B,proteinModification(P,T,187)) directlyIncreases (catalyticActivity(proteinAbundance(HGNC:SKP2)) directlyIncreases degradation(proteinAbundance(HGNC:CDKN1B)))</div><div class='line' id='LC6178'><br/></div><div class='line' id='LC6179'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC6180'>SET Evidence = &quot;Activation of AKT alone had little or no effect on total p21Cip1 expression measured</div><div class='line' id='LC6181'>in whole-cell lysates (Fig. 7A, lanes 1 to 4), whereas activation of RAF alone</div><div class='line' id='LC6182'>led to robust induction of p21Cip1 as reported previously (Fig. 7A, lanes 5 to7,</div><div class='line' id='LC6183'>and 7B).&quot;</div><div class='line' id='LC6184'>SET Species = &quot;10090&quot;</div><div class='line' id='LC6185'><br/></div><div class='line' id='LC6186'>kinaseActivity(proteinAbundance(HGNC:AKT1)) causesNoChange proteinAbundance(HGNC:CDKN1A)</div><div class='line' id='LC6187'>kinaseActivity(proteinAbundance(HGNC:RAF1)) increases proteinAbundance(HGNC:CDKN1A)</div><div class='line' id='LC6188'><br/></div><div class='line' id='LC6189'>SET Evidence = &quot;coactivation of RAF and AKT led to sustained cdk2 activity (lanes 8 to 10), whereas</div><div class='line' id='LC6190'>activation of RAF or AKT alone elicited, at best, only transient activation of</div><div class='line' id='LC6191'>cdk2 (lanes 2 to 7).&quot;</div><div class='line' id='LC6192'><br/></div><div class='line' id='LC6193'>compositeAbundance(proteinAbundance(HGNC:RAF1),proteinAbundance(HGNC:AKT1)) increases kinaseActivity(proteinAbundance(HGNC:CDK2))</div><div class='line' id='LC6194'><br/></div><div class='line' id='LC6195'>SET Evidence = &quot;RAF-induced p21Cip1 was readily detected in complex with cdk2 (lanes 5 to 7).&quot;</div><div class='line' id='LC6196'><br/></div><div class='line' id='LC6197'>kinaseActivity(proteinAbundance(HGNC:RAF1)) increases complexAbundance(proteinAbundance(HGNC:CDKN1A),proteinAbundance(HGNC:CDK2))</div><div class='line' id='LC6198'><br/></div><div class='line' id='LC6199'>SET Evidence = &quot;AKT activation elicits sustained cdk2 activation, not by inhibiting p21Cip1 expression</div><div class='line' id='LC6200'>but by promoting the removal of p21Cip1 from cdk2 complexes.&quot;</div><div class='line' id='LC6201'><br/></div><div class='line' id='LC6202'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases complexAbundance(proteinAbundance(HGNC:CDK2),proteinAbundance(HGNC:CDKN1A))</div><div class='line' id='LC6203'>complexAbundance(proteinAbundance(HGNC:CDK2),proteinAbundance(HGNC:CDKN1A)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:CDK2))</div><div class='line' id='LC6204'><br/></div><div class='line' id='LC6205'>SET Evidence = &quot;AKT promoted nuclear export of RAF-induced p21Cip1 into a cytoplasmic compartment</div><div class='line' id='LC6206'>as reported previously (Fig. 7C) (65).&quot;</div><div class='line' id='LC6207'><br/></div><div class='line' id='LC6208'>kinaseActivity(proteinAbundance(HGNC:AKT1)) increases translocation(proteinAbundance(HGNC:CDKN1A),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC6209'><br/></div><div class='line' id='LC6210'>UNSET STATEMENT_GROUP</div><div class='line' id='LC6211'><br/></div><div class='line' id='LC6212'>SET STATEMENT_GROUP = &quot;Group 49&quot;</div><div class='line' id='LC6213'><br/></div><div class='line' id='LC6214'>SET CellLine = &quot;HeLa&quot;</div><div class='line' id='LC6215'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC6216'>SET Evidence = &quot;Thus Lys559, which lies within the N-terminal extension of class II HDACs, is required</div><div class='line' id='LC6217'>for sumoylation of HDAC4 in vitro and in vivo and is likely to be the predominant</div><div class='line' id='LC6218'>modification site for SUMO.&quot;</div><div class='line' id='LC6219'>SET Citation = {&quot;PubMed&quot;,&quot;The EMBO journal&quot;,&quot;12032081&quot;,&quot;&quot;,&quot;Kirsh O|Seeler JS|Pichler A|Gast A|Müller S|Miska E|Mathieu M|Harel-Bellan A|Kouzarides T|Melchior F|Dejean A&quot;,&quot;&quot;}</div><div class='line' id='LC6220'>SET Species = &quot;9606&quot;</div><div class='line' id='LC6221'><br/></div><div class='line' id='LC6222'>proteinAbundance(HGNC:HDAC4,proteinModification(S,K,559))</div><div class='line' id='LC6223'><br/></div><div class='line' id='LC6224'>SET Cell = &quot;COS Cells&quot;</div><div class='line' id='LC6225'>SET Evidence = &quot;COS-7 cells were transiently transfected with expression vectors for SUMO-1 together</div><div class='line' id='LC6226'>with HDAC4 or HDAC4-K559R followed by immunoprecipitation using the anti-HDAC4</div><div class='line' id='LC6227'>antibodies and an assay for histone deacetylase activity (Figure 4B). Although</div><div class='line' id='LC6228'>the two proteins were expressed at a similar level (inset), the HDAC activity</div><div class='line' id='LC6229'>associated with HDAC4-K559R was significantly reduced, to a level barely above that</div><div class='line' id='LC6230'>of endogenous HDAC4 (compare lane 3 with lanes 1 and 2).&quot;</div><div class='line' id='LC6231'><br/></div><div class='line' id='LC6232'>proteinAbundance(HGNC:HDAC4,proteinModification(S,K,559)) directlyIncreases catalyticActivity(proteinAbundance(HGNC:HDAC4))</div><div class='line' id='LC6233'><br/></div><div class='line' id='LC6234'>SET Evidence = &quot;As seen in Figure 4C, both the modified and unmodified HDAC4 species were retained</div><div class='line' id='LC6235'>efficiently by GST–N-CoR, GST–MEF2C and GST–14-3-3ε but not by the GST–PML control.&quot;</div><div class='line' id='LC6236'><br/></div><div class='line' id='LC6237'>complexAbundance(proteinAbundance(HGNC:HDAC4),proteinAbundance(HGNC:NCOR1))</div><div class='line' id='LC6238'>complexAbundance(proteinAbundance(HGNC:HDAC4),proteinAbundance(HGNC:MEF2C))</div><div class='line' id='LC6239'>complexAbundance(proteinAbundance(HGNC:HDAC4),proteinAbundance(HGNC:YWHAE))</div><div class='line' id='LC6240'><br/></div><div class='line' id='LC6241'>SET Evidence = &quot;The ability of the sumoylation-deficient HDAC4-K559R mutant to repress transcription</div><div class='line' id='LC6242'>was slightly impaired when compared with that of the wild-type HDAC4 protein</div><div class='line' id='LC6243'>(Figure 4A).&quot;</div><div class='line' id='LC6244'><br/></div><div class='line' id='LC6245'>proteinAbundance(HGNC:HDAC4,proteinModification(S,K,559)) directlyIncreases transcriptionalActivity(proteinAbundance(HGNC:HDAC4))</div><div class='line' id='LC6246'><br/></div><div class='line' id='LC6247'>SET Evidence = &quot;As expected, expression of a construct (HDAC4-ΔNLS) lacking these residues rendered</div><div class='line' id='LC6248'>the protein entirely cytoplasmic, albeit without impairing the protein&#39;s ability</div><div class='line' id='LC6249'>to aggregate (Figure 6B). Western blot analysis of cells expressing HDAC4- ΔNLS</div><div class='line' id='LC6250'>demonstrated this protein to be unable to undergo SUMO-1 modification (Figure</div><div class='line' id='LC6251'>6C, lane 3), even upon co-expression of exogenous His-SUMO-1 (Figure 6C, lane</div><div class='line' id='LC6252'>4). This inability, however, is not an intrinsic property of this protein since</div><div class='line' id='LC6253'>modification by SUMO-1 occurs as efficiently as for the full-length HDAC4 protein</div><div class='line' id='LC6254'>using the in vitro assay (Figure 6C, compare lane 8 with lane 6).&quot;</div><div class='line' id='LC6255'><br/></div><div class='line' id='LC6256'>translocation(proteinAbundance(HGNC:HDAC4),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;) directlyIncreases proteinAbundance(HGNC:HDAC4,proteinModification(S,K,559))</div><div class='line' id='LC6257'><br/></div><div class='line' id='LC6258'>SET Evidence = &quot;Consistent with previous observations, transfection of a constitutively active CaMKI</div><div class='line' id='LC6259'>vector in HeLa cells induced nuclear exclusion of HDAC4 in the vast majority</div><div class='line' id='LC6260'>of the cells (Figure 6D).&quot;</div><div class='line' id='LC6261'><br/></div><div class='line' id='LC6262'>kinaseActivity(proteinAbundance(HGNC:CAMK1)) increases translocation(proteinAbundance(HGNC:HDAC4),MESHCL:&quot;Cell Nucleus&quot;,MESHCL:Cytoplasm)</div><div class='line' id='LC6263'><br/></div><div class='line' id='LC6264'>SET Evidence = &quot;Moreover RanBP2 functions catalytically as 5 ng of BP2ΔFG were sufficient to promote</div><div class='line' id='LC6265'>modification of a 100-fold molar excess of HDAC4. Thus, RanBP2 plays an E3-like</div><div class='line' id='LC6266'>role in SUMO modification of HDAC4.&quot;</div><div class='line' id='LC6267'><br/></div><div class='line' id='LC6268'>catalyticActivity(proteinAbundance(HGNC:RANBP2)) directlyIncreases proteinAbundance(HGNC:HDAC4,proteinModification(S,K,559))</div><div class='line' id='LC6269'><br/></div><div class='line' id='LC6270'>UNSET STATEMENT_GROUP</div><div class='line' id='LC6271'><br/></div><div class='line' id='LC6272'>SET STATEMENT_GROUP = &quot;Group 50&quot;</div><div class='line' id='LC6273'><br/></div><div class='line' id='LC6274'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC6275'>SET Evidence = &quot;A POSH mutant that is unable to bind Akt2&quot;</div><div class='line' id='LC6276'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of biological chemistry&quot;,&quot;14504284&quot;,&quot;2003-10-21&quot;,&quot;Figueroa C|Tarras S|Taylor J|Vojtek AB&quot;,&quot;&quot;}</div><div class='line' id='LC6277'>SET Species = &quot;9606&quot;</div><div class='line' id='LC6278'><br/></div><div class='line' id='LC6279'>complexAbundance(proteinAbundance(HGNC:SH3RF1),proteinAbundance(HGNC:AKT2))</div><div class='line' id='LC6280'><br/></div><div class='line' id='LC6281'>SET Evidence = &quot;In addition, we show that the association of MLK3 with POSH is increased upon inhibition</div><div class='line' id='LC6282'>of the endogenous phosphatidylinositol 3-kinase/Akt signaling pathway.&quot;</div><div class='line' id='LC6283'><br/></div><div class='line' id='LC6284'>kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;)) decreases complexAbundance(proteinAbundance(HGNC:SH3RF1),proteinAbundance(HGNC:MAP3K11))</div><div class='line' id='LC6285'><br/></div><div class='line' id='LC6286'>SET Evidence = &quot;Akt2 binds to a POSH-MLK-MKK-JNK complex and phosphorylates MLK3&quot;</div><div class='line' id='LC6287'><br/></div><div class='line' id='LC6288'>kinaseActivity(proteinAbundance(HGNC:AKT2)) directlyIncreases proteinAbundance(HGNC:MAP3K11,proteinModification(P))</div><div class='line' id='LC6289'><br/></div><div class='line' id='LC6290'>SET Evidence = &quot;phosphorylation of MLK3 by Akt2 results in the disassembly of the JNK complex bound</div><div class='line' id='LC6291'>to POSH and down-regulation of the JNK signaling pathway&quot;</div><div class='line' id='LC6292'><br/></div><div class='line' id='LC6293'>proteinAbundance(HGNC:MAP3K11,proteinModification(P)) directlyDecreases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC6294'><br/></div><div class='line' id='LC6295'>SET CellLine = &quot;293&quot;</div><div class='line' id='LC6296'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC6297'>SET Evidence = &quot;This increase in the MLK-POSH complex is accompanied by an increase in phospho-c-Jun,</div><div class='line' id='LC6298'>a measure of JNK pathway activation (Fig. 5B).&quot;</div><div class='line' id='LC6299'><br/></div><div class='line' id='LC6300'>complexAbundance(proteinAbundance(HGNC:MAP3K11),proteinAbundance(HGNC:SH3RF1)) increases proteinAbundance(HGNC:JUN,proteinModification(P))</div><div class='line' id='LC6301'>complexAbundance(proteinAbundance(HGNC:MAP3K11),proteinAbundance(HGNC:SH3RF1)) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC6302'>kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;)) directlyIncreases proteinAbundance(HGNC:JUN,proteinModification(P))</div><div class='line' id='LC6303'><br/></div><div class='line' id='LC6304'>SET Evidence = &quot;The association of MLK3 with POSH is substantially increased by LY294002 treatment</div><div class='line' id='LC6305'>(Fig. 5C). Thus, inhibition of endogenous Akt kinases enhances the ability of</div><div class='line' id='LC6306'>POSH to scaffold MLK3.&quot;</div><div class='line' id='LC6307'><br/></div><div class='line' id='LC6308'>abundance(SCHEM:&quot;LY 294002&quot;) increases complexAbundance(proteinAbundance(HGNC:SH3RF1),proteinAbundance(HGNC:MAP3K11))</div><div class='line' id='LC6309'><br/></div><div class='line' id='LC6310'>SET Evidence = &quot;Introduction of MLK3 into cells alone activates the JNK signaling pathway, as assessed</div><div class='line' id='LC6311'>by Western blot analysis of phospho-c-Jun levels (Fig. 6A).&quot;</div><div class='line' id='LC6312'><br/></div><div class='line' id='LC6313'>proteinAbundance(HGNC:MAP3K11) increases kinaseActivity(proteinAbundance(PFH:&quot;MAPK JNK Family&quot;))</div><div class='line' id='LC6314'>proteinAbundance(HGNC:MAP3K11) increases proteinAbundance(HGNC:JUN,proteinModification(P))</div><div class='line' id='LC6315'><br/></div><div class='line' id='LC6316'>UNSET STATEMENT_GROUP</div><div class='line' id='LC6317'><br/></div><div class='line' id='LC6318'>SET STATEMENT_GROUP = &quot;Group 51&quot;</div><div class='line' id='LC6319'><br/></div><div class='line' id='LC6320'>SET MuskuloskeletalSystem = &quot;Muscle, Skeletal&quot;</div><div class='line' id='LC6321'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC6322'>SET Evidence = &quot;Transgenic expression of PGC-1α recently has been shown to dramatically increase the</div><div class='line' id='LC6323'>content of type I muscle fibers in skeletal muscle, but the relationship between</div><div class='line' id='LC6324'>PGC-1α expression and the key components in calcium signaling is not clear.&quot;</div><div class='line' id='LC6325'>SET Citation = {&quot;PubMed&quot;,&quot;Proceedings of the National Academy of Sciences of the United States of America&quot;,&quot;12764228&quot;,&quot;2003-06-22&quot;,&quot;Handschin C|Rhee J|Lin J|Tarr PT|Spiegelman BM&quot;,&quot;&quot;}</div><div class='line' id='LC6326'>SET Species = &quot;10090&quot;</div><div class='line' id='LC6327'><br/></div><div class='line' id='LC6328'>proteinAbundance(MGI:Ppargc1a) increases biologicalProcess(GO:&quot;skeletal muscle adaptation&quot;)</div><div class='line' id='LC6329'><br/></div><div class='line' id='LC6330'>SET Evidence = &quot;In this report, we show that the PGC-1α promoter is regulated by both CaMKIV and CnA</div><div class='line' id='LC6331'>activity. CaMKIV activates PGC-1α largely through the binding of cAMP response</div><div class='line' id='LC6332'>element-binding protein to the PGC-1α promoter.&quot;</div><div class='line' id='LC6333'><br/></div><div class='line' id='LC6334'>proteinAbundance(MGI:Camk4) increases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6335'>transcriptionalActivity(proteinAbundance(PFM:&quot;Creb Family&quot;)) increases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6336'><br/></div><div class='line' id='LC6337'>SET Evidence = &quot;Transgenic expression of PGC-1α recently has been shown to dramatically increase the</div><div class='line' id='LC6338'>content of type I muscle fibers in skeletal muscle, but the relationship between</div><div class='line' id='LC6339'>PGC-1α expression and the key components in calcium signaling is not clear.&quot;</div><div class='line' id='LC6340'><br/></div><div class='line' id='LC6341'>proteinAbundance(MGI:Ppargc1a) increases biologicalProcess(GO:&quot;muscle cell differentiation&quot;)</div><div class='line' id='LC6342'><br/></div><div class='line' id='LC6343'>SET Evidence = &quot;Moreover, we show that a positive feedback loop exists between PGC-1α and members</div><div class='line' id='LC6344'>of the myocyte enhancer factor 2 (MEF2) family of transcription factors. MEF2s</div><div class='line' id='LC6345'>bind to the PGC-1α promoter and activate it, predominantly when coactivated by PGC-1α.</div><div class='line' id='LC6346'>MEF2 activity is stimulated further by CnA signaling.&quot;</div><div class='line' id='LC6347'><br/></div><div class='line' id='LC6348'>transcriptionalActivity(proteinAbundance(PFM:&quot;Mef2 Family&quot;)) directlyIncreases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6349'>transcriptionalActivity(proteinAbundance(MGI:Ppargc1a)) directlyIncreases transcriptionalActivity(proteinAbundance(PFM:&quot;Mef2 Family&quot;))</div><div class='line' id='LC6350'>phosphataseActivity(complexAbundance(NCM:&quot;Calcineurin Complex&quot;)) increases transcriptionalActivity(proteinAbundance(PFM:&quot;Mef2 Family&quot;))</div><div class='line' id='LC6351'><br/></div><div class='line' id='LC6352'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC6353'><br/></div><div class='line' id='LC6354'>transcriptionalActivity(proteinAbundance(MGI:Ppargc1a)) increases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6355'><br/></div><div class='line' id='LC6356'>SET Evidence = &quot;Promoter fragments that contain either 2 or 6 kb of 5&#39; flanking region of mouse PGC-1α</div><div class='line' id='LC6357'>both are activated at least 3-fold by the expression of constitutively active</div><div class='line' id='LC6358'>CaMKIV (Fig. 1A). In contrast, expression of a constitutively active CnA has</div><div class='line' id='LC6359'>very little effect on reporter gene activity, consistent with the results obtained</div><div class='line' id='LC6360'>previously for PGC-1α mRNA expression in CaMKIV and CnA transgenic mice (11).</div><div class='line' id='LC6361'>However, the combination of CaMKIV and CnA has a powerful effect on the PGC-1α</div><div class='line' id='LC6362'>promoter, increasing transcription by ~7-fold (Fig. 1A).&quot;</div><div class='line' id='LC6363'><br/></div><div class='line' id='LC6364'>transcriptionalActivity(proteinAbundance(MGI:Camk4)) directlyIncreases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6365'>phosphataseActivity(complexAbundance(NCM:&quot;Calcineurin Complex&quot;)) causesNoChange rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6366'>phosphataseActivity(complexAbundance(NCM:&quot;Calcineurin Complex&quot;)) increases (transcriptionalActivity(proteinAbundance(MGI:Camk4)) directlyIncreases rnaAbundance(MGI:Ppargc1a))</div><div class='line' id='LC6367'><br/></div><div class='line' id='LC6368'>SET Evidence = &quot;CaMKIV has been shown to phosphorylate and activate many proteins, including CREB.</div><div class='line' id='LC6369'>Because CREB has been shown to be an important activator of PGC-1α gene expression</div><div class='line' id='LC6370'>in the fasted liver (24), we used the dominant-negative ACREB protein to examine</div><div class='line' id='LC6371'>a potential role for CREB in the CaMKIV-mediated control of the PGC-1α promoter.</div><div class='line' id='LC6372'>Although ACREB alone had no effect on the PGC-1α promoter, this protein severely</div><div class='line' id='LC6373'>reduced the activation of the PGC-1α promoter by CaMKIV alone or CaMKIV</div><div class='line' id='LC6374'>in combination with CnA (Fig. 1A).&quot;</div><div class='line' id='LC6375'><br/></div><div class='line' id='LC6376'>proteinAbundance(MGI:Camk4) directlyIncreases transcriptionalActivity(proteinAbundance(MGI:Creb1))</div><div class='line' id='LC6377'><br/></div><div class='line' id='LC6378'>SET DigestiveSystem = &quot;Liver&quot;</div><div class='line' id='LC6379'><br/></div><div class='line' id='LC6380'>transcriptionalActivity(proteinAbundance(MGI:Creb1)) increases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6381'>transcriptionalActivity(proteinAbundance(MGI:Creb1)) increases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6382'>transcriptionalActivity(proteinAbundance(MGI:Creb1)) increases (proteinAbundance(MGI:Camk4) directlyIncreases rnaAbundance(MGI:Ppargc1a))</div><div class='line' id='LC6383'><br/></div><div class='line' id='LC6384'>SET Evidence = &quot;As shown in Fig. 1C, mutagenesis of the CRE site abolished induction of the mouse</div><div class='line' id='LC6385'>PGC-1α promoter by forskolin, as expected.&quot;</div><div class='line' id='LC6386'><br/></div><div class='line' id='LC6387'>abundance(SCHEM:Colforsin) increases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6388'><br/></div><div class='line' id='LC6389'>SET Evidence = &quot;Because MEF2 and NFAT transcription factors are known targets of CaMKIV and CnA in</div><div class='line' id='LC6390'>muscle fiber-type determination, we tested the role of these factors in the control</div><div class='line' id='LC6391'>of the PGC-1α promoter.&quot;</div><div class='line' id='LC6392'><br/></div><div class='line' id='LC6393'>kinaseActivity(proteinAbundance(MGI:Camk4)) increases transcriptionalActivity(proteinAbundance(PFM:&quot;Mef2 Family&quot;))</div><div class='line' id='LC6394'>kinaseActivity(proteinAbundance(MGI:Camk4)) increases transcriptionalActivity(proteinAbundance(PFM:&quot;Nfat Family&quot;))</div><div class='line' id='LC6395'><br/></div><div class='line' id='LC6396'>SET Evidence = &quot;As shown in Fig. 2A, a coactivation by PGC-1α of both MEF2C and MEF2D, but not NFAT,</div><div class='line' id='LC6397'>was observed on the PGC-1α promoter. These data suggest that PGC-1α might participate</div><div class='line' id='LC6398'>in the activation of its own promoter and that the MEF2 proteins may function</div><div class='line' id='LC6399'>both in the regulation of PGC-1α expression and as downstream targets of</div><div class='line' id='LC6400'>PGC-1α coactivation of other muscle-selective genes.&quot;</div><div class='line' id='LC6401'><br/></div><div class='line' id='LC6402'>transcriptionalActivity(proteinAbundance(MGI:Mef2c)) increases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6403'>transcriptionalActivity(proteinAbundance(MGI:Mef2d)) increases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6404'><br/></div><div class='line' id='LC6405'>SET Evidence = &quot;As shown in Fig. 2B, CnA is able to substantially increase the activity of MEF2C and</div><div class='line' id='LC6406'>MEF2D on the PGC-1α promoter. The strongest effect was observed when MEF2C or</div><div class='line' id='LC6407'>MEF2D was expressed with both CnA and PGC-1α (Fig. 2B).&quot;</div><div class='line' id='LC6408'><br/></div><div class='line' id='LC6409'>phosphataseActivity(complexAbundance(NCM:&quot;Calcineurin Complex&quot;)) increases (transcriptionalActivity(proteinAbundance(MGI:Mef2c)) increases rnaAbundance(MGI:Ppargc1a))</div><div class='line' id='LC6410'>phosphataseActivity(complexAbundance(NCM:&quot;Calcineurin Complex&quot;)) increases (transcriptionalActivity(proteinAbundance(MGI:Mef2c)) increases rnaAbundance(MGI:Ppargc1a))</div><div class='line' id='LC6411'><br/></div><div class='line' id='LC6412'>SET Evidence = &quot;We next examined whether mutations of this MEF2 site affects MEF2 activity on the</div><div class='line' id='LC6413'>PGC-1α promoter. The mutated 2-kb promoter (called ΔMEF2; see Fig. 3A) is no longer</div><div class='line' id='LC6414'>able to mediate MEF2C or MEF2D induction alone, when activated by CnA or coactivated</div><div class='line' id='LC6415'>by PGC-1α, suggesting that this site is responsible for the MEF2 action</div><div class='line' id='LC6416'>(Fig. 3B). Moreover, electrophoretic mobility-shift assays revealed binding of</div><div class='line' id='LC6417'>MEF2C to this MEF-binding site but not the mutated ΔMEF site in the PGC-1α promoter</div><div class='line' id='LC6418'>(Fig. 3C). The identity of the MEF2C–DNA complex was confirmed by using an</div><div class='line' id='LC6419'>anti-MEF2 antibody that leads to a supershift of the DNA–protein complex.&quot;</div><div class='line' id='LC6420'><br/></div><div class='line' id='LC6421'>transcriptionalActivity(proteinAbundance(MGI:Mef2c)) directlyIncreases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6422'>transcriptionalActivity(proteinAbundance(MGI:Mef2d)) directlyIncreases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6423'><br/></div><div class='line' id='LC6424'>SET Evidence = &quot;To confirm that the coactivation of MEF2C by PGC-1α observed in reporter gene assays</div><div class='line' id='LC6425'>(Fig. 3B) was linked to direct binding of these two proteins, we tested whether</div><div class='line' id='LC6426'>PGC-1α directly interacts with MEF2C on this MEF-binding site. Increasing amounts</div><div class='line' id='LC6427'>of PGC-1α protein (amino acids 31–797) decreased the mobility of the complex</div><div class='line' id='LC6428'>containing MEF2C bound to the MEF-binding site, as visualized by a supershift</div><div class='line' id='LC6429'>in electrophoretic mobility-shift assays (Fig. 3D). As a control, PGC-1α protein</div><div class='line' id='LC6430'>that lacks the MEF2C-interaction domain (amino acids 1–180; see ref. 7) was not</div><div class='line' id='LC6431'>able to bind to MEF2C. Inclusion of an MEF2- specific antibody was able to supershift</div><div class='line' id='LC6432'>further the protein–DNA complex containing MEF2C, PGC-1α, and the MEF2-binding</div><div class='line' id='LC6433'>site (Fig. 3E). Neither a shift nor a supershift could be obtained when using</div><div class='line' id='LC6434'>the mutated ΔMEF site. These results indicate that MEF2s bind to the PGC-1α</div><div class='line' id='LC6435'>promoter and that PGC-1α coactivates MEF2 proteins on the PGC-1α promoter by a</div><div class='line' id='LC6436'>direct protein–protein interaction.&quot;</div><div class='line' id='LC6437'><br/></div><div class='line' id='LC6438'>transcriptionalActivity(proteinAbundance(MGI:Ppargc1a)) directlyIncreases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6439'>transcriptionalActivity(complexAbundance(proteinAbundance(MGI:Ppargc1a),proteinAbundance(MGI:Mef2c))) directlyIncreases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6440'><br/></div><div class='line' id='LC6441'>SET Evidence = &quot;Real-time PCR primers were designed for the PGC-1α  3&#39; untranslated region that allows</div><div class='line' id='LC6442'>for determination of the levels of ectopically expressed and endogenous PGC-1α.</div><div class='line' id='LC6443'>As shown in Fig. 4B and as expected, ectopic PGC-1α is detected only in the</div><div class='line' id='LC6444'>muscle of transgenic mice. Strikingly, a 7-fold elevation of endogenous PGC-1α</div><div class='line' id='LC6445'>mRNA was seen in the transgenic animals as compared with wild-type mice (Fig. 4B).</div><div class='line' id='LC6446'>A robust increase in the transcript levels of cytochrome c and myoglobin also</div><div class='line' id='LC6447'>was observed in the RNA isolated from skeletal muscle of the transgenic mice,</div><div class='line' id='LC6448'>whereas GAPDH transcript levels remained unchanged (Fig. 4B). These results indicate</div><div class='line' id='LC6449'>a regulation of PGC-1α transcription by PGC-1α  protein in an apparent autoregulatory</div><div class='line' id='LC6450'>loop.&quot;</div><div class='line' id='LC6451'><br/></div><div class='line' id='LC6452'>transcriptionalActivity(proteinAbundance(MGI:Ppargc1a)) increases rnaAbundance(MGI:Ppargc1a)</div><div class='line' id='LC6453'><br/></div><div class='line' id='LC6454'>SET Evidence = &quot;Expression of myoglobin in C2C12 myotubes also required infection of both PGC-1α and</div><div class='line' id='LC6455'>MEF2C (Fig. 5C).&quot;</div><div class='line' id='LC6456'><br/></div><div class='line' id='LC6457'>compositeAbundance(proteinAbundance(MGI:Ppargc1a),proteinAbundance(MGI:Mef2c)) increases rnaAbundance(MGI:Mb)</div><div class='line' id='LC6458'><br/></div><div class='line' id='LC6459'>SET Evidence = &quot;Troponin I slow is induced after infection with virally encoded MEF2C, and the addition</div><div class='line' id='LC6460'>of PGC-1α  has no further effect (Fig. 5D). In contrast, GLUT4 transcript</div><div class='line' id='LC6461'>levels can be elevated by PGC-1α alone, independent of MEF2C infection, consistent</div><div class='line' id='LC6462'>with previous reports (7) (Fig. 5E).&quot;</div><div class='line' id='LC6463'><br/></div><div class='line' id='LC6464'>proteinAbundance(MGI:Mef2c) increases rnaAbundance(MGI:Tnni1)</div><div class='line' id='LC6465'>proteinAbundance(MGI:Ppargc1a) increases rnaAbundance(MGI:Slc2a4)</div><div class='line' id='LC6466'><br/></div><div class='line' id='LC6467'>UNSET STATEMENT_GROUP</div><div class='line' id='LC6468'><br/></div><div class='line' id='LC6469'>SET STATEMENT_GROUP = &quot;Group 52&quot;</div><div class='line' id='LC6470'><br/></div><div class='line' id='LC6471'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC6472'>SET Evidence = &quot;The anaphase-promoting complex (APC) or cyclosome is a ubiquitin ligase that initiates</div><div class='line' id='LC6473'>anaphase and mitotic exit.&quot;</div><div class='line' id='LC6474'>SET Citation = {&quot;PubMed&quot;,&quot;The EMBO journal&quot;,&quot;14657031&quot;,&quot;&quot;,&quot;Kraft C|Herzog F|Gieffers C|Mechtler K|Hagting A|Pines J|Peters JM&quot;,&quot;&quot;}</div><div class='line' id='LC6475'>SET Species = &quot;9606&quot;</div><div class='line' id='LC6476'><br/></div><div class='line' id='LC6477'>catalyticActivity(complexAbundance(NCH:&quot;Anaphase Promoting Complex&quot;)) increases biologicalProcess(GO:anaphase)</div><div class='line' id='LC6478'>catalyticActivity(complexAbundance(NCH:&quot;Anaphase Promoting Complex&quot;)) increases biologicalProcess(GO:&quot;exit from mitosis&quot;)</div><div class='line' id='LC6479'><br/></div><div class='line' id='LC6480'>SET Evidence = &quot;APC activation is thought to depend on APC phosphorylation and Cdc20 binding.&quot;</div><div class='line' id='LC6481'><br/></div><div class='line' id='LC6482'>proteinAbundance(HGNC:CDC20) directlyIncreases catalyticActivity(complexAbundance(NCH:&quot;Anaphase Promoting Complex&quot;))</div><div class='line' id='LC6483'><br/></div><div class='line' id='LC6484'>SET Evidence = &quot;APC phosphorylation by Cdk1, but not by Plk1, is sufficient for increased Cdc20 binding</div><div class='line' id='LC6485'>and APC activation.&quot;</div><div class='line' id='LC6486'><br/></div><div class='line' id='LC6487'>kinaseActivity(proteinAbundance(HGNC:CDK1)) directlyIncreases complexAbundance(proteinAbundance(HGNC:CDC20),complexAbundance(NCH:&quot;Anaphase Promoting Complex&quot;))</div><div class='line' id='LC6488'>kinaseActivity(proteinAbundance(HGNC:CDK1)) directlyIncreases catalyticActivity(complexAbundance(NCH:&quot;Anaphase Promoting Complex&quot;))</div><div class='line' id='LC6489'>kinaseActivity(proteinAbundance(HGNC:PLK1)) causesNoChange catalyticActivity(complexAbundance(NCH:&quot;Anaphase Promoting Complex&quot;))</div><div class='line' id='LC6490'>kinaseActivity(proteinAbundance(HGNC:PLK1)) causesNoChange complexAbundance(proteinAbundance(HGNC:CDC20),complexAbundance(NCH:&quot;Anaphase Promoting Complex&quot;))</div><div class='line' id='LC6491'><br/></div><div class='line' id='LC6492'>SET CellLine = &quot;HeLa&quot;</div><div class='line' id='LC6493'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC6494'>SET Evidence = &quot;Cdc20 peptides were only found in mitotic APC samples, confirming that Cdc20 associates</div><div class='line' id='LC6495'>with APC in a mitosis-specific manner.&quot;</div><div class='line' id='LC6496'><br/></div><div class='line' id='LC6497'>biologicalProcess(GO:mitosis) positiveCorrelation complexAbundance(proteinAbundance(HGNC:CDC20),complexAbundance(NCH:&quot;Anaphase Promoting Complex&quot;))</div><div class='line' id='LC6498'><br/></div><div class='line' id='LC6499'>SET Evidence = &quot;We raised antibodies against two mitosis-specific sites on Cdc27 (phospho-S427 and</div><div class='line' id='LC6500'>phospho-T447) and one each on Apc1 (phospho-S355), Cdc16 (phospho-S558) and Cdc23</div><div class='line' id='LC6501'>(phospho-T556.&quot;</div><div class='line' id='LC6502'><br/></div><div class='line' id='LC6503'>biologicalProcess(GO:mitosis) positiveCorrelation proteinAbundance(HGNC:CDC27,proteinModification(P,S,427))</div><div class='line' id='LC6504'>biologicalProcess(GO:mitosis) positiveCorrelation proteinAbundance(HGNC:CDC27,proteinModification(P,T,447))</div><div class='line' id='LC6505'>biologicalProcess(GO:mitosis) positiveCorrelation proteinAbundance(HGNC:ANAPC1,proteinModification(P,S,355))</div><div class='line' id='LC6506'>biologicalProcess(GO:mitosis) positiveCorrelation proteinAbundance(HGNC:CDC16,proteinModification(P,S,558))</div><div class='line' id='LC6507'>biologicalProcess(GO:mitosis) positiveCorrelation proteinAbundance(HGNC:CDC23,proteinModification(P,T,556))</div><div class='line' id='LC6508'><br/></div><div class='line' id='LC6509'>SET Evidence = &quot;Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in</div><div class='line' id='LC6510'>the presence of either non-radioactive ATP or [γ-32P]ATP. The latter reactions</div><div class='line' id='LC6511'>were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure</div><div class='line' id='LC6512'>3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23.&quot;</div><div class='line' id='LC6513'><br/></div><div class='line' id='LC6514'>kinaseActivity(proteinAbundance(HGNC:CDK1)) directlyIncreases proteinAbundance(HGNC:ANAPC1,proteinModification(P))</div><div class='line' id='LC6515'>kinaseActivity(proteinAbundance(HGNC:CDK1)) directlyIncreases proteinAbundance(HGNC:CDC27,proteinModification(P))</div><div class='line' id='LC6516'>kinaseActivity(proteinAbundance(HGNC:CDK1)) directlyIncreases proteinAbundance(HGNC:ANAPC5,proteinModification(P))</div><div class='line' id='LC6517'>kinaseActivity(proteinAbundance(HGNC:CDK1)) directlyIncreases proteinAbundance(HGNC:CDC16,proteinModification(P))</div><div class='line' id='LC6518'>kinaseActivity(proteinAbundance(HGNC:CDK1)) directlyIncreases proteinAbundance(HGNC:CDC23,proteinModification(P))</div><div class='line' id='LC6519'>kinaseActivity(proteinAbundance(HGNC:PLK1)) directlyIncreases proteinAbundance(HGNC:ANAPC1,proteinModification(P))</div><div class='line' id='LC6520'>kinaseActivity(proteinAbundance(HGNC:PLK1)) directlyIncreases proteinAbundance(HGNC:CDC27,proteinModification(P))</div><div class='line' id='LC6521'>kinaseActivity(proteinAbundance(HGNC:PLK1)) directlyIncreases proteinAbundance(HGNC:ANAPC5,proteinModification(P))</div><div class='line' id='LC6522'>kinaseActivity(proteinAbundance(HGNC:PLK1)) directlyIncreases proteinAbundance(HGNC:CDC16,proteinModification(P))</div><div class='line' id='LC6523'>kinaseActivity(proteinAbundance(HGNC:PLK1)) directlyIncreases proteinAbundance(HGNC:CDC23,proteinModification(P))</div><div class='line' id='LC6524'><br/></div><div class='line' id='LC6525'>SET Evidence = &quot;We recently found that HeLa cells depleted of Plk1 by this protocol enter mitosis</div><div class='line' id='LC6526'>but are then delayed in prometaphase by the spindle checkpoint.&quot;</div><div class='line' id='LC6527'><br/></div><div class='line' id='LC6528'>proteinAbundance(HGNC:PLK1) decreases biologicalProcess(GO:&quot;response to spindle checkpoint signal&quot;)</div><div class='line' id='LC6529'>proteinAbundance(HGNC:PLK1) increases biologicalProcess(GO:&quot;mitotic prometaphase&quot;)</div><div class='line' id='LC6530'><br/></div><div class='line' id='LC6531'>SET Evidence = &quot;When APC was isolated from Plk1 RNAi cells or from control cells 10 h after the second</div><div class='line' id='LC6532'>thymidine release, i.e. when control cells were progressing through mitosis</div><div class='line' id='LC6533'>and when most Plk1 RNAi cells were in prometaphase, no difference in the ubiquitination</div><div class='line' id='LC6534'>activities of the APC samples could be detected, further supporting the</div><div class='line' id='LC6535'>notion that APC activation was not compromised in the Plk1 RNAi cells (Figure</div><div class='line' id='LC6536'>7B).&quot;</div><div class='line' id='LC6537'><br/></div><div class='line' id='LC6538'>proteinAbundance(HGNC:PLK1) causesNoChange catalyticActivity(complexAbundance(NCH:&quot;Anaphase Promoting Complex&quot;))</div><div class='line' id='LC6539'><br/></div><div class='line' id='LC6540'>SET Evidence = &quot;These observations indicate that normal Plk1 levels are not essential for APC-mediated</div><div class='line' id='LC6541'>degradation of cyclin A.&quot;</div><div class='line' id='LC6542'><br/></div><div class='line' id='LC6543'>proteinAbundance(HGNC:PLK1) causesNoChange degradation(proteinAbundance(PFH:&quot;CCNA Family&quot;))</div><div class='line' id='LC6544'><br/></div><div class='line' id='LC6545'>UNSET STATEMENT_GROUP</div><div class='line' id='LC6546'><br/></div><div class='line' id='LC6547'>SET STATEMENT_GROUP = &quot;Group 53&quot;</div><div class='line' id='LC6548'><br/></div><div class='line' id='LC6549'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC6550'>SET Evidence = &quot;Mutations and deletions of tumor suppressor genes, such as p53 or PTEN (phosphatase</div><div class='line' id='LC6551'>and tensin homologue deleted on chromosome 10), are two of the several events</div><div class='line' id='LC6552'>underlying the loss of apoptotic pathways (4).&quot;</div><div class='line' id='LC6553'>SET Citation = {&quot;PubMed&quot;,&quot;Cancer research&quot;,&quot;16540633&quot;,&quot;&quot;,&quot;Goswami A|Ranganathan P|Rangnekar VM&quot;,&quot;&quot;}</div><div class='line' id='LC6554'>SET Species = &quot;9606&quot;</div><div class='line' id='LC6555'><br/></div><div class='line' id='LC6556'>proteinAbundance(HGNC:TP53) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC6557'>proteinAbundance(HGNC:PTEN) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC6558'><br/></div><div class='line' id='LC6559'>SET Disease = &quot;Neoplasms&quot;</div><div class='line' id='LC6560'>SET Evidence = &quot;The interaction of the cell survival kinase, Akt1 (5), with the prostate apoptosis</div><div class='line' id='LC6561'>response-4 protein, Par-4 (6), results in phosphorylation and silencing of Par-4</div><div class='line' id='LC6562'>(7) and thus offers an intervention target for the selective induction of apoptosis</div><div class='line' id='LC6563'>in cancer cells.&quot;</div><div class='line' id='LC6564'><br/></div><div class='line' id='LC6565'>complexAbundance(proteinAbundance(HGNC:AKT1),proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6566'>kinaseActivity(proteinAbundance(HGNC:AKT1)) directlyIncreases proteinAbundance(HGNC:PAWR,proteinModification(P))</div><div class='line' id='LC6567'>kinaseActivity(proteinAbundance(HGNC:AKT1)) directlyDecreases molecularActivity(proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6568'><br/></div><div class='line' id='LC6569'>SET Evidence = &quot;Akt1 is a key cell survival protein functionally involved in antiapoptosis in various</div><div class='line' id='LC6570'>cancers (8, 9).&quot;</div><div class='line' id='LC6571'><br/></div><div class='line' id='LC6572'>proteinAbundance(HGNC:AKT1) decreases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC6573'><br/></div><div class='line' id='LC6574'>SET Evidence = &quot;Akt1 activity is elevated in cancer due to the loss of PTEN tumor suppressor function&quot;</div><div class='line' id='LC6575'><br/></div><div class='line' id='LC6576'>phosphataseActivity(proteinAbundance(HGNC:PTEN)) decreases kinaseActivity(proteinAbundance(HGNC:AKT1))</div><div class='line' id='LC6577'><br/></div><div class='line' id='LC6578'>SET Evidence = &quot;A, Akt1, which is activated by PI3K, plays a central role in cell survival by inactivating</div><div class='line' id='LC6579'>key agonists of apoptosis.&quot;</div><div class='line' id='LC6580'><br/></div><div class='line' id='LC6581'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases molecularActivity(proteinAbundance(HGNC:CDKN1B))</div><div class='line' id='LC6582'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases molecularActivity(proteinAbundance(HGNC:CDKN1A))</div><div class='line' id='LC6583'>kinaseActivity(proteinAbundance(HGNC:AKT1)) increases catalyticActivity(proteinAbundance(HGNC:MDM2))</div><div class='line' id='LC6584'>catalyticActivity(proteinAbundance(HGNC:MDM2)) decreases transcriptionalActivity(proteinAbundance(HGNC:TP53))</div><div class='line' id='LC6585'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases molecularActivity(proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6586'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases molecularActivity(proteinAbundance(HGNC:BAD))</div><div class='line' id='LC6587'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases kinaseActivity(proteinAbundance(HGNC:GSK3B))</div><div class='line' id='LC6588'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases transcriptionalActivity(proteinAbundance(HGNC:FOXO3))</div><div class='line' id='LC6589'><br/></div><div class='line' id='LC6590'>SET CellStructure = &quot;Cytoplasm&quot;</div><div class='line' id='LC6591'>SET Evidence = &quot;Par-4 is ubiquitously expressed in normal tissues and cell types and is found primarily</div><div class='line' id='LC6592'>in the cytoplasm (12–15).&quot;</div><div class='line' id='LC6593'><br/></div><div class='line' id='LC6594'>proteinAbundance(HGNC:PAWR)</div><div class='line' id='LC6595'><br/></div><div class='line' id='LC6596'>SET CellStructure = &quot;Cell Nucleus&quot;</div><div class='line' id='LC6597'>SET Evidence = &quot;Par-4 localizes both to the cytoplasm and the nucleus in many but not all cancer cells</div><div class='line' id='LC6598'>and clinical specimens (6, 13–17).&quot;</div><div class='line' id='LC6599'><br/></div><div class='line' id='LC6600'>proteinAbundance(HGNC:PAWR)</div><div class='line' id='LC6601'><br/></div><div class='line' id='LC6602'>SET Evidence = &quot;inhibition of endogenous Par-4 with antisense oligodeoxynucleotides, a dominant-negative</div><div class='line' id='LC6603'>leucine zipper domain, or RNA interference precludes apoptosis&quot;</div><div class='line' id='LC6604'><br/></div><div class='line' id='LC6605'>molecularActivity(proteinAbundance(HGNC:PAWR)) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC6606'>proteinAbundance(HGNC:PAWR) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC6607'><br/></div><div class='line' id='LC6608'>SET Evidence = &quot;Par-4 knockout mice spontaneously develop tumors of the liver, lung, and endometrium,</div><div class='line' id='LC6609'>exhibit prostatic intraepithelial neoplasia (PIN), and show an increased frequency</div><div class='line' id='LC6610'>of estrogen-inducible tumors in the endometrium and BBN-inducible tumors</div><div class='line' id='LC6611'>in the bladder (18).&quot;</div><div class='line' id='LC6612'>SET Species = &quot;10090&quot;</div><div class='line' id='LC6613'><br/></div><div class='line' id='LC6614'>proteinAbundance(HGNC:PAWR) decreases pathology(MESHD:&quot;Liver Neoplasms&quot;)</div><div class='line' id='LC6615'>proteinAbundance(HGNC:PAWR) decreases pathology(MESHD:&quot;Lung Neoplasms&quot;)</div><div class='line' id='LC6616'>proteinAbundance(HGNC:PAWR) decreases pathology(MESHD:&quot;Endometrial Neoplasms&quot;)</div><div class='line' id='LC6617'><br/></div><div class='line' id='LC6618'>SET Disease = &quot;Prostatic Intraepithelial Neoplasia&quot;</div><div class='line' id='LC6619'><br/></div><div class='line' id='LC6620'>proteinAbundance(HGNC:PAWR) decreases pathology(MESHD:&quot;Prostatic Intraepithelial Neoplasia&quot;)</div><div class='line' id='LC6621'><br/></div><div class='line' id='LC6622'>SET Evidence = &quot;Par-4 action is not inhibited by Bcl-2 or BclxL overexpression (19).&quot;</div><div class='line' id='LC6623'>SET Species = &quot;9606&quot;</div><div class='line' id='LC6624'><br/></div><div class='line' id='LC6625'>proteinAbundance(HGNC:BCL2) causesNoChange molecularActivity(proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6626'>proteinAbundance(HGNC:BCL2L1) causesNoChange molecularActivity(proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6627'><br/></div><div class='line' id='LC6628'>SET Disease = &quot;Prostatic Neoplasms&quot;</div><div class='line' id='LC6629'>SET Evidence = &quot;Importantly, overexpression of Par-4 in prostate cancer xenografts by i.t. injections</div><div class='line' id='LC6630'>of adenoviral Par-4, either in s.c. tumors in nude mice or in orthotopic tumors</div><div class='line' id='LC6631'>in the prostatic milieu (6, 19), results in apoptosis and tumor growth inhibition,&quot;</div><div class='line' id='LC6632'>SET Species = &quot;10090&quot;</div><div class='line' id='LC6633'><br/></div><div class='line' id='LC6634'>proteinAbundance(HGNC:PAWR) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC6635'>proteinAbundance(HGNC:PAWR) decreases biologicalProcess(SDIS:&quot;tumor growth&quot;)</div><div class='line' id='LC6636'><br/></div><div class='line' id='LC6637'>SET Evidence = &quot;Indeed, our recent studies reveal that binding of Akt1 to Par-4 results in both Par-4</div><div class='line' id='LC6638'>phosphorylation and inactivation of its proapoptotic potential (7).&quot;</div><div class='line' id='LC6639'>SET Species = &quot;9606&quot;</div><div class='line' id='LC6640'><br/></div><div class='line' id='LC6641'>complexAbundance(proteinAbundance(HGNC:AKT1),proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6642'>kinaseActivity(proteinAbundance(HGNC:AKT1)) directlyIncreases proteinAbundance(HGNC:PAWR,proteinModification(P))</div><div class='line' id='LC6643'>kinaseActivity(proteinAbundance(HGNC:AKT1)) directlyDecreases molecularActivity(proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6644'><br/></div><div class='line' id='LC6645'>SET Evidence = &quot;Both approaches led to the identification of the cell survival kinase, Akt1, as a</div><div class='line' id='LC6646'>Par-4–interacting protein in prostate cancer cell lines (7).&quot;</div><div class='line' id='LC6647'><br/></div><div class='line' id='LC6648'>complexAbundance(proteinAbundance(HGNC:PAWR),proteinAbundance(HGNC:AKT1))</div><div class='line' id='LC6649'><br/></div><div class='line' id='LC6650'>SET Evidence = &quot;Nuclear translocation of Par-4 is essential for the inhibition of NF-κB-dependent</div><div class='line' id='LC6651'>transcriptional activity&quot;</div><div class='line' id='LC6652'><br/></div><div class='line' id='LC6653'>translocation(proteinAbundance(HGNC:PAWR),MESHCL:Cytoplasm,MESHCL:&quot;Cell Nucleus&quot;) decreases transcriptionalActivity(complexAbundance(NCH:&quot;Nfkb Complex&quot;))</div><div class='line' id='LC6654'><br/></div><div class='line' id='LC6655'>SET Evidence = &quot;Par-4 partner proteins WT1, ZIPK/DAXX, and THAP&quot;</div><div class='line' id='LC6656'><br/></div><div class='line' id='LC6657'>complexAbundance(proteinAbundance(HGNC:PAWR),proteinAbundance(HGNC:WT1))</div><div class='line' id='LC6658'>complexAbundance(proteinAbundance(HGNC:PAWR),proteinAbundance(HGNC:DAXX))</div><div class='line' id='LC6659'><br/></div><div class='line' id='LC6660'>SET Evidence = &quot;Akt1 binding and phosphorylation of Par-4 results in 14-3-3-mediated cytoplasmic retention</div><div class='line' id='LC6661'>of Par-4 and abrogation of apoptosis.&quot;</div><div class='line' id='LC6662'><br/></div><div class='line' id='LC6663'>proteinAbundance(HGNC:PAWR,proteinModification(P)) directlyIncreases complexAbundance(proteinAbundance(PFH:&quot;14-3-3 Family&quot;),proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6664'><br/></div><div class='line' id='LC6665'>SET CellStructure = &quot;Cytoplasm&quot;</div><div class='line' id='LC6666'><br/></div><div class='line' id='LC6667'>complexAbundance(proteinAbundance(PFH:&quot;14-3-3 Family&quot;),proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6668'>complexAbundance(proteinAbundance(PFH:&quot;14-3-3 Family&quot;),proteinAbundance(HGNC:PAWR)) directlyDecreases (molecularActivity(proteinAbundance(HGNC:PAWR)) increases biologicalProcess(GO:&quot;apoptotic process&quot;))</div><div class='line' id='LC6669'><br/></div><div class='line' id='LC6670'>SET Evidence = &quot;PTEN induced apoptosis in prostate cancer cells via a mechanism that was inhibited</div><div class='line' id='LC6671'>by blocking endogenous Par-4 expression with RNA interference.&quot;</div><div class='line' id='LC6672'><br/></div><div class='line' id='LC6673'>proteinAbundance(HGNC:PAWR) increases (proteinAbundance(HGNC:PTEN) increases biologicalProcess(GO:&quot;apoptotic process&quot;))</div><div class='line' id='LC6674'><br/></div><div class='line' id='LC6675'>SET Disease = &quot;Neoplasms&quot;</div><div class='line' id='LC6676'>SET Evidence = &quot;although phosphorylation of Par-4 at the T155 residue by PKA activates the Par-4 apoptotic</div><div class='line' id='LC6677'>potential in cancer cells, T155 phosphorylation does not induce apoptosis</div><div class='line' id='LC6678'>in the presence of Par-4 phosphorylation by AKT1 and cytoplasmic retention by</div><div class='line' id='LC6679'>14-3-3 proteins.&quot;</div><div class='line' id='LC6680'><br/></div><div class='line' id='LC6681'>proteinAbundance(HGNC:PAWR,proteinModification(P,T,163)) directlyIncreases molecularActivity(proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6682'>molecularActivity(proteinAbundance(HGNC:PAWR)) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC6683'><br/></div><div class='line' id='LC6684'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC6685'>SET Evidence = &quot;We recently showed that the cancer-selective proapoptotic protein Par-4 is a key target</div><div class='line' id='LC6686'>for inactivation by PI3K/Akt signaling&quot;</div><div class='line' id='LC6687'><br/></div><div class='line' id='LC6688'>molecularActivity(proteinAbundance(HGNC:PAWR)) increases biologicalProcess(GO:&quot;apoptotic process&quot;)</div><div class='line' id='LC6689'>kinaseActivity(proteinAbundance(HGNC:AKT1)) decreases molecularActivity(proteinAbundance(HGNC:PAWR))</div><div class='line' id='LC6690'><br/></div><div class='line' id='LC6691'>UNSET STATEMENT_GROUP</div><div class='line' id='LC6692'><br/></div><div class='line' id='LC6693'>SET STATEMENT_GROUP = &quot;Group 54&quot;</div><div class='line' id='LC6694'><br/></div><div class='line' id='LC6695'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC6696'>SET Evidence = &quot;To generate mice that express a constitutively active mutant of Hck (i.e., HckY499F),</div><div class='line' id='LC6697'>we used gene targeting in ES cells to introduce a tyrosine (Y499) to phenylalanine</div><div class='line' id='LC6698'>(F) substitution in exon 13 of the endogenous hck gene.&quot;</div><div class='line' id='LC6699'>SET Citation = {&quot;PubMed&quot;,&quot;The Journal of experimental medicine&quot;,&quot;12208875&quot;,&quot;&quot;,&quot;Ernst M|Inglese M|Scholz GM|Harder KW|Clay FJ|Bozinovski S|Waring P|Darwiche R|Kay T|Sly P|Collins R|Turner D|Hibbs ML|Anderson GP|Dunn AR&quot;,&quot;&quot;}</div><div class='line' id='LC6700'>SET Species = &quot;10090&quot;</div><div class='line' id='LC6701'><br/></div><div class='line' id='LC6702'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) directlyIncreases kinaseActivity(proteinAbundance(MGI:Hck))</div><div class='line' id='LC6703'><br/></div><div class='line' id='LC6704'>SET RespiratorySystem = &quot;Lung&quot;</div><div class='line' id='LC6705'>SET Evidence = &quot;the lungs of all adult HckF/F mice (3–4 mo and older) showed areas of atelectasis,</div><div class='line' id='LC6706'>inflammatory infiltration into the interstitium and alveoli, and some areas of</div><div class='line' id='LC6707'>enlarged airspaces&quot;</div><div class='line' id='LC6708'><br/></div><div class='line' id='LC6709'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases pathology(MESHD:&quot;Pulmonary Atelectasis&quot;)</div><div class='line' id='LC6710'><br/></div><div class='line' id='LC6711'>SET RespiratorySystem = {&quot;Pulmonary Alveoli&quot;,&quot;Lung&quot;}</div><div class='line' id='LC6712'><br/></div><div class='line' id='LC6713'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases pathology(MESHD:Inflammation)</div><div class='line' id='LC6714'><br/></div><div class='line' id='LC6715'>SET RespiratorySystem = &quot;Lung&quot;</div><div class='line' id='LC6716'>SET Evidence = &quot;Eosinophils represented the most prominent cell type within the infiltrates (30 ±</div><div class='line' id='LC6717'>9% of total BAL-F cells in HckF/F mice versus 2 ± 1% in HckY/Y mice).&quot;</div><div class='line' id='LC6718'><br/></div><div class='line' id='LC6719'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases pathology(MESHD:&quot;Pulmonary Eosinophilia&quot;)</div><div class='line' id='LC6720'><br/></div><div class='line' id='LC6721'>SET Tissue = &quot;Epithelium&quot;</div><div class='line' id='LC6722'>SET Evidence = &quot;The epithelium lining conducting airways was frequently hypertrophic and many epithelial</div><div class='line' id='LC6723'>cells were enlarged due to excessive production and/or accumulation of mucus</div><div class='line' id='LC6724'>material (Fig. 2, c and d).&quot;</div><div class='line' id='LC6725'><br/></div><div class='line' id='LC6726'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases pathology(MESHD:Hypertrophy)</div><div class='line' id='LC6727'><br/></div><div class='line' id='LC6728'>SET Evidence = &quot;lungs from HckF/F mice showed areas of mild emphysema, as histologically evident from</div><div class='line' id='LC6729'>alveolar enlargement with the loss of the orderly appearance of the acinus,</div><div class='line' id='LC6730'>and signs of fibrosis characterized by deposition of extracellular matrix in the</div><div class='line' id='LC6731'>alveolar septa (Fig. 2, e and f).&quot;</div><div class='line' id='LC6732'><br/></div><div class='line' id='LC6733'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases pathology(MESHD:Emphysema)</div><div class='line' id='LC6734'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases pathology(MESHD:&quot;Pulmonary Fibrosis&quot;)</div><div class='line' id='LC6735'><br/></div><div class='line' id='LC6736'>SET Evidence = &quot;BAL-F recovered from the lungs of mutant mice revealed elevated levels of IL-5 (70</div><div class='line' id='LC6737'>± 27 pg/ml in HckY/Y versus 17 ± 5 pg/ml in HckY/Y) and eotaxin (37 ± 8 pg/ml</div><div class='line' id='LC6738'>in HckY/Y versus 23 ± 4 pg/ml in HckY/Y), features associated with eosinophilia</div><div class='line' id='LC6739'>(28, 29).&quot;</div><div class='line' id='LC6740'><br/></div><div class='line' id='LC6741'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases proteinAbundance(MGI:Il5)</div><div class='line' id='LC6742'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases proteinAbundance(MGI:Ccl11)</div><div class='line' id='LC6743'>proteinAbundance(MGI:Il5) positiveCorrelation pathology(MESHD:&quot;Pulmonary Eosinophilia&quot;)</div><div class='line' id='LC6744'>proteinAbundance(MGI:Ccl11) positiveCorrelation pathology(MESHD:&quot;Pulmonary Eosinophilia&quot;)</div><div class='line' id='LC6745'><br/></div><div class='line' id='LC6746'>SET RespiratorySystem = &quot;Pulmonary Alveoli&quot;</div><div class='line' id='LC6747'>SET Evidence = &quot;Such a pulmonary challenge with LPS elicits a rapid and transient neutrophilic inflammatory</div><div class='line' id='LC6748'>response, followed by macrophage invasion into the alveolar spaces (31).&quot;</div><div class='line' id='LC6749'><br/></div><div class='line' id='LC6750'>abundance(CHEBI:lipopolysaccharide) increases biologicalProcess(GO:&quot;neutrophil activation&quot;)</div><div class='line' id='LC6751'>abundance(CHEBI:lipopolysaccharide) increases biologicalProcess(GO:&quot;regulation of macrophage activation&quot;)</div><div class='line' id='LC6752'><br/></div><div class='line' id='LC6753'>SET RespiratorySystem = &quot;Lung&quot;</div><div class='line' id='LC6754'>SET Evidence = &quot;By contrast, the number of macrophages and eosinophils in BAL-F from unchallenged</div><div class='line' id='LC6755'>HckF/F mice were profoundly elevated in comparison to those detected in BAL-F from</div><div class='line' id='LC6756'>unchallenged HckY/Y mice, with macrophages accounting for about onethird of</div><div class='line' id='LC6757'>all cells recovered in BAL-F from HckF/F mice&quot;</div><div class='line' id='LC6758'><br/></div><div class='line' id='LC6759'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases biologicalProcess(GO:&quot;regulation of macrophage activation&quot;)</div><div class='line' id='LC6760'><br/></div><div class='line' id='LC6761'>SET Evidence = &quot;analysis of BAL-F from LPS-challenged HckF/F mice, but not from similarly challenged</div><div class='line' id='LC6762'>HckY/Y mice, revealed a rapid and transient increase in levels of the proinflammatory</div><div class='line' id='LC6763'>cytokine TNFα (Fig. 5 c),&quot;</div><div class='line' id='LC6764'><br/></div><div class='line' id='LC6765'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases (abundance(CHEBI:lipopolysaccharide) increases proteinAbundance(MGI:Tnf))</div><div class='line' id='LC6766'><br/></div><div class='line' id='LC6767'>SET Evidence = &quot;Analysis of BAL-F from LPSchallenged HckF/F mice revealed exaggerated induction of</div><div class='line' id='LC6768'>MMP-2 and MMP-9 activity when compared with that detected in BAL-F from LPS-challenged</div><div class='line' id='LC6769'>HckY/Y mice (Fig. 5 d).&quot;</div><div class='line' id='LC6770'><br/></div><div class='line' id='LC6771'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases (abundance(CHEBI:lipopolysaccharide) increases peptidaseActivity(proteinAbundance(MGI:Mmp9)))</div><div class='line' id='LC6772'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases (abundance(CHEBI:lipopolysaccharide) increases peptidaseActivity(proteinAbundance(MGI:Mmp2)))</div><div class='line' id='LC6773'><br/></div><div class='line' id='LC6774'>SET HemicAndImmuneSystem = &quot;Macrophages&quot;</div><div class='line' id='LC6775'>SET Evidence = &quot;The increased release of NO into the culture medium of LPSstimulated BMDMs from HckF/F</div><div class='line' id='LC6776'>mice is likely to be explained by the increased expression of inducible nitric</div><div class='line' id='LC6777'>oxide synthetase (iNOS; Fig. 7 c).&quot;</div><div class='line' id='LC6778'><br/></div><div class='line' id='LC6779'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases (abundance(CHEBI:lipopolysaccharide) increases abundance(CHEBI:&quot;nitric oxide&quot;))</div><div class='line' id='LC6780'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases (abundance(CHEBI:lipopolysaccharide) increases proteinAbundance(MGI:Nos2))</div><div class='line' id='LC6781'><br/></div><div class='line' id='LC6782'>SET HemicAndImmuneSystem = {&quot;Monocytes&quot;,&quot;Macrophages&quot;}</div><div class='line' id='LC6783'>SET Evidence = &quot;Collectively, these observations suggested that monocytes and macrophages in HckF/F</div><div class='line' id='LC6784'>mice have enhanced phagocytic activity.&quot;</div><div class='line' id='LC6785'><br/></div><div class='line' id='LC6786'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases biologicalProcess(GO:phagocytosis)</div><div class='line' id='LC6787'><br/></div><div class='line' id='LC6788'>SET Cell = &quot;Neutrophils&quot;</div><div class='line' id='LC6789'>SET Evidence = &quot;PMNs derived from HckF/F mice had a modestly enhanced migratory capacity when compared</div><div class='line' id='LC6790'>with PMNs from wild-type mice (unpublished data).&quot;</div><div class='line' id='LC6791'><br/></div><div class='line' id='LC6792'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC6793'><br/></div><div class='line' id='LC6794'>SET HemicAndImmuneSystem = &quot;Macrophages&quot;</div><div class='line' id='LC6795'>SET Evidence = &quot;BMDMs derived from HckF/F mice exhibited an enhanced capacity to migrate when tested</div><div class='line' id='LC6796'>in in vitro \&quot;wound-healing\&quot; assays (unpublished data).&quot;</div><div class='line' id='LC6797'><br/></div><div class='line' id='LC6798'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC6799'><br/></div><div class='line' id='LC6800'>SET Evidence = &quot;PMNs from HckF/F mice released approximately twofold more superoxide in response to</div><div class='line' id='LC6801'>TNFα or fMLP stimulation than did their wild-type counterparts when plated on</div><div class='line' id='LC6802'>fibrinogen-coated microtiter plates&quot;</div><div class='line' id='LC6803'><br/></div><div class='line' id='LC6804'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases (proteinAbundance(MGI:Tnf) increases abundance(CHEBI:superoxide))</div><div class='line' id='LC6805'>proteinAbundance(MGI:Hck,substitution(Y,499,F)) increases (abundance(CHEBIID:53490) increases abundance(CHEBI:superoxide))</div><div class='line' id='LC6806'><br/></div><div class='line' id='LC6807'>UNSET STATEMENT_GROUP</div><div class='line' id='LC6808'><br/></div><div class='line' id='LC6809'>SET STATEMENT_GROUP = &quot;Group 55&quot;</div><div class='line' id='LC6810'><br/></div><div class='line' id='LC6811'>SET CellLine = &quot;MCF7&quot;</div><div class='line' id='LC6812'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC6813'>SET Evidence = &quot;In transiently transfected MCF-7 human breast cancer cells, overexpression of COUP-TFI</div><div class='line' id='LC6814'>inhibited TCDD-activated reporter gene activity from the CYP1A1 promoter.</div><div class='line' id='LC6815'>TCDD inhibited estradiol (E2)-activated reporter gene activity from a consensus</div><div class='line' id='LC6816'>ERE and from the EREs in the pS2 and Fos genes, and COUP-TFI did not block the antiestrogenic</div><div class='line' id='LC6817'>activity of TCDD.&quot;</div><div class='line' id='LC6818'>SET Citation = {&quot;PubMed&quot;,&quot;Archives of biochemistry and biophysics&quot;,&quot;10620335&quot;,&quot;&quot;,&quot;Klinge CM|Kaur K|Swanson HI&quot;,&quot;&quot;}</div><div class='line' id='LC6819'>SET Species = &quot;9606&quot;</div><div class='line' id='LC6820'><br/></div><div class='line' id='LC6821'>proteinAbundance(HGNC:NR2F1) decreases rnaAbundance(HGNC:CYP1A1)</div><div class='line' id='LC6822'>abundance(CHEBIID:28119) increases rnaAbundance(HGNC:CYP1A1)</div><div class='line' id='LC6823'>proteinAbundance(HGNC:NR2F1) decreases (abundance(CHEBIID:28119) increases rnaAbundance(HGNC:CYP1A1))</div><div class='line' id='LC6824'><br/></div><div class='line' id='LC6825'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC6826'>SET Evidence = &quot;Estradiol reportedly blocked TCDD-induced accumulation of CYP1A1 mRNA and AHR-mediated</div><div class='line' id='LC6827'>activation of the CYP1A1 gene promoter in MCF-7 cells (32).&quot;</div><div class='line' id='LC6828'><br/></div><div class='line' id='LC6829'>abundance(SCHEM:Tetrachlorodibenzodioxin) increases rnaAbundance(HGNC:CYP1A1)</div><div class='line' id='LC6830'>transcriptionalActivity(proteinAbundance(HGNC:AHR)) directlyIncreases rnaAbundance(HGNC:CYP1A1)</div><div class='line' id='LC6831'>abundance(SCHEM:Estradiol) decreases (abundance(SCHEM:Tetrachlorodibenzodioxin) increases rnaAbundance(HGNC:CYP1A1))</div><div class='line' id='LC6832'>abundance(SCHEM:Estradiol) decreases (transcriptionalActivity(proteinAbundance(HGNC:AHR)) directlyIncreases rnaAbundance(HGNC:CYP1A1))</div><div class='line' id='LC6833'><br/></div><div class='line' id='LC6834'>SET Evidence = &quot;We examined how TCDD, alone or in combination with E2, affected luciferase reporter</div><div class='line' id='LC6835'>gene expression from the CYP1A1 promoter in MCF-7 cells. As anticipated, TCDD</div><div class='line' id='LC6836'>induced a 3.5-fold induction of luciferase activity (Fig. 7A). E2 stimulated a</div><div class='line' id='LC6837'>2-fold induction of luciferase activity from the CYP1A1 promoter.&quot;</div><div class='line' id='LC6838'><br/></div><div class='line' id='LC6839'>abundance(SCHEM:Tetrachlorodibenzodioxin) increases rnaAbundance(HGNC:CYP1A1)</div><div class='line' id='LC6840'>abundance(SCHEM:Estradiol) increases rnaAbundance(HGNC:CYP1A1)</div><div class='line' id='LC6841'><br/></div><div class='line' id='LC6842'>SET Evidence = &quot;Cotransfection with COUP–TFI significantly inhibited TCDD-stimulated luciferase activity</div><div class='line' id='LC6843'>from the CYP1A1 promoter (Fig. 7A). E2 did not relieve the COUP–TFI-mediated</div><div class='line' id='LC6844'>inhibition of TCDD-induced activity. COUP–TFI also inhibited the E2-induced</div><div class='line' id='LC6845'>activity from the CYP1A1 promoter.&quot;</div><div class='line' id='LC6846'><br/></div><div class='line' id='LC6847'>proteinAbundance(HGNC:NR2F1) decreases (abundance(SCHEM:Tetrachlorodibenzodioxin) increases rnaAbundance(HGNC:CYP1A1))</div><div class='line' id='LC6848'>proteinAbundance(HGNC:NR2F1) decreases (abundance(SCHEM:Estradiol) increases rnaAbundance(HGNC:CYP1A1))</div><div class='line' id='LC6849'><br/></div><div class='line' id='LC6850'>SET Evidence = &quot;TCDD inhibits E2-induction of pS2, a human breast cancer prognostic marker (47), and</div><div class='line' id='LC6851'>stimulates c-fos expression (48).&quot;</div><div class='line' id='LC6852'><br/></div><div class='line' id='LC6853'>abundance(SCHEM:Tetrachlorodibenzodioxin) decreases (abundance(SCHEM:Estradiol) increases rnaAbundance(HGNC:TFF1))</div><div class='line' id='LC6854'>abundance(SCHEM:Estradiol) increases rnaAbundance(HGNC:TFF1)</div><div class='line' id='LC6855'>abundance(SCHEM:Tetrachlorodibenzodioxin) increases rnaAbundance(HGNC:FOS)</div><div class='line' id='LC6856'><br/></div><div class='line' id='LC6857'>SET Evidence = &quot;Here we tested how expression of COUP–TFI affected TCDD activity from the natural</div><div class='line' id='LC6858'>ERE sequences from the pS2 and c-fos promoters in transiently transfected MCF-7</div><div class='line' id='LC6859'>cells. E2 alone stimulated a 1.6- to 2.1-fold induction in luciferase activity</div><div class='line' id='LC6860'>from the pS2 ERE (Fig. 8A). 4-OHT blocked the E2 activity, indicating the specificity</div><div class='line' id='LC6861'>of the induction by ER. TCDD alone gave a 1.4-fold induction in luciferase</div><div class='line' id='LC6862'>activity. Cotreatment with TCDD suppressed E2-stimulated luciferase activity. COUP–TFI</div><div class='line' id='LC6863'>inhibited both E2- and TCDD-stimulated luciferase activity from pS2.&quot;</div><div class='line' id='LC6864'><br/></div><div class='line' id='LC6865'>abundance(CHEBIID:16469) increases rnaAbundance(HGNC:TFF1)</div><div class='line' id='LC6866'>abundance(SCHEM:&quot;4,17beta-Dihydroxy-4-androstene-3-one&quot;) decreases (abundance(CHEBIID:16469) increases rnaAbundance(HGNC:TFF1))</div><div class='line' id='LC6867'>abundance(SCHEM:Tetrachlorodibenzodioxin) increases rnaAbundance(HGNC:TFF1)</div><div class='line' id='LC6868'>abundance(SCHEM:Tetrachlorodibenzodioxin) decreases (abundance(CHEBIID:16469) increases rnaAbundance(HGNC:TFF1))</div><div class='line' id='LC6869'>proteinAbundance(HGNC:NR2F1) decreases (abundance(CHEBIID:16469) increases rnaAbundance(HGNC:TFF1))</div><div class='line' id='LC6870'>proteinAbundance(HGNC:NR2F1) decreases (abundance(SCHEM:Tetrachlorodibenzodioxin) increases rnaAbundance(HGNC:TFF1))</div><div class='line' id='LC6871'><br/></div><div class='line' id='LC6872'>SET Evidence = &quot;Although both ERα and AHR/ARNT specifically interact with the regulatory region of</div><div class='line' id='LC6873'>the c-fos gene, only E2 induced reporter activity from the FOS-1211 construct</div><div class='line' id='LC6874'>(Fig. 8B). The FOS-1211 oligomer binds ERa and AHR/ARNT in EMSA (data not shown).</div><div class='line' id='LC6875'>TCDD suppressed the E2-stimulated luciferase activity. COUP–TFI significantly</div><div class='line' id='LC6876'>inhibited E2-stimulated luciferase activity from FOS–1211, but had no effect in</div><div class='line' id='LC6877'>TCDD-treated cells.&quot;</div><div class='line' id='LC6878'><br/></div><div class='line' id='LC6879'>transcriptionalActivity(proteinAbundance(HGNC:ESR1)) directlyIncreases rnaAbundance(HGNC:FOS)</div><div class='line' id='LC6880'>complexAbundance(proteinAbundance(HGNC:AHR),proteinAbundance(HGNC:ARNT),geneAbundance(HGNC:FOS))</div><div class='line' id='LC6881'>abundance(SCHEM:Estradiol) increases rnaAbundance(HGNC:FOS)</div><div class='line' id='LC6882'>abundance(SCHEM:Tetrachlorodibenzodioxin) decreases (abundance(SCHEM:Estradiol) increases rnaAbundance(HGNC:FOS))</div><div class='line' id='LC6883'>proteinAbundance(HGNC:NR2F1) decreases (abundance(SCHEM:Estradiol) increases rnaAbundance(HGNC:FOS))</div><div class='line' id='LC6884'><br/></div><div class='line' id='LC6885'>UNSET STATEMENT_GROUP</div><div class='line' id='LC6886'><br/></div><div class='line' id='LC6887'>SET STATEMENT_GROUP = &quot;Group 56&quot;</div><div class='line' id='LC6888'><br/></div><div class='line' id='LC6889'>SET TextLocation = &quot;Abstract&quot;</div><div class='line' id='LC6890'>SET Evidence = &quot;Glycogen synthase kinase 3 (GSK-3) is implicated in multiple biological processes</div><div class='line' id='LC6891'>including metabolism, gene expression, cell fate determination, proliferation,</div><div class='line' id='LC6892'>and survival. GSK-3 activity is inhibited through phosphorylation of serine 21 in</div><div class='line' id='LC6893'>GSK-3α and serine 9 in GSK-3β.&quot;</div><div class='line' id='LC6894'>SET Citation = {&quot;PubMed&quot;,&quot;Proceedings of the National Academy of Sciences of the United States of America&quot;,&quot;11035810&quot;,&quot;&quot;,&quot;Fang X|Yu SX|Lu Y|Bast RC|Woodgett JR|Mills GB&quot;,&quot;&quot;}</div><div class='line' id='LC6895'><br/></div><div class='line' id='LC6896'>proteinAbundance(PFH:&quot;GSK3 Family&quot;) association biologicalProcess(GO:&quot;cell fate determination&quot;)</div><div class='line' id='LC6897'>proteinAbundance(PFH:&quot;GSK3 Family&quot;) association biologicalProcess(GO:&quot;cell proliferation&quot;)</div><div class='line' id='LC6898'><br/></div><div class='line' id='LC6899'>SET Evidence = &quot;GSK-3 activity is inhibited through phosphorylation of serine 21 in GSK-3α and serine</div><div class='line' id='LC6900'>9 in GSK-3β. These serine residues of GSK-3 have been previously identified</div><div class='line' id='LC6901'>as targets of protein kinase B (PKByAkt), a serineythreonine kinase located downstream</div><div class='line' id='LC6902'>of phosphatidylinositol 3-kinase.&quot;</div><div class='line' id='LC6903'><br/></div><div class='line' id='LC6904'>proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:GSK3A))</div><div class='line' id='LC6905'>proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:GSK3B))</div><div class='line' id='LC6906'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) directlyIncreases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC6907'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) directlyIncreases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC6908'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:GSK3A))</div><div class='line' id='LC6909'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:GSK3B))</div><div class='line' id='LC6910'><br/></div><div class='line' id='LC6911'>SET Evidence = &quot;Here, we show that serine 21 in GSK-3α and serine 9 in GSK-3β are also physiological</div><div class='line' id='LC6912'>substrates of cAMP dependent protein kinase A. Protein kinase A physically associates</div><div class='line' id='LC6913'>with, phosphorylates, and inactivates both isoforms of GSK-3.&quot;</div><div class='line' id='LC6914'><br/></div><div class='line' id='LC6915'>kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;)) directlyIncreases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC6916'>kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;)) directlyIncreases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC6917'>kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:GSK3A))</div><div class='line' id='LC6918'>kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;)) directlyDecreases kinaseActivity(proteinAbundance(HGNC:GSK3B))</div><div class='line' id='LC6919'><br/></div><div class='line' id='LC6920'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC6921'>SET TextLocation = &quot;Results&quot;</div><div class='line' id='LC6922'>SET Evidence = &quot;In Rat1, NIH 3T3, and HEK293 cells, increases in the intracellular levels of cAMP</div><div class='line' id='LC6923'>stimulate phosphorylation of GSK-3α and -β, as demonstrated by immunoblotting with</div><div class='line' id='LC6924'>GSK-3 phosphorylation-specific antibodies. As shown in Fig. 1, the cell-permeable</div><div class='line' id='LC6925'>cAMP analogue 8-Br-cAMP induced a marked increase in phosphorylation of GSK-3α</div><div class='line' id='LC6926'>and - β at serine 21 and 9, respectively, whereas the structurally related</div><div class='line' id='LC6927'>cGMP analogue 8-Br-cGMP had little effect. Forskolin, which activates adenyl cyclase</div><div class='line' id='LC6928'>thus raising intracellular cAMP levels (15), triggered a similar elevation</div><div class='line' id='LC6929'>in GSK-3 phosphorylation at serine 21 and 9. In Rat1 cells, isoproterenol, which</div><div class='line' id='LC6930'>activates the b-adrenergic receptor stimulating adenylate cyclase and increasing</div><div class='line' id='LC6931'>endogenous cAMP levels (16, 17), also efficiently stimulated GSK-3 phosphorylation</div><div class='line' id='LC6932'>at these serine sites. In NIH 3T3 cells that contain few of the β-adrenergic</div><div class='line' id='LC6933'>receptors, stimulation with other G-protein-coupled receptor agonists, such as</div><div class='line' id='LC6934'>lysophosphatidic acid. also led to GSK-3 phosphorylation (data not shown)&quot;</div><div class='line' id='LC6935'>SET Species = &quot;10116&quot;</div><div class='line' id='LC6936'><br/></div><div class='line' id='LC6937'>abundance(CHEBI:forskolin) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC6938'>abundance(CHEBI:forskolin) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC6939'><br/></div><div class='line' id='LC6940'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC6941'>SET Species = &quot;10090&quot;</div><div class='line' id='LC6942'><br/></div><div class='line' id='LC6943'>abundance(SCHEM:&quot;lysophosphatidic acid&quot;) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC6944'>abundance(SCHEM:&quot;lysophosphatidic acid&quot;) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC6945'>abundance(CHEBI:forskolin) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC6946'>abundance(CHEBI:forskolin) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC6947'><br/></div><div class='line' id='LC6948'>SET CellLine = &quot;HEK001&quot;</div><div class='line' id='LC6949'>SET Cell = &quot;Cell Line&quot;</div><div class='line' id='LC6950'>SET UrogenitalSystem = &quot;Kidney&quot;</div><div class='line' id='LC6951'>SET Species = &quot;9606&quot;</div><div class='line' id='LC6952'><br/></div><div class='line' id='LC6953'>abundance(CHEBI:forskolin) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC6954'>abundance(CHEBI:forskolin) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC6955'><br/></div><div class='line' id='LC6956'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC6957'>SET Species = &quot;10116&quot;</div><div class='line' id='LC6958'><br/></div><div class='line' id='LC6959'>abundance(SCHEM:Isoproterenol) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC6960'><br/></div><div class='line' id='LC6961'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC6962'>SET Species = &quot;10090&quot;</div><div class='line' id='LC6963'><br/></div><div class='line' id='LC6964'>abundance(SCHEM:&quot;lysophosphatidic acid&quot;) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC6965'>abundance(SCHEM:&quot;lysophosphatidic acid&quot;) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC6966'><br/></div><div class='line' id='LC6967'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC6968'>SET Species = &quot;10116&quot;</div><div class='line' id='LC6969'><br/></div><div class='line' id='LC6970'>abundance(SCHEM:Isoproterenol) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC6971'><br/></div><div class='line' id='LC6972'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC6973'>SET Species = &quot;10090&quot;</div><div class='line' id='LC6974'><br/></div><div class='line' id='LC6975'>abundance(SCHEM:&quot;8-Bromo cyclic adenosine monophosphate&quot;) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC6976'>abundance(SCHEM:&quot;8-Bromo cyclic adenosine monophosphate&quot;) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC6977'><br/></div><div class='line' id='LC6978'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC6979'>SET Species = &quot;10116&quot;</div><div class='line' id='LC6980'><br/></div><div class='line' id='LC6981'>abundance(SCHEM:&quot;8-Bromo cyclic adenosine monophosphate&quot;) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC6982'>abundance(SCHEM:&quot;8-Bromo cyclic adenosine monophosphate&quot;) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC6983'><br/></div><div class='line' id='LC6984'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC6985'>SET Evidence = &quot;PI3K-dependent activation of PKB is an intermediary in the phosphorylation and inactivation</div><div class='line' id='LC6986'>of GSK-3 induced by insulin and other growth factors (10, 12, 14). Insulin</div><div class='line' id='LC6987'>and IGF-1 efficiently activate the PI3K pathway in NIH 3T3 and Rat1 cells,</div><div class='line' id='LC6988'>respectively. GSK-3 phosphorylation induced by insulin and IGF-1 were eliminated</div><div class='line' id='LC6989'>by pretreatment with the PI3K inhibitors wortmannin or LY294002. In contrast,</div><div class='line' id='LC6990'>the effects of 8-Br-cAMP or forskolin on GSK-3 phosphorylation in these cell lines</div><div class='line' id='LC6991'>were not altered by inhibition of PI3K activity with wortmannin or LY294002 (Fig.</div><div class='line' id='LC6992'>2A), excluding the possibility that PKA induces GSK-3 phosphorylation through</div><div class='line' id='LC6993'>activation of PI3K.&quot;</div><div class='line' id='LC6994'>SET Species = &quot;10090&quot;</div><div class='line' id='LC6995'><br/></div><div class='line' id='LC6996'>abundance(CHEBIID:50864) increases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC6997'><br/></div><div class='line' id='LC6998'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC6999'>SET Species = &quot;10116&quot;</div><div class='line' id='LC7000'><br/></div><div class='line' id='LC7001'>proteinAbundance(HGNC:IGF1) increases kinaseActivity(complexAbundance(NCH:&quot;p85/p110 PI3Kinase Complex&quot;))</div><div class='line' id='LC7002'><br/></div><div class='line' id='LC7003'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC7004'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7005'><br/></div><div class='line' id='LC7006'>abundance(CHEBIID:50864) increases kinaseActivity(proteinAbundance(HGNC:GSK3A))</div><div class='line' id='LC7007'><br/></div><div class='line' id='LC7008'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC7009'>SET Species = &quot;10116&quot;</div><div class='line' id='LC7010'><br/></div><div class='line' id='LC7011'>proteinAbundance(HGNC:IGF1) increases kinaseActivity(proteinAbundance(HGNC:GSK3A))</div><div class='line' id='LC7012'><br/></div><div class='line' id='LC7013'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC7014'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7015'><br/></div><div class='line' id='LC7016'>abundance(CHEBIID:50864) increases kinaseActivity(proteinAbundance(HGNC:GSK3B))</div><div class='line' id='LC7017'><br/></div><div class='line' id='LC7018'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC7019'>SET Species = &quot;10116&quot;</div><div class='line' id='LC7020'><br/></div><div class='line' id='LC7021'>proteinAbundance(HGNC:IGF1) increases kinaseActivity(proteinAbundance(HGNC:GSK3B))</div><div class='line' id='LC7022'><br/></div><div class='line' id='LC7023'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC7024'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7025'><br/></div><div class='line' id='LC7026'>abundance(CHEBIID:52289) decreases (abundance(CHEBIID:50864) increases kinaseActivity(proteinAbundance(HGNC:GSK3A)))</div><div class='line' id='LC7027'><br/></div><div class='line' id='LC7028'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC7029'>SET Species = &quot;10116&quot;</div><div class='line' id='LC7030'><br/></div><div class='line' id='LC7031'>abundance(CHEBIID:52289) decreases (abundance(CHEBIID:50864) increases kinaseActivity(proteinAbundance(HGNC:GSK3B)))</div><div class='line' id='LC7032'><br/></div><div class='line' id='LC7033'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC7034'>SET Evidence = &quot;To determine whether PKA-induced PKB activation accounts for GSK-3 phosphorylation</div><div class='line' id='LC7035'>after treatment with 8-Br-cAMP, forskolin, or isoproterenol, PKB phosphorylation</div><div class='line' id='LC7036'>at serine 473 and threonine 308, which is crucial for activation of PKB (20),</div><div class='line' id='LC7037'>was assessed. As expected, insulin and IGF-1 strongly stimulated phosphorylation</div><div class='line' id='LC7038'>of PKB at serine 473 in NIH 3T3 or Rat1 cells (Fig. 2B). In contrast, 8-Br-cAMP,</div><div class='line' id='LC7039'>forskolin, and isoproterenol did not significantly alter PKB phosphorylation</div><div class='line' id='LC7040'>at serine 473 (Fig. 2B). Similar results were obtained with a threonine 308 phosphorylation-specific</div><div class='line' id='LC7041'>antibody (data not shown).&quot;</div><div class='line' id='LC7042'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7043'><br/></div><div class='line' id='LC7044'>abundance(CHEBIID:50864) increases proteinAbundance(HGNC:AKT1,proteinModification(P,S,473))</div><div class='line' id='LC7045'>proteinAbundance(HGNC:IGF1) increases proteinAbundance(HGNC:AKT1,proteinModification(P,S,473))</div><div class='line' id='LC7046'><br/></div><div class='line' id='LC7047'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC7048'>SET Species = &quot;10116&quot;</div><div class='line' id='LC7049'><br/></div><div class='line' id='LC7050'>abundance(CHEBIID:50864) increases proteinAbundance(HGNC:AKT1,proteinModification(P,S,473))</div><div class='line' id='LC7051'>proteinAbundance(HGNC:IGF1) increases proteinAbundance(HGNC:AKT1,proteinModification(P,S,473))</div><div class='line' id='LC7052'><br/></div><div class='line' id='LC7053'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC7054'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7055'><br/></div><div class='line' id='LC7056'>abundance(CHEBIID:50864) increases proteinAbundance(HGNC:AKT1,proteinModification(P,T,308))</div><div class='line' id='LC7057'>proteinAbundance(HGNC:IGF1) increases proteinAbundance(HGNC:AKT1,proteinModification(P,T,308))</div><div class='line' id='LC7058'><br/></div><div class='line' id='LC7059'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC7060'>SET Species = &quot;10116&quot;</div><div class='line' id='LC7061'><br/></div><div class='line' id='LC7062'>abundance(CHEBIID:50864) increases proteinAbundance(HGNC:AKT1,proteinModification(P,T,308))</div><div class='line' id='LC7063'>proteinAbundance(HGNC:IGF1) increases proteinAbundance(HGNC:AKT1,proteinModification(P,T,308))</div><div class='line' id='LC7064'><br/></div><div class='line' id='LC7065'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC7066'>SET Evidence = &quot;Forskolin increased PKB activity weakly in Rat1 and NIH 3T3 cells. A slightly stronger</div><div class='line' id='LC7067'>stimulation of PKB activity was seen in Rat1 cells treated with isoproterenol.</div><div class='line' id='LC7068'>However, activation of PKB by forskolin or isoproterenol was much less than</div><div class='line' id='LC7069'>that induced by IGF-1 or insulin (Fig. 2C).&quot;</div><div class='line' id='LC7070'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7071'><br/></div><div class='line' id='LC7072'>abundance(CHEBI:forskolin) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC7073'><br/></div><div class='line' id='LC7074'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC7075'>SET Species = &quot;10116&quot;</div><div class='line' id='LC7076'><br/></div><div class='line' id='LC7077'>abundance(CHEBI:forskolin) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC7078'><br/></div><div class='line' id='LC7079'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC7080'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7081'><br/></div><div class='line' id='LC7082'>abundance(SCHEM:Isoproterenol) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC7083'><br/></div><div class='line' id='LC7084'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC7085'>SET Species = &quot;10116&quot;</div><div class='line' id='LC7086'><br/></div><div class='line' id='LC7087'>abundance(SCHEM:Isoproterenol) increases kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;))</div><div class='line' id='LC7088'><br/></div><div class='line' id='LC7089'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC7090'>SET Evidence = &quot;As demonstrated in Fig. 2C, however, 8-Br-cAMP, forskolin, or isoproterenol stimulated</div><div class='line' id='LC7091'>phosphorylation of GSK-3α more efficiently than IGF-1 or insulin and increased</div><div class='line' id='LC7092'>phosphorylation of GSK-3β to levels comparable to those induced by IGF-1 or</div><div class='line' id='LC7093'>insulin.&quot;</div><div class='line' id='LC7094'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7095'><br/></div><div class='line' id='LC7096'>abundance(CHEBI:forskolin) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC7097'>abundance(CHEBI:forskolin) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC7098'>abundance(SCHEM:Isoproterenol) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC7099'>abundance(SCHEM:Isoproterenol) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC7100'><br/></div><div class='line' id='LC7101'>SET CellLine = &quot;Rat1-R12&quot;</div><div class='line' id='LC7102'>SET Species = &quot;10116&quot;</div><div class='line' id='LC7103'><br/></div><div class='line' id='LC7104'>abundance(CHEBI:forskolin) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC7105'>abundance(CHEBI:forskolin) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC7106'>abundance(SCHEM:Isoproterenol) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC7107'>abundance(SCHEM:Isoproterenol) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC7108'><br/></div><div class='line' id='LC7109'>SET CellLine = &quot;NIH/3T3&quot;</div><div class='line' id='LC7110'>SET Evidence = &quot;To determine whether the association between GSK-3 and PKAc is regulated by cAMP levels,</div><div class='line' id='LC7111'>GSK-3β was immunoprecipitated from HEK293 and NIH 3T3 cells treated with</div><div class='line' id='LC7112'>or without forskolin. The level of PKAc in GSK-3β immunoprecipitates was markedly</div><div class='line' id='LC7113'>reduced in forskolintreated cells compared with that in unstimulated cells (Fig.</div><div class='line' id='LC7114'>3C), suggesting that dissociation of the GSK-3β-PKAc complex occurs after PKA</div><div class='line' id='LC7115'>activation or GSK-3 phosphorylation.&quot;</div><div class='line' id='LC7116'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7117'><br/></div><div class='line' id='LC7118'>abundance(CHEBI:forskolin) decreases complexAbundance(proteinAbundance(HGNC:GSK3B),proteinAbundance(HGNC:PRKACA))</div><div class='line' id='LC7119'><br/></div><div class='line' id='LC7120'>SET Cell = &quot;HEK293 Cells&quot;</div><div class='line' id='LC7121'>SET Species = &quot;9606&quot;</div><div class='line' id='LC7122'><br/></div><div class='line' id='LC7123'>abundance(CHEBI:forskolin) decreases complexAbundance(proteinAbundance(HGNC:GSK3B),proteinAbundance(HGNC:PRKACA))</div><div class='line' id='LC7124'><br/></div><div class='line' id='LC7125'>SET Evidence = &quot;Transfection of PKAc, but not empty vector, enhanced phosphorylation of cotransfected</div><div class='line' id='LC7126'>GSK-3α and -β at serine 21 and 9 in HEK293 cells (Fig. 4A).&quot;</div><div class='line' id='LC7127'><br/></div><div class='line' id='LC7128'>proteinAbundance(HGNC:PRKACA) increases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21))</div><div class='line' id='LC7129'>proteinAbundance(HGNC:PRKACA) increases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9))</div><div class='line' id='LC7130'><br/></div><div class='line' id='LC7131'>SET Evidence = &quot;Consistent with this in vivo activity, PKAc enzyme efficiently phosphorylated GSK-3α</div><div class='line' id='LC7132'>and -β at serine 21 and 9 in vitro (Fig. 4B), which was blocked by addition</div><div class='line' id='LC7133'>of the PKA peptide inhibitor (PKI) (26). Similar results were obtained when immunoprecipitated</div><div class='line' id='LC7134'>GSK- 3α, immunoprecipitatedHA-GSK-3β, purified GSK-3α, or recombinant</div><div class='line' id='LC7135'>GSK-3β was used as substrate (Fig. 4B).&quot;</div><div class='line' id='LC7136'><br/></div><div class='line' id='LC7137'>kinaseActivity(proteinAbundance(HGNC:PRKACA)) directlyIncreases proteinAbundance(HGNC:GSK3A,proteinModification(P,S,21)) //in vitro</div><div class='line' id='LC7138'>kinaseActivity(proteinAbundance(HGNC:PRKACA)) directlyIncreases proteinAbundance(HGNC:GSK3B,proteinModification(P,S,9)) //in vitro</div><div class='line' id='LC7139'><br/></div><div class='line' id='LC7140'>SET Evidence = &quot;These in vivo and in vitro observations establish that PKA can directly phosphorylate</div><div class='line' id='LC7141'>and inactivate GSK-3.&quot;</div><div class='line' id='LC7142'><br/></div><div class='line' id='LC7143'>proteinAbundance(HGNC:PRKACA) directlyDecreases kinaseActivity(proteinAbundance(PFH:&quot;GSK3 Family&quot;))</div><div class='line' id='LC7144'>proteinAbundance(HGNC:PRKACA) directlyDecreases kinaseActivity(proteinAbundance(PFH:&quot;GSK3 Family&quot;))</div><div class='line' id='LC7145'>proteinAbundance(HGNC:PRKACA) decreases kinaseActivity(proteinAbundance(PFH:&quot;GSK3 Family&quot;)) //in vitro</div><div class='line' id='LC7146'>proteinAbundance(HGNC:PRKACA) directlyDecreases kinaseActivity(proteinAbundance(PFH:&quot;GSK3 Family&quot;)) //in vitro</div><div class='line' id='LC7147'><br/></div><div class='line' id='LC7148'>SET Evidence = &quot;BAD was originally demonstrated to be phosphorylated at serine 136 by PKB (32, 33).</div><div class='line' id='LC7149'>However, BAD can also be inactivated through phosphorylation of serine 112 by</div><div class='line' id='LC7150'>Rsk, which is located downstream of mitogen-activated protein kinases (MAPKyErk)</div><div class='line' id='LC7151'>(34–36), or alternatively by mitochondriaanchored PKA (37). Additionally, Rsk</div><div class='line' id='LC7152'>can phosphorylate CREB at the same serine 133 site as PKA, leading to the expression</div><div class='line' id='LC7153'>of cAMP-responsive genes (34).&quot;</div><div class='line' id='LC7154'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7155'><br/></div><div class='line' id='LC7156'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) directlyIncreases proteinAbundance(HGNC:BAD,proteinModification(P,S,136)) //mouse S136 not present in human, possibly S134</div><div class='line' id='LC7157'>kinaseActivity(proteinAbundance(PFH:&quot;AKT Family&quot;)) directlyDecreases molecularActivity(proteinAbundance(HGNC:BAD))</div><div class='line' id='LC7158'>kinaseActivity(proteinAbundance(PFH:&quot;RPS6KA Family&quot;)) directlyIncreases proteinAbundance(HGNC:BAD,proteinModification(P,S,112))</div><div class='line' id='LC7159'>kinaseActivity(proteinAbundance(PFH:&quot;RPS6KA Family&quot;)) directlyDecreases molecularActivity(proteinAbundance(HGNC:BAD))</div><div class='line' id='LC7160'>kinaseActivity(proteinAbundance(PFH:&quot;RPS6KA Family&quot;)) directlyIncreases proteinAbundance(HGNC:CREB1,proteinModification(P,S,133))</div><div class='line' id='LC7161'>kinaseActivity(proteinAbundance(PFH:&quot;PRKA Family&quot;)) directlyIncreases proteinAbundance(HGNC:CREB1,proteinModification(P,S,133))</div><div class='line' id='LC7162'><br/></div><div class='line' id='LC7163'>UNSET STATEMENT_GROUP</div><div class='line' id='LC7164'><br/></div><div class='line' id='LC7165'>SET STATEMENT_GROUP = &quot;Group 57&quot;</div><div class='line' id='LC7166'><br/></div><div class='line' id='LC7167'>SET CardiovascularSystem = &quot;Blood Vessels&quot;</div><div class='line' id='LC7168'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC7169'>SET Evidence = &quot;VEGF is the most critical driver of vascular formation, as it is required to initiate</div><div class='line' id='LC7170'>the formation of immature vessels by vasculogenesis or angiogenic sprouting.&quot;</div><div class='line' id='LC7171'>SET Citation = {&quot;PubMed&quot;,&quot;Journal of cellular physiology&quot;,&quot;12891700&quot;,&quot;&quot;,&quot;Michiels C&quot;,&quot;&quot;}</div><div class='line' id='LC7172'><br/></div><div class='line' id='LC7173'>proteinAbundance(HGNC:VEGFA) increases biologicalProcess(GO:vasculogenesis)</div><div class='line' id='LC7174'><br/></div><div class='line' id='LC7175'>SET Evidence = &quot;Ang1 and ephrinB2 are subsequently required for further remodeling and maturation</div><div class='line' id='LC7176'>of this initially immature vasculature notably as endothelial cells integrate with</div><div class='line' id='LC7177'>supporting cells such as smooth muscle cells and pericytes.&quot;</div><div class='line' id='LC7178'><br/></div><div class='line' id='LC7179'>proteinAbundance(HGNC:ANGPT1) increases biologicalProcess(GO:&quot;vasculature development&quot;)</div><div class='line' id='LC7180'>proteinAbundance(HGNC:EFNB2) increases biologicalProcess(GO:&quot;vasculature development&quot;)</div><div class='line' id='LC7181'><br/></div><div class='line' id='LC7182'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC7183'>SET Evidence = &quot;VEGF was initially defined, characterized, and purified for its ability to induce</div><div class='line' id='LC7184'>vascular leak and permeability as well as for its ability to promote endothelial</div><div class='line' id='LC7185'>cell proliferation (Ferrara, 1999).&quot;</div><div class='line' id='LC7186'><br/></div><div class='line' id='LC7187'>proteinAbundance(HGNC:VEGFA) increases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC7188'><br/></div><div class='line' id='LC7189'>SET HemicAndImmuneSystem = &quot;Endothelium, Lymphatic&quot;</div><div class='line' id='LC7190'>SET Evidence = &quot;VEGFR3 is largely restricted to lymphatic endothelium while VEGFR1 and R2 are expressed</div><div class='line' id='LC7191'>by vascular endothelium.&quot;</div><div class='line' id='LC7192'><br/></div><div class='line' id='LC7193'>proteinAbundance(HGNC:FLT4)</div><div class='line' id='LC7194'><br/></div><div class='line' id='LC7195'>SET CardiovascularSystem = &quot;Endothelium, Vascular&quot;</div><div class='line' id='LC7196'><br/></div><div class='line' id='LC7197'>proteinAbundance(HGNC:KDR)</div><div class='line' id='LC7198'>proteinAbundance(HGNC:FLT1)</div><div class='line' id='LC7199'><br/></div><div class='line' id='LC7200'>SET Evidence = &quot;VEGFR2 is the main receptor able to induce endothelial cell proliferation as well</div><div class='line' id='LC7201'>as migratory and sprouting activity and to help promote endothelial cells to form</div><div class='line' id='LC7202'>tubule-like structures&quot;</div><div class='line' id='LC7203'><br/></div><div class='line' id='LC7204'>proteinAbundance(HGNC:KDR) increases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC7205'>proteinAbundance(HGNC:KDR) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC7206'>proteinAbundance(HGNC:KDR) increases biologicalProcess(GO:&quot;sprouting angiogenesis&quot;)</div><div class='line' id='LC7207'><br/></div><div class='line' id='LC7208'>SET CardiovascularSystem = &quot;Blood Vessels&quot;</div><div class='line' id='LC7209'>SET Evidence = &quot;Failure of vasculogenesis is also observed in Flk-1 deficient mice (Shalaby et al.,</div><div class='line' id='LC7210'>1995).&quot;</div><div class='line' id='LC7211'>SET Species = &quot;10090&quot;</div><div class='line' id='LC7212'><br/></div><div class='line' id='LC7213'>proteinAbundance(MGI:Kdr) increases biologicalProcess(GO:vasculogenesis)</div><div class='line' id='LC7214'><br/></div><div class='line' id='LC7215'>SET Evidence = &quot;Ang1 would rather have a permissive role by optimizing the manner by which endothelial</div><div class='line' id='LC7216'>cells interact with each other and integrate with supporting cells and matrix.&quot;</div><div class='line' id='LC7217'><br/></div><div class='line' id='LC7218'>proteinAbundance(HGNC:ANGPT1) increases biologicalProcess(GO:&quot;cell-cell adhesion&quot;)</div><div class='line' id='LC7219'>proteinAbundance(HGNC:ANGPT1) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC7220'><br/></div><div class='line' id='LC7221'>SET Evidence = &quot;In a normal adult vessel, Ang1 is associated with Tie2 to keep the vessels in a stable</div><div class='line' id='LC7222'>state.&quot;</div><div class='line' id='LC7223'><br/></div><div class='line' id='LC7224'>complexAbundance(proteinAbundance(HGNC:ANGPT1),proteinAbundance(HGNC:TEK))</div><div class='line' id='LC7225'><br/></div><div class='line' id='LC7226'>SET Evidence = &quot;Ang2 bound to the same Tie2 receptor as did Ang1, it could not activate it. Instead,</div><div class='line' id='LC7227'>Ang2 provided the first example of a naturally occurring antagonist for a tyrosine</div><div class='line' id='LC7228'>receptor.&quot;</div><div class='line' id='LC7229'><br/></div><div class='line' id='LC7230'>proteinAbundance(HGNC:ANGPT2) directlyDecreases (proteinAbundance(HGNC:ANGPT1) directlyIncreases kinaseActivity(proteinAbundance(HGNC:TEK)))</div><div class='line' id='LC7231'><br/></div><div class='line' id='LC7232'>SET Evidence = &quot;recent knockout studies have suggested key role for ephrin B2 and it EphB4 receptor</div><div class='line' id='LC7233'>during vascular development mainly in early angiogenic remodeling (Gerety et</div><div class='line' id='LC7234'>al., 1999).&quot;</div><div class='line' id='LC7235'><br/></div><div class='line' id='LC7236'>complexAbundance(proteinAbundance(HGNC:EFNB2),proteinAbundance(HGNC:EPHB4)) increases biologicalProcess(GO:&quot;vasculature development&quot;)</div><div class='line' id='LC7237'>complexAbundance(proteinAbundance(HGNC:EFNB2),proteinAbundance(HGNC:EPHB4)) increases biologicalProcess(GO:&quot;blood vessel remodeling&quot;)</div><div class='line' id='LC7238'><br/></div><div class='line' id='LC7239'>SET Evidence = &quot;Stimuli like histamine, atrial natriuretic factor, or thrombin, induce a rapid and</div><div class='line' id='LC7240'>short-lived increase in vascular permeability while others like cytokines or VEGF</div><div class='line' id='LC7241'>induce a sustained response.&quot;</div><div class='line' id='LC7242'><br/></div><div class='line' id='LC7243'>abundance(CHEBI:histamine) increases biologicalProcess(GO:&quot;regulation of vascular permeability&quot;)</div><div class='line' id='LC7244'>abundance(SCHEM:&quot;Atrial natriuretic factor&quot;) increases biologicalProcess(GO:&quot;regulation of vascular permeability&quot;)</div><div class='line' id='LC7245'>proteinAbundance(HGNC:F2) increases biologicalProcess(GO:&quot;regulation of vascular permeability&quot;)</div><div class='line' id='LC7246'>proteinAbundance(HGNC:VEGFA) increases biologicalProcess(GO:&quot;regulation of vascular permeability&quot;)</div><div class='line' id='LC7247'><br/></div><div class='line' id='LC7248'>SET Evidence = &quot;The major antiplatelet agents secreted by endothelial cells are prostacyclin (PGI2)</div><div class='line' id='LC7249'>and nitric oxide (NO) (Cines et al., 1998).&quot;</div><div class='line' id='LC7250'><br/></div><div class='line' id='LC7251'>abundance(CHEBI:&quot;prostaglandin I2&quot;) decreases biologicalProcess(GO:&quot;blood coagulation&quot;)</div><div class='line' id='LC7252'>abundance(CHEBI:&quot;nitric oxide&quot;) decreases biologicalProcess(GO:&quot;blood coagulation&quot;)</div><div class='line' id='LC7253'><br/></div><div class='line' id='LC7254'>SET Cell = &quot;Blood Platelets&quot;</div><div class='line' id='LC7255'>SET Evidence = &quot;The major antiplatelet agents secreted by endothelial cells are prostacyclin (PGI2)</div><div class='line' id='LC7256'>and nitric oxide (NO) (Cines et al., 1998). Both synergistically increasecAMPcontent</div><div class='line' id='LC7257'>in platelets, hence preventing their aggregation (de Graaf et al., 1992).&quot;</div><div class='line' id='LC7258'><br/></div><div class='line' id='LC7259'>compositeAbundance(abundance(CHEBI:&quot;prostaglandin I2&quot;),abundance(CHEBI:&quot;nitric oxide&quot;)) increases abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;)</div><div class='line' id='LC7260'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;) decreases biologicalProcess(GO:&quot;platelet aggregation&quot;)</div><div class='line' id='LC7261'>compositeAbundance(abundance(CHEBI:&quot;prostaglandin I2&quot;),abundance(CHEBI:&quot;nitric oxide&quot;)) decreases biologicalProcess(GO:&quot;platelet aggregation&quot;)</div><div class='line' id='LC7262'><br/></div><div class='line' id='LC7263'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC7264'>SET Evidence = &quot;PGI2 and NO are constitutively released by endothelial cells but their synthesis is</div><div class='line' id='LC7265'>increased in response to a similar range of agonists, notably molecules involved</div><div class='line' id='LC7266'>in the coagulation process (e.g., bradykinine and thrombin)&quot;</div><div class='line' id='LC7267'><br/></div><div class='line' id='LC7268'>proteinAbundance(HGNC:F2) increases cellSecretion(abundance(CHEBI:&quot;prostaglandin I2&quot;))</div><div class='line' id='LC7269'>proteinAbundance(HGNC:F2) increases cellSecretion(abundance(CHEBI:&quot;nitric oxide&quot;))</div><div class='line' id='LC7270'>abundance(CHEBI:bradykinin) increases cellSecretion(abundance(CHEBI:&quot;prostaglandin I2&quot;))</div><div class='line' id='LC7271'>abundance(CHEBI:bradykinin) increases cellSecretion(abundance(CHEBI:&quot;nitric oxide&quot;))</div><div class='line' id='LC7272'><br/></div><div class='line' id='LC7273'>SET Evidence = &quot;The protein C/protein S pathway is initiated when thrombin interacts with the endothelial</div><div class='line' id='LC7274'>cell receptor thrombomodulin, facilitating activation of protein C (Sadler,</div><div class='line' id='LC7275'>1997).&quot;</div><div class='line' id='LC7276'><br/></div><div class='line' id='LC7277'>proteinAbundance(HGNC:F2) directlyIncreases molecularActivity(proteinAbundance(HGNC:THBD))</div><div class='line' id='LC7278'>molecularActivity(proteinAbundance(HGNC:THBD)) increases molecularActivity(proteinAbundance(HGNC:PROC))</div><div class='line' id='LC7279'><br/></div><div class='line' id='LC7280'>SET HemicAndImmuneSystem = &quot;Blood&quot;</div><div class='line' id='LC7281'>SET Evidence = &quot;Activated protein C inactivates two cofactors essential for blood coagulation: factors</div><div class='line' id='LC7282'>VIIIa and Va.&quot;</div><div class='line' id='LC7283'><br/></div><div class='line' id='LC7284'>molecularActivity(proteinAbundance(HGNC:PROC)) decreases molecularActivity(proteinAbundance(HGNC:F8))</div><div class='line' id='LC7285'>molecularActivity(proteinAbundance(HGNC:PROC)) decreases molecularActivity(proteinAbundance(HGNC:F5))</div><div class='line' id='LC7286'>molecularActivity(proteinAbundance(HGNC:F8)) increases biologicalProcess(GO:&quot;blood coagulation&quot;)</div><div class='line' id='LC7287'>molecularActivity(proteinAbundance(HGNC:F5)) increases biologicalProcess(GO:&quot;blood coagulation&quot;)</div><div class='line' id='LC7288'><br/></div><div class='line' id='LC7289'>SET Evidence = &quot;To be effective, protein C must form a complex with protein S, which is synthesized</div><div class='line' id='LC7290'>by endothelial cells (Stern et al., 1991; Esmon, 2000).&quot;</div><div class='line' id='LC7291'><br/></div><div class='line' id='LC7292'>complexAbundance(proteinAbundance(HGNC:PROC),proteinAbundance(HGNC:PROS1))</div><div class='line' id='LC7293'>proteinAbundance(HGNC:PROS1) directlyIncreases molecularActivity(proteinAbundance(HGNC:PROC))</div><div class='line' id='LC7294'><br/></div><div class='line' id='LC7295'>SET Cell = &quot;Blood Platelets&quot;</div><div class='line' id='LC7296'>SET Evidence = &quot;Complex formation between thrombin and thrombomodulin also prevents thrombin from</div><div class='line' id='LC7297'>being able to clot fibrinogen or to activate platelets (Esmon, 1995).&quot;</div><div class='line' id='LC7298'><br/></div><div class='line' id='LC7299'>molecularActivity(proteinAbundance(HGNC:F2)) increases biologicalProcess(GO:&quot;platelet activation&quot;)</div><div class='line' id='LC7300'>complexAbundance(proteinAbundance(HGNC:F2),proteinAbundance(HGNC:THBD)) directlyDecreases molecularActivity(proteinAbundance(HGNC:F2))</div><div class='line' id='LC7301'><br/></div><div class='line' id='LC7302'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC7303'>SET Evidence = &quot;It must be noted that the natural inhibitor of t-PA, plasminogen activator inhibitor</div><div class='line' id='LC7304'>type 1 (PAI-1) is also constitutively secreted by endothelial cells.&quot;</div><div class='line' id='LC7305'><br/></div><div class='line' id='LC7306'>molecularActivity(proteinAbundance(HGNC:SERPINE1)) directlyDecreases peptidaseActivity(proteinAbundance(HGNC:PLAT))</div><div class='line' id='LC7307'><br/></div><div class='line' id='LC7308'>SET Evidence = &quot;The second is the von Willebrand factor (vWF) of which endothelial cells are the major</div><div class='line' id='LC7309'>source (Denis, 2002). vWF is constitutively secreted into the plasma and the</div><div class='line' id='LC7310'>subendothelial matrix. It is also stored in high amount in Weibel–Palade bodies,</div><div class='line' id='LC7311'>which can be mobilized rapidly in response to agonists like thrombin (van Mourik</div><div class='line' id='LC7312'>et al., 2002).&quot;</div><div class='line' id='LC7313'><br/></div><div class='line' id='LC7314'>proteinAbundance(HGNC:F2) increases cellSecretion(proteinAbundance(HGNC:VWF))</div><div class='line' id='LC7315'><br/></div><div class='line' id='LC7316'>SET Evidence = &quot;vWF binds and stabilizes coagulation factor VIII and is a specific factor required</div><div class='line' id='LC7317'>for the binding of platelets to exposed extracellular matrix components when the</div><div class='line' id='LC7318'>vessel wall is damaged (Ruggeri and Preissner, 1999).&quot;</div><div class='line' id='LC7319'><br/></div><div class='line' id='LC7320'>complexAbundance(proteinAbundance(HGNC:VWF),proteinAbundance(HGNC:F8))</div><div class='line' id='LC7321'>proteinAbundance(HGNC:VWF) directlyDecreases degradation(proteinAbundance(HGNC:F8))</div><div class='line' id='LC7322'><br/></div><div class='line' id='LC7323'>SET Cell = &quot;Blood Platelets&quot;</div><div class='line' id='LC7324'><br/></div><div class='line' id='LC7325'>proteinAbundance(HGNC:VWF) increases biologicalProcess(GO:&quot;cell-matrix adhesion&quot;)</div><div class='line' id='LC7326'><br/></div><div class='line' id='LC7327'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC7328'>SET Evidence = &quot;However, when exposed to thrombin, cytokines, or LPS, endothelial cells synthesize</div><div class='line' id='LC7329'>and express tissue factor at their surface (Nawroth et al., 1986; Mackman, 1997).&quot;</div><div class='line' id='LC7330'><br/></div><div class='line' id='LC7331'>proteinAbundance(HGNC:F2) increases cellSurfaceExpression(proteinAbundance(HGNC:F3))</div><div class='line' id='LC7332'>abundance(CHEBI:lipopolysaccharide) increases cellSurfaceExpression(proteinAbundance(HGNC:F3))</div><div class='line' id='LC7333'><br/></div><div class='line' id='LC7334'>SET Evidence = &quot;Thrombin is the main effector protease of the coagulation cascade. Factor Xa, activated</div><div class='line' id='LC7335'>by factor VIIa and tissue factor, converts prothrombin to active thrombin.&quot;</div><div class='line' id='LC7336'><br/></div><div class='line' id='LC7337'>peptidaseActivity(proteinAbundance(HGNC:F2)) increases biologicalProcess(GO:&quot;blood coagulation&quot;)</div><div class='line' id='LC7338'>complexAbundance(proteinAbundance(HGNC:F3),proteinAbundance(HGNC:F7)) increases peptidaseActivity(proteinAbundance(HGNC:F10))</div><div class='line' id='LC7339'>peptidaseActivity(proteinAbundance(HGNC:F10)) increases peptidaseActivity(proteinAbundance(HGNC:F2))</div><div class='line' id='LC7340'><br/></div><div class='line' id='LC7341'>SET CellStructure = &quot;Cell Membrane&quot;</div><div class='line' id='LC7342'>SET Evidence = &quot;In endothelial cells, thrombin causes vWF release, the appearance of P-selectin at</div><div class='line' id='LC7343'>the plasma membrane, production of PAF and chemokines.&quot;</div><div class='line' id='LC7344'><br/></div><div class='line' id='LC7345'>proteinAbundance(HGNC:F2) increases proteinAbundance(HGNC:SELP)</div><div class='line' id='LC7346'><br/></div><div class='line' id='LC7347'>SET Evidence = &quot;PAR-1, the one present at the surface of endothelial cells, is activated when thrombin</div><div class='line' id='LC7348'>cleaves its amino-terminal extracellular domain (exodomain) at a specific</div><div class='line' id='LC7349'>site.&quot;</div><div class='line' id='LC7350'><br/></div><div class='line' id='LC7351'>peptidaseActivity(proteinAbundance(HGNC:F2)) directlyIncreases molecularActivity(proteinAbundance(HGNC:F2R))</div><div class='line' id='LC7352'><br/></div><div class='line' id='LC7353'>SET Evidence = &quot;The NO generation by endothelial cells is constitutive but may be enhanced by a wide</div><div class='line' id='LC7354'>variety of compounds, including acetylcholine, angiotensin II, bradykinin, histamine,</div><div class='line' id='LC7355'>adenine nucleotides, arachidonic acid&quot;</div><div class='line' id='LC7356'><br/></div><div class='line' id='LC7357'>abundance(CHEBI:acetylcholine) increases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC7358'>abundance(CHEBI:&quot;angiotensin II&quot;) increases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC7359'>abundance(CHEBI:bradykinin) increases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC7360'>abundance(CHEBI:histamine) increases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC7361'>abundance(CHEBI:&quot;arachidonic acid&quot;) increases abundance(CHEBI:&quot;nitric oxide&quot;)</div><div class='line' id='LC7362'><br/></div><div class='line' id='LC7363'>SET Evidence = &quot;It is synthesized from oxygen and L-arginine by NO synthase (NOS).&quot;</div><div class='line' id='LC7364'><br/></div><div class='line' id='LC7365'>catalyticActivity(proteinAbundance(PFH:&quot;NOS Family&quot;)) increases reaction(reactants(abundance(CHEBI:dioxygen),abundance(CHEBI:&quot;L-arginine&quot;)),products(abundance(CHEBI:&quot;nitric oxide&quot;)))</div><div class='line' id='LC7366'><br/></div><div class='line' id='LC7367'>SET CardiovascularSystem = &quot;Muscle, Smooth, Vascular&quot;</div><div class='line' id='LC7368'>SET Evidence = &quot;EDRF diffuses to the vascular smooth muscle cells where it stimulates soluble guanylate</div><div class='line' id='LC7369'>cyclase, resulting in an increased formation of cyclic GMP and subsequent</div><div class='line' id='LC7370'>relaxation (Fig. 2A) (Denninger and Marletta, 1999).&quot;</div><div class='line' id='LC7371'><br/></div><div class='line' id='LC7372'>abundance(CHEBI:&quot;nitric oxide&quot;) increases catalyticActivity(proteinAbundance(PFH:&quot;GUCY Family&quot;))</div><div class='line' id='LC7373'>catalyticActivity(proteinAbundance(PFH:&quot;GUCY Family&quot;)) increases abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic GMP&quot;)</div><div class='line' id='LC7374'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic GMP&quot;) increases biologicalProcess(GO:&quot;relaxation of vascular smooth muscle&quot;)</div><div class='line' id='LC7375'><br/></div><div class='line' id='LC7376'>SET TextLocation = {&quot;Review&quot;,&quot;Review&quot;}</div><div class='line' id='LC7377'>SET Evidence = &quot;infusion of a NOS inhibitor, like L-NMMA, increases the resting blood pressure (Fleming</div><div class='line' id='LC7378'>et al., 1996).&quot;</div><div class='line' id='LC7379'><br/></div><div class='line' id='LC7380'>abundance(CHEBIID:28229) directlyDecreases catalyticActivity(proteinAbundance(PFH:&quot;NOS Family&quot;))</div><div class='line' id='LC7381'>abundance(CHEBIID:28229) increases biologicalProcess(MESHPP:&quot;Blood Pressure&quot;)</div><div class='line' id='LC7382'><br/></div><div class='line' id='LC7383'>SET TextLocation = &quot;Review&quot;</div><div class='line' id='LC7384'>SET Evidence = &quot;Endothelium generates PGI2, which relaxes the underlying smooth muscle cells through</div><div class='line' id='LC7385'>activation of adenylate cyclase and subsequent generation of cAMP.&quot;</div><div class='line' id='LC7386'><br/></div><div class='line' id='LC7387'>abundance(CHEBI:&quot;prostaglandin I2&quot;) increases catalyticActivity(proteinAbundance(PFH:&quot;ADCY Family&quot;))</div><div class='line' id='LC7388'>catalyticActivity(proteinAbundance(PFH:&quot;ADCY Family&quot;)) directlyIncreases abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;)</div><div class='line' id='LC7389'>abundance(CHEBI:&quot;3&#39;,5&#39;-cyclic AMP&quot;) increases biologicalProcess(GO:&quot;relaxation of vascular smooth muscle&quot;)</div><div class='line' id='LC7390'><br/></div><div class='line' id='LC7391'>SET Evidence = &quot;Endothelial cells constitutively release PGI2 (Moncada et al., 1976) which appears</div><div class='line' id='LC7392'>to be involved in the regulation of resting vascular tone, in addition to EDRF.</div><div class='line' id='LC7393'>It is released in higher amount in response to ligand binding on the cell surface</div><div class='line' id='LC7394'>such as thrombin, arachidonic acid, histamine, serotonin&quot;</div><div class='line' id='LC7395'><br/></div><div class='line' id='LC7396'>proteinAbundance(HGNC:F2) increases cellSecretion(abundance(CHEBI:&quot;prostaglandin I2&quot;))</div><div class='line' id='LC7397'>abundance(CHEBI:&quot;arachidonic acid&quot;) increases cellSecretion(abundance(CHEBI:&quot;prostaglandin I2&quot;))</div><div class='line' id='LC7398'>abundance(CHEBI:histamine) increases cellSecretion(abundance(CHEBI:&quot;prostaglandin I2&quot;))</div><div class='line' id='LC7399'>abundance(CHEBI:serotonin) increases cellSecretion(abundance(CHEBI:&quot;prostaglandin I2&quot;))</div><div class='line' id='LC7400'><br/></div><div class='line' id='LC7401'>SET Evidence = &quot;The endothelinA (ETA) receptor is situated on the vascular smooth muscle cells and</div><div class='line' id='LC7402'>has a high affinity for ET-1 and ET-2 but not for ET-3.&quot;</div><div class='line' id='LC7403'><br/></div><div class='line' id='LC7404'>proteinAbundance(HGNC:EDN1) directlyIncreases molecularActivity(proteinAbundance(HGNC:EDNRA))</div><div class='line' id='LC7405'>proteinAbundance(HGNC:EDN2) directlyIncreases molecularActivity(proteinAbundance(HGNC:EDNRA))</div><div class='line' id='LC7406'>proteinAbundance(HGNC:EDN3) causesNoChange molecularActivity(proteinAbundance(HGNC:EDNRA))</div><div class='line' id='LC7407'><br/></div><div class='line' id='LC7408'>SET Evidence = &quot;the endothelinB (ETB) receptor is situated on the endothelial cells and has a similar</div><div class='line' id='LC7409'>affinity for the three endothelin isoforms.&quot;</div><div class='line' id='LC7410'><br/></div><div class='line' id='LC7411'>proteinAbundance(HGNC:EDN1) directlyIncreases molecularActivity(proteinAbundance(HGNC:EDNRB))</div><div class='line' id='LC7412'>proteinAbundance(HGNC:EDN2) directlyIncreases molecularActivity(proteinAbundance(HGNC:EDNRB))</div><div class='line' id='LC7413'>proteinAbundance(HGNC:EDN3) directlyIncreases molecularActivity(proteinAbundance(HGNC:EDNRB))</div><div class='line' id='LC7414'><br/></div><div class='line' id='LC7415'>SET Evidence = &quot;Binding to ETA receptor stimulated phospholipase C initiating in turn events leading</div><div class='line' id='LC7416'>eventually to smooth muscle cell contraction (Kedzierski and Yanagisawa, 2001).&quot;</div><div class='line' id='LC7417'><br/></div><div class='line' id='LC7418'>molecularActivity(proteinAbundance(HGNC:EDNRA)) increases catalyticActivity(proteinAbundance(PFH:&quot;PLC Family&quot;))</div><div class='line' id='LC7419'>catalyticActivity(proteinAbundance(PFH:&quot;PLC Family&quot;)) decreases biologicalProcess(GO:&quot;relaxation of vascular smooth muscle&quot;)</div><div class='line' id='LC7420'><br/></div><div class='line' id='LC7421'>SET Evidence = &quot;The result of ET binding to ETB receptor on endothelial cells is the release of EDRF/</div><div class='line' id='LC7422'>PGI2, which opposes the vasoconstricting action of ET.&quot;</div><div class='line' id='LC7423'><br/></div><div class='line' id='LC7424'>molecularActivity(proteinAbundance(HGNC:EDNRB)) increases cellSecretion(abundance(CHEBI:&quot;prostaglandin I2&quot;))</div><div class='line' id='LC7425'><br/></div><div class='line' id='LC7426'>SET Evidence = &quot;Vasoconstricting agents like ET-1 also exert mitogenic activity on smooth muscle cells</div><div class='line' id='LC7427'>(Alberts et al., 1994) while EDRF and PGI2 inhibit smooth muscle cell proliferation&quot;</div><div class='line' id='LC7428'><br/></div><div class='line' id='LC7429'>proteinAbundance(HGNC:EDN1) increases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC7430'>abundance(CHEBI:&quot;nitric oxide&quot;) decreases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC7431'>abundance(CHEBI:&quot;prostaglandin I2&quot;) decreases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC7432'><br/></div><div class='line' id='LC7433'>SET Evidence = &quot;Endothelial (eNOS) and neuronal (nNOS) isoforms are constitutively expressed and are</div><div class='line' id='LC7434'>activated by calmodulin/calcium.&quot;</div><div class='line' id='LC7435'><br/></div><div class='line' id='LC7436'>proteinAbundance(HGNC:CALM1) increases catalyticActivity(proteinAbundance(HGNC:NOS1))</div><div class='line' id='LC7437'>proteinAbundance(HGNC:CALM1) increases catalyticActivity(proteinAbundance(HGNC:NOS3))</div><div class='line' id='LC7438'><br/></div><div class='line' id='LC7439'>SET Evidence = &quot;Receptor-mediated agonist stimulation (e.g., bradykinin, acetylcholine, thrombin,</div><div class='line' id='LC7440'>histamine,...) leads to rapid enzyme activation by depalmitoylation, binding to</div><div class='line' id='LC7441'>calmodulin/calcium, displacement displacement of caveolin and release from the</div><div class='line' id='LC7442'>plasma membrane(Govers and Rabelink, 2001; Marletta, 2001).&quot;</div><div class='line' id='LC7443'><br/></div><div class='line' id='LC7444'>abundance(CHEBI:bradykinin) increases catalyticActivity(proteinAbundance(HGNC:NOS3))</div><div class='line' id='LC7445'>abundance(CHEBI:acetylcholine) increases catalyticActivity(proteinAbundance(HGNC:NOS3))</div><div class='line' id='LC7446'>proteinAbundance(HGNC:F2) increases catalyticActivity(proteinAbundance(HGNC:NOS3))</div><div class='line' id='LC7447'>abundance(CHEBI:histamine) increases catalyticActivity(proteinAbundance(HGNC:NOS3))</div><div class='line' id='LC7448'><br/></div><div class='line' id='LC7449'>SET Evidence = &quot;eNOS activity is also regulated at the transcriptional level: VEGF, insulin, bFGF</div><div class='line' id='LC7450'>increase eNOS expression while hypoxia and oxidized LDL decrease it (Sase and Michel,</div><div class='line' id='LC7451'>1997).&quot;</div><div class='line' id='LC7452'><br/></div><div class='line' id='LC7453'>proteinAbundance(HGNC:VEGFA) increases rnaAbundance(HGNC:NOS3)</div><div class='line' id='LC7454'>proteinAbundance(HGNC:INS) increases rnaAbundance(HGNC:NOS3)</div><div class='line' id='LC7455'>proteinAbundance(HGNC:FGF2) increases rnaAbundance(HGNC:NOS3)</div><div class='line' id='LC7456'>biologicalProcess(GO:&quot;response to hypoxia&quot;) decreases rnaAbundance(HGNC:NOS3)</div><div class='line' id='LC7457'>abundance(CHEBI:&quot;oxidised LDL&quot;) decreases rnaAbundance(HGNC:NOS3)</div><div class='line' id='LC7458'><br/></div><div class='line' id='LC7459'>SET Evidence = &quot;Shear stress causes rapid eNOS activation and upregulates eNOS gene expression by</div><div class='line' id='LC7460'>transcription activation of the eNOS promoter (Xiao et al., 1997).&quot;</div><div class='line' id='LC7461'><br/></div><div class='line' id='LC7462'>biologicalProcess(GO:&quot;cellular response to fluid shear stress&quot;) increases rnaAbundance(HGNC:NOS3)</div><div class='line' id='LC7463'><br/></div><div class='line' id='LC7464'>SET Evidence = &quot;the induced adherence in inflammatory situation requires induction of L-selectin ligand</div><div class='line' id='LC7465'>and/or of E- and P-selectins on the endothelial surface. E-selectin is transcriptionally</div><div class='line' id='LC7466'>induced by cytokines such as IL-1, TNF-α, or by LPS (Klein et al.,</div><div class='line' id='LC7467'>1995; Scholz et al., 1996).&quot;</div><div class='line' id='LC7468'><br/></div><div class='line' id='LC7469'>proteinAbundance(PFH:&quot;IL1 Family&quot;) increases rnaAbundance(HGNC:SELE)</div><div class='line' id='LC7470'>proteinAbundance(HGNC:TNF) increases rnaAbundance(HGNC:SELE)</div><div class='line' id='LC7471'>abundance(CHEBI:lipopolysaccharide) increases rnaAbundance(HGNC:SELE)</div><div class='line' id='LC7472'><br/></div><div class='line' id='LC7473'>SET Evidence = &quot;In contrast, P-selectin is stored in the membrane of storage granules, the Weibel–</div><div class='line' id='LC7474'>Palade bodies, in endothelial cells (McEver et al., 1989). Fusion of these granules</div><div class='line' id='LC7475'>with the plasma membrane is rapidly stimulated by proinflammatory mediators</div><div class='line' id='LC7476'>such as histamine and thrombin.&quot;</div><div class='line' id='LC7477'><br/></div><div class='line' id='LC7478'>abundance(CHEBI:histamine) increases translocation(proteinAbundance(HGNC:SELP),MESHCL:&quot;Cytoplasmic Granules&quot;,MESHCL:&quot;Cell Membrane&quot;)</div><div class='line' id='LC7479'>proteinAbundance(HGNC:F2) increases translocation(proteinAbundance(HGNC:SELP),MESHCL:&quot;Cytoplasmic Granules&quot;,MESHCL:&quot;Cell Membrane&quot;)</div><div class='line' id='LC7480'><br/></div><div class='line' id='LC7481'>SET Evidence = &quot;L-selectin (constitutive rolling on endothelial cells) and P- and/or E-selectins (inflammatory</div><div class='line' id='LC7482'>mediatorinduced capture) work cooperatively to initiate leukocyte</div><div class='line' id='LC7483'>migration.&quot;</div><div class='line' id='LC7484'><br/></div><div class='line' id='LC7485'>compositeAbundance(proteinAbundance(HGNC:SELL),proteinAbundance(HGNC:SELP),proteinAbundance(HGNC:SELE)) increases biologicalProcess(GO:&quot;leukocyte migration&quot;)</div><div class='line' id='LC7486'><br/></div><div class='line' id='LC7487'>SET Cell = &quot;Neutrophils&quot;</div><div class='line' id='LC7488'>SET Evidence = &quot;Preformed Mac-1 is stored in granules in neutrophils and can be rapidly mobilized</div><div class='line' id='LC7489'>to the neutrophil surface after exposure to degranulation stimuli such as the bacterial</div><div class='line' id='LC7490'>peptide fMLP or to cytokines (Altieri and Edgington, 1988). However, it</div><div class='line' id='LC7491'>is not yet competent for ligand binding. The ligand binding site lies on an extracellular</div><div class='line' id='LC7492'>region of the α subunit called the I domain, that is inaccessible to</div><div class='line' id='LC7493'>potential ligands unless integrins are activated. Integrin activation involves a</div><div class='line' id='LC7494'>conformational change such that the I domain is exposed (Oxvig et al., 1999). This</div><div class='line' id='LC7495'>change may be induced by phosphorylation of the cytoplasmic tail of the β subunit</div><div class='line' id='LC7496'>(Buyon et al., 1997), possibly through a pathway involving the small GTP-binding</div><div class='line' id='LC7497'>protein Rho, but this is still unclear.&quot;</div><div class='line' id='LC7498'><br/></div><div class='line' id='LC7499'>abundance(CHEBIID:53490) increases cellSurfaceExpression(complexAbundance(proteinAbundance(HGNC:ITGAM),proteinAbundance(HGNC:ITGB2)))</div><div class='line' id='LC7500'>proteinAbundance(HGNC:ITGB2,proteinModification(P)) directlyIncreases molecularActivity(complexAbundance(proteinAbundance(HGNC:ITGAM),proteinAbundance(HGNC:ITGB2)))</div><div class='line' id='LC7501'><br/></div><div class='line' id='LC7502'>SET HemicAndImmuneSystem = &quot;Leukocytes&quot;</div><div class='line' id='LC7503'>SET Evidence = &quot;Migration of all leukocytes depends mainly on β2 integrins (Mac-1 and LFA-1) and on</div><div class='line' id='LC7504'>ICAM-1, their ligand on endothelial cells.&quot;</div><div class='line' id='LC7505'><br/></div><div class='line' id='LC7506'>complexAbundance(proteinAbundance(HGNC:ITGAM),proteinAbundance(HGNC:ITGB2),proteinAbundance(HGNC:ICAM1)) increases biologicalProcess(GO:&quot;leukocyte migration&quot;)</div><div class='line' id='LC7507'>complexAbundance(proteinAbundance(HGNC:ITGAL),proteinAbundance(HGNC:ITGB2),proteinAbundance(HGNC:ICAM1)) increases biologicalProcess(GO:&quot;leukocyte migration&quot;)</div><div class='line' id='LC7508'><br/></div><div class='line' id='LC7509'>SET Evidence = &quot;Specific increased expression of glycolytic enzymes, glucose tranporter GLUT-1, VEGF,</div><div class='line' id='LC7510'>tyrosine hydroxylase, transferrin, and erythropoietin is observed, all proteins</div><div class='line' id='LC7511'>involved in the adaptative response of cells to hypoxia.&quot;</div><div class='line' id='LC7512'><br/></div><div class='line' id='LC7513'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases proteinAbundance(HGNC:SLC2A1)</div><div class='line' id='LC7514'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases proteinAbundance(HGNC:TH)</div><div class='line' id='LC7515'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases proteinAbundance(HGNC:TF)</div><div class='line' id='LC7516'>biologicalProcess(GO:&quot;response to hypoxia&quot;) increases proteinAbundance(HGNC:EPO)</div><div class='line' id='LC7517'><br/></div><div class='line' id='LC7518'>SET Cell = &quot;Endothelial Cells&quot;</div><div class='line' id='LC7519'>SET Evidence = &quot;Numerous molecules stimulate endothelial proliferation and migration, including VEGF,</div><div class='line' id='LC7520'>Ang1, and bFGF.&quot;</div><div class='line' id='LC7521'><br/></div><div class='line' id='LC7522'>proteinAbundance(HGNC:VEGFA) increases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC7523'>proteinAbundance(HGNC:VEGFA) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC7524'>proteinAbundance(HGNC:ANGPT1) increases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC7525'>proteinAbundance(HGNC:ANGPT1) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC7526'>proteinAbundance(HGNC:FGF2) increases biologicalProcess(MESHPP:&quot;Cell Proliferation&quot;)</div><div class='line' id='LC7527'>proteinAbundance(HGNC:FGF2) increases biologicalProcess(GO:&quot;cell migration&quot;)</div><div class='line' id='LC7528'><br/></div><div class='line' id='LC7529'>UNSET STATEMENT_GROUP</div><div class='line' id='LC7530'><br/></div></pre></div>
          </td>
        </tr>
      </table>
  </div>

          </div>
        </div>
      </div>
    </div>

  </div>

<div class="frame frame-loading large-loading-area" style="display:none;" data-tree-list-url="/OpenBEL/openbel-framework-resources/tree-list/00e6afd2fae5da40add133d5a59bc122f9d1d5ce" data-blob-url-prefix="/OpenBEL/openbel-framework-resources/blob/00e6afd2fae5da40add133d5a59bc122f9d1d5ce">
  <img src="https://a248.e.akamai.net/assets.github.com/images/spinners/octocat-spinner-64.gif?1329872008" height="64" width="64">
</div>

        </div>
      </div>
      <div class="context-overlay"></div>
    </div>

      <div id="footer-push"></div><!-- hack for sticky footer -->
    </div><!-- end of wrapper - hack for sticky footer -->

      <!-- footer -->
      <div id="footer" >
        
  <div class="upper_footer">
     <div class="container clearfix">

       <!--[if IE]><h4 id="blacktocat_ie">GitHub Links</h4><![endif]-->
       <![if !IE]><h4 id="blacktocat">GitHub Links</h4><![endif]>

       <ul class="footer_nav">
         <h4>GitHub</h4>
         <li><a href="https://github.com/about">About</a></li>
         <li><a href="https://github.com/blog">Blog</a></li>
         <li><a href="https://github.com/features">Features</a></li>
         <li><a href="https://github.com/contact">Contact &amp; Support</a></li>
         <li><a href="https://github.com/training">Training</a></li>
         <li><a href="http://enterprise.github.com/">GitHub Enterprise</a></li>
         <li><a href="http://status.github.com/">Site Status</a></li>
       </ul>

       <ul class="footer_nav">
         <h4>Clients</h4>
         <li><a href="http://mac.github.com/">GitHub for Mac</a></li>
         <li><a href="http://windows.github.com/">GitHub for Windows</a></li>
         <li><a href="http://eclipse.github.com/">GitHub for Eclipse</a></li>
         <li><a href="http://mobile.github.com/">GitHub Mobile Apps</a></li>
       </ul>

       <ul class="footer_nav">
         <h4>Tools</h4>
         <li><a href="http://get.gaug.es/">Gauges: Web analytics</a></li>
         <li><a href="http://speakerdeck.com">Speaker Deck: Presentations</a></li>
         <li><a href="https://gist.github.com">Gist: Code snippets</a></li>

         <h4 class="second">Extras</h4>
         <li><a href="http://jobs.github.com/">Job Board</a></li>
         <li><a href="http://shop.github.com/">GitHub Shop</a></li>
         <li><a href="http://octodex.github.com/">The Octodex</a></li>
       </ul>

       <ul class="footer_nav">
         <h4>Documentation</h4>
         <li><a href="http://help.github.com/">GitHub Help</a></li>
         <li><a href="http://developer.github.com/">Developer API</a></li>
         <li><a href="http://github.github.com/github-flavored-markdown/">GitHub Flavored Markdown</a></li>
         <li><a href="http://pages.github.com/">GitHub Pages</a></li>
       </ul>

     </div><!-- /.site -->
  </div><!-- /.upper_footer -->

<div class="lower_footer">
  <div class="container clearfix">
    <!--[if IE]><div id="legal_ie"><![endif]-->
    <![if !IE]><div id="legal"><![endif]>
      <ul>
          <li><a href="https://github.com/site/terms">Terms of Service</a></li>
          <li><a href="https://github.com/site/privacy">Privacy</a></li>
          <li><a href="https://github.com/security">Security</a></li>
      </ul>

      <p>&copy; 2012 <span title="0.11573s from fe6.rs.github.com">GitHub</span> Inc. All rights reserved.</p>
    </div><!-- /#legal or /#legal_ie-->

      <div class="sponsor">
        <a href="http://www.rackspace.com" class="logo">
          <img alt="Dedicated Server" height="36" src="https://a248.e.akamai.net/assets.github.com/images/modules/footer/rackspaces_logo.png?1329521041" width="38" />
        </a>
        Powered by the <a href="http://www.rackspace.com ">Dedicated
        Servers</a> and<br/> <a href="http://www.rackspace.com/cloud">Cloud
        Computing</a> of Rackspace Hosting<span>&reg;</span>
      </div>
  </div><!-- /.site -->
</div><!-- /.lower_footer -->

      </div><!-- /#footer -->

    

<div id="keyboard_shortcuts_pane" class="instapaper_ignore readability-extra" style="display:none">
  <h2>Keyboard Shortcuts <small><a href="#" class="js-see-all-keyboard-shortcuts">(see all)</a></small></h2>

  <div class="columns threecols">
    <div class="column first">
      <h3>Site wide shortcuts</h3>
      <dl class="keyboard-mappings">
        <dt>s</dt>
        <dd>Focus site search</dd>
      </dl>
      <dl class="keyboard-mappings">
        <dt>?</dt>
        <dd>Bring up this help dialog</dd>
      </dl>
    </div><!-- /.column.first -->

    <div class="column middle" style='display:none'>
      <h3>Commit list</h3>
      <dl class="keyboard-mappings">
        <dt>j</dt>
        <dd>Move selection down</dd>
      </dl>
      <dl class="keyboard-mappings">
        <dt>k</dt>
        <dd>Move selection up</dd>
      </dl>
      <dl class="keyboard-mappings">
        <dt>c <em>or</em> o <em>or</em> enter</dt>
        <dd>Open commit</dd>
      </dl>
      <dl class="keyboard-mappings">
        <dt>y</dt>
        <dd>Expand URL to its canonical form</dd>
      </dl>
    </div><!-- /.column.first -->

    <div class="column last js-hidden-pane" style='display:none'>
      <h3>Pull request list</h3>
      <dl class="keyboard-mappings">
        <dt>j</dt>
        <dd>Move selection down</dd>
      </dl>
      <dl class="keyboard-mappings">
        <dt>k</dt>
        <dd>Move selection up</dd>
      </dl>
      <dl class="keyboard-mappings">
        <dt>o <em>or</em> enter</dt>
        <dd>Open issue</dd>
      </dl>
      <dl class="keyboard-mappings">
        <dt><span class="platform-mac">⌘</span><span class="platform-other">ctrl</span> <em>+</em> enter</dt>
        <dd>Submit comment</dd>
      </dl>
    </div><!-- /.columns.last -->

  </div><!-- /.columns.equacols -->

  <div class="js-hidden-pane" style='display:none'>
    <div class="rule"></div>

    <h3>Issues</h3>

    <div class="columns threecols">
      <div class="column first">
        <dl class="keyboard-mappings">
          <dt>j</dt>
          <dd>Move selection down</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>k</dt>
          <dd>Move selection up</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>x</dt>
          <dd>Toggle selection</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>o <em>or</em> enter</dt>
          <dd>Open issue</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt><span class="platform-mac">⌘</span><span class="platform-other">ctrl</span> <em>+</em> enter</dt>
          <dd>Submit comment</dd>
        </dl>
      </div><!-- /.column.first -->
      <div class="column last">
        <dl class="keyboard-mappings">
          <dt>c</dt>
          <dd>Create issue</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>l</dt>
          <dd>Create label</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>i</dt>
          <dd>Back to inbox</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>u</dt>
          <dd>Back to issues</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>/</dt>
          <dd>Focus issues search</dd>
        </dl>
      </div>
    </div>
  </div>

  <div class="js-hidden-pane" style='display:none'>
    <div class="rule"></div>

    <h3>Issues Dashboard</h3>

    <div class="columns threecols">
      <div class="column first">
        <dl class="keyboard-mappings">
          <dt>j</dt>
          <dd>Move selection down</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>k</dt>
          <dd>Move selection up</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>o <em>or</em> enter</dt>
          <dd>Open issue</dd>
        </dl>
      </div><!-- /.column.first -->
    </div>
  </div>

  <div class="js-hidden-pane" style='display:none'>
    <div class="rule"></div>

    <h3>Network Graph</h3>
    <div class="columns equacols">
      <div class="column first">
        <dl class="keyboard-mappings">
          <dt><span class="badmono">←</span> <em>or</em> h</dt>
          <dd>Scroll left</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt><span class="badmono">→</span> <em>or</em> l</dt>
          <dd>Scroll right</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt><span class="badmono">↑</span> <em>or</em> k</dt>
          <dd>Scroll up</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt><span class="badmono">↓</span> <em>or</em> j</dt>
          <dd>Scroll down</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>t</dt>
          <dd>Toggle visibility of head labels</dd>
        </dl>
      </div><!-- /.column.first -->
      <div class="column last">
        <dl class="keyboard-mappings">
          <dt>shift <span class="badmono">←</span> <em>or</em> shift h</dt>
          <dd>Scroll all the way left</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>shift <span class="badmono">→</span> <em>or</em> shift l</dt>
          <dd>Scroll all the way right</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>shift <span class="badmono">↑</span> <em>or</em> shift k</dt>
          <dd>Scroll all the way up</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>shift <span class="badmono">↓</span> <em>or</em> shift j</dt>
          <dd>Scroll all the way down</dd>
        </dl>
      </div><!-- /.column.last -->
    </div>
  </div>

  <div class="js-hidden-pane" >
    <div class="rule"></div>
    <div class="columns threecols">
      <div class="column first js-hidden-pane" >
        <h3>Source Code Browsing</h3>
        <dl class="keyboard-mappings">
          <dt>t</dt>
          <dd>Activates the file finder</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>l</dt>
          <dd>Jump to line</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>w</dt>
          <dd>Switch branch/tag</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>y</dt>
          <dd>Expand URL to its canonical form</dd>
        </dl>
      </div>
    </div>
  </div>

  <div class="js-hidden-pane" style='display:none'>
    <div class="rule"></div>
    <div class="columns threecols">
      <div class="column first">
        <h3>Browsing Commits</h3>
        <dl class="keyboard-mappings">
          <dt><span class="platform-mac">⌘</span><span class="platform-other">ctrl</span> <em>+</em> enter</dt>
          <dd>Submit comment</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>escape</dt>
          <dd>Close form</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>p</dt>
          <dd>Parent commit</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>o</dt>
          <dd>Other parent commit</dd>
        </dl>
      </div>
    </div>
  </div>

  <div class="js-hidden-pane" style='display:none'>
    <div class="rule"></div>
    <h3>Notifications</h3>

    <div class="columns threecols">
      <div class="column first">
        <dl class="keyboard-mappings">
          <dt>j</dt>
          <dd>Move selection down</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>k</dt>
          <dd>Move selection up</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>o <em>or</em> enter</dt>
          <dd>Open notification</dd>
        </dl>
      </div><!-- /.column.first -->

      <div class="column second">
        <dl class="keyboard-mappings">
          <dt>e <em>or</em> shift i <em>or</em> y</dt>
          <dd>Mark as read</dd>
        </dl>
        <dl class="keyboard-mappings">
          <dt>shift m</dt>
          <dd>Mute thread</dd>
        </dl>
      </div><!-- /.column.first -->
    </div>
  </div>

</div>

    <div id="markdown-help" class="instapaper_ignore readability-extra">
  <h2>Markdown Cheat Sheet</h2>

  <div class="cheatsheet-content">

  <div class="mod">
    <div class="col">
      <h3>Format Text</h3>
      <p>Headers</p>
      <pre>
# This is an &lt;h1&gt; tag
## This is an &lt;h2&gt; tag
###### This is an &lt;h6&gt; tag</pre>
     <p>Text styles</p>
     <pre>
*This text will be italic*
_This will also be italic_
**This text will be bold**
__This will also be bold__

*You **can** combine them*
</pre>
    </div>
    <div class="col">
      <h3>Lists</h3>
      <p>Unordered</p>
      <pre>
* Item 1
* Item 2
  * Item 2a
  * Item 2b</pre>
     <p>Ordered</p>
     <pre>
1. Item 1
2. Item 2
3. Item 3
   * Item 3a
   * Item 3b</pre>
    </div>
    <div class="col">
      <h3>Miscellaneous</h3>
      <p>Images</p>
      <pre>
![GitHub Logo](/images/logo.png)
Format: ![Alt Text](url)
</pre>
     <p>Links</p>
     <pre>
http://github.com - automatic!
[GitHub](http://github.com)</pre>
<p>Blockquotes</p>
     <pre>
As Kanye West said:

> We're living the future so
> the present is our past.
</pre>
    </div>
  </div>
  <div class="rule"></div>

  <h3>Code Examples in Markdown</h3>
  <div class="col">
      <p>Syntax highlighting with <a href="http://github.github.com/github-flavored-markdown/" title="GitHub Flavored Markdown" target="_blank">GFM</a></p>
      <pre>
```javascript
function fancyAlert(arg) {
  if(arg) {
    $.facebox({div:'#foo'})
  }
}
```</pre>
    </div>
    <div class="col">
      <p>Or, indent your code 4 spaces</p>
      <pre>
Here is a Python code example
without syntax highlighting:

    def foo:
      if not bar:
        return true</pre>
    </div>
    <div class="col">
      <p>Inline code for comments</p>
      <pre>
I think you should use an
`&lt;addr&gt;` element here instead.</pre>
    </div>
  </div>

  </div>
</div>


    <div id="ajax-error-message">
      <span class="mini-icon mini-icon-exclamation"></span>
      Something went wrong with that request. Please try again.
      <a href="#" class="ajax-error-dismiss">Dismiss</a>
    </div>

    <div id="logo-popup">
      <h2>Looking for the GitHub logo?</h2>
      <ul>
        <li>
          <h4>GitHub Logo</h4>
          <a href="http://github-media-downloads.s3.amazonaws.com/GitHub_Logos.zip"><img alt="Github_logo" src="https://a248.e.akamai.net/assets.github.com/images/modules/about_page/github_logo.png?1306884371" /></a>
          <a href="http://github-media-downloads.s3.amazonaws.com/GitHub_Logos.zip" class="minibutton btn-download download">Download</a>
        </li>
        <li>
          <h4>The Octocat</h4>
          <a href="http://github-media-downloads.s3.amazonaws.com/Octocats.zip"><img alt="Octocat" src="https://a248.e.akamai.net/assets.github.com/images/modules/about_page/octocat.png?1306884371" /></a>
          <a href="http://github-media-downloads.s3.amazonaws.com/Octocats.zip" class="minibutton btn-download download">Download</a>
        </li>
      </ul>
    </div>

    
    <span id='server_response_time' data-time='0.11796' data-host='fe6'></span>
  </body>
</html>

